Citrus Sinensis ID: 019241
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 344 | 2.2.26 [Sep-21-2011] | |||||||
| Q08467 | 409 | Casein kinase II subunit | yes | no | 0.822 | 0.691 | 0.820 | 1e-131 | |
| Q08466 | 403 | Casein kinase II subunit | no | no | 0.834 | 0.712 | 0.82 | 1e-130 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.706 | 0.731 | 0.971 | 1e-128 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.706 | 0.729 | 0.946 | 1e-126 | |
| O64816 | 432 | Casein kinase II subunit | no | no | 0.709 | 0.564 | 0.897 | 1e-120 | |
| P40231 | 332 | Casein kinase II subunit | yes | no | 0.712 | 0.737 | 0.751 | 1e-109 | |
| P19139 | 391 | Casein kinase II subunit | yes | no | 0.729 | 0.641 | 0.780 | 1e-106 | |
| Q60737 | 391 | Casein kinase II subunit | yes | no | 0.729 | 0.641 | 0.780 | 1e-106 | |
| P68400 | 391 | Casein kinase II subunit | yes | no | 0.729 | 0.641 | 0.780 | 1e-106 | |
| P21868 | 391 | Casein kinase II subunit | yes | no | 0.729 | 0.641 | 0.780 | 1e-106 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 466 bits (1200), Expect = e-131, Method: Compositional matrix adjust.
Identities = 247/301 (82%), Positives = 263/301 (87%), Gaps = 18/301 (5%)
Query: 41 PIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIID-----KIEERNLAEIPLPAMS 95
P AH PILR+ +I+T T A + V ID +I + N AMS
Sbjct: 32 PTAHSPILRS---------SIVTPTARAVSEVSGCTTIDPDFLVEISDSNQTR----AMS 78
Query: 96 KARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCII 155
KARVYT+VNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGINVN+ E+CII
Sbjct: 79 KARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRGKYSEVFEGINVNSKEKCII 138
Query: 156 KILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
KILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPT
Sbjct: 139 KILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPT 198
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
LTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE
Sbjct: 199 LTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 258
Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAK
Sbjct: 259 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAK 318
Query: 336 V 336
V
Sbjct: 319 V 319
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-130, Method: Compositional matrix adjust.
Identities = 246/300 (82%), Positives = 264/300 (88%), Gaps = 13/300 (4%)
Query: 39 RAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNLAEIPLPA-MSK 96
RAP+AH I C + T T+ + G D+ ++ +LA+I L MSK
Sbjct: 25 RAPLAHSLIPPLTC--------VNTGTVESDVT---GIRFDRCLDTDSLAKISLSTVMSK 73
Query: 97 ARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK 156
ARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+CIIK
Sbjct: 74 ARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIK 133
Query: 157 ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
ILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTL
Sbjct: 134 ILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTL 193
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
TDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY
Sbjct: 194 TDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 253
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKV
Sbjct: 254 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKV 313
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 236/243 (97%), Positives = 241/243 (99%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1 MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
IIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 230/243 (94%), Positives = 238/243 (97%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct: 1 MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
+IKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct: 61 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1112), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/244 (89%), Positives = 234/244 (95%)
Query: 93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+ NE+
Sbjct: 98 APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157
Query: 153 CIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
C+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct: 158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217
Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277
Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct: 278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337
Query: 333 IAKV 336
IAKV
Sbjct: 338 IAKV 341
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P40231|CSK2A_SCHPO Casein kinase II subunit alpha OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cka1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 395 bits (1016), Expect = e-109, Method: Compositional matrix adjust.
Identities = 184/245 (75%), Positives = 213/245 (86%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P +S +RVY VN P+EYWDYE++ +G QD+YE++RKVGRGKYSEVFEG+NV N
Sbjct: 8 PVVSVSRVYAHVNEEMPREYWDYENMQEVFGYQDNYEIIRKVGRGKYSEVFEGLNVLNNS 67
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+CIIK+LKPVK KKIKREIKILQNL GGPN++ LLDIVRD SKTPSLIFE+V++ DF+
Sbjct: 68 KCIIKVLKPVKYKKIKREIKILQNLAGGPNIISLLDIVRDPESKTPSLIFEFVDNIDFRT 127
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LYPTL+DYDIRYY YELLKALD+CHS+GIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYH
Sbjct: 128 LYPTLSDYDIRYYSYELLKALDFCHSRGIMHRDVKPHNVMIDHKKRKLRLIDWGLAEFYH 187
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
G EYNVRVASRYFKGPELLVD ++YDYSLD+WS G MFA +IF+K+ FF G DN+DQLV
Sbjct: 188 AGMEYNVRVASRYFKGPELLVDFREYDYSLDIWSFGVMFAALIFKKDTFFRGRDNYDQLV 247
Query: 332 KIAKV 336
KIAKV
Sbjct: 248 KIAKV 252
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Plays a role in the translation of cell polarity into polarized growth. The alpha and alpha' chains contain the catalytic site. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 385 bits (989), Expect = e-106, Method: Compositional matrix adjust.
Identities = 196/251 (78%), Positives = 223/251 (88%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVTTILDF 342
+IAKV D
Sbjct: 244 RIAKVLGTEDL 254
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 385 bits (989), Expect = e-106, Method: Compositional matrix adjust.
Identities = 196/251 (78%), Positives = 223/251 (88%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVTTILDF 342
+IAKV D
Sbjct: 244 RIAKVLGTEDL 254
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (987), Expect = e-106, Method: Compositional matrix adjust.
Identities = 196/251 (78%), Positives = 223/251 (88%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVTTILDF 342
+IAKV D
Sbjct: 244 RIAKVLGTEDL 254
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (987), Expect = e-106, Method: Compositional matrix adjust.
Identities = 196/251 (78%), Positives = 223/251 (88%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVTTILDF 342
+IAKV D
Sbjct: 244 RIAKVLGTEDL 254
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 344 | ||||||
| 224074233 | 333 | predicted protein [Populus trichocarpa] | 0.706 | 0.729 | 0.991 | 1e-141 | |
| 224081839 | 333 | predicted protein [Populus trichocarpa] | 0.706 | 0.729 | 0.987 | 1e-141 | |
| 356541665 | 333 | PREDICTED: casein kinase II subunit alph | 0.706 | 0.729 | 0.983 | 1e-141 | |
| 147815306 | 333 | hypothetical protein VITISV_028706 [Viti | 0.706 | 0.729 | 0.987 | 1e-140 | |
| 388511795 | 333 | unknown [Lotus japonicus] | 0.706 | 0.729 | 0.983 | 1e-139 | |
| 356511951 | 411 | PREDICTED: casein kinase II subunit alph | 0.875 | 0.732 | 0.846 | 1e-139 | |
| 363814459 | 398 | uncharacterized protein LOC100820471 pre | 0.883 | 0.763 | 0.812 | 1e-138 | |
| 357476359 | 388 | Casein kinase 2 alpha subunit [Medicago | 0.843 | 0.747 | 0.816 | 1e-136 | |
| 391605 | 333 | casein kinase II catalytic subunit [Arab | 0.706 | 0.729 | 0.942 | 1e-136 | |
| 297816254 | 405 | hypothetical protein ARALYDRAFT_485358 [ | 0.866 | 0.735 | 0.815 | 1e-135 |
| >gi|224074233|ref|XP_002304312.1| predicted protein [Populus trichocarpa] gi|222841744|gb|EEE79291.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1309), Expect = e-141, Method: Compositional matrix adjust.
Identities = 241/243 (99%), Positives = 243/243 (100%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
+IKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61 VIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081839|ref|XP_002306500.1| predicted protein [Populus trichocarpa] gi|222855949|gb|EEE93496.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 507 bits (1305), Expect = e-141, Method: Compositional matrix adjust.
Identities = 240/243 (98%), Positives = 242/243 (99%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTDVNVLRPKEYWDYESL VQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1 MSKARVYTDVNVLRPKEYWDYESLAVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK+
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKV 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541665|ref|XP_003539294.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1303), Expect = e-141, Method: Compositional matrix adjust.
Identities = 239/243 (98%), Positives = 243/243 (100%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTDVNVLRPKEYWDYESLT+QWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1 MSKARVYTDVNVLRPKEYWDYESLTLQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
IIKILKPVKKKKIKREIKILQN+CGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNICGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815306|emb|CAN72246.1| hypothetical protein VITISV_028706 [Vitis vinifera] gi|296087344|emb|CBI33718.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1300), Expect = e-140, Method: Compositional matrix adjust.
Identities = 240/243 (98%), Positives = 242/243 (99%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVY DVNVLRPK+YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1 MSKARVYADVNVLRPKDYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388511795|gb|AFK43959.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1291), Expect = e-139, Method: Compositional matrix adjust.
Identities = 239/243 (98%), Positives = 242/243 (99%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTD+NVLRPKEYWDYESLTVQ GDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1 MSKARVYTDINVLRPKEYWDYESLTVQCGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
IIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511951|ref|XP_003524685.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1286), Expect = e-139, Method: Compositional matrix adjust.
Identities = 265/313 (84%), Positives = 279/313 (89%), Gaps = 12/313 (3%)
Query: 24 VLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEE 83
L LRFLL C ++ALRAP+A PI+R P N +T+T TV+ I+ +
Sbjct: 21 ALLLRFLLVCTLVALRAPVAQPPIVRIPP-------NHLTET--TNTVI---TIVHQRHR 68
Query: 84 RNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE 143
++ PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE
Sbjct: 69 TQISGSTRPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE 128
Query: 144 GINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
GINVN+NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEY
Sbjct: 129 GINVNSNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEY 188
Query: 204 VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263
VNSTDFKVLYPTLTDYDIRYYIYELLKA+DYCHSQGIMHRDVKPHNVMIDHELRKLRLID
Sbjct: 189 VNSTDFKVLYPTLTDYDIRYYIYELLKAIDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 248
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG
Sbjct: 249 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 308
Query: 324 HDNHDQLVKIAKV 336
HDNHDQLVKIAKV
Sbjct: 309 HDNHDQLVKIAKV 321
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363814459|ref|NP_001242864.1| uncharacterized protein LOC100820471 precursor [Glycine max] gi|255638871|gb|ACU19738.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1277), Expect = e-138, Method: Compositional matrix adjust.
Identities = 264/325 (81%), Positives = 278/325 (85%), Gaps = 21/325 (6%)
Query: 12 HKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTV 71
H+ PA L LRFLL C ++ALRAP+A PILR P N + +T T+
Sbjct: 5 HEAPAALL-------LRFLLVCTIVALRAPVAQPPILRIP--------NHLIETTNTFTI 49
Query: 72 VYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 131
V++ ++ AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR
Sbjct: 50 VHQRY------RTQISGSNRRAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 103
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD 191
KVGRGKYSEVFEGINVN+NERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRD
Sbjct: 104 KVGRGKYSEVFEGINVNSNERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 163
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ IMHRDVKPHNVM
Sbjct: 164 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQSIMHRDVKPHNVM 223
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY KGPELLVDLQDYDYSLDMWSLGCMFA
Sbjct: 224 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYIKGPELLVDLQDYDYSLDMWSLGCMFA 283
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKV 336
GMIFRKEPFFYGHDNHDQLVKIAKV
Sbjct: 284 GMIFRKEPFFYGHDNHDQLVKIAKV 308
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357476359|ref|XP_003608465.1| Casein kinase 2 alpha subunit [Medicago truncatula] gi|355509520|gb|AES90662.1| Casein kinase 2 alpha subunit [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 492 bits (1266), Expect = e-136, Method: Compositional matrix adjust.
Identities = 258/316 (81%), Positives = 272/316 (86%), Gaps = 26/316 (8%)
Query: 23 QVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLN--IITDTIAATTVVYEGAIIDK 80
Q LR LL C +++LRAP+A P +R P +S+ N II I++T
Sbjct: 7 QAPQLRLLLVCTLISLRAPVAQPPNVRIPTQSNESNTTTTIIVSQISST----------- 55
Query: 81 IEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSE 140
MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSE
Sbjct: 56 -------------MSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSE 102
Query: 141 VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200
VFEGINVN++ERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLI
Sbjct: 103 VFEGINVNSSERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 162
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260
FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR
Sbjct: 163 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 222
Query: 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF
Sbjct: 223 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 282
Query: 321 FYGHDNHDQLVKIAKV 336
FYGHDNHDQLVKIAKV
Sbjct: 283 FYGHDNHDQLVKIAKV 298
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|391605|dbj|BAA01091.1| casein kinase II catalytic subunit [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 491 bits (1263), Expect = e-136, Method: Compositional matrix adjust.
Identities = 229/243 (94%), Positives = 239/243 (98%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+C
Sbjct: 1 MSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKC 60
Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
IIKILKPVKKK+I+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61 IIKILKPVKKKEIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHGLRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297816254|ref|XP_002876010.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata] gi|297321848|gb|EFH52269.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1251), Expect = e-135, Method: Compositional matrix adjust.
Identities = 256/314 (81%), Positives = 275/314 (87%), Gaps = 16/314 (5%)
Query: 28 RFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNL 86
RFLL CA+L LRAP AH PI C + T T+ + G ++ ++ +L
Sbjct: 13 RFLLLCAILILRAPTAHSPIPPLTC--------VATGTVESDV---SGISFNRCLDSDSL 61
Query: 87 AEIPLP----AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
AEI L AMSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVF
Sbjct: 62 AEISLSSVTGAMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVF 121
Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
EGIN+N+NE+CIIKILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFE
Sbjct: 122 EGINMNSNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFE 181
Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
YVNSTDFKVLYPTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 182 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLI 241
Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 242 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 301
Query: 323 GHDNHDQLVKIAKV 336
GHDN DQLVKIAKV
Sbjct: 302 GHDNQDQLVKIAKV 315
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 344 | ||||||
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.706 | 0.729 | 0.893 | 2.3e-119 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.720 | 0.744 | 0.86 | 6.2e-117 | |
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.709 | 0.564 | 0.823 | 1.4e-110 | |
| UNIPROTKB|P21868 | 391 | CSNK2A1 "Casein kinase II subu | 0.712 | 0.626 | 0.726 | 1e-98 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.712 | 0.626 | 0.726 | 1e-98 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.712 | 0.626 | 0.726 | 1e-98 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.712 | 0.636 | 0.726 | 1e-98 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.712 | 0.626 | 0.726 | 1e-98 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.712 | 0.626 | 0.726 | 1e-98 | |
| MGI|MGI:88543 | 391 | Csnk2a1 "casein kinase 2, alph | 0.712 | 0.626 | 0.726 | 1e-98 |
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 1175 (418.7 bits), Expect = 2.3e-119, P = 2.3e-119
Identities = 217/243 (89%), Positives = 222/243 (91%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1 MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV 336
AKV
Sbjct: 241 AKV 243
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
Identities = 215/250 (86%), Positives = 222/250 (88%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct: 1 MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
LQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct: 61 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKV--TTILD 341
AKV T LD
Sbjct: 241 AKVLGTNELD 250
|
|
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 1.4e-110, P = 1.4e-110
Identities = 201/244 (82%), Positives = 215/244 (88%)
Query: 93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+ NE+
Sbjct: 98 APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157
Query: 153 CXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
C LQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct: 158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217
Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277
Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct: 278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337
Query: 333 IAKV 336
IAKV
Sbjct: 338 IAKV 341
|
|
| UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
| MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 178/245 (72%), Positives = 203/245 (82%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ L+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKV 336
+IAKV
Sbjct: 244 RIAKV 248
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6625 | 0.7034 | 0.7138 | yes | no |
| O64817 | CSK23_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9465 | 0.7063 | 0.7297 | no | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7808 | 0.7296 | 0.6419 | yes | no |
| Q8TG13 | CSK2A_NEUCR | 2, ., 7, ., 1, 1, ., 1 | 0.7875 | 0.6976 | 0.7142 | N/A | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7808 | 0.7296 | 0.6419 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.9711 | 0.7063 | 0.7319 | N/A | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7530 | 0.7122 | 0.6805 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7933 | 0.7034 | 0.7202 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7808 | 0.7296 | 0.6419 | yes | no |
| O76484 | CSK2A_SPOFR | 2, ., 7, ., 1, 1, ., 1 | 0.7851 | 0.7034 | 0.6855 | N/A | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.7346 | 0.7122 | 0.7040 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7808 | 0.7296 | 0.6419 | yes | no |
| Q8SRU0 | CSK2A_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.5375 | 0.6889 | 0.7429 | yes | no |
| Q4U925 | CSK2A_THEAN | 2, ., 7, ., 1, 1, ., 1 | 0.7346 | 0.7122 | 0.7040 | yes | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7510 | 0.7122 | 0.7379 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.75 | 0.7209 | 0.7359 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7768 | 0.7296 | 0.6419 | yes | no |
| P28020 | CSK21_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7768 | 0.7296 | 0.6403 | N/A | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7808 | 0.7296 | 0.6419 | yes | no |
| Q08467 | CSK21_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8205 | 0.8226 | 0.6919 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 344 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-61 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-60 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-50 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-48 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-47 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-43 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-37 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-36 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-35 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-35 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-34 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-34 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-33 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-33 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-33 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-32 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-32 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-31 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-31 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-31 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-29 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-29 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-29 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-28 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-28 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-28 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-26 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-26 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-26 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-26 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-25 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-09 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 3e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.002 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.002 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.003 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.004 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 5e-61
Identities = 69/227 (30%), Positives = 117/227 (51%), Gaps = 15/227 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----REIKILQNLCGGPN 181
YE++RK+G G + V++ + T + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQ 238
+V+L+D D L+ EY D L++ + + ++L+ L+Y HS
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
GI+HRD+KP N+++D +++ D+GLA+ V + ++ PE+L+ Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-TTILDFS 343
+D+WSLG + ++ K P F G + DQL I ++ L+F
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-FSGENILDQLQLIRRILGPPLEFD 222
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 3e-60
Identities = 75/216 (34%), Positives = 124/216 (57%), Gaps = 13/216 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNV 182
YE++ K+G G + +V+ + T + IK++K K KK I REIKIL+ L PN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQG 239
V+L D+ D+ L+ EY D F +L L++ + R+Y+ ++L AL+Y HS+G
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
I+HRD+KP N+++D + ++L D+GLA PG++ V + + PE+L+ + Y
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175
Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
++D+WSLG + ++ K P F G D +L K
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKKIG 210
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-50
Identities = 78/220 (35%), Positives = 126/220 (57%), Gaps = 16/220 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQNLCGGPN 181
YE + K+G G Y V++ + T E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
+VKLLD++ + L+FEY + D K L+ I+ +Y+LL+ L YCHS
Sbjct: 60 IVKLLDVIH--TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
I+HRD+KP N++I+ + L+L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 117 HRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y ++D+WS+GC+FA MI +P F G DQL KI ++
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 6e-48
Identities = 76/221 (34%), Positives = 124/221 (56%), Gaps = 15/221 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPN 181
YE + ++G G Y +V++ N T E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
+V+L +IV + + ++FEY+ D L T+ I+ Y+ +LL+ L Y HS
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVDLQ 295
GI+HRD+K N++I+++ L+L D+GLA Y +Y RV + +++ PELL+
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y +DMWS+GC+ A + F +P F G +QL KI ++
Sbjct: 178 RYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 81/220 (36%), Positives = 130/220 (59%), Gaps = 16/220 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
Y+ + K+G G Y V++ + T E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
++KLLD+ R + L+FE++++ +K++ L + I+ Y+Y+LL+ L +CHS
Sbjct: 60 IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
GI+HRD+KP N++I+ E L+L D+GLA F P + Y V +R+++ PELL+ +
Sbjct: 117 HGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y +D+WS+GC+FA ++ R+ P F G DQL KI +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRT 214
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 80/220 (36%), Positives = 115/220 (52%), Gaps = 15/220 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
YEV+ VG G Y V + N T E IK K KK RE+K+L+ L N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHSQ 238
+V L + R L+FEYV T ++L P D +R YI++LL+A+ YCHS
Sbjct: 62 IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 296
I+HRD+KP N+++ L+L D+G A P VA+R+++ PELLV +
Sbjct: 120 NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y +D+W++GC+ A ++ EP F G + DQL I K
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKC 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-45
Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 12/190 (6%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
+G G + V+ + T ++ IKI+K + REI+IL+ L PN+VKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
D+ L+ EY K L L++ +I + ++L+ L+Y HS GI+HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
+KP N+++D + K++L D+GL++ V + + PE+L+ Y D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 304 WSLGCMFAGM 313
WSLG + +
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-43
Identities = 74/222 (33%), Positives = 122/222 (54%), Gaps = 17/222 (7%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCGGP 180
Y+++ ++G G + VF+ + T E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCH 236
VVKLLD+ H L+ EY+ S +VL P L + ++ Y+ LLK + Y H
Sbjct: 60 YVVKLLDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
+ GIMHRD+KP N++I L++ D+GLA + + Y+ +VA+R+++ PELL
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ YD +D+W++GC+FA ++ P F G ++ +QL + +
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRT 216
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 79/228 (34%), Positives = 129/228 (56%), Gaps = 25/228 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 181
YE+++ +G G Y V ++ T + IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTLTDYDIRYYIYELLKALDYC 235
++ LLDI+R + + ++ E + TD KV+ LTD I+Y++Y++L+ L Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGP 288
HS ++HRD+KP N++++ L++ D+GLA + G EY V +R+++ P
Sbjct: 120 HSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWYRAP 175
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
ELL+ Y ++D+WS+GC+FA ++ RK P F G D DQL I +V
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEV 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 80/220 (36%), Positives = 127/220 (57%), Gaps = 19/220 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
YE +K+G G Y+ V++ + T IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDY 234
PN++ LLD+ H +L+FE++ TD + + LT DI+ Y+ L+ L+Y
Sbjct: 61 HPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 293
HS I+HRD+KP+N++I + L+L D+GLA + P ++ +V +R+++ PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ Y +DMWS+GC+FA ++ R PF G + DQL KI
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-39
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGPNV 182
+E++ K+G+G + EV++ + T + IK++K K+K I EI+IL+ C PN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 183 VKLLDIVRDQHSKTPSLIFEYVN----STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
VK ++ E+ + K TLT+ I Y ELLK L+Y HS
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
GI+HRD+K N+++ + +++LID+GL+ K N V + Y+ PE++ + YD
Sbjct: 118 GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 299 YSLDMWSLGCMFAGMIFRKEPFFY 322
Y D+WSLG + K P+
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 77/234 (32%), Positives = 126/234 (53%), Gaps = 31/234 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------REIKIL 173
D YE + K+G G Y +V++ + NT + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 174 QNLCGGPNVVKLLDIVR-DQHSKTPSL--IFEYVNSTDFKVLYPT--------LTDYDIR 222
Q L +V+LLD+ ++ + PSL +FEY+ +D K + L I+
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 281
++Y+LLK + +CH G+MHRD+KP N+++D + L++ D GL F P K Y +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ +++ PE+L+ Y +D+WS+GC+FA M RK+P F G QL+ I K
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFK 226
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 81/231 (35%), Positives = 126/231 (54%), Gaps = 30/231 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI-------------KREIKIL 173
YE+++K+G+G Y V++ I+ T E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKAL 232
Q L PN+VKLL++++ ++ K L+FEY+ + V+ L D RY +Y+LLKAL
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------VASRYFK 286
Y HS ++HRD+KP N++++ + R ++L D+GLA +E VA+R+++
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
PE+L+ Y +DMWS+GC+ M+ K P F G +QL KI +V
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVI 229
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 70/226 (30%), Positives = 113/226 (50%), Gaps = 28/226 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
Y+V++++G G + V+ N T E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD--------IRYYIYELLK 230
PN+VKL ++ R+ + +FEY+ LY + D IR IY++L+
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGN----LYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
L + H G HRD+KP N+++ +++ D+GLA Y V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
L+ Y +D+W+LGC+ A + + P F G DQL KI V
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSV 214
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 79/229 (34%), Positives = 124/229 (54%), Gaps = 33/229 (14%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
Y+ V K+G G Y V++ + T E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYEL 228
+ L PN+V+LLD+V ++ L+FE+++ D K L I+ Y+Y+L
Sbjct: 53 KEL-NHPNIVRLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 287
L+ + YCHS ++HRD+KP N++ID E L+L D+GLA F P + Y V + +++
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
PE+L+ + Y +D+WS+GC+FA M+ R+ P F G DQL +I +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRT 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (334), Expect = 8e-36
Identities = 67/234 (28%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGG 179
Y ++RK+G G + EV+ + + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
PN+VKL D Q + L+ EYV+ + L L++ + + + ++L AL+
Sbjct: 58 PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 286
Y HS+GI+HRD+KP N+++D + R ++LID+GLA+ + V + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 287 GPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVKIAKV 336
PE+L+ L S D+WSLG ++ PF Q +KI
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
|
Length = 384 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 80/225 (35%), Positives = 129/225 (57%), Gaps = 20/225 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
D YE V K+G G Y V++ + TNE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 179 GPNVVKLLDIVRDQHS-KTPSLIFEYVNSTDFKVLYPTLTDYD-----IRYYIYELLKAL 232
G N+V+L D+V HS K L+FEY++ D K + D+ I+ Y+Y++L+ +
Sbjct: 61 G-NIVRLQDVV---HSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
YCHS ++HRD+KP N++ID L+L D+GLA F P + + V + +++ PE+L
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ + Y +D+WS+GC+FA M+ +K P F G D+L KI ++
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRI 219
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 74/223 (33%), Positives = 122/223 (54%), Gaps = 21/223 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCG 178
YE + K+G G Y VF+ N T+E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDY 234
N+V+L D++ T L+FEY + D K + + ++ ++++LLK L +
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 293
CHS ++HRD+KP N++I+ +L+L D+GLA + P + Y+ V + +++ P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ Y S+DMWS GC+FA + P F G+D DQL +I ++
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 73/226 (32%), Positives = 126/226 (55%), Gaps = 18/226 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTN--ERCIIKILKPVKKKKIK-----REIKILQNLCGG 179
YE+++++G+G Y V N T+ E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 180 PNVVKL--LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYC 235
N+ L +DIV + L E + + +++ LTD + +IY++L L Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPEL 290
HS ++HRD+KP N++++ + +L++ D+GLA + N VA+R+++ PE+
Sbjct: 122 HSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
++ Q Y ++D+WS+GC+ A ++ RK P F G D DQL +I +V
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 76/219 (34%), Positives = 121/219 (55%), Gaps = 16/219 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
YE + VG G Y V + + T + IK K VKK + REI++L+ L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHS 237
N+V L+++ R + K L+FE+V+ T L YP D +R Y++++L+ +++CHS
Sbjct: 61 NLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 296
I+HRD+KP N+++ ++L D+G A PG+ Y VA+R+++ PELLV
Sbjct: 119 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
Y ++D+W++GC+ M EP F G + DQL I K
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 74/238 (31%), Positives = 123/238 (51%), Gaps = 43/238 (18%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
YE + ++G G Y V++ ++NT + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 174 QNL--CGGPNVVKLLDI---VRDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYY 224
+ L PN+V+LLD+ R +L+FE+V+ + K P L I+
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----V 280
+ +LL+ +D+ HS I+HRD+KP N+++ + + +++ D+GLA Y + + V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167
Query: 281 ASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
+ +++ PE+L LQ Y +DMWS+GC+FA + FR+ P F G DQL KI V
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVI 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 79/223 (35%), Positives = 128/223 (57%), Gaps = 20/223 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLC 177
+ YE + K+G G Y VF+ N T + I+ I K PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDPVIKKIALREIRMLKQL- 57
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKALDY 234
PN+V L+++ R + L+FEY + T L P + ++ I+ I++ L+A+++
Sbjct: 58 KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV- 292
CH +HRDVKP N++I + +++L D+G A PG +Y VA+R+++ PELLV
Sbjct: 116 CHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
D Q Y +D+W++GC+FA ++ +P + G + DQL I K
Sbjct: 175 DTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 67/222 (30%), Positives = 126/222 (56%), Gaps = 20/222 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
Y+++ K+G G +SEV + + T + IK +K K K REI+ L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSP 56
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDY 234
PN+++L++++ D+ + +L+FE ++ ++++ P L + ++ Y+Y+LLK+LD+
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
H GI HRD+KP N++I ++ L+L D+G + Y +++R+++ PE L+
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y +D+W++GC+F ++ P F G + DQ+ KI V
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDV 214
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 75/238 (31%), Positives = 125/238 (52%), Gaps = 29/238 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCG 178
DYE++ K+G G + EV++ + T +K IL +K REIKIL+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 179 GPNVVKLLDIV---RDQHSKTPS---LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELL 229
PNVV L+D+ D+ + ++ Y++ +L LT+ I+ Y+ +LL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--------HPG----KEYN 277
+ ++Y H I+HRD+K N++ID++ L++ D+GLA Y G ++Y
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
V +R+++ PELL+ + Y ++D+W +GC+FA M R+ P G + DQL I K
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFK 241
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 16/226 (7%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKK---IKREIKILQNLCGGP 180
++ +GRG + V+ ++ +T E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
N+V+ RD+ T ++ EYV+ + + L + IR Y ++L+ L Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 294
GI+HRD+K N+++D + ++L D+G A G+ + Y+ PE++
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVTTI 339
++Y + D+WSLGC M K P + N + KI
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP-WSELGNPMAALYKIGSSGEP 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 68/236 (28%), Positives = 132/236 (55%), Gaps = 23/236 (9%)
Query: 121 WGDQ--DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKIL 173
WG + D ++++ ++G G Y +V++ + +T E +K ++ +K+ REIKIL
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTP--------SLIFEYVNSTDFKVLYPTLTDYD---IR 222
+ L N+V L +IV D+ L+FEY++ +L L + I+
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRV 280
++ +LL+ L+YCH + +HRD+K N++++++ +++L D+GLA Y+ + Y +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKV 178
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ +++ PELL+ + Y ++D+WS GC+ G +F K+P F + QL I+++
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 70/235 (29%), Positives = 125/235 (53%), Gaps = 31/235 (13%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQN 175
W D Y+ + VG G Y +V + T + IK L + K+ RE+++L++
Sbjct: 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIR 222
+ NV+ LLD+ TP+ E + D ++ L+D I+
Sbjct: 71 MDH-ENVIGLLDVF------TPASSLE--DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
+ +Y++L+ L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E VA+
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVAT 178
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
R+++ PE++++ Y+ ++D+WS+GC+ A ++ K F G D+ DQL +I +
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLV 232
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 70/223 (31%), Positives = 124/223 (55%), Gaps = 23/223 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGG 179
Y+ + +G G Y V I+ + ++ IK + P K+ RE+KIL++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63
Query: 180 PNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYC 235
N++ + DI+R K ++ + + S +++ LT+ IRY++Y+LL+ L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 287
HS ++HRD+KP N++++ + +LR+ D+G+A H EY VA+R+++
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PELL+ L +Y ++DMWS+GC+FA M+ R++ F G + QL
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-32
Identities = 72/221 (32%), Positives = 124/221 (56%), Gaps = 17/221 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
++ V K+G G Y V++ N T E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCH 236
N+VKLLD++ + L+FE+++ K + + + I+ Y+++LL+ L +CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
S ++HRD+KP N++I+ ++L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y ++D+WSLGC+FA M+ R+ F G DQL +I +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRT 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 69/228 (30%), Positives = 111/228 (48%), Gaps = 38/228 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
DD++ + +G G +S V TN+ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 179 GPNVVKLLDIVRDQHSKTPSLIF--EYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
P ++KL +D+ + L F EY + + Y +L + R+Y E+L AL+
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------------EYNV 278
Y HS+GI+HRD+KP N+++D ++ +++ D+G A+ P
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 279 RVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
R F G PELL + + S D+W+LGC+ M+ K PF
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 76/231 (32%), Positives = 126/231 (54%), Gaps = 34/231 (14%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKI 172
DY + K+G G Y V++G N T + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIY 226
L+ L PN+V L D++ Q S+ LIFE++ S D K +L ++ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 285
++L+ + +CHS+ ++HRD+KP N++ID++ ++L D+GLA F P + Y V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ PE+L+ Y +D+WS+G +FA M +K P F+G DQL +I ++
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 77/234 (32%), Positives = 128/234 (54%), Gaps = 32/234 (13%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------R 168
+G + Y+ + K+G G Y+ V++G + T + V K+I+ R
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIR 52
Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTD-YDIRYY 224
E +L++L N+V L DI+ + KT +L+FEY++ TD K +++R +
Sbjct: 53 EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
+++LL+ L YCH + ++HRD+KP N++I E +L+L D+GLA P K Y+ V +
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQLVKIAKV 336
+++ P++L+ +Y SLDMW +GC+F M P F G D DQL KI +V
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRV 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 70/224 (31%), Positives = 123/224 (54%), Gaps = 23/224 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQNLCGG 179
++ + K+G G Y+ V++G N T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY------DIRYYIYELLKALD 233
N+V+L D++ ++ L+FEY++ D K T ++ + Y+LLK +
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
+CH ++HRD+KP N++I+ L+L D+GLA F P ++ V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ Y S+D+WS+GC+ A MI + P F G +N DQL+KI ++
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRI 216
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 68/227 (29%), Positives = 126/227 (55%), Gaps = 21/227 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----KIKREIKILQNLCGGP 180
Y+ + +G G Y V + T + IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 236
N++ +LDI+R ++ + ++ E + + +K++ L++ I+Y++Y++L+ L Y H
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 289
S ++HRD+KP N++++ L++ D+GLA E H G EY VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
++++ + Y ++D+WS+GC+ A M+ + P F G D QL I V
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGV 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 77/245 (31%), Positives = 135/245 (55%), Gaps = 31/245 (12%)
Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KK 165
Y+ E W D Y +++VG G Y V ++ T + IK L +P + K+
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------- 214
RE+++L+++ NV+ LLD+ TP L + + DF ++ P
Sbjct: 61 AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111
Query: 215 --TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
L++ I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ + +L+++D+GLA
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QT 168
Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
E V +R+++ PE++++ Y ++D+WS+GC+ A M+ K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227
Query: 333 IAKVT 337
I KVT
Sbjct: 228 IMKVT 232
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 73/226 (32%), Positives = 129/226 (57%), Gaps = 14/226 (6%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQN 175
W + Y +++VG G Y V I+ T E+ IK L +P + K+ RE+ +L++
Sbjct: 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 176 LCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
+ NV+ LLD+ S + L+ Y+ + K++ L++ ++Y +Y++L
Sbjct: 71 M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
L Y HS GI+HRD+KP N+ ++ + +L+++D+GLA H E V +R+++ PE++
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
++ Y+ ++D+WS+GC+ A M+ K F G D DQL +I KVT
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVT 231
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 73/221 (33%), Positives = 122/221 (55%), Gaps = 14/221 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IK--REIKILQNLCGG 179
D+YE + ++ G Y V+ + T E +K LK K+K+ I REI IL L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYC 235
PN+V + ++V + ++ EYV D K L T+ +++ + +LL + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
H I+HRD+K N+++++ L++ D+GLA E+ P K Y V + +++ PELL+
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
++Y ++DMWS+GC+FA ++ K+P F G DQL KI K
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFK 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-29
Identities = 78/222 (35%), Positives = 118/222 (53%), Gaps = 16/222 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
+ +EV+ VG G Y V + + T E IK K + K+ RE+K+L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCH 236
N+V+L + R + L+FEYV ++L P + +R YIY+L+KA+ +CH
Sbjct: 60 ENIVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
I+HRD+KP N++I H L+L D+G A G Y VA+R+++ PELL+
Sbjct: 118 KNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y ++DMWS+GC+ G + +P F G DQL I KV
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKV 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 74/227 (32%), Positives = 125/227 (55%), Gaps = 22/227 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
YE V ++G G Y +VF+ ++ R + LK V+ + + RE+ +L++L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 179 --GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELL 229
PNVV+L D+ R +L+FE+V+ T + KV P + I+ +++LL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+L+ Y +D+WS+GC+FA M FR++P F G + DQL KI V
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 70/225 (31%), Positives = 128/225 (56%), Gaps = 14/225 (6%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
+G Y + K+G G Y+ V++GI+ + +K++ ++ + RE +L+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNS--TDFKVLYPT-LTDYDIRYYIYELLKALD 233
N+V L DI+ + + T +FEY+++ + + +P L Y++R ++++LL+ L
Sbjct: 61 -KHANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
Y H Q I+HRD+KP N++I + L +L+L D+GLA P + Y+ V + +++ P++L+
Sbjct: 118 YIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKV 336
DY +LD+W GC+F M + +P F G + +QL KI V
Sbjct: 177 GATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 75/228 (32%), Positives = 129/228 (56%), Gaps = 28/228 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 181
Y ++ +GRG Y V N TNE+ IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
V+ + DI+ H + + +++E ++ TD + TL+D +Y++Y+LL+ L Y
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYNVRVASRYFKGP 288
HS ++HRD+KP N++++ L++ D+GLA +F EY V +R+++ P
Sbjct: 125 HSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM---TEY---VVTRWYRAP 177
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
ELL++ +Y ++D+WS+GC+FA ++ RK P F G D QL I ++
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITEL 224
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 70/232 (30%), Positives = 126/232 (54%), Gaps = 27/232 (11%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
W + Y+ + VG G Y V + ++ +K L +P + ++ RE+++L++
Sbjct: 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
+ NV+ LLD+ TP+ E N D V L+D +++
Sbjct: 71 M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
IY+LL+ L Y HS GI+HRD+KP NV ++ + +LR++D+GLA E VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRW 180
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
++ PE++++ Y+ ++D+WS+GC+ A ++ + + F G+D DQL +I +V
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEV 231
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 71/223 (31%), Positives = 124/223 (55%), Gaps = 17/223 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNVVKL 185
Y++ +G G + V+E I ++T+E+ IK +L+ + K RE+ I++NL N++ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124
Query: 186 LD------IVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
D +++ + +++ E++ T K + L + ++ Y Y+L +AL
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
Y HS+ I HRD+KP N++ID L+L D+G A+ G+ + SR+++ PEL++
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+Y +D+WSLGC+ A MI P F G + DQLV+I +V
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQV 286
|
Length = 440 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 70/233 (30%), Positives = 124/233 (53%), Gaps = 27/233 (11%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
W + Y+ + VG G Y V + T R +K L +P + K+ RE+++L++
Sbjct: 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
+ NV+ LLD+ TP+ E N D V LTD +++
Sbjct: 73 M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
IY++L+ L Y HS I+HRD+KP N+ ++ + +L+++D+GLA H E VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I ++
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 234
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 69/228 (30%), Positives = 130/228 (57%), Gaps = 21/228 (9%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
+G + Y + K+G G Y+ V++G + T+ +K ++ ++ RE+ +L++L
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELL 229
N+V L DI+ + K+ +L+FEY++ K L L D ++++ ++++LL
Sbjct: 62 -KHANIVTLHDIIHTE--KSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGP 288
+ L+YCH + ++HRD+KP N++I+ E +L+L D+GLA P K Y+ V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
++L+ DY +DMW +GC+F M + P F G +QL I ++
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRI 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 73/220 (33%), Positives = 119/220 (54%), Gaps = 20/220 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKP----VKKKKIKREIKILQNLCGGPN 181
Y ++ VG G + V + T + IK I+KP V K+ RE+K+L++L N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---STDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
++ L DI +P +V TD L + L I+Y++Y++L+ L Y H
Sbjct: 71 IISLSDIF-----ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
S G++HRD+KP N++I+ E L++ D+GLA P + V++RY++ PE+++ Q
Sbjct: 126 SAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQK 182
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
YD +D+WS GC+FA M +P F G D+ +Q I +
Sbjct: 183 YDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDL 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 70/222 (31%), Positives = 126/222 (56%), Gaps = 14/222 (6%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
+G D YE + K+G G Y+ V++G + + +K+++ +++ RE +L+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 177 CGGPNVVKLLDIVRDQHSK-TPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
N+V L DI+ H+K T +L+FEYV++ + + +P L +++ ++++LL+ L
Sbjct: 61 -KHANIVLLHDII---HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
Y H + I+HRD+KP N++I + +L+L D+GLA P Y+ V + +++ P++L
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ +Y LDMW +GC+F MI F D DQL +I
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLC 177
++E + ++G G Y V+ + + E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDY 234
PN+V+L ++V +H + L+ EY +L ++ ++ + +LL+ L Y
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 235 CHSQGIMHRDVKPHNV-MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
H I+HRD+K N+ + D L++ D+GLA Y P K +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
Y ++DMW++GC+ A + +P G +QL
Sbjct: 182 GCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 68/219 (31%), Positives = 123/219 (56%), Gaps = 15/219 (6%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
+G + Y + K+G G Y+ VF+G + T +K ++ ++ RE+ +L++L
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKAL 232
N+V L DIV S T L+FEY++ D K ++ ++++ ++Y++L+ L
Sbjct: 62 -KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
YCH + ++HRD+KP N++I+ E +L+L D+GLA P K Y+ V + +++ P++L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
+ +Y +DMW +GC+F M + P F G D+L
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 70/223 (31%), Positives = 122/223 (54%), Gaps = 21/223 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK----REIKILQNL--CGG 179
YE V ++G G Y V++ + ++ +K ++ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 180 PNVVKLLDIV----RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLK 230
PN+V+L+D+ D+ +K +L+FE+V+ D KV P L I+ + + L+
Sbjct: 62 PNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
LD+ H+ I+HRD+KP N+++ +++L D+GLA Y V + +++ PE+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
L+ Y +DMWS+GC+FA M FR++P F G+ DQL KI
Sbjct: 179 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKI 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG 179
D++++ +VG+G Y +VF +T E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCH 236
+VKLL +D + L EYV DF+ L L++ R+Y+ E+ +A+D H
Sbjct: 61 EWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
G +HRD+KP N +ID ++L D+GL++ Y N V S + PE+L +
Sbjct: 119 ELGYIHRDLKPENFLID-ASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
YD+++D WSLGCM + PF
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGGPNVVK 184
+G G + V+EG+N++ + +K + K++++EI +L L PN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
L R+ + E V L Y + + IR Y ++L L+Y H + +
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
HRD+K N+++D ++L D+G+A+ S Y+ PE++ Y +
Sbjct: 125 HRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 302 DMWSLGCMFAGMIFRKEPF 320
D+WSLGC M K P+
Sbjct: 184 DIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 67/219 (30%), Positives = 123/219 (56%), Gaps = 15/219 (6%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
+G + Y + K+G G Y+ VF+G + T +K ++ ++ RE+ +L+NL
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKAL 232
N+V L DI+ + T L+FEY++S D K ++ ++++ ++++LL+ L
Sbjct: 61 -KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
YCH + I+HRD+KP N++I+ E +L+L D+GLA P K Y+ V + +++ P++L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
+ +Y +DMW +GC+ M + P F G ++L
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
+G+G + +V +T + +K+LK KKKI + E IL + P +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 184 KLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYC 235
KL H +T L+ EY + F L ++ R+Y E++ AL+Y
Sbjct: 57 KL-------HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
HS GI++RD+KP N+++D + ++L D+GLA E G N + + PE+L
Sbjct: 110 HSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LG 167
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ Y ++D WSLG + M+ K P FY D + KI K
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP-FYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 119 VQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQN 175
V GD + Y+ + K+G G EV++ + T + IK L+ K+ I EI I+++
Sbjct: 12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD 71
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPT---LTDYDIRYYIYELL 229
C PN+V D ++ EY++ TD ++ + + I Y E+L
Sbjct: 72 -CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVL 126
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
+ L+Y HSQ ++HRD+K N+++ + ++L D+G A+ + N V + Y+ P
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMI 314
E++ +DY +D+WSLG M M
Sbjct: 186 EVIKR-KDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 74/231 (32%), Positives = 113/231 (48%), Gaps = 24/231 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLC 177
+ YE + K+G+G + EVF+ + T + +K +L +K+ REIKILQ L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68
Query: 178 GGPNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
NVV L++I R + + + L+FE+ D L T +I+ +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVAS 282
LL L Y H I+HRD+K N++I + L+L D+GLA + K Y RV +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+++ PELL+ +DY +DMW GC+ A M R P G+ QL I
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
YE+++++G+G + +V+ + + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 181 NVVKLLD-IVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
N++K + ++ EY + D K + I + +L AL
Sbjct: 60 NIIKYYESFEEKGKL---CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 291
Y HS+ I+HRD+KP N+ + ++L D+G+++ + V + Y+ PEL
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ + Y+Y D+WSLGC+ + K PF
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 65/230 (28%), Positives = 118/230 (51%), Gaps = 24/230 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVV 183
Y +R +G G VF ++ + ++R +K + + +K REIKI++ L N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 184 KLLDIVRDQHSKTPS------------LIFEYVNSTDFKVL--YPTLTDYDIRYYIYELL 229
K+ +++ S ++ EY+ TD + L++ R ++Y+LL
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYF 285
+ L Y HS ++HRD+KP NV I+ E L++ D+GLA P + + + ++++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ P LL+ +Y ++DMW+ GC+FA M+ K P F G +Q+ I +
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
+E+V +G G Y +V++ + T + IKI+ ++ +++IK E IL+ PN+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNS---TD----FKVLYPTLTDYDIRYYIYELLKA 231
++ L+ E TD + L + I Y + E L+
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 290
L Y H ++HRD+K N+++ ++L+D+G+ A+ N + + Y+ PE+
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184
Query: 291 LV-DLQD---YDYSLDMWSLG 307
+ D Q YD D+WSLG
Sbjct: 185 IACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 60/204 (29%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGP 180
D E R +G G + V+ + +R +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYC 235
NV+ LDI++ H I+ E + S K++ L+ ++ ++Y++L+ L Y
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVD 293
HS GI+HRD+KP N++++ L++ D+GLA P K V ++Y++ PE+L+
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRK 317
+ Y ++D+WS+GC+FA ++ R+
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNVVK 184
+ +G Y VF +T + IK++K K I++ E IL P VVK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
L Q K L+ EY+ D L +L + R YI E++ AL+Y HS GI+
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 292
HRD+KP N++ID L+L D+GL++ ++ N+ + + PE+++
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
Q + ++D WSLGC+ + PF
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 56/209 (26%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGP 180
+Y++ +GRG + V++G+N+ T + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDY 234
N+VK + + S + +I EY + L + + + Y+Y++L+ L Y
Sbjct: 60 NIVKYIGSIET--SDSLYIILEYA---ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
H QG++HRD+K N++ + ++L D+G+A + K+ V + Y+ PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
+ + D+WSLGC ++ P++
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-22
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
++++ +K+G+G++S V++ I + +K ++ ++ +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
PNV+K L + + ++ E ++ D FK + + I Y +L A
Sbjct: 61 HPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
L++ HS+ IMHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ + Y++ D+WSLGC+ M + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 52/192 (27%), Positives = 105/192 (54%), Gaps = 15/192 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPN 181
++ ++++ K+G G Y V++ I+ T + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 182 VVKLL-DIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYCH 236
+VK ++ ++ EY + K+ TLT+ +I +Y+ LK L+Y H
Sbjct: 60 IVKYYGSYFKNTDL---WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
S +HRD+K N++++ E + +L D+G++ + + N + + ++ PE++ +
Sbjct: 117 SNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 296 DYDYSLDMWSLG 307
Y+ D+WSLG
Sbjct: 175 GYNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 66/244 (27%), Positives = 119/244 (48%), Gaps = 39/244 (15%)
Query: 127 YEVVRKVGRGKYSEVFE--GINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
YE+ +GRG Y V++ N + IK K K++ REI +L+ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYEL 228
NVV L+++ + K+ L+F+Y + +V P ++ ++++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM---VKSLLWQI 117
Query: 229 LKALDYCHSQGIMHRDVKPHN--VMIDHELR-KLRLIDWGLAEFYH----PGKEYNVRVA 281
L + Y HS ++HRD+KP N VM + R +++ D GLA ++ P + + V
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 332
+ +++ PELL+ + Y ++D+W++GC+FA ++ EP F G + DQL +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 333 IAKV 336
I +V
Sbjct: 237 IFEV 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 30/225 (13%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPN 181
Y++ +G+G Y V I+ +T E+ IK + V +I REIK+L+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR------- 54
Query: 182 VVKLLDIVRDQHSKTPS---------LIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK 230
+++ DIV +H P ++FE + S +V+ LT ++++Y+LL+
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFK 286
AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+++
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 287 GPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PEL Y ++D+WS+GC+FA ++ K P F G + QL
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIK---REIKILQNLCGGP 180
+E++R +G+G + +V +T + +K + K V+K ++ E +ILQ L P
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
+V L +D + L+ + + D + Y ++ ++++I E++ AL+Y
Sbjct: 61 FLVNLWYSFQD--EENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
HS+GI+HRD+KP N+++D E + + D+ +A P + + PE+L Q
Sbjct: 117 HSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-Q 174
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVTTIL 340
Y ++D WSLG + K P + GH DQ+ + +L
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 34/223 (15%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKL 185
K+G G + +V+ +N++T E +K ++ P K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64
Query: 186 --LDIVRDQHSKTPSLIF-EYVN-STDFKVL-YPTLTDYD-IRYYIYELLKALDYCHSQG 239
+++ R++ IF EY + T ++L + + D IR Y +LL+ L Y HS G
Sbjct: 65 YGVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 290
I+HRD+KP N+ +DH ++L D+G A + PE+
Sbjct: 120 IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAYMAPEV 174
Query: 291 LV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
+ + + + D+WSLGC+ M K P + DN Q++
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-19
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCGGPNVV 183
++ + +G + V+ +T + IK+LK + K ++ K E I+ P V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGI 240
KL Q L+ EY+N D L TL + YI E++ ++ H +GI
Sbjct: 61 KLYYSF--QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
+HRD+KP N++ID + L+L D+GL+ K++ V + + PE ++ + D D
Sbjct: 119 IHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DKM 173
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
D WSLGC+ +F PF
Sbjct: 174 SDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 60/219 (27%), Positives = 112/219 (51%), Gaps = 13/219 (5%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
Y+ ++ +G G V + T + IK L K+ RE+ +++ L N
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKN 76
Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
++ LL++ Q S + L+ E +++ +V+ L + Y +Y++L + + HS
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 136
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++ + Y
Sbjct: 137 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 194
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
++D+WS+GC+ MI R F G D+ DQ KI +
Sbjct: 195 KENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQ 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 59/235 (25%), Positives = 111/235 (47%), Gaps = 39/235 (16%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------------REIKILQN 175
+G G Y +V + + T + IK +K ++ RE+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALD 233
+ N++ L+D+ + +L+ + + S KV+ LT+ ++ + ++L L+
Sbjct: 77 I-KHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---------------EFYHPGKEYNV 278
H MHRD+ P N+ I+ + ++ D+GLA E +E
Sbjct: 134 VLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+V + +++ PELL+ + Y +++DMWS+GC+FA ++ K P F G + DQL +I
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRI 246
|
Length = 335 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNV 182
D +E++ +G+G Y +V++ N +KIL P+ ++I+ E ILQ+L PNV
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 183 VKLLDIV--RDQHSKTPS-LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
VK + D+ L+ E N L L + I Y +Y L L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
+ H+ I+HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 292 VDLQDYDYSL----DMWSLG 307
Q YDYS D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 9e-18
Identities = 65/253 (25%), Positives = 127/253 (50%), Gaps = 30/253 (11%)
Query: 113 DYESLTVQWGDQ-----DDYEVVRKVGRGKYSEVFE------GINVNTNERCIIKILKPV 161
D + +VQ D Y+ ++ +G G V GINV + K+ +P
Sbjct: 4 DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINV-----AVKKLSRPF 58
Query: 162 KK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLY 213
+ K+ RE+ +L+ + N++ LL++ Q S + L+ E +++ +V++
Sbjct: 59 QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
L + Y +Y++L + + HS GI+HRD+KP N+++ + L+++D+GLA
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTN 176
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
V +RY++ PE+++ + Y ++D+WS+GC+ ++ + F G D+ DQ K+
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKV 234
Query: 334 AKV--TTILDFSN 344
+ T +F N
Sbjct: 235 IEQLGTPSAEFMN 247
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 55/210 (26%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERC------IIKILKPVKKKKIKREIKILQNLCGG 179
++++ +K+GRG++SEV+ + + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
PNV+K LD + + +++ E ++ D FK + + + Y +L A+
Sbjct: 62 PNVIKYLDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ Y++ D+WSLGC+ M + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 54/241 (22%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI-----KREIKILQNL 176
DD+EV++ +GRG + EV+ + +T + +K+L+ +K+ +I +R+I +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD- 59
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
P +VKL +D+ L+ EY+ D L + R+YI EL+ ALD
Sbjct: 60 --SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 234 YCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLA----------------------- 267
H G +HRD+KP N++ID H ++L D+GL
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 268 ---EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
K+ VR V + + PE+L Y D WSLG + M++ PF
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 321 F 321
+
Sbjct: 231 Y 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG--PNVVKLL 186
+GRG Y V+ G +V T +KI+ I+RE+ +L L PN+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 187 DIVRDQHSKTPSL--IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMH 242
+ K P L I EY + L + + I I E+L AL Y H G++H
Sbjct: 69 G----SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 243 RDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
RD+K N+++ + ++L D+G+ A + + V + Y+ PE++ + + YD
Sbjct: 125 RDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
D+WSLG M P + + D
Sbjct: 184 DIWSLGITIYEMATGNPP----YSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 13/216 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
Y+ ++ +G G V + + IK L +P + K+ RE+ +L N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 77
Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
++ LL++ Q S + L+ E +++ +V+ L + Y +Y++L + + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++ + Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 195
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
++D+WS+GC+ M+ R + F G D DQ K+
Sbjct: 196 KENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 51/214 (23%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
DDYE++ +G G + V+ I + NE+ IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 181 NVVK----------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 218
NVVK LLDI++ S P +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG---- 273
I + E+LK L+Y HS G +HRD+K N+++ E +++ D+G+ A G
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
K V + + PE++ + YD+ D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGP 180
DYEV+ +G+G + V + + + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY----ELLKALD 233
N+V+ D + D+ ++T ++ EY D L Y +I+ +LL AL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 234 YCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 287
CH ++HRD+KP N+ +D ++L D+GLA+ + V + Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
PE L YD D+WSLGC+ + P F N QL
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 49/191 (25%), Positives = 95/191 (49%), Gaps = 12/191 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
+ + ++ +G+G + EV++ I+ TN+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQ 238
+ K +I EY + +L P L + I + + E+L L+Y H +
Sbjct: 60 YITKYYGSFLKGSKLW--IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
G +HRD+K N+++ E ++L D+G++ + + N V + ++ PE++ Y
Sbjct: 118 GKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGY 175
Query: 298 DYSLDMWSLGC 308
D D+WSLG
Sbjct: 176 DEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR----EIKILQNLCGGPNVVKLL 186
+G+G + EV T + K L K +KK+K ++ E KIL+ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSL- 58
Query: 187 DIVRDQHSKTP-SLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
+K L+ +N D K V P + +Y +++ L++ H + I
Sbjct: 59 --AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
++RD+KP NV++D + +R+ D GLA GK+ R + + PE+L + YD+S
Sbjct: 117 VYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFS 174
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
+D ++LGC MI + PF
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKK---IKREIKILQNLCG 178
DD+E ++ +G G + V + + + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
P +V L Q L+ EYV + F L + R+Y +++ AL+Y
Sbjct: 61 -PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 287
HS I++RD+KP N+++D + +++ D+G A RV R +
Sbjct: 118 HSLDIVYRDLKPENLLLDSD-GYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PE+++ + Y ++D W+LG + M+ PFF DN Q+
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF--DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 57/216 (26%), Positives = 109/216 (50%), Gaps = 13/216 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
Y+ ++ +G G V + IK L +P + K+ RE+ +L N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 84
Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
++ LL++ Q S + ++ E +++ +V+ L + Y +Y++L + + HS
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++ + Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 202
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
++D+WS+GC+ MI F G D+ DQ K+
Sbjct: 203 KENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
++++G G + +V ++ + NT E+ +K L + +REI+IL+ L N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR----YYIYELLKALDYCHS 237
+VK + ++ LI EY+ S + D + ++ K +DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 293
Q +HRD+ N++++ E +++ D+GLA+ K+Y + ++ PE L
Sbjct: 128 QRYIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ S D+WS G + +P
Sbjct: 187 SKFSSAS-DVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
D +E++ +G+G Y +VF+ +N + +KIL P+ ++I+ E IL+ L PNV
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 183 VKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
VK + + K L+ E N L + + I Y ++E L L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
+ H +HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 292 VDLQD----YDYSLDMWSLG 307
Q YD D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 65/260 (25%), Positives = 125/260 (48%), Gaps = 44/260 (16%)
Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVK 162
P +Y D ES ++YEV++K+G G++ EVF + T E K LK +
Sbjct: 2 PGKYDDGESRL------NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55
Query: 163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPT 215
K ++ E+ +++ L N+V+ +D ++ ++ ++ E+ ++ D ++
Sbjct: 56 KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 216 LTDYDIRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHELRKL--------- 259
+ ++ I +LL AL YCH+ + ++HRD+KP N+ + +R +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 260 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLGCMFA 311
++ D+GL++ + V + Y+ PELL+ + + YD DMW+LGC+
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 312 GMIFRKEPFFYGHDNHDQLV 331
+ K P F+ +N QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNL 176
D++V VGRG + EV T + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYD-IRYYIYELLKAL 232
P + +L +D+ + L+ EY D L Y D D ++Y+ EL+ A+
Sbjct: 60 --SPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPEL 290
H G +HRD+KP NV+ID ++L D+G A K N + V + + PE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 291 LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPF 320
L + Y D WSLG + MI+ + PF
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGP 180
Q+DYE+++++G G Y +V++ ++ T E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
N+V + ++ EY S ++V L++ I Y E LK L Y H
Sbjct: 61 NIVAYFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
G +HRD+K N+++ E ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 119 ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 296 --DYDYSLDMWSLG 307
YD D+W+LG
Sbjct: 178 KGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 59/236 (25%), Positives = 113/236 (47%), Gaps = 34/236 (14%)
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
KVGRG Y V++ + + LK ++ I REI +L+ L PNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
+ + L+F+Y + ++ L ++ +Y++L + Y H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
+ ++HRD+KP N+++ E ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 336
LL+ + Y ++D+W++GC+FA ++ EP F+ +HDQL +I V
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 180
+G G + V+ G+N ++ E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
N+V+ L D + EYV L Y + +R ++ ++LK L+Y H+
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 290
+GI+HRD+K N+++D++ +++ D+G+++ +R ++ PE
Sbjct: 125 RGIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+V Y D+WSLGC+ M+ K PF + QL I K+
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 61/224 (27%), Positives = 117/224 (52%), Gaps = 19/224 (8%)
Query: 133 VGRGKYSEVFEGINVNTNE----RCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
+G G + V + N +C+ K I++ +++ I E +IL+ C P +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59
Query: 187 DIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
+D+ K ++ EY + + +L +Y R+YI ++ A +Y H++GI++R
Sbjct: 60 RTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
D+KP N+++D ++L+D+G A+ G++ + + PE++++ + YD+S+D
Sbjct: 118 DLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDY 175
Query: 304 WSLGCMFAGMIFRKEPFFYGHDNHDQLV---KIAKVTTILDFSN 344
WSLG + ++ + PF G D+ D + I K L+F N
Sbjct: 176 WSLGILLYELLTGRPPF--GEDDEDPMEIYNDILKGNGKLEFPN 217
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 179
++ + +K+GRG++SEV+ +G+ V + I ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
PNV+K + + +++ E ++ D FK + + + Y +L AL
Sbjct: 62 PNVIKYYASFIEDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELL 291
++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ Y++ D+WSLGC+ M + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 59/236 (25%), Positives = 113/236 (47%), Gaps = 34/236 (14%)
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
KVGRG Y V++ + + LK ++ I REI +L+ L PNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
+ + L+F+Y + ++ L ++ +Y++L + Y H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
+ ++HRD+KP N+++ E ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 336
LL+ + Y ++D+W++GC+FA ++ EP F+ +HDQL +I V
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPNVV 183
+G G +S ++ +V T +K + V+ +++EI+++ L P+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHII 66
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGI 240
++L +L E++ L Y + I Y +LL+ L Y H I
Sbjct: 67 RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
+HRDVK N++ID ++LR+ D+G A + G+ + + F PE+L +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-E 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQLV-KIAKVTT 338
Y S D+WS+GC+ M K P+ H NH L+ KIA TT
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 32/206 (15%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK-------------KKIKREIKILQNLCGG 179
+G+G Y V+ +NV T E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
N+V+ L + + S+ EYV T ++ +R++ ++L+ L Y H
Sbjct: 68 LNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 292
S+GI+HRD+K N+++D + ++ D+G+ + Y + +++ S ++ PE ++
Sbjct: 126 SKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182
Query: 293 DLQDYDYS--LDMWSLGC----MFAG 312
YS +D+WSLGC MFAG
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 6e-15
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
+R++G G + V+ +V TNE IK + K+ I +E+K LQ + PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
+ +H T L+ EY +++D +V L + +I + L+ L Y HS +
Sbjct: 89 EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202
Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
+D+WSLG + RK P F
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 131 RKVGRGKYSEVFEGI---NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
+K+G G + EV++G +K LK ++K +E ++++ L G PNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFK------------VLYPTLTDYDIRYYIYELLKA 231
+LL + ++ L+ EY+ D TL+ D+ + ++ K
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
++Y S+ +HRD+ N ++ +L +++ D+GL+ + Y + G
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171
Query: 288 ----PELLVDLQDYDYSLDMWSLGC 308
PE L D + D+WS G
Sbjct: 172 RWMAPESLKD-GIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
R +GRG Y++V + + N++ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ 238
+V L Q + L+ EYVN D L + R+Y E+ AL++ H +
Sbjct: 58 LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
GI++RD+K NV++D + ++L D+G+ E PG + + + PE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
+S+D W+LG + M+ + PF DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
+R++G G + V+ +V +E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
+ +H T L+ EY +++D +V L + +I + L+ L Y HS +
Sbjct: 79 QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
+HRDVK N+++ E ++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
+D+WSLG + RK P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
R +GRG Y++V + + ER I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
+V L HS +T S +F EYVN D L + R+Y E+ AL+
Sbjct: 58 LVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
Y H +GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQ 329
+DY +S+D W+LG + M+ + PF DN DQ
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKL 185
+ K+G+G + EVF+GI+ T + IKI+ + + I++EI +L C P V K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67
Query: 186 L-DIVRDQHSKTPSLIFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMH 242
++D +I EY+ + +L P L + I + E+LK LDY HS+ +H
Sbjct: 68 YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
RD+K NV++ E +++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 302 DMWSLGCMFAGMIFRKEP 319
D+WSLG + A + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK------KIKREIKILQNLCGGPNVV 183
+ ++G G + V+ N +TNE +K + K+ I +E+K LQ L PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
+ +H T L+ EY +++D +V L + +I + L+ L Y HS +
Sbjct: 85 EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198
Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
+D+WSLG + RK P F
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPN 181
R +GRG Y++V + + R I +K +KK+ ++ E + + P
Sbjct: 1 RVIGRGSYAKVLL-VELKKTRR--IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
+V L HS +T S +F E+V+ D L + R+Y E+ AL+
Sbjct: 58 LVGL-------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
+ H +GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+DY +S+D W+LG + M+ + PF
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
++G+G + EV++GI+ T E IKI+ + + I++EI +L C P + +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69
Query: 188 IVRDQHSKTPSL--IFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
+ K L I EY+ + +L P L + I + E+LK LDY HS+ +HR
Sbjct: 70 ----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 244 DVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
D+K NV++ E ++L D+G+A + + N V + ++ PE ++ YD+ D
Sbjct: 126 DIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKAD 183
Query: 303 MWSLG 307
+WSLG
Sbjct: 184 IWSLG 188
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
+K+G G + EV++G +K LK ++ RE +I++ L PNV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
VKLL + ++ ++ EY+ D Y P L+ D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
+ +HRD+ N ++ L +++ D+GL+ + Y R
Sbjct: 121 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
Q+D+E+++++G G Y +V++ NVNT E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 182 VVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 236
+V + RD+ + E+ + +Y L++ I Y E L+ L Y H
Sbjct: 68 IVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
S+G MHRD+K N+++ ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
Y+ D+W++G + + P F H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
D E V+ +G+G V++ + T + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
VVK S++ EY++ D + + + Y ++LK LDY H+
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
+ I+HRD+KP N++I+ + ++++ D+G+++ + N V + + PE + +
Sbjct: 118 KRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
Y Y+ D+WSLG K PF
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
+DYEVV+ +GRG + EV + +T + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
P VV+L +D + ++ EY+ D L +++YD+ R+Y E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
D HS G +HRDVKP N+++D + L+L D+G KE VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212
Query: 289 ELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 2e-13
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVK 184
+E+V VG G Y +V++G +V T + IK++ ++++IK+EI +L+ N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 185 LLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYC 235
++ L+ E+ + L TL + I Y E+L+ L +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 128 HQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 295 QD----YDYSLDMWSLG 307
++ YD+ D+WSLG
Sbjct: 187 ENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
YE+++K+G G + +++ + +E C+IK + PVK+K+ ++ IL PN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK--------VLYPTLTDYDIRYYIYELLKALDY 234
V Q + ++ EY + D VL+ ++ I + ++ L +
Sbjct: 62 VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
H + I+HRD+K N+ + +L D+G+A + E V + Y+ PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ Y+ D+WSLGC+ + K P F G++ H ++KI +
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 2e-13
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
V GD + Y K+G+G VF I+V T + IK + K KK+ I EI +++
Sbjct: 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
L PN+V LD +V D+ ++ EY+ V + + I E L+
Sbjct: 72 EL-KNPNIVNFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ 126
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
AL++ H+ ++HRD+K NV++ + ++L D+G P + + + V + Y+ PE
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+V + Y +D+WSLG M M+ + P+
Sbjct: 186 -VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
+K+G G + EV++G +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK-VL----YPTLTDYDIRYYIYELLKALDYCHS 237
VKLL + ++ ++ EY+ D L L+ D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
+ +HRD+ N ++ L +++ D+GL+ + Y V+
Sbjct: 122 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 18/186 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
++G+G + EVF+GI+ T + IKI+ + + I++EI +L C P V K
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69
Query: 188 IVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 242
+ K L I EY+ ++ D P ++ I + E+LK LDY HS+ +H
Sbjct: 70 ----SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 124
Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
RD+K NV++ E ++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKA 182
Query: 302 DMWSLG 307
D+WSLG
Sbjct: 183 DIWSLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
+G+G + V+ +V+T K ++ P K++ EI++L+NL +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
+RD+ KT ++ EY+ K Y LT+ R Y ++L+ + Y HS I+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
HRD+K N++ D ++L D+G L G + Y+ PE ++ + Y
Sbjct: 129 HRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGY 186
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338
D+WSLGC M+ K P+ ++ + I K+ T
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGP 180
+ +R++G G + V+ +V TNE IK + K+ I +E++ LQ P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHS 237
N ++ +H T L+ EY +++D +V L + +I + L+ L Y HS
Sbjct: 76 NTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 238 QGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDL 294
+HRD+K N+++ + KL D+G A P N V + Y+ PE L +D
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMDE 188
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFF 321
YD +D+WSLG + RK P F
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVK 184
+E+V VG G Y +V++G +V T + IK++ + +++IK EI +L+ N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 185 LLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYC 235
+ H L+ E+ + L L + I Y E+L+ L +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
H+ ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 138 HAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 295 QD----YDYSLDMWSLG 307
++ YDY D+WSLG
Sbjct: 197 ENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
+G+G + V+ + +T +K ++ P K++ EI++L+NL +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQ 68
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
+RD +T S+ E++ K Y LT+ R Y ++L+ + Y HS I+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
HRD+K N++ D + ++L D+G L G + Y+ PE ++ + Y
Sbjct: 129 HRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGY 186
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
D+WS+GC M+ K P+
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
DD E + ++G G V + ++ T + +K + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
+V + S+ EY++ + + + + +LK L Y H
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 237 SQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
+ I+HRDVKP N++++ +++L D+G++ G+ N V + + PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 292 VDLQDYDYSLDMWSLGCMF 310
DY D+WSLG
Sbjct: 172 QGN-DYSVKSDIWSLGLSL 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 62/235 (26%), Positives = 119/235 (50%), Gaps = 19/235 (8%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EI 170
YE + + +E++ ++G G + +V++ N T K+++ +++++ EI
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60
Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYI 225
+IL C P +VKLL ++ E+ V++ + L LT+ I+
Sbjct: 61 EILAT-CNHPYIVKLLGAF--YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVIC 116
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRY 284
++L+AL Y HS I+HRD+K NV++ + ++L D+G+ A+ + + + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 285 FKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ PE+++ ++D YDY D+WSLG M + EP + + L+KIAK
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 8e-13
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 119 VQWGDQD-DYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
V GD Y K+G+G V+ I+V T + IK + + KK+ I EI +++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYV---NSTDFKVLYPTLTDYDIRYYIYELL 229
PN+V LD +V D+ ++ EY+ + TD V + + I E L
Sbjct: 72 EN-KHPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
+AL++ HS ++HRD+K N+++ + ++L D+G P E + R V + Y+
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP--EQSKRSTMVGTPYWM 182
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
PE +V + Y +D+WSLG M M+ + P+
Sbjct: 183 APE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
+GRG + EV+ +T + +K L K+ IK+ Q N +L +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54
Query: 193 HS----------KTP---SLIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 236
TP S I + +N D + ++ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
YD S D +SLGCM ++ P F H D+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 28/240 (11%)
Query: 106 LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK 165
L P+E+W E++ ++G G + +V++ N T K++ +++
Sbjct: 1 LNPEEFW---------------EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE 45
Query: 166 IKR---EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD 220
++ EI IL + C PN+VKLLD +++ + F + D +L LT+
Sbjct: 46 LEDYMVEIDILAS-CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ 104
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
IR + L+AL+Y H I+HRD+K N++ + ++L D+G+ A+ + +
Sbjct: 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSF 163
Query: 280 VASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + Y+ PE+++ + YDY D+WSLG M + EP + + L+KIAK
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 26/222 (11%)
Query: 130 VRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPN 181
++ +G+G + +VF + + + +K+LK K + K E IL + P
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPF 59
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYELLKALDYC 235
+VKL Q LI +++ D +V++ T+ D+++Y+ EL ALD+
Sbjct: 60 IVKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMF---TEEDVKFYLAELALALDHL 114
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVD 293
HS GI++RD+KP N+++D E ++L D+GL++ H K Y+ Y PE +V+
Sbjct: 115 HSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM-APE-VVN 171
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + S D WS G + M+ P F G D + + I K
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGP 180
Q DYE++++VG G Y +V++ N++T E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 181 NVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
N+V + R++ + EY + +Y L++ I Y E L+ L Y
Sbjct: 67 NIVAYFGSYLSREKL----WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122
Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
HS+G MHRD+K N+++ D+ ++L D+G+ A+ + + + Y+ PE+
Sbjct: 123 HSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 294 LQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
++ Y+ D+W++G + + P F H
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-12
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
V GD + Y K+G+G V+ I++ T + IK + + KK+ I EI +++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
PN+V LD +V D+ ++ EY+ V + + I E L+
Sbjct: 72 E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
ALD+ HS ++HRD+K N+++ + ++L D+G P + + + V + Y+ PE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+V + Y +D+WSLG M M+ + P+
Sbjct: 186 -VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
+DY+VV+ +GRG + EV + ++ + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
P VV+L +D K ++ EY+ D L +++YD+ ++Y E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 290
D HS G++HRDVKP N+++D + L+L D+G + G + V + + PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
L Y D WS+G M+ PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (159), Expect = 5e-12
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNV 182
+K+G G + EV++G T + +K LK ++++ E I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
V+LL + + ++ EY+ D + LT D+ ++ K ++Y S
Sbjct: 64 VRLLGVCT--QGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 288
+ +HRD+ N ++ L +++ D+GL+ + Y R +A P
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173
Query: 289 ELLVDLQDYDYSLDMWSLG 307
E L D + S D+WS G
Sbjct: 174 ESLKDGKFTSKS-DVWSFG 191
|
Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 199 LIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
L+ +N D K +Y P + +Y E+L L+ H + ++RD+KP N+++D
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 313
+ +R+ D GLA G+ RV + + PE+L + Q Y S D W LGC+ M
Sbjct: 137 -DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEM 194
Query: 314 IFRKEPF 320
I + PF
Sbjct: 195 IEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI------LKPVKKKKIKR---------EIKILQN 175
R +G+G + EV C ++ K ++KK+IK+ E +IL+
Sbjct: 6 RVLGKGGFGEVCA---------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 56
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLK 230
+ VV L + + L+ +N D K +Y P + +Y E+
Sbjct: 57 V-NSRFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE
Sbjct: 114 GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE- 171
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+V + Y +S D W LGC+ MI K PF
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 126 DYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKKI----KREIKILQN 175
++E++R +G G Y +VF + + + +K+LK V+K K + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKAL 232
+ P +V L Q LI +YVN + F LY T+ ++R YI E++ AL
Sbjct: 61 VRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPEL 290
D+ H GI++RD+K N+++D E + L D+GL++ + +E + + PE+
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 291 LVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 320
+ +D ++D WSLG + ++ PF
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
SL + + TD ++ + D+RY+IY +++ L++ H +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDY 297
I++RD+KP NV++D++ +R+ D GLA G+ A + F PELL ++Y
Sbjct: 117 RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
D+S+D ++LG MI + PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
YE +R VGRG + V + IIK + PV++ K E QN C V+KLL
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMT-KDERLAAQNEC---QVLKLL 56
Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVL-----YP---TLTDY------------DIRYYIY 226
H P++I Y N + K L Y TL +Y I ++
Sbjct: 57 -----SH---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
++L AL + H++ I+HRD+K N+++D +++ D+G++ K Y V V + +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCY 167
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE L + + Y+ D+W+LGC+ + K F
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI--------KILQNLCGGPNVVK 184
+GRG + EV+ +T + +K L KK+IK + +I+ +L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 185 LLDIVRDQHSKTPS---LIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCHSQ 238
++ + H TP I + +N D + ++ ++R+Y E++ L++ H++
Sbjct: 59 IVCMTYAFH--TPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
+++RD+KP N+++D E +R+ D GLA + K + V + + PE+L YD
Sbjct: 117 FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGTAYD 174
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
S D +SLGCM ++ PF
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
+G+G + +V++ V + I +K + KK+I + ++ + G N+ +VR
Sbjct: 1 IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 193 HSKTPSLI---FEYVNSTDFKVLYPTLTDY-------------------DIRYYIYELLK 230
++P ++ F + +D LY +TDY ++YI EL+
Sbjct: 52 LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 289
AL++ H I++RD+KP N+++D + L D+GL++ K N + + PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+L+D + Y +D WSLG + M PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR------EIKILQNLCGGPNVVK 184
+GRG + EV+ + +T +K + P ++ K EI++L+NL +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
+RD K S+ EY+ K Y LT+ R Y ++L+ + Y HS I+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAE----FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
HRD+K N++ D ++L D+G ++ G + Y+ PE ++ + Y
Sbjct: 129 HRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGY 186
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338
D+WS+ C M+ K P+ ++ + I K+ T
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
V GD + Y K+G+G V+ ++V T + I+ + + KK+ I EI +++
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLK 230
PN+V LD +V D+ ++ EY+ V+ T D I E L+
Sbjct: 73 E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
AL++ HS ++HRD+K N+++ + ++L D+G P + + + V + Y+ PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+V + Y +D+WSLG M MI + P+
Sbjct: 187 -VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPN 181
+R +G G + +V ++ NT E+ +K LKP +K+EI+IL+NL N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYCHS 237
+VK I + LI E++ S K P + Y ++ K +DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLVD 293
+ +HRD+ NV+++ E ++++ D+GL + KEY + ++ PE L+
Sbjct: 128 RQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 294 LQDYDYSLDMWSLG 307
+ Y S D+WS G
Sbjct: 187 SKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 46/214 (21%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
+G+G + EV + V + + K + KK++K+ E +IL+ + P +V
Sbjct: 1 LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------ELLKALDYC- 235
+L + + + T ++ + D++Y+IY E+ + + Y
Sbjct: 57 --------------NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 236 ---------HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
HS I++RD+KP NV++D + RL D GLA GK R + +
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYM 161
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE+L + + Y Y +D +++GC M+ + PF
Sbjct: 162 APEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 55/226 (24%), Positives = 114/226 (50%), Gaps = 23/226 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGPN 181
D +E++ ++G G + +V++ + T KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 182 VVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
+V L + + ++ E+ ++S ++ LT+ IRY ++L+AL++ H
Sbjct: 64 IVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--- 292
S ++HRD+K N+++ + ++L D+G+ A+ ++ + + + Y+ PE++
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 293 -DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAK 335
YDY D+WSLG + + P H+ + L+KI K
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLKILK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE----IKILQNLCG-- 178
DD+E ++ +GRG + EV +T +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 179 -GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
P VVKL +D LI EY+ D L T T+ + R+YI E + A+D
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 235 CHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYH 271
H G +HRD+KP N+++D H ++L D+GL
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
DD+E+++ +GRG + EV +T +KIL K + + E +L N G
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN--G 58
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
+ L Q L+ +Y D L D D+ R+YI E++ A+
Sbjct: 59 DCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
H +HRD+KP NV++D +RL D+G L + +V V + + PE+L
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 293 DLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 321
++D Y D WSLG CM+ M++ + PF+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQN 175
++D + R +G G++ +V++G+ ++ I +K K P ++K +E I++
Sbjct: 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI------------FEYVNSTDFKVLYPTLTDYDIRY 223
P++VKL+ ++ + P I + VN + L
Sbjct: 64 F-DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL------- 111
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
Y Y+L AL Y S+ +HRD+ NV++ + KL D+GL+ + Y
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLEDESYYKASKGK 169
Query: 283 RYFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
K PE ++ + + + D+W G CM+ ++ +PF G N+D + +I
Sbjct: 170 LPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 37/236 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
DD+E+++ +GRG + EV NT + +KIL K + +KR E +L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN--KWEMLKRAETACFREERDVLVN- 57
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKAL 232
G + L Q L+ +Y D L D D+ R+Y+ E++ A+
Sbjct: 58 -GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPEL 290
D H G +HRD+KP NV++D +RL D+G L + NV V + + PE+
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 291 LVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF-------YG----HDNHDQL 330
L ++D Y D WSLG CM+ M++ + PF+ YG H H Q
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFYAESLVETYGKIMNHKEHFQF 229
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 36/134 (26%), Positives = 71/134 (52%), Gaps = 7/134 (5%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
+ EY+N D + +D+ +Y E++ L + HS+GI++RD+K N+++D +
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 256 LRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
+++ D+G+ + G + + + PE+L+ Q Y+ S+D WS G + M+
Sbjct: 133 -GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190
Query: 315 FRKEPFFYGHDNHD 328
+ P F+GHD +
Sbjct: 191 IGQSP-FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC 177
D++V++K+G+G Y V++ V LK V ++ EI+IL ++
Sbjct: 1 DFKVLKKLGKGSYGSVYK---VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV- 56
Query: 178 GGPNVVK----LLDIVR----DQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
PN++ LD + +++ L + L P + R +I +LL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI-QLL 113
Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
+ L H Q I+HRD+K N+++ ++L K+ D G+++ + + ++ P
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAP 170
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
E+ + Y Y D+WSLGC+ M PF
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
+D++V++ +GRG + EV + ++ + +K+L K + IKR E + +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
+V+L +D K ++ EY+ D L +++YDI R+Y E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
D HS G +HRDVKP N+++D L+L D+G VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212
Query: 289 ELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFF 321
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
+R +G G + +V ++ N T E +K LK K+EI IL+ L N
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHEN 67
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQG 239
+VK +Q K LI EYV + P L + + ++ + + Y HSQ
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLVDL 294
+HRD+ NV++D++ R +++ D+GLA+ G EY RV ++ E L +
Sbjct: 128 YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLKEN 185
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ Y+ D+WS G ++ +
Sbjct: 186 KFS-YASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
+D+E+++ +GRG + EV N ++ +KIL K + + E +L N G
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN--G 58
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
+ L Q L+ +Y D L D D+ R+Y+ E++ A+D
Sbjct: 59 DNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
H +HRD+KP N+++D +RL D+G L + +V V + + PE+L
Sbjct: 118 VHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
++D Y D WSLG M++ + PF+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 3/101 (2%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
R+Y E+ AL Y HS I++RD+KP N+++D + + L D+GL E K +
Sbjct: 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ + PE+L Q YD ++D W LG + M++ PF+
Sbjct: 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNV 182
+ +G+G + +V T+E +K+LK K ++ E ++L P +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 183 VKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDY 234
+L HS +T +F EYVN D +D R+Y E++ L +
Sbjct: 59 TQL-------HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
H +GI++RD+K NV++D E +++ D+G+ E G + + + PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
Q Y ++D W+LG + M+ + PF D+ D+L
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 57/210 (27%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKP---VKKKKI----KREIKILQN 175
++E+++ +G G Y +VF V +T + +K+L+ V+K K + E +L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKAL 232
+ P +V L Q LI +YV+ + F LY ++ ++R+Y E++ AL
Sbjct: 61 VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 290
++ H GI++RD+K N+++D E + L D+GL+ EF KE + + PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ + ++D WSLG + ++ PF
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
+G+G + V+ +V+T +K + P KK++ EI++L+NL +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
+RD +T S+ EY+ K Y LT+ R Y ++L+ ++Y HS I+
Sbjct: 69 YYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
HRD+K N++ D ++L D+G L G + Y+ PE ++ + Y
Sbjct: 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGY 184
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
D+WS+GC M+ K P+
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
+G+G + +V T+E IK+LK K I + E +IL P +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK---KDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 184 KLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
L H +T +F EYVN D +D R+Y E+ AL +
Sbjct: 60 AL-------HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
H G+++RD+K N+++D E +L D+G+ E G + + PE+L +
Sbjct: 113 HRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE- 170
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
+Y S+D W+LG + M+ + PF DN D L
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
+Y E+ L+ H + I++RD+KP N+++D +R+ D GLA G+ RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ PE +V + Y +S D W+LGC+ MI + PF
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 50/241 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
DD+E ++ +GRG + EV +T +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
G VVK+ +D+ + LI E++ D L TL++ ++YI E + A+D
Sbjct: 60 GAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 279
H G +HRD+KP N+++D + ++L D+GL EFY +P +++ +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 280 --------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
V + + PE+ + Y+ D WSLG + M+ P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 320 F 320
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 50/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKK---IKREIKILQNLCG 178
DD E ++ VG G + V + + +K++ ++ K+ + E ++L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYC 235
P +++L DQ ++ EYV + F L ++ +Y E++ AL+Y
Sbjct: 60 HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFF 321
++ ++D W+LG + M+ PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
R+Y E+ A+ Y HS I++RD+KP N+++D + + L D+GL E P + +
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ + PE+L + YD ++D W LG + M++ PF+
Sbjct: 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLC 177
D+E++ K+G+G + VF+ + ++R + +K + K+ R E ++L L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVR-KADKR--VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKA 231
+++ + D+ +++ EY + D L P D R++I LL
Sbjct: 57 DSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
L + HS+ I+HRD+K N+ +D +++ D G+A+ + N V + Y+ PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAK 335
D + Y+ D+W+LG + K PF +N L+ KI +
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF--DANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 28/198 (14%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPN 181
+ E V ++G G V++ I+ T +K++ + +++I REI+IL+++ PN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
VVK D+ H+ ++ E+++ + + L D ++L + Y H
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 292
+ I+HRD+KP N++I+ + +++ D+G LA+ P N V + + PE +
Sbjct: 187 RHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242
Query: 293 DLQD--YD-YSLDMWSLG 307
DL YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
+TP +F E+VN D +D R+Y E+ AL + H +GI++RD+K
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
NV++DHE +L D+G+ E GK + + + PE+L ++ Y S+D W++G
Sbjct: 126 NVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183
Query: 308 CMFAGMIFRKEPFFYGHDNHDQL 330
+ M+ PF +N D L
Sbjct: 184 VLLYEMLCGHAPF--EAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
R+Y E+ AL Y HS I++RD+KP N+++D + + L D+GL E +
Sbjct: 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ + PE+L Q YD ++D W LG + M++ PF+
Sbjct: 158 GTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
+Y EL L+ + I++RD+KP N+++D + +R+ D GLA G+ RV +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ PE++ + + Y +S D W LGC+ MI + PF
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 34/113 (30%), Positives = 65/113 (57%), Gaps = 5/113 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
R+Y E++ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ + PE+L D DY ++D W LG + M+ + PF+ + +H++L ++
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 37/121 (30%), Positives = 67/121 (55%), Gaps = 5/121 (4%)
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYN 277
Y +Y E++ L + HS+GI++RD+K NVM+D + +++ D+G+ E +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
+ + PE+L L+ Y +S+D WS G + M+ + P F+G D+ D+L + +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRVD 211
Query: 338 T 338
T
Sbjct: 212 T 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRY 284
+LKAL H+QG++HRD+K ++++ H+ R ++L D+G KE R V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ PEL+ L Y +D+WSLG M M+ + P+F
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 38/216 (17%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR------EIKILQNLCGG 179
D+E+ +G G + V + T E IK LK + K+K+ E IL L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDI-RYYIYELLKAL 232
P +V ++ +D+ + E+V + F L +P D+ ++Y EL+ A
Sbjct: 78 PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 289
+Y HS+ I++RD+KP N+++D++ +++ D+G A+ +V R F PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAK----------KVPDRTFTLCGTPE 180
Query: 290 LL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
L + + + ++D W++G + I PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 34/112 (30%), Positives = 61/112 (54%), Gaps = 3/112 (2%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
V + + + I +L+AL Y H+QG++HRD+K ++++ + R ++L D+G A+
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 168
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ V + Y+ PE++ L Y +D+WSLG M MI + P+F
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK----------ILQNLCGG 179
++ +G+G Y +VF+ V + I +K +KK I R K IL+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KH 59
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI------RYYIYELLKALD 233
P +V L I Q LI EY++ + L+ L I +Y+ E+ AL+
Sbjct: 60 PFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLALE 114
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
+ H QGI++RD+KP N+++D + ++L D+GL E H G + + + PE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ ++D WSLG + M+ PF
Sbjct: 174 R-SGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 17/150 (11%)
Query: 180 PNVVKLLD--IVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDY 234
PN+V++ +V D+ ++ E++ TD V + + + I +LKAL +
Sbjct: 76 PNIVEMYSSYLVGDELW----VVMEFLEGGALTDI-VTHTRMNEEQIATVCLAVLKALSF 130
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 291
H+QG++HRD+K ++++ + R ++L D+G KE R V + Y+ PE++
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
L Y +D+WSLG M M+ + P+F
Sbjct: 188 SRLP-YGTEVDIWSLGIMVIEMVDGEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 41/139 (29%), Positives = 73/139 (52%), Gaps = 8/139 (5%)
Query: 199 LIFEYVNSTD--FKVLYPTLTDYD-IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
+ EYVN + F + + D R+Y E++ ALDY HS I++RD+K N+M+D +
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
+++ D+GL E + + PE+L D DY ++D W LG + M+
Sbjct: 132 -GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189
Query: 315 FRKEPFFYGHDNHDQLVKI 333
+ PF+ + +H++L ++
Sbjct: 190 CGRLPFY--NQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK--REIKILQNLCGGPNV 182
Y V+R VG G + +VN++++ +K ++ P ++ R+ +L PN+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 183 VKLLDIVR-DQHSKTPSLIFEYVNSTDF--KV------LYPTLTDYDIRYYIYELLKALD 233
V + D H ++ EY + D K+ L+P T I + ++ +
Sbjct: 61 VAFKESFEADGHL---YIVMEYCDGGDLMQKIKLQRGKLFPEDT---ILQWFVQMCLGVQ 114
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
+ H + ++HRD+K N+ + K++L D+G A PG V + Y+ PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
++ Y+ D+WSLGC+ + K PF
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 127 YEVVRKVGRGKYSE-------------VFEGINVNTNERCIIKILKPVKKKKIKREIKIL 173
Y +R +G+G + E V++ +N + L +++ EI IL
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--------LTRLSEKERRDALNEIVIL 53
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTLTDYDIRY---YIYEL 228
L PN++ + D T + EY N K++ ++ Y++++
Sbjct: 54 SLL-QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI---DWGLAEFYHPGKEYNVR---VAS 282
+ A+ Y H GI+HRD+K N+ L K LI D+G+++ G EY++ V +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIF----LTKAGLIKLGDFGISKIL--GSEYSMAETVVGT 164
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
Y+ PE L Y++ D+W+LGC+ ++ K F
Sbjct: 165 PYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 57/252 (22%), Positives = 99/252 (39%), Gaps = 47/252 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
++ ++ +G+G VF T + +K+L +K+ K+KR E +IL L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-D 59
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALD 233
P + L Q L+ +Y + L L++ R+Y E+L AL+
Sbjct: 60 HPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEYNVRVASRY 284
Y H GI++RD+KP N+++ HE + L D+ L K +
Sbjct: 118 YLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 285 ---------------FKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
F G PE++ + ++D W+LG + M++ PF G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234
Query: 324 HDNHDQLVKIAK 335
+ + I K
Sbjct: 235 SNRDETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
R+Y E++ AL Y HS +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
+ + PE+L D DY ++D W LG + M+ + P FY D H++L
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD-HEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 160 PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
P +K+I RE++I ++ C P +VK D+ S + + EY +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 220 DIRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYH 271
R L LK L Y HS+ I+HRD+KP N+++ + +++L D+G++ E +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
+ ++ PE + + Y + D+WSLG
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
R+Y E+ AL Y HS I++RD+KP N+++D + L D+GL E
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
+ + PE++ Q YD ++D W LG + M++ P FY D +
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPP-FYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQN---LCGG 179
+++ +V+ + RG + +V+ G N ++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
P +V L + Q + L+ EY+ D K L +D YI E+ ALDY H
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNE-GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 20/47 (42%), Positives = 29/47 (61%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
I+ + ++L ALD HS GI+HRDVKP N++ ++ID G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 49/221 (22%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----------KREIKILQN 175
++E+++ +G G Y +VF V+ ++ + +K +KK I + E ++L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKAL 232
+ P +V L Q LI +Y+N + + +++ Y E++ AL
Sbjct: 61 IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 289
++ H GI++RD+K N+++D + L D+GL++ +H + Y+ Y P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM-APD 176
Query: 290 LLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
++ +D ++D WS+G + ++ PF + + Q
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
R+Y E++ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ + PE+L D DY ++D W LG + M+ + PF+ + +H++L ++
Sbjct: 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
+ EY+N D + +D R+Y E++ L + H +GI++RD+K NV++D +
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133
Query: 257 RKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
+++ D+G+ GK + + + PE+L Q Y+ S+D WS G + M+
Sbjct: 134 H-IKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEML 190
Query: 315 FRKEPFFYGHDNHDQL 330
+ P F+G D D+L
Sbjct: 191 IGQSP-FHGED-EDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
+G+G Y V+ +++T R IK + P + + + EI + L N+V+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYD--IRYYIYELLKALDYCHSQGIMH 242
D + + E V L + L D + I +Y ++L+ L Y H I+H
Sbjct: 73 -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 295
RD+K NV+++ +++ D+G ++ + + + F G PE++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
Y D+WSLGC M K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 3/107 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
L + I +L+AL Y HSQG++HRD+K ++++ + R ++L D+G A+
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 172
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ V + Y+ PE ++ Y +D+WSLG M M+ + P+F
Sbjct: 173 KRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277
R+Y ELL AL+ H +++RD+KP N+++D++ + L D+GL + + N
Sbjct: 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTN 151
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ + PELL+ Y ++D W+LG + M+ PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 62/249 (24%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCG 178
+ ++ +G G + EV V+TN +K L+ K + R E IL
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAE-AD 59
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
VVKL +D+ + + +Y+ D L L ++ R+YI EL A++
Sbjct: 60 NEWVVKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPG------------- 273
H G +HRD+KP N++ID + ++L D+GL +++Y G
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 274 ------------KEYNVR----------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
+ R V + + PE+L+ Y D WS+G +
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235
Query: 312 GMIFRKEPF 320
M+ + PF
Sbjct: 236 EMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKK-----IKREIKILQNLCG 178
+D+ V+ +G+G + EV +T + +K +LK KK +K E +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SD 59
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
P VV L +D ++ LI E++ D + Y T ++ R+Y+ E + A++
Sbjct: 60 SPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
H G +HRD+KP N++ID ++L D+GL+ +H
Sbjct: 118 HKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 48/212 (22%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 181
Y V+K+G G + + + ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FK-------VLYPTLTDYDIRYYIYELLKALD 233
+V+ + + + ++ +Y D +K VL+P + I + ++ AL
Sbjct: 61 IVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFP---EDQILDWFVQICLALK 115
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
+ H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE +
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
+ + Y+ D+W+LGC+ M K F G+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 13/151 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
+D+E ++ +GRG + EV +T +KIL+ ++K++ I+ E IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
VVK+ +D+ + LI E++ D L TLT+ + ++YI E + A+D
Sbjct: 60 SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
Y + +++G+G + V+ + +K+LK + ++ +E ++L L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
P +VK ++ + +I EY D K TL++ + + +LL
Sbjct: 61 HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
+ Y H + I+HRD+K N+ + + L L++ D+G++ + + Y+ PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 291 LVDLQDYDYSLDMWSLGCMFAGM 313
L Q YD D+WSLGC+ M
Sbjct: 177 LKH-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E GK
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ + PE ++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 165 KIKREIKILQNLCGGPNVVKL---------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
I E+ I++ PN+V+ L IV D P + E+ NS K
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109
Query: 216 LTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
T+ I +++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ V + + PE++ + Y D+W+ GC+ M + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 52/233 (22%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--------- 175
+D+E ++ + G Y V+ + T +R +K KI ++ IL+N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--------KINKQNLILRNQIQQVFVER 52
Query: 176 ----LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYEL 228
P VV + + + ++ EYV D L + + R Y E
Sbjct: 53 DILTFAENPFVVSMF--CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------FYHPGKEYNVR 279
+ AL+Y H+ GI+HRD+KP N++I + ++L D+GL++ Y E ++
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY----EGHIE 165
Query: 280 VASRYFK-----------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+R F PE+++ Q Y +D W++G + + PFF
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 26/208 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
Y ++ + G EVF ++ I+K + K REI IL+ + ++
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRAIIN 150
Query: 185 LLDIVRDQHSKTPSL------IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
L+ R + + + +F YV+ + L LL+AL Y H +
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR 204
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVD 293
GI+HRDVK N+ +D E L D+G A P + Y + PELL
Sbjct: 205 GIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA- 260
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
L Y D+WS G + M + F
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGI--NVNTNE---RCIIKILKPV----KKKKIKREIKIL 173
++ ++R++G+G + V+EG+ V E R IK + ++ + E ++
Sbjct: 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63
Query: 174 QNL-CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-------------LYPTLTDY 219
+ C +VV+LL +V + ++ E + D K T
Sbjct: 64 KEFNC--HHVVRLLGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPG 273
E+ + Y ++ +HRD+ N M+ +L +++ D+G+ ++Y G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKG 178
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
+ + V R+ PE L D + D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 53/228 (23%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
++ ++V+K+G G++ EV+ G N + + +K LKP + + E +++ L
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNS---TDF-------KVLYPTLTDYDIRYYIYELLKA 231
+V+L +V + + +I EY+ DF KVL P L D+ ++ +
Sbjct: 63 LVRLYAVVTKE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 288
+ Y + +HRD++ NV++ E ++ D+GLA EY R +++ + P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAK 335
E ++ + D+WS G + ++ + K P + G N D + + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR 190
+G+G Y V+ G+ N + +K L ++E + LQ +K ++IV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 191 D----QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHR 243
T S+ E+V + + L + Y ++L + Y H+ ++HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 244 DVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQD 296
D+K +NVM+ ++LID+G LA G N+ + Y+ PE++ +
Sbjct: 127 DIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SG 184
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
Y D+WS+GC M K P
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 19/117 (16%)
Query: 149 TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---- 198
T IK+L+ ++ + +RE + L PN+V LLD + P
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLF 55
Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
+FEYV + + L + + ++L AL H+QGI+HRD+KP N+M+
Sbjct: 56 AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 24/163 (14%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
Y+++R +G+G EV+ + + R +K ++ P+ KK+ RE KI +L P
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL-------TDYDIRYYIYELLKALD 233
+V + I D Y+ K L ++ + + + L
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 234 -------YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
Y HS+G++HRD+KP N+++ ++ ++DWG A F
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 22/193 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCIIK----ILKPVKKKKIKREIKILQNLCGGPNVVKLLD 187
++GRG + EVF G N +K L P K K +E +IL+ PN+V+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-------ALDYCHSQGI 240
+ + ++ E V DF L R + EL++ ++Y S+
Sbjct: 61 VCTQKQPIY--IVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 297
+HRD+ N ++ E L++ D+G++ G ++ + PE L + Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173
Query: 298 DYSLDMWSLGCMF 310
D+WS G +
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
+ EYVN D + + +Y E+ L + H +GI++RD+K NVM+D E
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137
Query: 256 LRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
+++ D+G+ KE+ V V +R F G PE++ Q Y S+D W+ G
Sbjct: 138 -GHIKIADFGMC------KEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 189
Query: 309 MFAGMIFRKEPF 320
+ M+ + PF
Sbjct: 190 LLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
Y VR VG+G Y EV + ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALD 233
+V R+ L++ + + LY L + + + ++ AL
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
Y H + I+HRD+K NV + +++ D G+A + + + + Y+ PEL
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ + Y+Y D+W+LGC M K F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
+Y++ Y+++ ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 278 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
V + + Y+ PEL + + Y DMWSLG + ++ PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 3/100 (3%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
+Y ++ L Y H I++RD+K N+++D E +++ D+GL E G +
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ F PE+L + Y ++D W LG + M+ + PF
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIK---REIKILQNLCGG 179
D+ + +G+G + +V T+E IKILK ++ ++ E ++L L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59
Query: 180 PNVVKLLDIVRDQHSKTPSL-----IFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
P + L HS ++ + EYVN D + + +Y E+
Sbjct: 60 PPFLTQL------HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 290
L + HS+GI++RD+K NVM+D E +++ D+G+ E G + + PE+
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ Q Y S+D W+ G + M+ + PF
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
Y V++ + G VF + ++KI +K E +LQN+ P+V+++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHR 243
D + ++ + +S + L I ++L+ L Y H+Q I+HR
Sbjct: 124 DTL--VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELLVDL 294
DVK N+ I+ ++ + D G A+F V + F G PE+L
Sbjct: 182 DVKTENIFINDV-DQVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLAR- 230
Query: 295 QDYDYSLDMWSLGCMFAGM------IFRKEPFF---YGHDNHDQLVKI 333
Y+ D+WS G + M IF P Y H L+KI
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
|
Length = 357 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 57/242 (23%), Positives = 111/242 (45%), Gaps = 56/242 (23%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
++++ +G G + +V E + E C +KI++ V K R+ KI ++ +
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKI---------EIQFM 179
Query: 187 DIVR--DQHSKTPSLIFE--YVNSTDFKVLY-----PTLTDYDIRY----------YIYE 227
+ VR D + P + + + N T + P L D+ +++ I++
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVM-------IDHELRK--------LRLIDWGLAEFYH 271
ALDY H++ +MH D+KP N++ +D + +R+ D G
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---- 295
Query: 272 PGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
E + R V++R+++ PE+++ L + YS DMWS+GC+ + + + + HDN +
Sbjct: 296 -CDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLE 352
Query: 329 QL 330
L
Sbjct: 353 HL 354
|
Length = 467 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 32/200 (16%)
Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKKI---KREIKILQNLCGGPNV 182
++++G+G + V ++ + NT E +K L+ + + +REI+IL++L N+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNI 67
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-----------YIYELLKA 231
VK + + L+ EY+ Y +L DY ++ Y ++ K
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLP-------YGSLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASR---YFKG 287
++Y S+ +HRD+ N++++ E R +++ D+GL + KE Y VR ++
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 288 PELLVDLQDYDYSLDMWSLG 307
PE L + + + D+WS G
Sbjct: 180 PESLTE-SKFSVASDVWSFG 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 54/223 (24%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
DD+E + ++G G VF+ + + R +I + +KP + +I RE+++L C P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 63
Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
+V LD V + + P I V+
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-------------- 109
Query: 220 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
++K L Y + IMHRDVKP N++++ +++L D+G++ N
Sbjct: 110 ------IAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 161
Query: 279 RVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
V +R + PE LQ YS+ D+WS+G M + P
Sbjct: 162 FVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 226 YELLKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
++KAL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 285 FKGPELLVDLQD----YDYSLDMWSLG 307
+ PE + D D YD D+WSLG
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLG 205
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDI 188
+G G V++ ++ T +K++ +K+I E++IL C P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 248
++ S+ E+++ V Y + ++ + ++K L Y S I+HRDVKP
Sbjct: 68 FFVENRI--SICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPS 124
Query: 249 NVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 306
N++++ +++L D+G++ K Y V + + PE + Q Y D+WSL
Sbjct: 125 NMLVNTR-GQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVWSL 179
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341
G F + + P+ N L+ + + I+D
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 30/112 (26%), Positives = 59/112 (52%), Gaps = 5/112 (4%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
++KAL+Y HS+ ++HRDVKP NV+I+ +++L D+G++ + + + +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
PE + ++ + YD D+WSLG + + P+ QL ++ +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 12/102 (11%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRK-LRLIDWGL- 266
+++ I Y + +LKALDY H G +HR VK +++I + LR L +I+ G
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 267 AEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG 307
H +Y+V+V + PE+L +LQ YD D++S+G
Sbjct: 158 LRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 15/147 (10%)
Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR----EIKILQNLCGGPN---V 182
++ +G G + EV V+T+ +K L+ KK + R +K +++ + V
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEADNEWV 63
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQG 239
VKL +D+ + + +Y+ D L + R+YI EL A++ H G
Sbjct: 64 VKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGL 266
+HRD+KP N++ID + ++L D+GL
Sbjct: 122 FIHRDIKPDNILIDLD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 50/209 (23%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
DD+E + ++G G V + ++ + R +I + +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
+V LD V + + P I ++
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105
Query: 220 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
+L+ L Y + IMHRDVKP N++++ +++L D+G++ N
Sbjct: 106 ------IAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 157
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLG 307
V +R + PE L Y D+WSLG
Sbjct: 158 FVGTRSYMSPERLQG-THYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 99 VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERC 153
VY D L W++ + +G + +G G + +V E + +
Sbjct: 17 VYIDPTQLPYDLKWEFPRNNLSFG--------KTLGAGAFGKVVEATAYGLSKSDAVMKV 68
Query: 154 IIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
+K+LKP +++ + E+KI+ +L N+V LL +I EY D
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCYGDL 126
Query: 210 -----KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
+ LT D+ + Y++ K + + S+ +HRD+ NV++ H + +++ D+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDF 185
Query: 265 GLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
GLA Y V+ +R + PE + + Y + D+WS G
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYG 230
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 125 DDYEVVRKVGRGKYSEV---------FEGINVNTNERCIIKILKPVKKKKIKREIKILQN 175
+D+ +R +G G + V F + + E+ KI+K + + E KIL N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY--DIR-YYIYELLKAL 232
P V L +D+ L+ E+V +F + D+ +Y +++
Sbjct: 87 YINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
+Y S I++RD+KP N+++D + +++ D+G A+ + Y + Y PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
++ + + D W+LG ++ PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
++ ++++K+G G++ EV+ G N N + +K LKP + + E +I++ L
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62
Query: 182 VVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVLYPTLTDYDIRY--------YIYELLKAL 232
+V+L +V S+ P ++ EY++ L L D + R ++ +
Sbjct: 63 LVQLYAVV----SEEPIYIVTEYMSKGS---LLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 289
Y +HRD++ N+++ L ++ D+GLA EY R +++ + PE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + D+WS G + ++ + + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEY 276
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL + H K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYY 160
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVKK----KKIKREIKILQNLCGGPNVV 183
R +G+G + V+ G ++++ + C +K L + ++ +E I+++ PNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHS 237
LL I +P ++ Y+ D + PT+ D + + ++ K ++Y S
Sbjct: 60 SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 291
+ +HRD+ N M+D E +++ D+GLA E+Y ++ ++ L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171
Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
LQ ++ D+WS G + ++ R P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 19/50 (38%), Positives = 31/50 (62%), Gaps = 1/50 (2%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270
I+ + ++L L+Y H GI H D+KP N+M+D R +ID+G+A +
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 5/109 (4%)
Query: 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
EY + D + TLT D+ + Y++ + +++ S+ +HRD+ NV++ + +++
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKI 173
Query: 262 IDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
D+GLA H Y R + PE L D + Y + D+WS G
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-05
Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 4/126 (3%)
Query: 148 NTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
+E ++KI K +RE+ ILQ L V + + + L+ E++
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
+ DI + ELL L + H D+ P N+++D + + L +IDW
Sbjct: 78 ETLDEV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEY 135
Query: 267 AEFYHP 272
A + P
Sbjct: 136 AGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNV 182
++ + RK+G G + EV+EG+ N R IKILK +K++ ++E++ L+ L ++
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64
Query: 183 VKLLDIVRDQHSKTPSLIF----------EYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
+ L + P I ++ S + +VL P + D+ + E +
Sbjct: 65 ISLFAVCS---VGEPVYIITELMEKGSLLAFLRSPEGQVL-PVASLIDMACQVAE---GM 117
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKG 287
Y Q +HRD+ N+++ +L ++ D+GLA + Y + ++ ++
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLS---SDKKIPYKW-TA 172
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
PE + D+WS G + M + + G +NH+ +I
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 15/89 (16%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF--------YHPGKEYNV 278
+LL A+DY H +GI+HRD+K NV+++ + L D+G A F +H G V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLG 307
PE+L Y S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349
|
Length = 461 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-- 272
LT D+ Y++ + ++Y SQ +HRD+ NV++ + +++ D+GLA H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNID 188
Query: 273 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 132 KVGRGKYSEVFEGINVNTNERCI---IKILKPVKKKKIK----REIKILQNLCGGPNVVK 184
K+G G + V G + + I +K LK K I +E I+ +L N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL--------KALDYCH 236
L +V ++ E L L + +++ L + Y
Sbjct: 61 LYGVVLTHPLM---MVTEL---APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPELLV 292
S+ +HRD+ N+++ + K+++ D+GL +++ V PE L
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 293 DLQDYDYSLDMWSLG-CMFAGMIFRKEPF 320
+ ++ D+W G ++ + +EP+
Sbjct: 174 TRT-FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 147 VNTNERCIIKILKPVKKKKI--KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
ER I K +K + I + EI L L N++K+ +I+R + + +
Sbjct: 189 KPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMIT 242
Query: 205 NSTDFKVLYPTLTDYDI-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
DF LY + D R + +LL A++Y H + ++HRD+K N+ ++
Sbjct: 243 QKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDMWSL 306
+ K+ L D+G A + R A Y PE+L Y D+WS
Sbjct: 302 CD-GKIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSC 354
Query: 307 GCMFAGMIFRKE-PFFYGHDN-HDQLVKIAKVTTILD 341
G + M+ P G QL+KI ++ D
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391
|
Length = 501 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 39/204 (19%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62
Query: 181 NVVKLLDIVRDQHSKTPSL-----------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
N+V+LL + ++ P + +Y+ + + + + + Y ++
Sbjct: 63 NLVQLLGVC----TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQIS 114
Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 285
A++Y + +HRD+ N ++ ++ L +++ D+GL+ G Y +++ +
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMT-GDTYTAHAGAKFPIKW 171
Query: 286 KGPELLVDLQDYDYSLDMWSLGCM 309
PE L + D+W+ G +
Sbjct: 172 TAPESLA-YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
+T D+ Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA +
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDY 192
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 193 YKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
I +L++AL+ H I+H D+K NV+ D ++ L D+GL + Y+ + Y
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--Y 172
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
F PE + +YD S D W++G + ++ K PF D
Sbjct: 173 FS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 19/83 (22%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 188 IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
++ D + +++ EY+ D K VL + ++ + + H GI+H D+
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455
Query: 247 PHNVMIDHELRKLRLIDWGLAEF 269
N ++ + +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
++ ++V+K+G G++ EV+ G N + + IK LK + + E +++ L P
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62
Query: 182 VVKLLDIVRDQHSKTPSLIF-EYVNS---TDFKVLYPTLTDYDIRYYIYELL-------K 230
+V+L +V ++ P I EY+ + DF T I+ I +L+ +
Sbjct: 63 LVRLYAVV----TQEPIYIITEYMENGSLVDF-----LKTPEGIKLTINKLIDMAAQIAE 113
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
+ + + +HRD++ N+++ L ++ D+GLA EY R +++ +
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMI 314
PE ++ + D+WS G + ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 21/190 (11%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGPNVVKLL 186
K+G+G + +V++G+ + N +K L P K+K +E +IL+ PN+VKL+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLI 58
Query: 187 DIVRDQHSKTPSLI-FEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIM 241
+ K P I E V LT + + ++Y S+ +
Sbjct: 59 GVCVQ---KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQDY 297
HRD+ N ++ L++ D+G++ G Y V + + PE L + Y
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL-NYGRY 172
Query: 298 DYSLDMWSLG 307
D+WS G
Sbjct: 173 TSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 12/129 (9%)
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
L + +R + P F+ + ++ + L Y++ + ++Y S+ +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-----AYQVARGMEYLESRRCIHRD 159
Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 300
+ NV++ + +++ D+GLA H K N R+ ++ PE L D + Y +
Sbjct: 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216
Query: 301 LDMWSLGCM 309
D+WS G +
Sbjct: 217 SDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 13/53 (24%), Positives = 24/53 (45%)
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
++ + L AL ++H D+ P N+++D R +ID+ A P
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 27/200 (13%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
D+ +++RK+G G++ EV+EG+ NT +K LKP + K E +I++ L P
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61
Query: 181 NVVKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKA 231
+++L + + K SL+ EY+ + L P L D ++
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115
Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
+ Y +Q +HRD+ NV++ ++ + K + D+GLA Y R +++ +
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICK--VADFGLARVIKE-DIYEAREGAKFPIKWTA 172
Query: 288 PELLVDLQDYDYSLDMWSLG 307
PE + D+WS G
Sbjct: 173 PE-AALYNRFSIKSDVWSFG 191
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 50/219 (22%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
+D E + +G G V + ++ T K++ K +K+I RE++I+ C
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CR 61
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
P +V ++++ + F S D +K P + + +++ L Y +
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLY 120
Query: 237 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
+ IMHRD+KP N++++ +++L D+G++ G+ N V + + PE
Sbjct: 121 NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE-- 172
Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHD 328
+Q Y++ D+WSLG + K PF + + + D
Sbjct: 173 -RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 133 VGRGKYSEVFEG-----INVNTNE-RCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
+G G + EV+EG + + R +K L+ +KK+ +E ++ N PN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDF----------KVLYPTLTDYDIRYYIYELLKAL 232
VKLL + + +I E + D + P LT ++ ++ K
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 284
Y +HRD+ N ++ + R +++ D+GLA + Y + R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 285 FKGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL 330
PE L+D + S D+WS G M+ + ++P + +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVA 281
Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA H K N R+
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
++ PE L D + Y + D+WS G +
Sbjct: 206 VKWM-APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 128 EVVRKVGRGKYSEVFEGINVNTNER-CI---IKILK----PVKKKKIKREIKILQNLCGG 179
E ++ +G G + V++G+ + E+ I IK+L+ P K+I E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYELL 229
P+VV+LL I S LI + + N D + + + ++
Sbjct: 69 PHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 285
K + Y + ++HRD+ NV++ + +++ D+GLA+ KEY+ +V ++
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 286 KGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPF 320
E ++ + Y + D+WS G ++ M F +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 18/95 (18%)
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYF- 285
+L+A+ Y H I+HRD+K N+ I+H + L D+G A + V + A++Y+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAA-------CFPVDINANKYYG 242
Query: 286 -------KGPELLVDLQDYDYSLDMWSLGCMFAGM 313
PELL Y ++D+WS G + M
Sbjct: 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 25/151 (16%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKIL-QNLCGGP 180
+ RG +E++ G + + +IK P +++++ +RE +I+ + G
Sbjct: 4 IKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 181 NV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
NV V +D ++ EY+ K L + ++ E+ + + HS
Sbjct: 62 NVPAVYFVDPENF------IIVMEYIEGEPLKDLINSNGMEELELS-REIGRLVGKLHSA 114
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
GI+H D+ N+++ K+ LID+GLAEF
Sbjct: 115 GIIHGDLTTSNMILSG--GKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 44/216 (20%)
Query: 133 VGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
+G G++ +V + R +K+LK + + + E +L+ + P+V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVI 66
Query: 184 KLLDIVRDQHSKTPSLIFEYV---------------------------NSTDFKVLYPTL 216
KL LI EY +S L
Sbjct: 67 KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
T D+ + +++ + + Y ++HRD+ NV++ E RK+++ D+GL+ + Y
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSY 183
Query: 277 NVRVASRY---FKGPELLVDLQDYDYSLDMWSLGCM 309
R R + E L D Y D+WS G +
Sbjct: 184 VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVL 218
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 26/104 (25%), Positives = 49/104 (47%), Gaps = 11/104 (10%)
Query: 167 KREIKILQNLC-GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
+ E ++L G N + D+ D +KT ++ EY+ K + D +
Sbjct: 45 RNEARLLSRARKAGVNTPVVYDV--DPDNKT--IVMEYIEGKPLKDVIEEGNDE----LL 96
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
E+ + + H GI+H D+ N+++ + KL LID+GL ++
Sbjct: 97 REIGRLVGKLHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----KREIK--ILQNLC----GGP 180
+ +G G++ V EG + I+K+ VK KI + E++ + + +C P
Sbjct: 5 KTLGEGEFGSVMEGQL--NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 181 NVVKLLDI----VRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRY-------YIYE 227
NV++L+ + V + +P +I ++ D +LY L D ++ +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK 286
+ ++Y S+ +HRD+ N M++ + + + D+GL++ + G Y R+A K
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 287 --GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
E L D + Y D+WS G + R + + G +N +
Sbjct: 180 WIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
+L+ L Y + IMHRDVKP N++++ +++L D+G++ N V +R +
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 169
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
PE LQ YS+ D+WS+G + + P
Sbjct: 170 SPE---RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 38/193 (19%), Positives = 83/193 (43%), Gaps = 24/193 (12%)
Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVK----KKKIKREIKILQNLCGGPNVV 183
+++G G + V +G+ + + + +K LK KK+ RE ++ L P +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59
Query: 184 KLLDIVRDQHSKTPS--LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
+L+ + K L+ E + + D++ +++ + Y S+
Sbjct: 60 RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVDL 294
+HRD+ NV++ + + ++ D+G++ G + Y A R+ + PE ++
Sbjct: 115 HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CINY 172
Query: 295 QDYDYSLDMWSLG 307
+ D+WS G
Sbjct: 173 GKFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 50/212 (23%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---------GPNVV 183
+G+G++ +V G + V K +K + Q PN+V
Sbjct: 14 IGKGEFGDVMLGDYRG----------QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 184 KLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 235
+LL +V ++ SL+ +Y+ S V+ T + ++ + ++Y
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLV-DYLRSRGRAVI----TLAQQLGFALDVCEGMEYL 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELL 291
+ +HRD+ NV++ +L ++ D+GLA KE + S PE L
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVA-KVSDFGLA------KEASQGQDSGKLPVKWTAPEAL 171
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
+ + D+WS G I E + +G
Sbjct: 172 -REKKFSTKSDVWSFG------ILLWEIYSFG 196
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 226 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVAS 282
+KAL+Y + I+HRDVKP N+++D R ++L D+G++
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 283 RYFKGPELLV--DLQDYDYSLDMWSLG 307
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 18/100 (18%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRKLRLID----WGLAEF 269
I + + ++L ALDY HS+G +HR VK ++++ + LR +
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 270 YHP-GKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG 307
P N+ S PE+L +LQ Y+ D++S+G
Sbjct: 163 DFPKSSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 344 | |||
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.01 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.96 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.46 | |
| PLN02236 | 344 | choline kinase | 97.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.11 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.91 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.86 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.12 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.89 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.8 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.77 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.48 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.44 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 95.38 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 95.37 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.41 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=371.58 Aligned_cols=250 Identities=85% Similarity=1.384 Sum_probs=243.8
Q ss_pred CCcccccccccccCCCCccCCCccceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHH
Q 019241 93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI 172 (344)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~ 172 (344)
..+.++++++++..++.++|+|+.+.+.|+.+++|++++++|+|.+++||.|.+..+++.++||++++...+.+.+|+.|
T Consensus 6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikI 85 (338)
T KOG0668|consen 6 VPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKI 85 (338)
T ss_pred cchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHH
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 173 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
|+.|++||||+++++...++.++.+.|++||.++.++..+.+.++..+++.++.++++||.|+|++||+|||+||.|+++
T Consensus 86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI 165 (338)
T ss_pred HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~ 332 (344)
|.+...++|+|||+|.++.++.+++.++.+++|..||.+.+.+.|+.+.|+|||||++..|++.+.||+.|.++.+|+.+
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 99888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCC
Q 019241 333 IAKVTTILDF 342 (344)
Q Consensus 333 i~~~~~~~~~ 342 (344)
|++++|+-++
T Consensus 246 IakVLGt~el 255 (338)
T KOG0668|consen 246 IAKVLGTDEL 255 (338)
T ss_pred HHHHhChHHH
Confidence 9999998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=358.77 Aligned_cols=208 Identities=31% Similarity=0.574 Sum_probs=184.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
...+|.+.++||+|+||+||+|+++.++..||||.+... ..+.+..|+.+|+.+ +|||||.++++++. ...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~--~~~i 84 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIED--DDFI 84 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEec--CCeE
Confidence 356788999999999999999999999999999998644 345578899999999 99999999999965 4788
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--C---CcEEEEeccccee
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--L---RKLRLIDWGLAEF 269 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~---~~~kl~DFGla~~ 269 (344)
|||||||++|+|..++ ..+++..++.++.|++.||++||+++||||||||+|||++.. . -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999998 369999999999999999999999999999999999999864 1 2589999999999
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+.++....+.||++.|||||++.. +.|+.|+|+||+|+++|+|++|+.|| ...+..|.+..+.+
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-DAETPKELLLYIKK 228 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-cccCHHHHHHHHhc
Confidence 998888888999999999999976 89999999999999999999999998 44455555555444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=360.68 Aligned_cols=215 Identities=35% Similarity=0.673 Sum_probs=195.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+.- ....-..+||.||++| +||||++|.+...+.....+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 4679999999999999999999999999999998852 3345578999999999 999999999999887678899
Q ss_pred EEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
||+|||+......... .|++.++..|+.|++.||+|||++||+|||||.+|||||.+ |.+||+|||||+++....
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCCCC
Confidence 9999999876554443 59999999999999999999999999999999999999999 899999999999887654
Q ss_pred -cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.++..+.|.+|+|||.+++...|+.++|+||.||||.||+.|++ .++|.++.+|+.+|.+++|.|.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP-I~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP-ILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC-CcCCccHHHHHHHHHHHhCCCC
Confidence 56788999999999999999999999999999999999999985 5599999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=347.38 Aligned_cols=207 Identities=30% Similarity=0.581 Sum_probs=186.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||+||.++.+.+++.+|+|++++. ..+...+|..||.++ +||+||+++-.| ++...
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysF--Qt~~k 99 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSF--QTEEK 99 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEec--ccCCe
Confidence 468899999999999999999999999999999999643 346678999999998 999999999999 55688
Q ss_pred cEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CC
Q 019241 197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~ 272 (344)
+|+|+||++||.|...++ .+++..++.|+.+|+.||.|||++|||||||||+|||+|.+ |.++|+|||+++.. ..
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcccC
Confidence 999999999999999985 69999999999999999999999999999999999999999 89999999999844 44
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+....+.|||+.|||||++.+ ..|+..+|+||+||++|||++|..|| .+.+..+...+|.+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF-~~~~~~~~~~~I~~ 239 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPF-YAEDVKKMYDKILK 239 (357)
T ss_pred CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCC-cCccHHHHHHHHhc
Confidence 456667899999999999998 79999999999999999999999999 45665666666654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=338.89 Aligned_cols=212 Identities=35% Similarity=0.658 Sum_probs=192.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+.|+.+.++|+|+||+||+|+++.+|+.||||.+.... .+-..+|+.+|+++ +|+|+|.++++|+. .+.++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence 56888899999999999999999999999999985332 34567999999999 99999999999965 467789
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CCCc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~~~ 275 (344)
|+|||+..-|..+- ..++...+..+++|++.|+.|+|+.++|||||||+|||++.+ +.+||||||+|+.+. ++..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence 99999998776654 568999999999999999999999999999999999999999 899999999999988 7777
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
++-.+.|++|+|||.+.+...|+..+|||++||++.||++|. |.++|.++-+|+..|...+|.+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~ 222 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLI 222 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccC
Confidence 788899999999999999899999999999999999999998 45589999999999999999763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=322.90 Aligned_cols=213 Identities=37% Similarity=0.720 Sum_probs=189.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|...++||+|.||.||+|++..+|+.||||.++..+. ....+|++.|+.+ +|+||+.++++| .+.....|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F--~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF--PHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc--cCCCceEE
Confidence 467778999999999999999999999999999874433 4567999999999 999999999999 55677789
Q ss_pred EEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 200 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
|+|||+.. |...++ .++..++..++.++++|++|||++.|+||||||.|+|++++ +.+||+|||+|+.+.+..
T Consensus 79 VfEfm~td-Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 79 VFEFMPTD-LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEecccc-HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCc
Confidence 99999864 444443 38999999999999999999999999999999999999999 899999999999887543
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~ 343 (344)
.....+.|++|+|||.+.+...|+..+||||.||++.||+-|. ||++|+++-||+..|.+.+|+|.-+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcc
Confidence 3445589999999999999999999999999999999999775 8889999999999999999998654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=340.17 Aligned_cols=214 Identities=33% Similarity=0.613 Sum_probs=190.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCC---ccEEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIFE 202 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~e 202 (344)
.|+..+++|+|+||.||+|....+++.+|||..-+.. +--.+|+++|+.+ +|||||+++-+|....+. +..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 4777899999999999999999999999999874322 2334799999998 999999999988765544 6679999
Q ss_pred eecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 203 YVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 203 ~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+........ ..++...++.+..|+++||.|||+.||+||||||.|+|+|.+.+.+||||||.|+....++..
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 99986544433 468888899999999999999999999999999999999999999999999999999888888
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
.+-..|++|+|||.+.+...|+.+.||||.||++.||+-|++-| .|++..+|+..|.+++|+|.-
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF-pG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF-PGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc-CCCCHHHHHHHHHHHhCCCCH
Confidence 88899999999999999999999999999999999999998555 899999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=350.96 Aligned_cols=206 Identities=26% Similarity=0.535 Sum_probs=185.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec------ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..+|...+.||+|||+.||++++..+|+.||+|++. ....++..+|++|.+.| +|||||+++++|++ ..++
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FED--s~nV 93 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFED--SNNV 93 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeec--CCce
Confidence 377999999999999999999999999999999984 34557789999999999 99999999999955 5889
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~- 273 (344)
|+|+|+|..++|..++ +.++|.+++++++||+.||.|||+.+|+|||||..|++++++ ..+||+|||||.....+
T Consensus 94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCcc
Confidence 9999999999998887 469999999999999999999999999999999999999999 68999999999888744
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+...+.|||+.|.|||++.. ...++.+||||+||++|.|+.|++||. ..+-.|.+.+|..
T Consensus 173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~vkety~~Ik~ 232 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE-TKTVKETYNKIKL 232 (592)
T ss_pred cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc-cchHHHHHHHHHh
Confidence 67778899999999999986 889999999999999999999999994 4444555555544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=336.04 Aligned_cols=205 Identities=22% Similarity=0.422 Sum_probs=183.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEe----cccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++.+.++.||+|..|+|||++++.+++.+|+|++ ++...+++.+|++++++. +||+||.+||.|..... .++++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 4667789999999999999999999999999998 455668899999999999 99999999999976644 58899
Q ss_pred EEeecCCchhhHcCC---CCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 201 FEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l~~---l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||||++|+|+.++.. +++..+..++.++++||.|||+ ++||||||||+|||++.. |.+||||||.++.+-+. ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hc
Confidence 999999999999864 9999999999999999999995 899999999999999998 89999999999887655 66
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CCCHHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG----HDNHDQLVKIA 334 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~----~~~~~~l~~i~ 334 (344)
++.+||..|||||.+.+ ..|+.++||||||++++|+.+|+.||... .+..+.+..|.
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 88999999999999988 89999999999999999999999999764 23345555553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=339.25 Aligned_cols=208 Identities=27% Similarity=0.471 Sum_probs=178.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----------hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
..+.|.+.+.||+|+||.|-+|..+.+++.||||++++.. .....+|+++|++| +|||||+++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence 4677899999999999999999999999999999996322 22356999999999 999999999999664
Q ss_pred CCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccc
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA 267 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla 267 (344)
.+.|+||||++||+|.+.+ ..+.+...+.+++|++.|+.|||++||+||||||+|||+..+ .-.+||+|||+|
T Consensus 249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 5668999999999998887 458888899999999999999999999999999999999755 236899999999
Q ss_pred eecCCCCcceecccCCCccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
+..+......+.|||+.|.|||++.+. ..+..++|+||+||+||-+++|.+||.....+.....+|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI 394 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI 394 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence 999888888899999999999999762 224458899999999999999999996544444333333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=329.20 Aligned_cols=214 Identities=31% Similarity=0.562 Sum_probs=192.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchH-----HHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
-+.|+.+++|++|+||.||+|+++.+++.||+|.++....+ .-.+|+.+|.++ +|||||.+-++....+-..+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence 35799999999999999999999999999999999754432 357999999999 899999999999877778899
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~- 273 (344)
+|||||+.. |..++ ++|...+++.++.|+++|++|||...|+|||||++|+|+++. |.+||+|||+|+.+...
T Consensus 154 ~VMe~~EhD-Lksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 154 IVMEYVEHD-LKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPL 231 (419)
T ss_pred eeHHHHHhh-HHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCc
Confidence 999999874 33333 479999999999999999999999999999999999999988 89999999999988754
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
..++..+.|.+|+|||.+++...|+++.|+||+||++.||+++++.| +|.++-+|+.+|.+++|+|.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf-~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF-PGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC-CCCchHHHHHHHHHHhCCCc
Confidence 45677789999999999999899999999999999999999998554 89999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=344.86 Aligned_cols=218 Identities=30% Similarity=0.566 Sum_probs=194.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--H--HHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--K--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|.++++||.|.||.||+|+...+++.||||.++.... + .-.+|+..|+++..||||+++.+++.+.+. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 45789999999999999999999999999999999874321 2 235899999999559999999999987653 889
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+|||||+.....-.- +.|++..++.|+.||++||+|+|+.|+.|||+||+|||+... ..+||+|||+|+.......
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccccCCC
Confidence 999999876433222 459999999999999999999999999999999999999965 5899999999999998888
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~ 343 (344)
++..+.|++|+|||+++....|+.+.|||++||+++|+.+-++.| +|.++-+++.+|.+++|+|+-+
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF-PG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF-PGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC-CCCcHHHHHHHHHHHhCCCccc
Confidence 899999999999999999899999999999999999999998555 8999999999999999999754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=317.46 Aligned_cols=205 Identities=23% Similarity=0.471 Sum_probs=184.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|+.++.||.|+||.|.+++.+.++..+|+|++++.. .+...+|..+|+.+ .||+++++++.|.+ ...
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCe
Confidence 3577889999999999999999999999999999997543 35567899999999 89999999999954 588
Q ss_pred cEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+++||||.+||.+..+++ ++++..++.++.||+.||+|||+.+|++|||||+|||+|.+ |.+||+|||+|+.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecCc
Confidence 899999999999999984 69999999999999999999999999999999999999999 89999999999987643
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..+.|||+.|+|||+++. .+++.++|.|||||++|||+.|..||+ +.+..+...+|.+
T Consensus 198 --T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~-~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFY-DDNPIQIYEKILE 255 (355)
T ss_pred --EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCc-CCChHHHHHHHHh
Confidence 677899999999999988 899999999999999999999999996 4444777777765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=328.17 Aligned_cols=208 Identities=26% Similarity=0.546 Sum_probs=180.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..+|++.++||+|+||+||++++..++..+|.|.++ ....+....|+.+|++| +|||||++++.-...+...++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence 456899999999999999999999999999999874 23446688999999999 999999999943333345578
Q ss_pred EEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHH--cC--cEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 199 lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~--~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
+|||||..|+|...+ +.+++..++++..|++.||.++|+ .+ |+||||||.||+++.+ |.+||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhH
Confidence 999999999999887 348999999999999999999998 55 9999999999999988 89999999999
Q ss_pred eecCCCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 268 EFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 268 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+....... ..+.+|||+||+||.+.+ .+|++++||||+||++|||+..+.||+ |++-.+...+|.+
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~-g~n~~~L~~KI~q 242 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFY-GDNLLSLCKKIEQ 242 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcc-cccHHHHHHHHHc
Confidence 98875543 355699999999999988 899999999999999999999999994 5565666666655
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=337.86 Aligned_cols=213 Identities=31% Similarity=0.544 Sum_probs=188.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|.+.+.||+|+|++|++|+++.+++.+|||++.+ .+.+-..+|-++|.+|.+||.|++|+-.|.| ...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccc
Confidence 35789999999999999999999999999999999853 2334467899999999999999999999955 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+|.|+||+++|+|..++ ..|++...+.++.||+.||+|||++|||||||||+|||+|.| +.+||+|||.|+.+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence 88999999999999988 468999999999999999999999999999999999999999 89999999999988643
Q ss_pred Ccc--------------eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 274 KEY--------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 274 ~~~--------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
... ..++||-.|.+||++.+ ...+.++|+|+|||+||.|+.|.+|| .+.++.-.+.+|.++.-.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALDYE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhccc
Confidence 211 45799999999999987 88999999999999999999999999 677778888888876554
Q ss_pred C
Q 019241 340 L 340 (344)
Q Consensus 340 ~ 340 (344)
+
T Consensus 306 f 306 (604)
T KOG0592|consen 306 F 306 (604)
T ss_pred C
Confidence 4
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.49 Aligned_cols=216 Identities=31% Similarity=0.512 Sum_probs=187.9
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
....++|+++..||+|+||.||+|+.+.+|..+|+|++++. ..+..+.|..+|... ++++||+++-.| ++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsF--QD~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSF--QDK 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEe--cCC
Confidence 34578999999999999999999999999999999999753 346678899999996 999999999999 556
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.++||||||++||++..++ ..|++..++.|+.+++.|++-+|+.|+|||||||+|+|||.. |.+||+||||+.-+.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD 292 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhh
Confidence 8899999999999999988 569999999999999999999999999999999999999998 899999999984221
Q ss_pred C----------------------C--C------------------------cceecccCCCccCcccccCCCCCCchhhH
Q 019241 272 P----------------------G--K------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDM 303 (344)
Q Consensus 272 ~----------------------~--~------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Dv 303 (344)
. . . .....+|||.|||||++.+ .+|+..+|+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDw 371 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDW 371 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccH
Confidence 0 0 0 0112479999999999998 789999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 304 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 304 wSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
||||||+||||.|.+|| .+.+..+.+.+|.+-.-++.+
T Consensus 372 WSLG~ImyEmLvGyPPF-~s~tp~~T~rkI~nwr~~l~f 409 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPF-CSETPQETYRKIVNWRETLKF 409 (550)
T ss_pred HHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhhhccC
Confidence 99999999999999999 678888988888876544433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=339.60 Aligned_cols=208 Identities=27% Similarity=0.482 Sum_probs=189.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|.++++||+|+||+|+++..+.+++.+|||++++. ..+..+.|..|+....+||.+++++.+| +...+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCe
Confidence 467899999999999999999999999999999999753 3466788999999887899999999999 66789
Q ss_pred cEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CC
Q 019241 197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~ 273 (344)
+|.||||+.||++..+. ..|++..++.|+.+++.||.|||+.|||+||||.+|||+|.+ |.+||+|||+++..- .+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCCCC
Confidence 99999999999955544 469999999999999999999999999999999999999999 899999999998754 55
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+.|||+.|||||++.+ ..|+.++|.|||||+||||+.|..|| .|++++|....|..
T Consensus 523 ~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVN 582 (694)
T ss_pred CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhc
Confidence 67788899999999999988 89999999999999999999999999 78899998888865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=329.69 Aligned_cols=206 Identities=21% Similarity=0.381 Sum_probs=173.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeE-EEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-CIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.+...+.+.||+|+||+||+|.+. |.. ||+|++.... .+.|.+|+.+|.++ +|||||+++|+|.++.. ..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~ 115 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SL 115 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ce
Confidence 344455567999999999999764 344 9999997543 46899999999999 99999999999966432 68
Q ss_pred EEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-cEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 198 SLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~-iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
++|||||++|+|..++ ..++...+..++.||++||+|||+++ |||||||++|||++.+...+||||||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 8999999999999988 35899999999999999999999999 99999999999999983399999999998776
Q ss_pred CC-CcceecccCCCccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 272 PG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.. .......||..|||||++.+ ...|+.|+|||||||++|||+||+.||..... .+....+.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~ 259 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVV 259 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHH
Confidence 54 33444789999999999985 26899999999999999999999999954443 44444443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=337.81 Aligned_cols=209 Identities=31% Similarity=0.581 Sum_probs=184.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCC-----CCccceeeEEEccCCCccE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-----PNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-----~niv~l~~~~~~~~~~~~~ 198 (344)
+|++++.||+|+||+|.+|.+..+++.||||+++... ..+-..|+.+|..+.+| -|+|+++++| ...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F--~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF--YFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc--cccccee
Confidence 7899999999999999999999999999999998543 35667899999999534 4899999999 5568999
Q ss_pred EEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-CCcEEEEecccceecCC
Q 019241 199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 199 lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~ 272 (344)
||+|.++.. |.+++ ..++...++.++.||+.||.+||+.+|||+||||+|||+.+- ...+||+|||.|.....
T Consensus 265 iVfELL~~N-LYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 265 IVFELLSTN-LYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eeehhhhhh-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 999988764 45555 358899999999999999999999999999999999999653 34799999999987543
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
. ......++.|+|||++++ ..|+.+.||||||||+.||++| .|+++|.++.+|++.|.+++|.||
T Consensus 344 ~--vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 344 R--VYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred c--ceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCC
Confidence 2 236789999999999999 8999999999999999999999 577799999999999999999887
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=318.61 Aligned_cols=220 Identities=32% Similarity=0.597 Sum_probs=192.9
Q ss_pred eccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEc--
Q 019241 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRD-- 191 (344)
Q Consensus 119 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-- 191 (344)
..+....+|..++.||+|+||.|+.+.+..+|+.||+|.+.. ...++..+|+.+|+++ +|+||+.+++.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccc
Confidence 444556777778999999999999999999999999998752 3346788999999999 89999999999865
Q ss_pred -cCCCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 192 -QHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 192 -~~~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
...+..|+|+|+| +.+|...++ .+++..+..+++|+++||.|+|+.+|+||||||.|+|++.+ ..+||||||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccce
Confidence 3346789999999 456666662 38999999999999999999999999999999999999999 68899999999
Q ss_pred eecCC---CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 268 EFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 268 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
+...+ ....+.-+.|++|+|||++.....|+.+.||||.||++.||++|+..| .|.+..+|+..|.+++|+|+-
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCH
Confidence 98864 334456688999999999999899999999999999999999999666 899999999999999999963
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=314.14 Aligned_cols=216 Identities=32% Similarity=0.603 Sum_probs=187.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCC-ccceeeEEEccC----
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN-VVKLLDIVRDQH---- 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~---- 193 (344)
...|+.+++||+|.||+||+|+.+.+|+.||+|.++-.. .....+|+.+++++ +|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 345677889999999999999999999999999986332 34568999999999 9999 999999996543
Q ss_pred CCccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
....++|+||++.. |..++. .++...++.+++|++.||+|||+.+|+||||||+|||++++ +.+||+|||+
T Consensus 89 ~~~l~lvfe~~d~D-L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGl 166 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRD-LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGL 166 (323)
T ss_pred cceEEEEEEeeccc-HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccch
Confidence 12678999999754 344432 36667899999999999999999999999999999999997 8999999999
Q ss_pred ceecC-CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 019241 267 AEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343 (344)
Q Consensus 267 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~ 343 (344)
|+... +...+...++|.+|+|||++.+...|+...||||+||++.||++++. .+.|+++.+++.+|.+++|+|.-+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~-LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP-LFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC-CCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99876 55667888999999999999998799999999999999999999775 558999999999999999999643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=331.08 Aligned_cols=191 Identities=30% Similarity=0.614 Sum_probs=174.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..+ +.+.+|++|++.+ +||||+.++++| +...+.++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf--Et~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF--ETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh--cccceEEE
Confidence 567888999999999999999999999999999975443 3488999999999 999999999999 55689999
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|.||+.| +|..++ ..++++.++.++.++..||.|||+.+|+|||+||+|||++.. +.+|+||||+|+.+..+...
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence 9999999 888877 569999999999999999999999999999999999999998 89999999999988765443
Q ss_pred -eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 277 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
+...||+.|||||.+.+ ..|+..+|+||+||++||+.+|++||+
T Consensus 157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCch
Confidence 44589999999999886 899999999999999999999999996
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=322.90 Aligned_cols=210 Identities=30% Similarity=0.519 Sum_probs=182.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|.+.+.||+|+||+|+.|++..+++.||+|+++.. ..+.+.+|+.+++++..||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 467899999999999999999999999999999987642 2346678999999994499999999999654
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY- 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~- 270 (344)
...++||||+.+|+|.+++ ..+.+.+++.++.|++.|++|||++||+||||||+|||++.+.+.+||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 5589999999999998887 468999999999999999999999999999999999999987568999999999988
Q ss_pred CCCCcceecccCCCccCcccccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.........+||+.|+|||++.+...| +.++||||+||+||.|++|+.||.. .+......+|.+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~ 237 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK 237 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc
Confidence 466778889999999999999984425 5899999999999999999999943 444555555543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=318.07 Aligned_cols=209 Identities=30% Similarity=0.562 Sum_probs=181.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------hHHHHHHHHHHHHHhCCCCcccee
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNVVKLL 186 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~h~niv~l~ 186 (344)
.++|++.+.||+|.||.|-+|++..+++.||+|++.+.. .++..+|+.||+++ .|+|||+|+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 578999999999999999999999999999999984211 24678999999999 999999999
Q ss_pred eEEEccCCCccEEEEEeecCCchhhHc--CC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEe
Q 019241 187 DIVRDQHSKTPSLIFEYVNSTDFKVLY--PT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263 (344)
Q Consensus 187 ~~~~~~~~~~~~lv~e~~~~~~l~~~l--~~-l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~D 263 (344)
++..++.+..+|||+|||..|.+...- .. +++.+++.|++++..||+|||.+|||||||||+|+|++++ +.+||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEeec
Confidence 999999999999999999988765443 22 8899999999999999999999999999999999999999 8999999
Q ss_pred cccceecCC------CCcceecccCCCccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 264 WGLAEFYHP------GKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 264 FGla~~~~~------~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
||.+..... .......+||+.|+|||.+.+. ...+++.||||+||+||.|+.|+.||+ ++...+...+|+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-~~~~~~l~~KIv 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-DDFELELFDKIV 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-cchHHHHHHHHh
Confidence 999876522 2233457999999999999872 345789999999999999999999994 555666677776
Q ss_pred H
Q 019241 335 K 335 (344)
Q Consensus 335 ~ 335 (344)
+
T Consensus 333 n 333 (576)
T KOG0585|consen 333 N 333 (576)
T ss_pred c
Confidence 5
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.76 Aligned_cols=214 Identities=24% Similarity=0.465 Sum_probs=186.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
...|+...+||+|+.|.||.+....+++.||||.+.. ..++-+.+|+.+|+.. +|+|||++++.|... ..++.|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeEEE
Confidence 5678889999999999999999999999999999853 3346678999999999 999999999988554 678999
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~ 277 (344)
||||++|+|-+... .+++.++..++++++.||+|||.+||+|||||.+|||++.+ +.+||+|||+|..+.... .-.
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccCccc
Confidence 99999999988874 48999999999999999999999999999999999999999 889999999998887665 445
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFSN 344 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~~ 344 (344)
..+||++|||||++.. ..|++++||||||++++||+.|.+||++ .+....+ .+...-|+|++.+
T Consensus 428 TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAl-yLIa~ng~P~lk~ 491 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRAL-YLIATNGTPKLKN 491 (550)
T ss_pred cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CChHHHH-HHHhhcCCCCcCC
Confidence 6699999999999987 8899999999999999999999999987 3333333 3445678877653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.77 Aligned_cols=197 Identities=21% Similarity=0.359 Sum_probs=170.8
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++++|...+.||+|+||+||+|.. .++..||||.++... ..+|.+|++++.++ +|||+|+++|||.+.+. ..+
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~ 148 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRL 148 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEE
Confidence 3578888889999999999999964 455899999987543 56799999999999 79999999999976532 588
Q ss_pred EEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHc---CcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~---~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
||||||++|+|.+.+. .++|..+.+|+.++|+||+|||+. .|||||||++|||+|++ ..+||+|||+|+..
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccC
Confidence 9999999999999872 679999999999999999999974 49999999999999988 68899999999776
Q ss_pred CC-CCcceec-ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 271 HP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 271 ~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. ....... .||.+|+|||++.. ...+.++|||||||+|.|++||+.+....
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 54 3333333 89999999999876 78999999999999999999999888643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.75 Aligned_cols=206 Identities=21% Similarity=0.409 Sum_probs=176.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.+.+++++.||+|.||+||.|.+. +...||+|.++. ...+.|.+|+++|++| +|+|||+++++|..+ ..++|||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVt 280 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVT 280 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEE
Confidence 345667799999999999999753 445799999975 3457899999999999 999999999999664 4688999
Q ss_pred EeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||+.|+|.++++. +...+...++.|||+||+||+++++|||||.++|||++++ ..+||+|||+|+... ++.+
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~-d~~Y 358 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIG-DDEY 358 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccC-CCce
Confidence 99999999999853 7888999999999999999999999999999999999999 799999999999544 3444
Q ss_pred eecccC---CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 277 NVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 277 ~~~~~t---~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
....+. ..|.|||.+.. ..++.++|||||||+||||+|....++.+.++.+.+..+.+-
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred eecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence 444443 34999999877 889999999999999999999555555899999999888763
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.31 Aligned_cols=205 Identities=28% Similarity=0.485 Sum_probs=175.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++++.||+|+||+||+|++..+++.+|+|+++.. ....+.+|+.++..+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence 4789999999999999999999999999999998642 224577899999999 99999999999954 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence 999999999998887 458999999999999999999999999999999999999988 789999999987543211
Q ss_pred -----------------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 019241 275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319 (344)
Q Consensus 275 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~P 319 (344)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0123478999999999987 7799999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 019241 320 FFYGHDNHDQLVKIAK 335 (344)
Q Consensus 320 f~~~~~~~~~l~~i~~ 335 (344)
|. +.+..+...++.+
T Consensus 236 f~-~~~~~~~~~~i~~ 250 (363)
T cd05628 236 FC-SETPQETYKKVMN 250 (363)
T ss_pred CC-CCCHHHHHHHHHc
Confidence 94 4555566666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=306.38 Aligned_cols=216 Identities=31% Similarity=0.580 Sum_probs=181.9
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
++..++|++.++||+|+||+||+|++..+++.+|+|+++... ...+.+|+.+++.+ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~ 77 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KET 77 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCe
Confidence 356789999999999999999999999999999999986322 34577899999999 99999999999965 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||++++.+.... ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVP 156 (303)
T ss_pred EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCC
Confidence 89999999765443332 348889999999999999999999999999999999999988 78999999999754322
Q ss_pred -CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.......++..|+|||++.+...++.++||||+||++|||++|..||....+..+++..+...++.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 224 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP 224 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCC
Confidence 2334457889999999987656789999999999999999999999976666677888877776654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.37 Aligned_cols=216 Identities=31% Similarity=0.558 Sum_probs=181.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEcc------CCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------HSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------~~~~ 196 (344)
..++|++.++||+|+||+||+|++..+++.||||.+... .....+|+.+++.+ +|+||+++++++... ....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence 457899999999999999999999999999999988532 23456799999999 999999999876432 1234
Q ss_pred cEEEEEeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
.++||||++++...... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.+.+.+||+|||+|+..
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 67899999975432221 358899999999999999999999999999999999999977457999999999877
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
..........+|+.|+|||++.+...++.++|||||||++|||++|..|| .+.+..+++.++.+.+|+++
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCC
Confidence 65555555678999999999877567999999999999999999999888 57777888999998888764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.26 Aligned_cols=214 Identities=30% Similarity=0.610 Sum_probs=182.1
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+..++|++.++||+|+||+||+|++..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCL 78 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeE
Confidence 4567899999999999999999999999999999998632 234677999999999 99999999999954 4678
Q ss_pred EEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+++ ++..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence 899999986 6666552 37888999999999999999999999999999999999988 78999999999765432
Q ss_pred -CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......++..|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+.+..+.+.+++++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPT 224 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCC
Confidence 22334577899999999877567899999999999999999999998 46667778888888777654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=307.65 Aligned_cols=208 Identities=26% Similarity=0.465 Sum_probs=172.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++...+.||+|+||+||++.+..+++..|||...... .+.+.+|+.+|.++ +|||||+++|.........++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 44666789999999999999999999999999986544 45589999999999 699999999974333223678999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC----C
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----G 273 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~----~ 273 (344)
||+++|+|.+++. .+++..++++.+|+++||+|||++||+||||||+|||++...+.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999999874 5899999999999999999999999999999999999998337899999999987653 1
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.......||+.|||||++.+....+.++|||||||++.||+||+.||..-....+.+..|
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i 235 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI 235 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH
Confidence 223356899999999999862334469999999999999999999995433333333333
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=318.00 Aligned_cols=205 Identities=27% Similarity=0.505 Sum_probs=173.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|+++++||+|+||+||++++..+++.||+|++... ..+.+.+|+++++++ +||||++++++|.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence 4789999999999999999999999999999998532 234578899999999 99999999999954 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence 999999999998876 458899999999999999999999999999999999999988 7899999999863321000
Q ss_pred ------------------------------------------------ceecccCCCccCcccccCCCCCCchhhHHHHH
Q 019241 276 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307 (344)
Q Consensus 276 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlG 307 (344)
....+||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence 012468999999999877 7799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 308 CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 308 v~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
|++|||++|..||. +.+..+.+..+.+
T Consensus 236 vil~elltG~~Pf~-~~~~~~~~~~i~~ 262 (377)
T cd05629 236 AIMFECLIGWPPFC-SENSHETYRKIIN 262 (377)
T ss_pred hhhhhhhcCCCCCC-CCCHHHHHHHHHc
Confidence 99999999999994 4444555555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=314.01 Aligned_cols=204 Identities=30% Similarity=0.512 Sum_probs=173.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++++.||+|+||+||+|++..+++.||||+++.. ....+.+|+++++.+ +|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence 4789999999999999999999999999999998642 224577899999999 89999999999955 47789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence 999999999998876 358999999999999999999999999999999999999988 789999999987543211
Q ss_pred --------------------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhC
Q 019241 275 --------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316 (344)
Q Consensus 275 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g 316 (344)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence 0112368999999999876 7789999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHH
Q 019241 317 KEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 317 ~~Pf~~~~~~~~~l~~i~ 334 (344)
..||. +.+..+....+.
T Consensus 236 ~~Pf~-~~~~~~~~~~i~ 252 (364)
T cd05599 236 YPPFC-SDNPQETYRKII 252 (364)
T ss_pred CCCCC-CCCHHHHHHHHH
Confidence 99994 334444444443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=299.80 Aligned_cols=194 Identities=26% Similarity=0.434 Sum_probs=170.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.|+..+.||+|+||+||+|.+..+++.||+|.+.... ...+.+|+.+++++ +|+|++++++++.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence 3788899999999999999999999999999985322 23567899999999 99999999999954 467899
Q ss_pred EEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
||||+++++|...+ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCC
Confidence 99999999997665 248889999999999999999999999999999999999988 789999999998775555
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 5556688999999999987 789999999999999999999999996443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.40 Aligned_cols=212 Identities=25% Similarity=0.422 Sum_probs=180.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..+.|++...||.|..++||+|+...+++.||||++.-. ..+.+.+|+..|+.+ +||||++++..|.. ...+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv--~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV--DSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--cceeE
Confidence 467899999999999999999999999999999999632 236788999999998 99999999999965 47789
Q ss_pred EEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+||.||.+|++.+++ ..+++..+..+.+++++||.|||++|.||||||+.|||++.+ |.|||+|||.+..+..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDS 179 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeeccc
Confidence 999999999998877 458999999999999999999999999999999999999999 89999999987655433
Q ss_pred C-cc----eecccCCCccCccc-ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 K-EY----NVRVASRYFKGPEL-LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~-~~----~~~~~t~~y~aPE~-~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
. .. +..+||++|||||+ ......|++|+||||||++..||.+|..||. .....+.+ +..+.+.+|
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~-k~pPmkvL--l~tLqn~pp 250 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS-KYPPMKVL--LLTLQNDPP 250 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc-cCChHHHH--HHHhcCCCC
Confidence 2 22 44589999999999 5556789999999999999999999999993 33333333 344556655
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=327.37 Aligned_cols=208 Identities=23% Similarity=0.451 Sum_probs=182.0
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
....+.+..+.||+|.||+||+|+.. .....||||.++.. ...+|++|++++..+ +|||||+++|.|.+
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~- 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCRE- 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEcc-
Confidence 34667888999999999999999743 23467999999854 346899999999999 99999999999965
Q ss_pred CCCccEEEEEeecCCchhhHcC-------------C----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP-------------T----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~-------------~----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~ 255 (344)
....|+|+|||..|||.+++. . ++..+...++.|||.||+||-++.+|||||..+|+|+.++
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 467789999999999999982 2 7888999999999999999999999999999999999998
Q ss_pred CCcEEEEecccceecCCCCcceeccc---CCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 019241 256 LRKLRLIDWGLAEFYHPGKEYNVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 331 (344)
Q Consensus 256 ~~~~kl~DFGla~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~ 331 (344)
..|||+|||+++.+...+.+..... ...||+||.|.. .++++++|||||||+|||+++ |..|| .+.+++|+++
T Consensus 640 -l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn~EVIe 716 (774)
T KOG1026|consen 640 -LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSNQEVIE 716 (774)
T ss_pred -eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccchHHHHH
Confidence 7999999999998887777665533 456999999987 899999999999999999999 66676 6899999999
Q ss_pred HHHH
Q 019241 332 KIAK 335 (344)
Q Consensus 332 ~i~~ 335 (344)
.|.+
T Consensus 717 ~i~~ 720 (774)
T KOG1026|consen 717 CIRA 720 (774)
T ss_pred HHHc
Confidence 8875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.22 Aligned_cols=205 Identities=25% Similarity=0.458 Sum_probs=172.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.+|+++++||+|+||+||+|++..+++.+|+|++... ....+.+|+++++.+ +|+||+++++.|.+ ....+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~ 77 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLY 77 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEE
Confidence 3688999999999999999999999999999998642 234678899999999 99999999999965 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC--
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-- 273 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccc
Confidence 999999999998877 347889999999999999999999999999999999999988 78999999997532100
Q ss_pred ----------------------------------------------CcceecccCCCccCcccccCCCCCCchhhHHHHH
Q 019241 274 ----------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307 (344)
Q Consensus 274 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlG 307 (344)
......+||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG 235 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG 235 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence 00112468999999999877 7799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 308 CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 308 v~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
|++|||++|+.||. +.+..+...++.+
T Consensus 236 vil~elltG~~Pf~-~~~~~~~~~~i~~ 262 (382)
T cd05625 236 VILYEMLVGQPPFL-AQTPLETQMKVIN 262 (382)
T ss_pred HHHHHHHhCCCCCC-CCCHHHHHHHHHc
Confidence 99999999999995 4444444444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.30 Aligned_cols=194 Identities=27% Similarity=0.479 Sum_probs=167.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.|++++.||+|+||+||+|++..+++.+|+|++... ....+.+|+++++.+ +|+||+++++++.+ ....++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEEE
Confidence 688999999999999999999999999999998532 234578899999999 99999999999965 467899
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCccccccccc
Confidence 99999999998877 458899999999999999999999999999999999999988 789999999975331000
Q ss_pred ----------------------------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHH
Q 019241 275 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 308 (344)
Q Consensus 275 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv 308 (344)
.....+||..|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence 0123468999999999877 77899999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 019241 309 MFAGMIFRKEPFFYGH 324 (344)
Q Consensus 309 ~l~ell~g~~Pf~~~~ 324 (344)
++|||++|..||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999996443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=316.41 Aligned_cols=206 Identities=25% Similarity=0.474 Sum_probs=185.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.-|++.+.||.|+-|.|.+|++..+|+.+|||++.+. ....+++|+-||+.+ .|||++++|+.++ +..++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe--~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWE--NKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeec--cCceEE
Confidence 4578889999999999999999999999999998543 245688999999999 9999999999994 458899
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+|.||+++|.|.+++ ..+++.+..+++.||+.|+.|+|..+|+|||+||+|+|+|.+ +.+||+|||+|..-.++..
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCcc
Confidence 999999999998887 579999999999999999999999999999999999999998 5599999999999888888
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..+.||++.|.|||++.+....+.++||||+||+||.|++|+.||. +++-...+.++.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdNir~LLlKV~~ 226 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDNIRVLLLKVQR 226 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-CccHHHHHHHHHc
Confidence 8999999999999999996666799999999999999999999993 5555666677665
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=307.73 Aligned_cols=215 Identities=25% Similarity=0.482 Sum_probs=183.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.+.||+|+||+||++++..+++.+|+|.++.. ....+.+|+.+++.+ +|+||+++++++.....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence 468899999999999999999999999999999998532 235677899999999 99999999999864332
Q ss_pred -CccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 195 -KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 195 -~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
...++||||++++.+......+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTACTN 176 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccccC
Confidence 3568999999987666555678999999999999999999999999999999999999988 78999999999866544
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+++.++.+.++++.
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCc
Confidence 44455678999999999977 779999999999999999999999994 5566677777777776654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=312.39 Aligned_cols=209 Identities=27% Similarity=0.453 Sum_probs=177.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||.||++++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCE
Confidence 467899999999999999999999999999999998531 234577899999998 99999999999954 477
Q ss_pred cEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccCC
Confidence 899999999999998874 47888899999999999999999999999999999999988 789999999998765332
Q ss_pred c--ceecccCCCccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 E--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 ~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
. ....+||+.|+|||++... ..++.++|+||+||++|||++|+.||. +.+..+...+|.+.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~-~~~~~~~~~~i~~~ 262 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMDH 262 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC-CCCHHHHHHHHHhC
Confidence 2 2355799999999998752 237899999999999999999999995 44555566666553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=301.23 Aligned_cols=202 Identities=23% Similarity=0.451 Sum_probs=173.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|.+..+++.+|+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence 4789999999999999999999999999999998532 234578899999999 99999999999854 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||+++++|..++ ..+++.....++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC--
Confidence 999999999998876 358899999999999999999999999999999999999988 78999999999866432
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~i~ 211 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFF-DDNPFGIYEKIL 211 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHH
Confidence 234578999999999877 678999999999999999999999995 344444444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=313.15 Aligned_cols=203 Identities=27% Similarity=0.465 Sum_probs=170.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++++.||+|+||+||+|++..+++.+|+|++... ....+.+|+++++.+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999998532 235678899999999 99999999999955 46789
Q ss_pred EEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC--
Q 019241 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-- 273 (344)
+||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence 9999999999998873 47888899999999999999999999999999999999988 78999999997532100
Q ss_pred ------------------------------------------CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHH
Q 019241 274 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311 (344)
Q Consensus 274 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ 311 (344)
......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily 235 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence 00112468999999999877 77899999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHH
Q 019241 312 GMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 312 ell~g~~Pf~~~~~~~~~l~~i 333 (344)
||++|+.||.. .+..+....+
T Consensus 236 ell~G~~Pf~~-~~~~~~~~~i 256 (376)
T cd05598 236 EMLVGQPPFLA-DTPAETQLKV 256 (376)
T ss_pred ehhhCCCCCCC-CCHHHHHHHH
Confidence 99999999953 3334433333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=297.54 Aligned_cols=211 Identities=36% Similarity=0.639 Sum_probs=180.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++.+.||+|+||+||+|++..+++.+|+|+++.. ..+.+.+|+++++.+ +|+||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence 4799999999999999999999999999999998632 235678999999999 99999999999954 467899
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
||||++++++..+. ..+++..++.++.|++.||.|||+.+++||||||+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccc
Confidence 99999998877654 358899999999999999999999999999999999999988 789999999998764332
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
......++..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+..++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCC
Confidence 2233468899999999977 67899999999999999999999888 45666677777777776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=305.12 Aligned_cols=203 Identities=24% Similarity=0.422 Sum_probs=175.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.+|+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCEE
Confidence 57899999999999999999999999999999998642 235678999999999 99999999999955 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+.+++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCCC-
Confidence 9999999999998876 357889999999999999999999999999999999999988 78999999999876432
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.
T Consensus 172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~ 228 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFF-DDTPFRIYEKIL 228 (329)
T ss_pred -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCC-CCCHHHHHHHHh
Confidence 234578999999999887 678999999999999999999999995 333344444443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=305.98 Aligned_cols=202 Identities=32% Similarity=0.569 Sum_probs=175.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+++++.+ +|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence 4689999999999999999999999999999998642 234577899999999 89999999999954 46789
Q ss_pred EEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||+++++|..++. .+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||++..... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--c
Confidence 9999999999999873 58899999999999999999999999999999999999988 7899999999976543 3
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~ 211 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLK 211 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHH
Confidence 345678999999999887 689999999999999999999999994 444444444443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=305.55 Aligned_cols=214 Identities=29% Similarity=0.577 Sum_probs=187.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..+.|++.+.||+|.||.||+|+.+.+|+.+|+|++.+.. .....+|+.+|+++.+|||++.+.+.|++. ..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--Ce
Confidence 4678999999999999999999999999999999996433 357899999999995599999999999664 57
Q ss_pred cEEEEEeecCCchhhHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC---CcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~~--l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~---~~~kl~DFGla~~~~ 271 (344)
.++|||++.||.|.+.+.. +++.++..++.|++.++.|||+.|++||||||+|+|+.... +.+|++|||++....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 8899999999999887744 99999999999999999999999999999999999996552 379999999999998
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
++......+||++|+|||++.. ..|+..+||||+||++|.|++|..||. +.++.+...+|.+ |.++|
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~-~~~~~~~~~~i~~--~~~~f 257 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFW-GETEFEIFLAILR--GDFDF 257 (382)
T ss_pred CCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCc-CCChhHHHHHHHc--CCCCC
Confidence 8777888999999999999876 789999999999999999999999994 5555555555543 54444
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=309.83 Aligned_cols=205 Identities=29% Similarity=0.505 Sum_probs=174.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++++.||+|+||+||++++..+++.+|+|+++.. ....+.+|+.++..+ +|+|++++++.+.+ ....+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999998632 235677899999999 99999999999954 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence 999999999998886 358999999999999999999999999999999999999988 899999999986542211
Q ss_pred -----------------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 019241 275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319 (344)
Q Consensus 275 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~P 319 (344)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence 0123478999999999877 7899999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 019241 320 FFYGHDNHDQLVKIAK 335 (344)
Q Consensus 320 f~~~~~~~~~l~~i~~ 335 (344)
|. +.+..+...++.+
T Consensus 236 f~-~~~~~~~~~~i~~ 250 (360)
T cd05627 236 FC-SETPQETYRKVMN 250 (360)
T ss_pred CC-CCCHHHHHHHHHc
Confidence 94 4444555555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.67 Aligned_cols=206 Identities=25% Similarity=0.445 Sum_probs=179.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..+.|++++.||+|.-|+||+++...++..+|+|++.+.. ..+.+.|-+||+.+ +||.++.||..| +.+.+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f--et~~~ 151 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF--ETDKY 151 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee--eccce
Confidence 3567899999999999999999999999999999996432 34566799999999 999999999999 55688
Q ss_pred cEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.|++||||+||+|..+++ .+++..++.|+.+++.||+|||..|||+|||||+|||+-++ |.+.|+||.|+....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP 230 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence 999999999999998873 49999999999999999999999999999999999999999 899999999963210
Q ss_pred ----------------------------------C-C----------------------CcceecccCCCccCcccccCC
Q 019241 272 ----------------------------------P-G----------------------KEYNVRVASRYFKGPELLVDL 294 (344)
Q Consensus 272 ----------------------------------~-~----------------------~~~~~~~~t~~y~aPE~~~~~ 294 (344)
. . ...+..+||-.|.|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 01223578999999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 295 ~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
..-+.++|+|+|||++|||+.|..|| .|.++.+.+..|.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv 348 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIV 348 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHh
Confidence 78899999999999999999999999 6888888877664
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=300.97 Aligned_cols=208 Identities=23% Similarity=0.535 Sum_probs=186.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
...+|++.+.||+|.||.|-++.+...|+.||||.+++.. .-.+.+|++||..| +||||+.++++| .+...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF--ENkdK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF--ENKDK 127 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh--cCCce
Confidence 4578999999999999999999999999999999986433 23578999999999 999999999999 44567
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+.+||||..+|.|.+++ ..+++.+.+.+++||..|+.|+|+.+++|||||.+|||+|++ +.+||+|||++..+...
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhccc
Confidence 88999999999999998 569999999999999999999999999999999999999999 78999999999999988
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...+++||++.|.+||++.+...-+..+|-|||||+||.|+.|..|| .|.|-.....+|.+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~ 267 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISR 267 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhc
Confidence 88999999999999999988555678999999999999999999999 56665555555543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=281.25 Aligned_cols=212 Identities=26% Similarity=0.464 Sum_probs=187.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|.||.||.|+.+.++-.||+|++.+. ...++.+|++|-.+| +||||.++|++|.+ ...
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd--~~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHD--SKR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheec--cce
Confidence 467889999999999999999999999999999998532 346788999999999 99999999999954 588
Q ss_pred cEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.||++||...|++...+. ++++.....++.|+|.||.|+|.++||||||||+|+|++.+ +.+||+|||.+...+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC
Confidence 899999999999887774 58899999999999999999999999999999999999998 899999999886654
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.....+.|||..|.+||+..+ ...|..+|+|++|++.||++.|..||.... ..+...+|.++--..|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFP 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCC
Confidence 556677899999999999877 889999999999999999999999996444 7788888877654443
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=307.99 Aligned_cols=209 Identities=28% Similarity=0.457 Sum_probs=176.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||.||+|++..+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+ ...
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence 468999999999999999999999999999999998532 224467899999998 99999999999954 477
Q ss_pred cEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCC
Confidence 899999999999988873 47888899999999999999999999999999999999988 789999999998765432
Q ss_pred c--ceecccCCCccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 E--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 ~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
. .....||+.|+|||++... ..++.++|||||||++|||++|..||. +.+..+...+|.+.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~ 262 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNH 262 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC-CCCHHHHHHHHHcC
Confidence 2 2345799999999998752 237899999999999999999999994 44444555555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=304.27 Aligned_cols=204 Identities=22% Similarity=0.408 Sum_probs=173.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-eEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||.||+|++..++ ..+|+|.+.. ...+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~ 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKD--ES 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEe--CC
Confidence 4678999999999999999999876554 6899998853 2235677899999999 99999999999955 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecCC
Confidence 789999999999998887 358899999999999999999999999999999999999988 7899999999987643
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+.......+.
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~-~~~~~~~~~~i~ 241 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKIL 241 (340)
T ss_pred C--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCC-CCCHHHHHHHHh
Confidence 2 334678999999999977 778999999999999999999999995 334444444443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.10 Aligned_cols=205 Identities=26% Similarity=0.426 Sum_probs=172.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+..|..++..+..|++++++++++.+ ....++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 588999999999999999999999999999998632 235577899999998445678889998854 467899
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CCCc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~~~ 275 (344)
||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCc
Confidence 99999999998776 358899999999999999999999999999999999999988 789999999987532 2333
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+||..|+|||++.+ ..++.++||||+||++|||++|+.||. +.+..+....+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~ 215 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIME 215 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHc
Confidence 445679999999999987 778999999999999999999999994 4444555555543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=307.73 Aligned_cols=208 Identities=26% Similarity=0.452 Sum_probs=176.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.++||+|+||+||++++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~~ 117 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DKY 117 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCE
Confidence 467899999999999999999999999999999998532 224477899999999 99999999999954 477
Q ss_pred cEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 899999999999998874 47888899999999999999999999999999999999988 799999999998765432
Q ss_pred --cceecccCCCccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 --EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......||+.|+|||++.+. ..++.++|||||||++|||++|+.||. +.+..+...+|.+
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~ 261 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMD 261 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC-CCCHHHHHHHHHc
Confidence 22345789999999998652 247899999999999999999999995 4444555555544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=293.82 Aligned_cols=212 Identities=32% Similarity=0.620 Sum_probs=176.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc-----chHHHHHHHHHHHHHh--CCCCccceeeEEEc---cC
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRD---QH 193 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---~~ 193 (344)
++|++.+.||+|+||+||+|++.. +++.||+|.++.. ....+.+|+.+++.+. +||||++++++|.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 478999999999999999998854 5688999988532 2245677888887763 59999999998853 23
Q ss_pred CCccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
....++||||+++ ++..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceE
Confidence 3567899999985 566555 237889999999999999999999999999999999999988 789999999998
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
............+|..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.++.+.+.++.+..+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCC
Confidence 7765544556678999999999876 67899999999999999999999888 5666778888888776644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.58 Aligned_cols=205 Identities=25% Similarity=0.414 Sum_probs=173.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+|++.+.||+|+||+||+|++..+++.+|+|+++... ...+..|..++..+..|++++++++++.+ ....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 5788999999999999999999999999999986421 23456788888887678999999999954 467889
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~ 275 (344)
||||+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCc
Confidence 99999999998776 458999999999999999999999999999999999999988 7899999999976432 223
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~ 215 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIME 215 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 345678999999999987 779999999999999999999999994 4444555555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=302.61 Aligned_cols=187 Identities=26% Similarity=0.456 Sum_probs=163.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.+|+|+++.. ....+.+|+.+++++ +||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 224577899999999 99999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCccccee
Confidence 999998776 458999999999999999999999999999999999999988 7899999999975432 23334567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCC
Confidence 9999999999876 7799999999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=304.16 Aligned_cols=214 Identities=25% Similarity=0.475 Sum_probs=183.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC----
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---- 193 (344)
..++|++.+.||+|+||.||++.+..+++.+|||++... ....+.+|+.+++.+ +|+||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 468899999999999999999999999999999998632 235677899999999 9999999999885432
Q ss_pred CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
....++||||++++........+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 179 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccCCC
Confidence 23578999999886655555678899999999999999999999999999999999999988 78999999999876554
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.......+|..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+.++.+.++++
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~ 244 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTP 244 (364)
T ss_pred CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCC
Confidence 44455678999999999987 77999999999999999999999999 5666677777777766654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.22 Aligned_cols=212 Identities=32% Similarity=0.602 Sum_probs=175.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---Ccc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~ 197 (344)
+|++.++||+|+||.||+|++..+++.||+|.++.. ....+.+|+++++++ +||||+++++++..... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 589999999999999999999999999999998632 234678999999999 99999999998864322 357
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+.+ +|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccccccc
Confidence 999999974 666655 358999999999999999999999999999999999999988 789999999997653221
Q ss_pred ----cceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 275 ----EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 275 ----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
......+|..|+|||++.+. ..++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.++
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCC
Confidence 12335789999999997642 56889999999999999999999888 45566666776766666553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=300.25 Aligned_cols=205 Identities=29% Similarity=0.475 Sum_probs=173.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||++++..+++.+|+|++... ..+.+.+|+.+++.+ +|+||+++++++.+ ..+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence 4789999999999999999999999999999998631 234578899999998 99999999999954 47789
Q ss_pred EEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++. .+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 9999999999988763 48899999999999999999999999999999999999988 789999999997665433
Q ss_pred cc--eecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 275 EY--NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 ~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.. ....||+.|+|||++.. ...++.++|||||||++|||++|+.||. +.+..+....+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~-~~~~~~~~~~i~ 221 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 221 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC-CCCHHHHHHHHH
Confidence 22 23468999999999863 2457889999999999999999999995 334444444443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=305.37 Aligned_cols=209 Identities=24% Similarity=0.368 Sum_probs=177.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
.++|+++++||+|+||.||+|++..+++.||+|... ...+.+|+++++++ +||||++++++|.. ....++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEEec
Confidence 468999999999999999999999999999999753 34678999999999 99999999999955 4677899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC--Cccee
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNV 278 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~--~~~~~ 278 (344)
+.+ ++..++ ..+++.++..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+..... .....
T Consensus 165 ~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCccccccccccccccc
Confidence 974 555444 458899999999999999999999999999999999999988 78999999999754322 22334
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------CCHHHHHHHHHhhCCCC
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------DNHDQLVKIAKVTTILD 341 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~------~~~~~l~~i~~~~~~~~ 341 (344)
..||+.|+|||++.+ ..++.++|||||||++|||++|..||+... +...++..+.+.+|+++
T Consensus 243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 579999999999877 779999999999999999999999987543 24567777777777654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=303.01 Aligned_cols=213 Identities=26% Similarity=0.499 Sum_probs=180.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.+.||+|+||.||++.+..+++.+|+|.++.. ....+.+|+.+++.+ +|+||+++++++.....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence 468999999999999999999999999999999998632 235677899999999 99999999998864322
Q ss_pred -CccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 195 -KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 195 -~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
...++||||++++........+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 172 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCCCc
Confidence 3568999999887666555678999999999999999999999999999999999999988 78999999999876554
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.......+|..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+.++.
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCC
Confidence 44455688999999999877 77999999999999999999999998 455556666666555554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=299.64 Aligned_cols=187 Identities=26% Similarity=0.472 Sum_probs=163.1
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||++++..+++.||+|+++.. ....+.+|+.+++.+ +||||++++++|.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 234567899999999 99999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccccc
Confidence 999998766 358999999999999999999999999999999999999988 7899999999875432 22334457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 8999999999876 7789999999999999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=305.54 Aligned_cols=205 Identities=31% Similarity=0.572 Sum_probs=176.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|++..+++.||+|+++. .....+.+|++++..+ +|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence 478999999999999999999999999999999863 2335678899999999 99999999999954 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence 999999999998887 358999999999999999999999999999999999999988 789999999997665433
Q ss_pred -----------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 275 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 275 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~ 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYS-DT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCC-CC
Confidence 2234578999999999987 6899999999999999999999999954 33
Q ss_pred CHHHHHHHHH
Q 019241 326 NHDQLVKIAK 335 (344)
Q Consensus 326 ~~~~l~~i~~ 335 (344)
..+...++.+
T Consensus 235 ~~~~~~~i~~ 244 (350)
T cd05573 235 LQETYNKIIN 244 (350)
T ss_pred HHHHHHHHhc
Confidence 4555555544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.52 Aligned_cols=199 Identities=22% Similarity=0.398 Sum_probs=164.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||.||+|.+. .+++.||+|+++... .+.+.+|+.+++++.+||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 4578999999999999999999752 345689999986422 356889999999997899999999988643
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 214 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------------------------------------------------------- 214 (344)
....+++|||+++|+|..++.
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 345789999999999987663
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCc
Q 019241 215 ------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYF 285 (344)
Q Consensus 215 ------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y 285 (344)
.+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++........ ....++..|
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccc
Confidence 25677788899999999999999999999999999999988 78999999999865433221 123456789
Q ss_pred cCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 019241 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGH 324 (344)
Q Consensus 286 ~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~ 324 (344)
+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999877 778999999999999999997 888885433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=296.81 Aligned_cols=200 Identities=25% Similarity=0.453 Sum_probs=167.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.||+|+++.. ..+.+..|..++....+||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999998642 223455677777766689999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~~~~ 280 (344)
++++|..++ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++..... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccccc
Confidence 999998776 458899999999999999999999999999999999999988 78999999999765322 3334557
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
||..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~ 210 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILN 210 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc
Confidence 8999999999877 678999999999999999999999994 4444555554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=299.90 Aligned_cols=206 Identities=27% Similarity=0.448 Sum_probs=173.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||++++..+++.+|+|+++.. ....+.+|..++..+ +|+||+++++++.+ ....+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 5799999999999999999999999999999998632 223477889999888 99999999999954 47789
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+.+++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999999999999887 347889999999999999999999999999999999999988 789999999998765433
Q ss_pred cc--eecccCCCccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EY--NVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.. ....||..|+|||++.+. ..++.++|||||||++|||++|+.||. +.+..+...++..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~ 222 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMN 222 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc-CCCHHHHHHHHHc
Confidence 32 235789999999998642 357889999999999999999999995 3344444444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=308.65 Aligned_cols=201 Identities=15% Similarity=0.356 Sum_probs=168.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.+...+...||+|+||+||+|.+- -.||||+++- ...+.|++|+..+++- +|.||+-+.|+|..+ .. .
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p--~~-A 463 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP--PL-A 463 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC--ce-e
Confidence 355677899999999999999874 3589999962 3457899999999998 999999999999654 33 7
Q ss_pred EEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec---C
Q 019241 199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY---H 271 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~---~ 271 (344)
+|..+|+|.+|..++. +|.....+.|+.|+++||.|||.++|||||||..||++.++ +.|||+|||++..- .
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeeec
Confidence 9999999999999883 58888999999999999999999999999999999999998 89999999998532 2
Q ss_pred CCCcceecccCCCccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 272 PGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.........|...|||||++... .+|++.+|||||||++|||++|..||. +...+..+-.+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmV 605 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMV 605 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEe
Confidence 23344556778889999999753 468999999999999999999999996 44444443333
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.44 Aligned_cols=214 Identities=30% Similarity=0.618 Sum_probs=179.3
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
++..++|++.++||+|+||+||+|++..+++.+|+|.++.. ....+.+|+++++++ +|+|++++++++.. ...
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 78 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHT--DKS 78 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEee--CCe
Confidence 44568899999999999999999999999999999998632 234577899999999 99999999999954 467
Q ss_pred cEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++ ++..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSV 156 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCC
Confidence 8899999987 454444 237888999999999999999999999999999999999988 7899999999976543
Q ss_pred CC-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 273 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.. ......++..|+|||++.+...++.++|||||||++|||++|+.||. +.+..+.+..+.+.++.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~ 224 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP-GSTVEDELHLIFRLLGTP 224 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCC
Confidence 22 23345678899999998775678999999999999999999999984 555566777777766654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=296.99 Aligned_cols=203 Identities=24% Similarity=0.432 Sum_probs=169.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHH---HHhCCCCccceeeEEEccCCCcc
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQ---NLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~---~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
|++++.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|..++. .+ +||||+++++++.+ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~--~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQT--EDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEc--CCEE
Confidence 67889999999999999999999999999998632 2245666766654 44 79999999999954 4678
Q ss_pred EEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CC
Q 019241 198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~ 274 (344)
++||||+++++|...+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||+++.... ..
T Consensus 78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCC
Confidence 9999999999998776 358999999999999999999999999999999999999988 7899999999875432 22
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~ 215 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVN 215 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 3344578999999999877 778999999999999999999999994 4444455444443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=298.60 Aligned_cols=187 Identities=26% Similarity=0.458 Sum_probs=163.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||++++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999998632 234677899999999 99999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......+
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccccc
Confidence 999998776 458899999999999999999999999999999999999988 7899999999875432 22334457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCC
Confidence 8999999999876 6789999999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=300.45 Aligned_cols=206 Identities=28% Similarity=0.449 Sum_probs=175.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||++++..+++.+|+|+++.. ..+.+.+|+.+++.+ +|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence 4789999999999999999999999999999998643 234578899999988 99999999999854 46789
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999999999998887 358899999999999999999999999999999999999988 789999999998765443
Q ss_pred cc--eecccCCCccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.. ....+|+.|+|||++.. ...++.++|||||||++|||++|+.||.. .+..+.+.++.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~ 223 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN 223 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHc
Confidence 32 23478999999999863 35678999999999999999999999953 344445555543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=297.74 Aligned_cols=206 Identities=26% Similarity=0.448 Sum_probs=173.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.++||+|+||+||++++..+++.+|+|++... ....+.+|+.++..+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQD--ENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCEEE
Confidence 4789999999999999999999999999999998532 123477899999998 99999999999954 46788
Q ss_pred EEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++. .+++..++.++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 9999999999998873 47888999999999999999999999999999999999988 789999999997654332
Q ss_pred c--ceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 E--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. .....||+.|+|||++.. ...++.++|||||||++|||++|+.||. +.+..+...++.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~ 222 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMN 222 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC-CCCHHHHHHHHhC
Confidence 2 223578999999999863 2468899999999999999999999995 4444555555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=296.60 Aligned_cols=195 Identities=23% Similarity=0.438 Sum_probs=166.1
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||+|+||+||+|++..+++.+|+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 79999999999999999999999998632 234577899999999 99999999999954 4678899999999
Q ss_pred CchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-CcceecccC
Q 019241 207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS 282 (344)
Q Consensus 207 ~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~~~~~t 282 (344)
++|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++..... ......+||
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCC
Confidence 9998876 358899999999999999999999999999999999999988 78999999999764322 233445789
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~-~~~~~~~~~~~ 205 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYRKI 205 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcC-CCCHHHHHHHH
Confidence 99999999887 778999999999999999999999995 33334444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=283.99 Aligned_cols=208 Identities=28% Similarity=0.508 Sum_probs=181.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..+.|++.+.||+|.|+.||++.+..+|+.+|+|+++ ....+++.+|+.|-+.| +||||+++.+.+. .....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~--~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQ--EESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhc--cccee
Confidence 4678888999999999999999999999999998874 34557889999999999 9999999999984 45778
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~ 272 (344)
++|+|+|.|+++..-+ .-+++..+..+++||+++|+|+|..||||||+||+|+|+... ...+||+|||+|.....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 8999999999986544 237888899999999999999999999999999999999543 34699999999999987
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+.....++||+.|||||++.. .+|+..+|||+.||+||-|+.|++||+ +.+......+|++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~ 226 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKA 226 (355)
T ss_pred ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhc
Confidence 777788999999999999987 889999999999999999999999994 5566666677755
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.52 Aligned_cols=192 Identities=27% Similarity=0.436 Sum_probs=169.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.|++.++||+|+||+||++.+..+++.||+|.+.... ...+.+|+.+++++ +|+||+++++.+.+ ....++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecC--CCeEEE
Confidence 4788999999999999999999999999999986422 23467899999999 99999999999954 467899
Q ss_pred EEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
||||+.+++|...+ ..+++..+..++.|++.||.|||+.+++||||||+||+++++ +.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence 99999999998765 248899999999999999999999999999999999999988 789999999998775555
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......++..|+|||++.+ ..++.++||||+||++|||++|..||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 5455688999999999876 7789999999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.19 Aligned_cols=205 Identities=24% Similarity=0.401 Sum_probs=171.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+..|..+++.+.+|++++++++++.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 477889999999999999999999999999998632 224567788898888567888899998854 467889
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~ 275 (344)
||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCCcc
Confidence 99999999998876 458999999999999999999999999999999999999988 78999999998754322 22
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....||..|+|||++.+ ..++.++||||+||++|||++|+.||. +.+..+....+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~ 215 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIME 215 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 334568999999999876 778999999999999999999999994 4444444444433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.78 Aligned_cols=200 Identities=26% Similarity=0.472 Sum_probs=178.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC----CCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~ 196 (344)
..+...+.||+|+||.||+|+++.+|+.||||.+++ ...+...+|+++|+++ +|+|||++++.-.... ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence 445566889999999999999999999999999875 3456788999999999 7999999999876655 567
Q ss_pred cEEEEEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC---CCcEEEEecccc
Q 019241 197 PSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLA 267 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~---~~~~kl~DFGla 267 (344)
..++||||.+|+|...+. .+++.+...++.+++.||.|||+.||+||||||.||++-.. ...-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 889999999999999984 49999999999999999999999999999999999998432 235799999999
Q ss_pred eecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
+...++....+.+||..|.+||...+...|+..+|.|||||++|++.||..||-+-..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9999999999999999999999998558899999999999999999999999976433
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=301.16 Aligned_cols=213 Identities=29% Similarity=0.563 Sum_probs=179.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---Ccc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~ 197 (344)
+|++.++||+|+||+||++.+..+++.||+|.+... ..+.+.+|+++++.+ +|+||+++++++..... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 467889999999999999999999999999988532 235678999999999 99999999999865431 267
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++|+||+.+. +...+ ..+++..++.++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+++......
T Consensus 80 ~lv~e~~~~~-l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 80 YVVTELMQSD-LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEEeeccccC-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccCc
Confidence 8999999864 44443 358999999999999999999999999999999999999988 789999999998654332
Q ss_pred --cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
......++..|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++..|.+.+|.++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCH
Confidence 2233467889999999987566899999999999999999999998 566778888999888887653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=295.66 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=168.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999998632 234567888888877689999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|..++ ..+++..+..++.|++.||+|||+.+++||||||+|||++.+ +.+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccc
Confidence 999998776 458999999999999999999999999999999999999988 7899999999876432 23334457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~ 209 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAIL 209 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHh
Confidence 8999999999876 778999999999999999999999994 444455555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=296.53 Aligned_cols=199 Identities=25% Similarity=0.402 Sum_probs=168.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.||+|+++.. ....+..|.+++..+.+||||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999998642 224567788888877689999999999955 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|...+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccccc
Confidence 999998766 458899999999999999999999999999999999999988 7899999999976432 22334457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
||..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~ 209 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESIL 209 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHH
Confidence 8999999999876 778999999999999999999999994 445555555544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=305.29 Aligned_cols=212 Identities=22% Similarity=0.432 Sum_probs=175.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCC------CCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGG------PNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h------~niv~l~~~~~~~~~~ 195 (344)
.++|++.++||+|+||+||+|.+..+++.||||+++.. .......|+++++.+ .| .++++++++|... ..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~i~~~~~~~-~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV-RQADPADRFPLMKIQRYFQNE-TG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHH-hhcCcccCcceeeeEEEEEcC-Cc
Confidence 57899999999999999999999999999999999642 234567788888887 44 4588899988653 35
Q ss_pred ccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCC---------------
Q 019241 196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR--------------- 257 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~--------------- 257 (344)
+.|+|||++.+..+..+. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.+..
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 788999998554443332 358999999999999999999998 59999999999999986521
Q ss_pred cEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 258 ~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
.+||+|||.+.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.++.+++..+.+.+
T Consensus 286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHc
Confidence 48999999886432 23345689999999999987 78999999999999999999999998 5667788888888888
Q ss_pred CCCC
Q 019241 338 TILD 341 (344)
Q Consensus 338 ~~~~ 341 (344)
|.++
T Consensus 362 g~~p 365 (467)
T PTZ00284 362 GRLP 365 (467)
T ss_pred CCCC
Confidence 8764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.27 Aligned_cols=201 Identities=28% Similarity=0.450 Sum_probs=179.5
Q ss_pred ceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEE
Q 019241 117 LTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVR 190 (344)
Q Consensus 117 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~ 190 (344)
+..+....+.|+.-++||+||||.||-++.+.+|+.+|+|.+.+.. .....+|-.||.++ ..+.||.+--.|
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAf- 254 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAF- 254 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeee-
Confidence 3334445678899999999999999999999999999999885322 23356799999999 889999998888
Q ss_pred ccCCCccEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 191 DQHSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 191 ~~~~~~~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
+....+|+|+..|+||+|...+. .|++..++.|+.+|+.||++||+.+||.||+||+|||+|+. |.++|+|+|
T Consensus 255 -eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISDLG 332 (591)
T KOG0986|consen 255 -ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISDLG 332 (591)
T ss_pred -cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeeccc
Confidence 44578999999999999988873 58999999999999999999999999999999999999998 899999999
Q ss_pred cceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 266 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+|..+..++....++||.+|||||++.+ ..|+++.|.||+||+||||+.|+.||-.
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9999998888888999999999999988 6699999999999999999999999953
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=279.45 Aligned_cols=196 Identities=24% Similarity=0.479 Sum_probs=176.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-------cc----hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-------VK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-------~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
-+.|+..+.||.|..++|.++..+.++..+|+|++.. .. .+...+|+.||+++.+||+|+++.+++ +
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 3556777899999999999999999999999999842 11 234568999999999999999999999 4
Q ss_pred CCCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.+...++|+|.|+.|.|.+++. .+++...+.+++|+..|++|||.++||||||||+|||+|++ ..+||+|||+|..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQ 172 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeec
Confidence 4578899999999999999985 48999999999999999999999999999999999999999 6899999999999
Q ss_pred cCCCCcceecccCCCccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+.+++.....|||++|.|||.+.. ...|+..+|+|++||++|.|+.|+.||+.
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 999999999999999999999853 35688999999999999999999999964
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.76 Aligned_cols=198 Identities=23% Similarity=0.437 Sum_probs=166.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||.||+|++..+++.||+|+++.. .......|..++....+|+|++++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999998642 234566788888766689999999999954 46889999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
.+++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccC
Confidence 999998776 358899999999999999999999999999999999999988 7899999999875322 22334567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~-~~~~~~~~~~~ 208 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH-GDDEDELFESI 208 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence 8999999999887 779999999999999999999999994 44444444444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=286.41 Aligned_cols=211 Identities=31% Similarity=0.601 Sum_probs=175.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHh--CCCCccceeeEEEcc---CCC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---HSK 195 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---~~~ 195 (344)
+|++.+.||+|+||+||+|++..+++.+|+|.++.. ....+.+|+.+++.+. +|+||+++++++.+. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999999999999999998632 1235667888887763 699999999988643 234
Q ss_pred ccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..+++|||+.+ ++..++ ..+++..++.++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccccc
Confidence 57899999986 555554 238899999999999999999999999999999999999988 78999999999876
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
..........+|..|+|||++.+ ..++.++||||+||++|||++|+.|| .+.+..+.+.++.+..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLP 226 (288)
T ss_pred cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCC
Confidence 54444445678899999999877 67999999999999999999998877 5566677777777766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.49 Aligned_cols=194 Identities=24% Similarity=0.450 Sum_probs=166.5
Q ss_pred CeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
+|++.+.||+|+||+||++++. .+++.+|+|+++.. ..+.+.+|+.+++.+.+|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4889999999999999998764 47889999998632 124577899999999779999999999854 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCccccc
Confidence 788999999999998876 458999999999999999999999999999999999999988 7899999999976543
Q ss_pred CC--cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 273 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 273 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.. ......||..|+|||++.+...++.++|||||||++|||++|..||..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 22 223457899999999988645688999999999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=296.28 Aligned_cols=187 Identities=26% Similarity=0.466 Sum_probs=162.5
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||++++..+++.+|+|+++.. ....+.+|+++++.+ +|+||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3699999999999999999999999998642 224567899999998 99999999999854 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceec
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 279 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~ 279 (344)
++++|..++ ..+++..+..++.|++.||+|||+ .||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccc
Confidence 999998776 358999999999999999999997 799999999999999988 7899999999875432 2333445
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.||..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCC
Confidence 78999999999876 7789999999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=290.13 Aligned_cols=209 Identities=26% Similarity=0.549 Sum_probs=170.3
Q ss_pred eeecccCCeeEEEEEEc--CCCeEEEEEEecccc-hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCC
Q 019241 131 RKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
++||+|+||+||+|++. .+++.+|+|.++... ...+.+|+.+++++ +||||+++++.+.+......+++|||+++.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 68999999999999865 466889999986433 45678999999999 999999999999776667789999999864
Q ss_pred chhhHc------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC---CCCcEEEEecccceecCC
Q 019241 208 DFKVLY------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 208 ~l~~~l------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~---~~~~~kl~DFGla~~~~~ 272 (344)
+..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++. +.+.+||+|||+++....
T Consensus 86 -l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 86 -LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred -HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 44333 14788899999999999999999999999999999999942 236899999999987643
Q ss_pred CC----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHhhCCC
Q 019241 273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVTTIL 340 (344)
Q Consensus 273 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~--------~~~~l~~i~~~~~~~ 340 (344)
.. ......+|+.|+|||++.+...++.++||||+||++|||++|+.||....+ ..+++..+.+.+|.+
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244 (317)
T ss_pred CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence 22 223457899999999998756789999999999999999999999964332 246677777777654
Q ss_pred C
Q 019241 341 D 341 (344)
Q Consensus 341 ~ 341 (344)
.
T Consensus 245 ~ 245 (317)
T cd07868 245 A 245 (317)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.65 Aligned_cols=187 Identities=27% Similarity=0.497 Sum_probs=163.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.||+|+++.. ....+.+|..++..+.+||||++++++|.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999999642 224577899999998789999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CCCCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~~~~~~~~~ 280 (344)
++++|..++ ..+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++.. .........+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccccc
Confidence 999998765 468999999999999999999999999999999999999988 78999999998753 2233344567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
||..|+|||++.+ ..++.++|+|||||++|||++|+.||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcc
Confidence 8999999999987 778999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.33 Aligned_cols=197 Identities=27% Similarity=0.479 Sum_probs=165.0
Q ss_pred eeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 131 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.||+|+||.||++++. .+++.+|+|+++.. ....+.+|+++++.+ +||||++++++|.. ....++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEec--CCeEEEE
Confidence 67999999999999764 46789999998632 124567899999999 99999999999955 4678899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcc
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~ 276 (344)
|||+++++|...+ ..+.+..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence 9999999998876 347888899999999999999999999999999999999988 7899999999875432 2233
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~-~~~~~~~~~~~ 212 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKI 212 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCC-CCCHHHHHHHH
Confidence 44578999999999877 678999999999999999999999994 34444444444
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=290.51 Aligned_cols=198 Identities=25% Similarity=0.449 Sum_probs=166.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.||+|+++.. ....+..|..++....+||||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998643 234466788888765599999999999955 46788999999
Q ss_pred cCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeec
Confidence 9999988873 58899999999999999999999999999999999999988 7899999999875432 22334567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~i 208 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFH-GHDEEELFQSI 208 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence 8999999999876 778999999999999999999999994 33444444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=299.47 Aligned_cols=209 Identities=27% Similarity=0.519 Sum_probs=185.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|..++++|+|+||.++.++.+.++..+++|.+.- ..+....+|+.+++++ .|||||.+.+.|.+. +...+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 4678899999999999999999999999999998852 2234578899999998 999999999999653 34589
Q ss_pred EEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+||+||+||++.+.+. .++++.+..++.|++.|+.|||+.+|+|||||+.||+++.+ +.+||+|||+|+.+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 9999999999998873 48999999999999999999999999999999999999999 67899999999999877
Q ss_pred C-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
. ...+.+||++||.||++.+ .+|+.|+|||||||++|||++-+.+| .+.+..+...+|.+..
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGL 222 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhcc
Confidence 6 6667799999999999988 89999999999999999999999998 5666677777777665
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.49 Aligned_cols=184 Identities=20% Similarity=0.361 Sum_probs=164.0
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCC
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
..++-||+|+.|.||+|+. .++.||||.++ +.-+.+++-|++| +|+||+.+.|+|. ..-.+|+|||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVCt--qsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVCT--QSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeeec--CCceeEEeeeccccc
Confidence 3457899999999999954 57889999775 2334578889999 9999999999995 457789999999999
Q ss_pred chhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCCC
Q 019241 208 DFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284 (344)
Q Consensus 208 ~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~ 284 (344)
-|...++ .+.......+..+||.||.|||...|||||||.-||||+.+ ..+||+|||-++........-.++||..
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 9999884 57888889999999999999999999999999999999998 7999999999988776666677899999
Q ss_pred ccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 285 y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
|||||+|.+ .+.+.|+|||||||+||||+||..||..
T Consensus 277 WMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 277 WMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccc
Confidence 999999988 8999999999999999999999999954
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=291.75 Aligned_cols=187 Identities=27% Similarity=0.510 Sum_probs=164.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.+|+|+++.. ..+.+.+|..++.++.+|+||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999999642 224577899999998789999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CCCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~~~~~~~~ 280 (344)
++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceeccc
Confidence 999998765 469999999999999999999999999999999999999988 789999999997532 233444567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCC
Confidence 9999999999877 788999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=290.84 Aligned_cols=194 Identities=24% Similarity=0.431 Sum_probs=165.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|+.+++||+|+||+||+|++..+++.||+|++.... ...+.+|+++++.+ +|+||+++++++.+ ....++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence 466888899999999999999999999999999985432 35688999999999 99999999999954 467889
Q ss_pred EEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-ccee
Q 019241 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV 278 (344)
Q Consensus 200 v~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~ 278 (344)
||||+++++|... ....+..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...... ....
T Consensus 150 v~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 150 LLEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred EEecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecccccccccc
Confidence 9999999998654 345677788899999999999999999999999999999988 789999999998765332 2345
Q ss_pred cccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 279 RVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
..||..|+|||++.. ....+.++|||||||++|||++|+.||..
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 678999999998743 13345689999999999999999999963
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=295.75 Aligned_cols=193 Identities=26% Similarity=0.480 Sum_probs=172.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
...|+..+.||+|+||.||+|.+..+++.||+|++.- ...+.+++|+.+|..+ +++||.++|+.+..+ ..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g--~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKG--TKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeec--ccHHH
Confidence 4557777999999999999999999999999999863 3446788999999999 999999999998654 66789
Q ss_pred EEEeecCCchhhHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-
Q 019241 200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l~~---l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~- 275 (344)
+||||.+|++...++. +.+..+..++++++.||.|||..+.+|||||+.|||+..+ +.+|++|||.+-.......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhc
Confidence 9999999999988843 4788888899999999999999999999999999999999 8999999999977765433
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
...++||++|||||++.. ..|+.++||||||++.+||.+|.+|+.
T Consensus 168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 367899999999999985 899999999999999999999999984
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=294.52 Aligned_cols=187 Identities=28% Similarity=0.508 Sum_probs=163.1
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.+|+|+++.. ....+.+|+.++.++.+||||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 224567888888887789999999999955 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CCCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~~~~~~~~ 280 (344)
++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccccc
Confidence 999998765 468999999999999999999999999999999999999988 789999999997543 223334567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCc
Confidence 8999999999987 778999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.35 Aligned_cols=213 Identities=31% Similarity=0.604 Sum_probs=178.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC---
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH--- 193 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--- 193 (344)
...++|++++.||+|+||+||+|.+..+++.||+|.++.. ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence 3467899999999999999999999999999999998642 234577899999999 9999999999885332
Q ss_pred -CCccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 194 -SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 194 -~~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
....+++++++ ++++..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~ 168 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQA 168 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceec
Confidence 23468899987 56676665 358999999999999999999999999999999999999988 78999999999876
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.. ......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 43 2344578999999999877567899999999999999999999998 4555566667776665544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=291.99 Aligned_cols=198 Identities=24% Similarity=0.461 Sum_probs=163.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHH-HHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+.||+|+||+||+|++..+++.+|+|++.... ...+..|.. +++.+ +|+||+++++++.+ ....++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence 36999999999999999999999999986321 123444444 45566 99999999999954 4678899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceec
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 279 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~ 279 (344)
+++++|..++ ..+.+..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccc
Confidence 9999998877 347888999999999999999999999999999999999988 7899999999975432 2334456
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+.+..+.
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~ 209 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNIL 209 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHHHH
Confidence 79999999999887 779999999999999999999999995 444445444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=293.27 Aligned_cols=197 Identities=24% Similarity=0.463 Sum_probs=163.5
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHH-HHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+.||+|+||+||+|++..+++.+|+|++... ....+..|... ++.+ +||||+++++.+.. ....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence 4699999999999999999999999998632 22345556554 4556 99999999999954 4678899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceec
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 279 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~ 279 (344)
+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccc
Confidence 9999997776 458999999999999999999999999999999999999988 7899999999875432 2333445
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~~ 208 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNI 208 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCC-CCCHHHHHHHH
Confidence 78999999999877 778999999999999999999999995 34444444444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=289.47 Aligned_cols=198 Identities=25% Similarity=0.435 Sum_probs=167.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|++..+++.+|+|+++.. ....+.+|..+++.+.+|+||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998642 234567888999888689999999999955 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|...+ ..+++..+..++.|++.||.|||+.+++||||||+|||++.+ +.+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccccee
Confidence 999998776 358999999999999999999999999999999999999988 7899999999875322 22334457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
++..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~-~~~~~~~~~~i 208 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDELFQSI 208 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC-CCCHHHHHHHH
Confidence 8999999999977 778999999999999999999999994 44444444444
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=291.79 Aligned_cols=197 Identities=26% Similarity=0.483 Sum_probs=162.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHH-HHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+.||+|+||+||+|++..+++.||+|++.... ...+.+|... ++.+ +||||+++++.+.+ ....++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 36999999999999999999999999986321 2334455554 4566 99999999999954 4678899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceec
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR 279 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~ 279 (344)
+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccc
Confidence 9999998776 358899999999999999999999999999999999999988 7899999999875432 2333445
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i 208 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNI 208 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCC-CCCHHHHHHHH
Confidence 78999999999877 779999999999999999999999995 33444444444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=290.82 Aligned_cols=197 Identities=25% Similarity=0.470 Sum_probs=162.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHH-HHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+.||+|+||+||+|++..+++.+|+|++.... ...+.+|.. +++.+ +|+||+++++.+.+ ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence 46999999999999999999999999986321 233455554 46666 99999999999954 4678899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CCCcceec
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVR 279 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~~~~~~~ 279 (344)
+++++|...+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++... ........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccc
Confidence 9999997766 358899999999999999999999999999999999999988 789999999987532 22333445
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.||+.|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+....+
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i 208 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNI 208 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHH
Confidence 78999999999876 7789999999999999999999999953 3333333333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.72 Aligned_cols=192 Identities=28% Similarity=0.434 Sum_probs=168.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.|+..+.||+|+||+||+|.+..+++.+|+|.++... ...+.+|+++++++ +|+|++.+.+.+.. ....++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence 3677899999999999999999999999999986432 23467899999999 99999999999854 467899
Q ss_pred EEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+|||+++++|...+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence 99999999997765 248899999999999999999999999999999999999988 789999999997765444
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......++..|+|||++.+ ..++.++|+|||||++|||++|..||..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 4455678999999999876 7799999999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=300.42 Aligned_cols=206 Identities=24% Similarity=0.421 Sum_probs=171.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC----eEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
.++..+.++||+|.||.||+|+....+ ..||+|..+. ....+|.+|.++|+++ +|||||+++|++.+.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~- 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLE- 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC-
Confidence 455666699999999999999876643 2389998873 2346789999999999 999999999999654
Q ss_pred CCccEEEEEeecCCchhhHcCC----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..+++|||+|+||+|.++++. ++..+...++.+.+.||+|||++++|||||.++|+|++.+ +.+||+|||+++.
T Consensus 234 -~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 234 -EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRA 311 (474)
T ss_pred -CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccC
Confidence 567799999999999999953 7889999999999999999999999999999999999987 6789999999876
Q ss_pred cCCCCcce-ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...-.... ...-...|+|||.+.. ..|++++|||||||++||+++ |..|| .+..+.+..++|..
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVK 377 (474)
T ss_pred CcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHh
Confidence 43111111 1234567999999987 689999999999999999999 67776 78888888888843
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.96 Aligned_cols=194 Identities=22% Similarity=0.380 Sum_probs=170.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++++.||+|+||+||++++..++..+|+|++... ..+.+.+|+++++++ +|+||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 79 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 79 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence 357899999999999999999999999999999998643 235688999999999 99999999999965 36788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-
Confidence 999999999999887 3488999999999999999999986 69999999999999988 78999999999765432
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2344578999999999887 6799999999999999999999999943
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=281.88 Aligned_cols=186 Identities=26% Similarity=0.418 Sum_probs=161.4
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||+|+||+||++.+..+++.+|+|.+.... .+.+..|+.+++.+ +|+|++++.+++.. ....++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 699999999999999999999999985321 24567899999999 99999999999854 4668899999999
Q ss_pred CchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-cee
Q 019241 207 TDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV 278 (344)
Q Consensus 207 ~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~~~ 278 (344)
++|...+ ..+++..+..++.|++.||+|||+.+|+||||||+||+++.+ +.++|+|||++........ ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccc
Confidence 9997654 248899999999999999999999999999999999999987 7899999999977654322 234
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
..+|..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 578899999999987 77899999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.74 Aligned_cols=203 Identities=24% Similarity=0.427 Sum_probs=171.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCC-CeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ...+.+|+.+++.+ +||||++++++|.. ....++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKS--DDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE--CCEEEEE
Confidence 4599999999999999999988777 7889999764322 24567899999999 99999999999965 4678999
Q ss_pred EEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCCc
Confidence 99999999987652 47888999999999999999999999999999999999988 78999999999876543
Q ss_pred Cc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 274 KE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 274 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~-~~~~~~~~~~~ 283 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK-GPSQREIMQQV 283 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence 22 234578999999999876 779999999999999999999999994 33434444443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=315.59 Aligned_cols=207 Identities=23% Similarity=0.439 Sum_probs=177.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-----eEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..+..++.+.||+|.||.||+|...... ..||+|.++. +...+|.+|..+|+++ +|||||+++|.|.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~-- 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD-- 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--
Confidence 3567888999999999999999865432 3599999864 3457899999999999 99999999999976
Q ss_pred CCccEEEEEeecCCchhhHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEe
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~D 263 (344)
....++++|||++|+|..+++ .+...++..++.|||+|++||+++++|||||..+|+|++.. ..+||+|
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaD 845 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIAD 845 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcc
Confidence 466779999999999999984 37899999999999999999999999999999999999998 8999999
Q ss_pred cccceecCCCCcceeccc---CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 264 WGLAEFYHPGKEYNVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 264 FGla~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
||+|+.+...+.++.... ...|||||.+.+ ..++.|+|||||||++||++|...+.|.+.++.+.+....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence 999997765555443322 345999999998 8899999999999999999996666668888888877543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=296.57 Aligned_cols=192 Identities=25% Similarity=0.363 Sum_probs=164.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
..+|.+.+.||+|+||.||+|++..+++.||+|... ...+.+|+++++++ +|+||+++++++.. ....++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEEc
Confidence 457999999999999999999999999999999643 34567899999999 99999999999855 4667899999
Q ss_pred ecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc---c
Q 019241 204 VNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y 276 (344)
Q Consensus 204 ~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~---~ 276 (344)
+.+ ++..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++....... .
T Consensus 242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence 975 554444 348999999999999999999999999999999999999988 7899999999987643322 1
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
....||..|+|||++.+ ..++.++|||||||++|||++|..|++...
T Consensus 320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~ 366 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366 (461)
T ss_pred cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCC
Confidence 23468999999999977 779999999999999999999988876543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=257.21 Aligned_cols=213 Identities=32% Similarity=0.598 Sum_probs=186.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|.-.++||+|.||+||+|++..+++.||+|.++-. ......+|+-+++.+ +|+|||++++... ..+.+-+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlh--sdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLH--SDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhc--cCceeEEe
Confidence 355568999999999999999999999999998532 246678999999999 9999999999884 34667799
Q ss_pred EEeecCCchhhH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 201 FEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 201 ~e~~~~~~l~~~----l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
+|||.... ..+ ...++.+.++.++.|+++||.++|+.++.|||+||+|.|++.+ +.+|++|||+++..+-.- .
T Consensus 80 fe~cdqdl-kkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvrc 157 (292)
T KOG0662|consen 80 FEFCDQDL-KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHhhHHH-HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceEe
Confidence 99997643 333 2568889999999999999999999999999999999999999 899999999998776443 4
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~ 343 (344)
+...+.|.+|++|.++.+..-|+++.|+||-||++.|+.....|.++|.+.++|+.+|...+|++.-+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 56678899999999999988899999999999999999998888889999999999999999998643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.06 Aligned_cols=202 Identities=27% Similarity=0.509 Sum_probs=173.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|+++++||+|+||+||+|++..++..+|+|++... ....+..|+.+++.+ +||||++++++|.+.....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEE
Confidence 467899999999999999999999999999999998632 235688999999999 99999999999876666778
Q ss_pred EEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHc-------CcEeecCCCCceEEeCC--------
Q 019241 198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE-------- 255 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~-------~iiHrDlkp~NiLl~~~-------- 255 (344)
++||||+++++|..++ ..+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999998876 3589999999999999999999984 49999999999999642
Q ss_pred --------CCcEEEEecccceecCCCCcceecccCCCccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 256 --------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 256 --------~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
...+||+|||++.............+|+.|+|||++.. ...++.++|||||||+||||++|..||....+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 13489999999987755544455689999999999864 24588999999999999999999999965443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.15 Aligned_cols=207 Identities=22% Similarity=0.382 Sum_probs=173.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+|+.++..+ +|+|++++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCc
Confidence 457999999999999999999999999999999998532 234577899999998 99999999887754322
Q ss_pred ---CccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEec
Q 019241 195 ---KTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264 (344)
Q Consensus 195 ---~~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DF 264 (344)
...++||||+++++|..++. .+++..+..++.|++.||.|||+.+|+||||||+|||++.+ +.+||+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DF 187 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDF 187 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEec
Confidence 13679999999999988762 48899999999999999999999999999999999999988 78999999
Q ss_pred ccceecCCC---CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 265 GLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 265 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
|+++.+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~-~~~~~~~~~~~ 257 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD-GENMEEVMHKT 257 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHH
Confidence 999876432 22234578999999999987 779999999999999999999999994 34444444433
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.44 Aligned_cols=211 Identities=25% Similarity=0.492 Sum_probs=186.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.-|.+.+.||+|.|..|-++++..+|+.||||++++.+ ..++.+|+.-|+.+ +|||||++|++...+ ..+||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ--TKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ--TKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhccc--ceEEE
Confidence 34777889999999999999999999999999997543 35678999999998 999999999998554 56789
Q ss_pred EEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|+|+-.+|+|.+++ ..+.+...++|+.||+.|+.|+|+..+|||||||+|+.+-+..|-+||.|||++..+.+++.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999987 46999999999999999999999999999999999999988889999999999999999999
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.++.||+..|.|||++++......++|||||||+||.|++|+.||. ..++.|.+-.|++-.-+
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq-eANDSETLTmImDCKYt 237 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ-EANDSETLTMIMDCKYT 237 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc-cccchhhhhhhhccccc
Confidence 9999999999999999995555579999999999999999999995 44556666666654433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=281.64 Aligned_cols=213 Identities=30% Similarity=0.617 Sum_probs=178.1
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+..++|++.++||+|+||.||+|++..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~ 79 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSL 79 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeE
Confidence 4567899999999999999999999999999999998632 234677899999999 99999999999954 4678
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+++ ++..++ ..+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||++......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence 899999985 555554 347889999999999999999999999999999999999988 78999999999764322
Q ss_pred C-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
. ......++..|+|||++.+...++.++|||||||++|||++|+.||. +.+..+++..+.+.++.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~-~~~~~~~~~~~~~~~~~~ 224 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP-GSTVEEQLHFIFRILGTP 224 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCC
Confidence 2 22344678899999998775678899999999999999999999984 555567777776666543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=291.24 Aligned_cols=199 Identities=28% Similarity=0.485 Sum_probs=167.8
Q ss_pred eeecccCCeeEEEEEEc---CCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 131 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
+.||+|+||+||++++. .+++.+|+|+++.. ....+.+|+++++++ +|+||+++++++.+ ....++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence 67999999999998763 57889999998642 234567899999999 99999999999955 467889999
Q ss_pred eecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cccee
Q 019241 203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV 278 (344)
Q Consensus 203 ~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~~ 278 (344)
|+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceec
Confidence 999999988763 48999999999999999999999999999999999999988 78999999999765443 23344
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.+
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~~i~~ 212 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILK 212 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHHHHHc
Confidence 678999999999876 678999999999999999999999994 4444555554443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=281.07 Aligned_cols=212 Identities=33% Similarity=0.616 Sum_probs=179.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||+||+|++..+|+.+|+|.++.. ....+.+|+++++++ +|+|++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence 588899999999999999999999999999998532 224577899999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cc
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~ 276 (344)
+||++++.+..+. ..+++..++.++.|+++||.|||+.+++|+||||+||+++.+ +.+||+|||+++...... ..
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCc
Confidence 9999864433332 348999999999999999999999999999999999999988 789999999997654332 22
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
....++..|+|||++.+...++.++|||||||++|||++|+.||+.+.+..+.+..+.+.++.++
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 34567888999999877566899999999999999999999999888888888888877776544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=280.19 Aligned_cols=193 Identities=26% Similarity=0.436 Sum_probs=169.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.|+..+.||+|+||+||++.+..+++.+|+|.+.... ...+.+|+.+++++ +|+|++++++.+.+ ....++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence 3677899999999999999999999999999885321 23467899999999 99999999999954 467899
Q ss_pred EEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
||||+++++|..++ ..+++..+..++.|++.||.|||+.+|+||||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence 99999999998776 248889999999999999999999999999999999999988 789999999998765544
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 4455678999999999877 67999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=291.69 Aligned_cols=199 Identities=24% Similarity=0.366 Sum_probs=164.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||+|++... +..||+|.++... ...+.+|+++++.+.+|+||++++++|.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 356799999999999999999986443 3579999986432 34578899999998789999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 214 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------------------------------------------------------- 214 (344)
....++||||+++++|..++.
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 467889999999999987652
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce---
Q 019241 215 --------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--- 277 (344)
Q Consensus 215 --------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~--- 277 (344)
.+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeecc
Confidence 25677889999999999999999999999999999999987 789999999998664332221
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 325 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~ 325 (344)
...++..|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 273 ~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 273 NARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred CCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 1234567999999876 779999999999999999997 9999865433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=278.14 Aligned_cols=185 Identities=28% Similarity=0.409 Sum_probs=162.1
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||+|+||+||++++..+++.+|+|.+... ....+..|+++++++ +||||+++++.+.+ ....++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 79999999999999999999999998532 123456799999999 99999999999954 4678999999999
Q ss_pred CchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceeccc
Q 019241 207 TDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281 (344)
Q Consensus 207 ~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~ 281 (344)
++|...+ ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++.............+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCC
Confidence 9998765 247888889999999999999999999999999999999988 7899999999987765555555678
Q ss_pred CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 282 t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999887 5699999999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=276.44 Aligned_cols=207 Identities=15% Similarity=0.326 Sum_probs=169.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
+.++|++.+.||+|+||.||+|.+. ..+..+|+|.++... ...+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence 4678999999999999999999764 445789999987432 24678899999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..++.++.|++.||+|||+.+++||||||+|||++.+ +.++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence 7899999999999998763 47899999999999999999999999999999999999988 789999999876543
Q ss_pred CCCcce--ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...... ...++..|+|||++.+ ..++.++|||||||++||+++ |..||. +.+..+....+.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~ 223 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVED 223 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHC
Confidence 222221 1234567999999877 789999999999999999875 888884 4444555555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=291.28 Aligned_cols=197 Identities=25% Similarity=0.431 Sum_probs=163.4
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHh--CCCCccceeeEEEccCCCccEEEEEee
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
||+|+||+||+|++..+++.||+|++.... ......|..++.+.. +||||+++++.+.+ ....++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 799999999999999999999999985321 233455777777664 79999999999954 46788999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceecc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV 280 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~ 280 (344)
++++|...+ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCcc
Confidence 999998776 358999999999999999999999999999999999999988 7899999999875432 23334567
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
||..|+|||++.+...++.++|||||||++|||++|..||. +.+..+....+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~-~~~~~~~~~~i 209 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY-AEDTQQMYRNI 209 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC-CCCHHHHHHHH
Confidence 89999999998765568999999999999999999999995 33444444444
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=280.96 Aligned_cols=202 Identities=20% Similarity=0.416 Sum_probs=164.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC----------------CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV 183 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv 183 (344)
.++|++.++||+|+||.||+|++.. ++..||+|++.... ...+.+|++++.++ +|+||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence 5688999999999999999997532 34479999986532 34688999999999 999999
Q ss_pred ceeeEEEccCCCccEEEEEeecCCchhhHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 019241 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------------------TLTDYDIRYYIYELLKALDYCHSQGIM 241 (344)
Q Consensus 184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~----------------------~l~~~~~~~~~~~i~~~L~~LH~~~ii 241 (344)
++++++.+. ...++||||+++++|..++. .+++..+..++.|++.||.|||+.||+
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999654 56789999999999987762 256677889999999999999999999
Q ss_pred eecCCCCceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh--C
Q 019241 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--R 316 (344)
Q Consensus 242 HrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~--g 316 (344)
||||||+|||++.+ +.+||+|||+++........ ....++..|+|||++.. ..++.++|||||||++|||++ +
T Consensus 161 H~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999988 78999999999876443322 12344678999999876 679999999999999999987 4
Q ss_pred CCCCCCCCCCHHHHH
Q 019241 317 KEPFFYGHDNHDQLV 331 (344)
Q Consensus 317 ~~Pf~~~~~~~~~l~ 331 (344)
..||. +.+..+.+.
T Consensus 239 ~~p~~-~~~~~~~~~ 252 (304)
T cd05096 239 EQPYG-ELTDEQVIE 252 (304)
T ss_pred CCCCC-cCCHHHHHH
Confidence 55664 334444433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.31 Aligned_cols=215 Identities=31% Similarity=0.576 Sum_probs=178.3
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+..++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+++++.+ +|+|++++++++.+ ....
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 78 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeE
Confidence 45688999999999999999999999999999999985322 23577899999999 99999999999954 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~- 273 (344)
++|+||+.++.+.... ..+.+..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||+++.....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence 8999999755444333 246788889999999999999999999999999999999988 78999999998754322
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.......++..|+|||.+.+...++.++|||||||++|||++|..||....+..+++.++...+|.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP 224 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence 2233446788899999987645688999999999999999999999976666677777777766644
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=285.80 Aligned_cols=194 Identities=23% Similarity=0.399 Sum_probs=169.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.++||+|+||+||++++..++..+|+|+++.. ....+.+|+++++.+ +|+||++++++|.+ ....+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEE
Confidence 457899999999999999999999999999999988643 235688999999999 99999999999965 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++ ..+++..+..++.|++.||.|||+. +++|+||||+|||++.+ +.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-
Confidence 999999999998887 3478888899999999999999985 79999999999999988 78999999998765322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2234578899999999876 6789999999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=281.49 Aligned_cols=209 Identities=26% Similarity=0.562 Sum_probs=167.7
Q ss_pred eeecccCCeeEEEEEEcC--CCeEEEEEEecccc-hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCC
Q 019241 131 RKVGRGKYSEVFEGINVN--TNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
.+||+|+||+||+|++.. ++..+|+|.++... ...+.+|+++++++ +|+|++++++++........++||||++++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 589999999999998654 55789999986543 35678999999999 999999999999766667889999999875
Q ss_pred chhhHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC---CCCcEEEEecccceecCCC
Q 019241 208 DFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 208 ~l~~~l-----------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~---~~~~~kl~DFGla~~~~~~ 273 (344)
.+.... ..+++..++.++.|++.||.|||+.+|+||||||+|||++. +.+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 433221 13788889999999999999999999999999999999942 2368999999999876533
Q ss_pred C----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHhhCCC
Q 019241 274 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~--------~~~~l~~i~~~~~~~ 340 (344)
. ......+|..|+|||++.+...++.++|||||||++|||++|..||....+ ...++.++.+.+|.+
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07867 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244 (317)
T ss_pred cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence 2 123446789999999987756689999999999999999999999964332 234566666666644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=287.59 Aligned_cols=192 Identities=22% Similarity=0.352 Sum_probs=164.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
...+|++++.||+|+||.||+|++..+++.||+|+... .....|+.+++++ +|+||+++++++.. ....++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVS--GAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEe--CCeeEEEEE
Confidence 35679999999999999999999999999999998643 2345799999999 99999999999965 466789999
Q ss_pred eecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCccee
Q 019241 203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278 (344)
Q Consensus 203 ~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 278 (344)
++.+. +..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++..........
T Consensus 138 ~~~~~-l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 138 HYSSD-LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred ccCCc-HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCccccc
Confidence 99764 44443 358899999999999999999999999999999999999988 7899999999976443334445
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
..||..|+|||++.+ ..++.++|||||||++|||+++..|++..
T Consensus 216 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 216 LAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 678999999999987 67999999999999999999977777554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.06 Aligned_cols=196 Identities=26% Similarity=0.472 Sum_probs=175.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|+.++.||+|.||.|.+++.+.+++.+|+|++++. .......|-.+|+.. .||.+..+--.| +....+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCceE
Confidence 47899999999999999999999999999999999753 224456788999998 999999998888 556889
Q ss_pred EEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CCC
Q 019241 198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~~ 273 (344)
|.||||.+||.|...+. .+++...+.+..+|..||.|||+++||.||||.+|.|+|.+ |.+||+|||+++.. ..+
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhccccc
Confidence 99999999999988774 48999999999999999999999999999999999999999 89999999999753 345
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
......|||+.|.|||++.+ ..|+.++|.|.+||++|||++|+.||++.+
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccc
Confidence 56678899999999999987 889999999999999999999999997644
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=285.56 Aligned_cols=215 Identities=27% Similarity=0.483 Sum_probs=181.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC----
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---- 193 (344)
..++|++.+.||+|+||+||+|.+..+++.+|+|.+... ....+.+|+.+++++ +|+|+++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence 468899999999999999999999999999999998532 234677899999999 9999999999886432
Q ss_pred CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
....++||||+.+.........+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||+++.....
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 171 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCCC
Confidence 23578999999875444444458999999999999999999999999999999999999988 78999999999876554
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+++.++.+.+|.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFP-GTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHhcCCCC
Confidence 44445567889999999987 789999999999999999999999984 5566777777777777653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.13 Aligned_cols=208 Identities=25% Similarity=0.447 Sum_probs=184.6
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
+.||+|.||+||-|.++.+|+.||||++++ ...+++.+|+.||+++ .||.||++...|+. ....+.|||-+.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl~ 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKLH 646 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhhc
Confidence 689999999999999999999999999863 3457789999999999 99999999999954 567889999999
Q ss_pred CCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCCCcceec
Q 019241 206 STDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKEYNVR 279 (344)
Q Consensus 206 ~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~~~~~~~ 279 (344)
|.-|...+ .++++.....++.||+.||+|||-++|+|+||||+|||+.+. +-.+||||||+|++++...-....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 98888777 469999999999999999999999999999999999999653 457999999999999877777788
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
+||+.|.|||++.+ +.|+.+.|+||.||++|--++|..||..+.+-.+|+..-+=|..+-|+
T Consensus 727 VGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW 788 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW 788 (888)
T ss_pred cCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch
Confidence 99999999999988 899999999999999999999999998888878877665555555444
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=274.58 Aligned_cols=208 Identities=34% Similarity=0.633 Sum_probs=177.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++.+.||+|+||.||+|++..+++.+|+|.+... ..+.+.+|+++++++ +|+|++++++++.+ ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence 4789999999999999999999989999999988532 235578999999999 99999999999955 467889
Q ss_pred EEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
||||++++++..+.. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccc
Confidence 999999999887763 58999999999999999999999999999999999999988 789999999998765443 2
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
.....++..|+|||++.+...++.++|+|||||++|||++|..||. +.++.+.+..+.+.+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~-~~~~~~~~~~~~~~~ 217 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP-GKSDVDQLYLIRKTL 217 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHh
Confidence 3344678889999998765668899999999999999999998884 555566666665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.40 Aligned_cols=213 Identities=33% Similarity=0.632 Sum_probs=177.6
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+..++|++.+.||+|+||+||+|.+..+++.||+|.+.... ...+.+|+++++++ +|+||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~ 78 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL 78 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence 45688999999999999999999999899999999985322 24567899999999 99999999999954 4788
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+.+ +|..++ ..+++..++.++.|++.||.|||+.+++||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCC
Confidence 999999986 676655 247889999999999999999999999999999999999988 78999999998754322
Q ss_pred -CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.......++..|+|||++.+...++.++||||+||++|+|++|+.||....+..+++..+.+.++.
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT 223 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence 122233567889999998765668999999999999999999999996555566777766665554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=289.06 Aligned_cols=195 Identities=23% Similarity=0.415 Sum_probs=162.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEE-----cCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++.+.||+|+||+||+|++ ..++..||+|+++.. ..+.+.+|+.+++.+.+||||++++++|.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 56899999999999999999974 345678999998643 234678899999999789999999999955 4
Q ss_pred CccEEEEEeecCCchhhHcC------------------------------------------------------------
Q 019241 195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------ 214 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~------------------------------------------------------------ 214 (344)
...++||||+++|+|..++.
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 66789999999999877652
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 215 ------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 215 ------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
.+++..+..++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence 25677788999999999999999999999999999999987 78999999999876543322
Q ss_pred e---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 277 N---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 277 ~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
. ...++..|+|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 1 1234557999999877 779999999999999999998 7878743
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.28 Aligned_cols=193 Identities=19% Similarity=0.385 Sum_probs=162.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
...+|++.+.||+|+||+||+|++..+++ .||+|.++... .+++.+|+.+++.+ +|+||++++++|..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~--- 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT--- 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC---
Confidence 45679999999999999999998766655 38999986432 35688899999999 99999999999854
Q ss_pred CccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++++||+.+|++.+++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL 159 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccc
Confidence 34679999999999988763 37788889999999999999999999999999999999988 78999999999876
Q ss_pred CCCCccee---cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 271 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 271 ~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
........ ..++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 54333222 233567999999877 788999999999999999998 888883
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=277.47 Aligned_cols=197 Identities=19% Similarity=0.261 Sum_probs=165.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEc--cCCCccEEEEE
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLIFE 202 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e 202 (344)
..||+|++|.||+|.+ +++.||+|.++... .+.+.+|+.+++++ +||||+++++++.+ ......++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5689999999999976 78899999986432 25677999999999 99999999999876 44457889999
Q ss_pred eecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCCCCccee
Q 019241 203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278 (344)
Q Consensus 203 ~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 278 (344)
|+++|+|..++. .+++.....++.|++.||.|||+. +++||||||+|||++.+ +.+||+|||+++...... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~--~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPP--FK 179 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhcccc--cc
Confidence 999999999873 478888999999999999999984 89999999999999988 789999999998654322 34
Q ss_pred cccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
..++..|+|||++.+. ..++.++|||||||++|||++|..||. +.+..+....+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~~~~~~~~~~i~ 235 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKEIYDLII 235 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-CCCHHHHHHHHH
Confidence 5678899999998652 578999999999999999999999995 444455555543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.61 Aligned_cols=210 Identities=24% Similarity=0.330 Sum_probs=174.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc--CCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..+|++++.||+|+||+||+|... .++..||+|.+... ....+|+++++++ +|+||+++++++.. ....+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEEe
Confidence 467999999999999999999754 35678999988643 3457899999999 99999999999954 46788999
Q ss_pred EeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc---
Q 019241 202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--- 275 (344)
Q Consensus 202 e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~--- 275 (344)
|++.+. +..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.++|+|||++........
T Consensus 166 e~~~~~-l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 166 PKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hhcCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCccccccc
Confidence 999754 44444 458999999999999999999999999999999999999988 7899999999976643322
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHhhCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVTTILD 341 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~--~~~~~l~~i~~~~~~~~ 341 (344)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||+... ...+++..+.+.++..+
T Consensus 244 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 244 CYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred ccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 224578999999999876 778999999999999999999999996543 34667777777666544
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.80 Aligned_cols=193 Identities=24% Similarity=0.428 Sum_probs=165.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.++||+|+||+||+|++..+++.||+|+++.. ..+++.+|+++++++ +|||++++++++.+ ....+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence 5899999999999999999999999999999998632 235688999999999 99999999999955 46788
Q ss_pred EEEEeecCCchhhHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEec
Q 019241 199 LIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~--------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DF 264 (344)
++|||+++++|..++. .++...+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDF 157 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDW 157 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEec
Confidence 9999999999988763 23455678899999999999999999999999999999988 78999999
Q ss_pred ccceecCCCC-------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 265 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 265 Gla~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
|+++...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9998662110 0112368999999999877 7789999999999999999999999954
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.35 Aligned_cols=210 Identities=27% Similarity=0.456 Sum_probs=183.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||.|..++.+.+++.+|+|++++ ....-|..|.++|..- +.+.|+++.-.| ++.++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF--QD~~~ 149 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF--QDERY 149 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh--cCccc
Confidence 46789999999999999999999999999999999864 2345688999999986 889999999999 55699
Q ss_pred cEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+|+|||||+||+|..++. .+++..++.|+.+|..||.-||+.|+|||||||+|||+|.. |.+||+|||.+-.+..+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcCCC
Confidence 999999999999998885 47799999999999999999999999999999999999998 89999999999877755
Q ss_pred Cc--ceecccCCCccCcccccC---C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 274 KE--YNVRVASRYFKGPELLVD---L-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 274 ~~--~~~~~~t~~y~aPE~~~~---~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
+. ....+|||-|.+||++.. + +.|+..+|+||+||++|||+.|..||| .++-.+..-+|++-.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-adslveTY~KIm~hk 297 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-ADSLVETYGKIMNHK 297 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-HHHHHHHHHHHhchh
Confidence 44 345699999999999864 2 568999999999999999999999996 455566666666553
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=268.81 Aligned_cols=193 Identities=31% Similarity=0.599 Sum_probs=169.3
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchH-----HHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
|++++.||+|+||+||++++..+++.+|+|++...... ...+|+.+++++ +|+||+++++++.+ ....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence 78899999999999999999999999999999754432 234599999999 99999999999965 57788999
Q ss_pred EeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CCCCcce
Q 019241 202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYN 277 (344)
Q Consensus 202 e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~~~~~~ 277 (344)
||+++++|..++ ..+++..+..++.|+++||++||+.+++|+||||+||+++.+ +.++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence 999999998766 568999999999999999999999999999999999999977 78999999999864 3334445
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...++..|+|||++.....++.++|+||+|+++|+|++|..||...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5678899999999873478999999999999999999999999644
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=287.61 Aligned_cols=202 Identities=24% Similarity=0.400 Sum_probs=165.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||.||+|++... +..||+|+++... .+.+.+|+++++++..||||++++++|.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 467899999999999999999986433 3579999996432 35688999999999459999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 214 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------------------------------------------------------- 214 (344)
....++||||+++++|..++.
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 467899999999999876641
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 215 ----------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 215 ----------------------------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
.+++..+..++.|++.||+|||+.+++||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 2566777889999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+ +.+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....+..
T Consensus 273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 8 78999999999876433221 22345678999999877 778999999999999999997 8889854433333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.00 Aligned_cols=200 Identities=22% Similarity=0.380 Sum_probs=167.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeE-EEc---cC-C
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDI-VRD---QH-S 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~-~~~---~~-~ 194 (344)
...++++.+.|.+|||+.||+|++...+..+|+|++-.. ..+...+|+++|++|.+|+|||.+++. ... .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 467899999999999999999999988899999987433 335678999999999889999999993 221 12 2
Q ss_pred CccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 195 KTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
....|+||||.++.|-+++ ..|++.++.+|+.|+++|+.+||..+ |||||||-+||||+.+ +..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCccccc
Confidence 4578999999988887776 35999999999999999999999887 9999999999999999 79999999998
Q ss_pred eecCCCC-cc---------eecccCCCccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 268 EFYHPGK-EY---------NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 268 ~~~~~~~-~~---------~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
....... .. -....|+.|+|||++. ....++.|+|||+|||+||-|++...||..+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 5432221 11 1235788999999974 2367899999999999999999999999764
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=272.68 Aligned_cols=205 Identities=32% Similarity=0.640 Sum_probs=169.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||+||+|++..+++.||+|.++.. ....+.+|+.+++.+ +|+|++++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence 488899999999999999999999999999998532 235688999999999 89999999999965 4678999
Q ss_pred EEeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 201 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
|||+++ ++..++ ..+++..++.++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence 999985 565554 347899999999999999999999999999999999999988 789999999997654322
Q ss_pred -cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
......++..|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+....+.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~ 217 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRI 217 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHH
Confidence 22334668889999998765668899999999999999999999885 44444444444333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.40 Aligned_cols=212 Identities=19% Similarity=0.371 Sum_probs=184.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
-+...+.+.||.|.||+|++|+.+..+ ..||||.+|. ....+|..|..||.++ +||||++|.|+... .+.
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SKP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Cce
Confidence 456788899999999999999987766 4699999984 3456799999999999 99999999999954 578
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++|.|||++|+|+.+++ +|...++..+++.|+.||.||-+.++|||||.++|||++.+ -.+|++|||+++.+.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 783 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeeccc
Confidence 899999999999999994 48888999999999999999999999999999999999999 6899999999998865
Q ss_pred CC--cceeccc--CCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 273 GK--EYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 273 ~~--~~~~~~~--t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
+. .++...| ...|.|||.|.- .+++.++|||||||++||.++ |..|| -.+++.|.++.|.+-+..|+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPY-WdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred CCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcc-cccchHHHHHHHHhccCCCC
Confidence 43 2333333 356999999987 899999999999999999776 78887 57889999999998777664
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.49 Aligned_cols=214 Identities=27% Similarity=0.535 Sum_probs=180.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++++ +|+|++++++++.+......
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 4578999999999999999999999999999999986322 23466899999999 99999999999976555678
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+++ ++..++ ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence 999999986 454443 348899999999999999999999999999999999999988 78999999999876543
Q ss_pred C-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
. ......++..|+|||++.+...++.++|||||||++|||++|+.|| .+.++.+.+..+.+.++.+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCC
Confidence 2 2233355778999999876567899999999999999999999888 4566778888888776653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=274.41 Aligned_cols=191 Identities=21% Similarity=0.394 Sum_probs=167.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++++.||+|+||+||+|++..+++.+|+|++... ....+.+|+++++++ +|||++++++++... ...+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence 4678889999999999999999999999999998532 235688999999999 999999999999654 667899
Q ss_pred EEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecc
Q 019241 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280 (344)
Q Consensus 201 ~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~ 280 (344)
|||++++++..+ ..+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++...... ......
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCC
Confidence 999999998654 467889999999999999999999999999999999999988 78999999999766432 334457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
++..|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 8899999999987 6789999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=269.35 Aligned_cols=195 Identities=24% Similarity=0.442 Sum_probs=168.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++++ +|+|++++++++.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 5788999999999999999999999999999987421 124678899999999 9999999999987655567
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.+++|||+++++|..++ ..+++.....++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence 88999999999998876 457888899999999999999999999999999999999988 78999999998765321
Q ss_pred ----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 12233467888999999877 6789999999999999999999999953
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=267.84 Aligned_cols=194 Identities=25% Similarity=0.452 Sum_probs=167.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+.|++.+.||+|++|.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDD--ET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccC--Ce
Confidence 4688889999999999999999999999999987532 124678899999999 999999999999654 58
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++++||++++++...+ ..+++.....++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 89999999999998876 357888899999999999999999999999999999999987 78999999999765432
Q ss_pred Ccc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 211 23457788999999987 66899999999999999999999998543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.21 Aligned_cols=208 Identities=26% Similarity=0.416 Sum_probs=181.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..+|.++..||+|+||.|-++..+.+.+.+|||++++.. .+-...|-.+|....+-|.++++..+| +.-..+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhe
Confidence 457899999999999999999989999999999997432 223445777777665678999999999 555778
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~~ 273 (344)
|.||||++||+|...+ .++.+..+..++.+|+-||-+||++|||.||||.+|||+|.+ +.+||+|||+++.- -++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccccCC
Confidence 9999999999998877 468899999999999999999999999999999999999999 89999999999753 345
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
....+.+||+.|+|||++.- ++|+.++|.||+||+||||+.|+.|| .|.+++|....|.+-
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEH 565 (683)
T ss_pred cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHc
Confidence 56678899999999999986 89999999999999999999999998 788888888888763
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=270.56 Aligned_cols=211 Identities=30% Similarity=0.576 Sum_probs=175.2
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
|+++++||+|+||.||+|.+..+++.+|+|.++... .....+|+.+++++.+|+|++++++++.+......++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999999999999999986421 2234578999999866999999999997765577899999
Q ss_pred eecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceec
Q 019241 203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279 (344)
Q Consensus 203 ~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 279 (344)
|++++.+.... ..+++..+..++.|++.||+|||+.+++||||+|+||+++. +.+||+|||+++...........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence 99864444333 24899999999999999999999999999999999999998 68999999999877554444445
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.++..|+|||++.....++.++|||||||++|||++|..|| .+.+..+....+.+.+|.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~ 218 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTP 218 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCC
Confidence 67889999998765466789999999999999999999888 5566667777777666654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=270.27 Aligned_cols=201 Identities=27% Similarity=0.556 Sum_probs=171.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||+|++..+++.+|+|.++. .....+.+|+++++.+ +|||++++++++.+. ...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence 578999999999999999999999999999998743 1224578899999999 999999999998654 6778
Q ss_pred EEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
+++||+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~ 157 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence 9999999999987652 37888899999999999999999999999999999999988 789999999998765
Q ss_pred CCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 019241 272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330 (344)
Q Consensus 272 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l 330 (344)
.... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||+....+...+
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~ 216 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216 (267)
T ss_pred chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH
Confidence 3322 223467888999999876 678999999999999999999999997655443333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=284.57 Aligned_cols=212 Identities=21% Similarity=0.378 Sum_probs=178.0
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
...+...+.++||+|.||.|.+|+ ..+...||||.+++.. ...|.+|+++|.++ +||||+.++|.|..+ ..+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~D--ePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQD--DPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecC--Cch
Confidence 356778889999999999999995 4557999999998643 36799999999999 999999999999664 567
Q ss_pred EEEEEeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
|+++|||++|+|.+++.. ........++.||+.||+||.+.++|||||.++|+|+|.+ ..+||+|||+++.+..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCccccccccc
Confidence 899999999999999832 3555667899999999999999999999999999999999 6899999999998776
Q ss_pred CCcceec---ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 273 GKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 273 ~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~--g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
+..+... +-...|||||.++. .++++++|+|+||+++||+++ ...|| ...++++......+++...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py-~~lt~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPY-SQLTDEQVVENAGEFFRDQ 760 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCch-hhhhHHHHHHhhhhhcCCC
Confidence 6665443 45677999999998 889999999999999999865 56787 4555566666665555443
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=272.50 Aligned_cols=201 Identities=25% Similarity=0.477 Sum_probs=173.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||++.+..+++.+|+|.+... ..+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence 4789999999999999999999999999999998532 235678899999999 89999999999954 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||+++++|..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence 999999999998886 458999999999999999999999999999999999999988 78999999999876543
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....+
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~ 210 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI 210 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Confidence 334578889999999876 678899999999999999999999995433 33333333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=279.93 Aligned_cols=196 Identities=20% Similarity=0.303 Sum_probs=167.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHH-hCCCCccceeeEEEccC--CCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--SKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~~~~~lv 200 (344)
....++.+.||+|+||.||||+. +++.||||++.....+.|++|-+|+... .+|+||+++++.-+... ...++||
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 45566678999999999999954 5699999999989999999999998854 28999999999765433 3467899
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHH---------cCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS---------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~---------~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
++|.+.|+|.+++. ..+|.+..+++..+++||+|||+ ..|+|||||++|||+..| .++.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEE
Confidence 99999999999984 59999999999999999999995 259999999999999999 7899999999988
Q ss_pred cCCCC---cceecccCCCccCcccccCCCCCC-----chhhHHHHHHHHHHHHhCCCCCCC
Q 019241 270 YHPGK---EYNVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 270 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~-----~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+.++. .....+||..|||||++.+...+. .+.||||+|.+||||+++..-++.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 87653 334579999999999997644443 479999999999999998876643
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=270.41 Aligned_cols=209 Identities=32% Similarity=0.616 Sum_probs=179.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||.||+|++..+++.+|+|++.... ...+.+|+.+++++ +|+|++++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence 5889999999999999999999999999999986432 35788999999999 89999999999955 4678899
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
+||+ +++|..++ ..+++.+++.++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence 9999 89888776 348999999999999999999999999999999999999987 789999999998765433
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
......++..|+|||++.+...++.++||||+||++|||++|..|| .+.++.+.+..+.+.++.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF-PGENDIEQLAIVFRTLGTP 220 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc-CCCCHHHHHHHHHHHcCCC
Confidence 2344578889999999876566789999999999999999996554 6777777777777766544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=278.64 Aligned_cols=214 Identities=30% Similarity=0.584 Sum_probs=176.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC---CC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~ 195 (344)
..++|++.++||+|+||+||+|++..+++.||+|.+++. ....+.+|+.+++++ +|+|++++++++.... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence 457899999999999999999999999999999998642 234577899999999 8999999999875432 23
Q ss_pred ccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
..++++||+.+ ++...+ ..+++..++.++.|++.||+|||+.||+||||||+||+++.+ +.+||+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeecccc
Confidence 57899999986 455444 358999999999999999999999999999999999999988 78999999999766432
Q ss_pred Ccc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
... ....++..|+|||.+.+...++.++||||+||++|+|++|+.||. +.+...++..+.+.++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~-~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP-GKDYLHQLNLILGVLGTP 229 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCC
Confidence 221 224678899999998765678999999999999999999999984 555556666666666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=272.98 Aligned_cols=200 Identities=25% Similarity=0.433 Sum_probs=170.5
Q ss_pred eccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 119 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
......+.|+++++||+|+||.||+|++..+++.+++|.+.... .+.+.+|+.+++.+ +|+|++++++.+.. ..
T Consensus 6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 82 (292)
T cd06644 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--DG 82 (292)
T ss_pred cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--CC
Confidence 33445688999999999999999999999999999999986443 35678899999999 99999999999855 36
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||++++++..++ ..+++..+..++.|++.+|.|||+.+++||||||+||+++.+ +.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~ 161 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNV 161 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceecc
Confidence 789999999999987764 358999999999999999999999999999999999999987 789999999987543
Q ss_pred CC-CcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.. .......++..|+|||++.. ...++.++|+|||||++|||++|..||..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 22 22344567889999999852 24578899999999999999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=272.44 Aligned_cols=205 Identities=20% Similarity=0.428 Sum_probs=169.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-----eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++.+.||+|+||.||+|.+...+ ..+|+|.++... ...+.+|+.+++++ +|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--C
Confidence 357888999999999999999876555 679999986432 35688999999999 99999999999954 4
Q ss_pred CccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC
Q 019241 195 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~ 255 (344)
...+++|||+++++|..++. .+++..+..++.|++.||.|||+.+++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 66789999999999988762 36778889999999999999999999999999999999988
Q ss_pred CCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 019241 256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 331 (344)
Q Consensus 256 ~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~ 331 (344)
+.++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+ +.+..+...
T Consensus 161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~-~~~~~~~~~ 237 (283)
T cd05048 161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIE 237 (283)
T ss_pred -CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHH
Confidence 7899999999986543322 223455778999999877 678999999999999999998 999985 444444444
Q ss_pred HHH
Q 019241 332 KIA 334 (344)
Q Consensus 332 ~i~ 334 (344)
.+.
T Consensus 238 ~i~ 240 (283)
T cd05048 238 MIR 240 (283)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=275.76 Aligned_cols=205 Identities=19% Similarity=0.326 Sum_probs=165.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe--EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..++. .+++|.++.. ....+.+|++++.++.+|+|++++++++.+ ....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence 4678999999999999999999877765 4577776532 234678899999999789999999999954 4678
Q ss_pred EEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc
Q 019241 198 SLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 258 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~ 258 (344)
++||||+++++|..++. .+++..+..++.|++.|++|||+.|++||||||+|||++.+ +.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~~ 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YV 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-Cc
Confidence 99999999999988763 36788899999999999999999999999999999999988 78
Q ss_pred EEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 259 ~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
+||+|||+++.............+..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+..+....+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL 236 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHH
Confidence 99999999864321111222234567999998866 678999999999999999998 898884 44444444333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.77 Aligned_cols=210 Identities=25% Similarity=0.440 Sum_probs=177.3
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCCccEE
Q 019241 123 DQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l 199 (344)
..++|++.. +||-|-.|.|..|.++.+++.+|+|++. +..+..+|++.--...+|+|||+++++|+.. +.+.+.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 356666654 7999999999999999999999999995 4455668888766667999999999988643 3346678
Q ss_pred EEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCC
Q 019241 200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 200 v~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~ 272 (344)
|||.|+||.|...++ .+++.++..|+.||+.|+.|||+.+|.||||||+|+|.... ...+||+|||+|+.-..
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999988873 39999999999999999999999999999999999999643 24689999999998776
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---CHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---NHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~---~~~~l~~i~~ 335 (344)
.....+.+.|++|.|||++-. ++|+..+|+||+||++|-|++|.+||+..+. ......+|..
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 777888999999999999765 8899999999999999999999999987543 2344444533
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=273.50 Aligned_cols=204 Identities=19% Similarity=0.341 Sum_probs=165.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe--EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||+|++..++. .+++|.++.. ..+.+.+|++++.++.+|||++++++++.+ ....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 578999999999999999998877664 4688887632 235688899999999779999999999854 45688
Q ss_pred EEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcE
Q 019241 199 LIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 259 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~ 259 (344)
+++||+++++|..++. .+++..++.++.|++.||+|||+.|++||||||+|||++.+ +.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence 9999999999988762 36788899999999999999999999999999999999988 789
Q ss_pred EEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 260 kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
||+|||++..............+..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+...++
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~-~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKL 231 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHH
Confidence 9999999864322111112233456999999876 678999999999999999997 989984 34444444444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=273.97 Aligned_cols=213 Identities=26% Similarity=0.529 Sum_probs=174.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcC--CCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVN--TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+|++.++||+|+||.||+|.+.. +++.+|+|.+... ....+.+|+.+++.+ +|||++++++++.+......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 58889999999999999999888 8899999998752 235678899999999 99999999999977655788
Q ss_pred EEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC----CCCcEEEEeccc
Q 019241 198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGL 266 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~----~~~~~kl~DFGl 266 (344)
++||||++++.+.... ..+++..++.++.|++.||.|||+.+++||||||+||+++. + +.+||+|||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcc
Confidence 9999999875443221 25788899999999999999999999999999999999998 6 7899999999
Q ss_pred ceecCCCCc----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--------HHHHHHHH
Q 019241 267 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--------HDQLVKIA 334 (344)
Q Consensus 267 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~--------~~~l~~i~ 334 (344)
+........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||...... .+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 986643222 223467888999999877567899999999999999999999999643322 24555555
Q ss_pred HhhCCC
Q 019241 335 KVTTIL 340 (344)
Q Consensus 335 ~~~~~~ 340 (344)
+.++.+
T Consensus 239 ~~l~~~ 244 (316)
T cd07842 239 EVLGTP 244 (316)
T ss_pred HHhCCC
Confidence 555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=272.05 Aligned_cols=210 Identities=32% Similarity=0.611 Sum_probs=177.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++.++||+|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++.+ +|+|++++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence 4789999999999999999999889999999987532 235678899999999 99999999999954 467899
Q ss_pred EEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
|+||++++++..+.. .+++..+..++.|++.||+|||+.+++|+||+|+||+++++ +.++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence 999999999887753 48899999999999999999999999999999999999988 789999999998764432 2
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.....++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+.++....+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~ 219 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGN 219 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCC
Confidence 233467888999999876566789999999999999999999877 455556666666655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=272.16 Aligned_cols=212 Identities=32% Similarity=0.577 Sum_probs=178.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||.||+|.+..+++.+++|.++... ...+.+|+++++++ +|+|++++++++........+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 357888999999999999999999899999999986322 23567899999999 899999999998766557899
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~- 273 (344)
+||||+++ +|..++ ..+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence 99999986 665554 248999999999999999999999999999999999999988 78999999999876543
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.......++..|+|||.+.+...++.++|+|||||++|||++|..||. +.+..+.+.++....+.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~-~~~~~~~~~~~~~~~~~ 225 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLLGT 225 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCC
Confidence 333445678889999998765567899999999999999999998884 55556666666665553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=291.40 Aligned_cols=203 Identities=28% Similarity=0.468 Sum_probs=173.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..|+.++.||.|+||.||-+++..+.+.||||.+.- .+-.++.+|+..|+++ .|||.+.+-|+|... ...+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre--~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE--HTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc--chHH
Confidence 346678999999999999999999999999999852 2235688999999999 999999999999664 5667
Q ss_pred EEEEeecCC--chhh-HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNST--DFKV-LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~--~l~~-~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
||||||-|. ++.. .-+++.+.++..|..+.+.||+|||+.+.||||||..|||+++. +.|||+|||.|....+
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCc---
Confidence 999999765 3333 33679999999999999999999999999999999999999988 8999999999988754
Q ss_pred ceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.++++||++|||||+|+. .+.|+-++||||||++..||..+++|+|+ ++-...+.+|++
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-MNAMSALYHIAQ 239 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQ 239 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-chHHHHHHHHHh
Confidence 456899999999999963 46799999999999999999999999875 344455555554
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=271.44 Aligned_cols=209 Identities=35% Similarity=0.627 Sum_probs=175.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+|++.+.||+|+||.||+|.+..+++.||+|.++... ...+..|+++++++ +|+|++++++++.+ ....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 4788899999999999999999999999999986432 23467899999999 89999999999965 4678
Q ss_pred EEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+ +++|..++. .+++..+..++.|+++||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence 9999999 888888873 48899999999999999999999999999999999999988 78999999999876543
Q ss_pred C-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
. ......++..|+|||.+.+...++.++|+|||||++|||++|..|| .+.++.+.+.++.+.++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~-~~~~~~~~~~~~~~~~~~~ 222 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL-PGDSDIDQLGKIFEALGTP 222 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc-cCCccHHHHHHHHHHcCCC
Confidence 2 2333456788999999866567899999999999999999995544 6666777777776655443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=279.92 Aligned_cols=197 Identities=22% Similarity=0.397 Sum_probs=163.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||+|++.. +++.||+|+++... .+.+.+|+++++++.+|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 35689999999999999999997433 45789999986322 245678999999997799999999988644
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 214 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------------------------------------------------------- 214 (344)
....+++|||+++++|..++.
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 356789999999999987652
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCcc
Q 019241 215 -----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFK 286 (344)
Q Consensus 215 -----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~ 286 (344)
.+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.++|+|||+++.+...... ....++..|+
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 46788899999999999999999999999999999999987 78999999999876433221 1234456799
Q ss_pred CcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 287 aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 243 aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999887 789999999999999999998 9888853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=269.87 Aligned_cols=197 Identities=26% Similarity=0.471 Sum_probs=169.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
..++|++.+.||+|+||.||+|++..+++.+|+|++... ....+.+|+.+++++ +|+|++++++++... ...++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~--~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSR--EKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--CEEEE
Confidence 467899999999999999999999999999999998643 234677899999999 999999999999653 67789
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
||||+++++|..++ ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecccccc
Confidence 99999999998876 358899999999999999999999999999999999999988 789999999998664322 2
Q ss_pred ceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.....++..|+|||.+.. ...++.++|+|||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 234568889999998752 245788999999999999999999999543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.19 Aligned_cols=201 Identities=23% Similarity=0.472 Sum_probs=171.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||.||+|++..+++.+++|.+.. .....+.+|+++++++ +|+|++++++++.+ ....++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence 47888999999999999999999999999998753 2346688899999999 99999999999954 4678999
Q ss_pred EEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence 9999999998876 347888899999999999999999999999999999999988 7899999999987654332
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~ 332 (344)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.. .+..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~ 212 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILK 212 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHH
Confidence 233467889999999877 6789999999999999999999999943 333333333
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.49 Aligned_cols=210 Identities=36% Similarity=0.613 Sum_probs=178.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ..+.+.+|+++++++ +|+|++++++++.+ ....++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence 4799999999999999999999999999999988632 236788999999999 89999999999965 467889
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
+|||++++++..+. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccc
Confidence 99999998877655 348899999999999999999999999999999999999987 789999999998765443
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
......++..|+|||++.+...++.++|+||||+++|+|++|..|| .+.+..+.+..+...++.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~ 220 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSDIDQLYLIQKCLGP 220 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCC
Confidence 3334567888999999987448899999999999999999999888 455556666666665554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=268.86 Aligned_cols=213 Identities=32% Similarity=0.620 Sum_probs=173.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---Cc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~ 196 (344)
++|++.+.||+|+||+||+|++..+++.||+|.++.. ....+.+|+.+++.+.+|+|++++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999999999999999987532 225678899999999667999999998865432 23
Q ss_pred cEEEEEeecCCchhhHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 197 PSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l--------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
.+++|||+++ ++..++ ..+++..++.++.|++.||.|||+.+++||||+|+||+++.+.+.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 6899999997 555543 2378899999999999999999999999999999999999844789999999997
Q ss_pred ecCCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 269 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 269 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
..... .......++..|+|||++.+...++.++|+|||||++|+|++|..||. +.++.+.+.++.+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP-GDSELQQLLHIFKLLGT 230 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHHhCC
Confidence 65432 223334668889999998765668999999999999999999998884 55556666666655443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=269.07 Aligned_cols=210 Identities=33% Similarity=0.643 Sum_probs=172.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++.+.||+|++|+||+|.+..+++.+|+|.+... ..+.+.+|+++++++ +|+|++++++++.+ ....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence 5799999999999999999999999999999988532 235678999999999 99999999999954 468899
Q ss_pred EEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-
Q 019241 200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG- 273 (344)
Q Consensus 200 v~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~- 273 (344)
||||+++ ++...+. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+.+.+||+|||++......
T Consensus 79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9999976 4544431 25777888999999999999999999999999999999976467999999999765432
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.......++..|+|||++.+...++.++||||+||++|+|++|+.||.. .+..+.+.++.+.++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~-~~~~~~~~~~~~~~~~ 222 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG-DSEIDELFKIFRILGT 222 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCC
Confidence 2223346788999999987656689999999999999999999999854 4455555666555443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=266.35 Aligned_cols=196 Identities=26% Similarity=0.447 Sum_probs=167.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.+|+..+.||+|+||.||+|.+..++..+++|.++.. ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 3678889999999999999999999999999987532 124578899999999 9999999999987655567
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++++||+++++|..++ ..+++.....++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||+++.....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence 88999999999998876 347888999999999999999999999999999999999988 78999999998765321
Q ss_pred ----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 11223457888999999876 77899999999999999999999999543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.98 Aligned_cols=195 Identities=25% Similarity=0.456 Sum_probs=168.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.+|++.+.||+|+||.||+|++..+++.+|+|.+.. .....+.+|+++++++ +|+|++++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 578999999999999999999999999999998742 1224678899999999 9999999999987765667
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++++||+++++|...+ ..+++.....++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence 88999999999998776 347888999999999999999999999999999999999987 78999999999765321
Q ss_pred ----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 11223467888999999877 6789999999999999999999999953
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=271.01 Aligned_cols=195 Identities=28% Similarity=0.451 Sum_probs=165.6
Q ss_pred CCe-EEEeeecccCCeeEEEEE----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 125 DDY-EVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 125 ~~~-~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
++| ++++.||+|+||+||++. ...++..+|+|.++.. ....+.+|+++++++ +|+|++++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 445 889999999999998765 3356788999998643 245678999999999 999999999998766566
Q ss_pred ccEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
..+++|||+++++|..++. .+++.+++.++.|++.||+|||+.+++|+||||+|||++.+ +.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccCCc
Confidence 7899999999999988873 68999999999999999999999999999999999999988 78999999999876543
Q ss_pred Ccc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 221 12245567999999876 6789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=265.56 Aligned_cols=206 Identities=20% Similarity=0.394 Sum_probs=169.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|+++++||+|+||.||+|.+ .++..+|+|.+... ..+.+.+|+.+++++ +|+|++++++.+.+ ....+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYII 79 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEE
Confidence 357899999999999999999975 45667999988643 346788999999999 99999999999854 4667899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCCCce
Confidence 99999999988762 47788889999999999999999999999999999999988 7899999999987653322
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ....++..|+|||++.. ..++.++|||||||++|+|++ |..||. +.+..+....+.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~ 219 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSALQR 219 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCC-CCCHHHHHHHHHc
Confidence 1 12234567999999876 678999999999999999998 888883 4444444454443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=269.39 Aligned_cols=205 Identities=20% Similarity=0.395 Sum_probs=166.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|.+. .++..+|+|.++.. ...++.+|+.+++.+ +|+||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 4678999999999999999999764 23567999988532 234578999999999 99999999999944
Q ss_pred CCccEEEEEeecCCchhhHcCC-------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~-------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
....++||||+++++|..++.. +++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~ 159 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK 159 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEE
Confidence 4678899999999999887632 3567788899999999999999999999999999999988 7899
Q ss_pred EEecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 261 LIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 261 l~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
|+|||+++......... ...++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~-~~~~~~~~~~~~ 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFV 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHH
Confidence 99999987654332211 1244677999999876 778999999999999999999 56676 444444444433
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=267.71 Aligned_cols=216 Identities=29% Similarity=0.569 Sum_probs=180.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
...|+.+++||+|.||.||+|....++. .+|+|.++.++ .....+|+..++.+ +|+|++.+..+|... .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-C
Confidence 4568889999999999999996554433 68999987542 24567999999999 999999999988654 5
Q ss_pred CccEEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC---CCcEEEEec
Q 019241 195 KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDW 264 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~---~~~~kl~DF 264 (344)
...++++||.+...+.... +.++...++.++.||+.|+.|||+.-|+||||||.|||+..+ .|.|||+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 7889999999987655432 358889999999999999999999999999999999999654 478999999
Q ss_pred ccceecCCCC----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHH
Q 019241 265 GLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVK 332 (344)
Q Consensus 265 Gla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~--------~~~~l~~ 332 (344)
|+++.+.+.- .....+.|.+|+|||.+++...|+.+.|||+.||++.||++..+.|.-... ..+|+.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999886432 234457899999999999989999999999999999999999877743111 2679999
Q ss_pred HHHhhCCCC
Q 019241 333 IAKVTTILD 341 (344)
Q Consensus 333 i~~~~~~~~ 341 (344)
|.+++|+|.
T Consensus 261 If~vLG~Pt 269 (438)
T KOG0666|consen 261 IFEVLGTPT 269 (438)
T ss_pred HHHHcCCCc
Confidence 999999985
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=266.70 Aligned_cols=193 Identities=20% Similarity=0.385 Sum_probs=162.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.++||+|+||+||+|++..+++ .||+|+++... ...+.+|+.+++.+ +|+|++++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---
Confidence 45789999999999999999998776665 48999986432 35678899999998 99999999999854
Q ss_pred CccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++++||++++++..++. .+++..+..++.|++.||+|||+.+++||||||+|||++++ +.+||+|||+++..
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeec
Confidence 34679999999999988873 47899999999999999999999999999999999999887 78999999999876
Q ss_pred CCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 271 HPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 271 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
....... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 5332221 1234567999999876 679999999999999999998 787773
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=265.44 Aligned_cols=205 Identities=19% Similarity=0.372 Sum_probs=171.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..+|++.++||+|+||.||+|.+..+++.+|+|+++... ...+.+|+++++.+ +|+|++++++++.. ....+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEEE
Confidence 456889999999999999999999999999999987543 35788999999999 99999999999954 46778999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+++++|..++. .+++..+..++.|++.||+|||+.+++||||||+||+++++ +.+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccccccceee
Confidence 9999999988763 37888899999999999999999999999999999999988 78999999999876533221
Q ss_pred e--ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 277 N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 277 ~--~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
. ...++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~-~~~~~~~~~~~~~ 219 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLE 219 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHH
Confidence 1 1223557999999876 778999999999999999998 88887 3444444444443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=265.40 Aligned_cols=204 Identities=20% Similarity=0.363 Sum_probs=168.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|++..+ ..+|+|.++.. ..+.+.+|+++++++ +|+|++++++.+.+ ...++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEE
Confidence 356799999999999999999987655 46999998743 346789999999999 99999999998743 456899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence 99999999988874 36788899999999999999999999999999999999988 7899999999987654332
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
. ....++..|+|||+..+ ..++.++|+|||||++|||++ |..|| .+.++.+....+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~ 217 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVE 217 (262)
T ss_pred ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHh
Confidence 2 12345567999999876 678999999999999999999 66676 4444455544443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.01 Aligned_cols=195 Identities=26% Similarity=0.494 Sum_probs=170.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..+|++.+.||+|+||.||+|++..+++.+++|.+... ..+.+.+|+.+++.+ +|+|++++++.|.. ....++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCEEEEe
Confidence 56899999999999999999999999999999988632 235678899999998 99999999999865 4678999
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-ce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~~ 277 (344)
|||+++++|..++. .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........ ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhccccccccC
Confidence 99999999998874 47889999999999999999999999999999999999988 7899999999876543322 23
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 3578889999999876 67889999999999999999999999543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=268.91 Aligned_cols=199 Identities=26% Similarity=0.473 Sum_probs=169.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccC----CCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~ 196 (344)
..+.|++.+.||+|+||+||+|.+..+++.+|+|.+... ....+.+|+.+++++.+|+|+++++++|.... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 456788899999999999999999999999999998533 34578899999999867999999999986543 245
Q ss_pred cEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.+++|||+.+++|..++. .+++..+..++.|++.||+|||+.+|+|+||||+||+++++ +.++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCceecc
Confidence 789999999999988763 37888899999999999999999999999999999999988 789999999997654
Q ss_pred CC-CcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.. .......++..|+|||++.. ...++.++|||||||++|||++|..||..
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 32 22334578889999999863 24588899999999999999999999953
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=271.81 Aligned_cols=231 Identities=26% Similarity=0.433 Sum_probs=191.6
Q ss_pred CCccCCCccceeccCCC-CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCC-----
Q 019241 108 PKEYWDYESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG----- 179 (344)
Q Consensus 108 ~~~~~~~~~~~~~~~~~-~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h----- 179 (344)
.+....|....+..... .+|.+.++||.|-|+|||+|.|.++.+.||+|+.+... .+.-..|+.+|+++..+
T Consensus 60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 34445666666666565 89999999999999999999999999999999997543 35667899999998533
Q ss_pred --CCccceeeEEEc--cCCCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCce
Q 019241 180 --PNVVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNV 250 (344)
Q Consensus 180 --~niv~l~~~~~~--~~~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~Ni 250 (344)
.+||+|++.|.. .++.++|+|+|++....|.-.. +.++...++.|++|++.||.|||+ +||||.||||+||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv 219 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV 219 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence 479999999964 4567899999999887776544 569999999999999999999995 6999999999999
Q ss_pred EEe-----------------------------------------------------------------------------
Q 019241 251 MID----------------------------------------------------------------------------- 253 (344)
Q Consensus 251 Ll~----------------------------------------------------------------------------- 253 (344)
|+.
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 984
Q ss_pred -------------------------------------CC-----------------------------------------
Q 019241 254 -------------------------------------HE----------------------------------------- 255 (344)
Q Consensus 254 -------------------------------------~~----------------------------------------- 255 (344)
..
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence 00
Q ss_pred ----------CCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC--C
Q 019241 256 ----------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY--G 323 (344)
Q Consensus 256 ----------~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~--~ 323 (344)
.-.+||+|||-|.... ..++....|+.|+|||++++ ..|++.+||||++|++|||.||...|.+ |
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG 456 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSG 456 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCC
Confidence 0026788888776543 45566788999999999999 8999999999999999999999999964 2
Q ss_pred C---CCHHHHHHHHHhhCCCC
Q 019241 324 H---DNHDQLVKIAKVTTILD 341 (344)
Q Consensus 324 ~---~~~~~l~~i~~~~~~~~ 341 (344)
. .+++++++|++++|.+|
T Consensus 457 ~~Y~rDEDHiA~i~ELLG~iP 477 (590)
T KOG1290|consen 457 ENYSRDEDHIALIMELLGKIP 477 (590)
T ss_pred CCCCccHHHHHHHHHHHhhcc
Confidence 2 26899999999999887
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.94 Aligned_cols=192 Identities=23% Similarity=0.394 Sum_probs=168.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.++||+|+||.||++.+..++..+|+|.++.. ...++.+|+++++++ +||||++++++|.+ ....++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence 4689999999999999999999999999999998643 234578899999999 99999999999955 4678999
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||+++++|..++ ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.+ +.+||+|||++...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence 9999999999887 357889999999999999999997 599999999999999988 78999999998765432 23
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 34578899999999876 6788999999999999999999999953
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=293.02 Aligned_cols=210 Identities=27% Similarity=0.493 Sum_probs=179.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
...+.|+++..||.|+||.||+++++.++...|-|++.... .+.+.-|++||..+ +||+||++++.|. ..+.++
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy--~enkLw 105 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYY--FENKLW 105 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHh--ccCceE
Confidence 34667888999999999999999999999889999986443 35677899999998 9999999999773 347788
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CC
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~ 273 (344)
++.|||.||..+..+ +.+.+.++..+++|++.||.|||+.+|||||||+.|||++.+ |.++|+|||.+.... ..
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHH
Confidence 999999999988765 679999999999999999999999999999999999999999 899999999875432 22
Q ss_pred CcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 274 KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.....+.||++|||||+... ..+|++++||||||++|.||..+.+|- ...+..-++.+|++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKS 250 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKS 250 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhc
Confidence 34456899999999999753 368999999999999999999998665 666777777777663
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=267.45 Aligned_cols=209 Identities=33% Similarity=0.660 Sum_probs=173.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++++.||.|+||.||+|++..+++.+|+|.++.. ....+.+|+++++++ +|+|++++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence 478899999999999999999999999999988632 225688999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
|||+.+ ++..++ ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence 999974 566554 347889999999999999999999999999999999999988 789999999987654322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
......++..|+|||++.+...++.++|||||||++|||++|+.||. +.++.+.+.++.+..+.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTP 220 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCC
Confidence 22334568889999998765557899999999999999999999995 445555666666655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=267.79 Aligned_cols=200 Identities=20% Similarity=0.408 Sum_probs=164.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|++.++||+|+||+||+|++. .++..+++|.++... ...+.+|+++++++ +|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec--CC
Confidence 367889999999999999999853 455789999986422 25688999999999 99999999999855 46
Q ss_pred ccEEEEEeecCCchhhHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC
Q 019241 196 TPSLIFEYVNSTDFKVLYP--------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~--------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~ 255 (344)
..+++|||+++++|..++. .+++.++..++.|++.||+|||+.+++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 6789999999999988762 36778888999999999999999999999999999999988
Q ss_pred CCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 256 ~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
+.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+.
T Consensus 161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~-~~~~~~~ 235 (283)
T cd05090 161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEV 235 (283)
T ss_pred -CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCCHHHH
Confidence 7899999999976643322 122344567999999876 678999999999999999998 888884 3343333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=264.04 Aligned_cols=205 Identities=17% Similarity=0.332 Sum_probs=169.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.+.||+|+||.||++++. ++..+|+|.++.. ....+.+|+++++++ +|+||+++++++.+ ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv~ 78 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIVT 78 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEEE
Confidence 457889999999999999999764 4567999987643 346789999999999 99999999999954 46788999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~ 277 (344)
||+++++|..++. .+++..+..++.|++.||+|||+.+++||||||+||+++.+ +.+||+|||.++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceec
Confidence 9999999988763 37888899999999999999999999999999999999988 789999999997654332221
Q ss_pred --ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 278 --~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...++..|+|||++.. ..++.++|+||||+++|||++ |+.|| ...+..+.+..+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~-~~~~~~~~~~~i~~ 216 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISR 216 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHC
Confidence 2234557999999876 678999999999999999999 88888 44455555555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=267.65 Aligned_cols=206 Identities=24% Similarity=0.422 Sum_probs=167.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.+.||+|+||.||++++..+++.||+|.++... ..++..|+.++.+..+|+|++++++++.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 47899999999999999999999999999999986432 24556677765555599999999999965 4568899
Q ss_pred EEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 201 ~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
|||+++ +|..++ ..+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence 999985 444333 2478999999999999999999997 99999999999999988 7899999999987654
Q ss_pred CCcceecccCCCccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.......+.+..+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence 4333445788899999988542 3468899999999999999999999966555555555443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=273.86 Aligned_cols=195 Identities=24% Similarity=0.437 Sum_probs=173.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..+-|.++++||+|+||.||++.++.+|..+|+|.+- ....+++.+|+.|++++ +.|++|++||.+... ..+++||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~--sDLWIVM 107 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKH--SDLWIVM 107 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhccC--CceEeeh
Confidence 3456888999999999999999999999999999875 34568899999999998 999999999966432 5578999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccc
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~ 276 (344)
|||..|+..+.+ +.+.+.++..+++..++||+|||...-||||||..|||++.+ |.+||+|||.|-.+.+. ...
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHHhh
Confidence 999999988876 569999999999999999999999999999999999999999 89999999999765433 234
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
++..||+.|||||++.. -.|+.++||||||++..||..|++||..
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccc
Confidence 56789999999999987 7899999999999999999999999854
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=269.14 Aligned_cols=198 Identities=25% Similarity=0.480 Sum_probs=169.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
..++|++.++||+|+||.||+|++..+++.+|+|.++... ...+.+|+.+++.+ +|||++++++.+.+ ....++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEE
Confidence 3567888999999999999999999999999999986433 24577899999999 99999999999855 467789
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
+|||+++++|..++ ..+++.++..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCcccc
Confidence 99999999998876 458999999999999999999999999999999999999988 789999999987654322 2
Q ss_pred ceecccCCCccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.....++..|+|||++. ....++.++|+|||||++|+|++|..||+...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 23457889999999974 22458899999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=267.20 Aligned_cols=200 Identities=27% Similarity=0.485 Sum_probs=170.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEc---cCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|.+..+++.+|+|+++... ...+.+|+.+++++.+|+|++++++++.. ......
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 5788999999999999999999999999999999986432 35688899999999679999999998753 234568
Q ss_pred EEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
++||||+++++|..++ ..+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+|||++...
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~ 174 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCceeec
Confidence 9999999999998764 347888899999999999999999999999999999999988 78999999999876
Q ss_pred CCCC-cceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 271 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 271 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.... ......++..|+|||++.. ...++.++||||+||++|||++|..||...
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 4332 2234568899999999753 145788999999999999999999999643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=266.59 Aligned_cols=209 Identities=29% Similarity=0.501 Sum_probs=173.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccC---CCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~ 197 (344)
..++|++.+.||+|+||.||++.+..+++.+|+|++... ....+.+|+.+++++.+|+|++++++++...+ ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 478899999999999999999999999999999998643 34667889999999878999999999986543 2467
Q ss_pred EEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
++||||+++++|..++ ..+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||++...
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~~~~ 178 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQL 178 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccchhc
Confidence 9999999999998765 357899999999999999999999999999999999999988 78999999998765
Q ss_pred CCCC-cceecccCCCccCcccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 271 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 271 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.... ......++..|+|||++.... .++.++|||||||++|||++|+.||... +..+.+.++
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~ 245 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKI 245 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHH
Confidence 4332 223456788899999976422 3688999999999999999999999543 333444433
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=262.47 Aligned_cols=196 Identities=27% Similarity=0.511 Sum_probs=170.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.+.||+|+||.||+|.+..+++.+++|++... ..+.+.+|+++++++ +|+|++++++++.+ ....+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence 47899999999999999999999889999999998643 346788999999999 99999999999855 4678899
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
|||++++++..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence 9999999998876 458999999999999999999999999999999999999988 789999999987654332 2
Q ss_pred ceecccCCCccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.....++..|+|||.+... ..++.++|+|||||++|||++|..||...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 3345678889999998762 27889999999999999999999999543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=268.76 Aligned_cols=213 Identities=33% Similarity=0.555 Sum_probs=175.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC----
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---- 194 (344)
-++|++.++||+|+||.||+|++..+++.+|+|.+... ....+.+|+++++++ +|||++++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 56799999999999999999999999999999988532 123457899999999 99999999998865422
Q ss_pred --CccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 195 --KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 195 --~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
...++||||+.+ ++...+. .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCCcc
Confidence 345899999986 4444432 58999999999999999999999999999999999999988 789999999997
Q ss_pred ecCCCCc-----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 269 FYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 269 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
....... .....++..|+|||.+.+...++.++|+||||+++|||++|+.|| .+.+..+.+..+.++.|.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 6643221 123456788999999876556789999999999999999999887 4566677777777776644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=288.93 Aligned_cols=198 Identities=23% Similarity=0.432 Sum_probs=171.6
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCc
Q 019241 132 KVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD 208 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~ 208 (344)
.||+|.||+||-|+|..+...+|||-+... ..+-+..|+..-++| .|+|||+++|.| ..+++.-+.||-.+||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~--senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV--SENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc--CCCCeEEEEeecCCCCc
Confidence 699999999999999999999999988532 234578899999999 999999999999 44567889999999999
Q ss_pred hhhHcC----CC--CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-CCcceeccc
Q 019241 209 FKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA 281 (344)
Q Consensus 209 l~~~l~----~l--~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~~~~~~~~~ 281 (344)
|..+++ ++ ++..+..+.+||++||.|||+..|||||||-+|+|++.-.|.+||+|||-++.... +.-..++.|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 999884 35 77788899999999999999999999999999999998879999999999987653 334456789
Q ss_pred CCCccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 019241 282 SRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 282 t~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~ 332 (344)
|..|||||++.. ...|+.++|||||||++.||.||++||..-.+....+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 999999999964 467999999999999999999999999876666554443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.20 Aligned_cols=205 Identities=22% Similarity=0.424 Sum_probs=169.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|.+.+.||+|+||.||+|.+.. +++.+|+|.++.. ..+.+.+|+++++++ +|+|++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--
Confidence 4568889999999999999997643 3578999998643 235788999999999 999999999999654
Q ss_pred CccEEEEEeecCCchhhHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC
Q 019241 195 KTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~-----------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~ 257 (344)
...+++|||+++++|..++. .+++..+..++.|++.|+.|||+.|++||||||+||+++.+ +
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~ 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-L 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-C
Confidence 67899999999999988763 26778889999999999999999999999999999999988 8
Q ss_pred cEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 258 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 258 ~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
.+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.. .+..+....+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~-~~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHH
Confidence 9999999999765433221 22344677999999877 779999999999999999998 9999853 3444444444
Q ss_pred H
Q 019241 334 A 334 (344)
Q Consensus 334 ~ 334 (344)
.
T Consensus 238 ~ 238 (280)
T cd05049 238 T 238 (280)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=261.51 Aligned_cols=205 Identities=21% Similarity=0.411 Sum_probs=170.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||.||+|.+. +++.+|+|.++.. ..+++.+|+++++++ +|+|++++++++.. ....+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL--EEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEec--CCCeeee
Confidence 4577999999999999999999864 4567999998643 346788999999999 89999999999854 4677899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||+++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIY 158 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCCcc
Confidence 99999999988873 47899999999999999999999999999999999999988 7899999999987653222
Q ss_pred ceeccc---CCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~---t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+ +..|+|||++.+ ..++.++|+|||||++|||++ |+.|| .+.+..+.+..+.+
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~ 219 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQ 219 (261)
T ss_pred -cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHc
Confidence 11222 346999999876 778999999999999999999 88887 45555555555543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=265.88 Aligned_cols=192 Identities=18% Similarity=0.355 Sum_probs=160.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|++.+.||+|+||+||+|.+..+++ .+++|.+.... ..++..|+.+++++ +|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 4678889999999999999999877776 47777775322 24566788888888 99999999998843 4
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++++||+.+++|..++. .+++..+..++.|++.||+|||+.+++||||||+|||++.+ +.+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence 4679999999999998872 47899999999999999999999999999999999999988 789999999998764
Q ss_pred CCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 272 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 272 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
+... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 3322 122345668999999876 679999999999999999998 888883
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=272.29 Aligned_cols=213 Identities=25% Similarity=0.477 Sum_probs=181.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHHhCC-C----CccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGG-P----NVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h-~----niv~l~~~~~~~~~~ 195 (344)
..++|+++..+|+|.||.|-++.+..++..||+|+++.... +.-.-|+++|+++..+ | -++.+.++| ...+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hccC
Confidence 47899999999999999999999999999999999985443 5566799999999433 2 377787888 5568
Q ss_pred ccEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC---------------
Q 019241 196 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--------------- 255 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--------------- 255 (344)
+.|+|+|.+.... .++++ +++...++.++.|+++++++||+.+++|.||||+|||+.+.
T Consensus 165 hiCivfellG~S~-~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 165 HICIVFELLGLST-FDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred ceEEEEeccChhH-HHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 8999999886544 44554 38999999999999999999999999999999999998421
Q ss_pred ----CCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 256 ----LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 256 ----~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
...++++|||.|..-. ......+.|..|+|||++++ -+|+.++||||+||+|+|+.+|...| +.+++.|+++
T Consensus 244 r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceec--cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHHHHH
Confidence 1248999999998754 33466789999999999998 88999999999999999999999988 6888999999
Q ss_pred HHHHhhCCCCC
Q 019241 332 KIAKVTTILDF 342 (344)
Q Consensus 332 ~i~~~~~~~~~ 342 (344)
.+..++|++|-
T Consensus 320 MMerIlGp~P~ 330 (415)
T KOG0671|consen 320 MMERILGPIPS 330 (415)
T ss_pred HHHHhhCCCcH
Confidence 99999998874
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=267.76 Aligned_cols=206 Identities=21% Similarity=0.398 Sum_probs=169.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|.+.+.||+|+||+||++.+. .++..+|+|.++... .+.+.+|+++++++ +|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 567899999999999999999752 345678999886432 35688999999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcE
Q 019241 196 TPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 259 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~ 259 (344)
..+++|||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~ 159 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLV 159 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-CcE
Confidence 7899999999999988763 37899999999999999999999999999999999999988 789
Q ss_pred EEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 260 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 260 kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
||+|||+++........ ....++..|+|||++.+ ..++.++|+|||||++|||++ |..||. +.+..+....+.+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~-~~~~~~~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc
Confidence 99999999865433221 12234667999999876 778999999999999999998 888874 4444455554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=284.36 Aligned_cols=211 Identities=25% Similarity=0.440 Sum_probs=185.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..+++.+..||-||||.|=++........+|+|++++. ..+....|-+||... ..+.||++|..|.+ +++.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyv 495 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYV 495 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhh
Confidence 45677788999999999999876655556899988642 335677899999998 79999999999955 5889
Q ss_pred EEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
|++||-|-||.++..++ .|++...+.++..+++|++|||++|||.|||||+|.|+|.+ |-+||.|||+|+.+..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCC
Confidence 99999999999999984 59999999999999999999999999999999999999999 889999999999999999
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
...++|||+.|.|||++++ ...+.++|.||||+++|||++|.+|| .+.+.......|-+-+..+
T Consensus 575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i 638 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKI 638 (732)
T ss_pred ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhh
Confidence 9999999999999999998 88999999999999999999999999 6777766666665544433
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=267.60 Aligned_cols=195 Identities=27% Similarity=0.517 Sum_probs=170.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..+|++.+.||.|+||+||+|.+..+++.+++|.+... ..+.+.+|+.+++.+ +|+|++++++++.+ ....++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEEE
Confidence 56799999999999999999999999999999988532 345678899999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-ce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~~ 277 (344)
+||+++++|..++. .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccccccCC
Confidence 99999999988774 48999999999999999999999999999999999999988 7899999999876544332 23
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3467889999999876 67899999999999999999999999543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=264.66 Aligned_cols=210 Identities=35% Similarity=0.645 Sum_probs=176.9
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
|++.++||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+|++++++++.+......++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 67889999999999999999999999999999643 235678899999999 899999999999765346789999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--c
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--E 275 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~--~ 275 (344)
||+++ ++..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.+||+|||++....... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccc
Confidence 99986 566554 258899999999999999999999999999999999999988 789999999998765443 2
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.....++..|+|||.+.+...++.++|||||||++|||++|+.||. ..+..+.+..+.+..+.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSP 221 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCC
Confidence 3345667889999988765668899999999999999999999984 455566677776666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=263.51 Aligned_cols=192 Identities=22% Similarity=0.454 Sum_probs=167.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+|++.++||+|+||.||++++..+++.+|+|.++.. ..+.+.+|+.+++.+ +|+|++++++.+.+ ....+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence 588899999999999999999999999999988532 235678899999999 99999999999954 46789999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 275 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~- 275 (344)
||++++++..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++++ +.++++|||++........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeecccccc
Confidence 9999999877652 37888899999999999999999999999999999999988 7899999999976643322
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCC
Confidence 233568888999999876 6789999999999999999999999953
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=269.45 Aligned_cols=204 Identities=25% Similarity=0.441 Sum_probs=171.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|.+..+++.+|+|.+... ..+.+.+|+++++.+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence 4789999999999999999999999999999998643 234578899999999 89999999999854 46789
Q ss_pred EEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++|||+.+++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccc
Confidence 9999999999988863 47889999999999999999999999999999999999988 78999999998654321
Q ss_pred Cc------------------------------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~ 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence 11 112357888999999877 678999999999999999999999994 4
Q ss_pred CCCHHHHHHHH
Q 019241 324 HDNHDQLVKIA 334 (344)
Q Consensus 324 ~~~~~~l~~i~ 334 (344)
.+..+.+..+.
T Consensus 235 ~~~~~~~~~~~ 245 (316)
T cd05574 235 SNRDETFSNIL 245 (316)
T ss_pred CchHHHHHHHh
Confidence 44445444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=265.81 Aligned_cols=193 Identities=25% Similarity=0.479 Sum_probs=170.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.+.||.|+||.||+|++..+++.+|+|.+... ....+.+|+++++.+ +|+|++++++++.+. ...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence 4688889999999999999999999999999998633 235678999999999 899999999998654 778999
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~ 277 (344)
+||+++++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++++ +.++|+|||+++..... ....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccccccc
Confidence 99999999988875 47999999999999999999999999999999999999998 78999999999877644 2334
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
...++..|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4577888999999887 6699999999999999999999999953
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.56 Aligned_cols=209 Identities=20% Similarity=0.396 Sum_probs=178.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.+....+..||+|++|.|-+.++..+|...|+|.+.. +..++..+|+++..+....|.+|.++|...+. ...++
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEE
Confidence 4555667889999999999999999999999999852 34466778999888776899999999977554 55678
Q ss_pred EEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 200 IFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 200 v~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.||.|... ++.+. ...++.-+-+++..+..||.|||++ .+||||+||+|||++.+ |.+|+||||.+-.+.
T Consensus 123 cME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 123 CMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYLV 200 (282)
T ss_pred eHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceeeh
Confidence 89988754 33333 3488888999999999999999975 89999999999999999 899999999998887
Q ss_pred CCCcceecccCCCccCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 272 PGKEYNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
++-..+...|...|||||.+.. ...|+.++||||||+++.||.+++.||.++.++-+++.++.+-
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 6666666788999999999854 2468999999999999999999999999999999999998763
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=264.61 Aligned_cols=209 Identities=31% Similarity=0.651 Sum_probs=174.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+|++.++||.|++|+||+|++..+++.+|+|.++.. ..+.+.+|+++++++ +|+|++++++++.+ ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEee--CCcEEEEE
Confidence 588999999999999999999999999999998643 235677899999999 99999999999965 46678999
Q ss_pred EeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 202 e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
||+++ ++..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++++ +.++|+|||++.......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcc
Confidence 99996 555544 247899999999999999999999999999999999999988 789999999997554322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
......++..|++||++.+...++.++|+|||||++|+|++|..||. +.+..+.+.++.+..+.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNEDQLLKIFRIMGTP 220 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCC
Confidence 22334678889999998765668899999999999999999999984 556667767666654433
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=260.71 Aligned_cols=203 Identities=24% Similarity=0.420 Sum_probs=173.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||.||++.+..+++.+|+|.+... ....+.+|+++++++ +|+|++++++.+.. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence 588999999999999999999999999999998532 245688999999999 99999999998854 4678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|.+++. .+++..+..++.|++.||+|||++|++|+||+|+||+++.+.+.+||+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999988873 3788899999999999999999999999999999999987656789999999987765544
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.. .+..+...++
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~-~~~~~~~~~~ 213 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKI 213 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCccc-CchHHHHHHH
Confidence 445678889999999876 6788999999999999999999999843 3333333333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=262.05 Aligned_cols=205 Identities=18% Similarity=0.343 Sum_probs=168.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.+.||+|+||+||+|.+. ++..+|+|.++.. ..+.+.+|+.+++++ +||||+++++++.+. ...+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQ--RPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccC--CCcEEEE
Confidence 467899999999999999999654 4456999988643 246789999999999 999999999999543 5678999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~ 277 (344)
||+.+++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||.++.........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCceee
Confidence 9999999988763 47899999999999999999999999999999999999988 789999999998665433221
Q ss_pred --ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 278 --~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...++..|++||.+.+ ..++.++|||||||++|||++ |..||. ..+..+....+.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~ 216 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQ 216 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHhc
Confidence 1234567999999876 678999999999999999998 888884 3333444444433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=260.79 Aligned_cols=202 Identities=24% Similarity=0.462 Sum_probs=172.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++++.||.|+||.||.+++..+++.+++|.+.. ....++.+|+++++++ +|+|++++++++.+ ....+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence 58899999999999999999999999999998753 2235688999999999 99999999999965 4678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
|||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 99999999998873 37888999999999999999999999999999999999988 789999999998765433
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
......++..|+|||++.+ ..++.++|+|||||++|||++|..||. ..+..+....+
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~-~~~~~~~~~~~ 213 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFD-ATNPLNLVVKI 213 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHH
Confidence 2344568899999999877 668899999999999999999999984 34444444444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=264.16 Aligned_cols=203 Identities=20% Similarity=0.404 Sum_probs=164.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC----
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 194 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---- 194 (344)
|++.+.||+|+||.||+|....+ +..+|+|.++... ...+.+|++.++.+ +|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 45678999999999999987653 4789999986321 24688999999999 99999999998854332
Q ss_pred CccEEEEEeecCCchhhHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 195 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
...++++||+++++|..++ ..+++..+..++.|++.||+|||+.+++||||||+||+++++ +.+||+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence 3478999999999998775 247888999999999999999999999999999999999988 789999999
Q ss_pred cceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 266 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
+++........ .....+..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.++.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~ 228 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYL 228 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence 99876543322 12234567999999866 778999999999999999999 77776 455555544444
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=266.38 Aligned_cols=195 Identities=22% Similarity=0.437 Sum_probs=164.9
Q ss_pred CCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..+|++++.||+|+||+||+|. +..+++.||+|.++... .+.+.+|+++++++ +|+|++++++++...+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 4578999999999999999997 34578899999986543 34688999999999 9999999999886655567
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccccC
Confidence 899999999999998873 37889999999999999999999999999999999999988 7899999999987654
Q ss_pred CCcce----ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 273 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... ...++..|+|||++.+ ..++.++|+|||||++|||++|..|+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 33211 1123345999999876 678999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=265.25 Aligned_cols=195 Identities=27% Similarity=0.554 Sum_probs=168.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||++++..+++.+|+|.+... ....+.+|+.+++.+ +|+|++++++++.+ ....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCeEE
Confidence 4678889999999999999999899999999987531 235678899999999 99999999999965 46778
Q ss_pred EEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
++|||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence 9999999999988752 37889999999999999999999999999999999999988 789999999987664
Q ss_pred CCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 272 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 3322 233468889999999876 678899999999999999999999996443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=268.49 Aligned_cols=195 Identities=26% Similarity=0.499 Sum_probs=170.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
..++|++++.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +|+|+++++++|.. ....++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEE
Confidence 357899999999999999999999999999999998632 335678899999998 99999999999954 467889
Q ss_pred EEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-c
Q 019241 200 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y 276 (344)
Q Consensus 200 v~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~ 276 (344)
||||+++++|..++. .+++..+..++.|++.||.|||+.+++|+||||+|||++.+ +.++|+|||++....+... .
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCccCc
Confidence 999999999998873 47888999999999999999999999999999999999988 7899999999987654332 2
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 33467889999999877 7789999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=272.82 Aligned_cols=214 Identities=33% Similarity=0.623 Sum_probs=177.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.+.||+|+||+||+|++..+++.||+|.++.. ....+.+|+.+++.+ +|+|++++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheeccccccc
Confidence 457899999999999999999999999999999988532 234577899999999 99999999998864422
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++++||+.+ +|..++ ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 82 NDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTS 159 (337)
T ss_pred CcEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccC
Confidence 457999999974 565554 458999999999999999999999999999999999999988 789999999998764
Q ss_pred CC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.. .......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+..+....+.+..|.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSP 228 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCC
Confidence 43 22234467888999999876456899999999999999999999998 4555566666666666543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=274.36 Aligned_cols=214 Identities=35% Similarity=0.652 Sum_probs=177.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+.. .....+.+|+.+++++.+|+||++++++|...+....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35778899999999999999999988999999998742 2234577899999999789999999999876656678
Q ss_pred EEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
++||||+++ +|..++. .+++.....++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 85 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccccccc
Confidence 999999985 6766653 47888888999999999999999999999999999999988 789999999997664332
Q ss_pred -----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 275 -----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 275 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
......++..|+|||++.+...++.++|+|||||++|+|++|+.|| .+.+..+...++....+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCC
Confidence 1223467889999999876567889999999999999999999998 455556666666655544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=267.95 Aligned_cols=205 Identities=24% Similarity=0.462 Sum_probs=172.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.++||.|+||+||+|.+..++..+|+|.++... .+.+.+|+++++++ +|+|++++++.+.. ....++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEEE
Confidence 467899999999999999999998899999999986433 35688899999999 89999999999965 4677899
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cc
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~ 275 (344)
|||+++++|..++. .+++..++.++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhcccccc
Confidence 99999999988863 48999999999999999999999999999999999999988 78999999998655332 22
Q ss_pred ceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.....++..|+|||++.. ...++.++|+|||||++|||++|+.||. +.+..+.+.++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~-~~~~~~~~~~~ 220 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKI 220 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc-cCCHHHHHHHH
Confidence 334568889999999752 2457889999999999999999999984 33333333333
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=262.12 Aligned_cols=194 Identities=26% Similarity=0.507 Sum_probs=171.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.++|++.+.||+|+||.||+|.+..+++.+++|.++... .+.+.+|+++++++ +|+|++++++.+.+ ....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCcEEEEEe
Confidence 467889999999999999999998889999999986443 57899999999999 99999999999965 477889999
Q ss_pred eecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cce
Q 019241 203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277 (344)
Q Consensus 203 ~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~ 277 (344)
|+++++|..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCccccc
Confidence 99999998876 347899999999999999999999999999999999999988 789999999998765433 333
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
...++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4567889999999876 6789999999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=266.52 Aligned_cols=204 Identities=25% Similarity=0.454 Sum_probs=170.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||++++..+++.|++|.+.... ...+.+|+++++.+ +|+||+++++.+.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence 46889999999999999999999999999999986432 24577899999998 99999999999854 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++++|..++ ..+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.++|+|||+++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence 999999999998887 447889999999999999999999999999999999999987 789999999986421110
Q ss_pred ---------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 275 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
......++..|+|||.+.+ ..++.++|+|||||++|||++|..||. +.+..+.+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~-~~~~~~~~~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHH
Confidence 0012356778999999876 678999999999999999999999995 444444444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=268.79 Aligned_cols=210 Identities=28% Similarity=0.552 Sum_probs=179.2
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCC---ccEEEE
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIF 201 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~ 201 (344)
.+-||.|+||.||-++|..+|+.||+|.+-. ...+.+-+|+.+|..+ +|.|++..++...-.+.. .+|.+.
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3779999999999999999999999998743 3457788999999999 999999999877433322 345677
Q ss_pred EeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc--c
Q 019241 202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--Y 276 (344)
Q Consensus 202 e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~--~ 276 (344)
|.|... |...+ ..++...+.-+++||++||.|||+.+|.||||||.|.|++.+ ..+||||||+|+....++. .
T Consensus 137 ELmQSD-LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 137 ELMQSD-LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHhh-hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchhhhhhh
Confidence 777654 44443 458889999999999999999999999999999999999999 7899999999998765443 3
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~ 343 (344)
+..+.|.+|+|||++.+...|+.+.||||.||++.|++.++..| +..++-+++..|.+++|+|..+
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHHHHHHHHHHhCCCcHH
Confidence 45688999999999999899999999999999999999888877 7888899999999999999754
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=265.55 Aligned_cols=203 Identities=26% Similarity=0.465 Sum_probs=169.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
-|++.+.||+|+||.||+|.+..++..+++|.+.... .+.+.+|+++++.+ +|+|++++++++... ...++|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeC--CEEEEEEE
Confidence 3677899999999999999999999999999986433 35678899999999 999999999998653 67789999
Q ss_pred eecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccce
Q 019241 203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 277 (344)
Q Consensus 203 ~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~ 277 (344)
|++++++..++ ..+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.+||+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccccccc
Confidence 99999998765 348899999999999999999999999999999999999988 78999999998765332 2233
Q ss_pred ecccCCCccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 278 VRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
...++..|+|||++. ....++.++|+|||||++|||++|+.||.. .+..+....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~ 220 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKI 220 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-cCHHHHHHHH
Confidence 456888999999974 224578899999999999999999999853 3334444444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.73 Aligned_cols=213 Identities=30% Similarity=0.612 Sum_probs=175.0
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccC--
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH-- 193 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-- 193 (344)
+...++|++.+.||+|+||.||+|.+..+++.||+|.++... .+.+.+|+++++++ +|+||+++++++....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 91 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence 345789999999999999999999999999999999986422 34577899999999 9999999999885432
Q ss_pred --CCccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 --SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 --~~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....+++++++ ++++..++ ..+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++..
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~ 169 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARH 169 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccccc
Confidence 23467888876 56776665 358999999999999999999999999999999999999988 7899999999876
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
... ......++..|+|||.+.+...++.++|||||||++|||++|+.||. +.+..+.+.++.+..+.
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGT 236 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCC
Confidence 432 22345678899999998765678899999999999999999999984 44555555666555443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=260.88 Aligned_cols=195 Identities=28% Similarity=0.565 Sum_probs=169.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||+|.+..+++.+|+|.++. ...+.+.+|+++++++ +|+|++++++++.+. ...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence 579999999999999999999988999999998752 2245788999999999 999999999999654 6778
Q ss_pred EEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
++|||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~ 157 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence 9999999999987762 37888999999999999999999999999999999999988 789999999987654
Q ss_pred CCC-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 272 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 272 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 332 2234568888999999876 778999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=264.90 Aligned_cols=205 Identities=20% Similarity=0.378 Sum_probs=168.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||+|.+... +..+|+|.+.... ...+.+|+++++.+ +|+|++++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-- 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST-- 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--
Confidence 467899999999999999999987643 3789999986432 24678899999999 99999999999955
Q ss_pred CCccEEEEEeecCCchhhHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.+++||||||+|||++.+ +.+|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~k 159 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVK 159 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEE
Confidence 467889999999999988763 25677888999999999999999999999999999999998 7899
Q ss_pred EEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 261 l~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++||+++ |..|| .+.+..+....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~~~~~~~~~~~~ 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLKFV 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC-ccCCHHHHHHHH
Confidence 999999976544322 122345678999999876 678999999999999999998 88777 444444444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=284.54 Aligned_cols=209 Identities=23% Similarity=0.429 Sum_probs=182.5
Q ss_pred CCCCe-EEEeeecccCCeeEEEEEEcCCCeEEE---EEEec----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~va---vK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
...+| +...+||+|+|-+||+|.|..+|..|| ||+-+ +...++|..|+.+|+.| +|+||+++++++.+...
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCC
Confidence 44454 556789999999999999988888877 33321 33447899999999999 99999999999998888
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHc--CcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~--~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
+.+.+|.|.|..|+|..++ +..+...++.+++||++||.|||++ .|||||||-+||+++.+.|.|||+|+|||..
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 8889999999999999997 4578888999999999999999987 5999999999999999999999999999988
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...... ....|||.|||||++. ..|+..+||||||++++||+|+..||..-.+..+...++..
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred hhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 764443 3479999999999986 68999999999999999999999999888888888888765
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=273.15 Aligned_cols=214 Identities=32% Similarity=0.626 Sum_probs=179.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~ 196 (344)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++++ +|+||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 47899999999999999999999999999999998642 235677899999999 899999999988543 3356
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||+.+ ++..++ ..+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeeccc
Confidence 7999999975 676665 348999999999999999999999999999999999999988 78999999999765432
Q ss_pred Cc-----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.. .....++..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+++..+...+|.++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCCh
Confidence 21 123467888999999876566899999999999999999999998 56666677777777777654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=260.18 Aligned_cols=192 Identities=26% Similarity=0.460 Sum_probs=166.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|++|.||++.+..+++.+|+|.+... ..+.+.+|+++++++ +|+|++++++.+... ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 588999999999999999999999999999998532 234678899999999 999999999987432 3457899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
|||++++++..++. .+++.++..++.|++.|+++||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence 99999999987762 37899999999999999999999999999999999999988 789999999998764322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 2233467889999999877 778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=267.25 Aligned_cols=194 Identities=24% Similarity=0.444 Sum_probs=166.1
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++++.||+|+||+||++++..+++.+|+|.++.. ....+.+|+++++++ +|+|++++++.+.. ....++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence 4688899999999999999999989999999988532 235688999999999 99999999999855 4778899
Q ss_pred EEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
|||+++++|..++. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence 99999999988763 58899999999999999999997 599999999999999987 78999999999765422
Q ss_pred CcceecccCCCccCcccccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 23345678889999998542 23588999999999999999999999543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=267.94 Aligned_cols=206 Identities=22% Similarity=0.417 Sum_probs=167.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..+|++.++||+|+||+||+|.+..+ +..+|+|+++... ...+.+|+.++..+ +|+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~-- 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE-- 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--
Confidence 34577789999999999999986543 5789999987432 24578899999999 999999999999554
Q ss_pred CccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC
Q 019241 195 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~ 255 (344)
...++++||+.+++|..++. .+++..+..++.|++.||.|||+.|++||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 56789999999999888762 36778889999999999999999999999999999999987
Q ss_pred CCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 019241 256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 331 (344)
Q Consensus 256 ~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~ 331 (344)
+.+||+|||+++........ ....++..|+|||.+.. ..++.++|||||||++|||++ |..|| .+.+..+...
T Consensus 161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~ 237 (283)
T cd05091 161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIE 237 (283)
T ss_pred -CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH
Confidence 78999999998765433221 22345678999999876 678999999999999999998 66666 4555555555
Q ss_pred HHHH
Q 019241 332 KIAK 335 (344)
Q Consensus 332 ~i~~ 335 (344)
.+.+
T Consensus 238 ~i~~ 241 (283)
T cd05091 238 MIRN 241 (283)
T ss_pred HHHc
Confidence 5544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.12 Aligned_cols=195 Identities=23% Similarity=0.399 Sum_probs=169.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|+..++||.|++|.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+||++++++|.+......++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4789999999999999999999999999999998643 235688999999999 99999999999976666678999
Q ss_pred EEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
|||+++++|.+++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence 9999999997764 237888899999999999999999999999999999999988 78999999998765432
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 22 23457788999999876 77899999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=260.90 Aligned_cols=194 Identities=29% Similarity=0.528 Sum_probs=169.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||.|+||.||++.+..+++.+|+|.++.. ..+.+.+|+++++.+ +|+|++++++++........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 588899999999999999999999999999998532 235677899999999 99999999998876656678999
Q ss_pred EEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHH-----HcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 201 ~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH-----~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
|||+++++|..++ ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.+ +.+||+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccccc
Confidence 9999999998776 35788999999999999999999 8899999999999999988 799999999998
Q ss_pred ecCCCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 269 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
....... .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 7765443 344578899999999877 6689999999999999999999999953
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=264.14 Aligned_cols=198 Identities=19% Similarity=0.332 Sum_probs=159.6
Q ss_pred eeecccCCeeEEEEEEcCCCe--EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||.||+|++..++. .+++|.++.. ..+.+.+|+++++++.+|||+++++++|.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 358999999999999877775 4688887632 235678899999999789999999999955 45678999999
Q ss_pred cCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 205 NSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 205 ~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
++++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg 157 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFG 157 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCC
Confidence 9999988763 36788899999999999999999999999999999999988 789999999
Q ss_pred cceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 266 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
++..............+..|+|||++.. ..++.++|||||||++|||++ |..||. +.+..+....+
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~ 224 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL 224 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-ccCHHHHHHHH
Confidence 9863321111112233556999999866 778999999999999999997 888883 44434444433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=280.46 Aligned_cols=195 Identities=26% Similarity=0.546 Sum_probs=178.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
....|.+...||+|.|++|.++++..++..||+|++++. ....+.+|+++|+.+ .|||||+++++.. ....+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~--t~~~l 130 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIE--TEATL 130 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeee--eccee
Confidence 356799999999999999999999999999999999643 235578999999999 9999999999994 45888
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
|+||||+.++.+..++ ....+...+.+..|+.++++|||+++|+|||||++|+|++.+ ..+||+|||++..+..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeecccc
Confidence 9999999999999988 457778899999999999999999999999999999999999 568999999999998888
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
.....+|++.|.|||++.+....+..+|+||+|++||.|+.|..||.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 88999999999999999987777899999999999999999999994
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=261.67 Aligned_cols=203 Identities=18% Similarity=0.347 Sum_probs=166.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.+|++.+.||+|+||.||+|.+. ++..+|+|++... ....+.+|+++++++ +|+|++++++++.+ ....++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEEEe
Confidence 45788899999999999999765 5668999998643 345788999999999 99999999999854 467889999
Q ss_pred eecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce-
Q 019241 203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN- 277 (344)
Q Consensus 203 ~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~- 277 (344)
|+++++|.+++. .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||+++...+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccccccccc
Confidence 999999988763 47888999999999999999999999999999999999988 789999999997654322211
Q ss_pred -ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 278 -VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 278 -~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
...++..|+|||.+.+ ..++.++|+|||||++|||++ |..||. +.++.+....+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~ 215 (256)
T cd05059 159 QGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVS 215 (256)
T ss_pred CCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC-CCCHHHHHHHHH
Confidence 1123346999999876 778999999999999999999 788874 444455444443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=260.57 Aligned_cols=196 Identities=20% Similarity=0.397 Sum_probs=161.0
Q ss_pred eecccCCeeEEEEEE--cCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 132 KVGRGKYSEVFEGIN--VNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+||+|+||+||+|.+ ..++..+|+|+++.. ..+++.+|+.+++.+ +|+||+++++++.. ...++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 589999999999964 456789999998633 235688999999999 99999999998843 4568999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc----e
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N 277 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~----~ 277 (344)
++++|..++ ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecC
Confidence 999998877 358899999999999999999999999999999999999988 78999999999876543221 1
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
...++..|+|||.+.. ..++.++|+|||||++|||++ |..||. +.+..+....+.
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~i~ 212 (257)
T cd05116 157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQMIE 212 (257)
T ss_pred CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHH
Confidence 1233468999999865 678899999999999999998 888884 344444444443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=262.88 Aligned_cols=194 Identities=25% Similarity=0.485 Sum_probs=171.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+|++.+.||.|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++++ +|||++++++.+. .....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQ--DEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhc--CCCeEEE
Confidence 588999999999999999999989999999998532 246788999999999 9999999999984 4577899
Q ss_pred EEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 200 v~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|+||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCccc
Confidence 999999999988873 68899999999999999999999999999999999999988 78999999999877655444
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 55678888999999876 668999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=263.54 Aligned_cols=202 Identities=21% Similarity=0.399 Sum_probs=165.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+|+.+++++ +|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC-
Confidence 35679999999999999999999876 67889999886332 34688899999999 999999999988554
Q ss_pred CCccEEEEEeecCCchhhHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRL 261 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl 261 (344)
...++||||+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+. ..+||
T Consensus 82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 56689999999999998762 378889999999999999999999999999999999998651 35899
Q ss_pred EecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 262 IDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 262 ~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
+|||+++......... ....+..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~ 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEV 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHH
Confidence 9999998763322211 1223457999999976 679999999999999999997 888884 4443333
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=258.86 Aligned_cols=186 Identities=23% Similarity=0.425 Sum_probs=157.3
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
+.||+|+||+||+|++..+++.+|+|.+... ....+.+|+++++++ +|+||++++++|.+ ....++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3699999999999999999999999987532 235688999999999 99999999999954 4678899999999
Q ss_pred CchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce---ec
Q 019241 207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VR 279 (344)
Q Consensus 207 ~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~---~~ 279 (344)
++|..++. .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.+||+|||++....+..... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCCCC
Confidence 99998873 37889999999999999999999999999999999999988 789999999987654321111 11
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
..+..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 22345999999876 678999999999999999998 777773
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=262.56 Aligned_cols=203 Identities=19% Similarity=0.402 Sum_probs=163.4
Q ss_pred EEEeeecccCCeeEEEEEEcCCCe--EEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC----CCc
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT 196 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~ 196 (344)
.+.++||+|+||.||+|++..++. .+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++++.... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 456889999999999999877665 6899987532 235678899999999 9999999999874321 235
Q ss_pred cEEEEEeecCCchhhHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 197 PSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
.+++|||+.+++|..++ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence 68999999999988765 237888899999999999999999999999999999999988 78999999999
Q ss_pred eecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 268 EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 268 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
+........ ....++..|++||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~ 228 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLR 228 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHH
Confidence 876543321 12245667999999876 678999999999999999999 67777 4444444444443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=272.96 Aligned_cols=199 Identities=23% Similarity=0.395 Sum_probs=162.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEE-----cCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++ ..+++.||||+++... ...+.+|+.++.++.+|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 357899999999999999999974 3467889999986422 245778999999997789999999988654
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 214 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------------------------------------------------------- 214 (344)
....+++|||+++++|..++.
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 356789999999999987652
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc---eecc
Q 019241 215 -----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRV 280 (344)
Q Consensus 215 -----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~ 280 (344)
.+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCC
Confidence 14667778899999999999999999999999999999988 78999999999765332221 1123
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGH 324 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~ 324 (344)
++..|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 243 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 4567999999876 778999999999999999997 888885433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=261.54 Aligned_cols=206 Identities=19% Similarity=0.375 Sum_probs=168.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.++|++.+.||+|+||.||+|++..++ ..+|+|.++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence 467889999999999999999876444 37999988643 235688999999999 99999999999954 467
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.+++|||+++++|..++. .+++.++..++.|++.||+|||+.+++||||||+|||++.+ +.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence 889999999999988873 47888999999999999999999999999999999999988 7899999999987654
Q ss_pred CCcce----ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ...++..|+|||.+.+ ..++.++|+|||||++||+++ |..||.. .+..+....+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~ 224 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQDVIKAIEE 224 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCccc-CCHHHHHHHHhC
Confidence 32211 1122457999999876 678999999999999999886 9999853 333444444444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=258.51 Aligned_cols=195 Identities=26% Similarity=0.483 Sum_probs=168.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+|+..+.||+|+||+||+|.+..+++.+++|.+... ..+.+.+|+++++.+ +|+|++++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence 466778999999999999999889999999987532 235688999999999 99999999999854 4678
Q ss_pred EEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++++||+++++|..++. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence 89999999999988873 37889999999999999999999999999999999999988 789999999998765544
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
......++..|++||.+.....++.++|+|||||++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 44556788899999998763348999999999999999999999995443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=287.27 Aligned_cols=210 Identities=22% Similarity=0.325 Sum_probs=161.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe-EEEEE------------------Eecc--cchHHHHHHHHHHHHHhCCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE-RCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNV 182 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~-~vavK------------------~~~~--~~~~~~~~E~~~l~~l~~h~ni 182 (344)
.++|+++++||+|+||+||+|..+.... ..+.| .++. .....+.+|+.+++++ +|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence 5789999999999999999987543221 11111 1111 1234578999999999 99999
Q ss_pred cceeeEEEccCCCccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC
Q 019241 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255 (344)
Q Consensus 183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~ 255 (344)
+++++++.+. ...+++++++.+..+..... ......++.++.|++.||+|||+.||+||||||+|||++.+
T Consensus 226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999654 56789999987655443321 12355677899999999999999999999999999999988
Q ss_pred CCcEEEEecccceecCCCCc--ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CCCHHHHH
Q 019241 256 LRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLV 331 (344)
Q Consensus 256 ~~~~kl~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~--~~~~~~l~ 331 (344)
+.+||+|||+++.+..... .....||..|+|||++.+ ..++.++|||||||++|||++|..+++.+ .+...++.
T Consensus 304 -~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 -GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred -CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 7899999999987654322 223578999999999887 77999999999999999999998655443 23456666
Q ss_pred HHHHhhC
Q 019241 332 KIAKVTT 338 (344)
Q Consensus 332 ~i~~~~~ 338 (344)
++.+.++
T Consensus 382 ~~~~~~~ 388 (501)
T PHA03210 382 KIIDSLS 388 (501)
T ss_pred HHHHhcc
Confidence 6665544
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=265.61 Aligned_cols=204 Identities=21% Similarity=0.369 Sum_probs=167.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..+|.+.+.||+|+||.||+|++. .++..+++|.++... .+.+.+|+++++++ +|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence 456889999999999999999753 345678999986443 35688999999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC
Q 019241 196 TPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~ 256 (344)
..++||||+++++|..++. .+++..++.++.|++.||+|||+++++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~- 159 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN- 159 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence 7899999999999988762 26888899999999999999999999999999999999988
Q ss_pred CcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 019241 257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 257 ~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~ 332 (344)
+.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .+..+.+..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~ 237 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIEC 237 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 7899999999976543322 122345678999999877 778999999999999999999 8888843 333444443
Q ss_pred H
Q 019241 333 I 333 (344)
Q Consensus 333 i 333 (344)
+
T Consensus 238 ~ 238 (291)
T cd05094 238 I 238 (291)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.89 Aligned_cols=203 Identities=19% Similarity=0.381 Sum_probs=166.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.+|++.+.||+|+||.||+|++..+++ .||+|.++.. ....+..|+.+++.+ +|||++++++++.+ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCce
Confidence 568899999999999999999876654 6999998643 235788999999999 99999999999844 4667
Q ss_pred EEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+++++|..++. .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCccccccccC
Confidence 89999999999988763 37889999999999999999999999999999999999988 78999999998765432
Q ss_pred Ccc---eecc---cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 274 KEY---NVRV---ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 274 ~~~---~~~~---~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
... .... .+..|+|||.+.. ..++.++|||||||++||+++ |..||. +.+..+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~-~~~~~~~~~~i 224 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVINAI 224 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCC-CCCHHHHHHHH
Confidence 221 1111 1346999999876 778999999999999999886 998985 33444444444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=261.31 Aligned_cols=193 Identities=26% Similarity=0.481 Sum_probs=166.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+|+..+.||+|+||.||++.+..+++.+|+|.+.... .+.+.+|+.+++++ +|+|++++++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence 4677789999999999999999999999999986322 35688999999999 99999999999954 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++|+||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+...++|+|||++......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 88999999999998877 458889999999999999999999999999999999999877456999999998766432
Q ss_pred C-----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 1 1123467888999999876 6789999999999999999999999954
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=265.13 Aligned_cols=198 Identities=19% Similarity=0.248 Sum_probs=150.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccchH--------------HHHHHHHHHHHHhCCCCccce
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKKK--------------KIKREIKILQNLCGGPNVVKL 185 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~--------------~~~~E~~~l~~l~~h~niv~l 185 (344)
..++|++.++||+|+||+||+|++..+ +..+|+|+....... ....+...+..+ +|+|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcE
Confidence 467899999999999999999998777 667788764321110 011222333445 79999999
Q ss_pred eeEEEccCC--CccEEEEEeecCCc--hhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEE
Q 019241 186 LDIVRDQHS--KTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261 (344)
Q Consensus 186 ~~~~~~~~~--~~~~lv~e~~~~~~--l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl 261 (344)
++++..... ...++++|++.... +.......++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcEEE
Confidence 997654322 23456677664432 22223346788889999999999999999999999999999999987 78999
Q ss_pred EecccceecCCCC--------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 262 IDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 262 ~DFGla~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
+|||+|+....+. ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999998764221 1223468999999999876 77999999999999999999999999544
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=265.72 Aligned_cols=204 Identities=21% Similarity=0.414 Sum_probs=167.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||++.+... ...+|+|.+.... ...+.+|+++++++.+|+|++++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 467899999999999999999987643 3789999986432 24577899999998779999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
....+++|||+++++|..++. .+++..+..++.|++.||+|||+.+|+||||||+||+++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 466889999999999988762 4788889999999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL 330 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l 330 (344)
+ +.+||+|||+++......... ...++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+..
T Consensus 168 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~ 244 (293)
T cd05053 168 D-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEELF 244 (293)
T ss_pred C-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC-CCCHHHHH
Confidence 8 789999999998765432211 1234567999999876 778999999999999999997 888884 33333433
Q ss_pred H
Q 019241 331 V 331 (344)
Q Consensus 331 ~ 331 (344)
.
T Consensus 245 ~ 245 (293)
T cd05053 245 K 245 (293)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=267.16 Aligned_cols=215 Identities=32% Similarity=0.583 Sum_probs=175.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.++||+|+||.||+|++..+++.+|+|.+... ....+.+|+++++++ +|+||+++++++.+...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 368999999999999999999999999999999988432 124577899999999 99999999998754332
Q ss_pred ---CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 195 ---KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 195 ---~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
...++|+||+.+..+..+. ..+++..+..++.|+++||+|||+.|++|+||||+||+++++ +.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccch
Confidence 3568999999875444333 358999999999999999999999999999999999999988 789999999997
Q ss_pred ecCCCCc------------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 269 FYHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 269 ~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
....... .....++..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+....+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHH
Confidence 6543221 112345778999999876566899999999999999999999887 566667777777766
Q ss_pred hCCC
Q 019241 337 TTIL 340 (344)
Q Consensus 337 ~~~~ 340 (344)
.+.+
T Consensus 243 ~~~~ 246 (311)
T cd07866 243 CGTP 246 (311)
T ss_pred hCCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=271.84 Aligned_cols=190 Identities=22% Similarity=0.279 Sum_probs=159.2
Q ss_pred EEeeeccc--CCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 129 VVRKVGRG--KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 129 ~~~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
++++||+| +||+||++++..+++.||+|.++.. ..+.+.+|+++++.+ +||||++++++|... ...++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence 45789999 7899999999999999999998643 224577899999999 999999999999654 6778999
Q ss_pred EeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-
Q 019241 202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 275 (344)
Q Consensus 202 e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~- 275 (344)
||++++++.+++ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.++++|||.+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 999999998876 248899999999999999999999999999999999999988 7899999986543321111
Q ss_pred -------ceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 -------YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 -------~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.....++..|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1123456779999998753 4589999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=265.26 Aligned_cols=200 Identities=20% Similarity=0.382 Sum_probs=163.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+|++.+.||+|+||+||+|++.. ....+++|.+.... ...+.+|+++++.+ +||||+++++.|.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCC
Confidence 47788999999999999998643 33578999886432 34688899999999 99999999999955 456
Q ss_pred cEEEEEeecCCchhhHcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 019241 197 PSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 249 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~---------------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~N 249 (344)
.++++||+.+++|..++. .+++..+..++.|++.||+|||+.+++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 789999999999988752 26778889999999999999999999999999999
Q ss_pred eEEeCCCCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 019241 250 VMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 325 (344)
Q Consensus 250 iLl~~~~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~ 325 (344)
||++++ +.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+..
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~ 234 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA 234 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence 999988 7899999999976543322 122345667999999876 778999999999999999998 88888 4444
Q ss_pred CHHHHH
Q 019241 326 NHDQLV 331 (344)
Q Consensus 326 ~~~~l~ 331 (344)
..+...
T Consensus 235 ~~~~~~ 240 (290)
T cd05045 235 PERLFN 240 (290)
T ss_pred HHHHHH
Confidence 444333
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=261.40 Aligned_cols=192 Identities=26% Similarity=0.524 Sum_probs=164.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------------hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .+.+.+|+++++++ +|+||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD-- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence 4667789999999999999998899999999885321 14577899999999 99999999999855
Q ss_pred CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
....+++|||+++++|..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||.++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~ 156 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKL 156 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence 46788999999999998887 347888899999999999999999999999999999999988 78999999998776
Q ss_pred CCCCc-------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 271 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 271 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 52211 112357788999999876 6788999999999999999999999954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=260.97 Aligned_cols=205 Identities=19% Similarity=0.366 Sum_probs=168.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.++|++.+.||+|+||+||+|++..+ ...+|+|.++... ...+.+|+.+++++ +|+|++++++.+.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence 46789999999999999999987654 4579999986432 35678899999999 99999999999854 466
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.+++|||+++++|..++. .+++..+..++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|||+++....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence 789999999999998863 47899999999999999999999999999999999999988 7899999999987752
Q ss_pred CC-ccee--cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 273 GK-EYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 273 ~~-~~~~--~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
.. .... ..++..|+|||.+.+ ..++.++|||||||++|||++ |..||.. .++.+....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~ 222 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVE 222 (266)
T ss_pred cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHH
Confidence 22 1111 234567999999876 678999999999999999998 9888843 33444444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=266.95 Aligned_cols=197 Identities=23% Similarity=0.410 Sum_probs=164.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||++.+. .++..+|+|.++... .+.+.+|+.+++++.+|+||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 3568999999999999999999752 345689999886432 24688999999999679999999999955
Q ss_pred CCccEEEEEeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
....+++|||+.+++|..++.. +++.++..++.|++.||.|||+.+++|+||||+|||++.+ +.++++|||+++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~ 189 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLAR 189 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcccc
Confidence 4668899999999999888732 7899999999999999999999999999999999999987 789999999998
Q ss_pred ecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 019241 269 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 323 (344)
Q Consensus 269 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~ 323 (344)
........ ....++..|+|||.+.+ ..++.++||||+||++|||++ |..||...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 65433221 12244677999999877 678999999999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.28 Aligned_cols=210 Identities=33% Similarity=0.646 Sum_probs=174.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|.+.+.||+|+||.||+|++..+++.+|+|.++.. ....+.+|+.+++.+ +|+||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCC
Confidence 457899999999999999999999999999999998532 224578899999999 99999999999864322
Q ss_pred -CccEEEEEeecCCchhhHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 195 -KTPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 195 -~~~~lv~e~~~~~~l~~~l~-~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
...++|+||+.. ++..... .+++..+..++.|++.||+|||+.+++||||||+||+++.+ +.+||+|||+++....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence 345899999975 5555544 68999999999999999999999999999999999999988 7899999999976532
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~ 338 (344)
......++..|+|||++.+...++.++|||||||++|||++|+.||. +.+..+.+..+....|
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTG 232 (342)
T ss_pred --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcC
Confidence 22334678889999998764568999999999999999999999995 4555566666666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=260.89 Aligned_cols=204 Identities=19% Similarity=0.399 Sum_probs=168.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|.+. ++..+|+|.++.. ..+.+.+|+.+++++ +|+|++++++++.+ ...+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEE
Confidence 4568899999999999999999754 5667999998643 346789999999999 99999999998843 456899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.+++||||||+||+++++ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence 99999999988763 37889999999999999999999999999999999999988 7899999999987644322
Q ss_pred ce--ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 276 YN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 276 ~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
.. ...++..|+|||.+.+ ..++.++|+|||||++|||++ |..|| .+.+..+....+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~ 217 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVE 217 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHH
Confidence 11 1234557999999876 678999999999999999999 77777 4555555555554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.60 Aligned_cols=215 Identities=28% Similarity=0.588 Sum_probs=177.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC----
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---- 193 (344)
..++|++.+.||+|+||+||+|.+..+++.||+|.++.. ....+.+|+++++++ +|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999999999999998632 224577899999999 9999999999986543
Q ss_pred ----CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 194 ----SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 194 ----~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
....++|+||++++.+.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++++ +.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCcccc
Confidence 23789999999985444333 258999999999999999999999999999999999999988 7899999999
Q ss_pred ceecCCCC--cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 267 AEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 267 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
+....... ......++..|+|||.+.+...++.++|||||||++|||++|+.||. ..+..+.+..+.+..+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCC
Confidence 98765433 22233567789999988764567899999999999999999998884 456677777777766544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.78 Aligned_cols=204 Identities=19% Similarity=0.363 Sum_probs=167.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.++||+|+||+||+|.+..+ ..+|+|.+... ..+.+.+|+++++++ +|+|++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence 46799999999999999999976554 46899987643 336788999999999 99999999998843 4578999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+.+++|.+++. .+++..+..++.|++.||+|||+.|++|+||||+||+++++ +.++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCccc
Confidence 9999999988773 26888899999999999999999999999999999999988 78999999999876433221
Q ss_pred --eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||. +..+.+....+.+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~ 218 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMVNREVLEQVER 218 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc
Confidence 12234567999998876 678999999999999999999 888874 4445555555443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=261.56 Aligned_cols=189 Identities=24% Similarity=0.453 Sum_probs=163.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCC
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
+.||+|+|+.|-.+....++..+|||++.+. .+++..+|++++.+..+|+||++++++|++. ...|||||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccCc
Confidence 5799999999999999999999999999754 3577889999999999999999999999664 5678999999999
Q ss_pred chhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC--------C
Q 019241 208 DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG--------K 274 (344)
Q Consensus 208 ~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~--------~ 274 (344)
.+...+ ..|++.++.+++.+|+.||.|||.+||.|||+||+|||-.+. ...+|||||.+..-+.-+ .
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 998877 459999999999999999999999999999999999998643 246899999997554322 2
Q ss_pred cceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
...+.+|+..|||||+..- ...|+.++|.|||||+||-|++|..||.
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 2345678888999999632 3579999999999999999999999995
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.58 Aligned_cols=185 Identities=18% Similarity=0.386 Sum_probs=154.8
Q ss_pred eecccCCeeEEEEEEc--CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
.||+|+||.||+|.+. .++..+|+|+++... .+.+.+|+.+++++ +|+||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999765 445679999986443 35588999999999 99999999998843 46789999999
Q ss_pred CCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc----e
Q 019241 206 STDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N 277 (344)
Q Consensus 206 ~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~----~ 277 (344)
+++|..++. .+++..+..++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||+++........ .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccC
Confidence 999998773 48999999999999999999999999999999999999988 78999999999765433221 1
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
...++..|+|||.+.. ..++.++|||||||++||+++ |..||..
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 1223467999999876 678999999999999999996 8888843
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.04 Aligned_cols=199 Identities=25% Similarity=0.460 Sum_probs=170.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccC----CCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~ 196 (344)
.+++|++.+.||+|+||+||+|.+..+++.+++|++... ..+.+.+|+.+++++.+|+|++++++++.+.. ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 468999999999999999999999889999999998643 34678899999999977999999999997543 356
Q ss_pred cEEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.++||||+++++|.+++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCcccee
Confidence 78999999999887765 257889999999999999999999999999999999999988 7899999999876
Q ss_pred cCCCC-cceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 270 YHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 270 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
..... ......++..|+|||++.. ...++.++|||||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 54332 2234568889999998753 23577899999999999999999999953
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=259.32 Aligned_cols=206 Identities=20% Similarity=0.411 Sum_probs=168.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.++|+..+.||+|+||.||+|++..++. .+++|.++.. ..+.+.+|+++++++ +|+|++++.+++.+ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CCC
Confidence 4578889999999999999998876554 7999988643 235688999999999 99999999999954 467
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++. .+++..+..++.|++.|++|||+.|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence 889999999999988872 47889999999999999999999999999999999999988 7899999999976643
Q ss_pred CCcce----ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ....+..|+|||++.. ..++.++|||||||++|||++ |..||. ..+..+....+.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~-~~~~~~~~~~i~~ 225 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYW-DMSNHEVMKAIND 225 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCC-cCCHHHHHHHHhc
Confidence 22111 1122346999999876 678999999999999999997 999984 3344555555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.41 Aligned_cols=204 Identities=20% Similarity=0.398 Sum_probs=168.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|+++++||+|+||.||+|.+ .+++.+|+|.+... ....+.+|+.+++++ +|+|++++++++.+ ...+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEE
Confidence 357899999999999999999974 45678999998643 346789999999999 99999999998743 457899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+.+++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++++ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence 99999999988762 47888899999999999999999999999999999999988 7899999999977653222
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
. ....++..|+|||++.. ..++.++|||||||++|||++ |+.||. +.+..+....+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~ 217 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLE 217 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHH
Confidence 1 12344567999999876 678899999999999999998 898884 444444444443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=266.52 Aligned_cols=200 Identities=21% Similarity=0.392 Sum_probs=163.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++|.+.+.||+|+||.||++++.. +...+|+|.++... ..++.+|+++++++.+|+|++++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4689999999999999999997643 23469999997432 245778999999997899999999999654
Q ss_pred CCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~ 253 (344)
...++||||+++++|..++. .+++.++..++.|++.||+|||+.|++||||||+||+++
T Consensus 97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 56789999999999988873 267788999999999999999999999999999999999
Q ss_pred CCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 254 ~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
.+ +.+||+|||.++........ ....++..|+|||++.+ ..++.++|+|||||++|||++ |..|| .+.+..+
T Consensus 175 ~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~~~~~~ 250 (307)
T cd05098 175 ED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEE 250 (307)
T ss_pred CC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CcCCHHH
Confidence 88 78999999998765432211 11223467999999877 678999999999999999998 77777 3443333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=269.88 Aligned_cols=212 Identities=28% Similarity=0.510 Sum_probs=174.2
Q ss_pred CCCCeEE-EeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----------------HHHHHHHHHHHHHhCCCCccc
Q 019241 123 DQDDYEV-VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNVVK 184 (344)
Q Consensus 123 ~~~~~~~-~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~~h~niv~ 184 (344)
..++|.. .+.||+|+||+||+|++..+++.||+|.++.... ..+.+|+++++.+ +|+|+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence 3456654 4679999999999999999999999999863221 1467899999999 9999999
Q ss_pred eeeEEEccCCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEE
Q 019241 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261 (344)
Q Consensus 185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl 261 (344)
+++++.. ....+++|||+.+ ++..++ ..+++.....++.|++.||+|||+.|++|+||+|+||+++.+ +.++|
T Consensus 85 ~~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl 160 (335)
T PTZ00024 85 LVDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKI 160 (335)
T ss_pred eeEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEE
Confidence 9999954 4678899999985 666655 348899999999999999999999999999999999999988 78999
Q ss_pred EecccceecCCC---------------CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 019241 262 IDWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326 (344)
Q Consensus 262 ~DFGla~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~ 326 (344)
+|||++...... .......++..|+|||.+.+...++.++|+|||||++|||++|..|| .+.++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~ 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENE 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCH
Confidence 999999765411 11122356778999999877556799999999999999999999888 46666
Q ss_pred HHHHHHHHHhhCCC
Q 019241 327 HDQLVKIAKVTTIL 340 (344)
Q Consensus 327 ~~~l~~i~~~~~~~ 340 (344)
.+.+..+.+.++.+
T Consensus 240 ~~~~~~i~~~~~~~ 253 (335)
T PTZ00024 240 IDQLGRIFELLGTP 253 (335)
T ss_pred HHHHHHHHHHhCCC
Confidence 77777777766644
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=262.16 Aligned_cols=205 Identities=21% Similarity=0.422 Sum_probs=171.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.++||+|+||+||+|.+.. ++.+++|.++... ...+.+|+.+++.+ +|+|++++++++.+ ....++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeEEE
Confidence 4568889999999999999998877 8899999986433 46788999999999 99999999999955 4678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence 99999999998874 37888999999999999999999999999999999999988 7899999999976643322
Q ss_pred c-eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+.+..+.+..+.+
T Consensus 160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~ 219 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITA 219 (261)
T ss_pred cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CcCCHHHHHHHHHh
Confidence 1 12234567999999876 678999999999999999998 78888 44555555555543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=267.52 Aligned_cols=213 Identities=32% Similarity=0.588 Sum_probs=174.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCC--CeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCCc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNT--NERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT 196 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~ 196 (344)
+|++.+.||+|+||.||++++..+ +..+|+|.+... ..+.+.+|+.+++++.+|+||+++++.+... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588899999999999999998877 889999988632 2356788999999996799999999975432 2345
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++++||+++ +|...+ ..+++..++.++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+++.....
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecccc
Confidence 6788898875 566655 458899999999999999999999999999999999999988 78999999999865432
Q ss_pred Cc-----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.. .....++..|+|||++.+...++.++|+||+||++|+|++|..|| .+.+..+.+.++.+.+|.++
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCC
Confidence 21 223467889999999876567899999999999999999999888 45555677777777776654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=280.26 Aligned_cols=206 Identities=26% Similarity=0.465 Sum_probs=174.4
Q ss_pred CccceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceee
Q 019241 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLD 187 (344)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~ 187 (344)
|..+.....+..-|..++-||-|+||+|.+++...+...+|+|.+++. .....+.|.+||..- +++.||+||-
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyy 696 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYY 696 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEE
Confidence 444444444567799999999999999999998899999999998643 235578899999998 9999999999
Q ss_pred EEEccCCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEec
Q 019241 188 IVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264 (344)
Q Consensus 188 ~~~~~~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DF 264 (344)
.|. +...+|+||||++||++..++ .-|.+..++.|+.++..|+++.|..|+|||||||+|||||.+ |.+||+||
T Consensus 697 SFQ--DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDF 773 (1034)
T KOG0608|consen 697 SFQ--DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDF 773 (1034)
T ss_pred Eec--cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeec
Confidence 994 457889999999999988876 458888999999999999999999999999999999999999 89999999
Q ss_pred ccceec---------CCCC----------------------------------cceecccCCCccCcccccCCCCCCchh
Q 019241 265 GLAEFY---------HPGK----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSL 301 (344)
Q Consensus 265 Gla~~~---------~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 301 (344)
||+.-+ ..+. .....+||+.|+|||++.. ..++..+
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~c 852 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLC 852 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccc
Confidence 998322 1110 0112479999999999998 8899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Q 019241 302 DMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 302 DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
|+||.||+||||+.|+.||....
T Consensus 853 dwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCC
Confidence 99999999999999999996543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.05 Aligned_cols=207 Identities=35% Similarity=0.688 Sum_probs=170.7
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
|++.++||.|++|+||+|.+..++..||+|++... ....+.+|+++++.+ +|+|++++++++.+ ....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence 56789999999999999999999999999998632 235678899999999 99999999999954 47789999
Q ss_pred EeecCCchhhHc---C--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cc
Q 019241 202 EYVNSTDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 275 (344)
Q Consensus 202 e~~~~~~l~~~l---~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~ 275 (344)
||++ +++..++ . .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence 9996 4676665 2 47899999999999999999999999999999999999987 78999999999765422 22
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.....++..|+|||++.+...++.++|+|||||++|+|++|..||.. .++.+.+.++.+..++
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~ 218 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG-DSEIDQLFRIFRTLGT 218 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCC
Confidence 23345688899999987655678999999999999999999999854 4444555555554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.89 Aligned_cols=200 Identities=31% Similarity=0.581 Sum_probs=167.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCC-----
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----- 194 (344)
...+|++.+.||+|+||+||+|++..+++.||+|.+... ..+.+.+|+++++++ +|+|++++++++.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence 357899999999999999999999999999999988543 335688899999999 99999999987754322
Q ss_pred -------CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 195 -------KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 195 -------~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
...++||||+++ ++..++ ..+++..++.++.|++.||.|||+.|++||||||+||+++.+.+.+||+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 346899999985 676665 3589999999999999999999999999999999999998665678999999
Q ss_pred cceecCCCC----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 266 LAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 266 la~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
+++...... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 997654321 11233578889999987665678899999999999999999999995443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=265.03 Aligned_cols=206 Identities=20% Similarity=0.370 Sum_probs=167.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
..++|++.+.||+|+||.||+|+.. .++..+|+|.++.. ..+.+.+|+.+++.+.+|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4678899999999999999999753 23457999998642 235688999999998789999999999955
Q ss_pred cCCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....+++|||+++++|..++. .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 467789999999999988762 25677788999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+.+ +.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+
T Consensus 171 ~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~ 247 (304)
T cd05101 171 TEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE 247 (304)
T ss_pred cCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHH
Confidence 988 78999999999876533221 22344567999999876 678999999999999999998 67776 4444444
Q ss_pred HHHHH
Q 019241 329 QLVKI 333 (344)
Q Consensus 329 ~l~~i 333 (344)
....+
T Consensus 248 ~~~~~ 252 (304)
T cd05101 248 LFKLL 252 (304)
T ss_pred HHHHH
Confidence 44433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=273.99 Aligned_cols=196 Identities=22% Similarity=0.386 Sum_probs=162.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|.+.++||+|+||.||+|++. .+++.||+|+++... ...+.+|+.++.++..|+||++++++|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3567888999999999999999853 345689999996432 24678899999999449999999999955
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------------------------------------------------------- 214 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------------------------------------------------------- 214 (344)
....++||||+++|+|.+++.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 467899999999999987662
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 215 ------------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 215 ------------------------------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
.+++..+..++.|++.||+|||+.+++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 14556678899999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
+.+ +.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||..
T Consensus 273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 987 7899999999986543221 122356778999999876 678999999999999999998 8888843
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=259.70 Aligned_cols=200 Identities=20% Similarity=0.375 Sum_probs=166.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|.+..+++ .+|+|.++... ...+.+|+.+++++ +|+|++++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence 45778999999999999999998776654 58999886432 35678899999999 99999999999865
Q ss_pred CccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...+++|||+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccccc
Confidence 56789999999999988763 47899999999999999999999999999999999999987 78999999999876
Q ss_pred CCCCccee---cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 271 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 271 ~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
........ ..++..|+|||.+.. ..++.++|+|||||++||+++ |..||. +.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~ 220 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEI 220 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCC-CCCHHHH
Confidence 54332221 123457999999876 778999999999999999998 998884 3333333
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=264.48 Aligned_cols=200 Identities=26% Similarity=0.467 Sum_probs=169.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEcc----CCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~ 196 (344)
..+.|++.+.||+|+||+||+|++..+++.+|+|++... ....+..|+.+++++.+|+|++++++++... ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 457888999999999999999999999999999998543 3356788999999987799999999988532 2357
Q ss_pred cEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.+++|||+++++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~ 172 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhhh
Confidence 799999999999988773 37788888999999999999999999999999999999988 789999999987553
Q ss_pred CC-CcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. .......++..|+|||.+.. ...++.++|+|||||++|||++|..||...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 22 22334568889999999763 246888999999999999999999999543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=264.73 Aligned_cols=193 Identities=19% Similarity=0.357 Sum_probs=161.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|+..+.||+|+||.||+|++..+++ .+|+|.+.... ...+.+|+.+++.+ +|+||++++++|..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--- 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLS--- 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcC---
Confidence 45778889999999999999999877775 47888886432 23678899999999 99999999999854
Q ss_pred CccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++++||++++++..++. .+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLL 159 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccc
Confidence 23569999999999888763 47888999999999999999999999999999999999887 78999999999876
Q ss_pred CCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 271 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
...... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 433221 22344668999999876 778999999999999999997 888883
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=257.01 Aligned_cols=207 Identities=19% Similarity=0.382 Sum_probs=173.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|.+. +++.+|+|.+.. ...+++.+|+.+++++ +|+|++++++++.. ....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence 4678999999999999999999864 557799999874 3446799999999999 89999999999854 3667899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.|+.|||+.+++|+||||+||+++.+ +.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence 99999999988873 47889999999999999999999999999999999999988 7899999999987653221
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHh
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
. .....+..|+|||.+.+ ..++.++|+|||||++|||++ |+.|| .+.+..+.+..+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~ 220 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERG 220 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC
Confidence 1 12234567999999876 678999999999999999998 88888 455556666666543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=265.37 Aligned_cols=195 Identities=27% Similarity=0.440 Sum_probs=165.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEE----cCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
...|++++.||+|+||.||++.. ..++..||+|.++... ...+.+|+++++.+ +|+|++++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 34578899999999999999974 4567899999986432 35688999999999 999999999999776557
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCccccccc
Confidence 7899999999999998862 47889999999999999999999999999999999999988 789999999998765
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... ....++..|+|||++.+ ..++.++|||||||++|||++++.|+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCc
Confidence 43321 12345667999999876 678999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=266.58 Aligned_cols=205 Identities=20% Similarity=0.381 Sum_probs=165.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++|.+.++||+|+||.||+|++.. ....+|+|.++... ...+.+|+.+++++.+|+||++++++|.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 4688999999999999999997532 34578999987432 24578899999998669999999999954
Q ss_pred CCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~ 253 (344)
....+++|||+++++|..++. .+++.++..++.|++.||.|||+.|++||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 466889999999999988762 267888899999999999999999999999999999999
Q ss_pred CCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 254 ~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
.+ +.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~~ 245 (314)
T cd05099 169 ED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEEL 245 (314)
T ss_pred CC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence 88 78999999999866432221 11233457999999876 778999999999999999999 78887 34444444
Q ss_pred HHHH
Q 019241 330 LVKI 333 (344)
Q Consensus 330 l~~i 333 (344)
...+
T Consensus 246 ~~~~ 249 (314)
T cd05099 246 FKLL 249 (314)
T ss_pred HHHH
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=264.69 Aligned_cols=203 Identities=19% Similarity=0.396 Sum_probs=163.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC--------------CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccce
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNT--------------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKL 185 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l 185 (344)
.++|++.++||+|+||.||+|++..+ ...||+|.++... ...+.+|+++++++ +|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 46899999999999999999976443 2358999986432 34688999999999 99999999
Q ss_pred eeEEEccCCCccEEEEEeecCCchhhHcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCce
Q 019241 186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP---------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV 250 (344)
Q Consensus 186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~---------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~Ni 250 (344)
++++.. ....++||||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999954 467889999999999988762 257788889999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 019241 251 MIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHD 325 (344)
Q Consensus 251 Ll~~~~~~~kl~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~--g~~Pf~~~~~ 325 (344)
+++.+ +.+||+|||++.......... ...++..|+|||++.. ..++.++|+|||||++|+|++ +..||. ..+
T Consensus 161 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~-~~~ 237 (295)
T cd05097 161 LVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLS 237 (295)
T ss_pred EEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc-ccC
Confidence 99987 789999999997654332211 2234567999999876 678999999999999999998 556763 334
Q ss_pred CHHHHHH
Q 019241 326 NHDQLVK 332 (344)
Q Consensus 326 ~~~~l~~ 332 (344)
..+....
T Consensus 238 ~~~~~~~ 244 (295)
T cd05097 238 DEQVIEN 244 (295)
T ss_pred hHHHHHH
Confidence 3443333
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=257.69 Aligned_cols=198 Identities=24% Similarity=0.394 Sum_probs=165.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.+.....||+|+||.||+|++..++..+++|.+... ..+.+.+|+.+++.+ +|+||+++++++.. ....++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEEE
Confidence 3344457899999999999999999999999988643 335688999999999 99999999999955 46788999
Q ss_pred EeecCCchhhHcC----CC--CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 202 EYVNSTDFKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l--~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
||+++++|..++. .+ ++..+..++.|++.||+|||+.||+||||||+||+++.+.+.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999988763 24 77788889999999999999999999999999999987547899999999976543222
Q ss_pred -ceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 276 -YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
.....++..|+|||++... ..++.++|+|||||++|+|++|+.||.....
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 2334678899999998652 3478999999999999999999999965443
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=258.65 Aligned_cols=205 Identities=22% Similarity=0.461 Sum_probs=168.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.++||+|+||.||+|.+... ...+++|..... ..+.+.+|+.+++++ +|+|++++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---C
Confidence 356788999999999999999987544 346899988643 235688999999999 99999999999854 4
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||+++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeecc
Confidence 4679999999999998873 37899999999999999999999999999999999999988 789999999998765
Q ss_pred CCCccee--cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 272 PGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
....... ..++..|+|||.+.. ..++.++|||||||++||+++ |..||. +.+..+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~ 222 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIE 222 (270)
T ss_pred cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHH
Confidence 4432222 223457999999866 678999999999999999996 999984 444455555444
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=267.52 Aligned_cols=212 Identities=33% Similarity=0.655 Sum_probs=174.6
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC-
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS- 194 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 194 (344)
|...++|++++.||+|+||+||++.+..++..||+|.+... ....+.+|+.+++++ +|+||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence 33567899999999999999999999999999999998532 124577899999999 99999999999864322
Q ss_pred ---CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 195 ---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 195 ---~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
...++||||+ ++++..++ ..+++..++.++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccccc
Confidence 2458999999 56777665 468999999999999999999999999999999999999988 7899999999976
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~ 338 (344)
.... .....++..|+|||.+.+...++.++|+|||||++|++++|..||. +.+......++.+..+
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTG 233 (343)
T ss_pred cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcC
Confidence 5432 2334678899999998764568899999999999999999999984 4444555555554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=258.52 Aligned_cols=191 Identities=25% Similarity=0.458 Sum_probs=163.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+|++.+.||+|+||+||+|.+ .+++.+|+|.++.. ....+.+|+++++++ +|+|++++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeec--CCe
Confidence 467789999999999999975 57888999987532 124578899999999 99999999999965 478
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++++||+++++|..++ ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence 89999999999999887 347889999999999999999999999999999999999988 78999999998754211
Q ss_pred -------CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 11223467888999999876 6788999999999999999999999954
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.63 Aligned_cols=199 Identities=23% Similarity=0.345 Sum_probs=168.3
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEcc---CCC
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HSK 195 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 195 (344)
.++++|++.++||+|||+-||+++...+++.+|+|.+.- ...+...+|++..+++ +|||+++++++...+ ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence 368999999999999999999999999999999998853 3456778999999999 999999999876432 335
Q ss_pred ccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
..|++++|...|+|.+.+. .+++.++..++.++++||++||+.. ++||||||.|||++++ +.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccC
Confidence 6899999999999888762 4899999999999999999999988 9999999999999987 7899999999
Q ss_pred ceecCCCC----------cceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 267 AEFYHPGK----------EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 267 a~~~~~~~----------~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+....-.- +......|..|+|||.+.- ....+.++|||||||+||+|+.|..||..
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 86543111 1122356888999999743 24578999999999999999999999953
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.96 Aligned_cols=194 Identities=19% Similarity=0.370 Sum_probs=162.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|+..++||+|+||+||++... .++..+|+|.++... ...+.+|+++++.+ +|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTE--GR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEec--CC
Confidence 467888999999999999999642 346689999886433 35688999999999 99999999999855 35
Q ss_pred ccEEEEEeecCCchhhHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC
Q 019241 196 TPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~ 257 (344)
..+++|||+++++|..++. .+++..+..++.|++.|++|||+.|++|+||||+|||++++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~ 159 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-L 159 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-C
Confidence 6789999999999988762 36788899999999999999999999999999999999987 7
Q ss_pred cEEEEecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 258 KLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 258 ~~kl~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
.+||+|||++.......... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 89999999997664332221 2234577999999877 678999999999999999998 8888843
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=266.46 Aligned_cols=203 Identities=21% Similarity=0.424 Sum_probs=170.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.|.....||+|+||.||++.+..++..+|+|.++.. ..+.+.+|+.+++.+ +|+|++++++.+.. ....++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence 4455557799999999999999889999999998542 235678999999999 99999999999854 46789999
Q ss_pred EeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-ccee
Q 019241 202 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV 278 (344)
Q Consensus 202 e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~ 278 (344)
||++++++..++ ..+++..+..++.|++.||+|||+.+++||||||+||+++.+ +.++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCce
Confidence 999999998876 458899999999999999999999999999999999999988 789999999987553222 2234
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
..++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.. .+..+.+..+
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~ 230 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRI 230 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHH
Confidence 568889999999876 6789999999999999999999999953 3333444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=257.96 Aligned_cols=195 Identities=25% Similarity=0.476 Sum_probs=169.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.+.||.|+||+||+|.+..++..+++|++... ....+.+|+++++.+ +|+|++++++.+.. ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence 4789999999999999999998889999999998632 346788999999999 99999999998855 4678899
Q ss_pred EEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+|+++++++..++. .+++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence 99999999988862 37888999999999999999999999999999999999988 789999999987665433
Q ss_pred cc-----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 275 EY-----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 275 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. ....++..|+|||++.....++.++|+|||||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 22 23467889999999887447899999999999999999999999543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=259.12 Aligned_cols=198 Identities=20% Similarity=0.342 Sum_probs=155.4
Q ss_pred eeecccCCeeEEEEEEcC--CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||+||+|.... ....+++|.+.... ...+.+|+++++.+ +|+||+++++.|.+ ....++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeC
Confidence 358999999999996433 34578888875332 24578899999998 99999999999954 46788999999
Q ss_pred cCCchhhHcCC--------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 205 NSTDFKVLYPT--------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 205 ~~~~l~~~l~~--------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
++++|..++.. .++.....++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhe
Confidence 99999988632 3566778899999999999999999999999999999988 78999999998754332221
Q ss_pred ---eecccCCCccCcccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 277 ---NVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 277 ---~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
....++..|+|||++.. ...++.++|||||||++|||++ |..|| ....+.+.+.++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~ 222 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQV 222 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHH
Confidence 22345667999998743 2457889999999999999999 66666 444444444443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.30 Aligned_cols=207 Identities=19% Similarity=0.390 Sum_probs=169.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC----------------eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----------------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV 182 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----------------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni 182 (344)
..++|++.+.||+|+||.||+|.+...+ ..+|+|.+... ..+.+.+|+++++++ +|+|+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCE
Confidence 3568899999999999999999865533 56899998643 245688899999999 99999
Q ss_pred cceeeEEEccCCCccEEEEEeecCCchhhHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCC
Q 019241 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 248 (344)
Q Consensus 183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~--------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~ 248 (344)
+++++++.. ....+++|||+.+++|..++. .+++..+..++.|++.||+|||+.+++|+||||+
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred eEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 999999955 367889999999999988762 4788899999999999999999999999999999
Q ss_pred ceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 019241 249 NVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYG 323 (344)
Q Consensus 249 NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~--g~~Pf~~~ 323 (344)
||+++.+ +.++|+|||+++........ ....++..|+|||++.. ..++.++|||||||++|||++ +..||. .
T Consensus 160 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~-~ 236 (296)
T cd05051 160 NCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE-H 236 (296)
T ss_pred ceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC-C
Confidence 9999988 78999999999865433322 22345678999999876 678999999999999999998 667773 4
Q ss_pred CCCHHHHHHHHH
Q 019241 324 HDNHDQLVKIAK 335 (344)
Q Consensus 324 ~~~~~~l~~i~~ 335 (344)
.+..+.+..+.+
T Consensus 237 ~~~~~~~~~~~~ 248 (296)
T cd05051 237 LTDQQVIENAGH 248 (296)
T ss_pred cChHHHHHHHHh
Confidence 444555444443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=259.92 Aligned_cols=188 Identities=24% Similarity=0.424 Sum_probs=156.0
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHH--hCCCCccceeeEEEccCCCccEEEEEe
Q 019241 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
.||+|+||.||++.+..+++.+|+|.+.... ...+.+|..+++.+ ..|+|++.+++.+.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999999999999999885321 12334454444433 268999999999955 3577899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecc
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~ 280 (344)
+++++|..++ ..+++..+..++.|++.||+|||+.+++||||||+|||++.+ +.++|+|||++...... ......
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceecccc-CccCcC
Confidence 9999998776 458999999999999999999999999999999999999988 78999999998765432 223457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
++..|+|||.+.....++.++|+||+||++|||++|..||...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 8999999999875466899999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=261.97 Aligned_cols=193 Identities=27% Similarity=0.495 Sum_probs=167.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..|+.+++||+|+||.||+|.+..++..+|+|+++... ...+.+|+.+++++ +|+|++++++.+.+ ....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEEE
Confidence 45777899999999999999999999999999986332 35688899999999 99999999999965 4678999
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~ 277 (344)
|||+++++|.+++. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCccccc
Confidence 99999999988774 48888999999999999999999999999999999999988 789999999997765433 223
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
...++..|+|||++.+ ..++.++|+|||||++|||++|..||..
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3467888999999876 6789999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=267.09 Aligned_cols=213 Identities=19% Similarity=0.299 Sum_probs=171.5
Q ss_pred eccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHH-hCCCCccceeeEEEcc--CCC
Q 019241 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQ--HSK 195 (344)
Q Consensus 119 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~--~~~ 195 (344)
++-....+.++.+.||+|.||+||+|.+ .|+.||||++...+...+.+|.+|++.+ -+|+||+.+++.-... ..-
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3334457899999999999999999966 5788999999988899999999999853 4999999999854322 223
Q ss_pred ccEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHc--------CcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~--------~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
.++||.+|.+.|+|.+++. .++-....+++..++.||+|||.. .|.|||||+.|||+..+ +.+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEeece
Confidence 5789999999999999984 588999999999999999999942 49999999999999999 899999999
Q ss_pred cceecCCCC-----cceecccCCCccCcccccCCCCC----C-chhhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 019241 266 LAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDY----D-YSLDMWSLGCMFAGMIFR----------KEPFFYGHD 325 (344)
Q Consensus 266 la~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~----~-~~~DvwSlGv~l~ell~g----------~~Pf~~~~~ 325 (344)
||-...... ..+.++||..|||||++.+.... + ..+||||||.++||+.-+ ..||+.-.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997665432 34668999999999998653221 1 369999999999998643 468876544
Q ss_pred CHHHHHHHH
Q 019241 326 NHDQLVKIA 334 (344)
Q Consensus 326 ~~~~l~~i~ 334 (344)
++...+++.
T Consensus 442 ~DPs~eeMr 450 (513)
T KOG2052|consen 442 SDPSFEEMR 450 (513)
T ss_pred CCCCHHHHh
Confidence 444444433
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=259.78 Aligned_cols=189 Identities=19% Similarity=0.285 Sum_probs=153.5
Q ss_pred eeecccCCeeEEEEEEc--CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||.||+|.+. .++..+|+|.++... ...+.+|+.+++++ +|+|++++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 35899999999999754 345679999886432 24688899999999 99999999999954 45678999999
Q ss_pred cCCchhhHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 205 NSTDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 205 ~~~~l~~~l~--------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
++++|..++. ..++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||+++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCccee
Confidence 9999988763 24556777899999999999999999999999999999988 78999999999754432221
Q ss_pred ---eecccCCCccCcccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 019241 277 ---NVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 323 (344)
Q Consensus 277 ---~~~~~t~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~ 323 (344)
....++..|+|||++.+. ..++.++|+|||||++|||++ |..||...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 223567789999998642 135789999999999999996 99999543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=258.80 Aligned_cols=201 Identities=26% Similarity=0.504 Sum_probs=162.7
Q ss_pred EEEeeecccCCeeEEEEEEc----CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 128 EVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++.+.||.|.||.||+|... ..+..|+||.++.. ..+.+.+|++.++++ +|+||++++|++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence 46789999999999999887 45678999999642 246789999999999 99999999999973 355789
Q ss_pred EEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
|+||+++++|.+++ ..+++..+..++.|++.||.|||+.+++|+||+++||+++.+ +.+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence 99999999998876 258899999999999999999999999999999999999998 799999999998773322
Q ss_pred cc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
.. ........|+|||.+.+ ..++.++||||||+++|||++ |..|| ...+..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~ 219 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLK 219 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHH
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccc-ccccccccccccc
Confidence 22 12345567999999877 668999999999999999999 67777 4445566555553
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=256.72 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=170.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||.||+|.+..+++.+++|.++.. ..+.+.+|+++++++ +|+||+++++.+.+ ....++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence 588899999999999999999889999999998643 345788999999999 99999999999854 4677899
Q ss_pred EEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc-
Q 019241 201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY- 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~- 276 (344)
+||+++++|.+++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++++ +.+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence 99999999998873 37888899999999999999999999999999999999987 78999999999776543221
Q ss_pred ----eecccCCCccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 277 ----NVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 277 ----~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
....++..|+|||++.+.. ..+.++||||||+++||+++|+.||....+....
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~ 215 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH
Confidence 1245778899999987632 3789999999999999999999999654443333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=257.06 Aligned_cols=190 Identities=17% Similarity=0.391 Sum_probs=161.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.++|++.+.||+|+||.||++.. .+..+|+|.++... .+.+.+|+.+++++ +|+|++++++++... ....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence 46789999999999999999965 47789999986433 45688999999999 999999999976543 356789999
Q ss_pred eecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce
Q 019241 203 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277 (344)
Q Consensus 203 ~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~ 277 (344)
|+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++++ +.+||+|||+++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccccC--C
Confidence 999999988763 27788899999999999999999999999999999999988 789999999987654322 2
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
....+..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2344567999999876 678999999999999999997 888884
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=263.61 Aligned_cols=193 Identities=19% Similarity=0.404 Sum_probs=160.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC----------------CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV 183 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv 183 (344)
.++|++.++||+|+||+||++.+.. +...+|+|+++... ...+.+|+.+++.+ +|+|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 5679999999999999999985432 34568999986432 35688999999999 999999
Q ss_pred ceeeEEEccCCCccEEEEEeecCCchhhHcCC--------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCc
Q 019241 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 249 (344)
Q Consensus 184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~N 249 (344)
++++++.+. ...+++|||+.+++|..++.. +++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999999554 567899999999999887632 5567889999999999999999999999999999
Q ss_pred eEEeCCCCcEEEEecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 019241 250 VMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFF 321 (344)
Q Consensus 250 iLl~~~~~~~kl~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~--g~~Pf~ 321 (344)
||++.+ +.++|+|||+++......... ...++..|++||+... ..++.++|+|||||++|||++ |..||.
T Consensus 161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999987 789999999997654332211 1233567999998876 679999999999999999998 677874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.95 Aligned_cols=204 Identities=21% Similarity=0.449 Sum_probs=172.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC----CeEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.+..+..++||.|.||.||+|....- .--||||..+. .+.+.|..|..+|+++ +||||++++|.|.+ .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~ 463 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---Q 463 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---c
Confidence 34456667899999999999986432 23588999874 4568899999999999 99999999999976 5
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++|||.++.|.|..+++ .++-..+..++.|++.+|.|||+.++|||||..+|||+... .++||+|||+++.+.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLE 542 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhcc
Confidence 6789999999999999984 47888888999999999999999999999999999999988 799999999999998
Q ss_pred CCCcceeccc--CCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 272 PGKEYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
+...+....| ..-|||||.+.- ..++.++|||-|||.+||++. |..|| .|-.+.+.+.+|.
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf-qgvkNsDVI~~iE 606 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF-QGVKNSDVIGHIE 606 (974)
T ss_pred ccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc-ccccccceEEEec
Confidence 7776665544 344999999854 789999999999999999887 88888 5655555554443
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=264.37 Aligned_cols=192 Identities=27% Similarity=0.498 Sum_probs=166.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.|+..+.||+|+||.||+|.+..+++.+|+|.++... .+.+.+|+++++++ +|+|++++++.+.. ....++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence 34666788999999999999999999999999986322 34688999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~ 277 (344)
|||++++++..++. .+++..+..++.|++.|+.|||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcchhhh
Confidence 99999999988773 47889999999999999999999999999999999999988 789999999997665332 222
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
...++..|+|||.+.+ ..++.++|+|||||++|||++|..||.
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 3467888999999877 678999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=256.41 Aligned_cols=193 Identities=22% Similarity=0.482 Sum_probs=167.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.++||+|+||+||++++..+++.+|+|.+.. ...+++.+|+.+++++ +|+|++++++++.+ ....++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence 58899999999999999999999999999998852 2235788999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||+.++++...+. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence 99999999887763 36888899999999999999999999999999999999988 7899999999987644322
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|..||..+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 223457888999999876 67889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.74 Aligned_cols=195 Identities=20% Similarity=0.430 Sum_probs=165.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||.||+|.+.. ++..|++|.++... ...+.+|+.+++++ +|+|++++++++... .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence 46789999999999999999998765 35789999886432 35578899999999 999999999988654 3
Q ss_pred CccEEEEEeecCCchhhHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEe
Q 019241 195 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~-----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~D 263 (344)
...++++||+.+++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d 160 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITD 160 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECC
Confidence 56789999999999988762 37888999999999999999999999999999999999988 7899999
Q ss_pred cccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 264 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 264 FGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
||+++.+.+.... ....++..|+|||++.+ ..++.++|||||||++||+++ |+.||.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 9999866443321 12345667999999876 678999999999999999999 999884
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=260.74 Aligned_cols=194 Identities=28% Similarity=0.506 Sum_probs=167.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHh--CCCCccceeeEEEccCCCccEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~l 199 (344)
.|++.+.||+|+||.||+|.+..+++.+|+|.++.. ...++.+|+.+++.+. .|+|++++++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 467789999999999999999999999999998532 3356888999999993 39999999999854 467889
Q ss_pred EEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-c
Q 019241 200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y 276 (344)
Q Consensus 200 v~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~ 276 (344)
+|||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence 99999999998876 357889999999999999999999999999999999999987 7899999999987654332 2
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
....++..|+|||.+.+...++.++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 3346888999999987656678999999999999999999999943
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=264.27 Aligned_cols=212 Identities=32% Similarity=0.590 Sum_probs=175.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
...++|++.+.||.|+||.||+|.+..+++.+|+|.+.. ...+.+.+|+++++.+ +|||+++++++|... ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence 357889999999999999999999999999999998743 2345678899999999 999999999988643 356
Q ss_pred cEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.++++||+. +++..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC--
Confidence 789999985 4677666 357888888999999999999999999999999999999987 7899999999976532
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+.......+.+.+|.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 2233466888999999876567899999999999999999999988 4444455555555555543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=267.48 Aligned_cols=205 Identities=20% Similarity=0.373 Sum_probs=165.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-------CeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
..+|++.+.||+|+||.||+|++... +..+|+|.++.. ..+.+.+|+++++++.+|+||++++++|.+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 45799999999999999999976432 236899988642 235688999999999779999999999954
Q ss_pred CCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~ 253 (344)
....++++||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 467889999999999988763 256778888999999999999999999999999999999
Q ss_pred CCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 254 ~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
.+ +.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.
T Consensus 169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~ 245 (334)
T cd05100 169 ED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEEL 245 (334)
T ss_pred CC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHH
Confidence 88 78999999999876533221 11233456999999877 778999999999999999998 77777 44444444
Q ss_pred HHHH
Q 019241 330 LVKI 333 (344)
Q Consensus 330 l~~i 333 (344)
...+
T Consensus 246 ~~~~ 249 (334)
T cd05100 246 FKLL 249 (334)
T ss_pred HHHH
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=259.78 Aligned_cols=210 Identities=31% Similarity=0.582 Sum_probs=176.2
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
|++.+.||+|+||+||+|++..+++.+++|.+... ......+|+..++++.+|+|++++++++.+ ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 57789999999999999999888999999998543 123455799999999339999999999965 577889999
Q ss_pred eecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce
Q 019241 203 YVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277 (344)
Q Consensus 203 ~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~ 277 (344)
|+ ++++...+ ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++++ +.++|+|||++..........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcC
Confidence 99 66666554 247899999999999999999999999999999999999988 789999999998776554545
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
...++..|+|||++.....++.++|+||||+++|||++|+.|| .+.+..+...++.+.++.+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~ 219 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPT 219 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCC
Confidence 5678889999999876567899999999999999999999888 55566777777777666543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=261.10 Aligned_cols=194 Identities=21% Similarity=0.428 Sum_probs=163.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .+.+.+|+.+++++ +|+|++++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence 45789999999999999999998643 57889999986432 35688899999999 99999999999854
Q ss_pred CCccEEEEEeecCCchhhHcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 248 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~ 248 (344)
....+++|||+++++|..++. .+++..+..++.|++.||+|||+.+++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 456789999999999988763 2567788999999999999999999999999999
Q ss_pred ceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 249 NVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 249 NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
||+++.+ +.++|+|||++......... .....+..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999988 78999999998765433221 12234566999999876 679999999999999999997 778885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=259.94 Aligned_cols=204 Identities=21% Similarity=0.404 Sum_probs=164.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||.||+|.... .+..+|+|.++... ...+.+|+.+++.+ +|+|++++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC-
Confidence 46789999999999999999996542 34579999876332 23577899999999 999999999998554
Q ss_pred CCccEEEEEeecCCchhhHcCC-------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~-------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
...++||||+++++|..++.. .....+..++.|++.||.|||+.+++||||||+|||++.+ +.++
T Consensus 82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~ 159 (288)
T cd05061 82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVK 159 (288)
T ss_pred -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEE
Confidence 567899999999999988732 3456778899999999999999999999999999999988 7899
Q ss_pred EEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 019241 261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 261 l~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~ 332 (344)
|+|||+++........ ....++..|+|||.+.+ ..++.++|+|||||++|||++ |..|| .+.+..+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~-~~~~~~~~~~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHH
Confidence 9999999765432221 11234567999999876 678999999999999999998 67777 34444444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.59 Aligned_cols=192 Identities=22% Similarity=0.422 Sum_probs=165.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.|+...+||+|+||.||++.+..+++.+|+|.++. ...+.+.+|+.+++.+ +|||++++++.+.. ....++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEEEe
Confidence 34445689999999999999988999999999853 2345688999999999 99999999999855 467889999
Q ss_pred eecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cceec
Q 019241 203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR 279 (344)
Q Consensus 203 ~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~~ 279 (344)
|++++++..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||++....... .....
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhcccccccccce
Confidence 999999988763 58899999999999999999999999999999999999988 789999999987554332 22345
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.++..|+|||++.+ ..++.++|||||||++|||++|..||+.
T Consensus 178 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 178 VGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 68889999999876 6789999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=260.03 Aligned_cols=192 Identities=17% Similarity=0.285 Sum_probs=156.9
Q ss_pred eeecccCCeeEEEEEEcCCCe-------EEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 131 RKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.||+|+||+||+|.+...+. .+++|.+.... .+.+.+|+.+++.+ +|+|++++++++... ...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeC--CCcEEE
Confidence 368999999999998765443 48888875432 35678899999998 999999999999653 567899
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC-------cEEEEeccccee
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-------KLRLIDWGLAEF 269 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~-------~~kl~DFGla~~ 269 (344)
|||+++++|..++. .+++.....++.|++.||+|||+.||+||||||+||+++.+.. .++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999988873 3788889999999999999999999999999999999987632 279999999876
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~ 328 (344)
..+. ....++..|+|||++.+...++.++|||||||++|||++|..+++...+..+
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 5432 2346788899999998756689999999999999999999655544444433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=256.92 Aligned_cols=191 Identities=27% Similarity=0.427 Sum_probs=159.2
Q ss_pred CCeEEEeee--cccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 125 DDYEVVRKV--GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 125 ~~~~~~~~l--G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
++|++.+.+ |+|+||.||++++..+++.+|+|.+........ |+.....+.+|+|++++++.|... ...++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence 455555555 999999999999999999999999865433222 333333344799999999999654 57899999
Q ss_pred eecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceec
Q 019241 203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279 (344)
Q Consensus 203 ~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 279 (344)
|+++++|..++. .+++..+..++.|+++||.|||+.|++||||||+||+++.+.+.++|+|||+++..... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~ 166 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY 166 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence 999999988762 58999999999999999999999999999999999999988438999999999766432 234
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 67889999999976 67899999999999999999999999643
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=264.26 Aligned_cols=193 Identities=21% Similarity=0.409 Sum_probs=168.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|++.++||+|+||+||++.+..+++.+|+|++... ..+.+.+|+++++.+ +|+|++++++++.+. ...++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEEE
Confidence 46788899999999999999999999999999987532 246788999999999 999999999999654 67899
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
||||+++++|..++ ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-c
Confidence 99999999998876 347899999999999999999997 689999999999999988 78999999998755322 2
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 234578899999999876 6789999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=256.01 Aligned_cols=187 Identities=27% Similarity=0.516 Sum_probs=164.5
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||.|+||.||+|++..+++.+|+|++... ..+.+.+|+++++.+ +|+|++++++.+.+ ....++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 69999999999999988999999998532 235688999999999 99999999999854 4678899999999
Q ss_pred CchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCC
Q 019241 207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283 (344)
Q Consensus 207 ~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~ 283 (344)
++|..++. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++.............++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCc
Confidence 99998873 47889999999999999999999999999999999999988 789999999998776544344457888
Q ss_pred CccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 284 ~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.|++||.+.+ ..++.++|+||+|+++|+|++|..||....
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9999999876 678999999999999999999999996554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=255.56 Aligned_cols=196 Identities=18% Similarity=0.377 Sum_probs=160.7
Q ss_pred eeecccCCeeEEEEEEcCCC---eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
++||+|+||.||+|.+...+ ..+|+|.+.... .+.+.+|+++++.+ +|+|++++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876655 789999986433 35688999999999 99999999998743 456899999
Q ss_pred ecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce---
Q 019241 204 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--- 277 (344)
Q Consensus 204 ~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~--- 277 (344)
+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+|||++.+ +.+||+|||+++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccccc
Confidence 99999998873 48899999999999999999999999999999999999988 789999999998765433221
Q ss_pred -ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 278 -VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 278 -~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
...++..|+|||.+.. ..++.++|||||||++|||++ |..||. ..+..+....+
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~-~~~~~~~~~~~ 211 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG-EMKGAEVIAML 211 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHH
Confidence 1122457999999876 679999999999999999998 888884 33334433333
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=266.48 Aligned_cols=212 Identities=34% Similarity=0.658 Sum_probs=180.7
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC---CCcc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~ 197 (344)
+|++.+.||+|+||.||+|++..+++.+|+|.+... ..+.+.+|+.+++.+ +|+|++++++++.... ....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 588999999999999999999888999999988643 235788999999999 8999999999986542 2367
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+++|||+++ ++..++ ..+++..+..++.|++.||+|||+.|++|+||||+|||++.+ +.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence 899999995 566555 258899999999999999999999999999999999999998 899999999998776543
Q ss_pred ----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 275 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 275 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+..+.+..+.+..|.++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCC
Confidence 2334567889999999987448899999999999999999999998 56666777888888777654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=255.05 Aligned_cols=195 Identities=26% Similarity=0.471 Sum_probs=172.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.+.||+|++|.||+|++..+++.+++|.+... ....+.+|+.++.++ +|+|++++++++.. ....+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc--CCeEEEE
Confidence 4688899999999999999999999999999998654 246788999999999 89999999999954 4778899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||+++++|..++ ..+++.....++.|+++|++|||+ .+++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence 9999999999887 458999999999999999999999 999999999999999988 78999999999876544333
Q ss_pred e-ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 277 N-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 277 ~-~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
. ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2 4567888999999877 678999999999999999999999995543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=261.93 Aligned_cols=195 Identities=26% Similarity=0.493 Sum_probs=169.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.+.||+|+||.||++.+..++..+|+|.+... ..+.+.+|+.+++++ +|||++++++.+.. ....++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLV--GDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeee--CCcEEEE
Confidence 57899999999999999999998889999999998532 235678899999999 89999999999965 4677899
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-ce
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~~ 277 (344)
+||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....+... ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceecccccccccc
Confidence 99999999998874 47888999999999999999999999999999999999988 7899999999876544332 23
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...++..|+|||.+.+ ..++.++|+|||||++|++++|..||...
T Consensus 174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3467888999999876 67899999999999999999999999543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.36 Aligned_cols=187 Identities=21% Similarity=0.345 Sum_probs=159.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
.++..+.||+|+||+||+|++..++..||+|.++.... ....|+++++++ +||||++++++|.+. ...++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence 45566889999999999999989999999999864332 234678999999 999999999999654 56789999999
Q ss_pred CCchhhHcCCCCHHHHHHHHHHHHHHHHHHH---HcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccC
Q 019241 206 STDFKVLYPTLTDYDIRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282 (344)
Q Consensus 206 ~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH---~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t 282 (344)
+++|.+++..+++..+..++.|+++||+||| +.+|+||||||+||+++.+ ...++. ||.+...... ....+|
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~~---~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCTD---TKCFIS 841 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-eccccccccC---CCcccc
Confidence 9999999999999999999999999999999 6699999999999999987 555664 6665433221 223678
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 99999999876 7799999999999999999999999854
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=258.24 Aligned_cols=194 Identities=23% Similarity=0.455 Sum_probs=164.4
Q ss_pred CeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
+|++.+.||+|+||.||++.+. .+++.+|+|+++.. ..+.+.+|+.+++++.+|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4788999999999999999864 47889999998632 235678899999999779999999999854 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++||||+|+|||++.+ +.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccc
Confidence 778999999999998876 348888999999999999999999999999999999999988 7899999999977643
Q ss_pred CC--cceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 273 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 273 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.. ......++..|+|||.+... ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 22 22234678899999998752 3467899999999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.96 Aligned_cols=197 Identities=20% Similarity=0.367 Sum_probs=163.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|+..++||+|+||+||++.+..+++.+|+|.+... ....+.+|+.++.++.+|+||+++++++.. ....+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEE
Confidence 3556678999999999999999999999999998642 235678899999999559999999998855 4567799
Q ss_pred EEeecCC--chhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 201 FEYVNST--DFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 201 ~e~~~~~--~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
|||+... ++...+ ..+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhcc
Confidence 9998753 222221 4588999999999999999999974 99999999999999988 7899999999976654
Q ss_pred CCcceecccCCCccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
........++..|+|||++.+. ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 4444455788899999998764 378999999999999999999999996443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.95 Aligned_cols=193 Identities=24% Similarity=0.421 Sum_probs=168.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.+.||+|+||.||++.+..+++.+|+|.+... ..+++.+|+++++++ +|+|++++++.+... ...+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence 4677889999999999999999999999999998643 235688999999999 899999999998554 778999
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||+++++|..++ ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.+ +.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence 9999999998887 457888999999999999999999 999999999999999997 7899999999876543322
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. ..++..|+|||.+.+ ..++.++|||||||++|+|++|..||...
T Consensus 157 ~~-~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 KT-FVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hc-ccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 22 678888999999877 68899999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=254.35 Aligned_cols=205 Identities=17% Similarity=0.354 Sum_probs=167.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||.||++.+ ..+..+|+|.+.... .+.+.+|+++++++ +|+|++++++.+.+ ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEE
Confidence 357899999999999999999974 455679999886433 35788999999999 99999999999854 567899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|.+++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence 99999999988873 36778888999999999999999999999999999999988 7899999999976543222
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ....++..|+|||++.. ..++.++|+|||||++|++++ |..||. +.+..+....+.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~ 218 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALER 218 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhC
Confidence 1 12234566999999876 678999999999999999998 888874 4444444444433
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=255.15 Aligned_cols=195 Identities=23% Similarity=0.419 Sum_probs=156.5
Q ss_pred eeecccCCeeEEEEEEcC---CCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+.||+|+||+||+|.+.. .+..+|+|.+... ..+.+.+|+.+++.+ +|+|++++++++... ....+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998643 3457999988532 235678899999999 999999999987543 3457899999
Q ss_pred ecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc----
Q 019241 204 VNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275 (344)
Q Consensus 204 ~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~---- 275 (344)
+.+++|..++. ...+..+..++.|++.||+|||+.+++||||||+|||++++ +.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeec
Confidence 99999998873 35677788899999999999999999999999999999988 7899999999976543221
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
.....++..|+|||.+.. ..++.++|||||||++|||++|..|++...+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~ 211 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211 (262)
T ss_pred ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 112244667999999876 67899999999999999999976665555444333
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=257.40 Aligned_cols=188 Identities=25% Similarity=0.423 Sum_probs=156.1
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHH--hCCCCccceeeEEEccCCCccEEEEEe
Q 019241 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
.||+|+||.||++.+..+++.||+|.+.... ...+..|..+++.+ ..|+|++++++++.+ ....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999999999999999885321 12234444443332 278999999999965 4678899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecc
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~ 280 (344)
+.+++|..++ ..+++..+..++.|++.||+|||+.+++||||||+||+++.+ +.++|+|||++...... ......
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcCcC
Confidence 9999998876 348999999999999999999999999999999999999988 78999999998765432 223457
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
++..|+|||++.+...++.++|+||+||++|||++|+.||...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 8999999999876456899999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.80 Aligned_cols=208 Identities=32% Similarity=0.620 Sum_probs=172.7
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHh--CCCCccceeeEEEccCC---Cc
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHS---KT 196 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~---~~ 196 (344)
|++.+.||+|+||.||+|++..+++.+|+|.++.. ....+.+|+.+++++. .|+|++++++++.+... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999999888999999998632 1245667888888773 59999999999965432 23
Q ss_pred cEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.+++|||+.+ ++..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence 7899999986 565544 248899999999999999999999999999999999999998 899999999998776
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhC
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~ 338 (344)
.........++..|+|||++.+ ..++.++|+|||||++|||++|..|| .+.+..+.+.++.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~ 223 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIG 223 (287)
T ss_pred CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcC
Confidence 5544444567888999999877 67899999999999999999998777 56667777777766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=257.33 Aligned_cols=191 Identities=29% Similarity=0.496 Sum_probs=166.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
-|++.++||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+.+++++ +|+|++++++++.+ ....++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEEE
Confidence 4677899999999999999998899999999976322 35688899999999 99999999999965 46788999
Q ss_pred EeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-ccee
Q 019241 202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV 278 (344)
Q Consensus 202 e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~ 278 (344)
||++++++..++. .+++..+..++.|++.++.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchhhhcc
Confidence 9999999998874 47899999999999999999999999999999999999988 789999999987664332 2233
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 467888999999876 678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=253.28 Aligned_cols=189 Identities=20% Similarity=0.402 Sum_probs=163.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.+.||+|+||.||+|.. .++.+|+|.++... .+++.+|+.+++.+ +|+|++++++++.+ ....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence 56788899999999999999965 47889999997543 46788999999999 99999999999865 46778999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+++++|..++. .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.+||+|||.++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccccccc-
Confidence 9999999998873 47899999999999999999999999999999999999988 7899999999987632222
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
....+..|+|||.+.. ..++.++|+|||||++|||++ |..||.
T Consensus 158 -~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 158 -SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred -cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 3344567999999876 678899999999999999997 888884
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.65 Aligned_cols=193 Identities=27% Similarity=0.534 Sum_probs=159.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
....|+++++||+||.+.||++.. .+.+.+|+|.+. ......|.+|+..|.+|.+|.+|+++++|-.. ..++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 456799999999999999999964 444556665542 33456799999999999999999999999743 5888
Q ss_pred EEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
|+||||-+ .+|..++. ..+...++.|..||+.++.+.|+.||||.||||.|+|+-. |.+||+|||.|..+.++
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCcc
Confidence 99999754 45666663 2555688999999999999999999999999999999986 58999999999988765
Q ss_pred Ccc---eecccCCCccCcccccCCC----------CCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 274 KEY---NVRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 274 ~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
... ...+||..||+||.+.... +.++++|||||||+||+|+.|+.||.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 433 3469999999999986521 25689999999999999999999994
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=258.16 Aligned_cols=186 Identities=27% Similarity=0.426 Sum_probs=161.7
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||+|+||+||+|.+..+++.+|+|.+... ....+.+|+++++.+ +|+|++++++.+.. ....|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 69999999999999999999999998532 234567899999999 89999999999954 4678999999999
Q ss_pred CchhhHc---C--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceeccc
Q 019241 207 TDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281 (344)
Q Consensus 207 ~~l~~~l---~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~ 281 (344)
++|..++ . .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccC
Confidence 9998776 2 58899999999999999999999999999999999999988 7899999999977654444445567
Q ss_pred CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 282 t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 888999999876 56899999999999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=254.26 Aligned_cols=184 Identities=18% Similarity=0.286 Sum_probs=155.7
Q ss_pred eeecccCCeeEEEEEEcCCC----------eEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 131 RKVGRGKYSEVFEGINVNTN----------ERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
+.||+|+||.||+|.+..++ ..+++|.++... ...+.+|+.+++.+ +|+|++++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 46899999999999987766 458888876433 56788999999999 99999999999865 4568
Q ss_pred EEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC-------cEEEEecccc
Q 019241 199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-------KLRLIDWGLA 267 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~-------~~kl~DFGla 267 (344)
+||||+++++|..++. .+++..+..++.|++.||.|||+.|++||||||+|||++.+ + .+||+|||++
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC-ccccCCceeEEeCCCCcc
Confidence 9999999999998873 47888899999999999999999999999999999999977 4 6999999999
Q ss_pred eecCCCCcceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFR-KEPFFY 322 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g-~~Pf~~ 322 (344)
..... .....++..|+|||++... ..++.++|||||||++|||++| ..||..
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 86543 2234566789999998763 3789999999999999999994 666643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=254.79 Aligned_cols=185 Identities=19% Similarity=0.292 Sum_probs=151.5
Q ss_pred eeecccCCeeEEEEEEcC------------CCeEEEEEEecccch---HHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 131 RKVGRGKYSEVFEGINVN------------TNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~------------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
+.||+|+||+||+|.... ....+++|.+..... ..+.+|+.+++.+ +||||+++++++.+. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence 368999999999997432 223688998864332 4677889999999 999999999999653 5
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC------cEEEEecc
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWG 265 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~------~~kl~DFG 265 (344)
..+++|||++++++..++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+.. .++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 6789999999999887763 3888999999999999999999999999999999999986521 28999999
Q ss_pred cceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCC
Q 019241 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFF 321 (344)
Q Consensus 266 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell-~g~~Pf~ 321 (344)
++...... ....++..|+|||++.+...++.++|||||||++|||+ +|..||.
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 98755322 23457788999999875577899999999999999998 4777763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=251.25 Aligned_cols=210 Identities=20% Similarity=0.365 Sum_probs=176.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
+.++.+.+..||+|+.|+||+++.+.+|...|||.+... ..+++...++++..-.+.|+||+.+|+|... ...+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHH
Confidence 445667788999999999999999999999999998532 3355667777776654689999999999654 4445
Q ss_pred EEEEeecC---CchhhHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~---~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+-||.|.. ..|......+++..+-.+...+.+||.||-+ .+|+|||+||+|||+|+. |.+|+||||.+-.+-++.
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeeccc
Confidence 67777753 2344444678999999999999999999985 589999999999999988 899999999998887777
Q ss_pred cceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..+...|.+.|||||.+.- ...|+.++||||||++++||.||..||...+.+-+.+-+|.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 7777889999999999854 356999999999999999999999999888899999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=270.51 Aligned_cols=207 Identities=24% Similarity=0.468 Sum_probs=175.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec--cc--------chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
-+++|-+++.||+|||+.||++.|...++.||||+-. +. -.+...+|..|-+.| +||.||++|++|.-.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec
Confidence 4678999999999999999999999999999999863 11 124456899999999 999999999999754
Q ss_pred CCCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHc--CcEeecCCCCceEEeCC--CCcEEEEecc
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHE--LRKLRLIDWG 265 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~--~iiHrDlkp~NiLl~~~--~~~~kl~DFG 265 (344)
....|-|+|||+|.+|+.+++ .+++.+++.|++||+.||.||.+. .|||-||||.|||+-.. .|.+||.|||
T Consensus 540 -tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred -cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 366799999999999999984 489999999999999999999975 59999999999999654 4679999999
Q ss_pred cceecCCCCcc--------eecccCCCccCcccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 266 LAEFYHPGKEY--------NVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 266 la~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
+++.+.++... ....||-+|.+||.+.- ..+.+.++||||+||++|..+.|+.||....+..+.+.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99998754332 33578999999999853 35689999999999999999999999976666555543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=266.16 Aligned_cols=212 Identities=31% Similarity=0.625 Sum_probs=176.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.+.||+|+||+||+|++..+++.+|+|.+... ....+.+|+.+++.+ +|+|++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence 467899999999999999999999999999999998632 234567899999999 99999999997754322
Q ss_pred -CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 -KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 -~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++|+||+. ++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEcccccccccc
Confidence 34789999995 5777766 358999999999999999999999999999999999999988 789999999997654
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.. .....++..|+|||.+.+...++.++|||||||++|||++|+.||. +.+..+.+..+.+..+.+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCC
Confidence 32 3344678889999998764578899999999999999999999994 455566777777766544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=258.19 Aligned_cols=215 Identities=31% Similarity=0.543 Sum_probs=182.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhCCCCccceeeEEEcc-----
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----- 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----- 192 (344)
..+.|+-..+||+|.||+||+|+...+++.||+|+.- ......-.+|+.+|+.+ +|+|++++++.|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcc
Confidence 3566777899999999999999999999999987642 22335567999999999 999999999988532
Q ss_pred -CCCccEEEEEeecCCc---hhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 193 -HSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 193 -~~~~~~lv~e~~~~~~---l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
.....++||++|+... |.....+++..++..++.+++.||.|+|+..|+|||+|+.|+||+.+ +.+||+|||+++
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeecccccc
Confidence 1234789999998753 33333568999999999999999999999999999999999999999 899999999997
Q ss_pred ecCCC-----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 269 FYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 269 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.+... ..++.++.|.+|++||.+++...|+.+.|||.-||++.||++|. |.+++.++..++..|..++|..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs-pimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS-PIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC-ccccCChHHHHHHHHHHHhccC
Confidence 66432 23556788999999999999999999999999999999999997 5568999999999999999865
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=250.02 Aligned_cols=196 Identities=29% Similarity=0.528 Sum_probs=172.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|+..+.||+|++|.||+|.+..+++.+++|++.... .+.+.+|+++++++ +|+|++++++.+.+......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999999899999999986544 56788999999999 89999999999965433678899
Q ss_pred EEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc--
Q 019241 201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-- 275 (344)
+||+++++|.+++. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence 99999999988773 57999999999999999999999999999999999999987 7899999999988765543
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.....++..|++||.+.. ...+.++||||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 445678888999999876 568999999999999999999999996554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=251.52 Aligned_cols=203 Identities=17% Similarity=0.394 Sum_probs=167.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..+|++.+.||+|+||.||++.+. .+..+|+|.++.. ....+.+|+++++++ +|+|++++++++.. ....+++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEEE
Confidence 357889999999999999999765 4668999988643 346789999999999 99999999999854 45678999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc-
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY- 276 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~- 276 (344)
||+++++|..++. .+++..+..++.|++.|++|||+.+++|+||||+||+++.+ +.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcccc
Confidence 9999999988763 37888999999999999999999999999999999999987 78999999998765432211
Q ss_pred -eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 277 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. ..+..+....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~ 214 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETI 214 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHH
Confidence 12234567999999876 678999999999999999998 888884 33334444443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=258.86 Aligned_cols=197 Identities=23% Similarity=0.430 Sum_probs=168.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|++.+.||+|+||.||+|+.. .+++.+|+|.++... .+.+.+|+++++.+ +|+|++++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence 356788899999999999999854 347899999987443 45789999999999 999999999999776667
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..+++|||+++++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence 8899999999999988873 38899999999999999999999999999999999999988 789999999998775
Q ss_pred CCCcce----ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 272 PGKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 272 ~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...... ...++..|++||.+.+ ..++.++|||||||++|||++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccc
Confidence 332211 1234556999999876 67899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=256.91 Aligned_cols=208 Identities=38% Similarity=0.697 Sum_probs=174.2
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+++++++ +|+|++++++++.+ ....++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhcc--CCCEEEEE
Confidence 566789999999999999998899999999986432 35678899999999 89999999999854 47788999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cc
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 276 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~ 276 (344)
||+++ ++...+ ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccc
Confidence 99987 554443 257899999999999999999999999999999999999988 789999999998776543 33
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
....++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+..+.+.++.+.++.+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~ 218 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTP 218 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCC
Confidence 33467788999999887447899999999999999999999888 4556666666666665543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.34 Aligned_cols=194 Identities=23% Similarity=0.400 Sum_probs=159.1
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
++||+|+||.||+|.. .++..+|+|.++... ...+.+|+++++.+ +|+|++++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999974 468889999986433 24578999999999 99999999999954 4567899999999
Q ss_pred CchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce--ecc
Q 019241 207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--VRV 280 (344)
Q Consensus 207 ~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~--~~~ 280 (344)
++|..++. .+++..+..++.|++.+|.|||+.|++|+||||+||+++.+ +.+||+|||++.......... ...
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCC
Confidence 99988763 37889999999999999999999999999999999999988 789999999997654322211 123
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 331 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~ 331 (344)
++..|+|||++.. ..++.++|||||||++|++++ |..||. +....+...
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~ 205 (250)
T cd05085 156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQARE 205 (250)
T ss_pred CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHH
Confidence 3556999999876 678999999999999999998 888884 333333333
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=253.64 Aligned_cols=193 Identities=24% Similarity=0.509 Sum_probs=167.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|+||.||+|.+..++..+|+|.+.. ...+.+.+|+++++.+ +|+|++++++.+.+ ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence 58889999999999999999999999999999853 2345678999999999 99999999999854 4678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||||+||+++++...+||+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999988763 3688899999999999999999999999999999999998745679999999977654332
Q ss_pred c-eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. ....++..|+|||++.+ ..++.++|+|||||++|||++|..||..
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 23467888999999876 6788999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=255.76 Aligned_cols=204 Identities=21% Similarity=0.431 Sum_probs=167.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|+++..||+|+||+||+|+... +.+.+++|.+.... ...+.+|+++++++ +|+|++++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence 4678899999999999999998653 34679999886432 35689999999999 99999999999954 4
Q ss_pred CccEEEEEeecCCchhhHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEE
Q 019241 195 KTPSLIFEYVNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~ 262 (344)
...++||||+++++|..++. .+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.++++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~ 159 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVS 159 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEc
Confidence 66789999999999998863 47899999999999999999999999999999999999988 789999
Q ss_pred ecccceecCCCC--cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 263 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 263 DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
|||+++...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.++.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHH
Confidence 999987543222 2223355677999999876 668899999999999999999 777874 33334444433
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=253.90 Aligned_cols=192 Identities=26% Similarity=0.496 Sum_probs=163.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-------------hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
+|.+.+.||+|+||.||+|.+..+++.+|+|.++... .+.+.+|+.+++.+ +|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence 4777899999999999999988899999999875210 13577899999999 99999999999855
Q ss_pred CCCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....++||||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++.
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 157 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKK 157 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence 467789999999999988773 48888899999999999999999999999999999999988 7899999999976
Q ss_pred cCCCC---cceecccCCCccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 270 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 270 ~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... ......++..|+|||.+.... .++.++|+||||+++||+++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 53221 122345788899999987633 47899999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=252.75 Aligned_cols=187 Identities=18% Similarity=0.390 Sum_probs=159.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
++|++.+.||+|+||.||++. .+++.+|+|.++.. ....+.+|+.+++++ +|+|++++++++.. ...+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEEEC
Confidence 568899999999999999984 47788999998643 446788999999999 99999999999854 346899999
Q ss_pred ecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCccee
Q 019241 204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278 (344)
Q Consensus 204 ~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 278 (344)
+.+++|..++. .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc--CCC
Confidence 99999988763 36888889999999999999999999999999999999988 78999999999764322 122
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
...+..|+|||.+.+ ..++.++|+|||||++|||++ |+.||.
T Consensus 157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 334567999999876 678999999999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.53 Aligned_cols=198 Identities=24% Similarity=0.453 Sum_probs=167.4
Q ss_pred eeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+.||+|+||.||+|.+... +..+++|.++... .+.+.+|++.++.+ +|+|++++++++.+ ....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 4699999999999998866 8899999987433 46788999999999 79999999999965 5778999999
Q ss_pred ecCCchhhHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 204 VNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 204 ~~~~~l~~~l~------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
+++++|..++. .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||.+....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~ 156 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY 156 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccc
Confidence 99999988863 36899999999999999999999999999999999999998 789999999998776
Q ss_pred CCC---cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 272 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
... ......++..|+|||.+.. ..++.++||||+||++|||++ |..||. ..+..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~ 221 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVLEYLR 221 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHH
Confidence 442 2233456788999999876 578999999999999999999 587874 444455555444
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=259.98 Aligned_cols=207 Identities=22% Similarity=0.380 Sum_probs=168.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.+.||+|+||+||+|.+..+++.+|||.++.. ....+.+|+.++.+..+|+||++++++|.+ ....+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence 457789999999999999999999888999999998643 224466788777777569999999999955 46788
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++|||+.+ ++..+. ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.+ +.+||+|||++..+...
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhccCC
Confidence 99999865 444433 358889999999999999999997 599999999999999987 78999999999776544
Q ss_pred CcceecccCCCccCcccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.....+.+.+.++
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 231 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH
Confidence 444445678889999998752 247889999999999999999999996544444444443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=274.53 Aligned_cols=210 Identities=26% Similarity=0.406 Sum_probs=175.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
..+.|++...+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++....+|+|++++.+.+.+ ..+.++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence 357788999999999999999999999999999999754 45566888888888899999999999954 588899999
Q ss_pred eecCCchhhHcCCCCH--HHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecc
Q 019241 203 YVNSTDFKVLYPTLTD--YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280 (344)
Q Consensus 203 ~~~~~~l~~~l~~l~~--~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~ 280 (344)
.+.++.+...+..... ..+..|+.+|+.++.|||++|++||||||+|||++.+.+.++|+|||.++...+. +...+
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~ 474 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA 474 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence 9999987766643222 4666799999999999999999999999999999533388999999999876544 55668
Q ss_pred cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 281 ~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
-|..|.|||++.. ..|+.++|+||||++||+|++|+.||....+. .+|...++.+++
T Consensus 475 ~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 475 LTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKF 531 (612)
T ss_pred hhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCcc
Confidence 8899999999985 89999999999999999999999999655544 334444455544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.56 Aligned_cols=212 Identities=21% Similarity=0.352 Sum_probs=174.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++.+.+..||.|+||+|+|-.++.+|+..|||.++.. ..+++..|.+...+-.+.||||+++|.+..+ +..++
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--Cceee
Confidence 34455578899999999999999999999999998632 3466788888877766889999999987543 55678
Q ss_pred EEEeecCCchhhHc--------CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 200 IFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 200 v~e~~~~~~l~~~l--------~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
-||.|.-. ++.+. ..+++..+..+.....+||+||-+ ..|||||+||+|||++.. |.+||||||.+-.+
T Consensus 141 CMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 141 CMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQL 218 (361)
T ss_pred eHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhH
Confidence 89998754 33222 458888888888889999999985 689999999999999998 89999999999777
Q ss_pred CCCCcceecccCCCccCcccccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.++-..+...|...|||||.+..... |+.++||||||++|||+.||+.|+...++--||+.++.. |.+|
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp 288 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPP 288 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCC
Confidence 66666677789999999999976444 999999999999999999999999777777777777743 5544
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=251.26 Aligned_cols=202 Identities=23% Similarity=0.452 Sum_probs=168.5
Q ss_pred eEEEeeecccCCeeEEEEEEcCCC----eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
+++.+.||.|+||.||++++...+ ..+|+|.++... .+.+.+|+.+++.+ +|+|++++++++.+. ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeE
Confidence 356789999999999999988766 899999997543 45788999999999 999999999999654 6788
Q ss_pred EEEEeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++|||++++++..++.. +++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceecccc
Confidence 99999999999887732 8999999999999999999999999999999999999988 78999999999876544
Q ss_pred Cccee--cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 274 KEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 ~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
..... ..++..|+|||.+.+ ..++.++|+||+||++|+|++ |..|| ...+..+....+.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~ 218 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLK 218 (258)
T ss_pred cccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHh
Confidence 33222 236678999999865 778999999999999999998 66666 4445444444443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.04 Aligned_cols=193 Identities=29% Similarity=0.498 Sum_probs=163.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|.+..+++.||+|.+... ..+.+.+|+++++.+ +|+|++++.++|.+. ..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~ 89 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HT 89 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--Ce
Confidence 356788999999999999999999889999999988522 124678999999999 999999999999654 56
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++|+||+.+..+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus 90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA 168 (307)
T ss_pred EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC
Confidence 78999999865433332 358999999999999999999999999999999999999988 78999999999765433
Q ss_pred CcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
....++..|+|||++.+ ...++.++||||||+++|||++|..||..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 23467888999999852 25688899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=251.60 Aligned_cols=197 Identities=20% Similarity=0.333 Sum_probs=162.2
Q ss_pred eeecccCCeeEEEEEEcC-CC--eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVN-TN--ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~-~~--~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
++||+|++|+||+|.+.. ++ ..+|+|.++... .+.+.+|+.+++++ +|+|++++++.+.+ ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999998755 33 368999987533 35788999999999 99999999999865 677899999
Q ss_pred ecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc--
Q 019241 204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-- 276 (344)
Q Consensus 204 ~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~-- 276 (344)
+++++|...+. .+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence 99999988762 47888999999999999999999999999999999999998 78999999999876542211
Q ss_pred --eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. ..+..+....+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~ 214 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKID 214 (257)
T ss_pred cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHH
Confidence 12345678999999876 678999999999999999998 999984 334344444443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.88 Aligned_cols=197 Identities=16% Similarity=0.298 Sum_probs=153.5
Q ss_pred eecccCCeeEEEEEEcCC--CeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 132 KVGRGKYSEVFEGINVNT--NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
+||+|+||+||+|+...+ ...+++|.++.. ..+.+.+|+.+++.+ +|||++++++.|.+ ....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecCC
Confidence 599999999999975433 345667776532 235788999999999 99999999999954 467789999999
Q ss_pred CCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC---c
Q 019241 206 STDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E 275 (344)
Q Consensus 206 ~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~---~ 275 (344)
+++|..++. ..++..+..++.|++.||+|||+.+++||||||+|||++.+ +.++|+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhhc
Confidence 999988763 24556678899999999999999999999999999999988 789999999986432211 1
Q ss_pred ceecccCCCccCcccccCC------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~ell~g-~~Pf~~~~~~~~~l~~i 333 (344)
.....++..|+|||++... ..++.++|||||||++|||+++ ..|| ...++.+.+.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~ 221 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDREVLNHV 221 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence 2234677889999997531 2457899999999999999985 4455 444555555543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=254.83 Aligned_cols=185 Identities=16% Similarity=0.221 Sum_probs=151.2
Q ss_pred eecccCCeeEEEEEEcC------------------------CCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccc
Q 019241 132 KVGRGKYSEVFEGINVN------------------------TNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVK 184 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~------------------------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~ 184 (344)
.||+|+||.||+|.... ....|++|+++... ...+.+|+.+++.+ +|+||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 59999999999997432 12358899886433 24677889999998 9999999
Q ss_pred eeeEEEccCCCccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC----
Q 019241 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---- 256 (344)
Q Consensus 185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~---- 256 (344)
++++|.+. ...++||||+++++|..++. .+++..+..++.|++.||+|||+++|+||||||+|||++.+.
T Consensus 81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 99999654 56789999999999988763 478899999999999999999999999999999999997541
Q ss_pred --CcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCC
Q 019241 257 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFY 322 (344)
Q Consensus 257 --~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell-~g~~Pf~~ 322 (344)
..+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 24899999988654322 22456788999999876567899999999999999995 68888853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=255.02 Aligned_cols=192 Identities=21% Similarity=0.437 Sum_probs=165.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.|...+.||+|++|.||++.+..+++.+++|.++.. ..+.+.+|+.+++.+ +|+|++++++++.. ....++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEEEe
Confidence 455568999999999999999899999999988532 235678899999999 99999999999854 467789999
Q ss_pred eecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cceec
Q 019241 203 YVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR 279 (344)
Q Consensus 203 ~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~~ 279 (344)
|+.+++|..++ ..+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+|||.+....... .....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccccc
Confidence 99999998877 357888999999999999999999999999999999999988 789999999886554322 22334
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.++..|+|||.+.+ ..++.++|+|||||++|||++|..||..
T Consensus 176 ~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 176 VGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred cCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 68889999999876 6789999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=250.87 Aligned_cols=195 Identities=28% Similarity=0.452 Sum_probs=161.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccch------HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+.||+|+||.||+|.+..+++.+|+|++..... ..+..|..++....+|+|++++++++.. ....++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 568999999999999999999999999864321 2344555555544489999999999954 46789999999
Q ss_pred cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceeccc
Q 019241 205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281 (344)
Q Consensus 205 ~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~ 281 (344)
++++|..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++.... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCC
Confidence 999999887 458899999999999999999999999999999999999987 7899999999876432 233467
Q ss_pred CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 282 t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
+..|+|||.+.+ ..++.++||||||+++|||++|..||. ..+..+....+
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~ 205 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNI 205 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHH
Confidence 888999999877 558999999999999999999999994 33444444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.59 Aligned_cols=205 Identities=25% Similarity=0.467 Sum_probs=173.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+++-..+||.|.||.||-|.+..+|+..|+|-++-. ..+.+.+|..++..+ .|||+|+++|+-.+. ...++.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHR--ekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHR--EKVYIF 1312 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecH--HHHHHH
Confidence 556678999999999999999999999999987522 225578999999999 999999999987443 456699
Q ss_pred EEeecCCchhhHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC---
Q 019241 201 FEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l~~---l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~--- 274 (344)
||||++|+|.+.+.. .++.-.+.+..|++.|+.|||+.|||||||||.||+++.+ |.+|++|||.|..+.++.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhcC
Confidence 999999999998743 5666677899999999999999999999999999999999 799999999998886553
Q ss_pred --cceecccCCCccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 275 --EYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
..+...||+.|||||++.+.. .-.-+.||||+|||+.||+||+.||.+-+++-..+.+++
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA 1455 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh
Confidence 335568999999999998732 345689999999999999999999976666665555553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=269.26 Aligned_cols=223 Identities=26% Similarity=0.456 Sum_probs=190.5
Q ss_pred CccceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhC-----CCCcccee
Q 019241 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCG-----GPNVVKLL 186 (344)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~-----h~niv~l~ 186 (344)
|..+.+...-.++|.+....|+|-||+|.+|.+...+..||||++.... .+.-.+|++||++|.. --|+++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4444444555789999999999999999999999999999999997543 3667899999999942 25899999
Q ss_pred eEEEccCCCccEEEEEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 187 DIVRDQHSKTPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 187 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
..| .+.+++|||+|-+... |...+. .|....++.|+.|+.-||..|-.+||+|.||||+|||+++....+|
T Consensus 501 r~F--~hknHLClVFE~LslN-LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 501 RHF--KHKNHLCLVFEPLSLN-LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHh--hhcceeEEEehhhhch-HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 988 5568999999987654 444442 3777889999999999999999999999999999999999888999
Q ss_pred EEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 261 l~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
|||||.|.....+ ..+....+..|.|||++++ -.|+...|+||.||+||||.||+..| +|.++.+++...+++.|++
T Consensus 578 LCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 578 LCDFGSASFASEN-EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eccCccccccccc-cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCCC
Confidence 9999999876543 3344456778999999999 88999999999999999999999988 8999999999999999998
Q ss_pred CC
Q 019241 341 DF 342 (344)
Q Consensus 341 ~~ 342 (344)
|.
T Consensus 655 p~ 656 (752)
T KOG0670|consen 655 PN 656 (752)
T ss_pred cH
Confidence 74
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=253.28 Aligned_cols=208 Identities=36% Similarity=0.669 Sum_probs=175.4
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
|+..+.||+|+||.||+|++..+++.+|+|.+... ..+.+.+|+.+++.+ +|+|++++++++.+ ....++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhc--CCceEEEe
Confidence 56778999999999999999999999999998643 235677899999999 89999999999854 47788999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cc
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 276 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~ 276 (344)
||+++ +|..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||.++...... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence 99985 677766 258899999999999999999999999999999999999998 789999999997765432 23
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.....+..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+.+.++.+.++.+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~ 218 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTP 218 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCC
Confidence 33456778999999877458899999999999999999998777 5666677777777666544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=251.73 Aligned_cols=193 Identities=22% Similarity=0.484 Sum_probs=164.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc-------------chHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
.|++.+.||+|+||+||+|++.. +++.+|+|.+... ...++.+|+.++.+..+|+|++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999877 6788999987421 123466788888764499999999999954
Q ss_pred cCCCccEEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEe
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLID 263 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~D 263 (344)
....+++|||++++++..++ ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~d 157 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITD 157 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEec
Confidence 46789999999999987765 247888999999999999999996 789999999999999988 7899999
Q ss_pred cccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 264 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
||.+.............++..|++||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 999987665544455678889999999876 6689999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.52 Aligned_cols=186 Identities=24% Similarity=0.422 Sum_probs=155.6
Q ss_pred eeecccCCeeEEEEEEcCCC------eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 131 RKVGRGKYSEVFEGINVNTN------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.||+|+||.||+|++.... +.+|+|.+... ....+.+|+++++.+ +|+||+++++++.+ ....+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999875433 68999987532 346788999999999 99999999999954 4567899
Q ss_pred EEeecCCchhhHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC-----cEEEEecc
Q 019241 201 FEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-----KLRLIDWG 265 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~-----~~kl~DFG 265 (344)
|||+++++|..++. .+++.++..++.|++.||+|||+.+++|+||||+||+++.+ + .++++|||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg 156 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDFG 156 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCcc
Confidence 99999999988763 26778889999999999999999999999999999999986 4 79999999
Q ss_pred cceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 266 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 99765433221 12344678999999876 678999999999999999998 888884
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=250.42 Aligned_cols=194 Identities=27% Similarity=0.514 Sum_probs=173.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|.+++.||+|+|..|..++.+.+.+.+|+|++++.- ..=.+.|-.+...-.+||.+|-+..+| +....+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceE
Confidence 578999999999999999999999999999999987432 122456777777777899999999999 555778
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~~ 273 (344)
+.|.||.++|+|.... ++++++.++.+..+|+.||.|||++|||.||||.+|+|+|.+ +.+||.|+|+++.. .++
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence 8999999999986655 569999999999999999999999999999999999999999 89999999999754 456
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
....+.+||+.|.|||++.+ ..|.+++|.|+|||+++||+.|+.||.
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcc
Confidence 67788899999999999988 899999999999999999999999995
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=253.15 Aligned_cols=195 Identities=28% Similarity=0.524 Sum_probs=170.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..+.|++.+.||+|+||.||+|.+..++..+++|+++... .+.+.+|++.++.+ +|+|++++++.+... ...+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEEE
Confidence 4677888999999999999999998889999999997544 56788999999999 999999999999654 678899
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
+||+++++|.+++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccchhh
Confidence 99999999998873 68999999999999999999999999999999999999987 789999999986554322 2
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.....++..|++||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus 173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 233457788999999876 6789999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=249.61 Aligned_cols=190 Identities=24% Similarity=0.495 Sum_probs=167.3
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.++||+|+||.||++++..+++.+++|.+... ....+.+|+++++++ +|+||+++++++.+ ....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLD--GNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhcc--CCEEEEE
Confidence 588899999999999999999999999999998632 234677899999999 89999999999854 3778899
Q ss_pred EEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+||+++++|..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 9999999998876 348889999999999999999999999999999999999987 78999999999877544
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3334567889999999877 778899999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=245.54 Aligned_cols=193 Identities=34% Similarity=0.594 Sum_probs=170.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
+|+..+.||+|++|.||++.+..+++.+++|++... ..+.+.+|+++++++ +|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence 477889999999999999999889999999998654 346788999999999 899999999998554 67789999
Q ss_pred eecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCccee
Q 019241 203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278 (344)
Q Consensus 203 ~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~ 278 (344)
|+++++|..++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccc
Confidence 99999998876 357999999999999999999999999999999999999987 7899999999987765443445
Q ss_pred cccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
..++..|++||.+.. ..++.++|+||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 678889999999876 56889999999999999999999998543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=256.01 Aligned_cols=192 Identities=29% Similarity=0.492 Sum_probs=162.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.+.|+..+.||+|+||+||++++..++..+|+|.+... ....+.+|+++++++ +|+|++++++++.+. ...
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 100 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--HTA 100 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CeE
Confidence 34577889999999999999999999999999998532 124678899999999 999999999999653 567
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+.+. +...+ ..+++.++..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 101 ~lv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 101 WLVMEYCLGS-ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP- 177 (317)
T ss_pred EEEEeCCCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC-
Confidence 8999999864 43333 348899999999999999999999999999999999999988 7899999999876543
Q ss_pred CcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.....++..|+|||.+.. ...++.++|||||||++|||++|+.||...
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 233567889999999752 256889999999999999999999999643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=246.45 Aligned_cols=193 Identities=26% Similarity=0.546 Sum_probs=168.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||.|+||.||++.+..+++.+++|.+... ....+.+|+++++.+ +|+|++++++.+.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence 588899999999999999999989999999998632 345688999999999 899999999998654 778899
Q ss_pred EEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+||+++++|...+ ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 9999999998776 347889999999999999999999999999999999999987 78999999999776544
Q ss_pred C-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 3 2233467888999999876 67899999999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=251.77 Aligned_cols=195 Identities=32% Similarity=0.592 Sum_probs=167.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||.||+|.+..+++.+|+|++... ..+.+.+|.++++++.+|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 4789999999999999999999999999999998642 235678899999999339999999999854 46788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
++|||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++++|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence 999999999998887 358999999999999999999999999999999999999988 789999999987654322
Q ss_pred --------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 275 --------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 275 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
......++..|+|||+... ..++.++|+||||+++|++++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1123356788999999876 66889999999999999999999999543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=245.24 Aligned_cols=194 Identities=28% Similarity=0.568 Sum_probs=169.4
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|++.+.||+|++|.||++++..+++.+++|.+.... ...+.+|+++++++ +|+|++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET--SDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe--CCEEEEE
Confidence 5788999999999999999999899999999986432 35688999999999 99999999999865 4678899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-c
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~ 276 (344)
|||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence 9999999998877 358999999999999999999999999999999999999987 7899999999987754433 2
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
....++..|+|||...+ ..++.++|+||+|+++|+|++|..||....
T Consensus 157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 34567888999999876 558899999999999999999999996433
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=251.44 Aligned_cols=201 Identities=21% Similarity=0.429 Sum_probs=160.2
Q ss_pred eEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC---
Q 019241 127 YEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK--- 195 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--- 195 (344)
|++.+.||+|+||+||+|.+. .+++.+|+|+++.. ..+++.+|+++++.+ +|||++++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 566789999999999999854 35689999998642 235678899999999 999999999988643222
Q ss_pred -ccEEEEEeecCCchhhHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 196 -TPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 196 -~~~lv~e~~~~~~l~~~l~---------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
..++++||+.++++..++. .+++..+..++.|++.||+|||+.+|+||||||+||+++.+ +.+||+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence 3468899999999876641 36888899999999999999999999999999999999987 789999999
Q ss_pred cceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 019241 266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV 331 (344)
Q Consensus 266 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~ 331 (344)
+++........ ....++..|++||.+.. ..++.++|||||||++|||++ |..|| .+.+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~ 226 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYN 226 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHH
Confidence 99866433211 12234567999999876 678899999999999999999 77777 4444443333
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=246.12 Aligned_cols=185 Identities=22% Similarity=0.413 Sum_probs=155.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
++||+|+||.||++.+.. ++.+++|.++.. ....+.+|+++++++ +|+||+++++++.+ ....++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 469999999999998777 899999988643 235788999999999 99999999999854 4678899999999
Q ss_pred CchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcce---ec
Q 019241 207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VR 279 (344)
Q Consensus 207 ~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~---~~ 279 (344)
+++..++. .+++..+..++.+++.||+|||+.+++||||||+||+++.+ +.+||+|||++.......... ..
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccC
Confidence 99988762 37888889999999999999999999999999999999988 789999999997654222111 12
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
..+..|+|||.+.+ ..++.++|+|||||++|||++ |..||.
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 23456999999876 678999999999999999999 777773
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=254.52 Aligned_cols=188 Identities=22% Similarity=0.424 Sum_probs=163.2
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
...+||+|+||.||++.+..+++.+|+|.+... ....+.+|+.+++.+ +|+|++++++.+.. ....+++|||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEEecCC
Confidence 346799999999999999999999999987532 335688899999999 99999999999965 467889999999
Q ss_pred CCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cceecccC
Q 019241 206 STDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVAS 282 (344)
Q Consensus 206 ~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~~~~t 282 (344)
++++..++ ..+++.....++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccccccC
Confidence 99998876 457889999999999999999999999999999999999988 789999999987654322 22335678
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 180 ~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 180 PYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 89999999876 678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=248.73 Aligned_cols=195 Identities=31% Similarity=0.540 Sum_probs=163.8
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||.|+||.||++++..+++.+++|++... ..+.+.+|+++++++ +|+|++++++.+.. ....++++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence 68999999999999988999999998643 235678899999999 89999999998854 5778999999999
Q ss_pred CchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC---------
Q 019241 207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------- 274 (344)
Q Consensus 207 ~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~--------- 274 (344)
++|..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence 9998876 458999999999999999999999999999999999999998 789999999987654321
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
......++..|++||...+ ...+.++|+||||+++|++++|..||.. .+..+....+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~ 213 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNI 213 (265)
T ss_pred cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHH
Confidence 1223457788999999877 5688999999999999999999999843 3334433333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=272.96 Aligned_cols=204 Identities=21% Similarity=0.366 Sum_probs=171.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.++..+.++||+|+||.|++|.|...+ ..||||.++.. ....|.+|+.+|.++ +|+|+++|||.+.+ .-
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---ch
Confidence 455677789999999999999887543 46899999743 347899999999999 99999999999976 45
Q ss_pred cEEEEEeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..+|+|+++.|+|.+.++. |....+..|+.||+.||.||.++++|||||..+|+|+-.. ..+||||||+.+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALG 263 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccC
Confidence 6799999999999888754 6677788999999999999999999999999999999887 799999999999887
Q ss_pred CCCcceeccc----CCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 272 PGKEYNVRVA----SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
.++....... ...|.|||.+.. ..++.++|||+|||++|||++ |..|| .|-...+.+..|-
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNID 329 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhcc
Confidence 6655443322 334999999877 889999999999999999999 56666 6777677666654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=265.99 Aligned_cols=200 Identities=20% Similarity=0.390 Sum_probs=169.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..+....++||-|.||.||.|.++.-.-.||||.++.. ..++|.+|..+|+.+ +|||+|+++|+|.. .-..|+|.
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEEE
Confidence 34566779999999999999999999999999999854 458899999999999 99999999999955 45667999
Q ss_pred EeecCCchhhHcCCC-----CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYPTL-----TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~~l-----~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||..|+|.++++.. +.--+.+++.||..||+||..+++|||||..+|+|+.++ ..+|++|||+++++..+ .+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgD-TY 420 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGD-TY 420 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhcCC-ce
Confidence 999999999999654 444467889999999999999999999999999999998 89999999999998644 33
Q ss_pred eeccc---CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 277 NVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 277 ~~~~~---t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
+...| ...|.|||.+.- ..++.|+|||+|||+|||+.|...-.|.|-+-.++
T Consensus 421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV 475 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 475 (1157)
T ss_pred ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Confidence 44444 345999999876 77899999999999999999854444466664443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=258.04 Aligned_cols=190 Identities=17% Similarity=0.272 Sum_probs=155.5
Q ss_pred eeeccc--CCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
..||+| +||+||++++..+++.||+|+++... .+.+.+|+.+++.+ +|+||++++++|.. ....++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEec
Confidence 456666 99999999999999999999986322 25678899999888 99999999999965 4677899999
Q ss_pred ecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c--
Q 019241 204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E-- 275 (344)
Q Consensus 204 ~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~-- 275 (344)
+.++++..++. .+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.++++||+.+....... .
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCcccc
Confidence 99999888763 37888899999999999999999999999999999999988 789999998653322111 0
Q ss_pred -----ceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 276 -----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 276 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.....++..|+|||++.+. ..++.++|||||||++|||++|..||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0112345569999998753 347899999999999999999999995443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.52 Aligned_cols=207 Identities=28% Similarity=0.464 Sum_probs=167.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEcc-------
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------- 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------- 192 (344)
.++|+.++.||+||||.||+++++-+|+.+|||.+.-. ...++.+|+..|.+| +|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence 35688899999999999999999999999999988522 335678999999999 999999999221100
Q ss_pred --------------------------------------------------------------------------------
Q 019241 193 -------------------------------------------------------------------------------- 192 (344)
Q Consensus 193 -------------------------------------------------------------------------------- 192 (344)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ----------------------CC--------CccEEEEEeecCCchhhHcCC--C--CHHHHHHHHHHHHHHHHHHHHc
Q 019241 193 ----------------------HS--------KTPSLIFEYVNSTDFKVLYPT--L--TDYDIRYYIYELLKALDYCHSQ 238 (344)
Q Consensus 193 ----------------------~~--------~~~~lv~e~~~~~~l~~~l~~--l--~~~~~~~~~~~i~~~L~~LH~~ 238 (344)
.+ ..+|+-||||+..++..+++. + .....++++++|+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 00 235778888888888887742 3 3667789999999999999999
Q ss_pred CcEeecCCCCceEEeCCCCcEEEEecccceecC-------------------CCCcceecccCCCccCcccccCCC--CC
Q 019241 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DY 297 (344)
Q Consensus 239 ~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~ 297 (344)
|+|||||||.||++|++ +.|||+|||+|.... +....+..+||..|+|||++.+.. .|
T Consensus 717 giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 99999999999999988 789999999997611 112345678999999999998755 69
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 298 ~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+.|+|+|||||+++||+ .||...++-...+..+.+
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~ 830 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRK 830 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc
Confidence 99999999999999998 578766666666666653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=250.08 Aligned_cols=194 Identities=27% Similarity=0.469 Sum_probs=162.9
Q ss_pred CeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
+|++.+.||+|+||.||++++. .+++.+|+|+++.. ..+.+.+|++++.++.+|+|++++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4788999999999999999754 46688999998632 224577899999999779999999999854 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..++||||+.+++|..++ ..+++..+..++.|++++|.|||+.+++|+||+|+||+++.+ +.++|+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence 788999999999998876 347889999999999999999999999999999999999988 7899999999876543
Q ss_pred CCc--ceecccCCCccCcccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 273 GKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 273 ~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
... .....++..|+|||.+.+.. ..+.++|+||||+++|||++|..||..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 322 22345788999999986522 368899999999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=276.45 Aligned_cols=141 Identities=29% Similarity=0.533 Sum_probs=126.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|+++++||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +|+||+++++.+.. ..+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEE
Confidence 468999999999999999999999999999999986432 25678899999998 99999999998854 4678
Q ss_pred EEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
++||||+.+++|..++. .+++..++.++.||+.||+|||+.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 99999999999988873 47888999999999999999999999999999999999988 789999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=259.35 Aligned_cols=215 Identities=30% Similarity=0.588 Sum_probs=191.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC---CCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.+.|..+++||+|.|++||++.+.. .++.||+|.+.. .....+.+|++.|..+.++.||+++.+++.. ....++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence 5678899999999999999998877 788999998864 4568899999999999999999999999954 567789
Q ss_pred EEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC--------
Q 019241 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------- 271 (344)
Q Consensus 200 v~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-------- 271 (344)
|+||++.....+++..++-.+++.+++.++.||.++|..|||||||||+|+|.+...+.-.|+|||+|....
T Consensus 113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999988888999999986210
Q ss_pred ---------C-----------------CCc-----------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHH
Q 019241 272 ---------P-----------------GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314 (344)
Q Consensus 272 ---------~-----------------~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell 314 (344)
+ ... .-.+.||++|+|||++...+..++++||||.||++.-++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 000 012469999999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 315 FRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 315 ~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
+++.||+...++-+.+++|+.+.|.-
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~ 298 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSA 298 (418)
T ss_pred ccccccccCccccchHHHHHHHhChH
Confidence 99999999999999999999988853
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=251.65 Aligned_cols=192 Identities=28% Similarity=0.468 Sum_probs=160.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
+.|...++||+|+||+||+|++..+++.+++|.+... ....+.+|+++++.+ +|+|++++++++.+. ...+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 97 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HTAW 97 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEE
Confidence 3466678899999999999999999999999998532 124577899999999 999999999999654 6678
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||+.+..+..+. ..+++.++..++.|++.++.|||+.|++|+||+|+||+++.+ +.+||+|||++.... .
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---P 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---C
Confidence 999999765433332 348899999999999999999999999999999999999988 789999999986432 2
Q ss_pred ceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.....++..|+|||++.. ...++.++|||||||++|||++|..||...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578889999999852 256888999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=269.29 Aligned_cols=200 Identities=26% Similarity=0.492 Sum_probs=175.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEc---cCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~ 197 (344)
..+.|++.+.||.|.+|.||+++.+.+++.+|+|++... ..++++.|.+|++.++.|||++.++|+|.. .....+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 567899999999999999999999999999999998653 457788999999999999999999998853 234678
Q ss_pred EEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
+||||||.+|+.-++.+ .+.|..+.+|++.++.|+.+||...++|||||-.|||++.+ +.|||+|||.+.....
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeeeeec
Confidence 99999999999888874 47888899999999999999999999999999999999999 8899999999877654
Q ss_pred C-CcceecccCCCccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 273 G-KEYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 273 ~-~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
. ...++..||++|||||++... ..|+.++|+||||++..||-.|.+|+...
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 3 345667999999999999763 34778999999999999999999998543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=242.28 Aligned_cols=196 Identities=28% Similarity=0.508 Sum_probs=166.1
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
||+|+||.||++.+..+++.+++|+++.. ....+..|+++++++ +|+|++++++.+. .....+++|||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQ--TEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence 69999999999999888999999998643 234688999999999 8999999999984 45778999999999
Q ss_pred CchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-CcceecccC
Q 019241 207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS 282 (344)
Q Consensus 207 ~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~~~~~t 282 (344)
++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCC
Confidence 99988773 47899999999999999999999999999999999999988 78999999999776543 234455678
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
..|++||.+.+ ...+.++|+||||+++|++++|..||.. .+..+....+.
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~ 206 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKIL 206 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHh
Confidence 88999999876 6688999999999999999999999943 33344444443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=274.36 Aligned_cols=198 Identities=21% Similarity=0.412 Sum_probs=165.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEec----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
...+..++||+|+||+||+|.+...++ +||+|++. .....++..|.-+|.++ +|+|+++++++|... .
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~ 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---T 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---h
Confidence 344556899999999999999876654 68888874 23457899999999999 999999999999553 3
Q ss_pred cEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
+.||.+||+.|.|.++. ..+.......+..||++||.|||+++++||||..+|||+..- +.+||.|||+|+...+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence 77999999999998887 358888899999999999999999999999999999999987 7899999999998876
Q ss_pred CCc-ceecc--cCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 273 GKE-YNVRV--ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 273 ~~~-~~~~~--~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
... +.... ..+-|||=|.+.. ..++.++|||||||++||++| |..|+ .+...+|.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py-~gi~~~eI 909 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPY-DGIPAEEI 909 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCcc-CCCCHHHh
Confidence 543 33332 2445999999887 889999999999999999998 77777 45554443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=252.87 Aligned_cols=192 Identities=29% Similarity=0.484 Sum_probs=162.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.+.|+..+.||+|+||+||+|++..+++.+|+|.+... ...++.+|+++++.+ +|+|++++++++.+. ...
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 90 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA 90 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--Cee
Confidence 45577789999999999999999999999999987531 124577899999999 999999999999654 667
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+.+ ++...+ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....+.
T Consensus 91 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 91 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc
Confidence 899999985 444433 348889999999999999999999999999999999999988 78999999999776433
Q ss_pred CcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
....++..|+|||.+.. ...++.++|||||||++|+|++|..||...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 23467889999999753 245788999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=251.78 Aligned_cols=188 Identities=20% Similarity=0.250 Sum_probs=154.4
Q ss_pred CCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhh
Q 019241 137 KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211 (344)
Q Consensus 137 ~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~ 211 (344)
++|.||.++...+++.+|+|+++.. ..+.+.+|+++++.+ +|+||+++++++.+ ....+++|||++++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIV--DSELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeec--CCeEEEEEeccCCCCHHH
Confidence 4556666666779999999998533 235788999999999 99999999999955 466789999999999988
Q ss_pred HcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc--------cee
Q 019241 212 LYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--------YNV 278 (344)
Q Consensus 212 ~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~--------~~~ 278 (344)
++. .+++..+..++.|++.||+|||+.+|+||||||+||+++.+ +.+||+|||.+........ ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccccccccccc
Confidence 763 47888999999999999999999999999999999999988 7899999999865532221 123
Q ss_pred cccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 019241 279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~ 328 (344)
..++..|+|||++... ..++.++|+|||||++|||++|..||....+...
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3566789999998653 3588999999999999999999999965444333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=244.95 Aligned_cols=190 Identities=25% Similarity=0.486 Sum_probs=161.1
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
+|.+.++||+|+||+||++.+...+..+++|+++. ....++..|+.+++++ +|||++++++++.+. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence 58889999999999999999888777777777653 1223566799999999 999999999998554 567
Q ss_pred EEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
++++||++++++..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||+++..
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~ 155 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLL 155 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeec
Confidence 8999999999998765 348899999999999999999999999999999999999864 6899999999876
Q ss_pred CCCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 271 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 271 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 44332 234467888999999866 678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=244.69 Aligned_cols=215 Identities=27% Similarity=0.502 Sum_probs=184.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC----
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---- 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---- 193 (344)
...+|.-+..+|.|.. .|.-+.|.-.++.||+|.+.. ...++..+|...+..+ .|+|+++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence 3567888888999999 777888888999999998742 2335677899999999 9999999999996432
Q ss_pred CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
....|+|||+|....-...+-.++-..+..+..|++.|++|||+.||+||||||+||++..+ ..+||+|||+|+.....
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTD 171 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccCcc
Confidence 24568999999877655555677888899999999999999999999999999999999999 79999999999876655
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
-..+..+.|++|+|||++.+ ..+...+||||+||++.||++|+..| +|.+--+++.+|.+.+|++|-
T Consensus 172 ~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCH
Confidence 34455688999999999998 55999999999999999999999888 699999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=257.30 Aligned_cols=195 Identities=26% Similarity=0.494 Sum_probs=170.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----------HHHHHHHHHHHHHh--CCCCccceeeEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------KKIKREIKILQNLC--GGPNVVKLLDIVR 190 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~E~~~l~~l~--~h~niv~l~~~~~ 190 (344)
..+|+.++.+|+|+||.|++|.++.+...|++|.+.+... -..-.|++||..+. .|+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4569999999999999999999999999999999864321 12446999999992 2899999999996
Q ss_pred ccCCCccEEEEEee-cCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 191 DQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 191 ~~~~~~~~lv~e~~-~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
++ .+.||++|-. ++.+|.+++ +.+++.+...|.+|++.|+++||++||||||||-+|+.++.+ |.+||+|||.
T Consensus 640 dd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfgs 716 (772)
T KOG1152|consen 640 DD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFGS 716 (772)
T ss_pred cC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeeccc
Confidence 64 6778999976 455777776 579999999999999999999999999999999999999999 8999999999
Q ss_pred ceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
|.... +......+||..|.|||++.+....+..-|||++|++||.++....||++
T Consensus 717 aa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 87654 45667789999999999998866678899999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=238.12 Aligned_cols=177 Identities=19% Similarity=0.275 Sum_probs=150.4
Q ss_pred cCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHc--
Q 019241 136 GKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-- 213 (344)
Q Consensus 136 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l-- 213 (344)
|.||.||++++..+++.+|+|.+.... .+.+|...+... .|||++++++++.+ ....+++|||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986432 344555555555 79999999999854 46789999999999998776
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCccccc
Q 019241 214 -PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292 (344)
Q Consensus 214 -~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~ 292 (344)
..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++++|||.+...... .....++..|+|||.+.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCcccC
Confidence 358999999999999999999999999999999999999988 78999999988655432 23345677899999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 293 ~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
. ..++.++|+||+||++|||++|..||.
T Consensus 156 ~-~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 156 I-SEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 5 678899999999999999999998764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=266.55 Aligned_cols=206 Identities=23% Similarity=0.438 Sum_probs=168.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---C----CCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV---N----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~---~----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++.++.+.||+|.||+|++|... . ....||||.++.. ..+.+..|+++|+.+..|+|+++++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 344466679999999999999632 1 2467999998642 346789999999999889999999999966
Q ss_pred CCCccEEEEEeecCCchhhHcC--C-----------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP--T-----------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~--~-----------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~ 253 (344)
....++|+||+..|+|..+++ . +...++..++.||+.||+||++.+++||||..+|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 577889999999999988872 3 77888999999999999999999999999999999999
Q ss_pred CCCCcEEEEecccceecCCCCcceec--cc--CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCC-CH
Q 019241 254 HELRKLRLIDWGLAEFYHPGKEYNVR--VA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHD-NH 327 (344)
Q Consensus 254 ~~~~~~kl~DFGla~~~~~~~~~~~~--~~--t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g-~~Pf~~~~~-~~ 327 (344)
.+ ..+||+|||+|+...+...+... .+ ...|||||.+.+ ..|+.++|||||||+|||+++. ..|| .+-. ..
T Consensus 453 ~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY-p~~~~~~ 529 (609)
T KOG0200|consen 453 KN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY-PGIPPTE 529 (609)
T ss_pred CC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC-CCCCcHH
Confidence 98 79999999999977665555432 22 334999999988 8899999999999999999994 5555 5544 45
Q ss_pred HHHHHHH
Q 019241 328 DQLVKIA 334 (344)
Q Consensus 328 ~~l~~i~ 334 (344)
+.+..+.
T Consensus 530 ~l~~~l~ 536 (609)
T KOG0200|consen 530 ELLEFLK 536 (609)
T ss_pred HHHHHHh
Confidence 5544443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-31 Score=229.88 Aligned_cols=205 Identities=31% Similarity=0.587 Sum_probs=175.4
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
|++.+.||+|++|+||++.+..+++.+++|.+... ..+.+.+|++.++++ +|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec--CCceEEEEe
Confidence 46678999999999999999888999999999754 456788999999999 99999999999854 366789999
Q ss_pred eecCCchhhHcCC----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--cc
Q 019241 203 YVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EY 276 (344)
Q Consensus 203 ~~~~~~l~~~l~~----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~--~~ 276 (344)
|+++++|..++.. +++.....++.+++.++.+||+.+++|+||+++||+++.+ +.++|+|||.+....... ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccc
Confidence 9999999888732 7888999999999999999999999999999999999988 789999999998776543 33
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCCHHHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY-GHDNHDQLVKIAK 335 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~-~~~~~~~l~~i~~ 335 (344)
....++..|++||.+.+...++.++|+||||++++||++|+.||.. ..+..+....|..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 4457788899999984436788899999999999999999999965 3444567676655
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=261.46 Aligned_cols=196 Identities=21% Similarity=0.315 Sum_probs=141.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC----CeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEE----EccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIV----RDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~----~~~~~ 194 (344)
..++|++.++||+|+||+||+|++..+ +..||+|.++.....+...+. .++.. .+.++..+...+ .....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence 467899999999999999999999888 899999988643322211111 11222 222333222221 11334
Q ss_pred CccEEEEEeecCCchhhHcCCC-----------------------CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceE
Q 019241 195 KTPSLIFEYVNSTDFKVLYPTL-----------------------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~~l-----------------------~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiL 251 (344)
...++||||+++++|..++... .+..+..++.|++.||+|||+.+|+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 6778999999999998776321 12335678999999999999999999999999999
Q ss_pred EeCCCCcEEEEecccceecCCCC--cceecccCCCccCcccccCCC---------------------CCCchhhHHHHHH
Q 019241 252 IDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDMWSLGC 308 (344)
Q Consensus 252 l~~~~~~~kl~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DvwSlGv 308 (344)
++.+.+.+||+|||+|+...... ......+++.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 99755789999999998654332 223457889999999764311 2445679999999
Q ss_pred HHHHHHhCCCCC
Q 019241 309 MFAGMIFRKEPF 320 (344)
Q Consensus 309 ~l~ell~g~~Pf 320 (344)
++|||+++..|+
T Consensus 368 iL~el~~~~~~~ 379 (566)
T PLN03225 368 IFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHhCcCCC
Confidence 999999876543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=250.18 Aligned_cols=197 Identities=21% Similarity=0.371 Sum_probs=147.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc----------------CCCeEEEEEEecccc---hHH--------------HHHH
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV----------------NTNERCIIKILKPVK---KKK--------------IKRE 169 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~---~~~--------------~~~E 169 (344)
..++|++.++||+|+||+||+|.+. ..++.||||.++... .++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999642 244679999985322 122 2346
Q ss_pred HHHHHHHhCCCC-----ccceeeEEEcc------CCCccEEEEEeecCCchhhHcCC-----------------------
Q 019241 170 IKILQNLCGGPN-----VVKLLDIVRDQ------HSKTPSLIFEYVNSTDFKVLYPT----------------------- 215 (344)
Q Consensus 170 ~~~l~~l~~h~n-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~l~~----------------------- 215 (344)
+.++.++ +|.+ +++++++|... .....+|||||+++++|.+++..
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777 4544 47788877532 12457899999999999876631
Q ss_pred ----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCccee--cccCCCccCcc
Q 019241 216 ----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPE 289 (344)
Q Consensus 216 ----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~--~~~t~~y~aPE 289 (344)
+++..++.++.|++.+|.|||+.+|+||||||+|||++.+ +.+||+|||++........... ..+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2455677899999999999999999999999999999988 7899999999976544333222 23478999999
Q ss_pred cccCCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCC
Q 019241 290 LLVDLQD-------------------Y--DYSLDMWSLGCMFAGMIFRKE-PFF 321 (344)
Q Consensus 290 ~~~~~~~-------------------~--~~~~DvwSlGv~l~ell~g~~-Pf~ 321 (344)
.+..... + ..+.||||+||++|+|++|.. ||.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9864211 1 124799999999999999986 553
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=220.79 Aligned_cols=188 Identities=33% Similarity=0.630 Sum_probs=163.5
Q ss_pred CCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhH
Q 019241 137 KYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212 (344)
Q Consensus 137 ~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~ 212 (344)
+||.||+|.+..+++.+++|++.... .+.+.+|++.++++ +|+|++++++.+... ...++++||+++++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999986433 57889999999999 999999999998653 677899999999999888
Q ss_pred cCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCcc
Q 019241 213 YPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289 (344)
Q Consensus 213 l~~---l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE 289 (344)
+.. +++..+..++.+++.++.|||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 743 7889999999999999999999999999999999999988 789999999998876554555667888999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 290 ~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
.... ..++.++|+||||+++|++++|..||....+....
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~ 195 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL 195 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9875 67888999999999999999999999653443333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=222.76 Aligned_cols=197 Identities=20% Similarity=0.384 Sum_probs=161.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.+.|.+.+.||+|.||.+-+++++.++..+++|.+.. ...++|.+|..---.|..|.||+.-|+.-- +.....+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence 5778999999999999999999999999999999853 345789999876666778999999887332 3446778999
Q ss_pred EeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE-eCCCCcEEEEecccceecCCCCccee
Q 019241 202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNV 278 (344)
Q Consensus 202 e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl-~~~~~~~kl~DFGla~~~~~~~~~~~ 278 (344)
||++.|+|..-.. .+.+.....++.|+++|++|||++++||||||.+|||+ +.++-.+||||||+.+..+ .....
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~tV~~ 179 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TTVKY 179 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--ceehh
Confidence 9999999998874 58889999999999999999999999999999999998 5566689999999987543 22222
Q ss_pred cccCCCccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 279 RVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 279 ~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...+-.|.+||+.... -..+..+|+|.||+++|.++||+.||...
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 3445568899986531 12467899999999999999999999643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=242.02 Aligned_cols=196 Identities=27% Similarity=0.507 Sum_probs=170.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.+++|+.+.++|+|.+|.|||++++.+++.+|+|+++- ...+..++|+-+++.. +|+||+.++|.+... ...++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~--dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRR--DKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhh--cCcEE
Confidence 57889999999999999999999999999999999873 3446677899998887 999999999988543 56789
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~ 275 (344)
.||||.+|+|.+.. ..+++.++.+..++.++||+|||+.|-+|||||-.|||++++ +.+|+.|||.+..+... .+
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhhhh
Confidence 99999999998876 469999999999999999999999999999999999999998 89999999998666432 23
Q ss_pred ceecccCCCccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
...+.||++|||||+.. ....|...+|+|++|+...|+-....|-+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 45679999999999964 235689999999999999999888877653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=243.89 Aligned_cols=189 Identities=25% Similarity=0.376 Sum_probs=154.3
Q ss_pred eEEEeeecccCCee-EEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 127 YEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 127 ~~~~~~lG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
|.-.+.+|.|+.|+ ||+|.. .++.||||.+-.....-..+|++.|+.-..||||+++++.- ++..+.|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence 33446789999987 589954 78899999998777788899999999888899999998765 55688899999997
Q ss_pred CCchhhHcCC-------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC----CCCcEEEEecccceecCCCC
Q 019241 206 STDFKVLYPT-------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 206 ~~~l~~~l~~-------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~----~~~~~kl~DFGla~~~~~~~ 274 (344)
.. |.+++.. ....+.+....|++.||++||+.+||||||||.||||+. ...+++|+|||+++.+..+.
T Consensus 587 ~s-L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 CS-LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hh-HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 64 4444422 122445778899999999999999999999999999976 23578999999999987654
Q ss_pred cc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCC
Q 019241 275 EY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFF 321 (344)
Q Consensus 275 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g-~~Pf~ 321 (344)
.. ....||.+|+|||++.. ..-+.++||+|+||++|+.++| .+||.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCC
Confidence 32 34478999999999987 5667799999999999999986 88994
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=214.99 Aligned_cols=207 Identities=19% Similarity=0.350 Sum_probs=166.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC-----eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
+++++..-.+-+|.||.||.|.++..+ +.|-+|.++.. ....+..|--.+..+ .|||+..+.+.+.+. .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-c
Confidence 567888889999999999999765433 34556666532 224566777777777 799999999988764 4
Q ss_pred CccEEEEEeecCCchhhHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEe
Q 019241 195 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~-----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~D 263 (344)
..++.++.+++-|+|..++. .++..+...++.|++.|++|||+.|+||.||..+|.+||+. -.+||+|
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltD 439 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTD 439 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEecc
Confidence 66789999999999999883 36777788899999999999999999999999999999988 7899999
Q ss_pred cccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 264 WGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 264 FGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
=.+++...+.+..- .......||+||.+.+ ..|+.++|+|||||++|||+| |+.|+ ..-|+.|.-..+.+
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKD 513 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhc
Confidence 99999887665431 2234556999999998 889999999999999999999 67776 45555665554443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-26 Score=195.84 Aligned_cols=177 Identities=32% Similarity=0.621 Sum_probs=154.5
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCc
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD 208 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~ 208 (344)
||+|++|.||++++..+++.+++|++..... +.+.+|++.++.+ +|++++++++++... ...++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 6899999999999888899999999976544 6899999999999 899999999999553 67789999999999
Q ss_pred hhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC-CCCcEEEEecccceecCCCC-cceecccC
Q 019241 209 FKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGK-EYNVRVAS 282 (344)
Q Consensus 209 l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~-~~~~~kl~DFGla~~~~~~~-~~~~~~~t 282 (344)
+..++. .+++..+..++.++++++.+||+.|++|+||+|.||+++. + +.++|+|||.+....... ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhcccCC
Confidence 998874 4789999999999999999999999999999999999998 6 789999999998765432 13345677
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHH
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 313 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 313 (344)
..|++||.+......+.+.|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 8899999987633788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=213.58 Aligned_cols=160 Identities=18% Similarity=0.236 Sum_probs=126.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++.. +++.+|||.+... ....+.+|+++|+++ +|+|++..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~---- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT---- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc----
Confidence 35779999999999999999998776 6778899986422 235689999999999 899998633322
Q ss_pred CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecC-CCCceEEeCCCCcEEEEecccceecCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDl-kp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
...++||||+++++|... .... ...++.|++++|.|||+.||+|||| ||+|||++.+ +.+||+|||+|+....
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFRR 164 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceeccc
Confidence 346899999999998743 2111 2467899999999999999999999 9999999877 7899999999987654
Q ss_pred CCc---------ceecccCCCccCcccccC
Q 019241 273 GKE---------YNVRVASRYFKGPELLVD 293 (344)
Q Consensus 273 ~~~---------~~~~~~t~~y~aPE~~~~ 293 (344)
... .....++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 321 123467778999999754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=190.28 Aligned_cols=211 Identities=21% Similarity=0.357 Sum_probs=167.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
....|.++++||+|+||.+|.|....+|+.||+|+-+. ....++..|..+.+.|.+...|..+..+.. +..+..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGT--EKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcc--ccccceeee
Confidence 46789999999999999999999999999999999753 445778899999999977788888888874 456778999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCCCc
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~~~ 275 (344)
+.+... |+++. +.++...+...+.|++.-++|+|.+++|||||||+|+|..-+ .+.+.++|||+|+.+.+...
T Consensus 91 dLLGPs-LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLLGPS-LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eccCcc-HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 988654 33332 579999999999999999999999999999999999998543 35789999999988754322
Q ss_pred --------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHhh
Q 019241 276 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVT 337 (344)
Q Consensus 276 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~--~~~~l~~i~~~~ 337 (344)
.....||..|.+-....+ ...+.+-|+-|+|.+|.+..-|..||..-.. ..+..++|.+..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 223467888877666655 5678899999999999999999999954322 234445555443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=200.06 Aligned_cols=196 Identities=22% Similarity=0.301 Sum_probs=158.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCC-eEEEEEEecccc---hHHHHHHHHHHHHHhC---CCCccceeeEEEccCCCccE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVK---KKKIKREIKILQNLCG---GPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~~~~~~ 198 (344)
+|++.++||+|+||.||+|.+..++ ..+|+|+..... ...+..|..++..+.. .+++..+++... ....+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999987774 678999875432 2268899999999942 368888888874 2346678
Q ss_pred EEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC----CcEEEEecccce-
Q 019241 199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAE- 268 (344)
Q Consensus 199 lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~----~~~kl~DFGla~- 268 (344)
+||+.+... |.++. +.++..++..++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||+++
T Consensus 98 iVM~l~G~s-L~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLLGPS-LEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEeccCcc-HHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 998877654 33333 5689999999999999999999999999999999999998652 469999999998
Q ss_pred -ecCCCC--------c-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 269 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 269 -~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.+.... . .....||..|.++.+..+ ...+.+.|+||++.++.|++.|..||....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 321111 1 123459999999998877 788999999999999999999999995433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=190.24 Aligned_cols=211 Identities=20% Similarity=0.354 Sum_probs=175.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.-.|++.++||+|+||.++.|.+.-+++.||||.-- +....++..|....+.|.+.++|..++-+- +++.+..||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence 456899999999999999999999999999999753 445578899999999998889999988766 56677889999
Q ss_pred eecCC--chhhHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC----CCCcEEEEecccceecCCCCc
Q 019241 203 YVNST--DFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 203 ~~~~~--~l~~~l-~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~----~~~~~kl~DFGla~~~~~~~~ 275 (344)
.+... +|.++. +.|+...+..++.|++.-++|+|++.+|.|||||+|+||.. +.+.+.++|||+|+.+.+...
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 88654 344443 67999999999999999999999999999999999999963 235689999999998865443
Q ss_pred --------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCCCHHHHHHHHHhh
Q 019241 276 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY--GHDNHDQLVKIAKVT 337 (344)
Q Consensus 276 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~--~~~~~~~l~~i~~~~ 337 (344)
.....||-.||+=...++ ..-+.+-|+-|+|-++++.+-|..||.. ..++.+...+|.+..
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred cccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 234579999999888887 7889999999999999999999999953 334566666665543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=184.92 Aligned_cols=168 Identities=13% Similarity=0.199 Sum_probs=130.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hH---H------HHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KK---K------IKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~---~------~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
+++|++++.||.|+||.||+..+ ++..+|+|++.+.. .. . +.+|++.+.++ .|+++..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 68999999999999999999744 46689999996432 11 1 57899999999 99999999998664
Q ss_pred cC------CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 192 QH------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 192 ~~------~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
.. ....+++|||++|.+|.++. .+++ ....+++.++..||+.|++|||+||+||+++.+ + ++|+|||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDfg 179 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDLS 179 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEECC
Confidence 32 23578999999999998763 2333 345699999999999999999999999999987 6 9999999
Q ss_pred cceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHH
Q 019241 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 313 (344)
Q Consensus 266 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 313 (344)
............. +.+. ..++.++|+||||+++...
T Consensus 180 ~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 180 GKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHH
Confidence 8865432211111 2223 5677899999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-23 Score=187.50 Aligned_cols=193 Identities=33% Similarity=0.594 Sum_probs=162.7
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCC-CccceeeEEEccCCCccEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~l 199 (344)
|++...||.|+||.||++.+. ..+++|.+... ....+.+|..+++.+ .|+ +++++++.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~--~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQD--EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEec--CCEEEE
Confidence 678899999999999999876 77889988532 246688999999999 666 89999999943 344689
Q ss_pred EEEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 200 v~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
+++++.++++..+.. .+.......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++.....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999999986663 68889999999999999999999999999999999999988336999999999865543
Q ss_pred C-------cceecccCCCccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 274 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 274 ~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
. ......++..|++||.+... ...+...|+||+|++++++++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 3 24567899999999998763 4788999999999999999999999754443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=175.74 Aligned_cols=182 Identities=17% Similarity=0.145 Sum_probs=139.8
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccch-------HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+...|++|+||+||.+. ..+.+++.+.++.... ..+.+|+++|++|.+++++++++++. ..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 45789999999999873 3778888777653222 25789999999996678999999862 247999
Q ss_pred EeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecC-CCCceEEeCCCCcEEEEecccceecCCCCc-----
Q 019241 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHPGKE----- 275 (344)
Q Consensus 202 e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDl-kp~NiLl~~~~~~~kl~DFGla~~~~~~~~----- 275 (344)
||+.|.+|...... ....+..|++.+|+++|+.||+|||| ||+|||++.+ +.++|+|||+|....+...
T Consensus 78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHHH
Confidence 99999998754322 12457789999999999999999999 7999999987 7899999999986554432
Q ss_pred ---------ceecccCCCccCcccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 276 ---------YNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 276 ---------~~~~~~t~~y~aPE~~~~~~~~~-~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
......++.|++|+...-....+ ...+.++.|+-+|.++||+.+++.+
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 11124577788887643322333 5678999999999999999988653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=224.11 Aligned_cols=142 Identities=12% Similarity=0.170 Sum_probs=108.6
Q ss_pred CC-CCccceeeEEEcc-----CCCccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCC
Q 019241 178 GG-PNVVKLLDIVRDQ-----HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 247 (344)
Q Consensus 178 ~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp 247 (344)
.| .||++++++|... +....+.++||+. ++|..++. .+++.++..++.||++||+|||++||+||||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 44 5888888877321 1235667788874 47887773 389999999999999999999999999999999
Q ss_pred CceEEeCC------------------CCcEEEEecccceecCCCC-----------------cceecccCCCccCccccc
Q 019241 248 HNVMIDHE------------------LRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLV 292 (344)
Q Consensus 248 ~NiLl~~~------------------~~~~kl~DFGla~~~~~~~-----------------~~~~~~~t~~y~aPE~~~ 292 (344)
+|||++.. .+.+|++|||+++...... ......+|++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 99999532 2456777777775421100 011235788999999988
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 293 ~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
+ ..++.++|||||||+||||++|..|+.
T Consensus 189 ~-~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 189 G-SSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred c-CCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 7 778999999999999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=176.47 Aligned_cols=133 Identities=18% Similarity=0.266 Sum_probs=104.9
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch------------HHH-----------------HHHHHHHHHHhCCC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KKI-----------------KREIKILQNLCGGP 180 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~~-----------------~~E~~~l~~l~~h~ 180 (344)
.+.||+|+||+||+|.+. +|+.||+|++++... ..| .+|++++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 367999999999999876 899999999964311 122 3499999999 777
Q ss_pred CccceeeEEEccCCCccEEEEEeecCCchhhH-c--CCCCHHHHHHHHHHHHHHHHHH-HHcCcEeecCCCCceEEeCCC
Q 019241 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEL 256 (344)
Q Consensus 181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-l--~~l~~~~~~~~~~~i~~~L~~L-H~~~iiHrDlkp~NiLl~~~~ 256 (344)
++.....+.. ...++||||++++++... + ..++...+..++.|++.+|.++ |+.||+||||||+|||++.
T Consensus 80 ~v~~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-- 153 (190)
T cd05147 80 GIPCPEPILL----KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-- 153 (190)
T ss_pred CCCCCcEEEe----cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--
Confidence 7644333221 123799999998876543 2 4588889999999999999999 7999999999999999984
Q ss_pred CcEEEEecccceec
Q 019241 257 RKLRLIDWGLAEFY 270 (344)
Q Consensus 257 ~~~kl~DFGla~~~ 270 (344)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 57999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=170.87 Aligned_cols=134 Identities=17% Similarity=0.205 Sum_probs=107.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----------------------------HHHHHHHHHHHHHhCCC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP 180 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~ 180 (344)
.+.||+|+||+||+|++. +|+.||||++++... ..+.+|.+.+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 467999999999999876 899999999864311 1235789999999 788
Q ss_pred CccceeeEEEccCCCccEEEEEeecCCchhhH-c--CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCC
Q 019241 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL 256 (344)
Q Consensus 181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-l--~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~ 256 (344)
++.....+... ..++||||++++++... + ..++..+...++.|++.++.+||+ .||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~- 153 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D- 153 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-
Confidence 87554444322 23799999998754322 2 346778889999999999999999 9999999999999999 5
Q ss_pred CcEEEEecccceecC
Q 019241 257 RKLRLIDWGLAEFYH 271 (344)
Q Consensus 257 ~~~kl~DFGla~~~~ 271 (344)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 689999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=165.31 Aligned_cols=113 Identities=23% Similarity=0.344 Sum_probs=92.3
Q ss_pred CchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccC
Q 019241 207 TDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282 (344)
Q Consensus 207 ~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t 282 (344)
|+|.+++ ..+++..++.++.|++.||.|||+.+ ||+|||++.+ +.+|+ ||+++...... ..+|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeecccc----CCCc
Confidence 3455554 24899999999999999999999998 9999999988 77888 99998765432 2678
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
+.|||||++.+ ..++.++|||||||++|||++|+.||.......+.+..+
T Consensus 68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 117 (176)
T smart00750 68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117 (176)
T ss_pred ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH
Confidence 99999999987 779999999999999999999999996544333333333
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=197.37 Aligned_cols=192 Identities=20% Similarity=0.403 Sum_probs=159.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhC---CCCccceeeEEEccCCCccE
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~~~~~~ 198 (344)
...+.|.+.+.||+|+||+||+|.... ++.||+|+-++.+..+|.--.+++.+| + -+.|..+.....-+ +.-+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~--~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERL-KPQMLPSIMHISSAHVFQ--NASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhh-chhhhcchHHHHHHHccC--Ccce
Confidence 346789999999999999999998766 999999999998888777666677777 3 13444444443223 4456
Q ss_pred EEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC------CCCcEEEEeccccee
Q 019241 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAEF 269 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~------~~~~~kl~DFGla~~ 269 (344)
||+||.+.|+|.+++. .+++..+..++.|+++-+++||..+|||+||||+|+||.. +...++|+|||-+-.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999999884 4889999999999999999999999999999999999942 224589999999854
Q ss_pred c---CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 019241 270 Y---HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318 (344)
Q Consensus 270 ~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~ 318 (344)
+ .++......++|..+-.+|+..+ ..|+..+|.|.++-+++-|++|+.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 4 44556778899999999999887 999999999999999999999964
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=162.32 Aligned_cols=135 Identities=20% Similarity=0.288 Sum_probs=104.2
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHh----CCCCccceeeEEEccCC-CccE-EE
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHS-KTPS-LI 200 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~-~~~~-lv 200 (344)
...||+|+||.||. +..+... +||+.... ..+.+.+|+.+++.+. .||||++++|++.+..+ ...+ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 37899999999996 5666666 68887643 4567899999999993 47999999999976532 2323 78
Q ss_pred EEe--ecCCchhhHcCC--CCHHHHHHHHHHHHHHH-HHHHHcCcEeecCCCCceEEeCC---CCcEEEEe-ccccee
Q 019241 201 FEY--VNSTDFKVLYPT--LTDYDIRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLID-WGLAEF 269 (344)
Q Consensus 201 ~e~--~~~~~l~~~l~~--l~~~~~~~~~~~i~~~L-~~LH~~~iiHrDlkp~NiLl~~~---~~~~kl~D-FGla~~ 269 (344)
+|| +.+++|.+++.. +++. ..++.|++.++ +|||+.+|+||||||+|||++.+ ...++|+| ||....
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence 999 457899998853 3433 45678888888 99999999999999999999743 23799999 554433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-22 Score=189.46 Aligned_cols=181 Identities=27% Similarity=0.399 Sum_probs=151.3
Q ss_pred ecccCCeeEEEEEE---cCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee
Q 019241 133 VGRGKYSEVFEGIN---VNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 133 lG~G~fg~V~~~~~---~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
+|+|.||.|++++. ...+..+|+|++++. .......|..++..+++|+.++++.-.++. ....++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 79999999998753 234566888887532 122566788899998779999999998844 45667999999
Q ss_pred cCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceeccc
Q 019241 205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281 (344)
Q Consensus 205 ~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~ 281 (344)
.++++...+. .+.+.....+..+++-+++++|+.+++|||+|++||+++.+ |.+++.|||+++..-..+.. ||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc---cc
Confidence 9999888774 36777888899999999999999999999999999999999 88999999999876544333 99
Q ss_pred CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 282 t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
|..|||||++. ..+.++|.||||++.+||++|..||..
T Consensus 156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99999999986 467899999999999999999999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=162.43 Aligned_cols=137 Identities=15% Similarity=0.211 Sum_probs=108.0
Q ss_pred CeEEEeeecccCCeeEEEEE-EcCCCeEEEEEEecccc---------------------------hHHHHHHHHHHHHHh
Q 019241 126 DYEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVK---------------------------KKKIKREIKILQNLC 177 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~-~~~~~~~vavK~~~~~~---------------------------~~~~~~E~~~l~~l~ 177 (344)
-|++.+.||+|+||.||+|. +..+|+.||+|+++... ...+.+|+.+++++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 47788999999999999998 66789999999986321 02256899999999
Q ss_pred CC--CCccceeeEEEccCCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcC-cEeecCCCCceE
Q 019241 178 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVM 251 (344)
Q Consensus 178 ~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~-iiHrDlkp~NiL 251 (344)
.+ ..+.+++++ . ..++||||+++.++.... ..+.......++.|++.++.+||+.| ++||||||+||+
T Consensus 108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 44 234444443 1 237999999998876543 23455567789999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecccceecC
Q 019241 252 IDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 252 l~~~~~~~kl~DFGla~~~~ 271 (344)
++ + +.++|+|||.+....
T Consensus 182 i~-~-~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-D-GKVVIIDVSQSVELD 199 (237)
T ss_pred EE-C-CCEEEEEChhhhccC
Confidence 99 4 689999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.6e-20 Score=158.18 Aligned_cols=132 Identities=25% Similarity=0.372 Sum_probs=109.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+.||+|++|.||+|.+ .+..+++|+..+.. ...+.+|+.++..+ .|+++.....++.+. ...++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence 5799999999999976 66788999764321 13577899999999 888887777666443 45679
Q ss_pred EEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 200 v~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
+|||+++++|...+..... ....++.+++.+|.+||+.+++|+|++|.|||++ + +.++|+|||.+...
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~~ 144 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEFS 144 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccCC
Confidence 9999999999988866555 7788999999999999999999999999999999 4 67899999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=191.41 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=151.8
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEec----ccc-hH----HHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVK-KK----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~----~~~-~~----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
...+.+|.|.+|.|+........+..+.|.+. +.. .. .+..|+-+-..+ .|+|++..+..+.+.... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~--~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGI--L 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccc--h
Confidence 45678999999988888776666655555442 111 11 144566666677 899998887776543322 2
Q ss_pred EEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
-.||||+. +|..++. .+...++..++.|++.|++|||+.|+.|||+|++|++++.+ +.+||+|||.+.......+
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcc
Confidence 44999999 8888773 48899999999999999999999999999999999999998 7999999999976653332
Q ss_pred -----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 019241 276 -----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328 (344)
Q Consensus 276 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~ 328 (344)
....+|+..|+|||++.+...-....||||.|+++..|++|+.||......++
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 34568899999999998844445689999999999999999999976544433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=164.92 Aligned_cols=192 Identities=22% Similarity=0.309 Sum_probs=121.9
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhC---------CCCccceeeEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCG---------GPNVVKLLDIVR 190 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~---------h~niv~l~~~~~ 190 (344)
.+...+.||.|+++.||.+++..+++.+|+|++.- ...+++++|......+.+ |-.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35567899999999999999999999999999731 223556666544433211 212222222222
Q ss_pred cc---------C-C--C---ccEEEEEeecCCchhhHcC------CC----CHHHHHHHHHHHHHHHHHHHHcCcEeecC
Q 019241 191 DQ---------H-S--K---TPSLIFEYVNSTDFKVLYP------TL----TDYDIRYYIYELLKALDYCHSQGIMHRDV 245 (344)
Q Consensus 191 ~~---------~-~--~---~~~lv~e~~~~~~l~~~l~------~l----~~~~~~~~~~~i~~~L~~LH~~~iiHrDl 245 (344)
.+ . . . +.+++|+-+. ++|..++. .. .......+..|+.+.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 0 1 3356666663 44544431 11 11222345589999999999999999999
Q ss_pred CCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCcccccCC-------CCCCchhhHHHHHHHHHHHHhCCC
Q 019241 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKE 318 (344)
Q Consensus 246 kp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DvwSlGv~l~ell~g~~ 318 (344)
+|+|++++.+ |.++|+||+.....+ ........+..|.+||..... -.++.+.|.|++|+++|.|++++.
T Consensus 172 ~~~nfll~~~-G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQD-GGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TT-S-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCC-CCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999 899999999876543 222224556779999976431 247889999999999999999999
Q ss_pred CCC
Q 019241 319 PFF 321 (344)
Q Consensus 319 Pf~ 321 (344)
||.
T Consensus 249 Pf~ 251 (288)
T PF14531_consen 249 PFG 251 (288)
T ss_dssp STC
T ss_pred CCC
Confidence 995
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=161.66 Aligned_cols=198 Identities=18% Similarity=0.274 Sum_probs=150.5
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.+..++.+|.+...|+.|+|++. |..+++|+++ ....+.|..|...|+-+ .||||..++|.| +.+.++.+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgac--nsppnlv~ 264 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGAC--NSPPNLVI 264 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhc--cCCCCceE
Confidence 44566778999999999999764 4456677775 23346789999999988 999999999999 44577889
Q ss_pred EEEeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 200 IFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 200 v~e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
+..||+-|+|...+.. .+..++.+++.++++|++|||+.. |.---|.+..+++|++ -+++|+ .+-+++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltaris-mad~kfsf- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARIS-MADTKFSF- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhhee-cccceeee-
Confidence 9999999999998854 567788999999999999999863 4445789999999998 455653 12222211
Q ss_pred CCcceecccCCCccCcccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
....+...+.||+||.++.... .-.++|+|||++++||+.|+..|| ...++.|.-.+|
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf-adlspmecgmki 401 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF-ADLSPMECGMKI 401 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc-ccCCchhhhhhh
Confidence 1223456788999999986322 235899999999999999999999 455555544444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-20 Score=182.27 Aligned_cols=174 Identities=28% Similarity=0.492 Sum_probs=128.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
..++|+.++.|-.|++|.||.++++.+.+.+|+|+-+. ..+.+- |+... +.|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~lilRn--ilt~a-~npfvv------------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NLILRN--ILTFA-GNPFVV------------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccccc---chhhhc--ccccc-CCccee-------------------
Confidence 35789999999999999999999999999999865321 111110 11111 233332
Q ss_pred eecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-----
Q 019241 203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 274 (344)
Q Consensus 203 ~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~----- 274 (344)
|+-...+ ..++.. ++.+++|||+.||+|||+||+|.+|+.- |.+|+.|||+++......
T Consensus 136 ----gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred ----chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhh
Confidence 3322232 233322 2788999999999999999999999987 899999999987542110
Q ss_pred -----------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 -----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.....+||+.|.|||++.. +.|+..+|+|++|+++||.+-|+.||+ |++.+|.+.+++..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd 273 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISD 273 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhh
Confidence 0123489999999999998 889999999999999999999999994 67677777666553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=149.93 Aligned_cols=133 Identities=20% Similarity=0.349 Sum_probs=105.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-------------------------hHHHHHHHHHHHHHhCCC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP 180 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~~h~ 180 (344)
.|.+.+.||+|+||.||++.. .+++.+|||++.... ......|..++..+ .+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence 367778999999999999976 479999999864321 11256788889988 666
Q ss_pred --CccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc
Q 019241 181 --NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 258 (344)
Q Consensus 181 --niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~ 258 (344)
.+...++. ...+++|||++++++...... .....++.+++.++.++|+.|++|+||||+||+++.+ +.
T Consensus 94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~ 163 (198)
T cd05144 94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK 163 (198)
T ss_pred CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence 44444442 234799999999988765431 4456788999999999999999999999999999987 78
Q ss_pred EEEEecccceec
Q 019241 259 LRLIDWGLAEFY 270 (344)
Q Consensus 259 ~kl~DFGla~~~ 270 (344)
++|+|||.+...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=147.28 Aligned_cols=129 Identities=21% Similarity=0.380 Sum_probs=100.7
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.||+|+||+||+|. .++..+++|...... .+++.+|++++..+ .|+++.....++.+. ...+++
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV 75 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence 38999999999997 356789999864211 24567899999999 676654444443323 445799
Q ss_pred EEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 201 ~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
|||++++++...+..... .++.+++.+|.+||+.|++|+|++|+||+++ + +.++++|||++....
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKYSD 140 (199)
T ss_pred EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcCCC
Confidence 999999999877643221 7899999999999999999999999999999 4 689999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=169.70 Aligned_cols=135 Identities=19% Similarity=0.349 Sum_probs=106.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEe--ccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~--~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..|...++||+|+||+||+|.+...+ +++|.. +.. ..+.+.+|+++++.+ +|++++....++.+.
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC-
Confidence 34456789999999999999764443 333332 110 124578899999999 899998877766543
Q ss_pred CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++||||+++++|..++. ....++.+++.+|.+||+.+++||||||+|||++ + +.++|+|||+++...
T Consensus 409 -~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~~~ 478 (535)
T PRK09605 409 -EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKYSD 478 (535)
T ss_pred -CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCcccccCC
Confidence 45679999999999988764 4577899999999999999999999999999995 3 578999999998653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.1e-19 Score=158.70 Aligned_cols=145 Identities=21% Similarity=0.336 Sum_probs=106.4
Q ss_pred hCCCCccceeeEEEcc-------------------------CCCccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHH
Q 019241 177 CGGPNVVKLLDIVRDQ-------------------------HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL 229 (344)
Q Consensus 177 ~~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~ 229 (344)
..|||||++.+.|.+. ++..+|+||.-.+.. |..++ +..+....+.++.|++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHhcCCCchHHHHHHHHHHH
Confidence 4799999999887642 234566777655543 34443 4577777888999999
Q ss_pred HHHHHHHHcCcEeecCCCCceEEeCC---CCcEEEEecccceecCC-------CCcceecccCCCccCcccccCCCC---
Q 019241 230 KALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQD--- 296 (344)
Q Consensus 230 ~~L~~LH~~~iiHrDlkp~NiLl~~~---~~~~kl~DFGla~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~--- 296 (344)
+|+.|||++||.|||+|++|||+.-+ .-.+.|+|||.+---.. ........|.-.-||||+......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998432 23578899998732221 112233456677999999754221
Q ss_pred -C-CchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 297 -Y-DYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 297 -~-~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. =.++|.|+.|-+.||+++...||+.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccc
Confidence 1 1489999999999999999999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=139.58 Aligned_cols=133 Identities=20% Similarity=0.324 Sum_probs=96.6
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch-----HHH----------------------HHHHHHHHHHhCC-CC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKI----------------------KREIKILQNLCGG-PN 181 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~E~~~l~~l~~h-~n 181 (344)
.+.||+|+||+||+|.+. +++.||||++++... ... ..|.+.+.++..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999865 789999999864221 111 3566666666222 23
Q ss_pred ccceeeEEEccCCCccEEEEEeecCCchhh-HcCCCCH-HHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCc
Q 019241 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYPTLTD-YDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRK 258 (344)
Q Consensus 182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~l~~l~~-~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~ 258 (344)
+.+.+++ ...++||||++++.+.. .+..... .+...++.+++.++.++|+ .+|+|+||||+||+++ + +.
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~ 152 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GK 152 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-Cc
Confidence 4445443 23479999999954321 1222222 6678899999999999999 9999999999999999 5 68
Q ss_pred EEEEecccceecC
Q 019241 259 LRLIDWGLAEFYH 271 (344)
Q Consensus 259 ~kl~DFGla~~~~ 271 (344)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-18 Score=173.66 Aligned_cols=190 Identities=21% Similarity=0.405 Sum_probs=137.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHH-HHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQ-NLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~-~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+|...+.||++.|=+|.+|++.. | .|+||++-+.. .+.|.++++-++ .+.++||++.+.-+- ...+..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~--~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL--VTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH--HhhHHHHHH
Confidence 67778999999999999996543 3 48999984332 234444333222 334899999987765 334666788
Q ss_pred EEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec----CCCC
Q 019241 201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY----HPGK 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~----~~~~ 274 (344)
-+|..+...+.+- +-+..-+.+.|+.|++.||..+|+.||+|+|||.+|||++.- +-+.|+||..-+.. ++..
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCcc
Confidence 8888765444332 236777788999999999999999999999999999999988 56799999876432 1222
Q ss_pred cceeccc----CCCccCcccccCCC----------CCCchhhHHHHHHHHHHHHh-CCCCC
Q 019241 275 EYNVRVA----SRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIF-RKEPF 320 (344)
Q Consensus 275 ~~~~~~~----t~~y~aPE~~~~~~----------~~~~~~DvwSlGv~l~ell~-g~~Pf 320 (344)
.+....- -.+|.|||.+.... ..+.+.||||+||+++||++ |++||
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 3333332 33599999986511 15678999999999999988 56666
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-16 Score=129.97 Aligned_cols=132 Identities=22% Similarity=0.328 Sum_probs=109.7
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHHhCC-CCccceeeEEEccCCCccEEEEEeecC
Q 019241 129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
+++.||+|.++.||++.... ..+++|...... ...+.+|..+++.+.++ .+++++++++... ...+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence 35789999999999997633 688999986543 36789999999999444 6899998887543 567899999999
Q ss_pred CchhhHcCCCCHHHHHHHHHHHHHHHHHHHHc---CcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 207 ~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~---~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..+..+ +......++.+++.++++||.. +++|+|++|+||+++.. +.++++|||.+..
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 877654 5667778899999999999984 79999999999999986 7899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-16 Score=140.04 Aligned_cols=132 Identities=17% Similarity=0.316 Sum_probs=101.0
Q ss_pred eeec-ccCCeeEEEEEEcCCCeEEEEEEecc----------------cchHHHHHHHHHHHHHhCCCCc--cceeeEEEc
Q 019241 131 RKVG-RGKYSEVFEGINVNTNERCIIKILKP----------------VKKKKIKREIKILQNLCGGPNV--VKLLDIVRD 191 (344)
Q Consensus 131 ~~lG-~G~fg~V~~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~ 191 (344)
..|| .||.|+||.+.. .+..+++|.+.. .....+.+|++++.++ .|+++ +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4687 899999999854 467889988742 1124577899999999 77764 677776543
Q ss_pred cCCC--ccEEEEEeecC-CchhhHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 192 QHSK--TPSLIFEYVNS-TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 192 ~~~~--~~~lv~e~~~~-~~l~~~l~~--l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
.... ..++|+|++++ .+|..++.. +++. .+.+++.++.+||+.||+||||||+|||++.+ +.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECCC
Confidence 2221 23599999997 688777643 3332 36789999999999999999999999999987 6899999999
Q ss_pred ceec
Q 019241 267 AEFY 270 (344)
Q Consensus 267 a~~~ 270 (344)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=149.53 Aligned_cols=115 Identities=19% Similarity=0.398 Sum_probs=102.2
Q ss_pred ccEEEEEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
++++.|++|...+|.+++. ..++.....++.|++.|++| ++.+|||+||.||....+ ..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 5789999999999999983 36677788899999999999 999999999999999888 6899999999876
Q ss_pred cCCCC-------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh
Q 019241 270 YHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 315 (344)
Q Consensus 270 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~ 315 (344)
..... ..+..+||..||+||.+.+ ..|+.++||||||++|+|++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH
Confidence 65444 4556789999999999998 889999999999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.9e-15 Score=141.39 Aligned_cols=158 Identities=23% Similarity=0.373 Sum_probs=123.5
Q ss_pred HHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCc-EeecCCCC
Q 019241 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGI-MHRDVKPH 248 (344)
Q Consensus 174 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~i-iHrDlkp~ 248 (344)
+.+ .|.|+.+++|.+.++ ...+.|.+||+-|+|.+.+. ++++.-...++++++.||.|||...| .|+.+++.
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 455 899999999999765 77789999999999999884 36777777889999999999998765 99999999
Q ss_pred ceEEeCCCCcEEEEecccceecCCC---CcceecccCCCccCcccccCCC---C---CCchhhHHHHHHHHHHHHhCCCC
Q 019241 249 NVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ---D---YDYSLDMWSLGCMFAGMIFRKEP 319 (344)
Q Consensus 249 NiLl~~~~~~~kl~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~---~---~~~~~DvwSlGv~l~ell~g~~P 319 (344)
|.++|.. ..+||+|||+....... .......-...|.|||.+.... . .+.+.|+||||++++|++++..|
T Consensus 79 nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999998 89999999998766421 1111112334599999987621 1 46789999999999999999999
Q ss_pred CCCCCCC---HHHHHHHHH
Q 019241 320 FFYGHDN---HDQLVKIAK 335 (344)
Q Consensus 320 f~~~~~~---~~~l~~i~~ 335 (344)
|...... +|....+.+
T Consensus 158 ~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred cccccccCChHHHHHHHHh
Confidence 9764433 344444444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-16 Score=156.31 Aligned_cols=198 Identities=24% Similarity=0.413 Sum_probs=157.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
...|.+.+.||+|+|+.|-...... ....+|+|.+... ..+....|..+-+.+.+|.|++++++...+ ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Cccc
Confidence 3456667779999999998886533 3345666666422 123445578777777559999999998854 4666
Q ss_pred EEEEEeecCCchhhHc-C----CCCHHHHHHHHHHHHHHHHHHH-HcCcEeecCCCCceEEeCCCC-cEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-~----~l~~~~~~~~~~~i~~~L~~LH-~~~iiHrDlkp~NiLl~~~~~-~~kl~DFGla~~~ 270 (344)
++..+|..++++.... . ..+......+..|+..++.|+| ..++.|||+||+|.+++.. + ..++.|||+|..+
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAY 175 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccc
Confidence 7999999998887766 2 3667788899999999999999 9999999999999999988 5 8899999999877
Q ss_pred CC-CC---cceeccc-CCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 271 HP-GK---EYNVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 271 ~~-~~---~~~~~~~-t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
.. .+ .....+| +..|+|||...+........|+||.|+++..+++|..|+....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 65 22 2334578 9999999998875566789999999999999999999996543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-14 Score=137.07 Aligned_cols=139 Identities=17% Similarity=0.284 Sum_probs=95.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHH-------------------------------------------
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------------------------------------- 167 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------------- 167 (344)
+.||.|++|+||+|+. .+|+.||||+.++...+.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999975 57899999998765433333
Q ss_pred HHHHHHHHHh---CCCCccceeeEEEccCCCccEEEEEeecCCchhhHcCC-CCHHHHHHHHHHHHH-HHHHHHHcCcEe
Q 019241 168 REIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLK-ALDYCHSQGIMH 242 (344)
Q Consensus 168 ~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-l~~~~~~~~~~~i~~-~L~~LH~~~iiH 242 (344)
+|...+.++. ++.+-+.+-..+.+. ....++||||++|.++.+.... ....+...++.+++. .+..+|..|++|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H 280 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFH 280 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCcee
Confidence 3444444431 122222322233221 2345799999999988765421 000123456666665 478899999999
Q ss_pred ecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 243 rDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
+|++|.||+++.+ +.++++|||++..+.+
T Consensus 281 ~D~hPgNilv~~~-g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 281 ADLHPGNIFVLKD-GKIIALDFGIVGRLSE 309 (437)
T ss_pred CCCCcccEEECCC-CcEEEEeCCCeeECCH
Confidence 9999999999888 7899999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.4e-14 Score=116.09 Aligned_cols=127 Identities=20% Similarity=0.276 Sum_probs=96.7
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
++.|+.|.++.||+++. .+..+++|+..+.. ...+.+|..+++.+.+...+.+++.... ...++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCC
Confidence 46789999999999965 47789999986543 3457889999999844433455666542 2246999999998
Q ss_pred chhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----EeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 208 ~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~i-----iHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
++... .........+++++|+.||+.++ +|+|++|.||+++ + +.++++|||.+..
T Consensus 77 ~l~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGM 136 (170)
T ss_pred ccccc-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccC
Confidence 87643 11123467899999999999875 9999999999999 4 5789999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-12 Score=109.24 Aligned_cols=132 Identities=18% Similarity=0.303 Sum_probs=97.8
Q ss_pred eeecccCCeeEEEEEEcC------CCeEEEEEEeccc-------------c------------hHHHH----HHHHHHHH
Q 019241 131 RKVGRGKYSEVFEGINVN------TNERCIIKILKPV-------------K------------KKKIK----REIKILQN 175 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~------~~~~vavK~~~~~-------------~------------~~~~~----~E~~~l~~ 175 (344)
..||.|.-+.||.|.... .+..+|||+.+.. . .+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997543 3578999997410 0 11222 79999999
Q ss_pred HhCC-CCccceeeEEEccCCCccEEEEEeecCCchhh-HcC--CCCHHHHHHHHHHHHHHHHHH-HHcCcEeecCCCCce
Q 019241 176 LCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYP--TLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNV 250 (344)
Q Consensus 176 l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~l~--~l~~~~~~~~~~~i~~~L~~L-H~~~iiHrDlkp~Ni 250 (344)
+... -++...+++ ...++||||+.+..+.. .+. .++..+...+..+++.+|..| |+.|++|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8443 577777765 23469999998753321 122 244556677889999999999 899999999999999
Q ss_pred EEeCCCCcEEEEecccceec
Q 019241 251 MIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 251 Ll~~~~~~~kl~DFGla~~~ 270 (344)
|+++ +.+.|+|||.+-..
T Consensus 157 L~~~--~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWHD--GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEC--CcEEEEECCCceeC
Confidence 9985 46899999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-12 Score=127.78 Aligned_cols=141 Identities=12% Similarity=0.240 Sum_probs=90.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHH----------------------------------------
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------------------------------------- 165 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 165 (344)
.|+. +.||+|++|+||+|+...+|+.||||+.++...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3444 68999999999999988779999999997543221
Q ss_pred ---HHHHHHHHHHHh---CCCCccceeeEEEccCCCccEEEEEeecCCchhhHc--C--CCCHHHHHHHHHHHH-HHHHH
Q 019241 166 ---IKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--TLTDYDIRYYIYELL-KALDY 234 (344)
Q Consensus 166 ---~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l--~--~l~~~~~~~~~~~i~-~~L~~ 234 (344)
+.+|...+.++. .+.+.+.+-..+.+- ....+|||||+.|+.+.+.. . ..+. ..++...+ .-+..
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHHHHHH
Confidence 233444444431 122223322333221 23457999999999886532 1 1111 12222221 12334
Q ss_pred HHHcCcEeecCCCCceEEeCCCC----cEEEEecccceecCC
Q 019241 235 CHSQGIMHRDVKPHNVMIDHELR----KLRLIDWGLAEFYHP 272 (344)
Q Consensus 235 LH~~~iiHrDlkp~NiLl~~~~~----~~kl~DFGla~~~~~ 272 (344)
+...|++|+|+||.||+++.+ + .++++|||++..+++
T Consensus 276 if~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence 456899999999999999987 5 899999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.3e-13 Score=126.63 Aligned_cols=195 Identities=22% Similarity=0.276 Sum_probs=154.7
Q ss_pred CCCeEEEeeecc--cCCeeEEEEEE--cCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGR--GKYSEVFEGIN--VNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~--G~fg~V~~~~~--~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
...+.+...+|. |.+|.||.+.. ..++..+|+|.-+ +.....-.+|+...+++..|+|.++.+..+. ..
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GS 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--cC
Confidence 455677889999 99999999987 7788899998743 1233445578888888878999999888774 45
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHH----HHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~----~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
...++-.|++... +..+. ..+++..++....+... ||.++|+.+++|-|+||.||+...+-...+++|||+
T Consensus 191 ~~lfiqtE~~~~s-l~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCGES-LQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeeccccch-hHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 6777888888844 43333 23778888888888888 999999999999999999999988845789999999
Q ss_pred ceecCCCCcce-----ec-ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 267 AEFYHPGKEYN-----VR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 267 a~~~~~~~~~~-----~~-~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...+.++.-.. .+ .+...|++||... .-++...|++|+|.++.+..++..++..+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 98887654221 11 5666799999875 46889999999999999999988877555
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-11 Score=119.52 Aligned_cols=165 Identities=20% Similarity=0.342 Sum_probs=125.4
Q ss_pred EEEEcCCCeEEEEEEecccch---HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHH
Q 019241 143 EGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219 (344)
Q Consensus 143 ~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~ 219 (344)
.|..+.++.+|.|...+.... ....+-++.|+.+ +||||+++++.+.. ....|+|.|-+.. |..++..+...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~lk~l~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEE--EGTLYLVTERVRP--LETVLKELGKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcc--cCceEEEeecccc--HHHHHHHhHHH
Confidence 455677888888888865444 5567888899999 99999999999854 4678899997754 44455667788
Q ss_pred HHHHHHHHHHHHHHHHH-HcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-ceecccCCCccCcccccCCCCC
Q 019241 220 DIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 297 (344)
Q Consensus 220 ~~~~~~~~i~~~L~~LH-~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~ 297 (344)
.+...+.||+.||.||| +++++|++|.-+.|+++.. |.+||++|.++........ ......-..|..|+.+.. .
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s-- 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S-- 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c--
Confidence 88899999999999998 6789999999999999998 8999999998854332211 111111223566765433 2
Q ss_pred CchhhHHHHHHHHHHHHhC
Q 019241 298 DYSLDMWSLGCMFAGMIFR 316 (344)
Q Consensus 298 ~~~~DvwSlGv~l~ell~g 316 (344)
+-..|.|-|||++||++.|
T Consensus 181 ~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhhHHHHHHHHhCc
Confidence 2467999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.9e-11 Score=102.55 Aligned_cols=138 Identities=25% Similarity=0.412 Sum_probs=104.4
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhC-CCCccceeeEEEccC-CCccEEEEEee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQH-SKTPSLIFEYV 204 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~-~~~~~lv~e~~ 204 (344)
+.||.|.++.||+++.. +|+.+++|+.... ....+.+|.++++.+.. +.++.+++.+..... ....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 66899999999999753 3578999997643 24678999999999943 245677887764321 12558999999
Q ss_pred cCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 019241 205 NSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS--------------------------------------------- 237 (344)
Q Consensus 205 ~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~--------------------------------------------- 237 (344)
++.++.... ..++..+...++.++++.|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 998887755 356777777788888888888873
Q ss_pred -----------cCcEeecCCCCceEEeCC-CCcEEEEeccccee
Q 019241 238 -----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEF 269 (344)
Q Consensus 238 -----------~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~ 269 (344)
..++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236999999999999983 25679999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.4e-10 Score=94.61 Aligned_cols=128 Identities=20% Similarity=0.345 Sum_probs=93.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-----------chHHHHHHHHHHHHHhC-CCCccceeeEEEccCCCccE
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~ 198 (344)
..+++|+-+.+|.+.+ -+..+++|.--+. ......+|..++.++.. .-+...++++. + ....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCE
Confidence 3578999999999854 3444777753211 12446789999998732 23555555544 4 3345
Q ss_pred EEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 199 LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
++|||.+|..+.+.+..-. ..++..+-.-+.-||..||+|+||.++||++..+ .+.++|||++..-
T Consensus 76 I~me~I~G~~lkd~l~~~~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEAR----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhcc----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 9999999999987765442 4466667777788999999999999999999976 4899999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.5e-12 Score=119.40 Aligned_cols=191 Identities=19% Similarity=0.124 Sum_probs=145.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc-CCCeEEEEEEecccch-----HHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..+|..+..||.|.|+.|+.+... .++..+++|-+..... ..-..|+-+...+..|.+++.....+.. ....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccc
Confidence 457889999999999999998655 6778888887753222 1124577777777789999998776633 3455
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++--||+++++..... ..+.+...++...|++.++.++|++.++|+|+||+||++..+....++.|||.+..+. -
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--F 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--e
Confidence 5888999998776554 3477888899999999999999999999999999999998854567999999986421 1
Q ss_pred cceecccCCCcc-CcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 019241 275 EYNVRVASRYFK-GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318 (344)
Q Consensus 275 ~~~~~~~t~~y~-aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~ 318 (344)
.......+.+++ ..|++.....+..++|++|||..+.|.+++..
T Consensus 420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 222233444455 46777666778899999999999999888754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4e-10 Score=92.95 Aligned_cols=137 Identities=19% Similarity=0.282 Sum_probs=96.7
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.+..|-+|+-+.|+++ ...|+.++||---+ -...+.++|..+|.++. --.|.--.=++.+. ..-
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~--~~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDT--YGG 85 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEec--CCC
Confidence 4578899999999999 45788888875311 12356778999999873 22332222234333 334
Q ss_pred EEEEEeecC-CchhhHc----C-CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcE--EEEeccccee
Q 019241 198 SLIFEYVNS-TDFKVLY----P-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEF 269 (344)
Q Consensus 198 ~lv~e~~~~-~~l~~~l----~-~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~--kl~DFGla~~ 269 (344)
+++|||+++ .++..++ . ...+.....++.++-+.+.-||..+++|+||..+||++.++.+.+ .++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 599999988 3455554 2 233333467888899999999999999999999999997764544 8999999865
Q ss_pred c
Q 019241 270 Y 270 (344)
Q Consensus 270 ~ 270 (344)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-11 Score=121.04 Aligned_cols=207 Identities=21% Similarity=0.290 Sum_probs=145.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..+.+.+.+-+-+|.++.++.+.-..++...+.|+... ...+....+-.++-.. .+|-++...-.+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence 35678888889999999999987767775556555431 1122222232222222 345555444332 22345
Q ss_pred cEEEEEeecCCchhhHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC--
Q 019241 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~~---l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-- 271 (344)
.+|+++|.+++++...+.. .+.+..+-++..+..+++|||+..+.|||++|.|.|...+ +..++.|||..+...
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccccccc
Confidence 5799999999998887743 5566677788889999999999999999999999999988 788999998432210
Q ss_pred -------------------CC-----------CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 272 -------------------PG-----------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 272 -------------------~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
.. .......+|+.|.+||..++ ..-...+|+|++|++++|.++|..||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~- 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF- 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC-
Confidence 00 00122367889999999988 66778899999999999999999998
Q ss_pred CCCCCHHHHHHHHH
Q 019241 322 YGHDNHDQLVKIAK 335 (344)
Q Consensus 322 ~~~~~~~~l~~i~~ 335 (344)
+..........|.+
T Consensus 1036 na~tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN 1049 (1205)
T ss_pred CCcchhhhhhcccc
Confidence 45555555555544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.6e-09 Score=90.57 Aligned_cols=123 Identities=24% Similarity=0.381 Sum_probs=80.7
Q ss_pred eEEEEEEcCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHHHHhCC-CCccceeeEE
Q 019241 140 EVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNVVKLLDIV 189 (344)
Q Consensus 140 ~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h-~niv~l~~~~ 189 (344)
.||.|. ..++..+|+|+.+... ....++|.++|.++... -++.+.+++-
T Consensus 1 ~Vy~~~-~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAI-DPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEE-ECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEE-CCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 388885 4667799999974110 12356799999999333 2677777653
Q ss_pred EccCCCccEEEEEeec--CCchhhHcC-CCCHHHHHHHHHHHHHHHHH-HHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 190 RDQHSKTPSLIFEYVN--STDFKVLYP-TLTDYDIRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 190 ~~~~~~~~~lv~e~~~--~~~l~~~l~-~l~~~~~~~~~~~i~~~L~~-LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
..++||||++ +..+..+.. .++..+...+..+++..+.. +|+.|++|+|+.+.|||++++ .+.|+|||
T Consensus 80 ------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred ------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 2359999999 655544332 12245567778888886665 579999999999999999986 68999999
Q ss_pred cceecC
Q 019241 266 LAEFYH 271 (344)
Q Consensus 266 la~~~~ 271 (344)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.4e-09 Score=95.85 Aligned_cols=188 Identities=16% Similarity=0.204 Sum_probs=128.4
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEE-----EccCCCccEEEEEee
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIV-----RDQHSKTPSLIFEYV 204 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~-----~~~~~~~~~lv~e~~ 204 (344)
.+.||+|+-+.+|-.-. -...+-|++...-...-.+-+..|.+...||-+-.-+.+= ....+..+.++|..+
T Consensus 16 gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 16 GRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 46799999999996522 1223457775333322233344455554565443311111 011122355677766
Q ss_pred cCCc-hhhH---------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 205 NSTD-FKVL---------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 205 ~~~~-l~~~---------l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++.. ...+ .+.+.|.-..+.++.++.+.+.||..|.+-+|++++|+|++++ +.+.|.|=..-....++.
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~ 171 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANGT 171 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccceeeccCCc
Confidence 5531 1222 2447888899999999999999999999999999999999988 788998855544445566
Q ss_pred cceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhC-CCCCC
Q 019241 275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFR-KEPFF 321 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g-~~Pf~ 321 (344)
.+...+|...|.+||.-.- .-.-+...|-|.|||++++++.| ++||.
T Consensus 172 ~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 172 LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 6777899999999997431 12345689999999999999987 99985
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.9e-08 Score=90.25 Aligned_cols=127 Identities=18% Similarity=0.161 Sum_probs=90.0
Q ss_pred EEEEEEcCCCeEEEEEEecccch--------------HHHHHHHHHHHHHhC-CCCccceeeEEEccC---CCccEEEEE
Q 019241 141 VFEGINVNTNERCIIKILKPVKK--------------KKIKREIKILQNLCG-GPNVVKLLDIVRDQH---SKTPSLIFE 202 (344)
Q Consensus 141 V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~---~~~~~lv~e 202 (344)
|.++. -+|+.+.||....... ..+.+|...+.++.. .-..+..+++..... ....++|+|
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 55553 3566788886643221 147789999988822 223444555553321 234679999
Q ss_pred eecCC-chhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC------CCCcEEEEeccccee
Q 019241 203 YVNST-DFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAEF 269 (344)
Q Consensus 203 ~~~~~-~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~------~~~~~kl~DFGla~~ 269 (344)
++++. ++.+++. ..+......++.+++..+.-||+.||+|+|+++.|||++. +...+.++||+.++.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99986 7877753 2445567789999999999999999999999999999985 235789999998864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.5e-08 Score=94.14 Aligned_cols=163 Identities=17% Similarity=0.264 Sum_probs=126.0
Q ss_pred CCeeEEEEEEcCCCeEEEEEEe---cccchHHHHHHHHHHHHHhCCCCccceeeEEEc--cCCCccEEEEEeecCC-chh
Q 019241 137 KYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLIFEYVNST-DFK 210 (344)
Q Consensus 137 ~fg~V~~~~~~~~~~~vavK~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e~~~~~-~l~ 210 (344)
.-.+.|++....+|..+++|++ +.........-+++++++ .|.|+|++.++|.. -+...+++||+|.++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4467899999999999999999 333333445668889999 99999999998752 1335788999998763 444
Q ss_pred hHc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 211 VLY------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 211 ~~l------------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
++. ...++..+|.|+.|+..||.++|+.|+.-+-|.+.+||++.+ .+++|+..|......+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeecC
Confidence 432 136788899999999999999999999999999999999987 4789988887776654
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~ 318 (344)
+.. |-+.+ -.+-|.=.||.+++.|.+|+.
T Consensus 446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-------------cchhH----HhhhhHHHHHHHHHHHhhccc
Confidence 431 11111 135688899999999999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.7e-09 Score=96.49 Aligned_cols=162 Identities=21% Similarity=0.249 Sum_probs=116.2
Q ss_pred HHHHHHHhCCCCccceeeEEEccCC---CccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHc-
Q 019241 170 IKILQNLCGGPNVVKLLDIVRDQHS---KTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ- 238 (344)
Q Consensus 170 ~~~l~~l~~h~niv~l~~~~~~~~~---~~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~- 238 (344)
...|..+ .|.|+++++.|+.+... ....++.|||+.|++..+++ .+....+.+++.||+.||.|||+.
T Consensus 118 Fdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3445556 79999999999865422 34567889999999999984 377888899999999999999986
Q ss_pred -CcEeecCCCCceEEeCCCCcEEEEecccceecCC------CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHH
Q 019241 239 -GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP------GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311 (344)
Q Consensus 239 -~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ 311 (344)
-|+|+++..+.|++..+ +-+|+.- +--....+ ........+-++|.+||.=.. ...+.++|||+||....
T Consensus 197 PpiihgnlTc~tifiq~n-gLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHN-GLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCAL 273 (458)
T ss_pred CccccCCcchhheeecCC-ceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHH
Confidence 49999999999999977 6666642 11111111 112223456778999997433 45677999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 312 GMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 312 ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
||--+..--.++.+..+.-..|++
T Consensus 274 emailEiq~tnseS~~~~ee~ia~ 297 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIAN 297 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhh
Confidence 998887655555554444444444
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.9e-08 Score=88.28 Aligned_cols=132 Identities=22% Similarity=0.375 Sum_probs=97.3
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------------------------chHHHHHHHHHHHHHhCC-C
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------------------------KKKKIKREIKILQNLCGG-P 180 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~E~~~l~~l~~h-~ 180 (344)
..+..+||-|.-|.||.|.+ ..+.++|||.=+-. .....++|.++|++|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35568999999999999964 47889999974210 112356899999999433 3
Q ss_pred CccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
.+.+.+++ +...+||||.++..|...- ++..+...++..|+.-+.-+-..|+||+|+++-||++++| +.+.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~ 242 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV 242 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence 67777765 3346999999997765442 2345555566666666666668999999999999999998 7889
Q ss_pred EEecccce
Q 019241 261 LIDWGLAE 268 (344)
Q Consensus 261 l~DFGla~ 268 (344)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99996553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-07 Score=82.32 Aligned_cols=108 Identities=25% Similarity=0.346 Sum_probs=83.2
Q ss_pred hHHHHHHHHHHHHHhC-CCCccceeeEEEccCC--CccEEEEEeecCC-chhhHcCC---CCHHHHHHHHHHHHHHHHHH
Q 019241 163 KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS--KTPSLIFEYVNST-DFKVLYPT---LTDYDIRYYIYELLKALDYC 235 (344)
Q Consensus 163 ~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~--~~~~lv~e~~~~~-~l~~~l~~---l~~~~~~~~~~~i~~~L~~L 235 (344)
.....+|...+..+.. .-.....+++...... ...++|+|++++. +|..++.. .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4567889988887732 2345666666644222 3347999999884 78887754 66777788999999999999
Q ss_pred HHcCcEeecCCCCceEEeCCC--CcEEEEecccceec
Q 019241 236 HSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFY 270 (344)
Q Consensus 236 H~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGla~~~ 270 (344)
|+.||+|+|+++.|||++.+. ..+.++||+.++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999872 26899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.4e-07 Score=79.29 Aligned_cols=132 Identities=17% Similarity=0.151 Sum_probs=94.5
Q ss_pred cccCCeeEEEEEEcCCCeEEEEEEec---------ccchHHHHHHHHHHHHHhCC-CCccceeeEEE---ccCCCccEEE
Q 019241 134 GRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCGG-PNVVKLLDIVR---DQHSKTPSLI 200 (344)
Q Consensus 134 G~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~---~~~~~~~~lv 200 (344)
|+||-|-|++... .|..+=+|.-. +.....|.+|+..++++... -.+.+.. ++. ......-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6788888888642 23356667643 44457899999999998322 2244444 332 2223345789
Q ss_pred EEeecC-CchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc--EEEEeccccee
Q 019241 201 FEYVNS-TDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF 269 (344)
Q Consensus 201 ~e~~~~-~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~--~kl~DFGla~~ 269 (344)
+|-+++ .+|.+++. +.+......++.+++..++-||+.|+.|+|+.+.|||++.+ +. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 997764 57777653 34666677899999999999999999999999999999855 45 89999987754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.1e-06 Score=76.84 Aligned_cols=138 Identities=21% Similarity=0.408 Sum_probs=83.8
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCC-CCccceeeEEEccC-CCccEEEEEeecC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVRDQH-SKTPSLIFEYVNS 206 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~-~~~~~lv~e~~~~ 206 (344)
++.|+.|..+.||+..... ..+++|..... ....+.+|..+++.+.++ ..+.+++....... ....+++|+++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4779999999999996544 58899998765 557788999999998544 23667777553332 2346899999999
Q ss_pred CchhhH----------------cC-------C---CCHHH---H---HHH---------------HHHHHH-HHHHHHH-
Q 019241 207 TDFKVL----------------YP-------T---LTDYD---I---RYY---------------IYELLK-ALDYCHS- 237 (344)
Q Consensus 207 ~~l~~~----------------l~-------~---l~~~~---~---~~~---------------~~~i~~-~L~~LH~- 237 (344)
..+... +. . ..... . ... ...+.. .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 877660 00 0 01000 0 000 011222 2333332
Q ss_pred ------cCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 238 ------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 238 ------~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++|+|+.+.|||++.+.+.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 35999999999999993325667999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.5e-07 Score=89.90 Aligned_cols=135 Identities=17% Similarity=0.365 Sum_probs=87.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHH-------------------------------------------
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------------------------------------- 167 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------------- 167 (344)
+-|+.++-|+||+|+. .+|+.||||+..|.-.+.+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5689999999999975 55999999998764433332
Q ss_pred HHHHHHHHHh----CCCCccceeeEEEccCCCccEEEEEeecCCchhhHc--C--CCCHHHHHHHHHHHHHH-HHHHHHc
Q 019241 168 REIKILQNLC----GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--TLTDYDIRYYIYELLKA-LDYCHSQ 238 (344)
Q Consensus 168 ~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l--~--~l~~~~~~~~~~~i~~~-L~~LH~~ 238 (344)
+|...+.++. +.++ +.+=..+.+ ......|+|||++|..+.+.. + .++ ...++..++++ +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhc
Confidence 3444444331 1121 111122211 124457999999998776653 2 233 33344333332 3444458
Q ss_pred CcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 239 ~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
|+.|.|.+|.||+++.+ +.+-+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 99999999999999999 8899999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.1e-06 Score=77.18 Aligned_cols=131 Identities=19% Similarity=0.242 Sum_probs=82.0
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHHhCC-CCccceeeEEEccCCCccEEEEEeecCCc
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTD 208 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~ 208 (344)
..||+|..+.||+. .+..+++|...+.. .....+|.++++.+... -.+.+.+++..+. ....+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--CeeeeeeeecCCcc
Confidence 56899999999984 24467789886533 45678999999998433 2357778877443 44568999999963
Q ss_pred -hhhHc---------------------CC-----CCHHHH-HHHHHH----------HHH-HHHHHHH----cCcEeecC
Q 019241 209 -FKVLY---------------------PT-----LTDYDI-RYYIYE----------LLK-ALDYCHS----QGIMHRDV 245 (344)
Q Consensus 209 -l~~~l---------------------~~-----l~~~~~-~~~~~~----------i~~-~L~~LH~----~~iiHrDl 245 (344)
+.... .. ...... ..+..+ +.. ..++|.+ ..++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11111 00 010000 001000 111 1222221 24789999
Q ss_pred CCCceEEeCCCCcEEEEeccccee
Q 019241 246 KPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 246 kp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.|.||+++++ + +.++||+.+..
T Consensus 161 ~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCC-C-cEEEechhcCc
Confidence 9999999987 5 89999998854
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.6e-06 Score=75.45 Aligned_cols=133 Identities=16% Similarity=0.237 Sum_probs=93.7
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch----------------------HH-----HHHHHHHHHHHh-CCCC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----------------------KK-----IKREIKILQNLC-GGPN 181 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----------------------~~-----~~~E~~~l~~l~-~h~n 181 (344)
...|.+|.-+.||+|. ..++..+|+|+++.... .+ ..+|+..|+++. .+-.
T Consensus 53 ~g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3467788889999995 46788999999852110 11 235777787773 2355
Q ss_pred ccceeeEEEccCCCccEEEEEeecCCc-hhhHcCC--CCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCC
Q 019241 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR 257 (344)
Q Consensus 182 iv~l~~~~~~~~~~~~~lv~e~~~~~~-l~~~l~~--l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~ 257 (344)
+.+-+++. ...|||||+.... -.-.+.. +...+...+..++++.+.-|-. .++||+||..=|||+.+ +
T Consensus 132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~--~ 203 (268)
T COG1718 132 VPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD--G 203 (268)
T ss_pred CCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC--C
Confidence 66666654 2359999997652 1112222 2333577788889999988876 89999999999999994 5
Q ss_pred cEEEEecccceecC
Q 019241 258 KLRLIDWGLAEFYH 271 (344)
Q Consensus 258 ~~kl~DFGla~~~~ 271 (344)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 78999999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-06 Score=77.36 Aligned_cols=133 Identities=19% Similarity=0.143 Sum_probs=84.3
Q ss_pred ecccCC-eeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhh
Q 019241 133 VGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211 (344)
Q Consensus 133 lG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~ 211 (344)
|-.|.+ ..||+... .+..+.+|+..........+|+++++.+.++--+.+++++.... ...++|||+++|..+..
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence 444444 88999853 34678889886544556788999999996665667788877543 45679999999876653
Q ss_pred HcC-------------------CCCH-------H--HHHHHHH--------------------HHHHHHHHHH-------
Q 019241 212 LYP-------------------TLTD-------Y--DIRYYIY--------------------ELLKALDYCH------- 236 (344)
Q Consensus 212 ~l~-------------------~l~~-------~--~~~~~~~--------------------~i~~~L~~LH------- 236 (344)
... .++. . ....... .....+..|-
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 310 1110 0 0000000 0111112221
Q ss_pred HcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 237 ~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++|+|+.|.|||++.+ +.+.|+||+.+...
T Consensus 162 ~~~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~~g 194 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPG-KFSGFIDLGRLGVA 194 (244)
T ss_pred ceEEECCCCCCccEEEeCC-cEEEEEEccccccc
Confidence 2348999999999999986 66789999988643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.3e-06 Score=73.59 Aligned_cols=137 Identities=15% Similarity=0.271 Sum_probs=89.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchH------------HHHHHHHHHHHHh--CCCCccceeeEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK------------KIKREIKILQNLC--GGPNVVKLLDIV 189 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~E~~~l~~l~--~h~niv~l~~~~ 189 (344)
..+|.+.+.+-......|.+- .-++..+++|..++.... ...+++..+.++. +--....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 577888888888777777776 345678899988643321 1223444444441 222233323222
Q ss_pred Ecc---CCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 190 RDQ---HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 190 ~~~---~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
... -....+++|||++|..+.+.. .+++ .+...+.+++.-||+.|+.|+|.+|.|++++.+ .++++||+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~ 180 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG 180 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence 211 113346899999998876542 2332 244667788999999999999999999999976 589999987
Q ss_pred cee
Q 019241 267 AEF 269 (344)
Q Consensus 267 a~~ 269 (344)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.9e-08 Score=97.11 Aligned_cols=182 Identities=16% Similarity=0.167 Sum_probs=136.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCC-ccceeeEEEccCCCccEEEEEee
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
-+...+-+++|+.+.++|.+...+...+ .+.+... ....-++++|.++ +||| .+..++-+ +.+.+.++.++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhhh
Confidence 3455677899999999999876666555 6666433 4455688899999 9999 55555544 5557788999999
Q ss_pred cCC-chhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceec
Q 019241 205 NST-DFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279 (344)
Q Consensus 205 ~~~-~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 279 (344)
..+ +..... -.+...+...+.+.-.+++++||+..-+|+| ||+..++ ..+..||+....+......+..
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccccccC
Confidence 887 221111 1245555566777788999999998888999 8888765 6799999999877766666777
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf 320 (344)
.+++.|+|||+..+ ..++...|.|++|+--.++--|-+|-
T Consensus 391 ~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCC
Confidence 89999999999877 77899999999998666666665543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.7e-06 Score=85.06 Aligned_cols=79 Identities=23% Similarity=0.314 Sum_probs=57.0
Q ss_pred EeeecccCCeeEEEEEEcCCC--eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCc--cceeeEEEccC-CCccEEE
Q 019241 130 VRKVGRGKYSEVFEGINVNTN--ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV--VKLLDIVRDQH-SKTPSLI 200 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~--~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~-~~~~~lv 200 (344)
+..++.|.++.+|+.....++ ..+++|+..+. ....+.+|.++++.+..|.++ .+++.+|.+.. ....++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 578899999999998654432 46777775321 235688999999999546654 88888886532 2457899
Q ss_pred EEeecCCc
Q 019241 201 FEYVNSTD 208 (344)
Q Consensus 201 ~e~~~~~~ 208 (344)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.6e-08 Score=94.69 Aligned_cols=96 Identities=16% Similarity=0.317 Sum_probs=75.0
Q ss_pred HHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceec----------ccCCCccCcccccCC
Q 019241 226 YELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----------VASRYFKGPELLVDL 294 (344)
Q Consensus 226 ~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~----------~~t~~y~aPE~~~~~ 294 (344)
.+++.||.|+|. .++||+.|.|++|.++.. +.+||+.|+.+....++..+... .....|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence 345599999995 589999999999999988 89999999998665543322211 22345999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 295 ~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.-.+.++|++|+||++|.+..|+.+...+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhc
Confidence 77889999999999999988555555443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-05 Score=67.92 Aligned_cols=125 Identities=22% Similarity=0.285 Sum_probs=90.4
Q ss_pred CCeEEEeeecccCC-eeEEEEEEcCCCeEEEEEEecc------------------------cchHHHHHHHHHHHHHhC-
Q 019241 125 DDYEVVRKVGRGKY-SEVFEGINVNTNERCIIKILKP------------------------VKKKKIKREIKILQNLCG- 178 (344)
Q Consensus 125 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~~vavK~~~~------------------------~~~~~~~~E~~~l~~l~~- 178 (344)
.+++.++.||.|.- |.||+++ -+|+.+|+|+++. ....-|..|.....+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78899999999999 9999995 4677999999420 011246789998888832
Q ss_pred -CCCc--cceeeEEEccC----------------CCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 019241 179 -GPNV--VKLLDIVRDQH----------------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 239 (344)
Q Consensus 179 -h~ni--v~l~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~ 239 (344)
+.++ ++.+||..-.. .....+|.||..... .+. ..-+.+|.+-|..+|..|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~----~~~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQ----IRDIPQMLRDLKILHKLG 184 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccc----hhHHHHHHHHHHHHHHCC
Confidence 3345 89999884221 112357888776554 222 234567788889999999
Q ss_pred cEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 240 IMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 240 iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
|+-+|+++.|.. + -||+|||.+
T Consensus 185 I~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 185 IVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred eeeccCcccccc---C---CEEEecccC
Confidence 999999999985 2 289999964
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.7e-06 Score=67.95 Aligned_cols=129 Identities=21% Similarity=0.327 Sum_probs=89.5
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeec
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 205 (344)
.+..+.||+|.+|.||+|.+ .+..+|+|+-+. .....++.|.++|..+..-.--.+++.|-.+ ++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhc
Confidence 34567899999999999965 455889998764 4557899999999999443344456655422 25699999
Q ss_pred CCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCC--CceEEeCCCCcEEEEeccccee
Q 019241 206 STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP--HNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 206 ~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp--~NiLl~~~~~~~kl~DFGla~~ 269 (344)
|-.|...-...+...+ ..++..---|-..||-|..|.- .||++.+ +.+.|+||..|+.
T Consensus 96 G~~L~~~~~~~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~--~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGGDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVND--RDVYIIDFDSATF 155 (201)
T ss_pred CcchhhhhhcccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecC--CcEEEEEccchhh
Confidence 9888766544433333 3344443345567888888863 4666665 3689999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=70.95 Aligned_cols=74 Identities=12% Similarity=0.176 Sum_probs=47.6
Q ss_pred eeecccCCe-eEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCC--CCccceeeEEEccCC-CccEEEEEeec
Q 019241 131 RKVGRGKYS-EVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHS-KTPSLIFEYVN 205 (344)
Q Consensus 131 ~~lG~G~fg-~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~-~~~~lv~e~~~ 205 (344)
+.|+.|+.. .||+. +..+++|+.... ....+.+|.++++.+.++ --+..+++.....+. ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 567777776 58976 134677886543 345788999999998433 134555554432221 24578999998
Q ss_pred CCch
Q 019241 206 STDF 209 (344)
Q Consensus 206 ~~~l 209 (344)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 8665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=78.13 Aligned_cols=133 Identities=21% Similarity=0.266 Sum_probs=85.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHH----------------------------------------HHHHH
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----------------------------------------IKREI 170 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~E~ 170 (344)
+-||..+.|+||+|+.+ +|+.||||+-++.-.+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57999999999999754 59999999975432211 33444
Q ss_pred HHHHHHh---CCCC------ccceeeEEEccCCCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHH-HHH
Q 019241 171 KILQNLC---GGPN------VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALD-YCH 236 (344)
Q Consensus 171 ~~l~~l~---~h~n------iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~-~LH 236 (344)
+...++. .|-+ |.+++-.+ .....|+||||+|..+.+.. ..++..++. ..+.++.. -+=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~---~~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDIL---NKLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHH---HHHHHHHHHHHH
Confidence 4443331 2334 44444433 23457999999997655442 335555433 33333222 223
Q ss_pred HcCcEeecCCCCceEEeC---CCCcEEEEecccceecC
Q 019241 237 SQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 237 ~~~iiHrDlkp~NiLl~~---~~~~~kl~DFGla~~~~ 271 (344)
..|++|+|=.|.||+++. ....+.+.|||+...+.
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 578999999999999994 23678999999987664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.9e-05 Score=65.52 Aligned_cols=74 Identities=15% Similarity=0.290 Sum_probs=50.5
Q ss_pred EeeecccCCeeEEEEEEcC-CCeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecC
Q 019241 130 VRKVGRGKYSEVFEGINVN-TNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
++.|..|-...+|++.... +++.+++|+...... -...+|..+++.+..+.-.+++++.+. . .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEeeCC
Confidence 4667888889999985432 356788998764322 223579999999855555666666542 1 289999988
Q ss_pred Cch
Q 019241 207 TDF 209 (344)
Q Consensus 207 ~~l 209 (344)
..+
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.00012 Score=62.58 Aligned_cols=127 Identities=20% Similarity=0.375 Sum_probs=88.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc-------------------hHHHHHHHHHHHHHh-----CCCCcccee
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNVVKLL 186 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~niv~l~ 186 (344)
..||+|+.=.||.- . .+....||+..+.. .++..+|+.-...+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56999999999974 3 34455789987666 577888888888773 268999999
Q ss_pred eEEEccCCCccEEEEEeecCC------chhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--
Q 019241 187 DIVRDQHSKTPSLIFEYVNST------DFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL-- 256 (344)
Q Consensus 187 ~~~~~~~~~~~~lv~e~~~~~------~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~-- 256 (344)
|+.+. +....+|+|.+.+. +|.+++. .++. . +...+-+-.+||-+.+|+.+|++|+||++....
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99954 45667999987442 4555552 2333 2 233333445677889999999999999996541
Q ss_pred C-cEEEEe-ccc
Q 019241 257 R-KLRLID-WGL 266 (344)
Q Consensus 257 ~-~~kl~D-FGl 266 (344)
. .+.|+| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 2 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.1e-05 Score=65.87 Aligned_cols=97 Identities=23% Similarity=0.196 Sum_probs=78.7
Q ss_pred HHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhh------HcCCCCHHHHHHHHHHHHHHHHHHHH---
Q 019241 167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV------LYPTLTDYDIRYYIYELLKALDYCHS--- 237 (344)
Q Consensus 167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~------~l~~l~~~~~~~~~~~i~~~L~~LH~--- 237 (344)
..|.-+++.+.+.+++++++|+|.+ +++.||...+++.. ....-+|..+.+++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3588889999555799999999922 47999999775531 12357899999999999999999986
Q ss_pred cCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 238 ~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..+.-.|++++|+-++++ +.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 348889999999999988 78999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.8e-05 Score=67.00 Aligned_cols=130 Identities=22% Similarity=0.246 Sum_probs=78.9
Q ss_pred ecccCCeeEEEEEEcCCCeEEEEEEecccch---HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCch
Q 019241 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209 (344)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l 209 (344)
+..|-.+.+|+.. .+++.+++|+...... -...+|..+++.+..+.-..+++..+ . .++||||++|..+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence 4567778999885 4566788888653322 14578999999995443345566554 2 2599999988654
Q ss_pred hhH-------c----------CC-------CCHH-HHHHHHHHH---------HHHHHHHHH--------cCcEeecCCC
Q 019241 210 KVL-------Y----------PT-------LTDY-DIRYYIYEL---------LKALDYCHS--------QGIMHRDVKP 247 (344)
Q Consensus 210 ~~~-------l----------~~-------l~~~-~~~~~~~~i---------~~~L~~LH~--------~~iiHrDlkp 247 (344)
... . .. ++.. .+..+..++ ...++.+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 0 01 1111 111211111 111222221 2489999999
Q ss_pred CceEEeCCCCcEEEEecccceecCC
Q 019241 248 HNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 248 ~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.||+++.+ + +.++||+.|....+
T Consensus 156 ~Nil~~~~-~-~~lIDwE~a~~gdp 178 (256)
T TIGR02721 156 YNLVVTPQ-G-LKLIDWEYASDGDI 178 (256)
T ss_pred CcEEEeCC-C-CEEEeccccCcCCH
Confidence 99999987 4 68999999865443
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0001 Score=67.22 Aligned_cols=137 Identities=14% Similarity=0.180 Sum_probs=85.1
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCC-CccceeeEEEc----cCCCccEEEEEee
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEYV 204 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~~ 204 (344)
++.|..|....+|+... ++..+++|+...........|+.++..+..+. .+.+.+..... ...+..+.|++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 56788888889999853 34468889987655667888999999884332 35555442110 1123457999999
Q ss_pred cCCchhhH-----------c-------CCC----------CHHHHH----------HHHHHHHHHHHHHHH-------cC
Q 019241 205 NSTDFKVL-----------Y-------PTL----------TDYDIR----------YYIYELLKALDYCHS-------QG 239 (344)
Q Consensus 205 ~~~~l~~~-----------l-------~~l----------~~~~~~----------~~~~~i~~~L~~LH~-------~~ 239 (344)
+|..+... + ..+ .+.... .....+...+.++.+ .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 88654320 0 011 100000 011112334444443 36
Q ss_pred cEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 240 iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 9999999999999987 5668999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0002 Score=65.52 Aligned_cols=74 Identities=18% Similarity=0.240 Sum_probs=50.5
Q ss_pred EeeecccCCeeEEEEEEcC------CCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 130 VRKVGRGKYSEVFEGINVN------TNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
++.|..|-...+|+..... .++.+++|+..... .....+|..+++.+..+.-..++++++.+ .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchh
Confidence 3556667777899886432 25789999986532 24567899999998655545667776631 2689
Q ss_pred EeecCCch
Q 019241 202 EYVNSTDF 209 (344)
Q Consensus 202 e~~~~~~l 209 (344)
||++|..+
T Consensus 77 e~i~G~~l 84 (302)
T cd05156 77 EFIPSRTL 84 (302)
T ss_pred heeCCCcC
Confidence 99888654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00032 Score=66.41 Aligned_cols=74 Identities=18% Similarity=0.239 Sum_probs=53.6
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec----------ccchHHHHHHHHHHHHHhCC--CCccceeeEEEccCCCcc
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILK----------PVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~----------~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~ 197 (344)
.+.||.|.+..||++.+..+++.++||.-. +...++...|.+.|+.+..+ .++++++.+- . ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence 467999999999999876544689999743 12345677888888887433 4677788774 2 335
Q ss_pred EEEEEeecCC
Q 019241 198 SLIFEYVNST 207 (344)
Q Consensus 198 ~lv~e~~~~~ 207 (344)
++||||+++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 6999999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00048 Score=63.30 Aligned_cols=139 Identities=18% Similarity=0.245 Sum_probs=83.4
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCC-CCccceeeEEE----ccCCCccEEEE
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVR----DQHSKTPSLIF 201 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~----~~~~~~~~lv~ 201 (344)
..+..++.|....+|+... .++ .+++|+.... .......|.+++..|.++ -.+.+.+.... ....+..++++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3356678888889999853 333 5778987543 345667788888888332 22455554221 01124568999
Q ss_pred EeecCCchhh-----------Hc-------CCCC--------HHHHH---------------HHHHHHHHHHHHHHH---
Q 019241 202 EYVNSTDFKV-----------LY-------PTLT--------DYDIR---------------YYIYELLKALDYCHS--- 237 (344)
Q Consensus 202 e~~~~~~l~~-----------~l-------~~l~--------~~~~~---------------~~~~~i~~~L~~LH~--- 237 (344)
+|++|..+.. .+ ..++ ..... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998854321 00 1110 00000 001122334555542
Q ss_pred ----cCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 238 ----QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 238 ----~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.+++|+|+.+.||+++.+ +...|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 579999999999999987 5668999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00053 Score=63.27 Aligned_cols=137 Identities=13% Similarity=0.221 Sum_probs=78.3
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCC-CCccceeeEE----EccCCCccEEEEEee
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIV----RDQHSKTPSLIFEYV 204 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~----~~~~~~~~~lv~e~~ 204 (344)
++.|+.|...++|+... .++ .+++|++.....+....|..+++.|..+ -.+.+.+... ........+++++|+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 45677788889999853 333 6888988633445666777888877322 1244444311 001124468999999
Q ss_pred cCCchhh-----------Hc-------CCC----------CH-HHHHH------------HHHH-HHHHHHHHH------
Q 019241 205 NSTDFKV-----------LY-------PTL----------TD-YDIRY------------YIYE-LLKALDYCH------ 236 (344)
Q Consensus 205 ~~~~l~~-----------~l-------~~l----------~~-~~~~~------------~~~~-i~~~L~~LH------ 236 (344)
+|..+.. .+ ..+ .+ ..... .+.+ +...++.+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 8864311 01 111 01 11100 0111 111222332
Q ss_pred -HcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 237 -SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 237 -~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++||+|+.+.|||++.+ ...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 2379999999999999966 4557999999853
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0014 Score=59.87 Aligned_cols=106 Identities=9% Similarity=0.109 Sum_probs=73.5
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCC--CCccceeeEEEccC-CCccEEEEEe
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQH-SKTPSLIFEY 203 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~-~~~~~lv~e~ 203 (344)
.-.+.||.|..+.||+... .++ .+.+|..+.. ....+.+|...|+.+.++ -.+.++++++.+.. ....++|||+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3357899999999999843 233 4677886552 456899999999999554 47899999886432 2457899999
Q ss_pred ecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 019241 204 VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237 (344)
Q Consensus 204 ~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~ 237 (344)
+++.++.+. .........+..+++++|.-||+
T Consensus 95 i~G~~~~~~--~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 95 LRGVSVEAP--ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred cCCEecCCC--CCCHHHHHHHHHHHHHHHHHHhC
Confidence 999876542 22333344555666666666664
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0043 Score=58.02 Aligned_cols=136 Identities=18% Similarity=0.271 Sum_probs=83.0
Q ss_pred EeeecccCCeeEEEEEEcC----CCeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 130 VRKVGRGKYSEVFEGINVN----TNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
+..|-.|-...+|++.... +++.+++|+..+... -.-.+|..+++.+..+.--.++++.+ .++ .|.+|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~ef 114 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG----RVEEF 114 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----eEEEe
Confidence 3456557888899986432 246788998864322 12367999999996655566777776 222 68999
Q ss_pred ecCCchhhH-------c----------CC--------C-CHHHHHHHHHH-----------------HHHHHHHHH----
Q 019241 204 VNSTDFKVL-------Y----------PT--------L-TDYDIRYYIYE-----------------LLKALDYCH---- 236 (344)
Q Consensus 204 ~~~~~l~~~-------l----------~~--------l-~~~~~~~~~~~-----------------i~~~L~~LH---- 236 (344)
+++.++... . .. . .+..+..+..+ +...++.|.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 977654321 0 00 0 11222222211 111222222
Q ss_pred ----HcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 237 ----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 237 ----~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++|+|+++.|||++++.+.+.++||..|....
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 22589999999999998754679999999986543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0027 Score=58.96 Aligned_cols=139 Identities=17% Similarity=0.234 Sum_probs=81.2
Q ss_pred CeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++ +.|..|=...+|+...... +..+++|+...... -.-.+|..+++.+..+.--.++++++ .+ . +|
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~--G--~i 88 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GN--G--MI 88 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CC--c--Ee
Confidence 3443 4454477788998854332 23788998864332 12357999999995554456777776 22 1 68
Q ss_pred EEeecCCchhhH-------c----------CC--------C-CHHHHHHHHHHH----------------------HHHH
Q 019241 201 FEYVNSTDFKVL-------Y----------PT--------L-TDYDIRYYIYEL----------------------LKAL 232 (344)
Q Consensus 201 ~e~~~~~~l~~~-------l----------~~--------l-~~~~~~~~~~~i----------------------~~~L 232 (344)
.+|+++..+... + .. . .+..+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 899877654210 0 00 1 112222222111 1112
Q ss_pred HHHH----Hc----CcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 233 DYCH----SQ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 233 ~~LH----~~----~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..+. .. -++|.|+.+.|||++++.+.++++||+.|....
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 2221 11 279999999999998654679999999986543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.30 E-value=4e-05 Score=81.20 Aligned_cols=150 Identities=11% Similarity=-0.027 Sum_probs=108.7
Q ss_pred HHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHc--
Q 019241 168 REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ-- 238 (344)
Q Consensus 168 ~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~-- 238 (344)
.|.+.++.. .|+++.....-.....+...+..++|+..|.+...+- .+.+.-+.....+...+..-+|+.
T Consensus 1278 ~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344455556 7888888777665555566678899999999888761 233333444444445666666643
Q ss_pred ---CcEeecCCCCceEEeCCCCcEEEEecccceecCCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHH
Q 019241 239 ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314 (344)
Q Consensus 239 ---~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell 314 (344)
-.+|+++|+.|.++..+ -.+|+.++|+.+...+. .......+++.|+.|+.... ..++.++|+|+.|+-+|+..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHh
Confidence 27899999999999988 57899999999944333 33445678888999998655 67888899999999999988
Q ss_pred hCCCCC
Q 019241 315 FRKEPF 320 (344)
Q Consensus 315 ~g~~Pf 320 (344)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 777666
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0089 Score=54.85 Aligned_cols=143 Identities=19% Similarity=0.325 Sum_probs=82.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec-----ccchHHHHHHHHHHHHHhC-CCCccceeeEEEccCCCccEEEEEe
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
++.+-.|-...+|...+ +++.+++. .. ........+|..+++.+.. ---+...++.|.+..-...+.||+|
T Consensus 30 v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 30 VEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 34443333334444433 26677777 21 1223556789999998743 2344556777755433467899999
Q ss_pred ecCCchhhHcCCC-----------------------------------CHHHHHHHHHHH--------------HHHHHH
Q 019241 204 VNSTDFKVLYPTL-----------------------------------TDYDIRYYIYEL--------------LKALDY 234 (344)
Q Consensus 204 ~~~~~l~~~l~~l-----------------------------------~~~~~~~~~~~i--------------~~~L~~ 234 (344)
++|.......... ...++..+..+. ..-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9884322221110 111111111111 122445
Q ss_pred HHHc--------CcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 235 CHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 235 LH~~--------~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|+.. .++|+|+.+.|++++.+ +.+=+.||+++...++....
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP~~Dl 235 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDPLEDL 235 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCcHHHH
Confidence 5432 47999999999999988 55889999999876655443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0017 Score=56.20 Aligned_cols=113 Identities=18% Similarity=0.274 Sum_probs=60.4
Q ss_pred CeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhH--c------------
Q 019241 150 NERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--Y------------ 213 (344)
Q Consensus 150 ~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~--l------------ 213 (344)
++.|++++.... ..-.-..|..+++.+..+..-.++++.+.+ . .|.+|+++..+..- .
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g--~v~e~i~g~~l~~~~~~~~~~~~~iA~~l 75 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----G--RVEEFIEGRTLSPEDFRNPEILKRIAKLL 75 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----E--EEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----C--cEEEEecccccChhhccChHHHHHHHHHH
Confidence 457888888655 334556799999999766777788887732 2 78899976554221 0
Q ss_pred C---C--C--------CHHHHHHH----------------------HHHHHHHHHHHHH--------cCcEeecCCCCce
Q 019241 214 P---T--L--------TDYDIRYY----------------------IYELLKALDYCHS--------QGIMHRDVKPHNV 250 (344)
Q Consensus 214 ~---~--l--------~~~~~~~~----------------------~~~i~~~L~~LH~--------~~iiHrDlkp~Ni 250 (344)
. . . -+..+..+ ...+..-+..+.+ ..++|.|+.+.||
T Consensus 76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni 155 (211)
T PF01633_consen 76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI 155 (211)
T ss_dssp HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence 0 0 0 01111111 1112222222221 2489999999999
Q ss_pred EE-eCCCCcEEEEeccccee
Q 019241 251 MI-DHELRKLRLIDWGLAEF 269 (344)
Q Consensus 251 Ll-~~~~~~~kl~DFGla~~ 269 (344)
|+ +.+ +.++++||..|..
T Consensus 156 l~~~~~-~~~~lIDfEya~~ 174 (211)
T PF01633_consen 156 LINNKD-GEVKLIDFEYAGY 174 (211)
T ss_dssp EETSSS-SCEEE--GTT-EE
T ss_pred EeccCC-CeEEEecHHHHhh
Confidence 99 444 7899999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0013 Score=68.62 Aligned_cols=152 Identities=14% Similarity=0.190 Sum_probs=108.1
Q ss_pred HHHHHHHHHHHhCCCCccceeeEEEccCCCc--cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 019241 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKT--PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGI 240 (344)
Q Consensus 166 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~--~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~i 240 (344)
...|.+.+.++ .|+|++.++.|-....... ..+..+++...++...+ ...+....+.+..++..||+|+|+...
T Consensus 229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34567777787 9999999998875432222 12334667666665555 457888889999999999999999876
Q ss_pred EeecCCCC---ceEEeCCCCcEEEE--ecccceecCCCCcceecccCCCccCcccccCCCCCC--chhhHHHHHHHHHHH
Q 019241 241 MHRDVKPH---NVMIDHELRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD--YSLDMWSLGCMFAGM 313 (344)
Q Consensus 241 iHrDlkp~---NiLl~~~~~~~kl~--DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~~DvwSlGv~l~el 313 (344)
.|.-+..+ +...+.+ +.+.++ ||+..+.............+..|.++|.... ...+ ...|+|.+|.....+
T Consensus 308 ~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence 66655555 3344444 455666 9998887776666666677777888887654 3343 347999999999999
Q ss_pred HhCCCCC
Q 019241 314 IFRKEPF 320 (344)
Q Consensus 314 l~g~~Pf 320 (344)
..|..+-
T Consensus 386 ~~~~~i~ 392 (1351)
T KOG1035|consen 386 SQGEDIS 392 (1351)
T ss_pred hhcCccc
Confidence 8886544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0067 Score=54.84 Aligned_cols=33 Identities=33% Similarity=0.616 Sum_probs=26.7
Q ss_pred CcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 239 ~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.++|+|+++.|||++.+....-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 489999999999999752345699999987644
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.01 Score=53.87 Aligned_cols=77 Identities=14% Similarity=0.190 Sum_probs=50.4
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHh--CCCCccceeeEEEccCCCccEEEEEee
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
.+-.+.++.|....+|+.. .+++.+.||+-.......|..|.+-|+.|. ..-.+.+++++.... ...+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEee
Confidence 4446789999999999984 677788999887666678999999999982 345677888887543 3458999999
Q ss_pred cCC
Q 019241 205 NST 207 (344)
Q Consensus 205 ~~~ 207 (344)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.013 Score=54.33 Aligned_cols=134 Identities=25% Similarity=0.306 Sum_probs=82.7
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCC--C---ccceeeEEEccCCC--ccEEEEEe
Q 019241 132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--N---VVKLLDIVRDQHSK--TPSLIFEY 203 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--n---iv~l~~~~~~~~~~--~~~lv~e~ 203 (344)
.|.+ .-..+|+... .+++ +++|+..+. ...++..|...++.|.++. - +..+=|-....-.. ..+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEe-cCCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 5567888853 3333 399999875 6678888999999985431 1 23333322222223 66789999
Q ss_pred ecCCchhh-Hc------------------CC-----------CCHH----HH---------HHHHHHHHHHHHHHHH---
Q 019241 204 VNSTDFKV-LY------------------PT-----------LTDY----DI---------RYYIYELLKALDYCHS--- 237 (344)
Q Consensus 204 ~~~~~l~~-~l------------------~~-----------l~~~----~~---------~~~~~~i~~~L~~LH~--- 237 (344)
++|..+.. .. +. ..|. .. .....++...++.+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99887762 11 11 1121 00 1123344445555543
Q ss_pred -----cC--cEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 238 -----QG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 238 -----~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
.+ +||+|+.|.||+++.+...+.+.|||.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 99999999999999883347899999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0013 Score=59.87 Aligned_cols=131 Identities=19% Similarity=0.308 Sum_probs=90.5
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEec-------cc--c----------------hHHHHHHHHHHHHHhCCC
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PV--K----------------KKKIKREIKILQNLCGGP 180 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-------~~--~----------------~~~~~~E~~~l~~l~~h~ 180 (344)
-+.+.+.||-|.-+-||.+.+ ..|++.++|+-+ .. + .-...+|...|+.|..|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467789999999999999964 456777888631 00 0 011346888888885543
Q ss_pred -CccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcE
Q 019241 181 -NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL 259 (344)
Q Consensus 181 -niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~ 259 (344)
-+.+.+++. ..|+|||++.+-.+.....-.+...+.. .+..-+--|-..|+||+|.+-=||+++++ +.+
T Consensus 172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~ly~---~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i 241 (465)
T KOG2268|consen 172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPTLYD---DLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKI 241 (465)
T ss_pred CCCCCccccc------ceeeHHHhhcccceeeeeecCChHHHHH---HHHHHHHHHHHcCceecccchheeEEecC-CCE
Confidence 344555543 3478999999887766544344444333 33333445668999999999999999987 778
Q ss_pred EEEecccc
Q 019241 260 RLIDWGLA 267 (344)
Q Consensus 260 kl~DFGla 267 (344)
+++||--.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.014 Score=54.10 Aligned_cols=134 Identities=19% Similarity=0.291 Sum_probs=91.7
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------------------------chHH-----HHHHHHHHHHHhC
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------------------------KKKK-----IKREIKILQNLCG 178 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------------------------~~~~-----~~~E~~~l~~l~~ 178 (344)
++-..|..|.-+.||-+. ..+|..+|||+++.. +... ...|+..|+++ .
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N 224 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence 344678899999999995 567777999998521 0111 24688888888 4
Q ss_pred CCCccceeeEEEccCCCccEEEEEeecCCchhh-Hc--CCCCHHHHHHHHHHHHHHHHHH-HHcCcEeecCCCCceEEeC
Q 019241 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LY--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 179 h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~l--~~l~~~~~~~~~~~i~~~L~~L-H~~~iiHrDlkp~NiLl~~ 254 (344)
.-.|..---... +...|||+|+....... .+ -.++...+..+-.|++.-|.-| +.++.||.||.=-|+|+.+
T Consensus 225 ~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 225 NAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD 300 (520)
T ss_pred hcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC
Confidence 333332222221 34469999998543322 12 2466667777777888888777 4689999999999999986
Q ss_pred CCCcEEEEeccccee
Q 019241 255 ELRKLRLIDWGLAEF 269 (344)
Q Consensus 255 ~~~~~kl~DFGla~~ 269 (344)
|.+.|+|-+-+..
T Consensus 301 --G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 --GKLYIIDVSQSVE 313 (520)
T ss_pred --CEEEEEEcccccc
Confidence 5789999886643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.013 Score=55.49 Aligned_cols=74 Identities=18% Similarity=0.196 Sum_probs=47.1
Q ss_pred eeecccCCeeEEEEEEcCCC-e-----EEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 131 RKVGRGKYSEVFEGINVNTN-E-----RCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~-~-----~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
+.|..|-...+|++...... . .|.+++...... -.-.+|+++++.+..+..-.++++.+.. ++++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------EEEEE
Confidence 45655888899998643321 1 244444322111 1235799999999666677778887721 39999
Q ss_pred eecCCchh
Q 019241 203 YVNSTDFK 210 (344)
Q Consensus 203 ~~~~~~l~ 210 (344)
|++|..+.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0057 Score=57.37 Aligned_cols=125 Identities=20% Similarity=0.199 Sum_probs=78.0
Q ss_pred eeecccCCeeEEEEEE---------------cCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCcccee---------
Q 019241 131 RKVGRGKYSEVFEGIN---------------VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL--------- 186 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~--------- 186 (344)
.-||.|+-.+||+|.. ..+.+.+|+|+..+...+++...+.||.....-.|++.=.
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v 274 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV 274 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence 4689999999999862 2234679999998877777766666665432222222111
Q ss_pred ------------------------eEEE----c-------cCCCccEEEEEeecCCchhhHcCC--CCHHHHHHHHHHHH
Q 019241 187 ------------------------DIVR----D-------QHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229 (344)
Q Consensus 187 ------------------------~~~~----~-------~~~~~~~lv~e~~~~~~l~~~l~~--l~~~~~~~~~~~i~ 229 (344)
.-|. . +......++-+|+.|..+..++.. .++.-+..++.-..
T Consensus 275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~ 354 (565)
T KOG1236|consen 275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV 354 (565)
T ss_pred HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence 1111 0 001122455567888888777754 44445556666556
Q ss_pred HHHHHHH-HcCcEeecCCCCceEEeCC
Q 019241 230 KALDYCH-SQGIMHRDVKPHNVMIDHE 255 (344)
Q Consensus 230 ~~L~~LH-~~~iiHrDlkp~NiLl~~~ 255 (344)
+++--|- -.+++|.|+.|.||++-.+
T Consensus 355 ~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 355 NALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred HHHHHHHHhhcceecccCCCcEEEEec
Confidence 6655443 4689999999999999543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.031 Score=52.13 Aligned_cols=71 Identities=18% Similarity=0.273 Sum_probs=46.3
Q ss_pred eecccCCeeEEEEEEcCCCeEEEEEEec----------ccchHHHHHHHHHHHHHhCC-C-CccceeeEEEccCCCccEE
Q 019241 132 KVGRGKYSEVFEGINVNTNERCIIKILK----------PVKKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~----------~~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~l 199 (344)
.||-|....||++.+..+++.++||--. +...++...|.+.|+...+. | .+++++.+- . ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~--e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T--EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c--cccee
Confidence 4799999999999875444678898642 12234556788888766332 3 455566553 2 33458
Q ss_pred EEEeecC
Q 019241 200 IFEYVNS 206 (344)
Q Consensus 200 v~e~~~~ 206 (344)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.024 Score=52.10 Aligned_cols=30 Identities=20% Similarity=0.338 Sum_probs=26.8
Q ss_pred CcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 239 ~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
+++|+|+.++|+|++.+ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 69999999999999887 6789999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.15 Score=48.49 Aligned_cols=71 Identities=18% Similarity=0.296 Sum_probs=49.6
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecc----------cchHHHHHHHHHHHHHhC--CCCccceeeEEEccCCCcc
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCG--GPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~~~~ 197 (344)
.+.||.|....||+..+ .+..++||.-.+ ....+-..|.+.|+.+.+ ..++.+++.++.+ ..
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence 57899999999999875 345688887531 133444566777776632 2578889998843 24
Q ss_pred EEEEEeecC
Q 019241 198 SLIFEYVNS 206 (344)
Q Consensus 198 ~lv~e~~~~ 206 (344)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 689999976
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.13 Score=49.73 Aligned_cols=75 Identities=15% Similarity=0.176 Sum_probs=49.6
Q ss_pred EEeeecccCCeeEEEEEEcCC--------CeEEEEEEecccchH--HHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 129 VVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~--------~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
-++.|..|=.-.+|++..... ++.|++++....... .-.+|..+++.+..+.--.++++.+ . + +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~--g--g 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF--S--G--G 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe--C--C--C
Confidence 456777787888999864321 467889988543322 2356888888885554445677766 2 2 2
Q ss_pred EEEEeecCCch
Q 019241 199 LIFEYVNSTDF 209 (344)
Q Consensus 199 lv~e~~~~~~l 209 (344)
.|.||+++..+
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 68999987633
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.21 Score=53.55 Aligned_cols=136 Identities=18% Similarity=0.290 Sum_probs=76.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccc-hHHHHHHHHHHHHHhCC-CC--ccceee--------EEEc-cCCCcc
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PN--VVKLLD--------IVRD-QHSKTP 197 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~n--iv~l~~--------~~~~-~~~~~~ 197 (344)
+.|+ |..-.+|+.. ..++..+++|+.++.. ......|...|..|..+ +. +.+.+- .+.+ .+....
T Consensus 31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 4557788874 4556689999998543 34555677788777432 22 333332 1111 111245
Q ss_pred EEEEEeecCCchhhHc---------------------C---------CCCHH-----------------HHHHHHHHHHH
Q 019241 198 SLIFEYVNSTDFKVLY---------------------P---------TLTDY-----------------DIRYYIYELLK 230 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---------------------~---------~l~~~-----------------~~~~~~~~i~~ 230 (344)
+-+++|++|..+.... . .+.|. ..+.++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 6789999987664310 0 01111 11222233333
Q ss_pred HHH-----HHH--HcCcEeecCCCCceEEeCCCC-cE-EEEecccce
Q 019241 231 ALD-----YCH--SQGIMHRDVKPHNVMIDHELR-KL-RLIDWGLAE 268 (344)
Q Consensus 231 ~L~-----~LH--~~~iiHrDlkp~NiLl~~~~~-~~-kl~DFGla~ 268 (344)
..+ .+. ..++||.|+++.|||++.+.. .+ =|+|||.+.
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 222 121 247999999999999997621 34 499999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.25 Score=45.71 Aligned_cols=71 Identities=17% Similarity=0.181 Sum_probs=43.3
Q ss_pred cCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCC-Ccccee---e-EEEccCCCccEEEEEeecCCc
Q 019241 136 GKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLL---D-IVRDQHSKTPSLIFEYVNSTD 208 (344)
Q Consensus 136 G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~---~-~~~~~~~~~~~lv~e~~~~~~ 208 (344)
+.-..||+.. ..++..+++|+.++. ....+..|.+.+..|..+. .++... | .+. ..+...+.++++++|..
T Consensus 36 s~eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~-~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH-EHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE-EECCEEEEEEeeeCCCC
Confidence 4456788884 445667999998654 4566788999988884331 122212 1 111 11245678999988753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.13 Score=48.81 Aligned_cols=73 Identities=21% Similarity=0.228 Sum_probs=49.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec---------ccchHHHHHHHHHHHHHhCC-C-CccceeeEEEccCCCccE
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~ 198 (344)
++.||-|.-.-||++.+..+++-++||--. +...++...|.++|+...+. | .+++++.+- . ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--S--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--c--HHhh
Confidence 578899999999999874445678888642 22345667788888876332 3 456666653 2 3345
Q ss_pred EEEEeecC
Q 019241 199 LIFEYVNS 206 (344)
Q Consensus 199 lv~e~~~~ 206 (344)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998854
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.058 Score=51.62 Aligned_cols=33 Identities=24% Similarity=0.458 Sum_probs=25.5
Q ss_pred cEeecCCCCceEEeCCCC----cEEEEecccceecCC
Q 019241 240 IMHRDVKPHNVMIDHELR----KLRLIDWGLAEFYHP 272 (344)
Q Consensus 240 iiHrDlkp~NiLl~~~~~----~~kl~DFGla~~~~~ 272 (344)
++|+|+...|||.+.+.+ ...|+||-.+....+
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G~~ 306 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRGSP 306 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhcCch
Confidence 799999999999998533 456789887755443
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.0089 Score=46.76 Aligned_cols=45 Identities=18% Similarity=0.379 Sum_probs=39.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHH
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL 176 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l 176 (344)
+-||.|+.|+||+|+. .+|+.||||+.++.-.+.+...+.+++.+
T Consensus 17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 5699999999999974 45999999999999999999999988876
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.082 Score=47.56 Aligned_cols=96 Identities=18% Similarity=0.214 Sum_probs=64.3
Q ss_pred HHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHc----------------------C-----CCCHH
Q 019241 167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------------P-----TLTDY 219 (344)
Q Consensus 167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l----------------------~-----~l~~~ 219 (344)
++|+...+.|..|..-.++++.|.. . |++||++|.+|..-. . +.-|.
T Consensus 126 e~Ev~afk~L~a~G~ap~Ly~tF~N----G--Lvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~~pkp~lw~ 199 (391)
T KOG4720|consen 126 ENEVIAFKLLAAYGFAPKLYGTFNN----G--LVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGGNPKPPLWE 199 (391)
T ss_pred HHHHHHHHHHHHcCcChhhhheecC----c--eEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCCCCCCcHHH
Confidence 4678888888888999999999933 2 999999998764321 0 01111
Q ss_pred HHHHH--------------------------HHHHHHHHHHHHHcC----cEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 220 DIRYY--------------------------IYELLKALDYCHSQG----IMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 220 ~~~~~--------------------------~~~i~~~L~~LH~~~----iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
.++.+ -.++..-=++|-..+ ++|.||=..||++|++.+.+..+||..+.
T Consensus 200 km~~f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~~~~~~v~fIDYEYa~ 278 (391)
T KOG4720|consen 200 KMRKFLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYDSEKGSVEFIDYEYAG 278 (391)
T ss_pred HHHHHHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeeccccCcEEEEeecccc
Confidence 11111 122222223333222 68999999999999998999999999874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.22 Score=43.31 Aligned_cols=86 Identities=21% Similarity=0.300 Sum_probs=58.8
Q ss_pred hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHH--cCc
Q 019241 163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS--QGI 240 (344)
Q Consensus 163 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~--~~i 240 (344)
..-|..+..+++++ -.|+++.. .+.....++.|.|...... ...++.-=++.|.-.|+ .+.
T Consensus 102 ~~~y~nky~v~Arm---hGilrL~N----Dn~~~yGvIlE~Cy~~~i~----------~~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 102 DALYFNKYRVFARM---HGILRLKN----DNNYKYGVILERCYKIKIN----------FSNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhhHHHHh---hheeEeec----CCCceeEEEEeeccCcccc----------hhHHHHHhHHHHHHhhccCCCe
Confidence 45678899999987 24666652 2344556888988643211 11122222456777784 479
Q ss_pred EeecCCCCceEEeCCCCcEEEEeccc
Q 019241 241 MHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 241 iHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
+|+|..|+|||-|.+ |-+||.|=+.
T Consensus 165 lHGD~np~NiM~D~~-G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKF-GYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheeecCC-CCEEecChhh
Confidence 999999999999998 8999999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 344 | ||||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-128 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-128 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-128 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-128 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-127 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-127 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-127 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-127 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-127 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-127 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-106 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-106 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-106 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-105 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-105 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-105 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-105 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-105 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-105 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-105 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-105 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-105 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-105 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-105 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-104 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-101 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-101 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-25 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-25 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-25 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-25 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-24 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-24 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-24 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-23 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-23 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-23 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-22 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-22 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-22 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-22 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-22 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-22 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-22 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-22 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-22 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-22 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-22 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-22 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-22 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-22 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-22 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-22 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-22 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-22 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-22 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-22 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-22 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-20 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-20 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-20 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-20 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-20 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-19 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-18 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-04 |
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 444 bits (1143), Expect = e-157
Identities = 195/245 (79%), Positives = 222/245 (90%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 3 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 63 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAKV 336
+IAKV
Sbjct: 243 RIAKV 247
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-55
Identities = 71/220 (32%), Positives = 116/220 (52%), Gaps = 13/220 (5%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
Y + +G G + V++ ++ E IK + K+ K RE++I++ L N+V+L
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DHCNIVRLR 113
Query: 187 DIVRDQHSKTPS----LIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCH 236
K L+ +YV T ++V TL ++ Y+Y+L ++L Y H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
S GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+ D
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y S+D+WS GC+ A ++ + P F G DQLV+I KV
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 272
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 75/223 (33%), Positives = 120/223 (53%), Gaps = 14/223 (6%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
+ Y + +G G + VF+ V ++E I K+L+ K+ RE++I++ + PNVV
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHPNVV 95
Query: 184 KLLDIVRDQHSKTPS----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKALD 233
L K L+ EYV T ++ Y T+ I+ Y+Y+LL++L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
Y HS GI HRD+KP N+++D L+LID+G A+ G+ + SRY++ PEL+
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG 215
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+Y ++D+WS GC+ A ++ + P F G DQLV+I KV
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKV 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-51
Identities = 64/227 (28%), Positives = 113/227 (49%), Gaps = 17/227 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNV 182
D ++V R G+G + V G +T IK I P + + + ++ L L PN+
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNI 81
Query: 183 VKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKA 231
V+L + ++ EYV T + Y I+ ++++L+++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 232 LDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
+ H S + HRD+KPHNV+++ L+L D+G A+ P + + SRY++ PE
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
L+ Q Y ++D+WS+GC+FA M+ + P F G ++ QL +I +V
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRV 247
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-51
Identities = 71/229 (31%), Positives = 117/229 (51%), Gaps = 30/229 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
+ YE + K+G G Y VF+ N +T + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYEL 228
+L+ L PN+V LL++ R + L+FEY + T L Y + ++ ++ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 287
L+A+++CH +HRDVKP N++I ++L D+G A P Y+ VA+R+++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
PELLV Y +D+W++GC+FA ++ P + G + DQL I K
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKT 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 73/225 (32%), Positives = 119/225 (52%), Gaps = 14/225 (6%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQN 175
+ + YE + VG G Y V + N +T IK K +K REIK+L+
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
L N+V LL++ + K L+FE+V+ T L +P L ++ Y+++++ +
Sbjct: 81 LRH-ENLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
+CHS I+HRD+KP N+++ ++L D+G A PG+ Y+ VA+R+++ PELL
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
V Y ++D+W++GC+ M F EP F G + DQL I
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMC 240
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-50
Identities = 70/252 (27%), Positives = 121/252 (48%), Gaps = 45/252 (17%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
Y + + +G G + V E ++ + +R +K + + K RE+ I++ L N++KL+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66
Query: 187 DIVRDQHSKTPS------------------------------------LIFEYVNSTDFK 210
D + P +I EYV T K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 211 VLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
VL ++ I YIY+L +A+ + HS GI HRD+KP N++++ + L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
G A+ P + + SR+++ PEL++ +Y S+D+WS+GC+F +I K P F G
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245
Query: 325 DNHDQLVKIAKV 336
+ DQLV+I ++
Sbjct: 246 TSIDQLVRIIQI 257
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 71/230 (30%), Positives = 121/230 (52%), Gaps = 31/230 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
YE + K+G G Y VF+ N T+E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
+L+ L N+V+L D++ T L+FE+ D K L ++ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
LLK L +CHS+ ++HRD+KP N++I+ +L+L ++GLA + P + Y+ V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
P++L + Y S+DMWS GC+FA + P F G+D DQL +I ++
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-49
Identities = 69/235 (29%), Positives = 122/235 (51%), Gaps = 34/235 (14%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------RE 169
D Y + K+G G Y EV++ I+ TNE V K+I+ RE
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIRE 83
Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY 226
+ +L+ L N+++L ++ H LIFEY D K P ++ I+ ++Y
Sbjct: 84 VSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYH-PGKEYNVRVA 281
+L+ +++CHS+ +HRD+KP N+++ L++ D+GLA + P +++ +
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ +++ PE+L+ + Y S+D+WS+ C++A M+ K P F G DQL KI +V
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEV 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-48
Identities = 69/229 (30%), Positives = 123/229 (53%), Gaps = 31/229 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
+ Y + K+G G Y+ V++G + T+ V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
L++L N+V L DI+ + S T L+FEY++ D K + ++++ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 287
L+ L YCH Q ++HRD+KP N++I+ +L+L D+GLA P K Y+ V + +++
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
P++L+ DY +DMW +GC+F M + P F G +QL I ++
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRI 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 77/225 (34%), Positives = 126/225 (56%), Gaps = 19/225 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNL 176
YE + +G G+++ V++ + NTN+ IK +K + + K REIK+LQ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKAL 232
PN++ LLD H SL+F+++ TD +V+ LT I+ Y+ L+ L
Sbjct: 70 SH-PNIIGLLDAF--GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
+Y H I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ Y +DMW++GC+ A ++ R PF G + DQL +I +
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFET 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 70/239 (29%), Positives = 115/239 (48%), Gaps = 40/239 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----------------R 168
YE V ++G G Y V++ + ++ V K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60
Query: 169 EIKILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTD 218
E+ +L+ L PNVV+L+D+ + L+FE+V D + P L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
I+ + + L+ LD+ H+ I+HRD+KP N+++ ++L D+GLA Y
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTP 178
Query: 279 RVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
V + +++ PE+L LQ Y +DMWS+GC+FA M FR++P F G+ DQL KI +
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDL 234
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-47
Identities = 65/233 (27%), Positives = 122/233 (52%), Gaps = 34/233 (14%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
++ + K+G G Y+ V++G+N T V K++K REI +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYY 224
++ L N+V+L D++ ++ T L+FE++ +S L ++Y+
Sbjct: 57 MKELKH-ENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
++LL+ L +CH I+HRD+KP N++I+ + L+L D+GLA + P ++ V +
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+++ P++L+ + Y S+D+WS GC+ A MI +P F G ++ +QL I +
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDI 224
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (406), Expect = 5e-47
Identities = 68/230 (29%), Positives = 120/230 (52%), Gaps = 33/230 (14%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
+ Y + K+G G Y V++ N N E KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGET--------FALKKIRLEKEDEGIPSTTIREIS 52
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
IL+ L N+VKL D++ + L+FE++ D K L L + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
LL + YCH + ++HRD+KP N++I+ E +L++ D+GLA + P ++Y + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
P++L+ + Y ++D+WS+GC+FA M+ P F G DQL++I ++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRI 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-47
Identities = 75/233 (32%), Positives = 125/233 (53%), Gaps = 33/233 (14%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 168
G + Y+ + KVG G Y V++ + + V K+I+ R
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRI--------VALKRIRLDAEDEGIPSTAIR 68
Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYY 224
EI +L+ L PN+V L+D++ + T L+FE++ D K + L D I+ Y
Sbjct: 69 EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFM-EKDLKKVLDENKTGLQDSQIKIY 124
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
+Y+LL+ + +CH I+HRD+KP N++I+ + L+L D+GLA + P + Y V +
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+++ P++L+ + Y S+D+WS+GC+FA MI K P F G + DQL KI +
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSI 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 72/240 (30%), Positives = 112/240 (46%), Gaps = 40/240 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
YE + K+G+G + EVF+ + T ++ V KK+ REIK
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPS------LIFEYVNSTDFKVL----YPTLTDYDI 221
ILQ L NVV L++I R + S L+F++ D L T +I
Sbjct: 69 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEI 126
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGKEY 276
+ + LL L Y H I+HRD+K NV+I + L+L D+GLA + Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
RV + +++ PELL+ +DY +D+W GC+ A M + + P G+ QL I+++
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 71/244 (29%), Positives = 130/244 (53%), Gaps = 16/244 (6%)
Query: 104 NVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVK 162
+++R K ++ + W Y VG G Y V I+ + E+ IK + +P +
Sbjct: 3 SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62
Query: 163 K----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP 214
K+ RE+ +L+++ NV+ LLD+ S L+ ++ + K++
Sbjct: 63 SEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
++ I+Y +Y++LK L Y HS G++HRD+KP N+ ++ + +L+++D+GLA
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEM 180
Query: 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
Y V +R+++ PE+++ Y+ ++D+WS+GC+ A M+ K F G D DQL +I
Sbjct: 181 TGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQI 236
Query: 334 AKVT 337
KVT
Sbjct: 237 LKVT 240
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-46
Identities = 72/236 (30%), Positives = 120/236 (50%), Gaps = 36/236 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
YE V ++G G Y +VF+ ++ R V K+++ RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63
Query: 172 ILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTDYDI 221
+L++L PNVV+L D+ + + L+FE+V D P + I
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
+ +++LL+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVV 181
Query: 282 SRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ +++ PE+L LQ Y +D+WS+GC+FA M FR++P F G + DQL KI V
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDV 234
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 61/231 (26%), Positives = 110/231 (47%), Gaps = 22/231 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
Y ++ +G G VF ++ + ++R IK + P K REIKI++ L N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLK 230
K+ +I+ S+ + ++ L + R ++Y+LL+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 286
L Y HS ++HRD+KP N+ I+ E L++ D+GLA P + + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
P LL+ +Y ++DMW+ GC+FA M+ K F G +Q+ I +
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESI 241
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-45
Identities = 70/241 (29%), Positives = 123/241 (51%), Gaps = 30/241 (12%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
YE+V+K+G+G Y V++ I+ T E +K I + ++ REI IL L G
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQ 238
N+V LL+++R + + L+F+Y+ + V+ L +Y +Y+L+K + Y HS
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------------------- 279
G++HRD+KP N++++ E +++ D+GL+ + +
Sbjct: 129 GLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 280 ---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
VA+R+++ PE+L+ Y +DMWSLGC+ ++ K P F G +QL +I V
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIGV 246
Query: 337 T 337
Sbjct: 247 I 247
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 67/224 (29%), Positives = 124/224 (55%), Gaps = 17/224 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
Y ++ VG G Y V ++ T + IK + +P + K+ RE+++L+++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83
Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDY 234
NV+ LLD+ + L+ ++ + K++ L + I++ +Y++LK L Y
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD 293
H+ GI+HRD+KP N+ ++ + +L+++D+GLA Y V +R+++ PE++++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
Y ++D+WS+GC+ A MI K F G D+ DQL +I KVT
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVT 242
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 65/240 (27%), Positives = 124/240 (51%), Gaps = 17/240 (7%)
Query: 109 KEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKK 163
++ E W + Y+ + VG G Y V + T R +K L +
Sbjct: 13 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 164 KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTD 218
K+ RE+++L+++ NV+ LLD+ S L+ + + ++ LTD
Sbjct: 73 KRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277
+++ IY++L+ L Y HS I+HRD+KP N+ ++ + +L+++D+GLA Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY- 189
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I ++
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-44
Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 22/238 (9%)
Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQ 174
+ + D+++ +G G Y V + T E IK ++P K + REIKIL+
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLK 230
+ N++ + +I R + + +I E + + +V+ L+D I+Y+IY+ L+
Sbjct: 65 HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----------- 279
A+ H ++HRD+KP N++I+ L++ D+GLA N
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
VA+R+++ PE+++ Y ++D+WS GC+ A + R+ P F G D QL+ I +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGII 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 57/240 (23%), Positives = 115/240 (47%), Gaps = 13/240 (5%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
R ++ E + Y+ ++ +G G V + IK + +P +
Sbjct: 7 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 164 --KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLT 217
K+ RE+ +++ + N++ LL++ Q S ++ E +++ +V+ L
Sbjct: 67 HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
+ Y +Y++L + + HS GI+HRD+KP N+++ + L+++D+GLA
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMT 184
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
V +RY++ PE+++ Y ++D+WS+GC+ MI F G D+ DQ K+ +
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 62/251 (24%), Positives = 109/251 (43%), Gaps = 24/251 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
E + + Q Y V R + G Y V G++ + IK + V
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62
Query: 164 -----------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF 209
K++ REI++L + PN++ L DI L+ E + +
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 210 KVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
+V++ ++ I+Y++Y +L L H G++HRD+ P N+++ + + D+ L
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNL 180
Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
A V R+++ PEL++ + + +DMWS GC+ A M RK F G
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTF 239
Query: 327 HDQLVKIAKVT 337
++QL KI +V
Sbjct: 240 YNQLNKIVEVV 250
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 63/225 (28%), Positives = 117/225 (52%), Gaps = 15/225 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
Y + +G G Y V + R IK + P + ++ REIKIL
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE 85
Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCH 236
N++ + DI+R + ++ + + + +K+L L++ I Y++Y++L+ L Y H
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLV 292
S ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337
+ + Y S+D+WS+GC+ A M+ + P F G DQL I +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGIL 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-42
Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 19/242 (7%)
Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
+++ E + Y+ ++ +G G V + + IK + +P +
Sbjct: 45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104
Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTD 218
K+ RE+ +++ + N++ LL++ Q + L+ E +++ +V+ L
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E 275
+ Y +Y++L + + HS GI+HRD+KP N+++ + L+++D+GLA
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTP 222
Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
Y V +RY++ PE+++ Y ++D+WS+GC+ M+ K F G D DQ K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277
Query: 336 VT 337
Sbjct: 278 QL 279
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-40
Identities = 63/251 (25%), Positives = 115/251 (45%), Gaps = 47/251 (18%)
Query: 124 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---------REIKIL 173
+D +E KVGRG Y V++ + + + K+I+ REI +L
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALL 72
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------YPTLTDYDI 221
+ L PNV+ L + + L+F+Y D + L +
Sbjct: 73 RELKH-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLA-EFYHPGKEY- 276
+ +Y++L + Y H+ ++HRD+KP N+++ E + +++ D G A F P K
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------- 325
+ V + +++ PELL+ + Y ++D+W++GC+FA ++ EP F+
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPY 249
Query: 326 NHDQLVKIAKV 336
+HDQL +I V
Sbjct: 250 HHDQLDRIFNV 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 26/238 (10%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
Y +++++G G S+VF+ +N + IK + EI L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
+++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 88 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 294
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D+
Sbjct: 146 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 295 ----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342
D+WSLGC+ M + K PF + +L I ++F
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
+ Y+ V+K+G G Y EV + T+ IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
PN++KL D D+ + L+ E D + + D I ++L + Y
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 236 HSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
H I+HRD+KP N++++ + ++++D+GL+ + K+ R+ + Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ YD D+WS+G + ++ P F G + + L K+
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKV 249
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 26/238 (10%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
Y +++++G G S+VF+ +N + IK + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
+++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 69 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342
D+WSLGC+ M + K PF + +L I ++F
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 46/234 (19%), Positives = 94/234 (40%), Gaps = 21/234 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
+ + +G+G + VF G + T + IK+ + + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
N+VKL I + ++ LI E+ + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
GI+HR++KP N+M +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338
+ Y ++D+WS+G F PF + K+ T
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 45/199 (22%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
D + RK+G G + +V ++ +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYELLKAL 232
PN++K+ ++ D H+ ++ E + L++ + + +++ AL
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
Y HSQ ++H+D+KP N++ +++ID+GLAE + + + + PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 291 LVDLQDYDYSLDMWSLGCM 309
+D + D+WS G +
Sbjct: 198 F--KRDVTFKCDIWSAGVV 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 13/212 (6%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
Q ++ + ++G G Y EVF+ + +K P + + E+ + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
P V+L + L E + + +L + + Y+ + L AL +
Sbjct: 116 HPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
HSQG++H DVKP N+ + R +L D+GL V+ + PELL
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-- 230
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
Y + D++SLG + E G
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQ 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-38
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 13/195 (6%)
Query: 123 DQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
DDY+V +V G G +V + N T E+ +K+L+ K +RE+++ P+
Sbjct: 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPH 116
Query: 182 VVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
+V+++D+ + ++ ++ E ++ + T+ + + + +A+ Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
HS I HRDVKP N++ L+L D+G A+ + Y+ PE+L
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 235
Query: 293 DLQDYDYSLDMWSLG 307
+ YD S DMWSLG
Sbjct: 236 GPEKYDKSCDMWSLG 250
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 23/226 (10%)
Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
DDY++ ++V G G +V E + T ++C +K+L K ++E+ GGP++
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 183 VKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDYC 235
V +LD+ + H +I E + + + T+ + + ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
HS I HRDVKP N++ + L+L D+G A+ + Y+ PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202
Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ YD S DMWSLG + G P FY + + +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKR 243
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 17/223 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
D Y+ R +G+G + EV + T + C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
PN++KL + D+ L+ E D + ++ D I ++L + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
H I+HRD+KP N++++ + +R+ID+GL+ + K+ ++ + Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
YD D+WS G + ++ P F G + +D L K+ K
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKVEK 241
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 26/238 (10%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG-G 179
Y +++++G G S+VF+ +N + IK + EI L L
Sbjct: 57 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
+++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 116 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 174 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342
D+WSLGC+ M + K PF + +L I ++F
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 43/196 (21%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPN 181
+ Y + +GRG++ V + ++ + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKAL 232
++ L + +IFE+++ ++ F+ L + +I Y++++ +AL
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115
Query: 233 DYCHSQGIMHRDVKPHNVM-IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
+ HS I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 292 VDLQDYDYSLDMWSLG 307
+ DMWSLG
Sbjct: 176 -QHDVVSTATDMWSLG 190
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 47/234 (20%), Positives = 94/234 (40%), Gaps = 24/234 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
+ + +G+G + VF G + T + IK+ + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
N+VKL I + ++ LI E+ + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
GI+HR++KP N+M +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF---FYGHDNHDQLVKIAK 335
+ Y ++D+WS+G F PF N + + KI
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 56/229 (24%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
+ Y +V +G+G + EV + + T + +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
PN++KL +I+ D S ++ E + L+ +++D I ++ +
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
Y H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 335
L YD D+WS G + +G P FYG + +D L ++
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRVET 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 37/242 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
D+E + +G+G + +V + N + IK ++ K I E+ +L +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 182 VVKLLDIVRDQHSKTPS-----------LIFEYVNS---TDFKVLYPTLTDYD-IRYYIY 226
VV+ ++ + + EY + D D
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
++L+AL Y HSQGI+HRD+KP N+ ID R +++ D+GLA+ H + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 287 G---------------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
E+L Y+ +DM+SLG +F MI+ PF G + + L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KI 333
K+
Sbjct: 240 KL 241
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 55/237 (23%), Positives = 108/237 (45%), Gaps = 33/237 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGP 180
D Y+++ ++G G + V + T I P+ K +K EI I+ L P
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKA 231
++ L D D++ LI E+++ + D+K +++ ++ Y+ + +
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161
Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
L + H I+H D+KP N+M + +++ID+GLA +P + V A+ F PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
+ D + + DMW++G + +G+ F G D+ + L + + +F
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRCD--WEFD 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 60/239 (25%), Positives = 113/239 (47%), Gaps = 30/239 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
+D Y++ ++G G+++ V + +T K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
+ NV+ L D+ ++ LI E V+ DF +L++ + +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
++Y H++ I H D+KP N+M+ + + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
E++ + + DMWS+G + +G F G + L I V+ DF
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITSVS--YDFD 238
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-37
Identities = 51/293 (17%), Positives = 110/293 (37%), Gaps = 34/293 (11%)
Query: 69 TTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDY 127
+ + + + + + D V + + + + ++ D Y
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159
Query: 128 EVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
++ ++G G + V T + K+ +++EI+ + L P +V
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVN 218
Query: 185 LLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
L D D + +I+E+++ K +++ + Y+ ++ K L +
Sbjct: 219 LHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHM 271
Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
H +H D+KP N+M +L+LID+GL P + V + F PE+ +
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EG 330
Query: 295 QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
+ Y DMWS+G + +G+ F G ++ + L + +
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSCD--WNMD 376
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 45/224 (20%), Positives = 90/224 (40%), Gaps = 18/224 (8%)
Query: 126 DYEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
+ +G G V+ G+ N +K + P RE+++L+ PNV++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
+D+ + + E +T + + + + + L + HS I+
Sbjct: 83 YFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 242 HRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVD 293
HRD+KPHN++I K + D+GL + G+ R + + PE+L +
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 294 L--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
++ Y++D++S GC+F +I F + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 53/237 (22%), Positives = 106/237 (44%), Gaps = 27/237 (11%)
Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLC 177
+ Y + K GRGK++ V + I+ +T + K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F----KVLYPTLTDYDIRYYIYELLKAL 232
P V+ L ++ + LI EY + F L +++ D+ I ++L+ +
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
Y H I+H D+KP N+++ + L ++++D+G++ E + + + PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 291 LVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
L + + DMW++G + F G DN + + I++V +D+S
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQVN--VDYS 253
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 72/299 (24%)
Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
K W D YE+ +G G Y V E + IK IL+ +
Sbjct: 36 SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95
Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTL 216
K+I REI IL L +VVK+LDIV + + ++ E + +DF K+ L
Sbjct: 96 CKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYL 153
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
T+ I+ +Y LL + Y HS GI+HRD+KP N +++ + +++ D+GLA +
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENG 212
Query: 277 NVR----------------------------VASRYFKGPELLVDLQDYDYSLDMWSLGC 308
N + V +R+++ PEL++ ++Y ++D+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 309 MFAGMI----------FRKEPFFYGHD--------------------NHDQLVKIAKVT 337
+FA ++ + P F G N DQL I +
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 13/194 (6%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
Y + +GRG + EV + T R K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
N+++L + D L+ E + V + D + ++L A+ YCH
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 238 QGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
+ HRD+KP N + L+LID+GLA + PGK +V + Y+ P++L
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 296 DYDYSLDMWSLGCM 309
Y D WS G M
Sbjct: 183 LYGPECDEWSAGVM 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 59/232 (25%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----------------PVKKKKIKR 168
+ Y VRK+G G Y EV N + IK++K ++I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FK--VLYPTLTDYDIRYYI 225
EI +L++L PN++KL D+ D+ L+ E+ + F+ + + D +
Sbjct: 96 EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
++L + Y H I+HRD+KP N++++ + L ++++D+GL+ F+ + R+ +
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
Y+ PE+L + Y+ D+WS G + ++ P F G ++ D + K+ K
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEK 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 44/230 (19%), Positives = 89/230 (38%), Gaps = 25/230 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
D++ + +G G + +VF+ + + +IK +K +K +RE+K L L N+V
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------------------PTLTDYDIRY 223
+ S K L+ L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
++ K +DY HS+ +++RD+KP N+ + +++++ D+GL + +
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ PE + QDY +D+++LG + A ++ + F L
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------------PVKKKKIKREIK 171
++YE +GRG S V I+ T + +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYEL 228
IL+ + G PN+++L D L+F+ + D+ TL++ + R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
L+ + H I+HRD+KP N+++D ++ ++L D+G + PG++ + + P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 289 ELL-----VDLQDYDYSLDMWSLGCM 309
E++ + Y +DMWS G +
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 6e-36
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 19/227 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
+E+ ++G G + V I+ +T E+ IK + P +++ EI+I++ L P
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 181 NVVKLLDIVRDQHSKTPS----LIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLK 230
NVV ++ P+ L EY D K L L + IR + ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 231 ALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
AL Y H I+HRD+KP N+++ + ++ID G A+ G+ V + + P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
ELL + + Y ++D WS G + I P F + Q +
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVR 237
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 56/226 (24%), Positives = 108/226 (47%), Gaps = 24/226 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
+ Y +V +G+G + EV + + T + +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
PN++KL +I+ D S ++ E D + +++D I ++ + Y
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195
Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 335
YD D+WS G + +G P FYG + +D L ++
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVET 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-36
Identities = 60/239 (25%), Positives = 114/239 (47%), Gaps = 30/239 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
+D Y++ ++G G+++ V + +T K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
+ PN++ L D+ ++ LI E V+ DF +L++ + +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
++Y H++ I H D+KP N+M+ + + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
E++ + + DMWS+G + +G F G + L I V+ DF
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITAVS--YDFD 238
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-35
Identities = 62/241 (25%), Positives = 113/241 (46%), Gaps = 34/241 (14%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
+D YE+ ++G G+++ V + T + K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELL 229
+ PN++ L DI ++ LI E V + DF +LT+ + ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 230 KALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
+ Y HS+ I H D+KP N+M+ + +++LID+G+A G E+ + F
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 287 GPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342
PE++ + + DMWS+G + +G F G + L I+ V DF
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISAVN--YDF 230
Query: 343 S 343
Sbjct: 231 D 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 58/239 (24%), Positives = 109/239 (45%), Gaps = 30/239 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
D Y+ ++G G+++ V + +T + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
+ PNV+ L ++ ++ LI E V DF +LT+ + ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
+ Y HS I H D+KP N+M+ + ++++ID+GLA G E+ + F P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
E++ + + DMWS+G + +G F G + L ++ V +F
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAVN--YEFE 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 64/274 (23%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
D+Y + +GRG Y V+ + NT + IK + + + K+I REI IL L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLYP--TLTDYDIRYYIYELLKALD 233
+++L D++ ++ E + +D K+ LT+ I+ +Y LL +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-------------- 279
+ H GI+HRD+KP N +++ + +++ D+GLA + K+ N+
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 280 ---------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPF 320
V +R+++ PEL++ ++Y S+D+WS GC+FA ++ + P
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 321 FYG-----------------HDNHDQLVKIAKVT 337
F G N DQL I +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 61/272 (22%), Positives = 122/272 (44%), Gaps = 32/272 (11%)
Query: 90 PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDYEVVRK--VGRGKYSEVFEGIN 146
+P SK V++ P +D+ +T + G Y V + +G G++ +V +
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110
Query: 147 VNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
T + IIK K+++K EI ++ L N+++L D ++ L+ EY
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIV--LVMEY 167
Query: 204 VNS-------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHE 255
V+ D T+ D ++ ++ + + + H I+H D+KP N++ ++ +
Sbjct: 168 VDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224
Query: 256 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG----CMFA 311
+++++ID+GLA Y P ++ V + F PE++ + + DMWS+G + +
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLS 283
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
G+ F G ++ + L I D
Sbjct: 284 GL-----SPFLGDNDAETLNNILACR--WDLE 308
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 51/196 (26%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
D+Y+V ++G+G +S V ++ T KI L +K++RE +I + L
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
PN+V+L D ++++ L+F+ V + V ++ D + I ++L+++ YC
Sbjct: 88 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
HS GI+HR++KP N+++ + + ++L D+GLA + + ++ + + PE+L
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 203
Query: 294 LQDYDYSLDMWSLGCM 309
Y +D+W+ G +
Sbjct: 204 KDPYSKPVDIWACGVI 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 51/194 (26%), Positives = 102/194 (52%), Gaps = 14/194 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
D+Y+V ++G+G +S V ++ T KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
PN+V+L D ++++ L+F+ V + V ++ D + I ++L+++ YC
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
HS GI+HR++KP N+++ + + ++L D+GLA + + ++ + + PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180
Query: 294 LQDYDYSLDMWSLG 307
Y +D+W+ G
Sbjct: 181 KDPYSKPVDIWACG 194
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----------KIKREIKIL 173
Y+ +GRG S V ++ T +KI++ ++ +RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLK 230
+ + G P+++ L+D L+F+ + D+ L++ + R + LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
A+ + H+ I+HRD+KP N+++D + ++RL D+G + PG++ + + PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 291 L-----VDLQDYDYSLDMWSLG 307
L Y +D+W+ G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACG 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
+D YE+ +G+G +S V IN T ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYEL 228
L P++V+LL+ ++FE+++ ++ +Y+ ++
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
L+AL YCH I+HRDVKPH V++ ++L +G+A + G RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCM 309
PE++ + Y +D+W G +
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVI 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 44/245 (17%), Positives = 90/245 (36%), Gaps = 39/245 (15%)
Query: 124 QDDYEVVRKVGRGKYSEV-FEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
++ + +G G V F+G +K + EIK+L PNV
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST---------DFKVLYPTLTDYDIRYYIYELLKALD 233
++ + E N +Y+ + ++ +
Sbjct: 72 IRYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 234 YCHSQGIMHRDVKPHNVMID------------HELRKLRLIDWGLAEFYHPGKEY----- 276
+ HS I+HRD+KP N+++ E ++ + D+GL + G+
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 277 NVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
N + ++ PELL + + S+D++S+GC+F ++ + + F D + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 247
Query: 331 VKIAK 335
I +
Sbjct: 248 SNIIR 252
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 124 QDDYEV---VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
Y++ + +G G +S + ++ +N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALDY 234
N+VKL ++ DQ L+ E +N + F K + ++ + Y + +L+ A+ +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121
Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
H G++HRD+KP N++ + ++++ID+G A P + + ++ PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 292 VDLQDYDYSLDMWSLG 307
+ YD S D+WSLG
Sbjct: 182 -NQNGYDESCDLWSLG 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNV 182
D +EV ++GRG S V+ T + +K + K V KK ++ EI +L L PN+
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
+KL +I SL+ E V T D V ++ D + ++L+A+ Y H
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
GI+HRD+KP N++ L++ D+GL++ + + PE+L
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225
Query: 296 DYDYSLDMWSLG 307
Y +DMWS+G
Sbjct: 226 AYGPEVDMWSVG 237
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 46/242 (19%), Positives = 96/242 (39%), Gaps = 39/242 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
D+E ++ +GRG + VFE N + IK ++ + ++K+ RE+K L L P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63
Query: 181 NVVKLLDIVRDQHSKTPS----------LIFEYVNSTDFKVL------YPTLTDYDIRYY 224
+V+ + ++++ + + + K +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYN 277
++ +A+++ HS+G+MHRD+KP N+ + +++ D+GL E
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 278 VRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
G PE + Y + +D++SLG + +++ PF + L
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238
Query: 332 KI 333
+
Sbjct: 239 DV 240
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 50/265 (18%), Positives = 106/265 (40%), Gaps = 31/265 (11%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
M + + + R Y ++ V ++ Y ++K+G G +S V ++
Sbjct: 1 MGSSHHHHHHSSGRENLY--FQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFY 57
Query: 154 IIKIL---KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTD 208
+K + + +++ +RE + + PN+++L+ + L+ +
Sbjct: 58 ALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116
Query: 209 -------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
K LT+ I + + + + L+ H++G HRD+KP N+++ E + L
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVL 175
Query: 262 IDWGLAEFYHPGKEYNVRVASR----------YFKGPELLVDLQDY---DYSLDMWSLGC 308
+D G E + + + ++ PE L +Q + D D+WSLGC
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGC 234
Query: 309 MFAGMIFRKEPFFYGHDNHDQLVKI 333
+ M+F + P+ D +
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKREIKI 172
+D+Y + + +G G EV T ++ I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELL 229
L+ L P ++K+ + + ++ E + D V L + + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQL 330
PE+LV + Y+ ++D WSLG +G P F H L
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-----PPFSEHRTQVSL 353
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 62/270 (22%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
Q Y + +G+G Y V I T IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV------------------------------- 204
L PN+ +L ++ D+ L+ E
Sbjct: 85 LHH-PNIARLYEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 205 ------------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
+ L + I + ++ AL Y H+QGI HRD+KP N +
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 253 DH-ELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDMWS 305
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
G + ++ P F G ++ D + ++
Sbjct: 262 AGVLLHLLLMGAVP-FPGVNDADTISQVLN 290
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 38/229 (16%), Positives = 77/229 (33%), Gaps = 31/229 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
++ + K+G G++ VF+ + IK K V ++ RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 179 GPNVVKLLDIVRDQHSKTPSLIF-EYVNS-------TDFKVLYPTLTDYDIRYYIYELLK 230
+VV+ + LI EY N ++ + + +++ + ++ +
Sbjct: 70 HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-------------- 276
L Y HS ++H D+KP N+ I + G + + K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
V F E+L + + D+++L + G
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 25/201 (12%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
Y+V +G G + V+ GI V+ N IK + + ++ E+ +L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 176 LC-GGPNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYIYE 227
+ G V++LLD + P LI E DF L + R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
+L+A+ +CH+ G++HRD+K N++ID +L+LID+G Y +R +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216
Query: 288 PELLVDLQDYD-YSLDMWSLG 307
PE + Y S +WSLG
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLG 236
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGG 179
+D Y++ V G G ++ V IN+ T++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALD 233
NV++L++ ++ L+FE + + + + + + ++ ALD
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNV--------RVASR 283
+ H++GI HRD+KP N++ +H ++ +++ D+ L + + S
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 284 YFKGPELL----VDLQDYDYSLDMWSLG 307
+ PE++ + YD D+WSLG
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKI 172
+D+Y + + +G G EV T ++ IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
L+ L P ++K+ + + ++ E + D V L + + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 288 PELLVDLQD--YDYSLDMWSLGCM 309
PE+LV + Y+ ++D WSLG +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
+DYEV+ +G G Y + + + + K + +K+ + E+ +L+ L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
PN+V+ D + D+ + T ++ EY D L + + + +L AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
CH + ++HRD+KP NV +D + + ++L D+GLA + + V + Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAK 335
PE + Y+ D+WSLGC+ + PF + +L KI +
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIRE 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 17/196 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
+ + + +G G +SEVF T + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYC 235
N+V L DI L+ + V + D + T+ D I ++L A+ Y
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
H GI+HRD+KP N++ E K+ + D+GL++ G + + + PE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 294 LQDYDYSLDMWSLGCM 309
+ Y ++D WS+G +
Sbjct: 182 -KPYSKAVDCWSIGVI 196
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 57/227 (25%), Positives = 117/227 (51%), Gaps = 28/227 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
YEV++ +G+G + +V + + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
NV+ +L+ + + S +L +E + F+ L +R + + +L+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS--MNL-YELIKKNKFQGFSLPL----VRKFAHSILQ 211
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
LD H I+H D+KP N+++ + R +++ID+G + + H + Y + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYRAPE 269
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+++ Y +DMWSLGC+ A + P G D DQL + ++
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIEL 314
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 11/190 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
D YEV +G G YS I+ TN +KI+ K+ EI+IL PN++
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
L D+ D ++ E + D + ++ + ++ + K ++Y H+QG++
Sbjct: 81 LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 297
HRD+KP N++ +R+ D+G A+ + F PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197
Query: 298 DYSLDMWSLG 307
D + D+WSLG
Sbjct: 198 DAACDIWSLG 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 49/196 (25%), Positives = 99/196 (50%), Gaps = 19/196 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
++Y++ ++G+G +S V + V + I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDY 234
PN+V+L D + ++ LIF+ V T + V ++ D + I ++L+A+ +
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 235 CHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
CH G++HR++KP N+++ +L+ ++L D+GLA + + + + PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 292 VDLQDYDYSLDMWSLG 307
Y +D+W+ G
Sbjct: 186 -RKDPYGKPVDLWACG 200
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 34/226 (15%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
V R + G ++ V+E +V + +K L + K + I +E+ ++ L G PN+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 184 KLLD--IVRDQHSKTPSLIF----EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKAL 232
+ + + S T F E + L L+ + Y+ +A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 233 DYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR------- 283
+ H Q I+HRD+K N+++ ++ ++L D+G A +Y+ R
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 284 ------YFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPF 320
++ PE ++DL D+W+LGC+ + FR+ PF
Sbjct: 209 TRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 48/196 (24%), Positives = 85/196 (43%), Gaps = 34/196 (17%)
Query: 122 GDQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
DDY+V +V G G +V + N T E+ +K+L+ K +RE+++ P
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 71
Query: 181 NVVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALD 233
++V+++D+ + ++ ++ E ++ + T+ + + + +A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
Y HS I HRDVKP N++ L+L D+G A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KETT 171
Query: 292 VDLQDYDYSLDMWSLG 307
+ YD S DMWSLG
Sbjct: 172 --GEKYDKSCDMWSLG 185
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 15/208 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
+ +VGRG + EV + T +C +K ++ + E+ L P +
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRI 112
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 239
V L VR+ ++ E + L + YY+ + L+ L+Y H++
Sbjct: 113 VPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVD 293
I+H DVK NV++ + + L D+G A P + Y G PE +V
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVM 229
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
+ D +D+WS CM M+ P+
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
Y R +G+G +++ FE + +T E KI+ KP +++K+ EI I ++L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
+VV D + ++ E + LT+ + RYY+ +++ Y
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
H ++HRD+K N+ ++ +L +++ D+GLA E Y +A
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE+L + + + +D+WS+GC+ ++ K PF
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
Y R +G+G +++ FE + +T E KI+ KP +++K+ EI I ++L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
+VV D + ++ E + LT+ + RYY+ +++ Y
Sbjct: 75 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
H ++HRD+K N+ ++ +L +++ D+GLA E Y +A
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE+L + + + +D+WS+GC+ ++ K PF
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 35/253 (13%), Positives = 65/253 (25%), Gaps = 42/253 (16%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNL--- 176
++V + G S VF +V E +K+ + +++ L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 177 --------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST--------- 207
P +L D L+ +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
V + +L++ S+G++H P N+ I + R L L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL 241
Query: 268 EFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
+ G + E L + ++L+ W LG + PF
Sbjct: 242 --WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 327 HDQLVKIAKVTTI 339
K +
Sbjct: 300 IKGSWKRPSLRVP 312
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK------ILKPVKKKKIKREIKILQNLCG 178
++ + +K+GRG++SEV+ + +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
PNV+K + + +++ E ++ D FK + + + Y +L A
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAK 335
+ + Y++ D+WSLGC+ M + PF+ N L KI +
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 27/203 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
+Y + +G+G + VF G + + IK++ E+ +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 176 LCGG---PNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYI 225
+ G P V++LLD +T L+ E D+ L + R +
Sbjct: 91 VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
+++ A+ +CHS+G++HRD+K N++ID +LID+G H Y +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204
Query: 286 KGPELLVDLQDYD-YSLDMWSLG 307
PE + Y +WSLG
Sbjct: 205 SPPEWISR-HQYHALPATVWSLG 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-31
Identities = 35/241 (14%), Positives = 85/241 (35%), Gaps = 31/241 (12%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVKKKKIKREIKILQNLC 177
V +G G +++V+E + N ++ ++K+ KP + ++++ L
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 178 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--------KVLYPTLTDYDIRYYIYE 227
+K Q+ L+ E + + + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLIDWGLA---EFYHPGK 274
+L ++ H I+H D+KP N ++ + L LID G + + + G
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
+ + + F+ E+L + + ++Y +D + + M+F + +
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 335 K 335
+
Sbjct: 300 R 300
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----------PVKKKKIKREIKILQ 174
Y + +G G + V+ ++ N+ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLK 230
+ N++K+LDI +Q L+ E S F +P L + Y +L+
Sbjct: 85 RVEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
A+ Y + I+HRD+K N++I + ++LID+G A + GK + + + PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPF 320
L+ Y L+MWSLG ++F + PF
Sbjct: 201 LMG-NPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 47/223 (21%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
+ Y ++K+G G + + + + +IK + ++++ +RE+ +L N+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL----YPTLTDYDIRYYIYELLKALDY 234
PN+V+ + + + + ++ +Y D FK + + I + ++ AL +
Sbjct: 83 PNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE+ +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAK 335
+ Y+ D+W+LGC+ + K F + LV KI
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIIS 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 56/232 (24%), Positives = 108/232 (46%), Gaps = 38/232 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 176
+D+E+ R +G+GK+ V+ + +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALD 233
PN+++L D + LI EY ++ L + YI EL AL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 285
YCHS+ ++HRD+KP N+++ L++ D+G + + +Y +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKV 336
PE++ + +D +D+WSLG + + K PF + + + +I++V
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRV 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 48/216 (22%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
+D++V +G+G ++ V+ +++T IK++ K ++++ E+KI L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP---TLTDYDIRYYIYELLKALDY 234
P++++L + D S L+ E ++ + + L ++ + R+++++++ + Y
Sbjct: 71 -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRY 284
HS GI+HRD+ N+++ + +++ D+GLA E Y ++
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNY---IS--- 180
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE+ + D+WSLGCMF ++ + PF
Sbjct: 181 ---PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 57/229 (24%), Positives = 114/229 (49%), Gaps = 30/229 (13%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
+V L +V + S +L ++ + +T+F+ + L R + ++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFRGVSLNL----TRKFAQQMCT 168
Query: 231 ALDYCHSQ--GIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
AL + + I+H D+KP N+++ + R ++++D+G + + + SR+++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
PE+L+ + YD ++DMWSLGC+ M EP F G + DQ+ KI +V
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEV 273
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 52/194 (26%), Positives = 105/194 (54%), Gaps = 20/194 (10%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
+Y +++ +G+G +++V ++ T IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
N+VKL +++ +T LI EY + D+ V + + + + R +++ A+ Y
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
CH + I+HRD+K N+++D ++ +++ D+G + + G + + + + PEL
Sbjct: 130 CHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187
Query: 295 QDYD-YSLDMWSLG 307
+ YD +D+WSLG
Sbjct: 188 KKYDGPEVDVWSLG 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-29
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLCGG 179
Y + +G G Y +V E ++ T R +KILK P + +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
NV++L+D++ ++ + ++ EY V Y +L+ L+Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 292
HSQGI+H+D+KP N+++ L++ G+AE HP + S F+ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 293 DLQDYD-YSLDMWSLG 307
L + + +D+WS G
Sbjct: 185 GLDTFSGFKVDIWSAG 200
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 51/231 (22%), Positives = 107/231 (46%), Gaps = 36/231 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
DD+++ R +G+GK+ V+ +K+L + + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
PN++++ + D K L+ E+ + +K L + + ++ EL AL YC
Sbjct: 74 -PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------EYNVRVASRYFK 286
H + ++HRD+KP N+++ ++ L++ D+G + + P +Y +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDY---LP----- 180
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKV 336
PE++ + +D +D+W G + + PF +H + +I V
Sbjct: 181 -PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNV 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 55/237 (23%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC------- 177
Y +VRK+G G +S V+ ++ N +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 178 ---GGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
G +++KLLD + + ++FE + ++ + + ++ +L
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELR-----KLRLIDWGLAEFYHPGKEYNVRVAS 282
L LDY H + GI+H D+KP NV+++ ++++ D G A +Y + Y + +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 198
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKI 333
R ++ PE+L+ + D+WS C+ +I F + + D + +I
Sbjct: 199 REYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQI 253
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLL 186
++GRG + V++G++ T L+ K K K E ++L+ L PN+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 187 DIVRDQHSKTPSLIF--EYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG-- 239
D ++ E + S + + + +R + ++LK L + H++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
I+HRD+K N+ I +++ D GLA V + + F PE+ + YD
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208
Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
S+D+++ G M + P + N Q+ +
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRV 242
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 56/249 (22%), Positives = 112/249 (44%), Gaps = 50/249 (20%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNL----CGGP 180
+ V+RK+G G + V +++ + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 181 NVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
N+VK ++ + PSL +E + ++ + I+ Y E+LKA
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRK------------------------LRLIDWGLA 267
L+Y + H D+KP N+++D + ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
F ++ + +R ++ PE++++L +D S DMWS GC+ A + + F H++
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265
Query: 328 DQLVKIAKV 336
+ L + +
Sbjct: 266 EHLAMMESI 274
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 25/218 (11%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI--LKPVKKKKIKREIKILQNLCGGPN 181
+E+V VG G Y +V++G +V T + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 182 VVKLLDIVRDQHSKTPS----LIFEY---------VNSTDFKVLYPTLTDYDIRYYIYEL 228
+ ++ L+ E+ + +T TL + I Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 287
L+ L + H ++HRD+K NV++ +++L+D+G+ A+ N + + Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 288 PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
PE++ ++ YD+ D+WSLG M P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 28/200 (14%)
Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIV 189
+G+G Y V+ G +++ R IK + + + EI + ++L N+V+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 190 RDQHSKTPSLIFEYVN----STDFKVLYPTLTDYD--IRYYIYELLKALDYCHSQGIMHR 243
+ + E V S + + L D + I +Y ++L+ L Y H I+HR
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 296
D+K NV+I+ L++ D+G + + + + F G PE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 297 YDYSLDMWSLGC----MFAG 312
Y + D+WSLGC M G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 55/245 (22%), Positives = 108/245 (44%), Gaps = 46/245 (18%)
Query: 127 YEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
YE+V +G G + +V E + + + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
V + D I + + FE++ +F+ +R+ Y+L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQPYPLPH----VRHMAYQLC 133
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRK------------------LRLIDWGLAEFYH 271
AL + H + H D+KP N++ + + +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
+ VA+R+++ PE++++L + D+WS+GC+ +R F H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249
Query: 332 KIAKV 336
+ K+
Sbjct: 250 MMEKI 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 51/249 (20%), Positives = 107/249 (42%), Gaps = 54/249 (21%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
YE+V +G G + +V E I+ +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
V++L+ IV + S ++++ F IR Y++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFLPFRLDH----IRKMAYQIC 128
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELR------------------KLRLIDWGLAEFYH 271
K++++ HS + H D+KP N++ ++++D+G A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNH 327
+ V++R+++ PE+++ L + D+WS+GC + G F HD+
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240
Query: 328 DQLVKIAKV 336
+ L + ++
Sbjct: 241 EHLAMMERI 249
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-26
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
+D+++V+ +G G Y EV +N T E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
NVVK + ++ + EY + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
H GI HRD+KP N+++D L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 47/193 (24%), Positives = 91/193 (47%), Gaps = 17/193 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPNV 182
D Y+ V+ +G G + + T E +K + + ++REI ++L PN+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78
Query: 183 VKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
V+ +++ TP+ + EY + + ++ + R++ +LL + YCH
Sbjct: 79 VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 237 SQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
S I HRD+K N ++D +L++ D+G ++ + V + + PE+L+ Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192
Query: 296 DYD-YSLDMWSLG 307
+YD D+WS G
Sbjct: 193 EYDGKIADVWSCG 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 56/229 (24%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKK------------------- 164
Y + ++G+G Y V N N N +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 165 -------KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT- 215
++ +EI IL+ PNVVKL++++ D + ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
L++ R+Y +L+K ++Y H Q I+HRD+KP N+++ + +++ D+G++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDA 192
Query: 276 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDMWSLGC-MFAGMIFRKEPF 320
+ V + F PE L + + + +LD+W++G ++ +F + PF
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPF 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 48/228 (21%)
Query: 115 ESLTVQW-GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKRE 169
+S + W ++DDYE+ +G G + V E+ IK + ++ +E
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63
Query: 170 IKILQNLCGGPNVVK----------------------LLDIVRDQHSKTPSLIFEYVNST 207
I+ + C PN+V +LDI++ +K
Sbjct: 64 IQAMS-QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------- 114
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
L + I + E+L+ L+Y H G +HRDVK N+++ + +++ D+G++
Sbjct: 115 -----SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS 168
Query: 268 EFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCM 309
F G + + F G PE++ ++ YD+ D+WS G
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 21/194 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
Y + +G G + +V G + T + +KIL K KIKREI+ L+ P
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71
Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
+++KL ++ TP+ F EYV+ D+ + + + + R ++L A+DY
Sbjct: 72 HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
CH ++HRD+KP NV++D + ++ D+GL+ G+ S + PE++
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 184
Query: 295 QDYD-YSLDMWSLG 307
+ Y +D+WS G
Sbjct: 185 RLYAGPEVDIWSCG 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 33/244 (13%), Positives = 74/244 (30%), Gaps = 53/244 (21%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNL--- 176
+G+ E + T E + + ++ K++K E+ L+ L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 177 ---------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-------- 207
++++ RD + ++ + S
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 208 -DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
+ +L + ++++ L H G++H ++P ++++D + L +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEH 252
Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFR 316
V SR F+ PEL +S D W+LG + +
Sbjct: 253 L---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 317 KEPF 320
P
Sbjct: 310 DLPI 313
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
Y + +G G + +V + T ++ +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYC 235
+++KL D++ TP+ I EY D+ V +T+ + R + +++ A++YC
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
H I+HRD+KP N+++D L +++ D+GL+ G S + PE++ +
Sbjct: 125 HRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182
Query: 296 DYD-YSLDMWSLG 307
Y +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
+D+++V+ +G G Y EV +N T E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
NVVK + ++ + EY + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
H GI HRD+KP N+++D L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
Y + +G G + +V G + T + +KIL K KI+REI+ L+ P
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76
Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
+++KL ++ TPS IF EYV+ D+ L + + R ++L +DY
Sbjct: 77 HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
CH ++HRD+KP NV++D + ++ D+GL+ G+ S + PE++
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 189
Query: 295 QDYD-YSLDMWSLG 307
+ Y +D+WS G
Sbjct: 190 RLYAGPEVDIWSSG 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/194 (26%), Positives = 98/194 (50%), Gaps = 15/194 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-KKIKREIKILQNLCGGPNV 182
++ ++V+ K+G G Y V++ I+ T + IK + ++I +EI I+Q C P+V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 183 VKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDYCH 236
VK + K L + EY + +D ++ TLT+ +I + LK L+Y H
Sbjct: 87 VKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
+HRD+K N++++ E +L D+G+ + + N + + ++ PE++ +
Sbjct: 143 FMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 200
Query: 296 DYDYSLDMWSLGCM 309
Y+ D+WSLG
Sbjct: 201 GYNCVADIWSLGIT 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 42/246 (17%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------------------PVKKK 164
+DY ++R + +GK++++ N+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-----------NSTDFKVLY 213
K E++I+ ++ + I+ + +I+EY+ K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
+ I+ I +L + Y H++ I HRDVKP N+++D R ++L D+G +E Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMV 203
Query: 273 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
K+ + F PE + Y+ +D+WSLG M + P F + +L
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-FSLKISLVELF 262
Query: 332 -KIAKV 336
I
Sbjct: 263 NNIRTK 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
++ + + K+G+G + EVF+GI+ T + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 180 PNVVKLLDIVRDQHSKTPSL--IFEYVN--STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
P V K + K L I EY+ S + L + I + E+LK LDY
Sbjct: 80 PYVTKYYG----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 135
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
HS+ +HRD+K NV++ +++L D+G+ + + N V + ++ PE++
Sbjct: 136 HSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFF 321
YD D+WSLG + + P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-24
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLC 177
+ + +R++G G + V+ +V +E IK + K+ I +E++ LQ
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-L 111
Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYVN---STDFKVLYPTLTDYDIRYYIYELLKAL 232
PN ++ + + + + EY S +V L + +I + L+ L
Sbjct: 112 RHPNTIQYRG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
Y HS ++HRDVK N+++ ++L D+G A P + V + Y+ PE+++
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 223
Query: 293 DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
+ + YD +D+WSLG + RK P F +
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 6e-24
Identities = 50/288 (17%), Positives = 102/288 (35%), Gaps = 84/288 (29%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGG 179
D+E ++ +GRG + VFE N + IK + + + ++K+ RE+K L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63
Query: 180 PNVVKLLD----------------------------------------IVRDQHSKTPSL 199
P +V+ + I R T +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 200 IFEYVNSTDFKVLY--------PTLTDY-------------DIRYYIYELLKALDYCHSQ 238
+ + S+ LY L D+ + ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 287
G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 184 GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
PE + +Y + +D++SLG + +++ F + + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
+ Y K+G+G V+ ++V T + I+ + + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
N+V LD + L + EY+ TD V + + I E L+AL++
Sbjct: 78 NIVNYLD----SYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFL 132
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
HS ++HRD+K N+++ + ++L D+G A+ + + V + Y+ PE +V
Sbjct: 133 HSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTR 190
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
+ Y +D+WSLG M MI + P+ +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 48/212 (22%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
+ + K+G G V ++ + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 181 NVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALD 233
NVV++ +V ++ L + E++ TD V L + I +L+AL
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 292
Y H+QG++HRD+K ++++ + +++L D+G A+ + V + Y+ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
Y +D+WSLG M M+ + P+F
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP 180
+ +E+V ++G G + +V++ N T K+++ + + EI+IL C P
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76
Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDY 234
+VKLL + L + E+ L LT+ I+ ++L+AL++
Sbjct: 77 YIVKLLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
HS+ I+HRD+K NV++ E +RL D+G+ A+ ++ + + + Y+ PE+++
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 294 LQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
YDY D+WSLG M + P +
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 6e-23
Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQN 175
+ YE++ +G+G V T E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 176 LCGGPNVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDF-KVLYP-TLTDYDIRYYIY 226
L PN+V I ++ L + ++ D + + + I Y +
Sbjct: 82 LFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRY 284
+LKALDY H G +HR VK +++I + K+ L H ++ V +Y
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 285 FKG------PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
PE+L +LQ YD D++S+G + PF
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 79 DKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWG-------DQDDYEVVR 131
++E+ ++ Y V Y + +QW ++ + R
Sbjct: 131 QRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190
Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNV 182
+G+G + EV T + K L+ KK+IK+ E +IL+ V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILE-KVNSRFV 246
Query: 183 VKLLDIVRDQHS--KTPS---LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKAL 232
V L +T L+ +N D + + + +Y E+ L
Sbjct: 247 VSL-------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
+ H + I++RD+KP N+++D +R+ D GLA G+ RV + + PE++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + Y +S D W+LGC+ MI + P F + ++ +
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVER 399
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQ- 174
+D+ V R +GRG + EV+ +T + +K L KK+IK E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245
Query: 175 -NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
+ P +V + TP I + +N D L ++ D+R+Y
Sbjct: 246 VSTGDCPFIVCM-------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
E++ L++ H++ +++RD+KP N+++D +R+ D GLA K+ + V + +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC-DFSKKKPHASVGTHGY 356
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
PE+L YD S D +SLGCM ++ P F H D+
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDK 399
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 43/225 (19%), Positives = 91/225 (40%), Gaps = 15/225 (6%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
+ +D E + ++G G +V++ T +K + + K+I ++ ++
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVN--STDFKVLYP-TLTDYDIRYYIYELLKALDYC 235
P +V+ + E + + K + + + ++KAL Y
Sbjct: 83 CPYIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 236 HSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE----L 290
+ G++HRDVKP N+++D +++L D+G++ K + + PE
Sbjct: 141 KEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
DYD D+WSLG + + P+ + + L K+ +
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 32/241 (13%), Positives = 73/241 (30%), Gaps = 50/241 (20%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGP 180
+G+ E + T E + + ++ K++K E+ L+ L G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 181 NVVKLLDIVRD-------QHSKTPSLIFEYVNSTDFKVLY-------------------- 213
N + +R + + +I ++ D VL
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 214 ------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+L + ++++ L H G++H ++P ++++D + L +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 258
Query: 268 EFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEP 319
G + + +L Q ++ D W+LG + P
Sbjct: 259 V--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 320 F 320
Sbjct: 317 N 317
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 73 YEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQ-------D 125
+ + + + P + + + Y +QW D
Sbjct: 126 LDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGED 185
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNL 176
+ R +GRG + EVF T + K L KK++K+ E KIL
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKRKGYQGAMVEKKILA-K 241
Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTDFKV-LYPTLTDYDI------RYY 224
+V L +T + L+ +N D + +Y D +Y
Sbjct: 242 VHSRFIVSL-------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASR 283
+++ L++ H + I++RD+KP NV++D + +R+ D GLA E + +
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
F PELL+ ++YD+S+D ++LG MI + P F
Sbjct: 354 GFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP-FRARG 393
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCG 178
+D++ + +G G +S V + T+ IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKA 231
P VKL + + Y + + K + + + R+Y E++ A
Sbjct: 89 HPFFVKLY------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
L+Y H +GI+HRD+KP N++++ ++ +++ D+G A+ + R S F G
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQY 198
Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PELL + + S D+W+LGC+ ++ PF N +
Sbjct: 199 VSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLI 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 17/212 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK----KKKIKREIKILQNLCGGPN 181
YEV + G ++ ++ N N R + +K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS 237
+V++ + V + + EYV K L + Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
G+++ D+KP N+M+ E +L+LID G + + F+ PE++
Sbjct: 201 IGLVYNDLKPENIMLTEE--QLKLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
+ D++++G A + + +
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 51/250 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
DD+E+++ +GRG +SEV T + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 177 CGGPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYEL 228
+ +L + + + L+ EY D +L + R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 286
+ A+D H G +HRD+KP N+++D +RL D+G + V S
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSC------LKLRADGTVRSLVAV 224
Query: 287 G------PELL------VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQL-VK 332
G PE+L Y D W+LG + M + + PF+ D+ + K
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAETYGK 281
Query: 333 IAKVTTILDF 342
I L
Sbjct: 282 IVHYKEHLSL 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 39/218 (17%), Positives = 83/218 (38%), Gaps = 58/218 (26%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGP 180
+D + + ++GRG Y V + ++ + + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 181 NVVK---------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
+V+ + +S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 220 DIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
+ +KAL++ I+HRD+KP N+++D ++L D+G++ +
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS------GQLVD 178
Query: 279 RVASRYFKG------PELL---VDLQDYDYSLDMWSLG 307
+A G PE + Q YD D+WSLG
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 22/195 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
DD+E + ++G G VF+ + + K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 237
+V S+ E+++ + + ++K L Y
Sbjct: 92 YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 238 QG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLV 292
+ IMHRDVKP N++++ +++L D+G++ G+ N V +R + PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL- 202
Query: 293 DLQDYDYSLDMWSLG 307
Y D+WS+G
Sbjct: 203 QGTHYSVQSDIWSMG 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 46/245 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
+DYEVV+ +GRG + EV + +T + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127
Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELL 229
P VV+L ++ + ++ EY+ D L +++YD+ R+Y E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 287
ALD HS G +HRDVKP N+++D L+L D+G + N V G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC------MKMNKEGMVRCDTAVG 231
Query: 288 ------PELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVT 337
PE+L Y D WS+G M+ PF+ D+ KI
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYSKIMNHK 289
Query: 338 TILDF 342
L F
Sbjct: 290 NSLTF 294
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 49/248 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
+D+E+++ +GRG + EV N ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYE 227
+ L H + + L+ +Y D +L L + R+Y+ E
Sbjct: 131 GDSKWITTL-------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYF 285
++ A+D H +HRD+KP N+++D +RL D+G + + V S
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC------LKLMEDGTVQSSVA 236
Query: 286 KG------PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIA 334
G PE+L ++ Y D WSLG M++ + PF+ ++ + KI
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVETYGKIM 294
Query: 335 KVTTILDF 342
F
Sbjct: 295 NHKERFQF 302
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
D ++ ++ +G G + V + + +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 179 GPNVVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKAL 232
P +VKL + K S ++ EYV + F L ++ R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
+Y HS +++RD+KP N++ID + +++ D+G A K R + G
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFA------KRVKGRTWT--LCGTPEAL 205
Query: 288 -PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PE+++ + Y+ ++D W+LG + M PFF D Q+
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI 246
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
D+ ++ +G+G + +V + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
P +V L H +T + +Y+N + F L + R+Y E+
Sbjct: 96 VKHPFLVGL-------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNV 278
AL Y HS I++RD+KP N+++D + + L D+GL E EY
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEY-- 205
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
+A PE+L Q YD ++D W LG + M++ PF+ N ++
Sbjct: 206 -LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEM 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 46/231 (19%), Positives = 96/231 (41%), Gaps = 38/231 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
D +E++R +G+G + +V +T + +K + ++ + +E++I+Q L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
P +V L + ++ + + D L + ++ +I EL+
Sbjct: 74 HPFLVNL-------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
ALDY +Q I+HRD+KP N+++D + + D+ +A G
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIA------AMLPRETQITTMAGTKP 179
Query: 288 ---PELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF-YGHDNHDQLVK 332
PE+ Y +++D WSLG ++ + P+ + ++V
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 49/237 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
D++++R +GRG Y++V T+ +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
P +V L HS +T S + EYVN D + L + R+Y E+
Sbjct: 69 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 177
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQL 330
A PE+L +DY +S+D W+LG + M+ + PF + D L
Sbjct: 178 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
D++E +R +G+G + +V T + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
P + +L +TP + E+VN D + + + R+Y E
Sbjct: 80 ARNHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
++ AL + H +GI++RD+K NV++DHE +L D+G+ E G +Y
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDY- 190
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
+A PE+L + Y ++D W++G + M+ PF +N D L
Sbjct: 191 --IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE--AENEDDL 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKL 185
+ V +K+G G + E+ G N+ TNE IK+ + ++ E + + L G + ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
PSL E + F + T + + +L+ ++Y HS+
Sbjct: 71 YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
+++RDVKP N +I + + + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 56/293 (19%), Positives = 111/293 (37%), Gaps = 70/293 (23%)
Query: 102 DVNVLRPKEYWDYESLTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK 159
D P +Y V+ GD Y V+RK+G G +S V+ ++ + +K++K
Sbjct: 12 DDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71
Query: 160 PVKK--KKIKREIKILQNLC-------GGPNVVKLLDI--VRDQHSKTPSLIFEY--VNS 206
+ + EI++L+++ VV+LLD + + ++FE +
Sbjct: 72 SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHL 131
Query: 207 TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI----------- 252
+ + L ++ I ++L+ LDY H++ I+H D+KP N+++
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 253 -------------------------------------DHELRKLRLIDWGLAEFYHPGKE 275
+ E K+++ D G A K
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 249
Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
+ + +R ++ E+L+ Y+ D+WS CM + + F H +
Sbjct: 250 FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLFEPHSGEE 300
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
+D++ ++ +G+G + +V T +KIL+ K+ I + E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61
Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
P + L +T + EY N + F L T+ R+Y E+
Sbjct: 62 TRHPFLTAL-------KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
+ AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--F 165
Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
G PE+L D DY ++D W LG + M+ + P FY +H++L
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYN-QDHERL 213
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 58/237 (24%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
D+ + +G+G + +V T+E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
P + +L HS +T + EYVN D + + +Y E
Sbjct: 77 PGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
+ L + S+GI++RD+K NVM+D E +++ D+G+ E G +Y
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDY- 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQL 330
+A PE++ Q Y S+D W+ G M AG + F G ++ D+L
Sbjct: 188 --IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEG-EDEDEL 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 49/237 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
D++++R +GRG Y++V T+ ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
P +V L HS +T S + EYVN D + L + R+Y E+
Sbjct: 112 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y +
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 220
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQL 330
A PE+L +DY +S+D W+LG + M+ + PF + D L
Sbjct: 221 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 46/231 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
D+ + +G+G + +V T+E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYEL 228
P + +L HS +T + EYVN D + + +Y E+
Sbjct: 399 GKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
L + S+GI++RD+K NVM+D E +++ D+G+ KE V + F
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC------KENIWDGVTTKT--F 502
Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
G PE++ Q Y S+D W+ G + M+ + P F G ++ D+L
Sbjct: 503 CGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEG-EDEDEL 550
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
Y + RK+G G + +++ G ++ E IK+ K ++ E KI + + GG + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
+ PSL E + F + + +++ ++Y HS+
Sbjct: 71 RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
+HRDVKP N ++ + + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 52/230 (22%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
+D+ + + +G+G + +VF TN+ IK LK V E ++L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLK 230
P + + +T + EY+N D + +Y E++
Sbjct: 77 HPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
L + HS+GI++RD+K N+++D + +++ D+G+ E +Y +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDY---I 185
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
A PE+L+ Q Y++S+D WS G + M+ + P F+G + ++L
Sbjct: 186 A------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEEL 226
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 31/156 (19%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
Y+V R++G G + +FEG N+ N++ IK +++ E + + L G + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
++ PSL E + + + + ++L + H +
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
+++RD+KP N +I + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
Y++V K+G G S V+ + N + IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
N+V ++D+ + L+ EY+ + L+ + ++L + + H
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
I+HRD+KP N++ID L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 42/197 (21%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
DD E + ++GRG Y V + +V + + +K + ++K++ ++ I P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN-STD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
V + + + E ++ S D T+ + + ++KAL++
Sbjct: 67 FTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 235 CHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE---L 290
HS+ ++HRDVKP NV+I+ ++++ D+G++ + ++ + + PE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 291 LVDLQDYDYSLDMWSLG 307
++ + Y D+WSLG
Sbjct: 184 ELNQKGYSVKSDIWSLG 200
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 27/169 (15%), Positives = 63/169 (37%), Gaps = 21/169 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPNVVK 184
+ + +K+G G + ++ N E+ ++K + + E+K Q + + K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 185 LLDIVRDQHSKTPSLIF---EYVNSTDFKV-----LYPTLTDYDIRYYIY---------- 226
++ + + P ++ L L + +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
+L L+Y H +H D+K N+++ ++ ++ L D+GL+ Y P
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 48/226 (21%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
D++++R +G G + V + + +K+LK V + K E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64
Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
P ++++ + +I +Y+ + F +L + ++Y E+
Sbjct: 65 HPFIIRM-------WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
AL+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFA------KYVPDVTYT--LCGTPD 168
Query: 288 ---PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PE++ + Y+ S+D WS G + M+ PF+ N +
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT 211
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 53/235 (22%)
Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKKKIKR--------EIKIL 173
+E+++ +G+G + +VF + + + +K+LK K +K E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80
Query: 174 QNLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
P +VKL H +T LI +++ D F L T+ D+++Y+
Sbjct: 81 VE-VNHPFIVKL-------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------E 275
EL ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K E
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
Y +A PE++ + + S D WS G + M+ PF + +
Sbjct: 192 Y---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ--GKDRKET 234
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 57/224 (25%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
+++E ++ +G+G + +V T +KILK K+ + + E ++LQN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204
Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
P + L +T + EY N + F L ++ R+Y E+
Sbjct: 205 SRHPFLTAL-------KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
+ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + +
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
PE+L D DY ++D W LG + M+ + PF+ + +H++L
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKL 357
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 38/217 (17%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPN 181
D + EV VGRG + V + + IK ++ +K E++ L + PN
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
+VKL L+ EY + + VL+ P T + + + + Y
Sbjct: 63 IVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 236 HS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
HS + ++HRD+KP N+++ L++ D+G A +
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGSA 167
Query: 288 ----PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE+ +Y D++S G + +I R++PF
Sbjct: 168 AWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 58/242 (23%), Positives = 112/242 (46%), Gaps = 54/242 (22%)
Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
+++E+++ +G G Y +VF + +T + +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
++ P +V L H +T + LI +Y+N + F L T+++++ Y+
Sbjct: 114 HIRQSPFLVTL-------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVRVAS 282
E++ AL++ H GI++RD+K N+++D + L D+GL+ KE R
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS------KEFVADETERAYD 219
Query: 283 RYFKG------PELLVDL-QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLV 331
F G P+++ +D ++D WSLG + G F +
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQA 272
Query: 332 KI 333
+I
Sbjct: 273 EI 274
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 5e-16
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 57/238 (23%)
Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
+ +E++R +G+G Y +VF + NT + +K+LK V+ K K E IL+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
P +V L +T LI EY++ + F L + +Y+
Sbjct: 77 E-VKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EY 276
E+ AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G EY
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQL 330
+A PE+L+ ++ ++D WSLG M G P F G +N +
Sbjct: 188 ---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTG-ENRKKT 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
+ + RK+G G + E++ G N+ TNE IK+ K ++ E KI + L GG + +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
+ PSL E + F L+ + +++ +++ HS+
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
+HRD+KP N ++ ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKI---LQNLC 177
Y + R VGRG +V+E + +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
P+VV + D + + +N D + L + ++ ALD
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
H+ G HRDVKP N+++ + L+D+G+A
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIA 181
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 33/225 (14%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGG 179
D +G+G + + + + T E ++K L ++ +E+K+++ L
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH- 66
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-ALD----- 233
PNV+K + ++ K + I EY+ L + D +Y + + A D
Sbjct: 67 PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 234 -YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---------YHPGKEYNVRVASR 283
Y HS I+HRD+ HN ++ + + D+GLA + R
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
G PE++ + YD +D++S G + +I R
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 52/231 (22%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKI 172
++ E +++G+G + V +G V IK L K ++ +RE+ I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-A 231
+ NL PN+VKL ++ + P ++ E+V D LY L D L+
Sbjct: 77 MSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLM 128
Query: 232 LD------YCHSQG--IMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYHPGKEYNVR 279
LD Y +Q I+HRD++ N+ + ++ D+GL+ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------Q 177
Query: 280 VASRYFKG---------PELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 320
+ G PE + ++ Y D +S + ++ + PF
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
YE+ +G G SEV ++ + +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 181 NVVKLLDI--VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
+V + D P ++ EYV+ + + +T I + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 27/208 (12%)
Query: 117 LTVQWG-DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREI 170
+ G D + K+ E+++G + ++K+LK K + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEEC 58
Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYI- 225
L+ PNV+ +L + + P+LI ++ + + VL+ + D
Sbjct: 59 PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 226 YELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VA 281
++ + + + H+ I + +VMID ++ R+ + F PG+ Y VA
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQSPGRMYAPAWVA 176
Query: 282 SRYFKGPELLVDLQDYDYSL--DMWSLG 307
PE L + DMWS
Sbjct: 177 ------PEALQKKPEDTNRRSADMWSFA 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 23/190 (12%), Positives = 57/190 (30%), Gaps = 38/190 (20%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGP 180
Y ++ G + ++ ++ + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
V ++LD+V + ++ E++ + V + + + L A D H G
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
+ P V + + G +V +A +
Sbjct: 150 VALSIDHPSRVRVSID---------G-----------DVVLAYPATMPDA--------NP 181
Query: 300 SLDMWSLGCM 309
D+ +G
Sbjct: 182 QDDIRGIGAS 191
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 29/173 (16%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 127 YEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
++V +G+G + ++ +V ++ C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLYPTLTDYDIRYYI------------- 225
+ K + + ++ P N ++ + D++
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 226 ---YELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
+L L+Y H +H D+K N++++++ ++ L+D+GLA Y P
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 4e-13
Identities = 36/258 (13%), Positives = 71/258 (27%), Gaps = 67/258 (25%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKR 168
+ + K+G G + EVF+ I + IKI+ ++I
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 169 EIKILQNLCG--------GPNVVKLLD--IVRDQHSK----------------------- 195
EI I + L + L V+ +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 196 ---TPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHN 249
++ E+ ++ + + +++L +L + HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
V++ + Y + S L V + DY S +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 310 FAGMIFRKEPFFYGHDNH 327
F + E F G ++
Sbjct: 239 FCDV-SMDEDLFTGDGDY 255
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 35/223 (15%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
+ E+ +G+G++ +V+ G + I+++ + K KRE+ +
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYPTLTDYDIRYYI---YELLKA 231
NVV + P L I T + V+ D+ E++K
Sbjct: 88 H-ENVVLFMGAC----MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
+ Y H++GI+H+D+K NV D+ K+ + D+GL + R G
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 288 --PELL--------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
PE++ D + D+++LG ++ + R+ PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 37/214 (17%), Positives = 83/214 (38%), Gaps = 30/214 (14%)
Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIKILQ-NL 176
VQ + +G+G++ EV+ G + +KI +++ RE +I Q +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFREAEIYQTVM 92
Query: 177 CGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKAL 232
N++ + + L+ +Y + + F L + + L
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 152
Query: 233 DYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
+ H + I HRD+K N+++ + D GLA + + + +A +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDT-IDIAPNH 210
Query: 285 FKG------PELL---VDLQDYDYSL--DMWSLG 307
G PE+L ++++ ++ D++++G
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 41/230 (17%), Positives = 96/230 (41%), Gaps = 37/230 (16%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYIYELLK-ALD-- 233
N++ + +++ ++ S+ LY L + ++ + +L+ A
Sbjct: 79 H-VNILLFMGYSTAPQ---LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTA 130
Query: 234 ----YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
Y H++ I+HRD+K +N+ + + +++ D+GLA + G
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQL---SGSI 186
Query: 288 ----PELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PE++ YS D+++ G + ++ + P+ +N DQ++
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ- 174
L VQ ++V+++G+G+Y EV+ G E+ +K+ ++ RE +I Q
Sbjct: 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQT 85
Query: 175 NLCGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLK 230
L N++ + LI +Y N + + L T D + Y +
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145
Query: 231 ALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
L + H++ I HRD+K N+++ + D GLA + V +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTN-EVDIPP 203
Query: 283 RYFKG------PELL---VDLQDYDYSL--DMWSLG 307
G PE+L ++ + + DM+S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 43/204 (21%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC 177
D + K+G G + V ++ +KIL + RE+ I++ L
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
PN+V + V S++ EY+ + +++L+ L + Y++ K
Sbjct: 93 H-PNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 232 LDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
++Y H++ I+HR++K N+++D + +++ D+GL+ + + ++S+ G
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRL-----KASTFLSSKSAAGTP 203
Query: 288 ----PELLVDLQDYDYSLDMWSLG 307
PE+L D + + D++S G
Sbjct: 204 EWMAPEVLRD-EPSNEKSDVYSFG 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 28/204 (13%)
Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVVKLL 186
++ VG+G+Y EV+ G N +KI +K RE ++ + N++ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 187 --DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCHSQ---- 238
D+ S LI Y + + L T D I + L + H +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 288
I HRD+K N+++ + + D GLA + + V + G P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186
Query: 289 ELL-----VDLQDYDYSLDMWSLG 307
E+L VD D +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 28/176 (15%), Positives = 58/176 (32%), Gaps = 30/176 (17%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKKKIKREIKILQNLCG 178
+++ R ++E +T ++ +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-----LYPTLTDYDIRYY--------- 224
V K + P+ + V+ ++ L +L +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA-LDVSPKHVLSERS 160
Query: 225 ----IYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275
LL AL++ H +H +V N+ +D E ++ L +G A Y P +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 41/223 (18%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQN 175
D + + +G G + +V+ + +K + + +++E K+
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALD 233
L PN++ L + + L+ E+ +VL DI ++ + ++
Sbjct: 63 LKH-PNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 234 YCHSQG---IMHRDVKPHNVMIDHELRK-------LRLIDWGLAEFYHPGKEYNVRVASR 283
Y H + I+HRD+K N++I ++ L++ D+GLA +H + +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------ 173
Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
G PE++ + D+WS G + ++ + PF
Sbjct: 174 -AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 41/230 (17%), Positives = 88/230 (38%), Gaps = 46/230 (20%)
Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIK 171
++ D+ +++ +GRG+Y V++G +ER + +K+ ++ E
Sbjct: 4 AASEPSLDL---DNLKLLELIGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINEKN 57
Query: 172 I-----LQNLCGGPNVVKLL--DIVRDQHSKTP-SLIFEYV-NSTDFKVLYPTLTDYDIR 222
I +++ N+ + + D + L+ EY N + K L +D+
Sbjct: 58 IYRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS 113
Query: 223 YYI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
+ + + + L Y H++ I HRD+ NV++ ++ + D+GL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTG 172
Query: 273 GKEYNVRVASRYFKG---------PELL------VDLQDYDYSLDMWSLG 307
+ PE+L D + +DM++LG
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 44/220 (20%), Positives = 84/220 (38%), Gaps = 32/220 (14%)
Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKRE 169
E+L Q +++ RG++ V++ NE +KI K+ + + E
Sbjct: 14 LGTENLYFQS---MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 170 IKILQNLCGGPNVVKLL--DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI- 225
+ L + N+++ + + LI + + L + ++ +I
Sbjct: 69 VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 226 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
+ + L Y H I HRD+K NV++ + L + D+GLA + GK
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKS 186
Query: 276 YNVRVAS----RYFKGPELLVD----LQDYDYSLDMWSLG 307
RY PE+L +D +DM+++G
Sbjct: 187 AGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMG 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQ 174
++ + +R +G G + +V NT E+ +K LKP +K+EI+IL+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELL 229
NL N+VK I + LI E++ S K Y + Y ++
Sbjct: 79 NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
K +DY S+ +HRD+ NV+++ E + +++ D+GL + KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEY 182
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 17/192 (8%)
Query: 130 VRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
+R +G G + +V N T E +K LK P + K+EI IL+ L +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
++K D + + L+ EYV + + ++ + + ++ + + Y H+Q
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 295
+HRD+ NV++D++ +++ D+GLA + Y VR PE L + +
Sbjct: 155 YIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 296 DYDYSLDMWSLG 307
+ Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 28/230 (12%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCG 178
+ +D + ++GRG + EVF G N +K + K K +E +IL+
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS- 170
Query: 179 GPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKAL 232
PN+V+L+ + + P I E V DF + L + + + +
Sbjct: 171 HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GP 288
+Y S+ +HRD+ N ++ + L++ D+G++ G Y R K P
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADG-VYAASGGLRQVPVKWTAP 284
Query: 289 ELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
E L + YS D+WS G ++ P + N + K
Sbjct: 285 EALNYGR---YSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEK 330
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 54/310 (17%), Positives = 113/310 (36%), Gaps = 31/310 (10%)
Query: 40 APIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARV 99
P+ HH R+S ++ + + + L V
Sbjct: 5 DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64
Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IK 156
+ D++ L P+ + + + +GRG + V+ G ++ + + I +K
Sbjct: 65 HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123
Query: 157 ILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
L + + + E I+++ PNV+ LL I P ++ Y+ D +
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN- 180
Query: 213 Y-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+ T D+ + ++ K + + S+ +HRD+ N M+D + +++ D+GLA
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLA 239
Query: 268 EFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKE 318
+ + +V + E L Q + D+WS G ++ M
Sbjct: 240 RDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 319 PFFYGHDNHD 328
P + + D
Sbjct: 296 P-YPDVNTFD 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 43/225 (19%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 276
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDY 234
N+V+LL + + P I E++ D+ + ++ + Y ++ A++Y
Sbjct: 277 NLVQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
+ +HR++ N ++ +++ D+GL+ G Y +++ + PE L
Sbjct: 334 LEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391
Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+W+ G ++ + P + G D + K
Sbjct: 392 AY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK---PVKKKKIKREIKILQN 175
++ + + ++G+G + V NT +K L+ P +++ +REI+IL+
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
L +VK + ++ L+ EY+ S DF + L + Y ++ K
Sbjct: 81 L-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--G 287
++Y S+ +HRD+ N++++ E +++ D+GLA+ K+ Y VR +
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 288 PELLVDLQDYDYSLDMWSLG 307
PE L D + D+WS G
Sbjct: 199 PESLSDNI-FSRQSDVWSFG 217
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 46/230 (20%), Positives = 104/230 (45%), Gaps = 25/230 (10%)
Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEV-------VRKVGRGKYSEVFEG----INVN 148
+ D ++ + + ++ + D+D + ++++G+G + V + N
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 149 TNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
T E +K L+ ++ ++ REI+IL++L N+VK + + LI EY+
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 206 S---TDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
D+ + + + Y ++ K ++Y ++ +HRD+ N+++++E R +++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKI 186
Query: 262 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
D+GL + Y V+ PE L + + + + D+WS G
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFG 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPV----KKKKIKREIKILQN 175
+GRG + V+ G ++ + + I +K L + + + E I+++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 82
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLK 230
PNV+ LL I +P ++ Y+ D + + T D+ + ++ K
Sbjct: 83 FS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAK 139
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRY 284
+ Y S+ +HRD+ N M+D + +++ D+GLA E+Y + ++ ++
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 285 FKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
E L Q + D+WS G ++ M P + + D
Sbjct: 199 M-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 42/200 (21%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEG----INVNTNERCIIKILKPVKKKKIK---REIKILQN 175
++ + ++++G+G + V + NT E +K L+ ++ ++ REI+IL++
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
L N+VK + + LI EY+ D+ + + + Y ++ K
Sbjct: 68 LQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--G 287
++Y ++ +HRD+ N+++++E R +++ D+GL + + V+
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 288 PELLVDLQDYDYSLDMWSLG 307
PE L + + + + D+WS G
Sbjct: 186 PESLTESK-FSVASDVWSFG 204
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ + K+G+G + EV+ G N R IK LKP + + +E ++++ L
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 322
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
+V+L +V S+ P I EY++ L + ++ + Y
Sbjct: 323 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
+HRD++ N+++ L ++ D+GLA EY R +++ K PE
Sbjct: 379 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436
Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + D+WS G + + P + G N + L ++ +
Sbjct: 437 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 32/233 (13%)
Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
DYE+ R +G G++ +V +GI ++ + IK K ++K +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRY 223
++ P++VKL+ ++ ++ P I E + + + +L +
Sbjct: 442 ALTMRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLIL 495
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 284 YFKG--PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
K PE + + + + D+W G CM+ ++ +P F G N+D + +I
Sbjct: 555 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 47/225 (20%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ + K+G+G + EV+ G N R IK LKP + + +E ++++ L
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 239
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
+V+L +V S+ P I EY++ L + ++ + Y
Sbjct: 240 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
+HRD++ N+++ L ++ D+GLA EY R +++ + PE
Sbjct: 296 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353
Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + D+WS G + + P + G N + L ++ +
Sbjct: 354 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
DYE+ R +G G++ +V +GI ++ + IK K ++K +E
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66
Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
++ P++VKL+ ++ ++ P I E + +V +L + Y
Sbjct: 67 ALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 25/163 (15%)
Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
Y + R +G G + EV+EG+ N I +K K K+K E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
I++NL P++VKL+ I+ + P+ I E + + +L + Y
Sbjct: 64 AVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
++ KA+ Y S +HRD+ N+++ ++L D+GL+
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLS 160
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 45/226 (19%), Positives = 87/226 (38%), Gaps = 28/226 (12%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGI---NVNTNERCIIKILKPV----KKKKIKREIKILQN 175
++ R +G+G + V+ G +C IK L + + + RE +++
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK----VLYPTLTDYDIRYYIYELLKA 231
L PNV+ L+ I+ P ++ Y+ D T D+ + ++ +
Sbjct: 79 LNH-PNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
++Y Q +HRD+ N M+D +++ D+GLA + Y+V+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHR---HARLPV 192
Query: 288 ----PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
E L + D+WS G ++ + P + D D
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFD 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 31/238 (13%), Positives = 78/238 (32%), Gaps = 39/238 (16%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-------IKILKPV---KKKKIKREIKI 172
+D +G+G ++++F+G+ + +K+L + +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIY 226
+ L ++V + +++ E+V Y +
Sbjct: 66 MSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAK 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI-------DWGLAEFYHPGKEYNVR 279
+L A+ + ++H +V N+++ E + D G++ P R
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 280 V---ASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ PE + + ++ + + D WS G ++ +P D+ +L
Sbjct: 181 IPWVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 36/236 (15%)
Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
+D + R +G+G++ V E + + +K+LK ++ RE
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFK---------VLYPTL 216
++ P+V KL+ + +K +I ++ D L
Sbjct: 76 AACMKEFDH-PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
+ ++ ++ ++Y S+ +HRD+ N M+ + + + D+GL+ + G Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYY 193
Query: 277 NVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
AS+ K E L D Y D+W+ G M+ M + P + G +N +
Sbjct: 194 RQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 46/228 (20%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 69
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
N+V+LL + + P I E++ + Y ++ + Y ++ A++
Sbjct: 70 NLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
Y + +HRD+ N ++ +++ D+GL+ G Y +++ K PE
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 291 LVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
L +S+ D+W+ G ++ + P + G D + K
Sbjct: 184 ---LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 37/213 (17%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
+D + + +G G++ V EG + + +K +K + ++ E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 170 IKILQNLCGGPNVVKLLDIVRD---QHSKTPSLIFEYVNSTDFK---------VLYPTLT 217
+++ PNV++LL + + Q P +I ++ D +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
+ ++ ++ ++Y ++ +HRD+ N M+ ++ + + D+GL++ + G Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYR 204
Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
++ K E L D + Y D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 123 DQDDYEV-------VRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKI 166
D +E + +GRG + +V E T +K+LK + + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NST 207
E+KIL ++ NVV LL + +I E+
Sbjct: 78 MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+ LT + Y +++ K +++ S+ +HRD+ N+++ + +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLA 195
Query: 268 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
+ +Y + +R K PE + D + Y D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 23/147 (15%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGI-NVNTNERCI---IKILKP----VKKKKIKREIKILQ 174
+ +G G++ EV++G+ ++ ++ + IK LK ++ E I+
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELL 229
N+++L ++ P +I EY+ + + + + + +
Sbjct: 102 QFS-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHEL 256
+ Y + +HRD+ N++++ L
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNL 184
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 16/146 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
D + + + VG G++ EV G +++ I IK LK +++ E I+
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
PN+++L +V P +I EY+ + + T + + +
Sbjct: 103 FD-HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
+ Y G +HRD+ N++I+ L
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNL 184
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 29/172 (16%), Positives = 67/172 (38%), Gaps = 33/172 (19%)
Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKR 168
D++EV R++G+G + V+EG+ + R IK + ++ +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------NSTDFKVLYPT 215
E +++ +VV+LL +V +I E + + +
Sbjct: 78 EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+ + E+ + Y ++ +HRD+ N M+ + +++ D+G+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMT 185
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
+ +++ ++ +G G + V++G+ + E+ IK L+ P K+I E ++
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
++ P+V +LL I T LI + + D+ + + + + ++ K
Sbjct: 73 SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
++Y + ++HRD+ NV++ +++ D+GLA+ ++ + K
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
E ++ Y + D+WS G ++ M F +P+ G + + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 16/146 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
+ + + +G G EV G +R + IK LK +++ E I+
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
PN+++L +V ++I EY+ + + T + + +
Sbjct: 107 FDH-PNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
+ Y G +HRD+ NV++D L
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNL 188
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 38/231 (16%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQ 174
+ + ++ +G G + V +G+ + IK+++ + + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
+L ++V+LL + + L+ +Y+ + D + L + + ++ K
Sbjct: 71 SLDH-AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
+ Y G++HR++ NV++ ++++ D+G+A+ P + + ++ K
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 288 PELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
E + Y+ D+WS G ++ M F EP+ G + + K
Sbjct: 186 LE---SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 40/199 (20%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ ++V ++G G++ EV+ G N + + +K LK + E +++ L
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQ 68
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
+V+L +V ++ P I EY+ + + LT + ++ + +
Sbjct: 69 RLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
+ + +HRD++ N+++ L ++ D+GLA EY R +++ K PE
Sbjct: 124 FIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181
Query: 291 LVDLQDYDYSL--DMWSLG 307
+ +++ D+WS G
Sbjct: 182 INYGT---FTIKSDVWSFG 197
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
+++ +++++G G++ V G +K++K + + + +E + + L P
Sbjct: 6 KREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HP 63
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDY 234
+VK + ++ P I EY+++ Y L + Y++ + + +
Sbjct: 64 KLVKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
S +HRD+ N ++D +L +++ D+G+
Sbjct: 120 LESHQFIHRDLAARNCLVDRDL-CVKVSDFGMT 151
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 31/193 (16%), Positives = 71/193 (36%), Gaps = 32/193 (16%)
Query: 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR----KVGRGKYSEVFEGINVNT 149
M K + ++ + + + + V W + + + +G+G +++ ++
Sbjct: 301 MHKNGRWMSLDETKIIPNYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDF 360
Query: 150 NERCIIKILKP-----------VKKKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKT 196
+ IIK ++K + RE + L + G P + D
Sbjct: 361 D--VIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDN 413
Query: 197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
++ Y+N K + D Y++ + + H ++H D+ N + D
Sbjct: 414 KRIMMSYINGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD--- 465
Query: 257 RKLRLIDWGLAEF 269
+ L +ID+GL +
Sbjct: 466 KDLYIIDFGLGKI 478
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 30/152 (19%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
D D ++++G G++ V G IK++K + + + E K++ NL
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HE 79
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
+V+L + Q P I EY+ + + + + ++ +A++Y
Sbjct: 80 KLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
S+ +HRD+ N +++ + +++ D+GL+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQG-VVKVSDFGLS 167
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 1e-05
Identities = 45/278 (16%), Positives = 91/278 (32%), Gaps = 76/278 (27%)
Query: 72 VYEGAIIDKIEERNLAEIPLPAMSKA-------------RVYTDVNVLRPKEYWDYESLT 118
V+E A +D + +++ ++P +SK L K+ +
Sbjct: 24 VFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF- 82
Query: 119 VQWGDQDDY----EVVRKVGRGK------YSEVFEGINVNTNERCIIKILKPVKKKKIKR 168
V+ + +Y ++ R Y E + + N N+ K V + +
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQV-FAK--YNVSRLQPYL 138
Query: 169 EIKI-LQNLCGGPNVV--------K--L-LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
+++ L L NV+ K + LD+ ++ DFK+ + L
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS---------YKVQCKMDFKIFWLNL 189
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
+ + + E+L+ L +++ DH I AE
Sbjct: 190 KNCNSPETVLEMLQKL--------LYQIDPNWTSRSDHSSNIKLRIHSIQAEL------- 234
Query: 277 NVRVASRYFKGPE----LLV--DLQDYDYSLDMWSLGC 308
R K LLV ++Q+ + + ++L C
Sbjct: 235 -----RRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSC 266
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 6e-05
Identities = 45/305 (14%), Positives = 90/305 (29%), Gaps = 55/305 (18%)
Query: 57 YNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYES 116
N + I IE+R+ + +V+ NV R + Y
Sbjct: 89 INYKFLMSPIKTEQRQPSMMTRMYIEQRD------RLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 117 LTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKI--LKPVKKKKIKREIKIL 173
++ + + +G GK + + + KI L + +++L
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 174 QNLCG--GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
Q L PN D HS L I+ + LLK+
Sbjct: 203 QKLLYQIDPNWTSRSD-----HSSNIKLRIH-----------------SIQAELRRLLKS 240
Query: 232 LDYCHSQGIMHRDVKPHNV--MIDHELRKL---RLIDWGLAEFYHPGKEYNVRV--ASRY 284
Y + ++ +V+ + + L R + +F ++ + S
Sbjct: 241 KPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISLDHHSMT 297
Query: 285 FKGPELL------VDLQDYDYSLDMWSLGCMFAGMI---FRKEPF---FYGHDNHDQLVK 332
E+ +D + D ++ + +I R + H N D+L
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 333 IAKVT 337
I + +
Sbjct: 358 IIESS 362
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 43/227 (18%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ ++ +K+G G++ EV+ N + + +K +KP + + E +++ L
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HD 243
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
+VKL +V +K P I E++ + DF + + ++ + + +
Sbjct: 244 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
+ +HRD++ N+++ L ++ D+GLA EY R +++ K PE +
Sbjct: 300 IEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI 357
Query: 292 VDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+++ D+WS G + + + + P + G N + + + +
Sbjct: 358 NFGS---FTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALER 400
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
D + + +G G + +V +K+LK + E++++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
+ + N++ LL +I EY + +V
Sbjct: 95 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+T D+ Y+L + ++Y SQ +HRD+ NV++ +++ D+GLA
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 40/221 (18%)
Query: 125 DDYEV-------VRKVGRGKYSEVFEG-----INVNTNERCIIKILKP----VKKKKIKR 168
+E + +G G + +V E I + +K+LKP +++ +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 169 EIKILQNLCGGPNVVKLLDIVRDQH-------------------SKTPSLIFEYVNSTDF 209
E+K+L L N+V LL K S I +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
+ L D+ + Y++ K + + S+ +HRD+ N+++ R ++ D+GLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD 194
Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
Y V+ +R K PE + + Y + D+WS G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
+ +++ ++ +G G + V++G+ + E+ IK L+ P K+I E ++
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
++ P+V +LL I T LI + + D+ + + + + ++ K
Sbjct: 73 SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
++Y + ++HRD+ NV++ +++ D+GLA+ ++ + K
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
E ++ Y + D+WS G ++ M F +P+ G + + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 35/213 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
++ + + +G G + +V E + + +K+LK +K+ + E+KI+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSL-IFEYV-----------------NSTDFKVLYPTLT 217
L N+V LL P L I EY F + T +
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
D+ ++ ++ + + + S+ +HRDV NV++ + ++ D+GLA Y
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYI 221
Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
V+ +R K PE + D Y D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 4e-05
Identities = 39/226 (17%), Positives = 89/226 (39%), Gaps = 24/226 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
D + V+++G G++ V G ++ IK ++ + ++ E +++ L P
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HP 63
Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
+V+L + +Q P + E++ + + ++ + + Y
Sbjct: 64 KLVQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLV 292
++HRD+ N ++ +++ D+G+ F +Y +++ K PE+
Sbjct: 121 EEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEV-- 176
Query: 293 DLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
YS D+WS G M+ K P + N + + I+
Sbjct: 177 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDIST 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
+ + ++++ +G+G++ +V G + +K +K + E ++ L N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 75
Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
+V+LL ++ ++ L + EY+ + D+ L + + ++ +A++Y
Sbjct: 76 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+HRD+ NV++ + ++ D+GL
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLT 164
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 31/187 (16%), Positives = 63/187 (33%), Gaps = 40/187 (21%)
Query: 108 PKEYW--DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCIIKILKP--- 160
P Y D+ + Q +G G + +V + IK +K
Sbjct: 16 PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 161 -VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------- 204
+ E+++L L PN++ LL + L EY
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123
Query: 205 ----NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260
TL+ + ++ ++ + +DY + +HRD+ N+++ +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAK 182
Query: 261 LIDWGLA 267
+ D+GL+
Sbjct: 183 IADFGLS 189
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
D + + +G G + +V +K+LK + E++++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
+ + N++ LL +I EY + +V
Sbjct: 141 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+T D+ Y+L + ++Y SQ +HRD+ NV++ +++ D+GLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP------VKKKKIKREIKIL 173
+ D ++ K+G G + V G + + + +K LKP RE+ +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYDIRY 223
+L N+++L +V P + + + L TL+
Sbjct: 76 HSLD-HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR----- 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVAS 282
Y ++ + + Y S+ +HRD+ N+++ +++ D+GL Y ++
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 283 RY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ F PE L +S D W G ++ + +EP + G + L KI K
Sbjct: 185 KVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 29/173 (16%), Positives = 65/173 (37%), Gaps = 33/173 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
D + + +G G + +V N + +K+LK + E++++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
+ + N++ LL +I EY +
Sbjct: 129 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
L+ D+ Y++ + ++Y S+ +HRD+ NV++ + +++ D+GLA
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLA 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 28/182 (15%), Positives = 63/182 (34%), Gaps = 32/182 (17%)
Query: 104 NVLRPKEYWD--YESLTVQWG-DQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCI---I 155
+ L+ + Y S + D + ++G G + +VF N+ + + +
Sbjct: 17 SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76
Query: 156 KILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------- 204
K LK + + RE ++L L ++V+ + + + ++FEY+
Sbjct: 77 KALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRF 133
Query: 205 ----------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
+ V L + ++ + Y +HRD+ N ++
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193
Query: 255 EL 256
L
Sbjct: 194 GL 195
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 27/162 (16%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
+ + ++++ +G+G++ +V G + +K +K + E ++ L N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 247
Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
+V+LL ++ ++ L + EY+ + D+ L + + ++ +A++Y
Sbjct: 248 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
+HRD+ NV++ + ++ D+GL + ++
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDT 345
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 28/168 (16%), Positives = 64/168 (38%), Gaps = 36/168 (21%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---------------------VKKKK 165
+ + +G GK S VF + C++K K + +
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
+ E + LQ L G V K+ + +++ E +++ + + + +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHP 272
+L+ + + +GI+H D+ +NV++ E + +ID+ + E
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEE 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 42/221 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
++ E + +G G + +V + + +K+LK +++ + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------------------NSTDF 209
L N+V LL LIFEY +
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
+ LT D+ + Y++ K +++ + +HRD+ NV++ + +++ D+GLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221
Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
Y VR +R K PE L + Y D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 39/240 (16%), Positives = 95/240 (39%), Gaps = 46/240 (19%)
Query: 125 DDYEVVR--------KVGRGKYSEVFEGI-NVNTNERCI-IKILKP----VKKKKIKREI 170
+ R ++G G + V +G+ + + + IK+LK +++ RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYD 220
+I+ L P +V+L+ + ++ +++ ++ + +
Sbjct: 62 QIMHQLD-NPYIVRLIGVC----QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-- 114
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
++++ + Y + +HRD+ NV++ + ++ D+GL+ Y R
Sbjct: 115 ---LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 170
Query: 280 VASRY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
A ++ K PE + +S D+WS G M+ + + ++P + + + I
Sbjct: 171 SAGKWPLKWYAPE---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 30/224 (13%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCI---IKILK-----PVKKKKIKREIKILQNLCGGPNV 182
+++G G + V +G + +KILK P K ++ E ++Q L P +
Sbjct: 23 KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYI 80
Query: 183 VKLLDIVRDQHSKTPS-LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
V+++ I L+ E + + D +I ++++ + Y
Sbjct: 81 VRMIGIC----EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 294
+HRD+ NV++ + ++ D+GL+ Y + ++ K PE +
Sbjct: 137 NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE---CI 192
Query: 295 QDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
Y +S D+WS G M+ + ++P + G + + K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEK 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 5/121 (4%)
Query: 190 RDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 249
+ SL + LT + Y +++ K +++ S+ +HRD+ N
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223
Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSL 306
+++ + +++ D+GLA + +Y + +R K PE + D + Y D+WS
Sbjct: 224 ILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF 281
Query: 307 G 307
G
Sbjct: 282 G 282
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 344 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.02 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.83 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.66 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.89 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.86 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=388.81 Aligned_cols=205 Identities=27% Similarity=0.507 Sum_probs=184.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|++..+++.||||++++ ...+.+.+|+++|+++ +||||++++++|.+ ....|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 569999999999999999999999999999999853 2346789999999999 99999999999965 47789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+|||||++|+|.+++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCC
Confidence 999999999999887 569999999999999999999999999999999999999988 899999999999875432
Q ss_pred --cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....+||+.|||||++.+ ..|+.++||||+||++|||++|+.|| .+.+..+.+.+|.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~ 248 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEGLIFAKIIK 248 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHc
Confidence 3456799999999999987 78999999999999999999999999 45666777777765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=392.04 Aligned_cols=206 Identities=20% Similarity=0.392 Sum_probs=183.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.+.|++.++||+|+||+||+|++..+|+.||||+++. ...+.+.+|+++|+++ +|||||+++++|.+ ...+|+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 3569999999999999999999999999999999853 3346688999999999 99999999999965 4678999
Q ss_pred EEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccce
Q 019241 201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~ 277 (344)
||||++|+|..++ ..+++.+++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCCCccc
Confidence 9999999999887 569999999999999999999999999999999999999988 89999999999987544 3456
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..|.+
T Consensus 229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~ 284 (346)
T 4fih_A 229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRD 284 (346)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHc
Confidence 6799999999999876 789999999999999999999999994 5566667776655
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=393.61 Aligned_cols=207 Identities=20% Similarity=0.445 Sum_probs=177.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|+++++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+++|+++ +|||||+++++|.+ ...+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEE
Confidence 457999999999999999999999999999999998632 235788999999999 99999999999965 4778
Q ss_pred EEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
|+|||||++|+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCCH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeecC
Confidence 99999999999998872 36889999999999999999999999999999999999988 8999999999987654
Q ss_pred CC-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.. .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+.+|.+
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~ 239 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIIS 239 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHH
T ss_pred CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHc
Confidence 32 2345689999999999987 78999999999999999999999999 45666777777765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=375.53 Aligned_cols=205 Identities=24% Similarity=0.531 Sum_probs=164.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence 6899999999999999999999999999999998532 235689999999999 99999999999955 47789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||++ |+|.+++ ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...+...
T Consensus 90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC--------
T ss_pred EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCCc
Confidence 9999995 6776665 469999999999999999999999999999999999999988 7899999999998776666
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+||+.|||||++.+...++.++||||+||++|||++|+.|| .+.+..+.+..|.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF-~~~~~~~~~~~i~~ 226 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-DDESIPVLFKNISN 226 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHc
Confidence 677899999999999987444578999999999999999999999 45555666666655
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=394.06 Aligned_cols=207 Identities=20% Similarity=0.386 Sum_probs=184.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.+.|+++++||+|+||+||+|++..+|+.||||+++. ...+.+.+|+.+|+++ +|||||+++++|.+ ...+|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999853 3446789999999999 99999999999965 4678999
Q ss_pred EEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccce
Q 019241 201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~ 277 (344)
||||++|+|.+++ ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.+... ....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCCcccc
Confidence 9999999999887 569999999999999999999999999999999999999988 89999999999887544 3456
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
..+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..|.+.
T Consensus 306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDN 362 (423)
T ss_dssp CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHS
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcC
Confidence 6799999999999877 789999999999999999999999994 55666677666553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=376.48 Aligned_cols=209 Identities=22% Similarity=0.408 Sum_probs=177.4
Q ss_pred CCCCe-EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc--CC
Q 019241 123 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HS 194 (344)
Q Consensus 123 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~ 194 (344)
...+| ++.++||+|+||+||+|++..+++.||+|++... ..+.|.+|+++++++ +|||||+++++|.+. ..
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCC
Confidence 34555 7788999999999999999999999999998532 235689999999999 999999999998653 23
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..+++|||||++|+|..++ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+.+.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 5679999999999999987 46999999999999999999999998 999999999999986437899999999986
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.. .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||....+..+....+.+
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~ 244 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc
Confidence 43 345566799999999998864 5999999999999999999999999644444444444433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=387.14 Aligned_cols=215 Identities=28% Similarity=0.499 Sum_probs=191.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|++.++||+|+||+||+|+++ .+++.||+|.+.+ ....++.+|+++|+.+.+||||++++++|.+ ..+.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEE
Confidence 578999999999999999999875 4678999998864 3456788999999999779999999999965 478899
Q ss_pred EEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-----
Q 019241 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~----- 274 (344)
||||+++++|.+++..+++.+++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+...+..
T Consensus 98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999999999999999999999999999999999999999999999999999876799999999998654321
Q ss_pred ------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 019241 275 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330 (344)
Q Consensus 275 ------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l 330 (344)
.....+||+.|||||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 12345799999999999886679999999999999999999999999999999999
Q ss_pred HHHHHhhCCC
Q 019241 331 VKIAKVTTIL 340 (344)
Q Consensus 331 ~~i~~~~~~~ 340 (344)
.+|.+++|++
T Consensus 258 ~~I~~~~G~~ 267 (361)
T 4f9c_A 258 AQIMTIRGSR 267 (361)
T ss_dssp HHHHHHHCHH
T ss_pred HHHHHhcCCc
Confidence 9999998864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=387.31 Aligned_cols=218 Identities=30% Similarity=0.588 Sum_probs=189.5
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc---
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--- 192 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--- 192 (344)
+...++|++++.||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+++|+++ +|||||++++++...
T Consensus 50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence 33467899999999999999999999999999999999642 235678999999999 999999999998643
Q ss_pred -CCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 193 -HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 193 -~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
+...+|+|||||++ +|..++ ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+
T Consensus 129 ~~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~ 206 (398)
T 4b99_A 129 GEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMAR 206 (398)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred ccCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceee
Confidence 23678999999974 566665 459999999999999999999999999999999999999988 899999999998
Q ss_pred ecCCC-----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 269 FYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 269 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
.+... ......+||+.|||||++.+...++.++||||+||++|||++|+.|| .+.+..+++..|.+..|+++.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCCh
Confidence 76432 23345699999999999988667899999999999999999999998 688889999999999998763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=377.20 Aligned_cols=207 Identities=21% Similarity=0.401 Sum_probs=177.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|.+.++||+|+||+||+|++. .++..||||+++... .++|.+|+++|+++ +|||||+++|+|.+ .
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--C
Confidence 4578999999999999999999865 357889999997543 46789999999999 99999999999954 4
Q ss_pred CccEEEEEeecCCchhhHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc
Q 019241 195 KTPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK 258 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~----------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~ 258 (344)
...++|||||++|+|.+++. .+++.++..++.|+++||+|||+++|+||||||+|||++.+ +.
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~~ 166 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LL 166 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-Cc
Confidence 67899999999999999872 48999999999999999999999999999999999999988 78
Q ss_pred EEEEecccceecCCCCcce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 259 LRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 259 ~kl~DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
+||+|||+|+......... ...||+.|||||++.+ ..|+.++|||||||++|||+| |+.|| .+.++.+.+..+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~i~ 244 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECIT 244 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHH
Confidence 9999999998765443322 2468999999999987 789999999999999999999 89998 4566677777765
Q ss_pred H
Q 019241 335 K 335 (344)
Q Consensus 335 ~ 335 (344)
+
T Consensus 245 ~ 245 (299)
T 4asz_A 245 Q 245 (299)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=383.36 Aligned_cols=205 Identities=24% Similarity=0.368 Sum_probs=175.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
.+.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|+.+++++ +|||||+++++|.+ ...+|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEec
Confidence 467899999999999999999999999999999996432 235799999999 99999999999965 4678999999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-----
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----- 275 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~----- 275 (344)
|++|+|.+++ ..+++..++.++.|++.||+|||++|||||||||+|||++.+...+||+|||+|+...+...
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 9999999987 46999999999999999999999999999999999999998833699999999998754322
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+.+|.+
T Consensus 212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIAS 270 (336)
T ss_dssp --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST-TTCCSCCHHHHHH
T ss_pred cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHc
Confidence 123579999999999987 789999999999999999999999994 4444555555544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=380.26 Aligned_cols=206 Identities=28% Similarity=0.486 Sum_probs=174.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|++++.||+|+||+||+|++. .+++.||+|+++.. ....+.+|+++++++ +|||||++++++.+ ..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQT--EG 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEE--TT
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CC
Confidence 367999999999999999999874 46789999998642 235688999999999 99999999999965 47
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..|+|||||++|+|.+++ ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceeccC
Confidence 789999999999999887 469999999999999999999999999999999999999998 8999999999986543
Q ss_pred C-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ......+||+.|||||++.+ ..|+.++||||+||++|||++|+.|| .+.+..+.+.+|.+
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILK 240 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CCcCHHHHHHHHHc
Confidence 3 34456789999999999987 78999999999999999999999999 46666777777765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=373.55 Aligned_cols=207 Identities=21% Similarity=0.395 Sum_probs=177.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..+++++.++||+|+||+||+|+.. .+++.||||+++.. ..++|.+|+.+++++ +|||||+++|+|.+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-- 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK-- 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--
Confidence 4567888999999999999999853 46789999999643 347899999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 194 SKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l-------------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
....++|||||++|+|.+++ ..+++.++..++.|++.||+|||+++||||||||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 46788999999999999987 23889999999999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCC---cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL 330 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l 330 (344)
+ +.+||+|||+|+...... .....+||+.|||||++.+ ..++.++|||||||++|||+| |..|| .+.++.+.+
T Consensus 181 ~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~ 257 (308)
T 4gt4_A 181 K-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVV 257 (308)
T ss_dssp G-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHH
T ss_pred C-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHH
Confidence 8 789999999998764332 2234578999999999987 789999999999999999998 78888 566666766
Q ss_pred HHHHH
Q 019241 331 VKIAK 335 (344)
Q Consensus 331 ~~i~~ 335 (344)
..+.+
T Consensus 258 ~~i~~ 262 (308)
T 4gt4_A 258 EMIRN 262 (308)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 66654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=373.04 Aligned_cols=203 Identities=17% Similarity=0.382 Sum_probs=168.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..+++++.++||+|+||+||+|++. ..||||+++.. ..+.|.+|+++++++ +|||||+++|+|.+ ...
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeE
Confidence 4577889999999999999999743 35899998632 236789999999999 99999999999854 457
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++|||||++|+|.+++ ..+++.++..++.|++.||+|||+++||||||||+|||++++ +.+||+|||+|+.....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccC
Confidence 8999999999999887 358999999999999999999999999999999999999988 79999999999876432
Q ss_pred ---CcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 274 ---KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 ---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
......+||+.|||||++.. ...|+.++|||||||++|||+||+.||. +.++.+.+..+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~~ 250 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFMV 250 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHHH
Confidence 23345689999999999864 2468999999999999999999999994 445555444443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=375.65 Aligned_cols=207 Identities=17% Similarity=0.333 Sum_probs=171.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|.+.++||+|+||+||+|++. .+++.||||+++... .++|.+|+++|+++ +|||||+++|+|.+ .
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--G 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 4567899999999999999999865 367899999997543 36799999999999 99999999999954 4
Q ss_pred CccEEEEEeecCCchhhHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC
Q 019241 195 KTPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~ 256 (344)
...++|||||++|+|..++. .+++.++..++.|++.||+|||+++||||||||+|||++.+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~- 194 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG- 194 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence 67899999999999998862 38899999999999999999999999999999999999998
Q ss_pred CcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 019241 257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 257 ~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~ 332 (344)
+.+||+|||+|+....... ....+||+.|||||++.+ ..++.++|||||||++|||+| |+.||. +.++.+.+..
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~ 272 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDC 272 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC-SSCHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC-CCCHHHHHHH
Confidence 7999999999987654332 234578999999999987 789999999999999999999 899984 5566677666
Q ss_pred HHH
Q 019241 333 IAK 335 (344)
Q Consensus 333 i~~ 335 (344)
+.+
T Consensus 273 i~~ 275 (329)
T 4aoj_A 273 ITQ 275 (329)
T ss_dssp HHH
T ss_pred HHc
Confidence 655
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=369.31 Aligned_cols=210 Identities=20% Similarity=0.373 Sum_probs=177.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-----eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||+||+|++...+ +.||||.++... .+.|.+|+++|+++..|||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 4678999999999999999999876543 689999996432 356889999999995559999999999543
Q ss_pred CCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
....++|||||++|+|..++. .+++.++..++.|+++||+|||+++||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 356789999999999999872 2789999999999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL 330 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l 330 (344)
+ +.+||+|||+|+....+... ...+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.....+.+..
T Consensus 221 ~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 221 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred C-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 8 79999999999877544332 23478999999999987 789999999999999999998 899995444455555
Q ss_pred HHHHH
Q 019241 331 VKIAK 335 (344)
Q Consensus 331 ~~i~~ 335 (344)
..+.+
T Consensus 299 ~~i~~ 303 (353)
T 4ase_A 299 RRLKE 303 (353)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 55544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=364.50 Aligned_cols=191 Identities=24% Similarity=0.458 Sum_probs=156.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC------
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------ 194 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------ 194 (344)
++|++++.||+|+||+||+|+++.+++.||||+++.. ..+.+.+|+++|+++ +|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 3589999999999999999999999999999998532 235688999999999 99999999999875432
Q ss_pred ----CccEEEEEeecCCchhhHcCC------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEec
Q 019241 195 ----KTPSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264 (344)
Q Consensus 195 ----~~~~lv~e~~~~~~l~~~l~~------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DF 264 (344)
.+.|+|||||++++|.+++.. ..+..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEccC
Confidence 246899999999999998732 4456688999999999999999999999999999999988 79999999
Q ss_pred ccceecCCCCc-------------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 265 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 265 Gla~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
|+|+....... ....+||+.|||||++.+ ..|+.++|||||||++|||++ ||.
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99987654322 233579999999999987 789999999999999999996 774
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=354.94 Aligned_cols=192 Identities=21% Similarity=0.290 Sum_probs=161.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHH--HHHHhCCCCccceeeEEEccCC--CccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI--LQNLCGGPNVVKLLDIVRDQHS--KTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~--l~~l~~h~niv~l~~~~~~~~~--~~~~lv 200 (344)
++|.+.++||+|+||+||+|++ +|+.||||+++....+.+.+|.++ +.++ +|||||+++++|.+.+. ..+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 4688899999999999999976 689999999987666666555544 4567 89999999999976543 257899
Q ss_pred EEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 201 ~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~--------~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
||||++|+|.+++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccc
Confidence 9999999999988 5689999999999999999999976 99999999999999998 79999999999887
Q ss_pred CCCCcc-----eecccCCCccCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCC
Q 019241 271 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPF 320 (344)
Q Consensus 271 ~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~ell~g~~Pf 320 (344)
...... ...+||+.|||||++.+.. .++.++|||||||++|||+||+.||
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 654322 2357999999999987521 3678999999999999999997765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=348.12 Aligned_cols=246 Identities=79% Similarity=1.318 Sum_probs=225.9
Q ss_pred cccccccccccCCCCccCCCccceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHH
Q 019241 95 SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ 174 (344)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 174 (344)
+.++...+.+...+.+++++......++..++|++.++||+|+||+||+|++..+++.||+|+++....+.+.+|+.+++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 85 (330)
T 3nsz_A 6 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 85 (330)
T ss_dssp CCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHH
T ss_pred CceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHH
Confidence 56666778888888899999888888888999999999999999999999999999999999999888899999999999
Q ss_pred HHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 175 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
++.+|+||+++++++.+......++||||+++++|..++..+++..++.++.|++.||+|||+.||+||||||+|||++.
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~ 165 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC
Confidence 99559999999999987667888999999999999999999999999999999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
+...+||+|||+++............+|..|+|||++.+...++.++|||||||++|||++|+.||+.+.++.+++..+.
T Consensus 166 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp TTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred CCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence 74589999999999887776677778999999999998767799999999999999999999999999999999999888
Q ss_pred HhhCCC
Q 019241 335 KVTTIL 340 (344)
Q Consensus 335 ~~~~~~ 340 (344)
+.++..
T Consensus 246 ~~~~~~ 251 (330)
T 3nsz_A 246 KVLGTE 251 (330)
T ss_dssp HHHCHH
T ss_pred HhcCCc
Confidence 877753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=376.07 Aligned_cols=210 Identities=23% Similarity=0.443 Sum_probs=188.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
++|++.+.||+|+||+||+|+++.+|+.||+|+++... .+.+.+|+++|+.+ +||||++++++|.+ ...+++||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 68999999999999999999999999999999986432 45688999999999 99999999999955 57889999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-CCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||++|+|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.+.+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 9999999988762 48999999999999999999999999999999999999854 368999999999998887777
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
...+||+.|||||++.+ ..|+.++||||+||++|||++|..|| .+.+..+.+..|.+....
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~~ 374 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWN 374 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCC
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCCC
Confidence 88899999999999987 78999999999999999999999999 566777888887765443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=374.90 Aligned_cols=194 Identities=26% Similarity=0.434 Sum_probs=170.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHH---HHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIK---ILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~---~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++++.||+|+||+||+|++..+|+.||||++++. ......+|.. +++.+ +|||||+++++|.+ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~--~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE--C
Confidence 47899999999999999999999999999999999532 2233445544 44445 89999999999955 5
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..+|+|||||+||+|..++ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeecC
Confidence 7889999999999999887 569999999999999999999999999999999999999998 899999999998876
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.. .....+||+.|||||++.+...|+.++|||||||++|||++|+.||..
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 43 345679999999999997656899999999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.56 Aligned_cols=215 Identities=26% Similarity=0.485 Sum_probs=186.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|+++++||+|+||+||+|++..+++.||||++... ..+++.+|+.+++.+ +||||+++++++.....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence 368999999999999999999999999999999998642 246678999999999 99999999999965422
Q ss_pred -CccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 195 -KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 195 -~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
...++||||++++.+..+...+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS 217 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----C
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCCC
Confidence 4569999999998777777789999999999999999999999999999999999999988 78999999999987766
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++.+|.+.+|++.
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCC
T ss_pred cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCC
Confidence 66667899999999999987 78999999999999999999999998 67888999999999998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.35 Aligned_cols=215 Identities=32% Similarity=0.633 Sum_probs=179.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++++.||+|+||+||+|.+..+++.||+|++.. .....+.+|+.+++++.+|+||+++++++...+....+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 4789999999999999999999999999999999853 23356778999999995599999999999876667889
Q ss_pred EEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC---
Q 019241 199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--- 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~--- 273 (344)
+||||+++ +|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCcccccccccccc
Confidence 99999995 666665 468999999999999999999999999999999999999988 78999999999875421
Q ss_pred -------------------CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 274 -------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
......+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII 244 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence 11233579999999999987678999999999999999999999998 5778899999999
Q ss_pred HhhCCCC
Q 019241 335 KVTTILD 341 (344)
Q Consensus 335 ~~~~~~~ 341 (344)
+.+|.++
T Consensus 245 ~~~~~p~ 251 (388)
T 3oz6_A 245 GVIDFPS 251 (388)
T ss_dssp HHHCCCC
T ss_pred HhcCCCC
Confidence 9988875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=327.18 Aligned_cols=207 Identities=24% Similarity=0.518 Sum_probs=181.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+++++.+ +||||+++++++.+ ....+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence 56899999999999999999999999999999998542 235678999999999 99999999999954 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCc
Confidence 999999999998876 579999999999999999999999999999999999999988 7899999999988776666
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+||+.|+|||++.+....+.++|||||||++|||++|+.|| .+.+..+....+.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~ 228 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLR 228 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Confidence 677789999999999988444458999999999999999999999 45555555555544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.38 Aligned_cols=208 Identities=25% Similarity=0.434 Sum_probs=177.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|..+++.+.+||||+++++++.+ ...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 357899999999999999999999999999999998642 335678899999998789999999999954 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~- 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecccC
Confidence 89999999999998877 569999999999999999999999999999999999999988 8999999999986432
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....|.+
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILN 238 (353)
T ss_dssp --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCC-CCCCHHHHHHHHHc
Confidence 334456689999999999877 77999999999999999999999999 45566666666655
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=320.14 Aligned_cols=214 Identities=32% Similarity=0.605 Sum_probs=189.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|+++++||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence 5899999999999999999999999999999998632 236688999999999 99999999999965 467889
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cc
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~ 275 (344)
||||++++.+..+. ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcccc
Confidence 99999986665554 469999999999999999999999999999999999999988 78999999999876533 33
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
.....+|+.|+|||++.+...++.++|||||||++|||++|..||+.+.+..+++..+.+.++.++.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 4456889999999999875568999999999999999999999999999999999999998887653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=337.74 Aligned_cols=209 Identities=26% Similarity=0.440 Sum_probs=181.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++.. ....+.+|..++..+ +||||++++++|.+ ...
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~~ 148 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--DNN 148 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCE
Confidence 467899999999999999999999999999999999642 223488999999998 99999999999955 477
Q ss_pred cEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhccc
Confidence 89999999999999887 358999999999999999999999999999999999999988 7999999999987755
Q ss_pred CCcc--eecccCCCccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 273 GKEY--NVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 273 ~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.... ...+||+.|+|||++. +...++.++|||||||++|||++|+.||. +.+..+...+|.+.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNH 296 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTH
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhc
Confidence 4432 3358999999999987 23568999999999999999999999994 55666777776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.40 Aligned_cols=209 Identities=28% Similarity=0.450 Sum_probs=181.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|+++++||+|+||+||+|++..+++.||+|+++. .....+.+|+.+++.+ +||||++++++|.+ ...
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 143 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY 143 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCE
Confidence 46789999999999999999999999999999999863 2234588999999999 99999999999954 577
Q ss_pred cEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeeccCC
Confidence 89999999999999887 468999999999999999999999999999999999999988 799999999998876544
Q ss_pred c--ceecccCCCccCcccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 E--YNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 ~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
. ....+||+.|+|||++.+.. .++.++|||||||++|||++|+.||. +.+..+...+|.+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNH 288 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhc
Confidence 2 33568999999999997632 17899999999999999999999994 55556666666543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=323.75 Aligned_cols=205 Identities=25% Similarity=0.465 Sum_probs=178.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++++.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEe--CCEE
Confidence 46899999999999999999999999999999998632 345688999999999 99999999999955 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~ 273 (344)
++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++... ..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCC
Confidence 9999999999998877 468999999999999999999999999999999999999988 799999999998643 33
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....|.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~ 218 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELIL 218 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCC-CCCHHHHHHHHH
Confidence 44556789999999999877 778999999999999999999999995 344444444443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.22 Aligned_cols=208 Identities=26% Similarity=0.478 Sum_probs=183.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-- 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN-- 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe--
Confidence 357899999999999999999999999999999998642 236789999999999 89999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC---cEEEEecccc
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLA 267 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~---~~kl~DFGla 267 (344)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+|||++.+.. .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 467899999999999999873 5899999999999999999999999999999999999987732 7999999999
Q ss_pred eecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..|.+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~ 232 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA 232 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHT
T ss_pred eEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 98876666667789999999999876 789999999999999999999999994 5555666666654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=322.70 Aligned_cols=208 Identities=24% Similarity=0.440 Sum_probs=181.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+..|..+++.+.+||||+++++++.+ ...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence 467899999999999999999999999999999999642 345678899999987799999999999955 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~- 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcccC
Confidence 89999999999998887 469999999999999999999999999999999999999988 7899999999986532
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....|..
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM 232 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHh
Confidence 334456789999999999987 779999999999999999999999994 5555566665544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.92 Aligned_cols=195 Identities=27% Similarity=0.515 Sum_probs=174.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|+++++||+|+||+||+|++..+++.||+|+++... .+.+.+|..+++++.+||||++++++|.+ ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 3568999999999999999999999999999999996432 24578899999988789999999999954 477
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec-CC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~-~~ 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+.. ..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeecccC
Confidence 89999999999998876 569999999999999999999999999999999999999998 89999999999863 34
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 445566789999999999987 789999999999999999999999995
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=319.69 Aligned_cols=208 Identities=23% Similarity=0.448 Sum_probs=183.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEec--CCEEEEE
Confidence 357899999999999999999999999999999998643 345688999999999 99999999999965 4678899
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-CCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+++...+...
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999999988873 48999999999999999999999999999999999999872 37899999999998877777
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.++.+.+..+.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~ 217 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMN 217 (321)
T ss_dssp EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH
T ss_pred cccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHc
Confidence 777889999999999877 678999999999999999999999994 4555666666654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=321.56 Aligned_cols=211 Identities=22% Similarity=0.407 Sum_probs=183.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEE
Confidence 467899999999999999999999999999999998642 346688999999999 899999999999877666889
Q ss_pred EEEEeecCCchhhHcCC------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE----eCCCCcEEEEecccce
Q 019241 199 LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLAE 268 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~~------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl----~~~~~~~kl~DFGla~ 268 (344)
+||||+++++|..++.. +++..+..++.|++.||+|||+.||+||||||+|||+ +.+ +.+||+|||+++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a~ 164 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAR 164 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTCE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCce
Confidence 99999999999988743 8999999999999999999999999999999999998 555 679999999999
Q ss_pred ecCCCCcceecccCCCccCcccccC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---CHHHHHHHHH
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---NHDQLVKIAK 335 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~---~~~~l~~i~~ 335 (344)
............+|..|+|||++.. ...++.++|||||||++|||++|+.||..... ..+.+.++..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 8877666667789999999999862 26789999999999999999999999964333 3445554443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=316.67 Aligned_cols=214 Identities=33% Similarity=0.649 Sum_probs=181.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+..++|+++++||+|+||+||+|++. +++.||+|+++... .+.+.+|+++++++ +||||+++++++. ....
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~ 93 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIH--SERC 93 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEEC--CSSC
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEc--cCCE
Confidence 45789999999999999999999874 58899999986322 35688999999999 9999999999995 4577
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||++++.+..+. ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 94 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCCC
Confidence 89999999974433333 248999999999999999999999999999999999999988 78999999999876533
Q ss_pred -CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.++.+.+..+.+.++.++
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~ 240 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPN 240 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCC
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCC
Confidence 33445688999999999887567899999999999999999999998 56677788888888888764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.60 Aligned_cols=216 Identities=30% Similarity=0.570 Sum_probs=185.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHHh--CCCCccceeeEEEcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQ 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~ 192 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+. +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4689999999999999999999999999999999986322 356788988888773 499999999999764
Q ss_pred CCC---ccEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEec
Q 019241 193 HSK---TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264 (344)
Q Consensus 193 ~~~---~~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DF 264 (344)
... ..++||||+++ +|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Df 164 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADF 164 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECSC
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEeeC
Confidence 322 57899999985 7777652 28999999999999999999999999999999999999988 78999999
Q ss_pred ccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 265 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
|+++............+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++.++.+.++.++.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCh
Confidence 99987766666667789999999999987 77999999999999999999999998 567778888999988877653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.43 Aligned_cols=208 Identities=24% Similarity=0.405 Sum_probs=181.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|..++..+.+||||+++++++.+ ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 357899999999999999999999999999999998642 345678899999887689999999999954 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-C
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~ 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++... .
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccccC
Confidence 89999999999998887 469999999999999999999999999999999999999988 799999999998643 2
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....|.+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~ 235 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIME 235 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHh
Confidence 334556789999999999977 778999999999999999999999994 5555666666654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=332.55 Aligned_cols=215 Identities=32% Similarity=0.562 Sum_probs=183.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccC----CCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~~l 199 (344)
..+|++.+.||+|+||+||+|++..+++.||||.+... .....+|+++++++ +|+||++++++|.... ..+.++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEe
Confidence 34699999999999999999999999999999998643 23345799999999 9999999999885432 234679
Q ss_pred EEEeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 200 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 200 v~e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
||||++++.+.... ..+++..++.++.|++.||+|||+.||+||||||+|||++.+.+.+||+|||+++.....
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 99999975433221 468999999999999999999999999999999999999976567899999999987666
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++.+|.+.+|++.
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCC
Confidence 55566789999999999987568999999999999999999999998 56777889999999888764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=324.52 Aligned_cols=196 Identities=22% Similarity=0.495 Sum_probs=177.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++.+ +||||++++++|.+ ...
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 89 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQD--EED 89 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCE
Confidence 35789999999999999999999999999999999853 2346788999999999 99999999999955 467
Q ss_pred cEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||+.+++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeeccCC
Confidence 899999999999988873 58999999999999999999999999999999999999988 79999999999988777
Q ss_pred CcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......+||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 77777899999999999874 24589999999999999999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.79 Aligned_cols=215 Identities=33% Similarity=0.616 Sum_probs=182.4
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC-
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS- 194 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 194 (344)
+...++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 99 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcc
Confidence 34568999999999999999999999999999999998532 235678999999999 89999999999965422
Q ss_pred ---CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 195 ---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 195 ---~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
...++||||+ +++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ 177 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred ccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecccc
Confidence 3568999999 77888776 569999999999999999999999999999999999999988 7899999999987
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
... ......+|+.|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++.+|.+.+|+++
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCC
Confidence 643 3345688999999999987677999999999999999999999998 57777889999999988875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=313.42 Aligned_cols=202 Identities=25% Similarity=0.483 Sum_probs=176.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.++||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEE--CCEEEEE
Confidence 5679999999999999999999999999999999853 3456788999999999 99999999999965 4678899
Q ss_pred EEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cce
Q 019241 201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~ 277 (344)
|||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCcccccC
Confidence 9999999999887 458999999999999999999999999999999999999988 789999999998775443 334
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
...||+.|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+...
T Consensus 175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~ 226 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALY 226 (297)
T ss_dssp CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHH
T ss_pred CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHH
Confidence 5689999999999987 7799999999999999999999999953 33333333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.98 Aligned_cols=212 Identities=30% Similarity=0.622 Sum_probs=170.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|+++++||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence 46899999999999999999999999999999998632 236788999999999 99999999999954 467899
Q ss_pred EEEeecCCchhhHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 200 IFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 200 v~e~~~~~~l~~~l---------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
||||+++ +|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAF 158 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEET
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceec
Confidence 9999995 666655 248899999999999999999999999999999999999988 78999999999876
Q ss_pred CCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
... .......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.++.+++..+.+.+|.++
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCC
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCC
Confidence 533 23345688999999999977567899999999999999999999998 56677888899988887653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=327.95 Aligned_cols=218 Identities=31% Similarity=0.590 Sum_probs=183.5
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC-
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS- 194 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 194 (344)
+...++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +|+||+++++++.....
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCC
Confidence 44578999999999999999999999999999999999642 235788999999999 99999999999865432
Q ss_pred --CccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 195 --KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 195 --~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
...++||||+++ +|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 101 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~~ 178 (432)
T 3n9x_A 101 KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLART 178 (432)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred cCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCccc
Confidence 568999999985 7777663 48999999999999999999999999999999999999988 7899999999987
Q ss_pred cCCCCc-----------------------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhC----------
Q 019241 270 YHPGKE-----------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR---------- 316 (344)
Q Consensus 270 ~~~~~~-----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g---------- 316 (344)
...... ....+||+.|+|||++.....++.++|||||||++|||++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 654321 25568899999999986657899999999999999999974
Q ss_pred CCCCCCCCC-----------------CHHHHHHHHHhhCCCC
Q 019241 317 KEPFFYGHD-----------------NHDQLVKIAKVTTILD 341 (344)
Q Consensus 317 ~~Pf~~~~~-----------------~~~~l~~i~~~~~~~~ 341 (344)
+.|++.+.+ ..+++..|.+++|+++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~ 300 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC
Confidence 455555554 3789999999999876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.93 Aligned_cols=208 Identities=26% Similarity=0.446 Sum_probs=181.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++++. ..+.+.+|..++..+ +|+||++++++|.+ ...
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~~ 135 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--ENY 135 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SSE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CCE
Confidence 467899999999999999999999999999999999642 224578999999998 99999999999955 477
Q ss_pred cEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheeccC
Confidence 89999999999999887 369999999999999999999999999999999999999988 7999999999988765
Q ss_pred CCcc--eecccCCCccCcccccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEY--NVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.... ...+||+.|+|||++.. ...++.++|||||||++|||++|+.||. +.+..+...+|.+
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVH 284 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHT
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 4432 34589999999999873 2568999999999999999999999994 5555666666654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.75 Aligned_cols=204 Identities=22% Similarity=0.468 Sum_probs=178.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|..+++.+ +||||+++++++.+ ....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCEE
Confidence 46799999999999999999999999999999998642 345678899999998 99999999999954 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC--
Confidence 9999999999999887 458999999999999999999999999999999999999988 8999999999987643
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+...+|.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~ 217 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILN 217 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 3345689999999999877 779999999999999999999999995 4444555555544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=316.17 Aligned_cols=206 Identities=26% Similarity=0.488 Sum_probs=181.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 46799999999999999999999999999999998532 246789999999999 99999999999955 4
Q ss_pred CccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC----cEEEEecccc
Q 019241 195 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----KLRLIDWGLA 267 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~----~~kl~DFGla 267 (344)
...++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+|||++.+ + .+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC-CCCCCCEEEEECCCC
Confidence 67889999999999999874 48999999999999999999999999999999999999877 4 7999999999
Q ss_pred eecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA 231 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHH
T ss_pred eECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHh
Confidence 98876666666789999999999876 779999999999999999999999994 4455555555544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.89 Aligned_cols=215 Identities=30% Similarity=0.584 Sum_probs=185.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEcc----------
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---------- 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---------- 192 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++... .....+|+++++.+ +|+||++++++|...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC----------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCccccccccc
Confidence 467899999999999999999999999999999998633 33345899999999 999999999998542
Q ss_pred --------------------------CCCccEEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 019241 193 --------------------------HSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG 239 (344)
Q Consensus 193 --------------------------~~~~~~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~ 239 (344)
...+.++||||+++ +|...+ ..+++..++.++.|++.||+|||+.|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 23457899999996 544433 45899999999999999999999999
Q ss_pred cEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 019241 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319 (344)
Q Consensus 240 iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~P 319 (344)
|+||||||+|||++.+.+.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|||++|+.|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 241 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence 99999999999998544789999999999887666666778999999999998756799999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhCCCC
Q 019241 320 FFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 320 f~~~~~~~~~l~~i~~~~~~~~ 341 (344)
| .+.+..+++.++.+.+|++.
T Consensus 242 f-~~~~~~~~~~~i~~~~g~p~ 262 (383)
T 3eb0_A 242 F-SGETSIDQLVRIIQIMGTPT 262 (383)
T ss_dssp S-CCSSHHHHHHHHHHHHCCCC
T ss_pred C-CCCChHHHHHHHHHHhCCCC
Confidence 8 57788899999999988764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=332.30 Aligned_cols=217 Identities=34% Similarity=0.603 Sum_probs=169.0
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC---
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH--- 193 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--- 193 (344)
...++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCccc
Confidence 3468999999999999999999999999999999998542 236688999999999 9999999999985432
Q ss_pred CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
....++||||++ ++|..++ ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTV 206 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCT
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhc
Confidence 256899999986 4666655 348999999999999999999999999999999999999998 78999999999876
Q ss_pred CCCC----------------------------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhC------
Q 019241 271 HPGK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR------ 316 (344)
Q Consensus 271 ~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g------ 316 (344)
.... .....+||+.|+|||++.....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 4321 223457899999999886657899999999999999999993
Q ss_pred ----CCCCCCCCC--------------------CHHHHHHHHHhhCCCC
Q 019241 317 ----KEPFFYGHD--------------------NHDQLVKIAKVTTILD 341 (344)
Q Consensus 317 ----~~Pf~~~~~--------------------~~~~l~~i~~~~~~~~ 341 (344)
+.|++.+.+ +.+++..|.+++|+++
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~ 335 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS 335 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence 333334443 3688999999999876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=321.37 Aligned_cols=207 Identities=26% Similarity=0.512 Sum_probs=180.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 46799999999999999999999999999999998642 235688999999999 99999999999955 46788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGla~~~~~~ 273 (344)
+||||+.+++|...+ ..+++.++..++.|++.||+|||+.||+||||||+|||++.+. +.+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999998776 3489999999999999999999999999999999999998652 35999999999887766
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.+
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKA 244 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHh
Confidence 66666789999999999876 779999999999999999999999994 4444555555544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=311.35 Aligned_cols=196 Identities=29% Similarity=0.569 Sum_probs=170.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------------------hHHHHHHHHHHH
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQ 174 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~ 174 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999986432 245889999999
Q ss_pred HHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 175 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
++ +||||+++++++.+......++||||+++++|..+. ..+++..+..++.|++.||+|||+.||+||||||+|||+
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99 999999999999876667889999999999988775 358999999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCC-cceecccCCCccCcccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 253 DHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
+.+ +.+||+|||+++...... ......||+.|+|||++.+... ++.++|||||||++|||++|+.||.
T Consensus 171 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 171 GED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 988 789999999998775433 2345679999999999876332 4789999999999999999999994
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=311.44 Aligned_cols=210 Identities=31% Similarity=0.654 Sum_probs=177.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++++.||+|+||+||+|++ .+++.+|+|+++... .+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEcc--CCeEEE
Confidence 6899999999999999999987 678899999985322 36788999999999 99999999999965 467899
Q ss_pred EEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-C
Q 019241 200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~ 274 (344)
||||+++ ++..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence 9999997 665554 458999999999999999999999999999999999999988 78999999999876532 2
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+.+.++.++
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~ 221 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPN 221 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCC
Confidence 3345678999999999977567899999999999999999999998 46667788888888777653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=317.91 Aligned_cols=196 Identities=28% Similarity=0.508 Sum_probs=174.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||+||+|++..+++.||+|+++... .+.+.+|..+++++.+||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 3468999999999999999999999999999999996431 24577899999988789999999999955 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-C
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~ 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++... .
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccccCC
Confidence 89999999999998877 469999999999999999999999999999999999999988 799999999998643 3
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 344556789999999999987 7789999999999999999999999954
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=318.83 Aligned_cols=205 Identities=23% Similarity=0.428 Sum_probs=180.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence 357899999999999999999999999999999998532 345688999999999 99999999999955 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceeccCC
Confidence 89999999999998887 469999999999999999999999999999999999999988 78999999999876533
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....|.+
T Consensus 195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~ 252 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVS 252 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCCHHHHHHHHHc
Confidence 345689999999999987 779999999999999999999999995 4455556566654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=322.86 Aligned_cols=196 Identities=17% Similarity=0.279 Sum_probs=172.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEE-----EEcCCCeEEEEEEecccchHHHHHHHHHHHHHhC---CCCccceeeEEEccC
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQH 193 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~ 193 (344)
...++|++.++||+|+||+||+| .+..+++.||+|+++.....++.+|+++++.+ . |+|++++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~~-- 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL-KPSMQHMFMKFYSAHLF-- 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEEC--
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHh-hhhhhhhhhhhheeeec--
Confidence 35688999999999999999999 46778999999999988888999999999998 5 8999999999955
Q ss_pred CCccEEEEEeecCCchhhHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC-----------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----------- 254 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~--------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~----------- 254 (344)
....++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 467789999999999998872 4899999999999999999999999999999999999987
Q ss_pred CCCcEEEEecccceecC---CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 255 ELRKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+ +.+||+|||+|+.+. ........+||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 219 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 219 S-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred c-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 5 789999999997653 2334455689999999999987 6799999999999999999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=315.97 Aligned_cols=204 Identities=27% Similarity=0.455 Sum_probs=175.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEE
Confidence 4678999999999999999999999999999999985332 35688999999999 99999999999954 46788
Q ss_pred EEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCCc
Confidence 9999999999998874 48999999999999999999999999999999999999988 789999999998664322
Q ss_pred --cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 019241 275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l 330 (344)
......||+.|+|||++.+...++.++|||||||++|||++|+.||....+.....
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 218 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 23356889999999999874445889999999999999999999996544443333
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=323.19 Aligned_cols=207 Identities=24% Similarity=0.459 Sum_probs=172.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHH-HHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKIL-QNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++++.||+|+||+||+|++..+++.||+|+++... ...+.+|..++ +.+ +||||++++++|.+ ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~--~~ 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--AD 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--SS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--CC
Confidence 4578999999999999999999999999999999996432 23455676664 455 99999999999955 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH- 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~- 271 (344)
..++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCcccccccc
Confidence 789999999999998877 458999999999999999999999999999999999999988 799999999998643
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
........+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+....|.+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~ 253 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILN 253 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSBHHHHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHh
Confidence 3344556789999999999887 789999999999999999999999994 4555666666654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=320.72 Aligned_cols=213 Identities=26% Similarity=0.489 Sum_probs=173.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC----
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---- 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---- 194 (344)
.++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 57899999999999999999999999999999998642 235678999999999 99999999999965432
Q ss_pred CccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 195 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
...++||||++++....+...+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSF 181 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC--------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeeccccccccc
Confidence 3679999999976555555679999999999999999999999999999999999999988 789999999998776555
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCC
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 5556789999999999987 77999999999999999999999998 5667778888887776654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.84 Aligned_cols=207 Identities=24% Similarity=0.482 Sum_probs=182.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.+.||+|+||+||+|++..+++.+|+|++... ....+.+|+++++.+ +||||+++++++.+ ....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEEEEE
Confidence 46899999999999999999999999999999998643 335688999999999 99999999999955 4778999
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-CCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+++.......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999988873 58999999999999999999999999999999999999753 36799999999998876666
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+.+..+.+
T Consensus 207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~ 264 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKR 264 (387)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHH
T ss_pred eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 667789999999999877 779999999999999999999999994 4555566665554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=319.77 Aligned_cols=198 Identities=25% Similarity=0.463 Sum_probs=162.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++++.||+|+||+||++++..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CCEEEEE
Confidence 568999999999999999999999999999999998643 346788999999999 99999999999965 4678899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC-CcEEEEecccceecCCCCcc
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~-~~~kl~DFGla~~~~~~~~~ 276 (344)
|||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+. +.+||+|||+++........
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9999999998876 5699999999999999999999999999999999999998762 24999999999865555555
Q ss_pred eecccCCCccCcccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~-~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
....||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||....
T Consensus 175 ~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp ------CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred CCCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 66789999999999987 4554 45999999999999999999996543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.83 Aligned_cols=216 Identities=31% Similarity=0.523 Sum_probs=185.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC-----
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----- 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----- 193 (344)
.++|++.++||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.+ +|+||+++++++.+..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 57899999999999999999999999999999988532 235688999999999 9999999999997643
Q ss_pred -CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 -~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....++||||++++.+..+. ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhccc
Confidence 35678999999975444433 468999999999999999999999999999999999999988 7899999999987
Q ss_pred cCCC-----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 270 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 270 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
.... .......+|+.|+|||++.+...++.++|||||||++|||++|..|| .+.+..+++..+.+..+.++-
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCh
Confidence 6522 22344578999999999987567899999999999999999999888 567778889999998887653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.22 Aligned_cols=212 Identities=25% Similarity=0.484 Sum_probs=184.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHh----CCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~ 196 (344)
..++|+++++||+|+||+||+|++..+++.||||+++.. ..+.+..|+.+++.+. .|+||+++++++.. ...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~ 110 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDH 110 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CCe
Confidence 478999999999999999999999999999999999743 3456788999999993 39999999999965 467
Q ss_pred cEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC-----------------
Q 019241 197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----------------- 254 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~----------------- 254 (344)
.++||||+ +++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 89999999 888877762 4899999999999999999999999999999999999975
Q ss_pred -------CCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH
Q 019241 255 -------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327 (344)
Q Consensus 255 -------~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~ 327 (344)
..+.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~ 265 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHEHM 265 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHH
T ss_pred cccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCcHH
Confidence 136899999999987543 3345678999999999987 77999999999999999999999999 466778
Q ss_pred HHHHHHHHhhCCCC
Q 019241 328 DQLVKIAKVTTILD 341 (344)
Q Consensus 328 ~~l~~i~~~~~~~~ 341 (344)
+.+..+.+..++++
T Consensus 266 ~~~~~~~~~~~~~p 279 (360)
T 3llt_A 266 EHLAMMESIIQPIP 279 (360)
T ss_dssp HHHHHHHHHTCCCC
T ss_pred HHHHHHHHhcCCCC
Confidence 88888888887765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.94 Aligned_cols=207 Identities=28% Similarity=0.492 Sum_probs=170.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
..++|++.+.||+|+||+||+|++. .+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc-
Confidence 3578999999999999999999875 68899999998643 234577899999999 99999999999955
Q ss_pred CCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKE 170 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC--
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCcccc
Confidence 46789999999999998877 458999999999999999999999999999999999999988 7899999999976
Q ss_pred cCCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+.++.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~ 235 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILK 235 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHh
Confidence 4332 33345679999999999877 778999999999999999999999994 4455555555554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.00 Aligned_cols=208 Identities=25% Similarity=0.475 Sum_probs=174.8
Q ss_pred CCeEE--EeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEV--VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~--~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+.|++ .+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFES--KNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEE
Confidence 34444 67899999999999999999999999999753 346788999999999 99999999999965 467899
Q ss_pred EEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC-CCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~-~~~~~kl~DFGla~~~~~~~ 274 (344)
||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++. +.+.+||+|||+++...+..
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999999987766 24899999999999999999999999999999999999942 33689999999999887766
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
......||+.|+|||++.. ..++.++|||||||++|||++|..|| .+.++.+.+..+.+..
T Consensus 244 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~ 304 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNNILACR 304 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTC
T ss_pred ccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcc
Confidence 6667789999999999876 78999999999999999999999999 4556666777766543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.65 Aligned_cols=194 Identities=23% Similarity=0.484 Sum_probs=172.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence 47899999999999999999999999999999998532 235788999999999 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+ ++++.+++ ..+++.+++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence 8999999 55666554 569999999999999999999999999999999999999988 789999999998877766
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 667789999999999998744447899999999999999999999953
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.72 Aligned_cols=195 Identities=28% Similarity=0.497 Sum_probs=171.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~ 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--DG 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 46799999999999999999999999999999998532 356789999999999 99999999999965 46
Q ss_pred ccEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEEEeccc
Q 019241 196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGL 266 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGl 266 (344)
..++||||+++++|...+. .+++..+..++.|++.||+|||+.||+||||||+|||++.+. ..+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 7899999999999976652 389999999999999999999999999999999999998652 3499999999
Q ss_pred ceecCCCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 267 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 988765433 345689999999999877 6789999999999999999999999953
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=310.26 Aligned_cols=195 Identities=24% Similarity=0.416 Sum_probs=167.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~ 85 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--DDC 85 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--SSE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--CCe
Confidence 46789999999999999999999999999999999842 1235688999999999 99999999999954 477
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC---
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCccccccc
Confidence 89999999999999887 458999999999999999999999999999999999999988 78999999999866533
Q ss_pred C--cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 K--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp ----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2 2234578999999999987 7789999999999999999999999953
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=324.80 Aligned_cols=207 Identities=25% Similarity=0.464 Sum_probs=177.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||+||+|.+..+++.+|+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CCEEE
Confidence 467999999999999999999999999999999986432 35688999999999 99999999999954 47788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~ 273 (344)
+||||+.+++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999998776 569999999999999999999999999999999999999842 267999999999876544
Q ss_pred C-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||. +.+..+....+.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~ 227 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKA 227 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHH
T ss_pred CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHh
Confidence 3 3345689999999999876 779999999999999999999999994 4555666666655
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=315.75 Aligned_cols=212 Identities=30% Similarity=0.615 Sum_probs=177.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|+++++||+|+||+||+|++..+++.||+|+++.... ..+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence 679999999999999999999999999999999864332 2355799999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Cc
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~ 275 (344)
|||+++ ++..++ ..+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCccc
Confidence 999986 555554 348999999999999999999999999999999999999988 78999999999865432 23
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
.....+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.++-
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTE 222 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCh
Confidence 345578999999999887677899999999999999999999998 567778899999998887653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.98 Aligned_cols=197 Identities=27% Similarity=0.473 Sum_probs=165.4
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEc--cCCCccEEE
Q 019241 124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv 200 (344)
.++|.+. +.||+|+||+||+|++..+++.||||+++. ...+.+|++++.++.+|+||++++++|.. .+....++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 4567776 689999999999999999999999999963 45678999998777799999999998864 224568999
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~ 273 (344)
|||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999999988873 38999999999999999999999999999999999999872 278999999999987665
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 55667789999999999876 78999999999999999999999999643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.18 Aligned_cols=208 Identities=27% Similarity=0.447 Sum_probs=164.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||++++++|.+ ....++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEEEE
Confidence 56899999999999999999999999999999999754 346688999999999 99999999999965 467889999
Q ss_pred eecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC--CCCcEEEEecccceecCCCCcce
Q 019241 203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYN 277 (344)
Q Consensus 203 ~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~--~~~~~kl~DFGla~~~~~~~~~~ 277 (344)
|+++++|..++. .+++.++..++.|++.||+|||+.||+||||||+|||++. +.+.+||+|||+++.........
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999988773 4899999999999999999999999999999999999975 22789999999998776555555
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...||+.|+|||++.+ ..++.++|||||||++|||++|..||.........+..+.+
T Consensus 209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 6789999999999887 67999999999999999999999999765555545555544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.48 Aligned_cols=214 Identities=29% Similarity=0.588 Sum_probs=171.0
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc----
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---- 192 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---- 192 (344)
...++|++++.||+|+||+||+|.+..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccc
Confidence 3468999999999999999999999999999999998542 235678999999999 899999999999643
Q ss_pred CCCccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
.....++|+||+ +++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC-------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeeccccccc
Confidence 225678999999 56777766 458999999999999999999999999999999999999988 78999999999875
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.. ......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..|.+.+|+++
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCC
T ss_pred cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCC
Confidence 43 2345688999999999887678999999999999999999999998 67777899999999988864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=308.35 Aligned_cols=211 Identities=33% Similarity=0.605 Sum_probs=178.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|+++++||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEE
Confidence 368999999999999999999999999999999885332 35578899999999 99999999999965 46788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-C
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~ 274 (344)
+||||++++++..+. ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++...... .
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccc
Confidence 999999999988775 458999999999999999999999999999999999999988 78999999999876533 3
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~ 221 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGD 221 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCS
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhcc
Confidence 3445688999999999987677899999999999999999999998 566677777777777664
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.11 Aligned_cols=214 Identities=33% Similarity=0.577 Sum_probs=182.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCC----CccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----~~~~l 199 (344)
..+|++.+.||+|+||+||+|++..+++ +|+|.+... .....+|+++++.+ +|+||++++++|..... ...++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence 4579999999999999999999877776 777766422 22334799999999 99999999999865332 24789
Q ss_pred EEEeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 200 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 200 v~e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
||||++++.+.... ..+++..++.++.|++.||+|||+.||+||||||+|||++.+.+.+||+|||+++.....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 99999987655432 469999999999999999999999999999999999999943389999999999988766
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++.+|.+.+|+++
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCC
Confidence 66667788999999999987567999999999999999999999998 57778899999999988865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=325.61 Aligned_cols=211 Identities=22% Similarity=0.408 Sum_probs=182.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+......+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeE
Confidence 467899999999999999999999999999999999642 346678999999999 999999999999877666889
Q ss_pred EEEEeecCCchhhHcCC------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE----eCCCCcEEEEecccce
Q 019241 199 LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLAE 268 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~~------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl----~~~~~~~kl~DFGla~ 268 (344)
+||||+++++|..++.. +++..++.++.|++.||+|||+.||+||||||+|||+ +.+ +.+||+|||+++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a~ 164 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAR 164 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGCE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCce
Confidence 99999999999998854 8999999999999999999999999999999999998 544 679999999999
Q ss_pred ecCCCCcceecccCCCccCcccccCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CCCHHHHHHHHH
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKEPFFYG---HDNHDQLVKIAK 335 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DvwSlGv~l~ell~g~~Pf~~~---~~~~~~l~~i~~ 335 (344)
............||..|+|||++.+. ..++.++|||||||++|||++|+.||... ....+.+.++..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 88766666667899999999998641 45778999999999999999999999643 334555555443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.16 Aligned_cols=196 Identities=21% Similarity=0.334 Sum_probs=172.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.+.||+|+||+||+|++..+++.||||++.. ...+.+.+|+.+++++.+|+||+++++++.+ ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEE
Confidence 35789999999999999999999999999999999863 3345789999999999889999999999965 46788999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc-----EEEEecccceecCC
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHP 272 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~-----~kl~DFGla~~~~~ 272 (344)
||+ +++|.+++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +. +||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBC
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeeec
Confidence 999 88888876 468999999999999999999999999999999999999987 55 99999999987654
Q ss_pred CCc--------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 273 GKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 273 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 332 245689999999999887 77999999999999999999999999643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.87 Aligned_cols=197 Identities=25% Similarity=0.417 Sum_probs=177.7
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
...++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence 3467899999999999999999999999999999998532 335678999999999 99999999999955 46
Q ss_pred ccEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 196 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..++||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence 7899999999999988762 38999999999999999999999999999999999999988 79999999999988
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 76666667799999999999987 77999999999999999999999999654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=324.86 Aligned_cols=207 Identities=25% Similarity=0.452 Sum_probs=182.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEE
Confidence 47899999999999999999999999999999999643 235688999999999 99999999999955 4678
Q ss_pred EEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+++++|.+++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhccccc
Confidence 99999999999999874 58999999999999999999999999999999999999988 789999999999887666
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....+||+.|+|||++.+....+.++|||||||++|||++|+.||. +.+..+...++.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~ 230 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICD 230 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHT
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhc
Confidence 66677999999999999874445789999999999999999999994 5555666666554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.15 Aligned_cols=207 Identities=24% Similarity=0.408 Sum_probs=182.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+..|..++..+.+|+||+++++++. .....
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~~ 417 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRL 417 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCEE
Confidence 57899999999999999999999999999999998632 33567889999998878999999999994 45778
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC-CC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~-~~ 273 (344)
++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+... ..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccccCC
Confidence 9999999999998887 569999999999999999999999999999999999999998 799999999998643 33
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+..|.+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~ 556 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIME 556 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHS
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCC-CCCCHHHHHHHHHh
Confidence 44556789999999999977 78999999999999999999999999 45666667666655
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=313.39 Aligned_cols=215 Identities=29% Similarity=0.575 Sum_probs=186.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC---CC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~ 195 (344)
..++|++++.||+|+||+||+|++..+++.||+|++.... .+.+.+|+++++++ +||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 4679999999999999999999999999999999986432 25688999999999 9999999999996532 24
Q ss_pred ccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
..++||||+++ +|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecCCC
Confidence 67899999996 666665 469999999999999999999999999999999999999988 78999999999876543
Q ss_pred Cc----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 274 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.. .....||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.++
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCC
Confidence 22 234588999999999877567999999999999999999999998 56777888888888888764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=310.81 Aligned_cols=189 Identities=27% Similarity=0.507 Sum_probs=152.2
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchh
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK 210 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~ 210 (344)
+.||+|+||+||+|++..+++.||+|++.......+.+|+.+++.+.+||||+++++++.+ ....++||||+++++|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccCCCcHH
Confidence 6899999999999999999999999999877778899999999999569999999999954 46788999999999998
Q ss_pred hHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEEEecccceecCCC-CcceecccCCC
Q 019241 211 VLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG-KEYNVRVASRY 284 (344)
Q Consensus 211 ~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGla~~~~~~-~~~~~~~~t~~ 284 (344)
.++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+. ..+||+|||+++..... ......++|+.
T Consensus 95 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~ 174 (325)
T 3kn6_A 95 ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174 (325)
T ss_dssp HHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------------
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcC
Confidence 877 4589999999999999999999999999999999999998762 27999999999876543 23345678999
Q ss_pred ccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 285 y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 175 y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 175 YAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 999999876 7799999999999999999999999954
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.05 Aligned_cols=214 Identities=30% Similarity=0.636 Sum_probs=177.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--NHRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--TTEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--CCEE
Confidence 3578999999999999999999999999999999986432 24567899999999 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC----CCcEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~----~~~~kl~DFGla~~~ 270 (344)
++||||+++ +|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+++..
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 899999996 776665 458999999999999999999999999999999999999533 246999999999876
Q ss_pred CCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
... .......+|..|+|||++.+...++.++|||||||++|||++|..|| .+.+..+.+.++.+.++.++
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCc
Confidence 533 33445678999999999987566899999999999999999999998 56677888888888887765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=310.81 Aligned_cols=203 Identities=25% Similarity=0.432 Sum_probs=167.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC-
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK- 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~- 195 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++++ +||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCC
Confidence 3678999999999999999999999999999999996432 24678999999999 999999999998654332
Q ss_pred -ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 -TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 -~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCccccc
Confidence 348999999999999887 459999999999999999999999999999999999999988 789999999998765
Q ss_pred CCC----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 272 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 272 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~ 227 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSV 227 (311)
T ss_dssp --------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHH
T ss_pred ccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHH
Confidence 432 2233568999999999987 789999999999999999999999994 3443333
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=306.41 Aligned_cols=203 Identities=21% Similarity=0.386 Sum_probs=164.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|++ +++.||+|++.... .+.+.+|+++++++ +||||+++++++.+ ....
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 109 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNL 109 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCC
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCce
Confidence 467899999999999999999976 68889999986432 35688999999999 99999999999954 4668
Q ss_pred EEEEEeecCCchhhHcCC------CCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~~------l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
++||||+++++|..++.. +++..+..++.|++.||+|||+.| |+||||||+|||++.+ +.+||+|||+++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCcc
Confidence 899999999999988743 889999999999999999999999 9999999999999988 7899999999976
Q ss_pred cCCCC-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 270 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 270 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~ 251 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAV 251 (309)
T ss_dssp -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHH
T ss_pred ccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence 54332 2345678999999999987 778999999999999999999999994 44444444444
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=306.80 Aligned_cols=195 Identities=22% Similarity=0.408 Sum_probs=171.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
..++|++.++||+|+||+||+|++..+++.||+|.+... ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEec--CCeeEE
Confidence 467899999999999999999999999999999988543 346788999999999 89999999999965 467889
Q ss_pred EEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccccc
Confidence 99999999999887 458999999999999999999999999999999999999988 7899999999987653322
Q ss_pred c---------------eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 Y---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 1 14578999999999987 7899999999999999999999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=308.43 Aligned_cols=207 Identities=26% Similarity=0.477 Sum_probs=181.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 46799999999999999999999999999999998632 246789999999999 99999999999955 4
Q ss_pred CccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC---cEEEEecccce
Q 019241 195 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE 268 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~---~~kl~DFGla~ 268 (344)
...++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+.. .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 67889999999999998873 4789999999999999999999999999999999999998722 79999999999
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITS 232 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHT
T ss_pred ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHh
Confidence 8776666666789999999999876 778999999999999999999999994 4455555555544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.57 Aligned_cols=196 Identities=27% Similarity=0.403 Sum_probs=174.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--KTD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--CCE
Confidence 457899999999999999999999999999999999532 235688999999999 99999999999954 467
Q ss_pred cEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 197 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.++||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceeee
Confidence 899999999999988762 48999999999999999999999999999999999999988 8999999999988
Q ss_pred cCCCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 270 YHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 270 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 765443 334589999999999987 78999999999999999999999999654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=313.66 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=175.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ....+|++++.++.+||||+++++++.+ ....++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence 567999999999999999999999999999999996543 3456899999998789999999999954 4778999999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC---cEEEEecccceecCCC-Ccc
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPG-KEY 276 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~---~~kl~DFGla~~~~~~-~~~ 276 (344)
+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||+..+.+ .+||+|||+++..... ...
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 9999998876 35899999999999999999999999999999999999855422 4999999999876543 334
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIA 334 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~--~~~~~l~~i~ 334 (344)
...++|+.|+|||++.+ ..++.++|||||||++|||++|..||.... +..+.+..+.
T Consensus 178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 236 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236 (342)
T ss_dssp CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH
T ss_pred eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc
Confidence 55688999999999876 668999999999999999999999996532 2344444443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.95 Aligned_cols=206 Identities=25% Similarity=0.459 Sum_probs=169.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||++++++|.+ ...
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~--~~~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDR 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEE--TTE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEee--CCE
Confidence 347899999999999999999999999999999998632 234567899999998 89999999999965 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++ ..+++..++.++.|++.||+|||+ .||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccC
Confidence 89999999999998877 568999999999999999999998 999999999999999988 7999999999986432
Q ss_pred -CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 273 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~ 362 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELIL 362 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHH
Confidence 334456789999999999987 789999999999999999999999994 344444444443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.55 Aligned_cols=208 Identities=26% Similarity=0.507 Sum_probs=179.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 80 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFH 80 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCEE
Confidence 4689999999999999999999999999999999986432 35678999999999 99999999999954 4677
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGla~~~~~ 272 (344)
++||||+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+||+++.+. ..+||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 8999999999987765 4589999999999999999999999999999999999998652 3499999999988776
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKA 221 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred CccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCC-CCchhHHHHHHHh
Confidence 666666789999999999877 778999999999999999999999994 4444445554444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.60 Aligned_cols=210 Identities=25% Similarity=0.524 Sum_probs=183.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHh-----CCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~~ 196 (344)
..+|++.++||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+. .|+||+++++++.. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCe
Confidence 578999999999999999999999999999999997543 366788999999883 56799999999965 477
Q ss_pred cEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc--EEEEeccccee
Q 019241 197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF 269 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~--~kl~DFGla~~ 269 (344)
.++||||+.+ +|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +. +||+|||++..
T Consensus 174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence 8999999985 565554 248999999999999999999999999999999999999987 44 99999999976
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.++.+++..+.+.+|.++
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 252 EHQ--RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred cCC--cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCC
Confidence 543 3345688999999999987 77999999999999999999999888 67788899999999988775
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=311.23 Aligned_cols=213 Identities=33% Similarity=0.633 Sum_probs=178.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+++++.+ +||||+++++++.+ .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--K 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--T
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--C
Confidence 3578999999999999999999999999999999986321 24678999999999 99999999999954 5
Q ss_pred CccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++||||+++ ++..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSF 162 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTT
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceec
Confidence 678899999997 5655552 48899999999999999999999999999999999999988 78999999999876
Q ss_pred CCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
... .......+|+.|+|||++.+...++.++|||||||++|||++|..|| .+.++.+.+.++.+.++.++
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPT 233 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCC
Confidence 433 33455688999999999977567899999999999999999998776 67777888888988877654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.08 Aligned_cols=205 Identities=27% Similarity=0.523 Sum_probs=180.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.+.||+|+||+||+|++..++..+|+|.+.. ...+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence 4679999999999999999999999999999999863 3457789999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE---eCCCCcEEEEecccceecCCCC
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl---~~~~~~~kl~DFGla~~~~~~~ 274 (344)
|||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||+ +.+ +.+||+|||++....+..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence 9999999998776 458999999999999999999999999999999999999 555 789999999999887776
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......+|+.|+|||++.+ .++.++|||||||++|||++|..||. +.++.+...++.+
T Consensus 164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDSEVMLKIRE 221 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHh
Confidence 6677789999999999865 48999999999999999999999994 4444555555544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=314.67 Aligned_cols=206 Identities=20% Similarity=0.357 Sum_probs=173.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
..++|++.+.||+|+||+||+|++. .++..||+|+++... .+.+.+|+.+++++.+||||++++++|.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999875 345679999997432 35688999999999789999999999954
Q ss_pred cCCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....++||||+++++|..++. .+++.++..++.|++.||+|||+.||+||||||+|||+
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 467889999999999988862 37889999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+.+ +.+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+
T Consensus 237 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~-~~~~~~ 313 (370)
T 2psq_A 237 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE 313 (370)
T ss_dssp CTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGG
T ss_pred CCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-CCCHHH
Confidence 988 7899999999987654332 223456778999999987 789999999999999999999 888884 444444
Q ss_pred HHHHH
Q 019241 329 QLVKI 333 (344)
Q Consensus 329 ~l~~i 333 (344)
....+
T Consensus 314 ~~~~~ 318 (370)
T 2psq_A 314 LFKLL 318 (370)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=305.99 Aligned_cols=193 Identities=23% Similarity=0.317 Sum_probs=162.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.++||+|+||+||+|++..+++.||||++... .......|+..+.++.+|+||++++++|.+ ....+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEE
Confidence 46899999999999999999999999999999998532 223455677777776699999999999964 47789
Q ss_pred EEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+.+ +|..++ ..+++..++.++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus 134 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 134 LQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC---
T ss_pred EEEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccCC
Confidence 99999954 565554 359999999999999999999999999999999999999988 789999999998876666
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......||+.|+|||++.+ .++.++|||||||++|||++|..||+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 6666789999999999865 689999999999999999999877753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=315.47 Aligned_cols=223 Identities=23% Similarity=0.403 Sum_probs=185.8
Q ss_pred cceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHh-------CCCCcccee
Q 019241 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-------GGPNVVKLL 186 (344)
Q Consensus 116 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-------~h~niv~l~ 186 (344)
.........++|++.++||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++.+. .|+||++++
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 33333334689999999999999999999999999999999997543 467889999999993 278899999
Q ss_pred eEEEcc--CCCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCC---
Q 019241 187 DIVRDQ--HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEL--- 256 (344)
Q Consensus 187 ~~~~~~--~~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~--- 256 (344)
+++... .....++||||+.++.+..+. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.+.
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred cceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 998632 346789999999776666554 3489999999999999999999998 999999999999998762
Q ss_pred ---------------------------------------------CcEEEEecccceecCCCCcceecccCCCccCcccc
Q 019241 257 ---------------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291 (344)
Q Consensus 257 ---------------------------------------------~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~ 291 (344)
..+||+|||++..... ......+|+.|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhh
Confidence 2699999999987653 34456889999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHHhhCCCC
Q 019241 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVKIAKVTTILD 341 (344)
Q Consensus 292 ~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~-----~~~~l~~i~~~~~~~~ 341 (344)
.+ ..++.++|||||||++|||++|+.||..... +.+++..+.+.+|.++
T Consensus 266 ~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p 319 (397)
T 1wak_A 266 IG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319 (397)
T ss_dssp HT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCC
T ss_pred cC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCC
Confidence 87 6799999999999999999999999964332 4677888888888764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.33 Aligned_cols=213 Identities=31% Similarity=0.579 Sum_probs=179.3
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
...++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 98 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK--KKR 98 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--CCE
Confidence 35688999999999999999999999999999999985322 34577899999999 89999999999965 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||++++++..+. ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC------
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceeecCC
Confidence 88999999999988774 568999999999999999999999999999999999999988 79999999999766433
Q ss_pred -CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCC
Q 019241 274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTI 339 (344)
Q Consensus 274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~ 339 (344)
.......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+....+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCS
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCC
Confidence 33445678999999999987557899999999999999999999998 556667777777766654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=305.39 Aligned_cols=203 Identities=20% Similarity=0.399 Sum_probs=176.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.|+..++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +|+||+++++++... ...++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence 477788999999999999999999999999998632 346788999999999 999999999999653 67889999
Q ss_pred eecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cceec
Q 019241 203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR 279 (344)
Q Consensus 203 ~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~~~~ 279 (344)
|+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccc
Confidence 999999999875 58999999999999999999999999999999999999988 789999999998765432 33456
Q ss_pred ccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 280 ~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~-~~~~~~~~~~~~ 254 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLR 254 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHH
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHh
Confidence 89999999999876 778999999999999999999999995 334444444443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=306.04 Aligned_cols=211 Identities=25% Similarity=0.468 Sum_probs=177.0
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|.+. +.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+..||||+++++++.+ ....
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 5678887 8899999999999999999999999998642 346788999999999778999999999954 4678
Q ss_pred EEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC--CCCcEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~--~~~~~kl~DFGla~~~ 270 (344)
++||||+.+++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++. +.+.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 8999999999998887 34899999999999999999999999999999999999987 1268999999999987
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~ 338 (344)
..........+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.+...
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~ 250 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETYLNISQVNV 250 (327)
T ss_dssp ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCC
T ss_pred CCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHhccc
Confidence 76656666789999999999876 78999999999999999999999999 45555666666655443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.71 Aligned_cols=215 Identities=32% Similarity=0.625 Sum_probs=181.2
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
+...++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++......
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCc
Confidence 34468999999999999999999999999999999998642 235678999999999 999999999999654322
Q ss_pred ----ccEEEEEeecCCchhhHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 196 ----TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 196 ----~~~lv~e~~~~~~l~~~l-~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..++||||+++ +|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC---
T ss_pred ccceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCccccc
Confidence 23899999995 555555 569999999999999999999999999999999999999988 78999999999865
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.. ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..|.++
T Consensus 195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCc
Confidence 43 3345678999999999887678999999999999999999999999 56777888888888777653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=318.77 Aligned_cols=198 Identities=24% Similarity=0.466 Sum_probs=163.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence 578999999999999999999999999999999986422 12478999999999 99999999999854
Q ss_pred CCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccc
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA 267 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla 267 (344)
...++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ ...+||+|||++
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 3468999999999998877 458999999999999999999999999999999999999754 135999999999
Q ss_pred eecCCCCcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
+...........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.....
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 88766655666789999999999853 35688999999999999999999999965433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.64 Aligned_cols=216 Identities=28% Similarity=0.485 Sum_probs=174.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCC-----Cc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----KT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----~~ 196 (344)
.++|++.+.||+|+||+||+|++..+++.||||++... ......+|++.++.+ +||||++++++|..... ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence 57899999999999999999999999999999988532 345677888888998 99999999999865322 23
Q ss_pred cEEEEEeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHH--HcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH--~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
.++||||++++.+.... ..+++..+..++.|++.||.||| +.||+||||||+|||++...+.+||+|||+++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 78999999987544322 35889999999999999999999 99999999999999999733799999999999
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
............+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+.+.++.++
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCC
Confidence 8876666667788999999999977566999999999999999999999998 56677888888888877664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=308.33 Aligned_cols=193 Identities=22% Similarity=0.415 Sum_probs=165.7
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCC------
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------ 194 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------ 194 (344)
++|++.+.||+|+||+||+|++..+++.||||+++. ...+.+.+|+.+++++ +||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence 579999999999999999999999999999999863 2346789999999999 99999999999865432
Q ss_pred -------------------------------------------------CccEEEEEeecCCchhhHcCC------CCHH
Q 019241 195 -------------------------------------------------KTPSLIFEYVNSTDFKVLYPT------LTDY 219 (344)
Q Consensus 195 -------------------------------------------------~~~~lv~e~~~~~~l~~~l~~------l~~~ 219 (344)
.+.++||||+++++|..++.. ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 237899999999999998732 5566
Q ss_pred HHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-------------cceecccCCCcc
Q 019241 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK 286 (344)
Q Consensus 220 ~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-------------~~~~~~~t~~y~ 286 (344)
.+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...... ......||+.|+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 788999999999999999999999999999999988 799999999998876542 223357899999
Q ss_pred CcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 019241 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320 (344)
Q Consensus 287 aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf 320 (344)
|||++.+ ..++.++|||||||++|||++|..|+
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 9999987 78999999999999999999987765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.65 Aligned_cols=202 Identities=16% Similarity=0.255 Sum_probs=166.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-----CeEEEEEEecccchHHHHHHHHHHHHHh--------------CCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVKKKKIKREIKILQNLC--------------GGPNVV 183 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~E~~~l~~l~--------------~h~niv 183 (344)
..++|++.++||+|+||+||+|.+..+ ++.||+|++.... ..+.+|+++++++. +|+||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 567899999999999999999988765 5789999986443 34455555555442 599999
Q ss_pred ceeeEEEccCC--CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe--CC
Q 019241 184 KLLDIVRDQHS--KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HE 255 (344)
Q Consensus 184 ~l~~~~~~~~~--~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~--~~ 255 (344)
++++++..... .+.++||||+ +++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99999865432 5578999999 89998887 4689999999999999999999999999999999999998 66
Q ss_pred CCcEEEEecccceecCCCCcc--------eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH
Q 019241 256 LRKLRLIDWGLAEFYHPGKEY--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327 (344)
Q Consensus 256 ~~~~kl~DFGla~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~ 327 (344)
+.+||+|||+++.+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+.
T Consensus 191 -~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 191 -DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp -TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred -CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 78999999999876533211 23459999999999887 679999999999999999999999996544443
Q ss_pred H
Q 019241 328 D 328 (344)
Q Consensus 328 ~ 328 (344)
+
T Consensus 269 ~ 269 (364)
T 3op5_A 269 K 269 (364)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=300.46 Aligned_cols=193 Identities=23% Similarity=0.478 Sum_probs=165.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|++.++||+|+||+||+|++..+++.+|+|++... ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeEEE
Confidence 47899999999999999999999999999999998632 347789999999999 99999999999954 467889
Q ss_pred EEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceec
Q 019241 200 IFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFY 270 (344)
Q Consensus 200 v~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~ 270 (344)
||||+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998876 569999999999999999999999999999999999999532 267999999999877
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..........+|+.|+|||++. ..++.++|||||||++|||++|+.||.
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 6666666678999999999975 468999999999999999999999994
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.43 Aligned_cols=199 Identities=21% Similarity=0.264 Sum_probs=172.7
Q ss_pred CCCCeEEEeeeccc--CCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.++||+| +||+||+|++..+++.||||+++... .+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DN 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEE--CC
Confidence 56789999999999 99999999999999999999986332 35678899999999 99999999999965 46
Q ss_pred ccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||.+...
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCEEC
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccccceee
Confidence 789999999999998886 458999999999999999999999999999999999999988 79999999998654
Q ss_pred CCCC--------cceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 271 HPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 271 ~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
.... ......||..|+|||++.+. ..++.++|||||||++|||++|+.||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3221 12234788899999998763 4689999999999999999999999954333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=307.78 Aligned_cols=207 Identities=18% Similarity=0.371 Sum_probs=172.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++..+++ .||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 46789999999999999999999875554 5999999743 235688999999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLE 202 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccccc
Confidence 788999999999999887 368999999999999999999999999999999999999988 789999999998775
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+.+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~ 269 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYW-NMTNRDVISSVEE 269 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TSCHHHHHHHHHT
T ss_pred cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHc
Confidence 43221 22345678999999976 678999999999999999999 998884 4444555555444
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=322.48 Aligned_cols=207 Identities=28% Similarity=0.550 Sum_probs=180.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----------------chHHHHHHHHHHHHHhCCCCcccee
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------------KKKKIKREIKILQNLCGGPNVVKLL 186 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~niv~l~ 186 (344)
..++|+++++||+|+||+||+|++..+++.+|+|+++.. ..+.+.+|+.+++++ +||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence 357899999999999999999999999999999998632 235688999999999 999999999
Q ss_pred eEEEccCCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC--cEEE
Q 019241 187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRL 261 (344)
Q Consensus 187 ~~~~~~~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~--~~kl 261 (344)
+++.+ ....++||||+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+.. .+||
T Consensus 113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99954 57789999999999998776 56999999999999999999999999999999999999987622 6999
Q ss_pred EecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 262 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 262 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+|||+++............||+.|+|||++.+ .++.++||||+||++|+|++|..|| .+.+..+.+..+.+
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEK 261 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHc
Confidence 99999998877666677889999999999764 6899999999999999999999999 45555666666655
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=297.54 Aligned_cols=206 Identities=27% Similarity=0.522 Sum_probs=174.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
++|++.+.||+|+||+||+|++..+++.+|+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--CC
Confidence 5799999999999999999999999999999998632 256789999999999 99999999999965 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC---CcEEEEeccccee
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEF 269 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~---~~~kl~DFGla~~ 269 (344)
..++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++||||||+||+++.+. ..+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 788999999999999887 4699999999999999999999999999999999999998762 1799999999988
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA 225 (283)
T ss_dssp CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHT
T ss_pred ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-CcchHHHHHHhHh
Confidence 766555566689999999999876 778999999999999999999999994 4444555555443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.51 Aligned_cols=207 Identities=26% Similarity=0.544 Sum_probs=179.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.++||+|+||+||+|++..+++.||+|++.. .....+.+|+++++++ +||||+++++++.+ ....+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence 4689999999999999999999999999999999852 3456789999999999 99999999999955 47788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~ 273 (344)
+||||+.+++|...+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999997766 579999999999999999999999999999999999999643 257999999999877766
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.......||+.|+|||++.+ .++.++||||+||++|+|++|..|| .+.+..+.+..+.+.
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETG 237 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHT
T ss_pred CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC
Confidence 66667789999999999875 5999999999999999999999999 455666666666553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=311.73 Aligned_cols=195 Identities=28% Similarity=0.509 Sum_probs=174.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----------chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence 46899999999999999999999999999999998643 234577899999999 99999999999954
Q ss_pred CCCccEEEEEeecCC-chhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 193 HSKTPSLIFEYVNST-DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~-~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
....++||||+.++ +|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAA 178 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccce
Confidence 46788999999776 888776 358999999999999999999999999999999999999988 789999999999
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
............||+.|+|||++.+...++.++|||||||++|||++|..||..
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 887766666778999999999998744458899999999999999999999954
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.92 Aligned_cols=215 Identities=26% Similarity=0.545 Sum_probs=168.9
Q ss_pred CCeEEE-eeecccCCeeEEEEEEc--CCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVV-RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~-~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.|++. ++||+|+||+||+|++. .+++.||+|+++.. ....+.+|+.+++++ +||||+++++++........++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 446653 47999999999999865 56889999999744 346788999999999 99999999999977667889999
Q ss_pred EEeecCCchhhHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE----eCCCCcEEEEec
Q 019241 201 FEYVNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDW 264 (344)
Q Consensus 201 ~e~~~~~~l~~~l~------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl----~~~~~~~kl~DF 264 (344)
|||++++ +..++. .+++..++.++.|++.||+|||+.||+||||||+|||+ +.+ +.+||+||
T Consensus 99 ~e~~~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kl~Df 176 (405)
T 3rgf_A 99 FDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADM 176 (405)
T ss_dssp EECCSEE-HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEEECCT
T ss_pred EeCCCCC-HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEEEEEC
Confidence 9999874 444331 38999999999999999999999999999999999999 444 78999999
Q ss_pred ccceecCCC----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHH
Q 019241 265 GLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVK 332 (344)
Q Consensus 265 Gla~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~--------~~~~l~~ 332 (344)
|+++..... ......+||+.|+|||++.+...++.++|||||||++|||++|+.||..... ..+++..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 999876532 2234568899999999998756799999999999999999999999954332 2589999
Q ss_pred HHHhhCCCCC
Q 019241 333 IAKVTTILDF 342 (344)
Q Consensus 333 i~~~~~~~~~ 342 (344)
|.+.+|.++-
T Consensus 257 i~~~~g~p~~ 266 (405)
T 3rgf_A 257 IFNVMGFPAD 266 (405)
T ss_dssp HHHHHCCCCT
T ss_pred HHHhhCCCCh
Confidence 9999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.29 Aligned_cols=207 Identities=28% Similarity=0.526 Sum_probs=178.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|+++++||+|+||+||+|++..++..+|+|+++. .....+.+|+.+++.+ +||||++++++|.+ ....+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 4579999999999999999999999999999999863 2346789999999999 99999999999955 46788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~ 273 (344)
+||||+++++|...+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999997766 569999999999999999999999999999999999999764 245999999999988776
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
......+||+.|+|||++. ..++.++||||+||++|+|++|..|| .+.+..+.+..+.+.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKG 252 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHT
T ss_pred ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC
Confidence 6667778999999999975 46899999999999999999999999 455666666666554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.97 Aligned_cols=215 Identities=28% Similarity=0.494 Sum_probs=173.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------------hHHHHHHHHHHHHHhCCCCccceeeE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKLLDI 188 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l~~~ 188 (344)
..++|++.+.||+|+||+||+|++.. ++.||||++.... .+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI 97 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence 47899999999999999999998654 8899999985321 26788999999999 99999999999
Q ss_pred EEcc---CCCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEE
Q 019241 189 VRDQ---HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262 (344)
Q Consensus 189 ~~~~---~~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~ 262 (344)
+... .....++||||++++.+..+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEEE
Confidence 8643 3346799999999644444332 48999999999999999999999999999999999999988 789999
Q ss_pred ecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 263 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.++
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCC
Confidence 9999987665555666789999999999887677999999999999999999999998 56677888888988888765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=304.01 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=170.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHH--HhCCCCccceeeEEEcc--CCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--LCGGPNVVKLLDIVRDQ--HSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~~~--~~~~~~ 198 (344)
..++|++.+.||+|+||+||+|++ +++.||||++.......+.+|.+++.. + +||||+++++++.+. .....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCceeE
Confidence 467899999999999999999976 689999999988777888889888887 5 899999999987543 235678
Q ss_pred EEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHH--------HcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH--------~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
+||||+++++|..++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAV 161 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEEeeCCCee
Confidence 9999999999999884 5899999999999999999999 9999999999999999988 789999999998
Q ss_pred ecCCCCcc-----eecccCCCccCcccccCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 019241 269 FYHPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFR----------KEPFFYGH 324 (344)
Q Consensus 269 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~ell~g----------~~Pf~~~~ 324 (344)
........ ....||+.|+|||++.+.. .++.++|||||||++|||++| ..||....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 76544332 2347899999999987632 345799999999999999999 88886543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=308.04 Aligned_cols=208 Identities=25% Similarity=0.475 Sum_probs=180.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++|++.+.||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+++++.+||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 367999999999999999999999999999999986432 34678899999999789999999999954
Q ss_pred CCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....++||||+++++|..++ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||++..
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCH 249 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccc
Confidence 47789999999999998887 469999999999999999999999999999999999999988 7899999999998
Q ss_pred cCCCCcceecccCCCccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...........||+.|+|||++.+ ...++.++|||||||++|||++|..||.. .+..+.+..+.+
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~ 319 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIME 319 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHh
Confidence 877666677789999999999863 23588999999999999999999999953 344444444433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.21 Aligned_cols=208 Identities=25% Similarity=0.490 Sum_probs=173.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence 5789999999999999999999999999999999853 2336788999999999 99999999999955 46
Q ss_pred ccEEEEEeecCCchhhHcCC-------------------------------------------CCHHHHHHHHHHHHHHH
Q 019241 196 TPSLIFEYVNSTDFKVLYPT-------------------------------------------LTDYDIRYYIYELLKAL 232 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~~-------------------------------------------l~~~~~~~~~~~i~~~L 232 (344)
..++||||+++++|..++.. +++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 78999999999999988731 25667888999999999
Q ss_pred HHHHHcCcEeecCCCCceEEeCCC-CcEEEEecccceecCCCC-----cceecccCCCccCcccccCC-CCCCchhhHHH
Q 019241 233 DYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDMWS 305 (344)
Q Consensus 233 ~~LH~~~iiHrDlkp~NiLl~~~~-~~~kl~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwS 305 (344)
+|||+.||+||||||+|||++.+. ..+||+|||+++...... ......+|+.|+|||++.+. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998762 279999999998764321 23456789999999998642 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 306 lGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
|||++|||++|+.||. +.+..+....+.+
T Consensus 262 lG~il~el~~g~~pf~-~~~~~~~~~~~~~ 290 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFP-GVNDADTISQVLN 290 (345)
T ss_dssp HHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCC-CCChHHHHHHHHh
Confidence 9999999999999994 4455555555544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.56 Aligned_cols=209 Identities=21% Similarity=0.362 Sum_probs=174.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEE-----EcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|+ +..+++.||||+++... .+.+.+|+++++++.+||||+++++++.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 46889999999999999999998 45567899999997532 356889999999997899999999999653
Q ss_pred CCccEEEEEeecCCchhhHcCC----------------------------------------------------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT---------------------------------------------------------- 215 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~---------------------------------------------------------- 215 (344)
....++||||+++++|..++..
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3457899999999999888732
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc---ceeccc
Q 019241 216 -----------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVA 281 (344)
Q Consensus 216 -----------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~---~~~~~~ 281 (344)
+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++....... .....+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCC
Confidence 7888999999999999999999999999999999999988 7899999999987644332 234567
Q ss_pred CCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 282 t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
|..|+|||++.+ ..++.++|||||||++|||++ |..||............+.
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 310 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH
Confidence 888999999887 779999999999999999998 9999965444444444433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=304.91 Aligned_cols=216 Identities=29% Similarity=0.556 Sum_probs=183.4
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEcc---CC
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HS 194 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~ 194 (344)
...++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++++ +||||+++++++... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence 35789999999999999999999999999999999996432 34677999999999 999999999988543 13
Q ss_pred CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
...++||||+++ +|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred ceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEeccccccccc
Confidence 567999999985 676665 469999999999999999999999999999999999999988 7899999999987653
Q ss_pred CCc-----------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 273 GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 273 ~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
... .....||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+..|.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCc
Confidence 221 122468999999999876578999999999999999999999998 56667788888888887765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=303.97 Aligned_cols=196 Identities=21% Similarity=0.427 Sum_probs=168.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEecccch---HHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.++||+|+||+||+|+ +..+++.||+|++..... +.+.+|+++++++ +||||+++++++......
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 46889999999999999999998 567889999999975433 5688999999999 999999999999766567
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP 165 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC---
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCccccccc
Confidence 7899999999999998873 38999999999999999999999999999999999999988 799999999998765
Q ss_pred CCCc----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 272 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 272 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccC
Confidence 4322 223356677999999987 779999999999999999999999884
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=294.55 Aligned_cols=209 Identities=25% Similarity=0.449 Sum_probs=181.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------------hHHHHHHHHHHHHHhCCCCccceeeEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVR 190 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~ 190 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+++++++.+||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4689999999999999999999999999999999986332 3557889999999956999999999995
Q ss_pred ccCCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 191 DQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 191 ~~~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
+ ....++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~ 171 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS 171 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred c--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence 4 47789999999999998887 468999999999999999999999999999999999999988 78999999999
Q ss_pred eecCCCCcceecccCCCccCccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.............++..|+|||++. ....++.++|||||||++|+|++|..||. +.+..+....+.+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~ 243 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMS 243 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc-CccHHHHHHHHhc
Confidence 8887666666778999999999985 23568899999999999999999999994 3444444444443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.52 Aligned_cols=208 Identities=24% Similarity=0.440 Sum_probs=178.6
Q ss_pred ccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 120 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
.....++|++.+.||+|+||+||+|++..+++.+|+|++... ..+.+.+|+.+++.+ +|+||+++++++.+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 86 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED-- 86 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--
Confidence 334578899999999999999999999999999999998532 245688999999999 99999999999955
Q ss_pred CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
....++||||+++++|..++ ..+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKV 165 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceec
Confidence 46788999999999998876 468999999999999999999999999999999999999988 78999999999876
Q ss_pred CCC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~ 227 (294)
T 2rku_A 166 EYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI 227 (294)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred ccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence 533 33445678999999999876 678999999999999999999999994 33333433333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.99 Aligned_cols=208 Identities=19% Similarity=0.337 Sum_probs=171.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEE-----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||+||+|+ +..+++.||||+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence 45789999999999999999998 4457789999998642 235688999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL 261 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl 261 (344)
....++||||+++++|..++. .+++.++..++.|++.||+|||+.||+||||||+|||++.+ ...+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 466789999999999998872 38899999999999999999999999999999999999854 135999
Q ss_pred EecccceecCCC---CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 262 IDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 262 ~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf-~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTS 301 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHT
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 999999755321 22334567889999999887 779999999999999999998 88888 44555555554443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.62 Aligned_cols=205 Identities=22% Similarity=0.394 Sum_probs=172.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence 4578999999999999999999999999999999987432 24678999999999 99999999999954 46788
Q ss_pred EEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCc
Confidence 9999999999988873 48999999999999999999999999999999999999988 789999999998754332
Q ss_pred cce---ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 275 EYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 275 ~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
... ...++..|+|||++.. ..++.++|||||||++|||++ |..|| .+.++.+....+
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~-~~~~~~~~~~~~ 328 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQTREFV 328 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSS-TTSCHHHHHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence 111 1234567999999876 678999999999999999998 88888 444444444333
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=297.88 Aligned_cols=196 Identities=17% Similarity=0.322 Sum_probs=172.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++.+.+|+|++++++++.+ ....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEE
Confidence 36789999999999999999999999999999999863 3446789999999999889999999999954 46788999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc-----EEEEecccceecCC
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHP 272 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~-----~kl~DFGla~~~~~ 272 (344)
||+ +++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +. +||+|||+++....
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEECCCTTCEESBC
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEEECcccccccc
Confidence 999 889988873 58999999999999999999999999999999999999866 33 99999999987754
Q ss_pred CCc--------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 273 GKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 273 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 322 244578999999999877 77899999999999999999999999653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=322.83 Aligned_cols=207 Identities=28% Similarity=0.531 Sum_probs=182.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||||++.. .....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 4689999999999999999999999999999999842 3456789999999999 99999999999955 4778
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC--CCCcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~--~~~~~kl~DFGla~~~~~ 272 (344)
++||||+.+++|...+ ..+++..+..++.|++.||.|||+.||+||||||+|||++. +.+.+||+|||+++....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999998776 56899999999999999999999999999999999999952 226899999999988876
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
........||+.|+|||++.+ .++.++||||+||++|+|++|..|| .+.+..+.+..+.+.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKG 242 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC
T ss_pred ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcC
Confidence 666667789999999999865 6899999999999999999999999 456666777776653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.56 Aligned_cols=207 Identities=24% Similarity=0.440 Sum_probs=178.9
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
....++|++.+.||+|+||+||++++..+++.+|+|++... ..+.+.+|+.+++.+ +|+||+++++++.+ .
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 113 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--N 113 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--S
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec--C
Confidence 34567899999999999999999999999999999998532 346688999999999 99999999999965 4
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++||||+++++|..++ ..+++.++..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++....
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVE 192 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecc
Confidence 6789999999999998876 468999999999999999999999999999999999999988 789999999998765
Q ss_pred CC-CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.. .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~ 253 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI 253 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHH
T ss_pred cCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHH
Confidence 33 33445678999999999987 778999999999999999999999994 33334444444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=296.00 Aligned_cols=207 Identities=26% Similarity=0.493 Sum_probs=175.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CCE
Confidence 457899999999999999999999999999999998532 245688999999999 89999999999955 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||+++++|...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC---
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCcc
Confidence 88999999999998876 568999999999999999999999999999999999999988 78999999998654432
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||. +.+..+....+.+.
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~ 222 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV 222 (279)
T ss_dssp ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHT
T ss_pred -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhC
Confidence 3345678999999999876 778999999999999999999999994 44545555555443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=307.65 Aligned_cols=196 Identities=20% Similarity=0.304 Sum_probs=168.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccC--CCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQH--SKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~~~ 198 (344)
..++|++.++||+|+||+||+|++. ++.||||+++.... ....+|+.+++++ +||||+++++++.+.. ....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEE
Confidence 5678999999999999999999764 78999999975443 3456688889998 9999999999997654 23468
Q ss_pred EEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHc----------CcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 199 lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~----------~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
+||||+++++|..++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEccCCc
Confidence 999999999999987 4589999999999999999999999 99999999999999988 7899999999
Q ss_pred ceecCCCCc---ceecccCCCccCcccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 267 AEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 267 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
++....... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 987754332 2335789999999998763 3456789999999999999999999954
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.72 Aligned_cols=206 Identities=17% Similarity=0.379 Sum_probs=174.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++. +++.||+|++... ..+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 83 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEE
Confidence 4578999999999999999999876 5778999999743 457799999999999 89999999999954 4678899
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEeccccccccccccccc
Confidence 99999999998873 38999999999999999999999999999999999999988 789999999998664332
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~-~~~~~~~~~~~~~~ 222 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDIST 222 (269)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHT
T ss_pred cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhc
Confidence 1223455678999999876 779999999999999999999 88888 44555555555544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=307.71 Aligned_cols=206 Identities=19% Similarity=0.374 Sum_probs=173.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-------CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
..++|++.++||+|+||+||+|++.. .+..||+|+++... .+.+.+|+++++++.+||||++++++|.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 46789999999999999999998754 33579999996432 25688999999999889999999999954
Q ss_pred cCCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||+
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 467889999999999998872 38999999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+.+ +.+||+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+
T Consensus 225 ~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~-~~~~~~~ 301 (382)
T 3tt0_A 225 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEE 301 (382)
T ss_dssp CTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred cCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHH
Confidence 988 7899999999987654322 233456778999999987 789999999999999999999 88888 3444444
Q ss_pred HHHHH
Q 019241 329 QLVKI 333 (344)
Q Consensus 329 ~l~~i 333 (344)
....+
T Consensus 302 ~~~~~ 306 (382)
T 3tt0_A 302 LFKLL 306 (382)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=305.80 Aligned_cols=206 Identities=20% Similarity=0.420 Sum_probs=173.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++. .+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence 4678999999999999999999886 345899999997532 35688999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLY---------------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l---------------------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlk 246 (344)
....++||||+++++|..++ ..+++.+++.++.|++.||+|||+.||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 56788999999999998876 348889999999999999999999999999999
Q ss_pred CCceEEeCCCCcEEEEecccceecCCCC---cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 247 p~NiLl~~~~~~~kl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
|+|||++.+ +.+||+|||+++...... ......+|..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 202 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~- 278 (343)
T 1luf_A 202 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY- 278 (343)
T ss_dssp GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-
T ss_pred cceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC-
Confidence 999999988 789999999997654332 2234567888999999886 679999999999999999999 888984
Q ss_pred CCCCHHHHHHHH
Q 019241 323 GHDNHDQLVKIA 334 (344)
Q Consensus 323 ~~~~~~~l~~i~ 334 (344)
+.+..+....+.
T Consensus 279 ~~~~~~~~~~~~ 290 (343)
T 1luf_A 279 GMAHEEVIYYVR 290 (343)
T ss_dssp TSCHHHHHHHHH
T ss_pred CCChHHHHHHHh
Confidence 444444444443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.64 Aligned_cols=212 Identities=32% Similarity=0.613 Sum_probs=178.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--- 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 194 (344)
..++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence 357899999999999999999999999999999998642 235678999999999 99999999999965432
Q ss_pred -CccEEEEEeecCCchhhHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 195 -KTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 195 -~~~~lv~e~~~~~~l~~~l-~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
...++||||+++ +|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 101 FYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA 178 (353)
T ss_dssp CCCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC---
T ss_pred ceeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCCC
Confidence 235899999985 666655 469999999999999999999999999999999999999988 7899999999976542
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+..|.+
T Consensus 179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVP 243 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBC
T ss_pred --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 2345678999999999877567899999999999999999999999 4666677888888877655
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.69 Aligned_cols=202 Identities=15% Similarity=0.273 Sum_probs=172.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-------eEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
..++|++.+.||+|+||+||+|++..++ ..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC- 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC-
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe-
Confidence 4678999999999999999999988776 47999998643 346788999999999 99999999999954
Q ss_pred CCCccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCc--------EE
Q 019241 193 HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--------LR 260 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~--------~k 260 (344)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+|||++.+ +. +|
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFIK 161 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEEE
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccccceee
Confidence 466789999999999998873 28999999999999999999999999999999999999887 44 99
Q ss_pred EEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 261 l~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
|+|||++..... .....+|..|+|||++.+...++.++|||||||++|||++|..|++...+......
T Consensus 162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 999999875432 23456788999999998756799999999999999999998777766655544443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=292.38 Aligned_cols=199 Identities=20% Similarity=0.324 Sum_probs=170.1
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----------hHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
...++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence 35789999999999999999999999999999999985321 16788999999999 99999999999843
Q ss_pred cCCCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCc-----EE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRK-----LR 260 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~-----~k 260 (344)
. . ++||||+++++|...+ ..+++..+..++.|++.||+|||+.| |+||||||+|||++.+ +. +|
T Consensus 95 ~--~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~k 169 (287)
T 4f0f_A 95 P--P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAK 169 (287)
T ss_dssp T--T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEE
T ss_pred C--C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEE
Confidence 2 2 6999999999997766 35899999999999999999999999 9999999999999876 44 99
Q ss_pred EEecccceecCCCCcceecccCCCccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 019241 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328 (344)
Q Consensus 261 l~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~ 328 (344)
|+|||+++... .......+|+.|+|||++.. ...++.++|||||||++|||++|+.||........
T Consensus 170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 99999997543 33455689999999999843 25678999999999999999999999965444443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.07 Aligned_cols=205 Identities=16% Similarity=0.331 Sum_probs=173.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++. ++..||+|+++.. ..+++.+|+++++++ +||||+++++++. .....++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~--~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCS--KEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEEC--SSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEc--cCCceEEE
Confidence 4678999999999999999999754 6778999999743 457789999999999 8999999999994 45678899
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||++.........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecchhhhh
Confidence 99999999988873 48999999999999999999999999999999999999988 78999999999876544322
Q ss_pred --eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
....+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~ 219 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVS 219 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc-ccChHHHHHHHH
Confidence 22345567999999876 678999999999999999999 888883 444444444443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=302.01 Aligned_cols=199 Identities=25% Similarity=0.468 Sum_probs=170.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHhCCCCccceeeEEEcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 192 (344)
.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+|+++++++ +||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence 467999999999999999999999999999999986422 23578999999999 999999999998643
Q ss_pred CCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEEEecccc
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA 267 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGla 267 (344)
..++||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+. ..+||+|||++
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 378999999999998876 3589999999999999999999999999999999999998752 24999999999
Q ss_pred eecCCCCcceecccCCCccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~ 326 (344)
+............+|+.|+|||++. +...++.++|||||||++|+|++|..||......
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 8876554445567999999999974 2367899999999999999999999999654443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=291.60 Aligned_cols=206 Identities=25% Similarity=0.457 Sum_probs=168.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCeE
Confidence 57899999999999999999999999999999998532 235788999999999 99999999999955 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+++++|.+++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccCCCc
Confidence 8999999999998877 468999999999999999999999999999999999999988 789999999998776555
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
......+++.|+|||++.+....+.++||||||+++|+|++|..||. +.+..+....+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~ 224 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIR 224 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhh
Confidence 55566889999999998874444789999999999999999999994 333344444443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.22 Aligned_cols=202 Identities=29% Similarity=0.473 Sum_probs=170.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+++++++ +||||+++++++.+ ....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 129 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTA 129 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCeE
Confidence 35689999999999999999999999999999998532 125688999999999 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+.+ ++...+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...+
T Consensus 130 ~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 130 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS-
T ss_pred EEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCC-
Confidence 899999985 444443 568999999999999999999999999999999999999988 8999999999987643
Q ss_pred CcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||.. .+..+.+..+.
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~-~~~~~~~~~~~ 266 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIA 266 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHH
Confidence 234679999999999852 36789999999999999999999999953 33344444443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=307.91 Aligned_cols=197 Identities=23% Similarity=0.451 Sum_probs=169.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
.++|++.+.||+|+||+||+|++. .+++.||||+++.. ..+.+.+|+++++++.+|+||+++++++.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 478999999999999999999884 58899999998632 235677899999999789999999999955
Q ss_pred CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
....++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 209 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCeec
Confidence 46788999999999998887 469999999999999999999999999999999999999988 78999999999876
Q ss_pred CCCC--cceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 271 HPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 271 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.... .....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 4322 22345799999999998752 45789999999999999999999999643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.61 Aligned_cols=207 Identities=22% Similarity=0.371 Sum_probs=175.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEE-----cCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++ ..+++.||+|+++... .+.+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 467899999999999999999985 4567899999997432 36688999999999889999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC---------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~---------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 467789999999999988872 38899999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+.+ +.+||+|||++......... ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||........
T Consensus 179 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 988 79999999999877544332 23356778999999877 779999999999999999999 9989855444444
Q ss_pred HHHHH
Q 019241 329 QLVKI 333 (344)
Q Consensus 329 ~l~~i 333 (344)
....+
T Consensus 257 ~~~~~ 261 (313)
T 1t46_A 257 FYKMI 261 (313)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 33333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=305.53 Aligned_cols=212 Identities=25% Similarity=0.437 Sum_probs=181.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCCC-----ccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPN-----VVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+..|+| ++++++++.. ..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CC
Confidence 3689999999999999999999999999999999997543 3567789999999855664 9999999965 46
Q ss_pred ccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHH--HcCcEeecCCCCceEEeC-CCCcEEEEecccc
Q 019241 196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLA 267 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH--~~~iiHrDlkp~NiLl~~-~~~~~kl~DFGla 267 (344)
..++||||+++ +|..++ ..+++..++.++.|++.||.||| +.||+||||||+|||++. +.+.+||+|||++
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 78999999976 666665 34899999999999999999999 579999999999999964 2367999999999
Q ss_pred eecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++.++.+.++.++
T Consensus 209 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 209 CQLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCC
T ss_pred eeccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCC
Confidence 87643 3345688999999999987 67999999999999999999999998 56777888999999888765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.89 Aligned_cols=205 Identities=27% Similarity=0.450 Sum_probs=176.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++.+ +|+||+++++++.+ ....++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEEEE
Confidence 5799999999999999999999999999999998632 246788999999999 99999999999965 4677899
Q ss_pred EEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC---
Q 019241 201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~--- 274 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcchh
Confidence 99999999998874 48999999999999999999999999999999999999988 789999999998664322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
......+|..|+|||++.+...++.++|||||||++|||++|..||....+.......+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh
Confidence 23445789999999998874445789999999999999999999997655544444443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=299.68 Aligned_cols=214 Identities=32% Similarity=0.622 Sum_probs=182.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-CCCeEEEEEEecccc-----hHHHHHHHHHHHHHh--CCCCccceeeEEEc---
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRD--- 191 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~--- 191 (344)
..++|++.+.||+|+||+||+|++. .+++.||+|+++... ...+.+|+.+++.+. +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999999985 678999999986322 346778888888774 79999999999862
Q ss_pred cCCCccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
......++||||+++ +|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~ 166 (326)
T 1blx_A 89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGL 166 (326)
T ss_dssp SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCS
T ss_pred CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCcc
Confidence 134678899999995 777765 238999999999999999999999999999999999999988 7899999999
Q ss_pred ceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
++............+|..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+.++.+.++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred cccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCC
Confidence 987665545556788999999999887 67999999999999999999999998 4666677888888877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=302.53 Aligned_cols=194 Identities=19% Similarity=0.379 Sum_probs=162.8
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeE----EEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
...++|++.++||+|+||+||+|++..+++. ||+|.++. ...+.+.+|+.+++++ +||||++++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-
Confidence 3567899999999999999999998877765 57777743 3346789999999999 999999999999653
Q ss_pred CCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++|+||+.+++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 166 (327)
T ss_dssp --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHH
T ss_pred --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeE
Confidence 367999999999998876 358999999999999999999999999999999999999988 7899999999987
Q ss_pred cCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 270 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 270 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
....... ....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 6544322 23355778999999987 789999999999999999999 998884
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.62 Aligned_cols=212 Identities=30% Similarity=0.564 Sum_probs=172.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEcc-------
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQ------- 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------- 192 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+++++++ +||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC-
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccccc
Confidence 3689999999999999999999999999999999986433 35688999999999 999999999988432
Q ss_pred -----CCCccEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 193 -----HSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 193 -----~~~~~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
.....++||||++ ++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+.+.+||+|||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 2356789999998 47887774 488999999999999999999999999999999999998654789999999
Q ss_pred cceecCCC----CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 266 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 266 la~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
+++..... .......+|..|+|||++.+...++.++|||||||++|||++|+.||. +.+..+.+..+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLILESI 241 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHHS
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhc
Confidence 99876432 223345678999999998766779999999999999999999999994 555566666665544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=299.79 Aligned_cols=203 Identities=23% Similarity=0.390 Sum_probs=172.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++. .++..||+|+++.. ..+.+.+|+.+++++.+||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 4688999999999999999999873 45678999998642 346788999999999789999999999954
Q ss_pred CCccEEEEEeecCCchhhHcCC--------------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT--------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 247 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~--------------------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp 247 (344)
....++||||+++++|..++.. +++..+..++.|++.||+|||+.||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4678899999999999888732 68889999999999999999999999999999
Q ss_pred CceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 019241 248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 323 (344)
Q Consensus 248 ~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~ 323 (344)
+|||++.+ +.+||+|||++......... ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 201 ~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 201 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999988 79999999999876543322 23456788999999877 779999999999999999998 99998554
Q ss_pred CCCHHH
Q 019241 324 HDNHDQ 329 (344)
Q Consensus 324 ~~~~~~ 329 (344)
......
T Consensus 279 ~~~~~~ 284 (344)
T 1rjb_A 279 PVDANF 284 (344)
T ss_dssp CCSHHH
T ss_pred CcHHHH
Confidence 444433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=307.75 Aligned_cols=205 Identities=25% Similarity=0.451 Sum_probs=166.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhC-CCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|.+.. ++.||||++... ..+.+.+|+.+++++.. |+||+++++++.. ....
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 4579999999999999999998654 889999998532 23668899999999943 6999999999965 4668
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||| +.+++|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||+++ +.+||+|||+++......
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccccccCCC
Confidence 99999 6777887776 45889999999999999999999999999999999999964 579999999998765433
Q ss_pred c---ceecccCCCccCcccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 275 E---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 275 ~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
. ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||....+..+.+..+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 2 234579999999999864 13689999999999999999999999965444444444443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=301.56 Aligned_cols=205 Identities=17% Similarity=0.342 Sum_probs=170.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeE----EEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|++..+++. ||+|.+... ....+.+|+.+++++ +||||+++++++.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence 578899999999999999999999888775 777776432 235677899999999 99999999999843
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++||||+.+++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLL 165 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGGS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCccccc
Confidence 5578999999999998876 258889999999999999999999999999999999999988 78999999999877
Q ss_pred CCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 271 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~ 231 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLE 231 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TSCTTHHHHHHH
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcc-ccCHHHHHHHHH
Confidence 54332 234567788999999986 679999999999999999999 999984 444444444443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=297.69 Aligned_cols=211 Identities=23% Similarity=0.470 Sum_probs=179.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEE-cCCCeEEEEEEecccc--hHHHHHHHHHHHHHhCCC------CccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGIN-VNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP------NVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~------niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++ ..+++.||+|+++... .+.+.+|+++++.+ +|+ +++++++++.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEE--
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccccc--
Confidence 367999999999999999999998 5688999999997533 36788999999988 554 59999999955
Q ss_pred CCccEEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------- 255 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~------------- 255 (344)
....++||||+ ++++..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 46789999999 667766652 47899999999999999999999999999999999999873
Q ss_pred -----CCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 019241 256 -----LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330 (344)
Q Consensus 256 -----~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l 330 (344)
.+.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHH
Confidence 25799999999987543 3345678999999999987 77999999999999999999999999 466677788
Q ss_pred HHHHHhhCCCC
Q 019241 331 VKIAKVTTILD 341 (344)
Q Consensus 331 ~~i~~~~~~~~ 341 (344)
..+.+.+++++
T Consensus 244 ~~~~~~~~~~p 254 (339)
T 1z57_A 244 AMMERILGPLP 254 (339)
T ss_dssp HHHHHHHCSCC
T ss_pred HHHHHHhCCCC
Confidence 88888887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=295.16 Aligned_cols=207 Identities=21% Similarity=0.384 Sum_probs=157.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHH-HHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIK-REIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~-~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.... .+.. ++...++.+ +||||+++++++.+ ....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~~~ 81 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EGDV 81 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSSE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cCCE
Confidence 45789999999999999999999999999999999864321 2233 333345555 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
++||||+++ ++..++ ..+++..++.++.|++.||+|||+. ||+||||||+|||++.+ +.+||+|||+++.
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGY 159 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence 899999986 554443 4699999999999999999999998 99999999999999988 7899999999988
Q ss_pred cCCCCcceecccCCCccCcccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 270 YHPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
...........+|+.|+|||++ .....++.++|||||||++|||++|+.||.......+.+.++.
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence 7666555666899999999997 2336789999999999999999999999965455455444443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=292.12 Aligned_cols=205 Identities=22% Similarity=0.452 Sum_probs=177.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+++++++ +|+||+++++++.+ ...
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 88 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RKR 88 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CCE
Confidence 457899999999999999999999999999999998532 246788999999999 99999999999965 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||||+++++|..++ ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSSS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCccc
Confidence 88999999999998876 468999999999999999999999999999999999999988 78999999999765432
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||. ..+..+....+.
T Consensus 168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~~ 225 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD-SPSHTETHRRIV 225 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHH
T ss_pred -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCC-CCCHhHHHHHHh
Confidence 3345678999999999887 678999999999999999999999994 334444444443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=295.99 Aligned_cols=205 Identities=24% Similarity=0.448 Sum_probs=175.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEEEE
Confidence 46799999999999999999999999999999998643 335688999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE---eCCCCcEEEEecccceecCCCC
Q 019241 201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl---~~~~~~~kl~DFGla~~~~~~~ 274 (344)
|||+++++|..++ ..+++..+..++.|++.||.|||+.|++||||||+||++ +.+ +.+||+|||+++.... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence 9999999998776 468999999999999999999999999999999999999 555 7899999999976543 2
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......+|+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~ 221 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY-EETESKLFEKIKE 221 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHH
T ss_pred ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHc
Confidence 3344578999999999876 779999999999999999999999994 4444555555544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=295.55 Aligned_cols=207 Identities=27% Similarity=0.486 Sum_probs=175.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||+||+|++..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 46899999999999999999999999999999998632 235688999999999 999999999998766667889
Q ss_pred EEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcC-----cEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~-----iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
+||||+++++|..++. .+++..++.++.|++.||+|||+.+ ++||||||+|||++.+ +.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCch
Confidence 9999999999988873 2899999999999999999999999 9999999999999988 7899999999
Q ss_pred ceecCCCCc-ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 267 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
++....... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~ 229 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIR 229 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHH
T ss_pred heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCc-ccCHHHHHHHHh
Confidence 987654322 234578999999999887 678999999999999999999999984 334344444443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.18 Aligned_cols=202 Identities=16% Similarity=0.235 Sum_probs=165.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC---CCeEEEEEEecccc--------------hHHHHHHHHHHHHHhCCCCccce
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKL 185 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l 185 (344)
..++|++.+.||+|+||+||+|++.. ++..+|+|+..... ...+.+|+.+++.+ +|+||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCccee
Confidence 46889999999999999999999887 78899999986432 12355677777877 99999999
Q ss_pred eeEEEcc--CCCccEEEEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC--c
Q 019241 186 LDIVRDQ--HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--K 258 (344)
Q Consensus 186 ~~~~~~~--~~~~~~lv~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~--~ 258 (344)
++++.+. .....++||||+ +++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ + .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCCc
Confidence 9998762 246789999999 999999885 58999999999999999999999999999999999999977 5 8
Q ss_pred EEEEecccceecCCCCc--------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 019241 259 LRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328 (344)
Q Consensus 259 ~kl~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~ 328 (344)
+||+|||+++.+..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.....+..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999987643221 134578999999999887 6799999999999999999999999965444433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.76 Aligned_cols=194 Identities=22% Similarity=0.389 Sum_probs=173.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEc------------
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD------------ 191 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------------ 191 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .+.+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC--------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccc
Confidence 46799999999999999999999999999999999744 35678999999999 99999999998854
Q ss_pred --cCCCccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEec
Q 019241 192 --QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264 (344)
Q Consensus 192 --~~~~~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DF 264 (344)
......++||||+++++|..++ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df 166 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDF 166 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECcc
Confidence 1234578999999999999887 358999999999999999999999999999999999999988 78999999
Q ss_pred ccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 265 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
|++.............+|+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99988876665666789999999999887 778999999999999999999998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.09 Aligned_cols=207 Identities=19% Similarity=0.337 Sum_probs=172.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++++.||+|+||+||+|.+. ++..||+|+++.. ..+.+.+|+++++++ +|+||+++++++. .....++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~--~~~~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCT--KQRPIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEEC--SSSSEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEe--cCCCeEEE
Confidence 4678999999999999999999765 6778999999743 457799999999999 8999999999994 45678899
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~- 275 (344)
|||+++++|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccccccccccc
Confidence 9999999998887 358999999999999999999999999999999999999988 7899999999986643221
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHh
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQG 237 (283)
T ss_dssp STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTT
T ss_pred cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccChhHHHHHHhcc
Confidence 223355678999999886 679999999999999999998 988884 44445555555443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.91 Aligned_cols=204 Identities=25% Similarity=0.461 Sum_probs=164.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCC--CCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|.+ .+++.||+|++... ..+.+.+|+.+++++ +| +||+++++++.+ ..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~--~~ 82 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEIT--DQ 82 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEEC--SS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEee--CC
Confidence 467899999999999999999976 56889999998532 235688999999999 55 999999999954 46
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..++||| +.+++|..++ ..+++.++..++.|++.||+|||+.||+||||||+|||+++ +.+||+|||+++....
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCCC--
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccccCc
Confidence 7899999 5677887776 46899999999999999999999999999999999999984 5799999999987654
Q ss_pred CCc---ceecccCCCccCcccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 273 GKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 273 ~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
... .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||....+....+..+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 233 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence 332 234579999999999853 2568899999999999999999999996544433333333
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=296.69 Aligned_cols=202 Identities=22% Similarity=0.357 Sum_probs=172.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe-----EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++..+++ .||+|.++.. ..+.+.+|+.+++++.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 56899999999999999999999876654 7999999653 345688999999999789999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-----------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~ 256 (344)
....++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~- 200 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG- 200 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG-
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC-
Confidence 467889999999999988762 36889999999999999999999999999999999999988
Q ss_pred CcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 257 RKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 257 ~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+.+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 78999999999866443322 23456778999999887 679999999999999999998 8888854444433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.12 Aligned_cols=205 Identities=19% Similarity=0.376 Sum_probs=175.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|++..++..||||+++.. ..+.+.+|+.+++++ +||||++++++|.+ ....++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence 356799999999999999999999999999999999743 457899999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence 99999999998872 48899999999999999999999999999999999999988 7899999999987654322
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
. ....++..|+|||++.. ..++.++|||||||++|||++ |..|| .+.+..+....+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~ 432 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELL 432 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHH
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHH
Confidence 2 12345678999999876 679999999999999999999 88887 444444444444
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.41 Aligned_cols=194 Identities=23% Similarity=0.497 Sum_probs=152.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED--SNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--SSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--CCeE
Confidence 46799999999999999999999999999999998532 236788999999999 99999999999955 4678
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+++++|..++ ..+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence 8999999999998886 348999999999999999999999999999999999999988 78999999999876533
Q ss_pred -CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334578999999999876 6789999999999999999999999954
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=299.04 Aligned_cols=211 Identities=25% Similarity=0.483 Sum_probs=179.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-eEEEEEEeccc--chHHHHHHHHHHHHHhCCCC------ccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV--KKKKIKREIKILQNLCGGPN------VVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~n------iv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++..++ +.||+|+++.. ..+.+.+|+.+++.+ +|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEE--
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeee--
Confidence 3689999999999999999999998776 78999999753 346688899999998 5554 8999998854
Q ss_pred CCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE-----------------
Q 019241 194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----------------- 252 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl----------------- 252 (344)
....++||||++++.+..+. ..+++..++.++.|++.||+|||+.||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 46789999999666555443 258999999999999999999999999999999999999
Q ss_pred --eCCCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 019241 253 --DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330 (344)
Q Consensus 253 --~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l 330 (344)
+.+ +.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+
T Consensus 174 ~~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHENREHL 248 (355)
T ss_dssp EEESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHH
T ss_pred cccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHH
Confidence 444 7899999999987543 3345688999999999987 77999999999999999999999999 466667888
Q ss_pred HHHHHhhCCCC
Q 019241 331 VKIAKVTTILD 341 (344)
Q Consensus 331 ~~i~~~~~~~~ 341 (344)
..+.+.+++++
T Consensus 249 ~~~~~~~~~~p 259 (355)
T 2eu9_A 249 VMMEKILGPIP 259 (355)
T ss_dssp HHHHHHHCCCC
T ss_pred HHHHHHcCCCc
Confidence 88888888765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=297.34 Aligned_cols=203 Identities=20% Similarity=0.384 Sum_probs=171.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++. .+++.||+|+++... .+.+.+|+++++++ +||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--
Confidence 4678999999999999999999873 455899999996432 35688999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHcCC---------------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT---------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~---------------------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlk 246 (344)
....++||||+++++|..++.. +++.++..++.|++.||+|||+.||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 4678899999999999888732 7888999999999999999999999999999
Q ss_pred CCceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 247 PHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 247 p~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
|+|||++.+ +.+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 178 p~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~- 254 (314)
T 2ivs_A 178 ARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP- 254 (314)
T ss_dssp GGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-
T ss_pred hheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC-
Confidence 999999988 78999999999877544322 23356778999999887 778999999999999999999 988884
Q ss_pred CCCCHHHHH
Q 019241 323 GHDNHDQLV 331 (344)
Q Consensus 323 ~~~~~~~l~ 331 (344)
+.+..+...
T Consensus 255 ~~~~~~~~~ 263 (314)
T 2ivs_A 255 GIPPERLFN 263 (314)
T ss_dssp TCCGGGHHH
T ss_pred CCCHHHHHH
Confidence 433333333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.01 Aligned_cols=206 Identities=20% Similarity=0.394 Sum_probs=162.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++. .++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CC
Confidence 3568999999999999999999876 46778999998643 235688999999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLE 198 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccccc
Confidence 7889999999999999873 58999999999999999999999999999999999999988 789999999998765
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
..... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~-~~~~~~~~~~i~ 264 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW-EMSNQDVIKAVD 264 (373)
T ss_dssp ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT-TCCHHHHHHHHH
T ss_pred cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHH
Confidence 43221 12234678999999886 779999999999999999998 999984 444444444443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.66 Aligned_cols=203 Identities=17% Similarity=0.365 Sum_probs=171.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.++||+|+||+||+|.+. ++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+. ....++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECT-TSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcC-CCceEEEE
Confidence 4678999999999999999999764 779999999754 457799999999999 999999999998653 24678999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+++++|.+++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++..... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--c
Confidence 9999999998873 27899999999999999999999999999999999999988 78999999999865432 2
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.
T Consensus 344 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~ 400 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVE 400 (450)
T ss_dssp ---CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTTHHHHHH
T ss_pred cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHH
Confidence 23467888999999987 789999999999999999998 998884 444445544443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.84 Aligned_cols=207 Identities=23% Similarity=0.396 Sum_probs=175.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~ 195 (344)
..+.|++.+.||+|+||+||+|.+..++..||+|++... ..+.+.+|+.+++++ +||||+++++++... ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence 355689999999999999999999999999999998632 235688999999999 999999999998653 235
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..++||||+++++|..++ ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.+.+.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 679999999999999887 46899999999999999999999999 9999999999999844378999999999754
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.. .......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||....+..+....+
T Consensus 183 ~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 242 (290)
T 1t4h_A 183 RA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242 (290)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred cc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH
Confidence 43 33455679999999998764 58999999999999999999999996544444444433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=288.02 Aligned_cols=193 Identities=19% Similarity=0.397 Sum_probs=158.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++ +++.+|+|+++.. ..+.+.+|+++++.+ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 79 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EP 79 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C-
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CC
Confidence 467899999999999999999976 4889999998532 235688999999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---cEeecCCCCceEEeCC-------CCcEEEEe
Q 019241 196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------LRKLRLID 263 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~---iiHrDlkp~NiLl~~~-------~~~~kl~D 263 (344)
..++||||+++++|..++ ..+++..+..++.|++.||+|||+.| |+||||||+|||++.+ .+.+||+|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 788999999999999887 46899999999999999999999999 9999999999999862 36799999
Q ss_pred cccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 264 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
||++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99998765433 234578999999999877 7799999999999999999999999953
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=295.17 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=169.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.++||+|+||+||+|+ +..+++.||+|+++.. ..+.+.+|+.+++++ +|+||+++++++.+...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG 97 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence 45679999999999999999998 5678999999998643 346789999999999 99999999999987666
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++...
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAI 176 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcccccccc
Confidence 7789999999999999887 458999999999999999999999999999999999999988 79999999999887
Q ss_pred CCCCc----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 019241 271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320 (344)
Q Consensus 271 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf 320 (344)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCC
Confidence 65433 223467778999999877 67889999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.02 Aligned_cols=194 Identities=18% Similarity=0.338 Sum_probs=169.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
..++|++.+.||+|+||+||+|++ .+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence 568899999999999999999984 57889999998643 346788999999999 99999999999954 567889
Q ss_pred EEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 200 IFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 200 v~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTE 191 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence 999999999998873 38899999999999999999999999999999999999988 7999999999987543
Q ss_pred CC---cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 273 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 273 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 22 2233468999999999877 6799999999999999999999999964
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=297.68 Aligned_cols=207 Identities=21% Similarity=0.374 Sum_probs=172.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-------CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
..++|++.+.||+|+||+||+|++. .++..||+|+++... .+.+.+|+.+++++.+||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4688999999999999999999875 456789999996432 35688999999999789999999999954
Q ss_pred cCCCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||+
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 467889999999999998873 27889999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD 328 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~ 328 (344)
+.+ +.+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+
T Consensus 191 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~ 267 (334)
T 2pvf_A 191 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE 267 (334)
T ss_dssp CTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCHHH
T ss_pred cCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC-cCCHHH
Confidence 988 78999999999877644322 23356778999999877 678999999999999999999 888883 444444
Q ss_pred HHHHHH
Q 019241 329 QLVKIA 334 (344)
Q Consensus 329 ~l~~i~ 334 (344)
....+.
T Consensus 268 ~~~~~~ 273 (334)
T 2pvf_A 268 LFKLLK 273 (334)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 444443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=294.55 Aligned_cols=198 Identities=26% Similarity=0.475 Sum_probs=166.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccC----CCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++++.+||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 57899999999999999999999999999999999863 345788999999999978999999999997643 467
Q ss_pred cEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.++||||+++++|..++ ..+++..++.++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||++....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCTTTC---
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeCcCceecC
Confidence 89999999999998887 358999999999999999999999999999999999999988 789999999997664
Q ss_pred CC-CcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
.. .......+|..|+|||++.. ...++.++|||||||++|+|++|..||.
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 32 22344578999999999862 2568899999999999999999999994
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.75 Aligned_cols=205 Identities=16% Similarity=0.344 Sum_probs=175.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|++. ++..||||+++.. ..+.+.+|+.+++++ +||||+++++++. ....++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---CCccEEE
Confidence 4678999999999999999999864 5778999999743 457899999999999 9999999999985 3567899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+.+++|.+++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCce
Confidence 99999999999874 58889999999999999999999999999999999999988 7899999999987643221
Q ss_pred --ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+....+.+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~ 400 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALER 400 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHH
T ss_pred eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 122345678999999876 679999999999999999999 88888 45566666666554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.32 Aligned_cols=208 Identities=20% Similarity=0.398 Sum_probs=159.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|++..++. .||+|+++.. ..+.+.+|+++++++ +||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecccc
Confidence 57889999999999999999998877665 8999998642 346788999999999 99999999999965432
Q ss_pred C----ccEEEEEeecCCchhhHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEE
Q 019241 195 K----TPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261 (344)
Q Consensus 195 ~----~~~lv~e~~~~~~l~~~l~---------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl 261 (344)
. ..++||||+.+++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~kl 178 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCV 178 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCEEE
Confidence 2 2389999999999988872 48999999999999999999999999999999999999988 78999
Q ss_pred EecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 262 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 262 ~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~ 253 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIYNYLI 253 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCcc-ccChHHHHHHHh
Confidence 999999876543322 23356678999999887 779999999999999999999 888874 444444444443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=296.99 Aligned_cols=199 Identities=24% Similarity=0.424 Sum_probs=165.8
Q ss_pred CCCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++. +.||+|+||+||+|++..+++.||||+++.. ..+.+.+|++++.++.+||||+++++++.+ ....+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~ 87 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFY 87 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEE
Confidence 35788885 6899999999999999999999999998643 356789999999996589999999999965 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC--cEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~--~~kl~DFGla~~~~~~ 273 (344)
+||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+.. .+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999999999998887 56899999999999999999999999999999999999987622 3999999998765422
Q ss_pred C--------cceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 K--------EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
. ......||+.|+|||++.+ ...++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 1 1223468999999999864 134788999999999999999999999653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.42 Aligned_cols=205 Identities=23% Similarity=0.453 Sum_probs=161.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++..+ +..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---C
Confidence 467899999999999999999988654 457999998643 235688999999999 99999999999843 5
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 167 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccccC
Confidence 6789999999999998873 58999999999999999999999999999999999999988 799999999998765
Q ss_pred CCCcc--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 272 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 272 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
..... ....+++.|+|||++.. ..++.++|||||||++|||++ |..||. +.+..+....+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~~i~ 231 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIE 231 (281)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHH
T ss_pred cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC-cCCHHHHHHHHH
Confidence 43322 23356678999999876 779999999999999999997 888884 444444444443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=291.60 Aligned_cols=194 Identities=28% Similarity=0.495 Sum_probs=173.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..+.|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++.+ +|+||+++++++.+ ....+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCeEE
Confidence 356799999999999999999999999999999998632 347789999999999 99999999999965 46788
Q ss_pred EEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
+||||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++....... .
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCC
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCccccc
Confidence 9999999999998874 58999999999999999999999999999999999999988 789999999998765443 2
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
.....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 345578999999999877 778999999999999999999999994
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=294.15 Aligned_cols=202 Identities=26% Similarity=0.527 Sum_probs=161.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++++.+ ...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCc
Confidence 456899999999999999999999999999999998631 235688999999999 99999999999965 467
Q ss_pred cEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 197 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.++||||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC-----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEeccceee
Confidence 889999999999988763 38999999999999999999999999999999999999988 7899999999987
Q ss_pred cCCCC-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 270 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 270 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.....+...
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 245 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245 (310)
T ss_dssp -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred ecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence 65432 2334578999999999877 77999999999999999999999999755444333
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.36 Aligned_cols=201 Identities=19% Similarity=0.388 Sum_probs=173.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence 567899999999999999999999999999999998743 346789999999999 99999999999954 5678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.+||+|||++........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence 99999999998873 38999999999999999999999999999999999999988 7899999999987654332
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ 329 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~ 329 (344)
. ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~-~~~~~~~ 221 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQV 221 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGH
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHH
Confidence 2 23356778999999877 679999999999999999999 888874 3333333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=292.11 Aligned_cols=201 Identities=15% Similarity=0.348 Sum_probs=159.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.++||+|+||+||+|++. ..+|+|+++.. ..+.+.+|+.+++++ +|+||+++++++.. ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---~~~ 94 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL 94 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccC---Ccc
Confidence 5788999999999999999999643 35999998632 235688999999999 99999999997632 557
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~- 272 (344)
++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC--------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccccccc
Confidence 8999999999998887 348899999999999999999999999999999999999988 7999999999976543
Q ss_pred --CCcceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 273 --GKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 273 --~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
........+|+.|+|||++.. ...++.++|||||||++|||++|+.||....+......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 236 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence 222344578999999999862 35688999999999999999999999955444333333
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.75 Aligned_cols=204 Identities=18% Similarity=0.374 Sum_probs=173.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++. ++..||+|.++.. ..+.+.+|+++++++ +||||+++++++.+ ...++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEE
Confidence 4578999999999999999999864 6778999998643 457899999999999 99999999999853 457899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|.+++. .+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence 99999999999985 58999999999999999999999999999999999999988 7899999999987754332
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
. ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~ 224 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLE 224 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHH
T ss_pred ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc-ccCHHHHHHHHh
Confidence 2 22345778999999876 678999999999999999999 888884 444445444443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=294.85 Aligned_cols=193 Identities=23% Similarity=0.417 Sum_probs=161.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee--CCeE
Confidence 578999999999999999999999999999999986432 25688999999999 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC--------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCccccccc
Confidence 8999999999999887 458999999999999999999999999999999999999988 789999999997765432
Q ss_pred --cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 2234578999999999877 778999999999999999999999994
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.44 Aligned_cols=197 Identities=22% Similarity=0.408 Sum_probs=173.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|+ +..+++.||+|++.... .+.+.+|+++++++ +|+||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCc
Confidence 56889999999999999999998 46788999999997543 35588999999999 999999999999776677
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEECC
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceecc
Confidence 8899999999999998873 48999999999999999999999999999999999999988 789999999998775
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
..... ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 44322 23457778999999877 6789999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=295.14 Aligned_cols=210 Identities=21% Similarity=0.376 Sum_probs=175.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEE-----cCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++ ..+++.||+|+++... .+.+.+|+.+++++.+||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 467899999999999999999985 3567899999996432 356889999999997799999999998653
Q ss_pred CCccEEEEEeecCCchhhHcCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYPT-------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~~-------------------l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
....++||||+++++|..++.. +++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3557899999999999988732 788899999999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL 330 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l 330 (344)
+ +.+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||.......+..
T Consensus 184 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 184 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred C-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 7 78999999999876543322 23467888999999877 779999999999999999998 999986555455544
Q ss_pred HHHHH
Q 019241 331 VKIAK 335 (344)
Q Consensus 331 ~~i~~ 335 (344)
..+.+
T Consensus 262 ~~~~~ 266 (316)
T 2xir_A 262 RRLKE 266 (316)
T ss_dssp HHHHH
T ss_pred HHhcc
Confidence 44433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=293.57 Aligned_cols=216 Identities=26% Similarity=0.461 Sum_probs=175.0
Q ss_pred CccceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEE
Q 019241 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVR 190 (344)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 190 (344)
++.........++|++.+.||+|+||+||+|++..+++.+|+|++... ..+.+.+|+++++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYY 86 (302)
T ss_dssp --CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred hcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeee
Confidence 334444455678999999999999999999999999999999998643 346788999999999 9999999999996
Q ss_pred ccCCCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 191 DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 191 ~~~~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
+ ....++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||+
T Consensus 87 ~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 163 (302)
T 2j7t_A 87 H--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGV 163 (302)
T ss_dssp C--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHH
T ss_pred e--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCC
Confidence 5 46788999999999998875 459999999999999999999999999999999999999988 7899999998
Q ss_pred ceecCCC-CcceecccCCCccCccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 267 AEFYHPG-KEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 267 a~~~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
+...... .......+|..|+|||++. ....++.++|||||||++|+|++|..||. ..+..+....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~ 235 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIA 235 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHH
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHh
Confidence 7543211 1223457899999999984 33678999999999999999999999994 333344444443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=289.44 Aligned_cols=193 Identities=18% Similarity=0.232 Sum_probs=167.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+..+..+.+||||+++++++.+ ....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 46799999999999999999999999999999998642 345678899999988789999999999965 46788
Q ss_pred EEEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC----------------
Q 019241 199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---------------- 255 (344)
Q Consensus 199 lv~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~---------------- 255 (344)
+||||+++++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999887 348999999999999999999999999999999999999843
Q ss_pred --CCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 256 --LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 256 --~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
...+||+|||.+....... ...+|..|+|||++.+...++.++|||||||++|+|++|..|+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 2478999999998765432 34689999999999875567789999999999999999987763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.56 Aligned_cols=195 Identities=19% Similarity=0.350 Sum_probs=168.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+.+++.+ +|++++..+..+.. .....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEE
Confidence 46889999999999999999999999999999999863 3446789999999999 77777666666643 346778999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe---CCCCcEEEEecccceecCCCC
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~---~~~~~~kl~DFGla~~~~~~~ 274 (344)
||+ +++|.+++. .+++..+..++.|++.||+|||+.||+||||||+|||++ .+ +.+||+|||+++......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcccccccc
Confidence 999 888888763 589999999999999999999999999999999999995 45 789999999998776443
Q ss_pred c--------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 2 244578999999999887 7799999999999999999999999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.14 Aligned_cols=194 Identities=24% Similarity=0.364 Sum_probs=161.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.++|++.+.||+|+||+||+|++ .++.||+|.+... ..+.+.+|+++++++ +||||+++++++. ...++||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~----~~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACL----NPVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCT----TTTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEc----CCcEEEE
Confidence 457899999999999999999976 4788999999644 346789999999999 9999999999884 2368999
Q ss_pred EeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHH---cCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 202 EYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 202 e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~---~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
||+++++|..++. .+++..+..++.|+++||+|||+ .||+||||||+|||++.+...+||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999998873 36788899999999999999999 89999999999999998844589999999976543
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~ 326 (344)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 209 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGP 209 (307)
T ss_dssp --------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred --ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence 2334578999999999876 78999999999999999999999999654443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=289.46 Aligned_cols=195 Identities=19% Similarity=0.351 Sum_probs=164.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.. .....+.+|+.+++.+ +|++++..++.+.. .....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecC-CCCceEEEE
Confidence 46889999999999999999999999999999998753 3345788999999999 77777777666643 346778999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE---eCCCCcEEEEecccceecCCCC
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl---~~~~~~~kl~DFGla~~~~~~~ 274 (344)
||+ +++|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.+ +.+||+|||+++......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCcc
Confidence 999 88888876 368999999999999999999999999999999999999 555 789999999998775443
Q ss_pred c--------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 2 234578999999999887 6799999999999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.82 Aligned_cols=204 Identities=17% Similarity=0.243 Sum_probs=171.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC--------CCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccc----------
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK---------- 184 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~---------- 184 (344)
..++|++.+.||+|+||+||+|++.. .++.||+|++... +.+.+|+++++++ +|||+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCc
Confidence 35789999999999999999999887 4889999998643 5788999999999 8999888
Q ss_pred -----eeeEEEccCCCccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 185 -----LLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 185 -----l~~~~~~~~~~~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
+++++.. .....++||||+ +++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.
T Consensus 117 ~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred cCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 5666654 246789999999 99998887 35899999999999999999999999999999999999998
Q ss_pred CCC--cEEEEecccceecCCCCc--------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 019241 255 ELR--KLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324 (344)
Q Consensus 255 ~~~--~~kl~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~ 324 (344)
+ + .+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 195 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 195 E-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp T-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred C-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 7 5 899999999977643221 133478999999999877 679999999999999999999999997655
Q ss_pred CCHHHHHHH
Q 019241 325 DNHDQLVKI 333 (344)
Q Consensus 325 ~~~~~l~~i 333 (344)
.+.+.+...
T Consensus 273 ~~~~~~~~~ 281 (352)
T 2jii_A 273 PNTEDIMKQ 281 (352)
T ss_dssp TCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 444444433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=302.19 Aligned_cols=199 Identities=20% Similarity=0.344 Sum_probs=166.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHH--HHhCCCCccceeeEEEc---cCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ--NLCGGPNVVKLLDIVRD---QHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~--~l~~h~niv~l~~~~~~---~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|++ +++.||||+++......+..|.+++. .+ +|+||+++++.+.. ......
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceE
Confidence 468899999999999999999965 78999999998777777777766654 35 99999999986643 223456
Q ss_pred EEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHc---------CcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~---------~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
++||||+++++|..++ ...++..+..++.|++.||+|||+. ||+||||||+|||++.+ +.+||+|||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~ 166 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGL 166 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeeccc
Confidence 8999999999999987 4578889999999999999999999 99999999999999988 7899999999
Q ss_pred ceecCCCC---------cceecccCCCccCcccccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 267 AEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 267 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
++...... ......||..|+|||++.+. ..++.++|||||||++|||++|+.||+.+.+
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 98765322 12244789999999998752 3456789999999999999999999877654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=297.35 Aligned_cols=205 Identities=22% Similarity=0.419 Sum_probs=177.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--------------------HHHHHHHHHHHHHhCCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNVV 183 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~~l~~l~~h~niv 183 (344)
.++|++.+.||+|+||+||+|++ +++.||+|++..... +.+.+|+.+++++ +||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence 57899999999999999999987 899999999853211 7899999999999 899999
Q ss_pred ceeeEEEccCCCccEEEEEeecCCchhhH------c-----CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceE
Q 019241 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL------Y-----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVM 251 (344)
Q Consensus 184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------l-----~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiL 251 (344)
++++++.+ ....++||||+++++|..+ + ..+++..++.++.|++.||.|||+ .|++||||||+|||
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999965 4678999999999999887 4 348999999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 019241 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330 (344)
Q Consensus 252 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l 330 (344)
++.+ +.+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|||++|..||.......+..
T Consensus 185 ~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9988 78999999999876543 4455678999999999987436666 9999999999999999999996555556766
Q ss_pred HHHHH
Q 019241 331 VKIAK 335 (344)
Q Consensus 331 ~~i~~ 335 (344)
..+.+
T Consensus 263 ~~i~~ 267 (348)
T 2pml_X 263 NNIRT 267 (348)
T ss_dssp HHHTS
T ss_pred HHHhc
Confidence 66654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.75 Aligned_cols=194 Identities=20% Similarity=0.315 Sum_probs=169.1
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
...++|++.+.||+|+||+||+|+ ..+++.||+|+++... ...+.+|+++++.+ +||||+++++++.+ ....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTER 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSCC
T ss_pred HHhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCce
Confidence 357889999999999999999996 4568899999986433 23689999999999 89999999999954 4677
Q ss_pred EEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHc---CcEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 198 SLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~---~iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
++||||+++++|..++. .+++..+..++.|++.||+|||+. ||+||||||+|||++.+ +.+||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~ 181 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 181 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSSC
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCccc
Confidence 89999999999998873 289999999999999999999999 99999999999999988 78999999999
Q ss_pred eecCCCCc--ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 268 EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 268 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCccc
Confidence 87653332 233468999999999876 678999999999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.92 Aligned_cols=194 Identities=23% Similarity=0.398 Sum_probs=170.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.++||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TTEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CCEEE
Confidence 467899999999999999999999999999999998643 235688999999999 99999999999965 46788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++ ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCcccccc-
Confidence 999999999999887 4689999999999999999999996 99999999999999988 78999999999755322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2344578999999999887 7899999999999999999999999954
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.79 Aligned_cols=208 Identities=27% Similarity=0.458 Sum_probs=171.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
.++|++.+.||+|+||.||+|.+..+++.+|+|+++.. ....+.+|+++++++ +|+||+++++++.+.....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 46899999999999999999999999999999998632 346788999999999 9999999999997666678
Q ss_pred cEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||++++....+. ..+++..+..++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||++....+
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence 89999999988332221 358999999999999999999999999999999999999988 7899999999987653
Q ss_pred C---CcceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 273 G---KEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 273 ~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
. .......+|..|+|||++.+. ..++.++|||||||++|||++|..||. +.+..+....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~ 226 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIYKLFENIG 226 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHHh
Confidence 2 223445789999999998752 234789999999999999999999994 444444444443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=290.09 Aligned_cols=208 Identities=22% Similarity=0.366 Sum_probs=170.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..+|++.+.||+|+||+||+|++..++ ..+|+|.++... .+.+.+|+.+++++ +||||+++++++.+. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCc
Confidence 456899999999999999999865433 468999986432 35688999999999 999999999987543 356
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECcccccccccc
Confidence 789999999999998873 38899999999999999999999999999999999999988 7899999999987654
Q ss_pred CCc-----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|..|++.+.+..+....+.+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 322 233456778999999877 77999999999999999999976666666665555544443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=290.34 Aligned_cols=195 Identities=27% Similarity=0.468 Sum_probs=168.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.+.||+|+||+||+|++..+++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.+ ....++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEEEEe
Confidence 467899999999999999999999999999999998643 457789999999999 99999999999965 46778999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cc
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 276 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~ 276 (344)
||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++....... ..
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSCB
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhcccc
Confidence 999999998876 368999999999999999999999999999999999999988 789999999998765432 23
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 183 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 45578999999999877 6789999999999999999999999953
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.56 Aligned_cols=194 Identities=24% Similarity=0.440 Sum_probs=164.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++... +..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---C
Confidence 467899999999999999999986543 346999998753 346788999999999 99999999999854 3
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||++....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIE 164 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC-
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcccc
Confidence 468999999999998887 348999999999999999999999999999999999999988 799999999998765
Q ss_pred CCCc--ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 272 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 4332 233456778999999876 779999999999999999998 9999953
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=286.13 Aligned_cols=206 Identities=17% Similarity=0.361 Sum_probs=174.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++. +++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 81 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 81 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEE
Confidence 4578999999999999999999875 6778999999743 457899999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
|||+++++|.+++ ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence 9999999998887 348999999999999999999999999999999999999988 789999999998654322
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......++..|+|||++.+ ..++.++||||||+++|||++ |..||. +.+..+....+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~i~~ 220 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDIST 220 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHT
T ss_pred ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC-CCCHHHHHHHHhc
Confidence 1123456778999999876 678999999999999999999 888884 4444555555443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=309.12 Aligned_cols=205 Identities=19% Similarity=0.363 Sum_probs=170.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|.+.. +..||||+++.. ..+.+.+|+++++++ +||||+++++++.+ ...++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence 46789999999999999999998754 567999999743 457899999999999 99999999999854 567899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++++|.+++. .+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCCce
Confidence 99999999999884 38999999999999999999999999999999999999987 7899999999987653322
Q ss_pred --ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.++.+.+..+.+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~ 396 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVER 396 (452)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHT
T ss_pred ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 223356778999999886 679999999999999999999 88888 45565666665544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=300.63 Aligned_cols=195 Identities=17% Similarity=0.183 Sum_probs=153.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHh-CCCCcccee-------eEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC-GGPNVVKLL-------DIVR 190 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-~h~niv~l~-------~~~~ 190 (344)
.+|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++.+. +|||+++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999999999999999997532 355778988888774 499977755 4554
Q ss_pred ccCC---------------CccEEEEEeecCCchhhHcC----CCCHHHH------HHHHHHHHHHHHHHHHcCcEeecC
Q 019241 191 DQHS---------------KTPSLIFEYVNSTDFKVLYP----TLTDYDI------RYYIYELLKALDYCHSQGIMHRDV 245 (344)
Q Consensus 191 ~~~~---------------~~~~lv~e~~~~~~l~~~l~----~l~~~~~------~~~~~~i~~~L~~LH~~~iiHrDl 245 (344)
.... ...++||||++ ++|..++. .+.+... ..++.|++.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 3322 34799999999 78888874 2444444 567799999999999999999999
Q ss_pred CCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 246 kp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
||+|||++.+ +.+||+|||+++.... ......+|+.|+|||++.+ ...++.++|||||||++|||++|+.||...
T Consensus 221 kp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPD-GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTT-SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCC-CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999988 7899999999987642 2224567799999999864 246899999999999999999999999654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=288.79 Aligned_cols=206 Identities=25% Similarity=0.550 Sum_probs=177.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCeEE
Confidence 4689999999999999999999999999999999853 2356789999999999 99999999999955 46788
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC--CcEEEEecccceecCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~--~~~kl~DFGla~~~~~~ 273 (344)
+||||+++++|...+ ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+. ..+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999987765 5699999999999999999999999999999999999997642 36999999999877655
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~ 236 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVET 236 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc
Confidence 55556678999999999865 48999999999999999999999994 4444555555544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=293.34 Aligned_cols=207 Identities=17% Similarity=0.358 Sum_probs=166.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC----eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|++..++ ..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--C
Confidence 4678999999999999999999876553 45999998643 234688999999999 99999999999954 5
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL 197 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcchhh
Confidence 6788999999999999887 358999999999999999999999999999999999999988 78999999999876
Q ss_pred CCCCc----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 271 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~ 265 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAIND 265 (333)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHT
T ss_pred ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHC
Confidence 54322 122345778999999876 779999999999999999999 999984 4444555554443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=299.69 Aligned_cols=215 Identities=27% Similarity=0.494 Sum_probs=179.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHh----------CCCCccceeeEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----------GGPNVVKLLDIVR 190 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----------~h~niv~l~~~~~ 190 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++++. +|+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467899999999999999999999999999999999743 3466889999999883 2899999999987
Q ss_pred ccC--CCccEEEEEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCC-----CC
Q 019241 191 DQH--SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----LR 257 (344)
Q Consensus 191 ~~~--~~~~~lv~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~-----~~ 257 (344)
... ....++||||+ +++|..++ ..+++..+..++.|++.||+|||+. ||+||||||+|||++.+ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 543 23778999999 77877766 3489999999999999999999998 99999999999999532 24
Q ss_pred cEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHH
Q 019241 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVK 332 (344)
Q Consensus 258 ~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~-----~~~~~l~~ 332 (344)
.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .+.+++.+
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 799999999987653 3344578999999999987 778999999999999999999999995432 24677888
Q ss_pred HHHhhCCCC
Q 019241 333 IAKVTTILD 341 (344)
Q Consensus 333 i~~~~~~~~ 341 (344)
+.+.+|.++
T Consensus 253 ~~~~~~~~p 261 (373)
T 1q8y_A 253 IIELLGELP 261 (373)
T ss_dssp HHHHHCSCC
T ss_pred HHHhcCCCC
Confidence 888888765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=287.03 Aligned_cols=203 Identities=19% Similarity=0.321 Sum_probs=170.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|++ +++.+|+|+++.. ..+.+.+|+.+++++ +||||+++++++.+......
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 357899999999999999999987 4889999998643 235688999999999 99999999999977656788
Q ss_pred EEEEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
++||||+++++|..++. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.+ +.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeee
Confidence 99999999999999883 3899999999999999999999999 9999999999999988 78999999987543
Q ss_pred CCCCcceecccCCCccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
. .....+|+.|+|||++.+.. .++.++|||||||++|||++|+.||. +.+..+....+.
T Consensus 164 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~ 224 (271)
T 3kmu_A 164 Q----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVA 224 (271)
T ss_dssp S----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT-TSCHHHHHHHHH
T ss_pred c----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccChHHHHHHHH
Confidence 2 23357899999999987622 23348999999999999999999994 344444444443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.41 Aligned_cols=206 Identities=17% Similarity=0.371 Sum_probs=172.7
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEEc--CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~-~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|.+.+ .||+|+||+||+|++. .++..||+|+++.. ..+.+.+|+++++++ +||||+++++++.. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---C
Confidence 456788877 9999999999999854 46788999999753 345688999999999 99999999999943 4
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeec
Confidence 578999999999999987 348999999999999999999999999999999999999988 799999999998775
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~i~~ 228 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQ 228 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHT
T ss_pred cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHhc
Confidence 44332 22345788999999876 678999999999999999998 999984 4455555554443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=308.28 Aligned_cols=194 Identities=16% Similarity=0.232 Sum_probs=158.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHh--CCCCcccee-------eE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLC--GGPNVVKLL-------DI 188 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~--~h~niv~l~-------~~ 188 (344)
.++|++.+.||+|+||+||+|++..+++.||||+++. ...+.+.+|+.+++.+. +||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5789999999999999999999889999999999852 23467889995544442 899999998 66
Q ss_pred EEccCC----------C-----ccEEEEEeecCCchhhHcC---CCCH-------HHHHHHHHHHHHHHHHHHHcCcEee
Q 019241 189 VRDQHS----------K-----TPSLIFEYVNSTDFKVLYP---TLTD-------YDIRYYIYELLKALDYCHSQGIMHR 243 (344)
Q Consensus 189 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~l~---~l~~-------~~~~~~~~~i~~~L~~LH~~~iiHr 243 (344)
+.+.+. . ..++||||+ +|+|..++. .+++ ..+..++.|++.||+|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 654321 1 378999999 578888774 2444 7777899999999999999999999
Q ss_pred cCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCcccccCC----------CCCCchhhHHHHHHHHHHH
Q 019241 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGM 313 (344)
Q Consensus 244 Dlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwSlGv~l~el 313 (344)
||||+|||++.+ +.+||+|||+++... ......+| +.|+|||++.+. ..++.++|||||||++|||
T Consensus 231 Dikp~NIll~~~-~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQR-GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTT-CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCC-CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999988 799999999998643 34445567 999999999872 1799999999999999999
Q ss_pred HhCCCCCCC
Q 019241 314 IFRKEPFFY 322 (344)
Q Consensus 314 l~g~~Pf~~ 322 (344)
++|+.||..
T Consensus 307 ltg~~Pf~~ 315 (377)
T 3byv_A 307 WCADLPITK 315 (377)
T ss_dssp HHSSCCC--
T ss_pred HHCCCCCcc
Confidence 999999953
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.52 Aligned_cols=194 Identities=19% Similarity=0.379 Sum_probs=161.2
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEE----EEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
...++|+++++||+|+||+||+|++..+++.+ |+|.+.. ...+.+.+|+.+++++ +||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-
Confidence 35789999999999999999999998888755 6666642 3457789999999999 999999999999653
Q ss_pred CCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++++||+.+++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 166 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC---
T ss_pred --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeE
Confidence 367999999999998876 358999999999999999999999999999999999999988 7899999999987
Q ss_pred cCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 270 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 270 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
....... ....+|..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 6543322 23355778999999987 789999999999999999999 998884
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=298.10 Aligned_cols=206 Identities=19% Similarity=0.335 Sum_probs=171.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEE--EEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERC--IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~v--avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..++..+ |+|.++. ...+.+.+|+++++++.+||||+++++++.+ ...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCc
Confidence 3578999999999999999999998888865 8998863 2345688999999998789999999999965 467
Q ss_pred cEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~ 257 (344)
.++||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ +
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~ 179 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y 179 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-C
Confidence 889999999999988872 48899999999999999999999999999999999999988 7
Q ss_pred cEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 258 ~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
.+||+|||+++............++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~ 254 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL 254 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHG
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC-CCcHHHHHHHh
Confidence 899999999975443333344567888999999876 678999999999999999998 999984 44444444433
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.58 Aligned_cols=207 Identities=22% Similarity=0.371 Sum_probs=172.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
-.|++.++||+|+||+||+|++..+++ .+|+|+++... .+.+.+|+.+++++ +||||+++++++.+.+ ...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CCc
Confidence 356778999999999999998765544 79999986432 35688999999999 9999999999996543 445
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+.+++|..++ ..+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILDR 177 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccCC
Confidence 8999999999999887 348899999999999999999999999999999999999988 78999999999765432
Q ss_pred C-----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||+...+..+....+.+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 243 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc
Confidence 2 2233466788999999876 77999999999999999999988888777666655555444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=292.22 Aligned_cols=207 Identities=19% Similarity=0.380 Sum_probs=162.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC---CCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|++.. +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 56789999999999999999998765 4568999998632 235688999999999 99999999999976543
Q ss_pred C---ccEEEEEeecCCchhhHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEE
Q 019241 195 K---TPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262 (344)
Q Consensus 195 ~---~~~lv~e~~~~~~l~~~l---------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~ 262 (344)
. ..++||||+++++|..++ ..+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kl~ 189 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCVA 189 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEEEC
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEEe
Confidence 3 458999999999998887 358999999999999999999999999999999999999988 789999
Q ss_pred ecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 263 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 263 DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHH
Confidence 9999987654322 223456778999999987 789999999999999999999 77777 444444444433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.88 Aligned_cols=196 Identities=22% Similarity=0.357 Sum_probs=164.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHH-hCCCCccceeeEEEccCC--CccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~l 199 (344)
..++|++.++||+|+||+||+|++. ++.||||++.......+.+|.+++... .+|+||+++++++.+... ...++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 3578999999999999999999764 899999999876667777777776654 289999999999876533 56799
Q ss_pred EEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 200 v~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~--------~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
||||+++++|..++ ..+++..+..++.|++.||+|||+. ||+||||||+|||++.+ +.+||+|||+++.
T Consensus 113 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVK 191 (337)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCcee
Confidence 99999999999987 4689999999999999999999998 99999999999999988 7899999999977
Q ss_pred cCCCCcc-----eecccCCCccCcccccCCCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCC
Q 019241 270 YHPGKEY-----NVRVASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFR----------KEPFFY 322 (344)
Q Consensus 270 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DvwSlGv~l~ell~g----------~~Pf~~ 322 (344)
....... ....||+.|+|||++.+ ..++. ++|||||||++|||++| ..||..
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 6543322 24578999999999876 44443 49999999999999999 777754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=291.56 Aligned_cols=206 Identities=28% Similarity=0.477 Sum_probs=167.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEcc---------
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--------- 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--------- 192 (344)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence 35799999999999999999999999999999998643 336688999999999 999999999988653
Q ss_pred --CCCccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 193 --HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 193 --~~~~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
.....++||||+++++|..++. .+++..++.++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~ 162 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGL 162 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcc
Confidence 2356789999999999998873 46788899999999999999999999999999999999988 7899999999
Q ss_pred ceecCCC---------------CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 267 AEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 267 a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
+...... .......+|..|+|||++.+...++.++|||||||++|||++ ||..+.+..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 9765422 122345789999999999875579999999999999999998 6654444344444
Q ss_pred HHH
Q 019241 332 KIA 334 (344)
Q Consensus 332 ~i~ 334 (344)
.+.
T Consensus 240 ~~~ 242 (303)
T 1zy4_A 240 KLR 242 (303)
T ss_dssp HHH
T ss_pred hcc
Confidence 443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.70 Aligned_cols=196 Identities=21% Similarity=0.365 Sum_probs=167.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.++||+|+||+||+|++..+++.||||+++. ....++.+|+++++.+..++++..+..++. .....++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~--~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV--EGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE--ETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe--eCCEEEEEE
Confidence 35789999999999999999999999999999999863 344678999999999944456666655553 346778999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe---CCCCcEEEEecccceecCCCC
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~---~~~~~~kl~DFGla~~~~~~~ 274 (344)
||+ +++|.+++ ..+++..++.++.||+.||+|||+.||+||||||+|||++ .+ +.+||+|||+++.+....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCCc
Confidence 999 88888876 3699999999999999999999999999999999999994 55 789999999998876443
Q ss_pred cc--------eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 275 EY--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 275 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. ....||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 21 25678999999999987 77999999999999999999999999643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=294.15 Aligned_cols=195 Identities=24% Similarity=0.406 Sum_probs=168.7
Q ss_pred CCeEEEeeecccCCeeEEEEEE----cCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 125 DDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+.|+++++||+|+||+||++.. ..+++.||+|+++... .+.+.+|+++++++ +||||+++++++.+.....
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCce
Confidence 3459999999999999988754 4578899999997532 35688999999999 8999999999998776678
Q ss_pred cEEEEEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECCTTC
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCccccccccccc
Confidence 899999999999999884 48999999999999999999999999999999999999988 789999999998876543
Q ss_pred c----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
. .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 2 223467788999999987 6788999999999999999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.23 Aligned_cols=198 Identities=23% Similarity=0.398 Sum_probs=153.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEc------cC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRD------QH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~ 193 (344)
...+|++.++||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++++.+||||+++++++.. ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3568999999999999999999999999999999885332 35688999999999559999999999853 23
Q ss_pred CCccEEEEEeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEecc
Q 019241 194 SKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
....+++|||++ ++|..++ ..+++..+..++.|++.||+|||+.| |+||||||+|||++.+ +.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCc
Confidence 345789999997 4665554 34999999999999999999999999 9999999999999988 789999999
Q ss_pred cceecCCCCcc-------------eecccCCCccCccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 266 LAEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 266 la~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
+++........ ....+|+.|+|||++. ....++.++|||||||++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99876543221 1446899999999983 236688999999999999999999999953
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.67 Aligned_cols=205 Identities=20% Similarity=0.388 Sum_probs=171.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++. .+++.||+|++.... ...+.+|+.+++++ +|+||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc--
Confidence 4678999999999999999999876 357889999986432 34588999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+|
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~k 178 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK 178 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeEE
Confidence 467889999999999988763 46889999999999999999999999999999999999988 7899
Q ss_pred EEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 019241 261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 261 l~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i 333 (344)
|+|||+++........ ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT-TTSCHHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCcc-ccCCHHHHHHHH
Confidence 9999999765433221 23356788999999876 679999999999999999999 77777 444444444443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.96 Aligned_cols=203 Identities=19% Similarity=0.359 Sum_probs=169.2
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEE--cCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVR-KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~-~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+ .||+|+||+||+|.+ ..+++.||+|+++... .+.+.+|+++++.+ +||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA--- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC---
Confidence 467899988 999999999999954 5667899999986432 46788999999999 99999999999932
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++||||+++++|..++ ..+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||++....
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR 168 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeec
Confidence 5678999999999999887 458999999999999999999999999999999999999988 799999999998775
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK 332 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~ 332 (344)
..... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~ 232 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAM 232 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHH
T ss_pred cCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHH
Confidence 44332 12345678999999876 678999999999999999999 999984 3343443333
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.84 Aligned_cols=197 Identities=22% Similarity=0.433 Sum_probs=153.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++... ...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcE
Confidence 468899999999999999999998889999999998632 345678899999999 999999999999654 5688
Q ss_pred EEEEeecCCchhhHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 199 LIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 199 lv~e~~~~~~l~~~l~-----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
+||||+++++|.+++. .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~ 168 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVS 168 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEeccch
Confidence 9999999999988763 38999999999999999999999999999999999999988 78999999998
Q ss_pred eecCCCC------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 268 EFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 268 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
....... ......+|+.|+|||++.+...++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 7654322 1234578999999999865456899999999999999999999999543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=300.30 Aligned_cols=206 Identities=21% Similarity=0.364 Sum_probs=159.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
...|++.+.||+|+||+||+|++..++ ..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+. ...
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCC
Confidence 345888999999999999999875433 46899998642 346788999999999 999999999987543 356
Q ss_pred cEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
.++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD 244 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC--------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeeccccccccc
Confidence 789999999999999873 47889999999999999999999999999999999999988 7899999999986643
Q ss_pred CCc-----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 273 GKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 273 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
... .....+|..|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~ 309 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309 (373)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence 321 123456778999999887 789999999999999999999555544555444443333
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=314.37 Aligned_cols=204 Identities=19% Similarity=0.366 Sum_probs=173.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.++||+|+||+||+|++.. +..||||+++.. ..+.+.+|+++|+++ +|+||+++++++.+ ...++||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEee
Confidence 4679999999999999999998754 567999999743 457899999999999 99999999999854 5678999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 275 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~- 275 (344)
||+.+++|.+++. .+++.++..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCcee
Confidence 9999999999884 38999999999999999999999999999999999999987 7899999999986643211
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.++.+.+..+.+
T Consensus 420 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~ 479 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVER 479 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHT
T ss_pred cccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 123345678999999886 679999999999999999999 88888 45555666665543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=292.30 Aligned_cols=198 Identities=21% Similarity=0.312 Sum_probs=170.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHH-hCCCCccceeeEEEccCC--CccEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~l 199 (344)
..++|++.+.||+|+||+||+|++ +++.||+|+++......+.+|.++++.+ .+||||+++++++..... ...++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 356899999999999999999976 5899999999877778889999999983 289999999999976543 27899
Q ss_pred EEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHH--------HcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 200 v~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH--------~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
||||+++++|..++ ..+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||++..
T Consensus 118 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVR 196 (342)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCcee
Confidence 99999999999987 45899999999999999999999 8999999999999999988 7899999999987
Q ss_pred cCCCCc-----ceecccCCCccCcccccCCCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 019241 270 YHPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGMIFR----------KEPFFYG 323 (344)
Q Consensus 270 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DvwSlGv~l~ell~g----------~~Pf~~~ 323 (344)
...... .....+|..|+|||++.+... ++.++|||||||++|||++| ..||...
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 765442 234578999999999876322 33689999999999999999 7888654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.22 Aligned_cols=198 Identities=22% Similarity=0.389 Sum_probs=167.4
Q ss_pred CCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCCc
Q 019241 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT 196 (344)
Q Consensus 122 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~ 196 (344)
...++|++.+.||+|+||+||+|++..+++.||+|++... ..+.+.+|+++++.+ +||||+++++++... ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCce
Confidence 3568899999999999999999999999999999988532 346688999999999 999999999998632 3357
Q ss_pred cEEEEEeecCCchhhHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 197 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~-------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.++||||+.+++|..++. .+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||++..
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~ 183 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchh
Confidence 789999999999987763 48999999999999999999999999999999999999988 7899999999876
Q ss_pred cCCCCc----------ceecccCCCccCcccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 270 YHPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 270 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
...... .....+|+.|+|||++.... .++.++|||||||++|||++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 532111 12345799999999986522 36889999999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.05 Aligned_cols=206 Identities=17% Similarity=0.367 Sum_probs=170.5
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEEc--CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~-~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..+++.+.+ +||+|+||+||+|.+. .++..||||+++.. ..+.+.+|+++++++ +||||++++++|.+ .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence 356677666 8999999999999875 35567999999743 457799999999999 99999999999964 4
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+.+++|..++. .+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCccccc
Confidence 5789999999999998873 48999999999999999999999999999999999999988 799999999998764
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+....+.+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~ 554 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQ 554 (613)
T ss_dssp --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCSHHHHHHHHT
T ss_pred CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHc
Confidence 33221 12345678999999976 789999999999999999998 99998 45666666666644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.22 Aligned_cols=203 Identities=18% Similarity=0.347 Sum_probs=166.4
Q ss_pred CeEEE-eeecccCCeeEEEEEE--cCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 126 DYEVV-RKVGRGKYSEVFEGIN--VNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 126 ~~~~~-~~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.+.+. ++||+|+||+||+|.+ ..+++.||||+++.. ..+++.+|+++++++ +||||++++++|.+ ...
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~~ 444 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESW 444 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SSE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CCE
Confidence 34443 4899999999999954 456789999999743 246799999999999 99999999999954 347
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC--
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCc
Confidence 8999999999999887 458999999999999999999999999999999999999988 799999999998765433
Q ss_pred c----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~ 587 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEK 587 (635)
T ss_dssp -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHT
T ss_pred cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 2 222356778999999976 789999999999999999998 99998 45555555555443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=291.43 Aligned_cols=207 Identities=19% Similarity=0.333 Sum_probs=166.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEE-----EcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|+ +..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC--
Confidence 46789999999999999999998 5567889999998532 235688999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL 261 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~----------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl 261 (344)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.||+||||||+|||++.+ ...+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 466789999999999998872 38889999999999999999999999999999999999843 246999
Q ss_pred EecccceecCCCC---cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 262 IDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 262 ~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
+|||++....... ......+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~ 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVT 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CcCHHHHHHHHh
Confidence 9999997654322 2233467889999999877 679999999999999999998 888884 444444444443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=285.38 Aligned_cols=196 Identities=24% Similarity=0.406 Sum_probs=164.8
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
|.....||+|+||+||+|++..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+ ....++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEEEe
Confidence 33346899999999999999999999999998643 346788999999999 99999999999965 4678899999
Q ss_pred ecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cc
Q 019241 204 VNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 276 (344)
Q Consensus 204 ~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~ 276 (344)
+++++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.+.+.+||+|||++....... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 99999988873 356888899999999999999999999999999999999843789999999998765432 23
Q ss_pred eecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~ 325 (344)
....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.....
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 445789999999998652 2488999999999999999999999964433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.62 Aligned_cols=196 Identities=27% Similarity=0.470 Sum_probs=170.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHHh-CCCCccceeeEEEcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVRDQ 192 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~ 192 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++++. +|+|++++++++.+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 5788999999999999999999999999999999986432 245778999999994 36999999999965
Q ss_pred CCCccEEEEEeecC-CchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 193 HSKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 193 ~~~~~~lv~e~~~~-~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
....++|||++.+ ++|..++ ..+++..++.++.|++.||+|||+.||+||||||+|||++.+.+.+||+|||+++
T Consensus 120 -~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 120 -PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 4678899999986 8888776 4689999999999999999999999999999999999999444799999999998
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... ......+|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 199 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 77543 33456789999999998774555789999999999999999999994
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.19 Aligned_cols=196 Identities=22% Similarity=0.438 Sum_probs=168.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEE----EcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++++.||+|+||+||+|+ +..+++.||+|++.... .+.+.+|+++++++ +|+||+++++++......
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCC
Confidence 45779999999999999999998 45688999999986533 35688999999999 999999999999766556
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++ ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhcc
Confidence 789999999999999887 348999999999999999999999999999999999999988 799999999998876
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 54332 22356677999999877 678999999999999999999998884
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=283.86 Aligned_cols=192 Identities=17% Similarity=0.384 Sum_probs=159.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.+.||+|+||+||+|++ +++.||+|+++.. ..+.+.+|+++++++ +|+||+++++++.+. ....++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEE
Confidence 457899999999999999999976 4889999999754 456789999999999 999999999987543 34678999
Q ss_pred EeecCCchhhHcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~~-----l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+++++|.+++.. +++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++...... .
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccccccccc--c
Confidence 99999999988742 7889999999999999999999999999999999999988 78999999999765432 2
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
....++..|+|||++.+ ..++.++|||||||++|||++ |+.||..
T Consensus 172 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 172 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 33467889999999876 778999999999999999998 9988843
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=285.80 Aligned_cols=208 Identities=22% Similarity=0.359 Sum_probs=153.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch----HHHH-HHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIK-REIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~-~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++..... .+.. ++..+++.+ +||||+++++++.+ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~--~~~~ 99 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT--NTDV 99 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC--SSEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEec--CCcE
Confidence 35789999999999999999999999999999999864322 2233 344455555 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
++||||+ ++.+..+. ..+++..+..++.|++.||.|||+. |++|+||||+|||++.+ +.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhccC
Confidence 9999999 44444443 4689999999999999999999995 99999999999999988 7899999999987765
Q ss_pred CCcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
........+|+.|+|||++.. ...++.++|||||||++|||++|+.||....++.+.+..+.+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence 555556689999999999852 356889999999999999999999999765555555555543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=290.37 Aligned_cols=196 Identities=28% Similarity=0.508 Sum_probs=148.3
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccC--CCccEE
Q 019241 123 DQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH--SKTPSL 199 (344)
Q Consensus 123 ~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~~~l 199 (344)
..++|++.+ .||+|+||+||+|++..+++.||+|++... ....+|+..+.+..+|+||+++++++.... ....++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 467899966 599999999999999999999999999643 334455555444559999999999986532 345789
Q ss_pred EEEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCC
Q 019241 200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 200 v~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~ 272 (344)
||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+++....
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999999988872 48999999999999999999999999999999999999864 24599999999987653
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 184 -NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred -cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 33345678999999999866 7789999999999999999999999954
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.99 Aligned_cols=205 Identities=20% Similarity=0.347 Sum_probs=163.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-CC--eEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TN--ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~--~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.+.||+|+||+||+|++.. ++ ..||+|+++.. ..+.+.+|+++++++ +||||+++++++.+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC-
Confidence 46789999999999999999998643 33 36899998632 246788999999999 999999999999653
Q ss_pred CCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++||||+++++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.+||+|||++..
T Consensus 94 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA 170 (291)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred --CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEcccccccc
Confidence 378999999999998877 348999999999999999999999999999999999999988 7899999999988
Q ss_pred cCCCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 019241 270 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 270 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~ 334 (344)
....... ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+.+..+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~ 238 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKID 238 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHH
T ss_pred ccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc-cCCHHHHHHHHH
Confidence 7544322 23456778999999876 678999999999999999999 998884 444455555443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.78 Aligned_cols=195 Identities=20% Similarity=0.391 Sum_probs=145.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHH-HHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|.+..+++.||+|+++... ..++..|+. +++.+ +||||+++++++.+ ....
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~--~~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFR--EGDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEEC--SSEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEe--CCce
Confidence 4688999999999999999999999999999999986432 234556666 44445 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc--------CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 198 SLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l--------~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
++||||+++ ++..++ ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||+++
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~ 174 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISG 174 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSSSC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCCce
Confidence 899999997 444332 4589999999999999999999998 99999999999999988 799999999998
Q ss_pred ecCCCCcceecccCCCccCccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
............+|..|+|||++. ....++.++|||||||++|||++|+.||..
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 776555555568999999999984 225689999999999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=286.82 Aligned_cols=196 Identities=26% Similarity=0.453 Sum_probs=163.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHHh---CCCCccceeeEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC---GGPNVVKLLDIVR 190 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~---~h~niv~l~~~~~ 190 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.++.++. +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4678999999999999999999999999999999996432 234567999999985 7999999999985
Q ss_pred ccCCCccEEEEEe-ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccc
Q 019241 191 DQHSKTPSLIFEY-VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266 (344)
Q Consensus 191 ~~~~~~~~lv~e~-~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGl 266 (344)
+ ....++|||+ +.+++|.+++ ..+++..+..++.|++.||+|||+.||+||||||+||+++.+.+.+||+|||+
T Consensus 109 ~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 109 T--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred c--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 4 4667899999 7889998887 45899999999999999999999999999999999999994338899999999
Q ss_pred ceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
+...... ......++..|+|||++.+....+.++|||||||++|||++|+.||.
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 9877543 34456789999999998764444569999999999999999999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=282.49 Aligned_cols=189 Identities=21% Similarity=0.300 Sum_probs=162.6
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
|...++||+|+||+||+|.+ +++.+|+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 107 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLCL 107 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceEE
Confidence 44458899999999999964 6889999998532 246788999999999 99999999999954 467889
Q ss_pred EEEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 200 v~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
||||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKF 186 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence 999999999988763 48999999999999999999999999999999999999988 78999999999876543
Q ss_pred Cc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 274 KE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 274 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 22 223478999999998864 5889999999999999999999999643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=296.85 Aligned_cols=196 Identities=21% Similarity=0.312 Sum_probs=158.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
..+.|.+.+.||+|+||+||.+ ...+++.||||++.....+.+.+|+.+++++.+||||+++++++.+ ....++|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E 89 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALE 89 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEEC
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEe
Confidence 3566777899999999999875 4667999999999877777889999999987689999999999854 477899999
Q ss_pred eecCCchhhHcCCC----------CHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC------------CCcEE
Q 019241 203 YVNSTDFKVLYPTL----------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------LRKLR 260 (344)
Q Consensus 203 ~~~~~~l~~~l~~l----------~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~------------~~~~k 260 (344)
|++ ++|.+++... .+..+..++.|++.||+|||+.||+||||||+|||++.+ ...+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 997 5888877321 233456799999999999999999999999999999753 24799
Q ss_pred EEecccceecCCCCc-----ceecccCCCccCcccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 019241 261 LIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 322 (344)
Q Consensus 261 l~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~ 322 (344)
|+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||++ |..||..
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 999999988764432 234579999999999865 2568999999999999999999 8989843
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.92 Aligned_cols=206 Identities=23% Similarity=0.458 Sum_probs=170.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC---CeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++..+ +..+|+|.++... .+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence 357899999999999999999988653 4679999986432 36788999999999 99999999999843 4
Q ss_pred ccEEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++++|..++. .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence 5789999999999998873 58899999999999999999999999999999999999988 799999999998765
Q ss_pred CCCcc--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.+..+.+
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIEN 607 (656)
T ss_dssp C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHc
Confidence 44322 23356678999999876 689999999999999999997 88888 45555666655544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=280.80 Aligned_cols=205 Identities=25% Similarity=0.461 Sum_probs=164.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhC-CCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++. +++.||+|++... ..+.+.+|+.+++++.. |+||+++++++.+ ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 102 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 102 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCE
Confidence 4678999999999999999999864 5889999998532 23668899999999943 6999999999955 467
Q ss_pred cEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
.++||| +.+++|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||+++ +.+||+|||+++.....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC----
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccccccccCc
Confidence 889999 6677887776 45899999999999999999999999999999999999975 68999999999876543
Q ss_pred Cc---ceecccCCCccCcccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 274 KE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 274 ~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.. .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||....+..+.+..+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 22 2345789999999998641 468899999999999999999999996554444444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.24 Aligned_cols=188 Identities=20% Similarity=0.250 Sum_probs=157.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHh--------CCCCccc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNVVK 184 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~niv~ 184 (344)
.++|++.++||+|+||+||+|++ +++.||||+++... .+.+.+|+.+++.+. +|+|+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46788899999999999999987 68999999986432 277899999999995 4788877
Q ss_pred eeeEEEcc----------------------------CCCccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHH
Q 019241 185 LLDIVRDQ----------------------------HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDY 234 (344)
Q Consensus 185 l~~~~~~~----------------------------~~~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~ 234 (344)
+.+.+... .....++||||+++|++...+ ..+++..++.++.|++.||+|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 77764311 257789999999998644444 458999999999999999999
Q ss_pred HH-HcCcEeecCCCCceEEeCCCC--------------------cEEEEecccceecCCCCcceecccCCCccCcccccC
Q 019241 235 CH-SQGIMHRDVKPHNVMIDHELR--------------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293 (344)
Q Consensus 235 LH-~~~iiHrDlkp~NiLl~~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~ 293 (344)
|| +.||+||||||+|||++.+ + .+||+|||+|+..... ..+||+.|+|||++.+
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 99 9999999999999999987 4 8999999999876532 3589999999999986
Q ss_pred CCCCCchhhHHHHHHH-HHHHHhCCCCC
Q 019241 294 LQDYDYSLDMWSLGCM-FAGMIFRKEPF 320 (344)
Q Consensus 294 ~~~~~~~~DvwSlGv~-l~ell~g~~Pf 320 (344)
.. +.++||||+|++ .+++++|..||
T Consensus 252 -~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 252 -DG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp -CS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred -CC-ccceehhhhhCCCCcccccccCCC
Confidence 33 899999998777 77888899998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.34 Aligned_cols=195 Identities=22% Similarity=0.332 Sum_probs=157.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
...+|++.+.||+|+||+||.. ...+++.||||++.+.....+.+|+++++.+.+||||+++++++.+ ....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEE
Confidence 4567999999999999997643 4678899999999876666788999999998779999999999954 467899999
Q ss_pred eecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC----CCcEEEEecccceecCCCC
Q 019241 203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 203 ~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~----~~~~kl~DFGla~~~~~~~ 274 (344)
|+++ +|..++. .+.+..+..++.|++.||+|||+.||+||||||+|||++.+ ...+||+|||+++......
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 9985 7777662 24556678899999999999999999999999999999532 1357899999998765432
Q ss_pred ----cceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 019241 275 ----EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIF-RKEPFF 321 (344)
Q Consensus 275 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~-g~~Pf~ 321 (344)
......||+.|+|||++.+ ...++.++|||||||++|||++ |..||.
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 2344579999999999874 2567889999999999999999 888883
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=310.22 Aligned_cols=198 Identities=27% Similarity=0.464 Sum_probs=171.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEc----cCCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD----QHSK 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~ 195 (344)
.++|++.++||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999998643 245688999999999 99999999998754 2256
Q ss_pred ccEEEEEeecCCchhhHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC--cEEEEecccc
Q 019241 196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA 267 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~--~~kl~DFGla 267 (344)
..++||||+++++|..++. .+++..++.++.|++.||+|||+.||+||||||+|||++.+.. .+||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7789999999999998873 4889999999999999999999999999999999999997622 4899999999
Q ss_pred eecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 98776666666789999999999876 78999999999999999999999999643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=308.88 Aligned_cols=191 Identities=23% Similarity=0.369 Sum_probs=164.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-CCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC--
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK-- 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~-- 195 (344)
..++|++.+.||+|+||+||+|++.. +++.||||++... ....+.+|+++++++ +||||++++++|.+....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCC
Confidence 35899999999999999999999876 7899999998643 235678999999999 999999999999764331
Q ss_pred -ccEEEEEeecCCchhhHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 196 -TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 196 -~~~lv~e~~~~~~l~~~l-~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
..++||||+++++|..++ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ .+||+|||+++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC
T ss_pred ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC
Confidence 158999999999998876 469999999999999999999999999999999999999975 7899999999876543
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 235 ---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred ---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCc
Confidence 45679999999999865 34899999999999999999988875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=283.00 Aligned_cols=202 Identities=20% Similarity=0.352 Sum_probs=165.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.+.||+|+||+||+|++.. .+|+|+++.. ..+.+.+|+.+++++ +|+||+++++++.+ ....
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 104 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMS--PPHL 104 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEEC--SSCE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCce
Confidence 46889999999999999999998743 4899998632 235678899999999 99999999999965 4668
Q ss_pred EEEEEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-
Q 019241 198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 272 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~- 272 (344)
++||||+++++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++ + +.+||+|||++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCccccccc
Confidence 89999999999999884 488999999999999999999999999999999999998 4 5789999999875432
Q ss_pred -----CCcceecccCCCccCcccccC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 273 -----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 273 -----~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
........|+..|+|||++.. ...++.++|||||||++|||++|+.||. +.+..+....+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~ 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQM 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS-SCCHHHHHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHh
Confidence 122334568899999999864 2457899999999999999999999994 33434444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=270.56 Aligned_cols=169 Identities=14% Similarity=0.194 Sum_probs=149.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
..++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++++ +|+||+++++++.+ ...
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT--RAG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--CCc
Confidence 3578999999999999999999999999999999996432 26788999999999 99999999999965 467
Q ss_pred cEEEEEeecCCchhhHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 197 PSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~~-l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
.++||||+++++|..++.. ....++..++.|++.||+|||+.||+||||||+|||++.+ +.+||+++|.
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~--------- 175 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPAT--------- 175 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCC---------
T ss_pred EEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEeccc---------
Confidence 8999999999999998854 5667788999999999999999999999999999999988 7889885432
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
++ .++.++|||||||++|||++|+.||..
T Consensus 176 ----------~~--------~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 176 ----------MP--------DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp ----------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred ----------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 22 378899999999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=266.60 Aligned_cols=175 Identities=28% Similarity=0.480 Sum_probs=152.5
Q ss_pred CCCeEEE-eeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEc--cCCCccEEE
Q 019241 124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv 200 (344)
.++|.+. +.||+|+||+||+|++..+++.||+|+++. ...+.+|+.++.++.+||||+++++++.. ......++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4678887 779999999999999999999999999963 45678999999776699999999999864 224678899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~ 273 (344)
|||+++++|..++. .+++..++.++.|++.||.|||+.||+||||||+|||++.+ .+.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999999988872 48999999999999999999999999999999999999973 2689999999987532
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
...++.++|||||||++|||++|+.||..
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 14577899999999999999999999953
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=284.42 Aligned_cols=193 Identities=15% Similarity=0.200 Sum_probs=149.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCC-CCccce---------e-
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG-PNVVKL---------L- 186 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h-~niv~l---------~- 186 (344)
...|+..+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++.+ .| +|.... .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence 44588899999999999999999999999999998621 246788999999988 55 322111 1
Q ss_pred -----------eEEEccC---CCccEEEEEeecCCchhhHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEe
Q 019241 187 -----------DIVRDQH---SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMH 242 (344)
Q Consensus 187 -----------~~~~~~~---~~~~~lv~e~~~~~~l~~~l~----------~l~~~~~~~~~~~i~~~L~~LH~~~iiH 242 (344)
.++.... ....+++|+++ +++|.+++. .+++..+..++.|++.||+|||+.||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111 22345666654 466766652 2567778889999999999999999999
Q ss_pred ecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccCCCccCccccc---------CCCCCCchhhHHHHHHHHHHH
Q 019241 243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDMWSLGCMFAGM 313 (344)
Q Consensus 243 rDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DvwSlGv~l~el 313 (344)
|||||+|||++.+ +.+||+|||+++.... .....+| +.|+|||++. ....++.++|||||||++|||
T Consensus 235 rDiKp~NILl~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 235 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp SCCCGGGEEECTT-CCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecC-CeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999998 7899999999987543 2445577 9999999983 335688999999999999999
Q ss_pred HhCCCCCCC
Q 019241 314 IFRKEPFFY 322 (344)
Q Consensus 314 l~g~~Pf~~ 322 (344)
++|+.||..
T Consensus 311 ltg~~Pf~~ 319 (413)
T 3dzo_A 311 WCADLPNTD 319 (413)
T ss_dssp HHSSCCCCT
T ss_pred HHCCCCCCC
Confidence 999999954
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-34 Score=283.60 Aligned_cols=184 Identities=20% Similarity=0.143 Sum_probs=129.8
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-------------chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
...+.|++|.+..++....|+.++||++... ..++|.+|+++|+++..|+||+++++++++ ....
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 3467788888887777778999999998532 235689999999999889999999999955 4778
Q ss_pred EEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccc
Q 019241 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY 276 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~ 276 (344)
||||||++|++|.+.+..........|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ...
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCS
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCccc
Confidence 9999999999999998543333345689999999999999999999999999999988 89999999999876543 334
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~P 319 (344)
...+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 55689999999999875 467789999999988876555433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=248.80 Aligned_cols=180 Identities=17% Similarity=0.235 Sum_probs=140.8
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
...+.||+|+||+||+| ...++.+++|...... .+.+.+|+++++++ +||||+++..++.+. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN 413 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence 34568999999999999 4456788888763211 24478999999999 999999555554333 45
Q ss_pred cEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
.++||||+++++|.+++.. ...++.|+++||+|||++||+||||||+|||++. .+||+|||+++........
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence 6899999999999999876 6689999999999999999999999999999997 7899999999987653321
Q ss_pred --------eecccCCCccCcccccC-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 019241 277 --------NVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPF 320 (344)
Q Consensus 277 --------~~~~~t~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~ell~g~~Pf 320 (344)
...+||+.|||||++.. ...|+..+|+||..+-..+.+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 35689999999999864 134778899999999998888887776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=202.33 Aligned_cols=143 Identities=18% Similarity=0.243 Sum_probs=118.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------------------chHHHHHHHHHHHHHhCCCCc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNV 182 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~~l~~l~~h~ni 182 (344)
...|++.+.||+|+||.||+|++ .+++.||+|+++.. ....+.+|+.+++++ + |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~- 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G- 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence 45677889999999999999998 88999999998632 234588999999999 5 5
Q ss_pred cceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEE
Q 019241 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262 (344)
Q Consensus 183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~ 262 (344)
+++.+++.. ...++||||+++++|.. +. ..+...++.|++.||.|||+.||+||||||+|||++ + +.+||+
T Consensus 164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~---~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~ 234 (282)
T 1zar_A 164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR---VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWII 234 (282)
T ss_dssp SSSCCEEEE---ETTEEEEECCCCEEGGG-CC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEEC
T ss_pred CCcCeEEec---cceEEEEEecCCCcHHH-cc---hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEE
Confidence 777776643 45689999999999988 42 234567999999999999999999999999999999 6 899999
Q ss_pred ecccceecCCCCcceecccCCCccCccccc
Q 019241 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLV 292 (344)
Q Consensus 263 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~ 292 (344)
|||+|+. +..++|||++.
T Consensus 235 DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE------------TTSTTHHHHHH
T ss_pred ECCCCeE------------CCCCCHHHHHH
Confidence 9999964 33467898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=182.60 Aligned_cols=135 Identities=18% Similarity=0.206 Sum_probs=108.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeE--EEEEEecccc---------------------------hHHHHHHHHHHHHH
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPVK---------------------------KKKIKREIKILQNL 176 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~l 176 (344)
-|++.+.||+|+||+||+|.+..+|+. ||||+++... ...+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999988778888 9999975321 12578899999999
Q ss_pred hCCCC--ccceeeEEEccCCCccEEEEEeecC-C----chhhHcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEeecCCCC
Q 019241 177 CGGPN--VVKLLDIVRDQHSKTPSLIFEYVNS-T----DFKVLYPTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPH 248 (344)
Q Consensus 177 ~~h~n--iv~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~l~~l~~~~~~~~~~~i~~~L~~LH-~~~iiHrDlkp~ 248 (344)
.|++ +..+++. ...++||||+.+ | +|.......++..+..++.|++.+|.||| +.||+||||||+
T Consensus 128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 6665 3444442 245799999953 3 66665544456678899999999999999 999999999999
Q ss_pred ceEEeCCCCcEEEEecccceec
Q 019241 249 NVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 249 NiLl~~~~~~~kl~DFGla~~~ 270 (344)
|||++. .++|+|||+|...
T Consensus 201 NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS---SEEECCCTTCEET
T ss_pred HEEEcC---cEEEEECcccccC
Confidence 999987 6899999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=159.72 Aligned_cols=134 Identities=16% Similarity=0.249 Sum_probs=99.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----------------hHH--------HHHHHHHHHHHhCC
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKK--------IKREIKILQNLCGG 179 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~--------~~~E~~~l~~l~~h 179 (344)
.-|++.++||+|+||.||+|.+ .+|+.||||+++... ... ..+|...|.++ .+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence 3489999999999999999976 568999999975210 011 13567777777 33
Q ss_pred CCc--cceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC
Q 019241 180 PNV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257 (344)
Q Consensus 180 ~ni--v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~ 257 (344)
.++ ...++. ...++||||+++..+..+.. ..+...+..|++.+|.+||+.|||||||||.|||++++ +
T Consensus 173 ~gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d-g 242 (397)
T 4gyi_A 173 EGFPVPEPIAQ------SRHTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE-K 242 (397)
T ss_dssp TTCSCCCEEEE------ETTEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE-E
T ss_pred cCCCCCeeeec------cCceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC-C
Confidence 332 222322 22379999999988876543 23456788999999999999999999999999999876 3
Q ss_pred ----------cEEEEecccceec
Q 019241 258 ----------KLRLIDWGLAEFY 270 (344)
Q Consensus 258 ----------~~kl~DFGla~~~ 270 (344)
.+.|+||+-+-..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3789999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-13 Score=122.71 Aligned_cols=138 Identities=18% Similarity=0.228 Sum_probs=111.9
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.|++...+|.|+++.||++.. .++.+++|+... .....+.+|..+++.+.++.++.++++++.+ ....++||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence 3578888899999999999953 367899999864 3445799999999999667888899998854 36678999
Q ss_pred EeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 019241 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------- 237 (344)
Q Consensus 202 e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~-------------------------------------------- 237 (344)
||++|.++...... ..+...++.+++++|..||+
T Consensus 90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999999876432 23345788999999999998
Q ss_pred ---------------cCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 238 ---------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 238 ---------------~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++|+|+++.|||++++ +.+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 458999999999999875 5567999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.7e-12 Score=114.39 Aligned_cols=136 Identities=18% Similarity=0.166 Sum_probs=101.0
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCC-CccceeeEEEccCCCccEEEEEee
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYV 204 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~ 204 (344)
.+.+....+.|..+.||++. ..+++.+++|+........+.+|+.+++.+..+. .+.+++++..+ ....++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEec
Confidence 44543333456669999995 4567789999987655567889999999995552 25668888754 35578999999
Q ss_pred cCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------------------
Q 019241 205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG--------------------------------------------- 239 (344)
Q Consensus 205 ~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~--------------------------------------------- 239 (344)
+|.++. ..... ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 98 PGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp SSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 999884 33332 2356778888888888643
Q ss_pred -------------cEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 240 -------------IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 240 -------------iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
++|+|++|.|||++.+ +.+.|+|||.+...
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~g 215 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcccC
Confidence 9999999999999876 55679999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-11 Score=115.03 Aligned_cols=140 Identities=20% Similarity=0.358 Sum_probs=108.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEec--ccc----hHHHHHHHHHHHHHhC-CCCccceeeEEEccCC-CccEEEE
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS-KTPSLIF 201 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~-~~~~lv~ 201 (344)
++.|+.|.++.||+... .+..+++|+.. +.. ...+.+|..+++.+.. +..+.+++.++.+... ...++||
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 57899999999999854 34678888875 322 3568899999999943 3568899998865422 4578999
Q ss_pred EeecCCchh-hHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 019241 202 EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS------------------------------------------- 237 (344)
Q Consensus 202 e~~~~~~l~-~~l~~l~~~~~~~~~~~i~~~L~~LH~------------------------------------------- 237 (344)
||++|..+. .....++..+...++.++++.|..||+
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 999998874 345678888889999999999999997
Q ss_pred ---------------cCcEeecCCCCceEEeCCCC-cEEEEecccceecC
Q 019241 238 ---------------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYH 271 (344)
Q Consensus 238 ---------------~~iiHrDlkp~NiLl~~~~~-~~kl~DFGla~~~~ 271 (344)
..++|+|+++.|||++.+.. .+.|+||+.+....
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 35899999999999997632 36899999987644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.3e-11 Score=110.27 Aligned_cols=185 Identities=17% Similarity=0.232 Sum_probs=124.9
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCC--ccceeeEEEccCC-CccEEEEEeecC
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN--VVKLLDIVRDQHS-KTPSLIFEYVNS 206 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~~-~~~~lv~e~~~~ 206 (344)
+.++.|.+..||+.. ..+++|+.... ....+.+|..+++.+..+.. +.+++........ ...++||++++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 568999999999862 45888987543 34678899999999844432 4455554422211 245799999999
Q ss_pred Cchhh-HcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 019241 207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHS------------------------------------------------ 237 (344)
Q Consensus 207 ~~l~~-~l~~l~~~~~~~~~~~i~~~L~~LH~------------------------------------------------ 237 (344)
..+.. ....++..+...++.+++..+..||+
T Consensus 101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 88764 44667888888889999999988886
Q ss_pred ----------cCcEeecCCCCceEEeCC-CCcEEEEecccceecCCCCcceecccCCCccCccccc----CC--------
Q 019241 238 ----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV----DL-------- 294 (344)
Q Consensus 238 ----------~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~----~~-------- 294 (344)
..++|+|+++.||+++.+ .+.+.|+||+.+....+............-..|+... .+
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~ 260 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV 260 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence 136999999999999984 3567899999987654432211111100001221110 00
Q ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCC
Q 019241 295 -QDYDYSLDMWSLGCMFAGMIFRKEPF 320 (344)
Q Consensus 295 -~~~~~~~DvwSlGv~l~ell~g~~Pf 320 (344)
.....-.+.|+++.++|.+.+|..+|
T Consensus 261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 261 LEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01123368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=5.1e-08 Score=88.25 Aligned_cols=179 Identities=16% Similarity=0.186 Sum_probs=116.6
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCC--CccceeeEEEccCCCccEEEEEeecC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPSLIFEYVNS 206 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~lv~e~~~~ 206 (344)
++.++.|....||+. +..+++|+-... ....+.+|..+|+.+..+- .+.+.+.++.. .....++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence 456888888999987 456888886432 3467889999999994432 35667776642 34567899999999
Q ss_pred Cchhh-HcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 019241 207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHSQ----------------------------------------------- 238 (344)
Q Consensus 207 ~~l~~-~l~~l~~~~~~~~~~~i~~~L~~LH~~----------------------------------------------- 238 (344)
..+.. ....++..+...++.++...|..||+.
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 88765 345566666666666666666666632
Q ss_pred -------------CcEeecCCCCceEEeC---CCCcEEEEecccceecCCCCcceecccCCCccCccc----cc--CCCC
Q 019241 239 -------------GIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL----LV--DLQD 296 (344)
Q Consensus 239 -------------~iiHrDlkp~NiLl~~---~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~----~~--~~~~ 296 (344)
.++|+|+++.|||++. +...+.|+||+.+....+......... ...++. +. ....
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~~Dla~~~~---~~~~~~~~~~~~Y~~~~~ 254 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLE---DCGELFTRQVMAYRGEVD 254 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGGGGGHHHHH---HTCHHHHHHHHHHTTCSC
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHHHHHHHHHH---hcCHHHHHHHHHhccccc
Confidence 3599999999999987 324458999999876554332221110 011111 11 0011
Q ss_pred C---CchhhHHHHHHHHHHHHhCC
Q 019241 297 Y---DYSLDMWSLGCMFAGMIFRK 317 (344)
Q Consensus 297 ~---~~~~DvwSlGv~l~ell~g~ 317 (344)
+ ..+.+.|++..+++.++.+.
T Consensus 255 ~~~~~~r~~~~~~~~~l~~~~~~~ 278 (306)
T 3tdw_A 255 LDTHIRKVSLFVTFDQVSYLLEGL 278 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHH
Confidence 1 35678899888777766553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=3.4e-08 Score=87.44 Aligned_cols=136 Identities=14% Similarity=0.100 Sum_probs=97.9
Q ss_pred eecccCCe-eEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCCchh
Q 019241 132 KVGRGKYS-EVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK 210 (344)
Q Consensus 132 ~lG~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~ 210 (344)
.+..|..| .||+.....++..+++|+-.......+.+|...|+.+..+--+.++++++.+. ...++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCcccc
Confidence 34555555 69998777777889999987666778899999999996665688899988654 5678999999998776
Q ss_pred hHcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------------
Q 019241 211 VLYPTLTDYDIRYYIYELLKALDYCHSQ---------------------------------------------------- 238 (344)
Q Consensus 211 ~~l~~l~~~~~~~~~~~i~~~L~~LH~~---------------------------------------------------- 238 (344)
...... ......+..+++..|.-||+.
T Consensus 109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 543221 122233444555555555521
Q ss_pred ------CcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 239 ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 239 ------~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
.++|+|+.+.|||++.+ +.+-|+||+.+....
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGIAD 225 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEEEE
T ss_pred cccCCcEEEcCCCCCCeEEEECC-eEEEEEECcccccCC
Confidence 26899999999999976 566799999986543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=2e-07 Score=85.88 Aligned_cols=83 Identities=13% Similarity=0.161 Sum_probs=58.7
Q ss_pred EEEeee-cccCCeeEEEEEEc--C----CCeEEEEEEecccc------hHHHHHHHHHHHHHhCC--CCccceeeEEEcc
Q 019241 128 EVVRKV-GRGKYSEVFEGINV--N----TNERCIIKILKPVK------KKKIKREIKILQNLCGG--PNVVKLLDIVRDQ 192 (344)
Q Consensus 128 ~~~~~l-G~G~fg~V~~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~ 192 (344)
...+.| +.|....+|+.... . +++.+++|+..... ...+.+|..+++.+..+ -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88889999988643 1 25678899875432 25688999999998554 4678888887543
Q ss_pred CC-CccEEEEEeecCCchh
Q 019241 193 HS-KTPSLIFEYVNSTDFK 210 (344)
Q Consensus 193 ~~-~~~~lv~e~~~~~~l~ 210 (344)
.. ...++||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 21 3468999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-06 Score=79.57 Aligned_cols=74 Identities=18% Similarity=0.213 Sum_probs=50.0
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEeccc----------chHHHHHHHHHHHHHhCC-C-CccceeeEEEccCCCcc
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~ 197 (344)
.+.||.|.++.||+++...+++.+++|...+. ....+..|.++++.+... + .+.+++.+. . ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence 47899999999999976556788999976432 224567899999988443 3 344566543 2 335
Q ss_pred EEEEEeecCC
Q 019241 198 SLIFEYVNST 207 (344)
Q Consensus 198 ~lv~e~~~~~ 207 (344)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.6e-05 Score=72.33 Aligned_cols=136 Identities=15% Similarity=0.197 Sum_probs=79.8
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCC-CCccceeeE-----EEccCCCccEEEEEe
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDI-----VRDQHSKTPSLIFEY 203 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~-----~~~~~~~~~~lv~e~ 203 (344)
++.|+.|..+.||++.. . +..+++|+... .......|..+++.+..+ -.+.+++.. +. ......+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~-~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT-D-SGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS-KHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEE-T-TEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE-EETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEe-C-CCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE-EECCEEEEEEEe
Confidence 35677778899999864 3 34588999875 334556677777776322 234555531 11 113456899999
Q ss_pred ecCCchh---------------hHc---CCC-------------CHHH-------------------------------H
Q 019241 204 VNSTDFK---------------VLY---PTL-------------TDYD-------------------------------I 221 (344)
Q Consensus 204 ~~~~~l~---------------~~l---~~l-------------~~~~-------------------------------~ 221 (344)
++|..+. .+. ..+ .+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 000 111 1111 0
Q ss_pred HHHHHHHHHHHHHHHH-------------cCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 222 RYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 222 ~~~~~~i~~~L~~LH~-------------~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..+..++..++++|++ ..++|+|+++.|||++.+ +.+.|+||+.+...
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~g 253 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhcccC
Confidence 1111223345666652 479999999999999766 67899999998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=4.7e-05 Score=68.87 Aligned_cols=76 Identities=20% Similarity=0.186 Sum_probs=60.2
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCC--CCccceeeEEEccCCCccEEEEEeecCC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
.+.|+.|.+..+|+... ++..+++|+........+..|...|+.|..+ ..+++++.++... ...++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccCC
Confidence 57799999999999853 5677889988766667789999999998543 5688888887543 5678999999886
Q ss_pred ch
Q 019241 208 DF 209 (344)
Q Consensus 208 ~l 209 (344)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.1e-05 Score=68.70 Aligned_cols=70 Identities=11% Similarity=0.078 Sum_probs=46.8
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEee-cC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NS 206 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~-~~ 206 (344)
++.|+.|....+|++ ..+++|+...... -...+|..+++.+..+.-..++++.+ .. .-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecCCC
Confidence 577889999999998 4688898864322 23467998888885444336777654 22 235899999 66
Q ss_pred Cch
Q 019241 207 TDF 209 (344)
Q Consensus 207 ~~l 209 (344)
..+
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=3.1e-05 Score=72.99 Aligned_cols=78 Identities=13% Similarity=0.128 Sum_probs=46.8
Q ss_pred HcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceeccc--CCCccCcccccCCC--CCCchhhHHHHHHHHHH
Q 019241 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAG 312 (344)
Q Consensus 237 ~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~e 312 (344)
...++|+|+++.|||++.+ + +.++||+.+....+......... ...|.+|+...... .-....++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 4569999999999999977 4 89999999876543322211111 12355555443211 11223445566777776
Q ss_pred HHhC
Q 019241 313 MIFR 316 (344)
Q Consensus 313 ll~g 316 (344)
.+.+
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.87 E-value=5.5e-05 Score=68.34 Aligned_cols=140 Identities=16% Similarity=0.188 Sum_probs=81.8
Q ss_pred EEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCC-CccceeeEEEc----cCCCccEEEE
Q 019241 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIF 201 (344)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~ 201 (344)
.-++.|+.|....+|+.... ++ .+++|+... .....+..|..+++.+..+. .+.+++..... ......++++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 34577888989999998643 33 688999875 34567788999999885432 23444432100 0123457899
Q ss_pred EeecCCchhh------------------HcCCC--------CHHHHHH---------------HHHHHHHHHHHHHH---
Q 019241 202 EYVNSTDFKV------------------LYPTL--------TDYDIRY---------------YIYELLKALDYCHS--- 237 (344)
Q Consensus 202 e~~~~~~l~~------------------~l~~l--------~~~~~~~---------------~~~~i~~~L~~LH~--- 237 (344)
+|++|..+.. ....+ ....... +...+...++.+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998864311 00111 1000000 00113445556653
Q ss_pred ----cCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 238 ----QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 238 ----~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
.+++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACND 218 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEEE
T ss_pred ccCCcccCCCCCCccCEEEeCC-ceEEEecchhccCc
Confidence 369999999999999976 45579999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00011 Score=69.38 Aligned_cols=73 Identities=15% Similarity=0.165 Sum_probs=53.0
Q ss_pred EeeecccCCeeEEEEEEcC-------CCeEEEEEEecccch-HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 130 VRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVKK-KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
++.|+.|-...+|++.... +++.+++|+...... ..+.+|..+++.+..+.-..++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----CEEE
Confidence 4678888899999997542 257899999854233 667789999999965554577888762 2 2899
Q ss_pred EeecCCc
Q 019241 202 EYVNSTD 208 (344)
Q Consensus 202 e~~~~~~ 208 (344)
||++|..
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.72 E-value=8.2e-05 Score=67.62 Aligned_cols=138 Identities=14% Similarity=0.134 Sum_probs=75.0
Q ss_pred eeecccCCee-EEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCC-CccceeeEEEccCCCccEEEEEeecCCc
Q 019241 131 RKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD 208 (344)
Q Consensus 131 ~~lG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~ 208 (344)
+.|+.|.... +|+.. ..++..+++|...+.....+..|+.+++.+..+. .+.+++.+. .... +++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEE-CTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEE-cCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence 4565554444 66764 2235667777665433255677888888885442 356777764 2222 68999987655
Q ss_pred hhhHc-----------------------------CCCCHHHHH--------HHH------------HHHHHHHHHHH---
Q 019241 209 FKVLY-----------------------------PTLTDYDIR--------YYI------------YELLKALDYCH--- 236 (344)
Q Consensus 209 l~~~l-----------------------------~~l~~~~~~--------~~~------------~~i~~~L~~LH--- 236 (344)
+...+ ..+...... .+. ..+...++.+-
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 43211 011111110 000 01112223331
Q ss_pred ---HcCcEeecCCCCceEEeCC---CCcEEEEecccceecCCC
Q 019241 237 ---SQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 237 ---~~~iiHrDlkp~NiLl~~~---~~~~kl~DFGla~~~~~~ 273 (344)
...++|+|+.+.|||++.+ .+.+.|+||+.+....+.
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~ 221 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA 221 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence 2369999999999999863 146899999999765543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0004 Score=64.46 Aligned_cols=134 Identities=13% Similarity=0.201 Sum_probs=83.2
Q ss_pred eeecccCCeeEEEEEEcC-------CCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 131 RKVGRGKYSEVFEGINVN-------TNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.|..|-...+|++.... +++.+++|+..+. ......+|..+++.+..+.-..++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccEE
Confidence 567778888899986432 3468899987432 345667899999998666556778887732 2899
Q ss_pred EeecCCchhhH--------------c-----------CCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 019241 202 EYVNSTDFKVL--------------Y-----------PTLT--DYDIRYYIYELL-------------------KALDYC 235 (344)
Q Consensus 202 e~~~~~~l~~~--------------l-----------~~l~--~~~~~~~~~~i~-------------------~~L~~L 235 (344)
||++|..+..- + +... +.++.++..++. ..++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99987544210 0 0111 234444544332 223333
Q ss_pred H----H----cCcEeecCCCCceEEeCC---CCcEEEEecccceec
Q 019241 236 H----S----QGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFY 270 (344)
Q Consensus 236 H----~----~~iiHrDlkp~NiLl~~~---~~~~kl~DFGla~~~ 270 (344)
. . ..++|+|+.+.|||++.+ .+.+.++||..+...
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 3 2 259999999999999865 357899999998653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0017 Score=57.58 Aligned_cols=77 Identities=14% Similarity=0.122 Sum_probs=55.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCC--CCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~l 199 (344)
....-++.+|.|..+.||+.+ ..+|+.+++|+.... ....+..|...|+.+... --+.+++++. ..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEE
T ss_pred CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceE
Confidence 345667899999999999996 567888999986432 234688999999999443 2355566543 2369
Q ss_pred EEEeecCCc
Q 019241 200 IFEYVNSTD 208 (344)
Q Consensus 200 v~e~~~~~~ 208 (344)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00062 Score=64.79 Aligned_cols=74 Identities=15% Similarity=0.214 Sum_probs=50.1
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecccchH--HHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEeecCC
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 207 (344)
++.|+.|-...+|++....++..+++|+..+.... ...+|..+++.+..+.-..++++.+ . . .+||||+++.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--T--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--T--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--C--C--eEEEEeeCCc
Confidence 46788898999999976444578899988543221 2268999999995544456788877 2 2 2699999875
Q ss_pred ch
Q 019241 208 DF 209 (344)
Q Consensus 208 ~l 209 (344)
.+
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00046 Score=62.34 Aligned_cols=135 Identities=14% Similarity=0.155 Sum_probs=80.1
Q ss_pred eeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCC-CccceeeEEEc----cCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~ 203 (344)
..++ |....||+.. ..+|+.+++|+..+. ....+..|..+++.+..+. .+++++.. .. ...+..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 4466 8888999874 345667899998643 4567888999999884432 24555543 11 012345789999
Q ss_pred ecCCchhh-----H------c-------C--------CCCHHHH----HHHH---------------HHHHHHHHHHH--
Q 019241 204 VNSTDFKV-----L------Y-------P--------TLTDYDI----RYYI---------------YELLKALDYCH-- 236 (344)
Q Consensus 204 ~~~~~l~~-----~------l-------~--------~l~~~~~----~~~~---------------~~i~~~L~~LH-- 236 (344)
++|..+.. . + . ..+.... ..++ ..+...++.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754321 0 0 0 0111111 0111 01111223332
Q ss_pred -----HcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 237 -----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 237 -----~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++|+|+++.|||++ + .+.|+||+.+....
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARNGP 225 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCEEC
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCcCc
Confidence 23589999999999998 4 67999999886544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00057 Score=62.96 Aligned_cols=73 Identities=15% Similarity=0.190 Sum_probs=46.4
Q ss_pred EeeecccCCeeEEEEEEcC--------CCeEEEEEEecccchH--HHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 130 VRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
+..|+.|....+|++.... .++.+++|+....... ....|..+++.+..+.-..++++.+ . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence 4667888889999986543 1267889987543221 2468999999885554355777654 2 258
Q ss_pred EEEeecCCc
Q 019241 200 IFEYVNSTD 208 (344)
Q Consensus 200 v~e~~~~~~ 208 (344)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0073 Score=54.92 Aligned_cols=71 Identities=8% Similarity=0.169 Sum_probs=44.3
Q ss_pred cccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCC--CCccceeeEEEc----cCCCccEEEEEeecCC
Q 019241 134 GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRD----QHSKTPSLIFEYVNST 207 (344)
Q Consensus 134 G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~----~~~~~~~lv~e~~~~~ 207 (344)
|.|....||+.. ..++ .+++|+..... ...|..+++.|.++ +++++.+..... ......+++|+|++|.
T Consensus 32 G~g~~N~vy~v~-~~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 32 GADTNAFAYQAD-SESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp TSCSSCEEEEEE-CSSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred cCccccceEEEE-eCCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 444468999985 3445 88999876543 25677888877433 225555543110 1235568999999886
Q ss_pred ch
Q 019241 208 DF 209 (344)
Q Consensus 208 ~l 209 (344)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 55
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.01 Score=55.78 Aligned_cols=74 Identities=16% Similarity=0.205 Sum_probs=50.8
Q ss_pred EeeecccCCeeEEEEEEcCC-------CeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 130 VRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
++.|..|-...+|+...... ++.+++++..+... -...+|..+++.+..+.-..++++.+ . -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCEE
Confidence 46677788889999875421 57789998754321 23468999999886555567777654 2 2589
Q ss_pred EEeecCCch
Q 019241 201 FEYVNSTDF 209 (344)
Q Consensus 201 ~e~~~~~~l 209 (344)
+||++|..+
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.026 Score=52.56 Aligned_cols=31 Identities=29% Similarity=0.523 Sum_probs=25.3
Q ss_pred cEeecCCCCceEEeC-----CCCcEEEEecccceec
Q 019241 240 IMHRDVKPHNVMIDH-----ELRKLRLIDWGLAEFY 270 (344)
Q Consensus 240 iiHrDlkp~NiLl~~-----~~~~~kl~DFGla~~~ 270 (344)
++|+|+.+.|||+.. +.+.+.++||..|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 689999999999942 3367999999998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.89 E-value=0.4 Score=40.45 Aligned_cols=99 Identities=9% Similarity=-0.029 Sum_probs=61.5
Q ss_pred chhhHc----CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcceecccC
Q 019241 208 DFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282 (344)
Q Consensus 208 ~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~t 282 (344)
+|...+ .+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+ |.|.+.+ +.+ ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s-----------~~~~ 100 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AAD-----------DAGE 100 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C-----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-ccc-----------cccc
Confidence 455555 679999999999999999877622 111233345678888887 6665543 111 0123
Q ss_pred CCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 283 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..+.+||... ...+.+.=|||||+++|.-+--..|-.
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 3456888753 456788899999999999987666543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.86 E-value=0.094 Score=49.74 Aligned_cols=59 Identities=12% Similarity=0.140 Sum_probs=18.1
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEE------EEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 129 VVRKVGRGKYSEVFEGINVNTNERCII------KILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~vav------K~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
+.++|| ||.||+|.......+||+ |..+. .....+.+|..+++.+ +|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEEe
Confidence 345676 999999987665567888 66543 1224577888888888 99999999886643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 344 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-83 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-35 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-29 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 254 bits (649), Expect = 1e-83
Identities = 195/245 (79%), Positives = 222/245 (90%)
Query: 92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
P S+ARVYTDVN RP+EYWDYES V+WG+QDDY++VRK+GRGKYSEVFE IN+ NE
Sbjct: 2 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61
Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
+ ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D S+TP+L+FE+VN+TDFK
Sbjct: 62 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 332 KIAKV 336
+IAKV
Sbjct: 242 RIAKV 246
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-45
Identities = 70/224 (31%), Positives = 116/224 (51%), Gaps = 13/224 (5%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
+ Y + +G G + V++ ++ E IK + K+ RE++I++ L N+
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75
Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKAL 232
V+L K L+ +YV T ++V TL ++ Y+Y+L ++L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
DY S+D+WS GC+ A ++ + P F G DQLV+I KV
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 6e-45
Identities = 58/234 (24%), Positives = 115/234 (49%), Gaps = 17/234 (7%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REI 170
YE +T +D +E++ ++G G + +V++ N T+ K++ +++++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIY 226
IL + PN+VKLLD +++ ++ E+ + LT+ I+
Sbjct: 61 DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
+ L AL+Y H I+HRD+K N++ + ++L D+G++ + + + + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 286 KGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
PE+++ + YDY D+WSLG M + P + + L+KIAK
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAK 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (390), Expect = 1e-44
Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 13/219 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPN 181
D Y+++ ++G G + V + T + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
++ L D D++ LI E+++ + +++ ++ Y+ + + L + H
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 238 QGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
I+H D+KP N+M + + +++ID+GLA +P + V A+ F PE++ D +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ DMW++G + ++ P F G D+ + L + +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKR 242
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (382), Expect = 3e-44
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 24/232 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIK 171
++YE +GRG S V I+ T + +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
IL+ + G PN+++L D L+F+ + + F L TL++ + R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
L+ + H I+HRD+KP N+++D ++ ++L D+G + PG++ + + P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 289 ELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
E++ + Y +DMWS G + ++ P F+ L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS 229
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-43
Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 14/220 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
DD+E + ++G G VF+ + + K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
+V S+ E+++ + + + + ++K L Y
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
+ IMHRDVKP N++++ ++L D+G++ N V +R + PE L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y D+WS+G M + P +L+ +V
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 5e-43
Identities = 54/221 (24%), Positives = 103/221 (46%), Gaps = 16/221 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
+D+E+ R +G+GK+ V+ + +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
PN+++L D LI EY + YI EL AL YC
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
HS+ ++HRD+KP N+++ L++ D+G + + P + + PE++ +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+D +D+WSLG + + K P F + + +I++V
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV 219
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (378), Expect = 6e-43
Identities = 49/219 (22%), Positives = 97/219 (44%), Gaps = 13/219 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPN 181
D Y++ ++G G + V T K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
+V L D D + +I+E+++ + + +++ + Y+ ++ K L + H
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 238 QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
+H D+KP N+M + +L+LID+GL P + V + F PE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
Y DMWS+G + ++ P F G ++ + L +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKS 239
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-42
Identities = 48/218 (22%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNV 182
+ Y + +GRG++ V + ++ + + K +K + +K+EI IL N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL---YPTLTDYDIRYYIYELLKALDYCHSQ 238
+ L + +IFE+++ D F+ + L + +I Y++++ +AL + HS
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 239 GIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ DMWSLG + ++ P F N + I
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMN 217
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-42
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 15/221 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
+D+++V+ +G G Y EV +N T E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS 237
NVVK R L EY F + P + + D + + ++L+ + Y H
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 294
GI HRD+KP N+++D L++ D+GLA + N + + PELL
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + +D+WS G + M+ + + + Q K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK 220
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-41
Identities = 65/224 (29%), Positives = 117/224 (52%), Gaps = 15/224 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
Y + +G G Y V + R IK + P + ++ REIKIL
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCH 236
N++ + DI+R + K L+ + + +K+L L++ I Y++Y++L+ L Y H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 292
S ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ + Y S+D+WS+GC+ A M+ + P F G DQL I +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGI 228
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 55/229 (24%), Positives = 104/229 (45%), Gaps = 14/229 (6%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
DDY+V +V G G +V + N T E+ +K+L+ K +RE+++ P++V
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 184 KLLDIVRDQHS--KTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDYCH 236
+++D+ + ++ K ++ E ++ + T+ + + + +A+ Y H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
S I HRDVKP N++ + L+L D+G A+ + Y+ PE+L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343
+ YD S DMWSLG + ++ P FY + + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKTRIRMGQYE 235
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 6e-41
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCG 178
+ +R++G G + V+ +V +E IK + K + I +E++ LQ L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
PN ++ +H T L+ EY + +V L + +I + L+ L Y
Sbjct: 75 -PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
HS ++HRDVK N+++ ++L D+G A P + V + Y+ PE+++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187
Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ YD +D+WSLG + RK P F + L IA+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGG 179
+DYEV+ +G G Y + + + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY------PTLTDYDIRYYIYELLKAL 232
PN+V+ D + D+ + T ++ EY D V+ L + + + +L AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
CH + ++HRD+KP NV +D + ++L D+GLA + + V + Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
PE + Y+ D+WSLGC+ + P F + KI +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIRE 228
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-40
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGP 180
+ Y K+G+G V+ ++V T + I+ + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
N+V LD ++ EY+ + + + I E L+AL++ HS
Sbjct: 78 NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
++HRD+K N+++ + ++L D+G + + + V + Y+ PE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+D+WSLG M MI + P + + L IA
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT 230
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-40
Identities = 67/236 (28%), Positives = 125/236 (52%), Gaps = 15/236 (6%)
Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKK 165
++ E W + Y ++ VG G Y V ++ T + IK L + K+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL-YPTLTDYD 220
RE+++L+++ NV+ LLD+ + L+ ++ + K++ + L +
Sbjct: 64 AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ + +++D+GLA E V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+R+++ PE++++ Y ++D+WS+GC+ A MI K F G D+ DQL +I KV
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKV 234
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 69/221 (31%), Positives = 119/221 (53%), Gaps = 13/221 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
YE + K+G G Y VF+ N T+E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
N+V+L D++ T L+FE+ + F L ++ ++++LLK L +CH
Sbjct: 61 KNIVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
S+ ++HRD+KP N++I+ +L ++GLA F P + Y+ V + +++ P++L +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y S+DMWS GC+FA + P F G+D DQL +I ++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 4e-39
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 14/221 (6%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGG 179
+D Y+ +G G +SEV + T + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYCH 236
PN+V L DI LI + V+ + F + T+ D I+++L A+ Y H
Sbjct: 67 PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 237 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
GI+HRD+KP N++ E K+ + D+GL++ PG + + + PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ Y ++D WS+G + ++ P FY ++ +I K
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILK 223
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-39
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCG 178
+D++ + +G G +S V + T+ IKIL+ K + RE ++ L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYC 235
P VKL +D Y + + + + + R+Y E++ AL+Y
Sbjct: 68 -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 292
H +GI+HRD+KP N++++ ++ +++ D+G A+ P + N V + + PELL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + S D+W+LGC+ ++ P F + + KI K
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIK 224
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 9e-39
Identities = 67/240 (27%), Positives = 124/240 (51%), Gaps = 16/240 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PV 161
RP ++ E W + Y+ + VG G Y V + T R +K L +
Sbjct: 1 RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 162 KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTPSLIFEYVNSTDFKVLY--PTL 216
K+ RE+++L+++ NV+ LLD+ S + ++ D + L
Sbjct: 60 HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
TD +++ IY++L+ L Y HS I+HRD+KP N+ ++ + +++D+GLA H E
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRL 234
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 70/222 (31%), Positives = 127/222 (57%), Gaps = 15/222 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
++++ V K+G G Y V++ N T E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYC 235
PN+VKLLD++ ++ L+FE+++ K + + I+ Y+++LL+ L +C
Sbjct: 61 PNIVKLLDVIHTENKLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 294
HS ++HRD+KP N++I+ E ++L D+GLA + P + Y V + +++ PE+L+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ Y ++D+WSLGC+FA M+ R+ F G DQL +I +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRT 218
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-38
Identities = 72/231 (31%), Positives = 115/231 (49%), Gaps = 22/231 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
YE + K+G+G + EVF+ + T ++ +K + +K+ REIKILQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68
Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLK 230
NVV L++I R + S + L+F++ +L T +I+ + LL
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 285
L Y H I+HRD+K NV+I + L+L D+GLA + K Y RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ PELL+ +DY +D+W GC+ A M R P G+ QL I+++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 237
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 72/221 (32%), Positives = 122/221 (55%), Gaps = 17/221 (7%)
Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGG 179
E + +G G+++ V++ + NTN+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
PN++ LLD H SL+F+++ + ++ LT I+ Y+ L+ L+Y H
Sbjct: 60 PNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++ PELL +
Sbjct: 118 QHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y +DMW++GC+ A ++ R PF G + DQL +I +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFET 216
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-38
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQ 174
+ Y+V +G G + V+ GI V+ N IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 175 NLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
+ G V++LLD S LI E + L + R + +++L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
+A+ +CH+ G++HRD+K N++ID +L+LID+G Y +R + PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
+ + + S +WSLG + M+ PF
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (336), Expect = 2e-37
Identities = 66/221 (29%), Positives = 121/221 (54%), Gaps = 15/221 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
+ Y + K+G G Y V++ N N E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
N+VKL D++ + L+FE+++ K+L L + ++ +LL + YCH
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 295
+ ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++ P++L+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
Y ++D+WS+GC+FA M+ P F G DQL++I ++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRI 216
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 69/227 (30%), Positives = 117/227 (51%), Gaps = 18/227 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK-----KKKIKREIKILQNLCG 178
YE V ++G G Y +VF+ ++ R + +K ++ RE+ +L++L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 179 G--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
PNVV+L D+ + + L+FE+V+ L P + I+ +++LL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
+ LD+ HS ++HRD+KP N+++ + +L D+GLA Y V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+L+ Y +D+WS+GC+FA M RK P F G + DQL KI V
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDV 230
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN 181
+ ++GRG + V++G++ T L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 182 VVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
+V+ D + K L+ E + S K + + +R + ++LK L + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 237 SQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
++ I+HRD+K N+ I +++ D GLA V + + F PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
+ YD S+D+++ G M + P + N Q+ +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRR 224
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQN 175
D Y+ ++G G+++ V + +T + K +K + ++ I+RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKAL 232
+ PNV+ L ++ ++ LI E V DF +LT+ + ++ ++L +
Sbjct: 70 IQ-HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 233 DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
Y HS I H D+KP N+M+ ++++ID+GLA G E+ + F PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
++ + + DMWS+G + ++ P F G + L ++ V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAV 231
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 2e-36
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 16/222 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
+D+ V R +GRG + EV+ +T + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 179 G--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
G P +V + S I + +N D + ++ D+R+Y E++ L+
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
+ H++ +++RD+KP N+++D +R+ D GLA + K + + + PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
YD S D +SLGCM ++ P F H D+
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRM 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
+D+ + + +G+G + +VF TN+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
P + + + + + + EY+N D +Y E++ L +
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
HS+GI++RD+K N+++D + ++ D+G+ E + N + + PE+L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
Q Y++S+D WS G + M+ + P F+G D + I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI 215
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 128 bits (323), Expect = 1e-35
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 17/226 (7%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
D YE+ +G G SEV ++ + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 178 GGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKAL 232
P +V + D + P ++ EYV+ + + +T I + +AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
++ H GI+HRDVKP N+MI I +A+ + + + + + PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
D D++SLGC+ ++ + P F G + +
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVR 228
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-35
Identities = 37/227 (16%), Positives = 95/227 (41%), Gaps = 23/227 (10%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKALD 233
N++ + +++ ++ + + L+ + + + +D
Sbjct: 63 H-VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPEL 290
Y H++ I+HRD+K +N+ + +L +++ D+GLA + S + PE+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 291 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ Y + D+++ G + ++ + P + +N DQ++ +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFMVG 223
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-35
Identities = 55/236 (23%), Positives = 113/236 (47%), Gaps = 13/236 (5%)
Query: 110 EYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKK 164
+++ E + Y+ ++ +G G V + + IK L K
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYD 220
+ RE+ +++ + N++ LL++ Q + + L+ E +++ +V+ L
Sbjct: 62 RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
+ Y +Y++L + + HS GI+HRD+KP N+++ + +++D+GLA V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+RY++ PE+++ Y ++D+WS+GC+ M+ K F G D DQ K+ +
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQ 233
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-34
Identities = 35/219 (15%), Positives = 91/219 (41%), Gaps = 14/219 (6%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPN 181
+ + ++++ +G+G++ +V G + +K +K + E ++ L N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SN 61
Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCH 236
+V+LL ++ ++ ++ EY+ + L L + + ++ +A++Y
Sbjct: 62 LVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
+HRD+ NV++ + ++ D+GL + + + + PE L + +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KK 176
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+WS G + + + D + ++ K
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-34
Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 42/251 (16%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKIL 173
+++ E + +G G + +V ++ +K+LK +++ + E+K++
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD------------------------- 208
L N+V LL S LIFEY D
Sbjct: 95 TQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 209 -FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
+ LT D+ + Y++ K +++ + +HRD+ NV++ H +++ D+GLA
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLA 211
Query: 268 EFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
Y VR + PE L + Y D+WS G + + + G
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 325 DNHDQLVKIAK 335
K+ +
Sbjct: 271 PVDANFYKLIQ 281
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-33
Identities = 37/221 (16%), Positives = 89/221 (40%), Gaps = 14/221 (6%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ ++V ++G G++ EV+ G N + + +K LK + E +++ L
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-Q 68
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
+V+L +V + +I EY+ + LT + ++ + + +
Sbjct: 69 RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDL 294
+ +HRD++ N+++ L ++ D+GLA + A K ++
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+WS G + ++ + G N + + + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (306), Expect = 5e-33
Identities = 38/226 (16%), Positives = 89/226 (39%), Gaps = 20/226 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKKKKIKREIKILQNLCGGPNVVKL 185
Y+V R++G G + +FEG N+ N++ IK + +++ E + + L G + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMH 242
Q L+ + + + +L + + ++L + H + +++
Sbjct: 67 YYF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 243 RDVKPHNVMIDHELRK----LRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 290
RD+KP N +I K + ++D+G+ +FY +E + +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
+ ++ D+ +LG +F + + G K ++
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERI 228
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 7e-33
Identities = 38/229 (16%), Positives = 82/229 (35%), Gaps = 21/229 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPVK------KKKIKREIKIL 173
+ D ++ K+G G + V G + + + +K LKP RE+ +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
+L N+++L +V K ++ E + Y ++
Sbjct: 66 HSLDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
+ + Y S+ +HRD+ N+++ +++ D+GL ++ V +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + + ++ D W G M + + G + L KI K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (303), Expect = 1e-32
Identities = 39/225 (17%), Positives = 86/225 (38%), Gaps = 18/225 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVV 183
+ Y + RK+G G + +++ G ++ E IK+ K ++ E KI + + GG +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
+ + ++ E + + F + + +++ ++Y HS+
Sbjct: 67 TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 241 MHRDVKPHNVMIDHELRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 290
+HRDVKP N ++ + + ID+GLA+ Y + + + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + D+ SLG + + G + K +
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYER 227
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 2e-32
Identities = 45/220 (20%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
D++++R +G G + V + + +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
P ++++ +D I +Y+ + ++Y E+ AL+Y
Sbjct: 63 HPFIIRMWGTFQDAQQIFM--IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
HS+ I++RD+KP N+++D +++ D+G A++ + + PE++ +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-K 176
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
Y+ S+D WS G + M+ P FY + KI
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN 215
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 6e-32
Identities = 40/222 (18%), Positives = 89/222 (40%), Gaps = 16/222 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
++ + K+G+G + EV+ G T R IK LKP + + +E ++++ L
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-E 72
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
+V+L +V ++ ++ EY++ L + ++ + Y
Sbjct: 73 KLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD 293
+HRD++ N+++ L ++ D+GLA + + PE +
Sbjct: 130 ERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+WS G + + + + G N + L ++ +
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 8e-32
Identities = 46/218 (21%), Positives = 94/218 (43%), Gaps = 13/218 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
D ++ ++ +G G + V + + +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCHS 237
P +VKL +D + + + + ++ R+Y +++ +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
+++RD+KP N++ID + +++ D+G A+ + PE+++ + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ ++D W+LG + M P F+ KI
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP-FFADQPIQIYEKIVS 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 8e-32
Identities = 44/218 (20%), Positives = 86/218 (39%), Gaps = 10/218 (4%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
+D++ ++ +G+G + +V T +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 179 GPNVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
P + L + T+ R+Y E++ AL+Y HS
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
+ +++RD+K N+M+D + +++ D+GL + +++ DY
Sbjct: 124 RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
++D W LG + M+ + P FY D+ I
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILM 219
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-32
Identities = 38/238 (15%), Positives = 83/238 (34%), Gaps = 29/238 (12%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNL 176
D +D + +G G + +V + R I + + E+++L L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------------------FKVLYPTLT 217
PN++ LL +H L EY + TL+
Sbjct: 68 GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
+ ++ ++ + +DY + +HRD+ N+++ ++ D+GL+ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKT 184
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + E L Y + D+WS G + ++ + G + K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-31
Identities = 44/225 (19%), Positives = 103/225 (45%), Gaps = 16/225 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK-------KKKIKREIKILQ 174
+++E+++ +G G Y +VF + +T + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALD 233
++ P +V L + + L + + T+++++ Y+ E++ AL+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 290
+ H GI++RD+K N+++D + L D+GL++ + + Y+ Y +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+D ++D WSLG + ++ P F + +I++
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISR 246
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 2e-31
Identities = 40/229 (17%), Positives = 84/229 (36%), Gaps = 20/229 (8%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
D ++ + +G G++ EV G +R I +K +K + E I+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKA 231
PNV+ L +V +I E++ + T + + +
Sbjct: 84 FDH-PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
+ Y +HRD+ N++++ L ++ D+GL+ F ++ K P
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 292 VD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + + D+WS G + ++ E ++ N D + I +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-31
Identities = 35/227 (15%), Positives = 88/227 (38%), Gaps = 14/227 (6%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
D + V+++G G++ V G +N ++ IK ++ + ++ E +++ L P
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKLSH-P 60
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD----FKVLYPTLTDYDIRYYIYELLKALDYCH 236
+V+L + +Q L+FE++ + + ++ + + Y
Sbjct: 61 KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDL 294
++HRD+ N ++ +++ D+G+ F + + + PE+
Sbjct: 119 EACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 176
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341
Y D+WS G + + + + N + + I+ +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-31
Identities = 40/221 (18%), Positives = 92/221 (41%), Gaps = 14/221 (6%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
D D ++++G G++ V G IK++K + + + E K++ NL
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-E 59
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
+V+L + Q + +I EY+ N L + ++ +A++Y
Sbjct: 60 KLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDL 294
S+ +HRD+ N +++ + +++ D+GL+ + + + + PE+L+
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+W+ G + + + + N + IA+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 6e-31
Identities = 37/221 (16%), Positives = 88/221 (39%), Gaps = 12/221 (5%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGP 180
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-P 73
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYC 235
N+V+LL + + +I E++ L ++ + Y ++ A++Y
Sbjct: 74 NLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDL 294
+ +HRD+ N ++ +++ D+GL+ + +
Sbjct: 132 EKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+W+ G + + + G D + K
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 46/245 (18%), Positives = 87/245 (35%), Gaps = 35/245 (14%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKIL 173
++ + +G G + +V E I + +K+LKP ++ + E+K+L
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---------------------FKVL 212
L N+V LL +I EY D +
Sbjct: 81 SYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
L D+ + Y++ K + + S+ +HRD+ N+++ H ++ D+GLA
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197
Query: 273 GKEYNVRVASRYFKG--PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
Y V+ +R + Y + D+WS G + + G +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 331 VKIAK 335
K+ K
Sbjct: 258 YKMIK 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 43/225 (19%), Positives = 93/225 (41%), Gaps = 17/225 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
++ E+ R +G G++ +V +GI ++ + +K K +K +E ++
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
P++VKL+ ++ + +I E + + +L + Y Y+L A
Sbjct: 65 F-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPEL 290
L Y S+ +HRD+ NV++ ++L D+GL+ + Y +
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
++ + + + D+W G ++ F G N+D + +I
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 2e-29
Identities = 43/250 (17%), Positives = 87/250 (34%), Gaps = 42/250 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKILQ 174
+++ E VR +G G + VF+ + +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK------------------------ 210
PN+VKLL + K L+FEY+ D
Sbjct: 72 EFDN-PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 211 ---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
P L+ + ++ + Y + +HRD+ N ++ + +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLS 187
Query: 268 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
+ Y A P + Y D+W+ G + + +YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 326 NHDQLVKIAK 335
+ + + +
Sbjct: 248 HEEVIYYVRD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-29
Identities = 38/228 (16%), Positives = 90/228 (39%), Gaps = 21/228 (9%)
Query: 123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCI--IKILKPVKKKK----IKREIKILQN 175
+D+ + ++G G + V +G+ ++ IK+LK +K + RE +I+
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKA 231
L P +V+L+ + + + L+ E K L + ++ ++++
Sbjct: 66 L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 287
+ Y + +HRD+ NV++ + ++ D+GL++ Y +
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
PE + + + D+WS G + + + + + I +
Sbjct: 181 PECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-29
Identities = 38/227 (16%), Positives = 91/227 (40%), Gaps = 21/227 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVKKKK----IKREIKILQN 175
+ +++ ++ +G G + V++G+ + E+ IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKA 231
+ P+V +LL I + LI + + D + + ++ K
Sbjct: 68 VDN-PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 288
++Y + ++HRD+ NV++ +++ D+GLA+ ++ +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
E ++ + Y + D+WS G ++ + G + + K
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 38/219 (17%), Positives = 82/219 (37%), Gaps = 20/219 (9%)
Query: 131 RKVGRGKYSEVFEGI--NVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVV 183
+++G G + V +G + +KILK P K ++ E ++Q L P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGI 240
+++ I + L+ E + D +I ++++ + Y
Sbjct: 72 RMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 296
+HRD+ NV++ + ++ D+GL++ + Y + PE +
Sbjct: 129 VHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ D+WS G + + + G + + K
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 1e-27
Identities = 50/259 (19%), Positives = 105/259 (40%), Gaps = 21/259 (8%)
Query: 99 VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---I 155
V+ D++ L P+ + + + +GRG + V+ G ++ + + I +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 156 KILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
K L + + E I+++ PNV+ LL I P ++ Y+ D +
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN 118
Query: 212 LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
T D+ + ++ K + + S+ +HRD+ N M+D + +++ D+GLA
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLA 177
Query: 268 EFYHPGKEYNVRVASRY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
+ + +V + + E L Q + D+WS G + ++ R P +
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 323 GHDNHDQLVKIAKVTTILD 341
+ D V + + +L
Sbjct: 237 DVNTFDITVYLLQGRRLLQ 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-27
Identities = 37/229 (16%), Positives = 86/229 (37%), Gaps = 21/229 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQ 174
+ +G G++ EV++G+ ++ + IK LK ++ E I+
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK 230
N+++L ++ +I EY+ + + + + +
Sbjct: 65 QFSH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 286
+ Y + +HRD+ N++++ L ++ D+GL+ E + +
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
PE + + S D+WS G + ++ E ++ NH+ + I
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-25
Identities = 41/238 (17%), Positives = 87/238 (36%), Gaps = 30/238 (12%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKIL 173
++ + R++G+G + V+EG+ R IK + + + E ++
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------------YPTLTDYD 220
+ +VV+LL +V + +I E + D K +
Sbjct: 78 KEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---N 277
+ E+ + Y ++ +HRD+ N M+ + +++ D+G+ + Y
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGG 193
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
+ + PE L D + D+WS G + + E + G N L + +
Sbjct: 194 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-25
Identities = 40/245 (16%), Positives = 90/245 (36%), Gaps = 35/245 (14%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVKKKK----IKREIK 171
+D + + +G G + +V + ++ + +K+LK +K + E++
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------------- 212
+++ + N++ LL +I EY + + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
L+ D+ Y++ + ++Y S+ +HRD+ NV++ + ++ D+GLA H
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 273 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
Y R L D Y + D+WS G + + + G +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 331 VKIAK 335
+ +
Sbjct: 248 KLLKE 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 2e-24
Identities = 42/253 (16%), Positives = 96/253 (37%), Gaps = 34/253 (13%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-----IKILKP----VKKKKIKREIKIL 173
+D ++ + +GRG + +V E ++ +K+LK + + + E+KIL
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------------------PT 215
++ NVV LL ++ L
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
LT + Y +++ K +++ S+ +HRD+ N+++ + +++ D+GLA + +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD 189
Query: 276 Y----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
Y + R+ ++ + + Y D+WS G + + + G ++
Sbjct: 190 YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 332 KIAKVTTILDFSN 344
+ K T + +
Sbjct: 248 RRLKEGTRMRAPD 260
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.2 bits (243), Expect = 9e-24
Identities = 52/237 (21%), Positives = 99/237 (41%), Gaps = 28/237 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNL-------- 176
Y +VRK+G G +S V+ ++ N +KI++ V + + EIK+LQ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 177 --CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYEL 228
G +++KLLD + ++ + + K + + ++ +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 229 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 284
L LDY GI+H D+KP NV+++ LI +A+ + S R
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-----FYGHDNHDQLVKIAKV 336
++ PE+L+ + D+WS C+ +I F + D + +I ++
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 9e-24
Identities = 42/240 (17%), Positives = 86/240 (35%), Gaps = 26/240 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVV 183
+ +G+G++ EV+ G E +KI +++ RE +I Q + N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 184 KLLDIVRDQHSKTPS--LIFEYVNSTD-FKVLY-PTLTDYDIRYYIYELLKALDYCHSQ- 238
+ + L+ +Y F L T+T + L + H +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 239 -------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 286
I HRD+K N+++ + D GLA + + N RV ++ +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 287 GPELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341
PE+L + + D++++G +F + R D + ++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 1e-18
Identities = 31/203 (15%), Positives = 69/203 (33%), Gaps = 34/203 (16%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------------VKKKKIKREIKILQ 174
+ + +G GK S VF + C++K K + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
+ KL + + + +++ E +++ + + + + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 287
+ +GI+H D+ +NV++ + +ID+ + E G +VR YF
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173
Query: 288 PELLVDLQDYDYSLDMWSLGCMF 310
+ Y D+ S
Sbjct: 174 -------RTYRTEKDINSAIDRI 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 344 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.85 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-52 Score=385.87 Aligned_cols=246 Identities=79% Similarity=1.318 Sum_probs=228.6
Q ss_pred CcccccccccccCCCCccCCCccceeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHH
Q 019241 94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL 173 (344)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l 173 (344)
.+.++++.+.+...+.++|+++...+.++..++|+++++||+|+||+||+|++..+++.||||+++....+++.+|+++|
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il 83 (328)
T d3bqca1 4 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL 83 (328)
T ss_dssp CCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHH
T ss_pred CCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHH
Confidence 46778889999999999999999999999999999999999999999999999999999999999988889999999999
Q ss_pred HHHhCCCCccceeeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEe
Q 019241 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253 (344)
Q Consensus 174 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~ 253 (344)
+++.+||||++++++|........++||||+++++|....+.+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence 99966999999999998777788999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 019241 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333 (344)
Q Consensus 254 ~~~~~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i 333 (344)
.+.+.+||+|||+|+...+........+|+.|+|||.+.+...++.++||||+||++|||++|+.||..+.++.++...+
T Consensus 164 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i 243 (328)
T d3bqca1 164 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243 (328)
T ss_dssp TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence 77567999999999988777777778999999999999886678999999999999999999999999888888888888
Q ss_pred HHhhCC
Q 019241 334 AKVTTI 339 (344)
Q Consensus 334 ~~~~~~ 339 (344)
.+.+|.
T Consensus 244 ~~~~g~ 249 (328)
T d3bqca1 244 AKVLGT 249 (328)
T ss_dssp HHHHCH
T ss_pred HHHHCC
Confidence 888774
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=364.29 Aligned_cols=206 Identities=26% Similarity=0.496 Sum_probs=182.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++.+.||+|+||+||+|++..+++.||+|++.. ...+.+.+|+++++++ +||||+++++++.+ ....
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEE--CCEE
Confidence 3679999999999999999999999999999999853 2346788999999999 99999999999965 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+++|+|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... .
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~-~ 159 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-S 159 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC-C
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCC-C
Confidence 9999999999998876 569999999999999999999999999999999999999988 7899999999987653 3
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
......||+.|||||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV 219 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTT
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHHHHHHHHHcC
Confidence 4456789999999999987 77999999999999999999999999 566666777776653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=367.90 Aligned_cols=204 Identities=27% Similarity=0.452 Sum_probs=176.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|+++++||+|+||+||+|+++.+++.||||+++.. ..+.+.+|+++++++ +||||+++++++.+ ....++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--CceeEE
Confidence 46899999999999999999999999999999998532 235688999999999 99999999999965 477889
Q ss_pred EEEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC--
Q 019241 200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-- 274 (344)
||||+++|+|.+++. .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCCcc
Confidence 999999999998874 48999999999999999999999999999999999999988 789999999998765332
Q ss_pred -cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
.....+||+.|||||++.+...++.++||||+||++|||++|+.||....+......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 217 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 234568999999999998744457889999999999999999999965544444333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=368.08 Aligned_cols=205 Identities=26% Similarity=0.483 Sum_probs=180.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|+++++||+|+||+||+|++..+|+.||||+++. ...+.+.+|+++++++ +||||++++++|.+ ....++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999853 3446789999999999 99999999999965 4678999
Q ss_pred EEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-Ccce
Q 019241 201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN 277 (344)
Q Consensus 201 ~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~~~~ 277 (344)
|||+++++|..++ ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccccccc
Confidence 9999999998876 569999999999999999999999999999999999999988 78999999999887544 3445
Q ss_pred ecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+.
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~ 229 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIA 229 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHH
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHH
Confidence 6689999999999987 789999999999999999999999994 444455555444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=367.84 Aligned_cols=213 Identities=26% Similarity=0.454 Sum_probs=182.1
Q ss_pred eeccCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc---cchHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 118 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.......+.|+++++||+|+||+||+|++..+++.||+|+++. ...+.+.+|+++++++ +||||+++++++.+ .
T Consensus 5 ~r~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~ 81 (288)
T d2jfla1 5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--E 81 (288)
T ss_dssp EESSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEE--T
T ss_pred cCCCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--C
Confidence 3334445789999999999999999999999999999999864 3346789999999999 99999999999965 4
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++||||+++|+|..++ ..+++.+++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKN 160 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhcc
Confidence 6788999999999998875 359999999999999999999999999999999999999988 78999999999765
Q ss_pred CCC-CcceecccCCCccCcccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 271 HPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 271 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
... ......+||+.|+|||++.. ...|+.++|||||||++|||++|+.||. +.+..+.+.++.+
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~ 229 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAK 229 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHH
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHc
Confidence 432 22345689999999999852 3568999999999999999999999994 5555666666654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=364.78 Aligned_cols=205 Identities=27% Similarity=0.501 Sum_probs=179.0
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|++..+++.||||+++. ...+.+.+|+++++++ +||||++++++|.+ ....+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEEC--SSEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEE--CCEEE
Confidence 579999999999999999999999999999999853 2346789999999999 99999999999965 47789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~- 274 (344)
+||||+++|+|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++++ +.+||+|||+|+......
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccCCc
Confidence 999999999998876 569999999999999999999999999999999999999988 789999999998875432
Q ss_pred --cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+.+|.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIK 224 (288)
T ss_dssp ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHT
T ss_pred ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHc
Confidence 2344689999999999987 789999999999999999999999994 5566667777755
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=364.92 Aligned_cols=207 Identities=27% Similarity=0.480 Sum_probs=169.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc-----hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|++++.||+|+||+||+|+++.+|+.||+|+++... .+.+.+|+++++++ +||||+++++++.+......++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEE
Confidence 67999999999999999999999999999999986432 35588999999999 9999999999998766677899
Q ss_pred EEEeecCCchhhHc-------CCCCHHHHHHHHHHHHHHHHHHHHcC-----cEeecCCCCceEEeCCCCcEEEEecccc
Q 019241 200 IFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLA 267 (344)
Q Consensus 200 v~e~~~~~~l~~~l-------~~l~~~~~~~~~~~i~~~L~~LH~~~-----iiHrDlkp~NiLl~~~~~~~kl~DFGla 267 (344)
||||+++|+|.+++ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccce
Confidence 99999999999876 35999999999999999999999976 9999999999999988 78999999999
Q ss_pred eecCCCC-cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 268 EFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 268 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+...... .....+||+.|||||++.+ ..++.++|||||||++|||++|+.|| .+.+..+...+|.+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf-~~~~~~~~~~~i~~ 228 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIRE 228 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHH
T ss_pred eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCC-CCCCHHHHHHHHHc
Confidence 8875443 3345789999999999876 78999999999999999999999999 45566666666654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=376.00 Aligned_cols=210 Identities=22% Similarity=0.370 Sum_probs=179.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
..++|+++++||+|+||+||+|++..+++.||+|+++. ...+++.+|+.+|+++ +||||++++++|.+ ....+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEEC--SSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEE
Confidence 46789999999999999999999999999999999853 2346788999999999 99999999999965 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~-~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
+||||+++++|..++ ..+++..++.++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+...+.
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCCC-
Confidence 999999999999887 4699999999999999999999975 99999999999999988 78999999999876432
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTT 338 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~ 338 (344)
.....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||........+...+....|
T Consensus 159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 221 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221 (322)
T ss_dssp TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------
T ss_pred ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcC
Confidence 3345689999999999988 78999999999999999999999999776666665555554444
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=357.32 Aligned_cols=208 Identities=22% Similarity=0.407 Sum_probs=176.4
Q ss_pred CCCe-EEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCC
Q 019241 124 QDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSK 195 (344)
Q Consensus 124 ~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~ 195 (344)
..+| ++.++||+|+||+||+|++..+++.||+|.+... ..+.+.+|+++|+++ +||||++++++|.+. ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence 4455 7778999999999999999999999999998532 235688999999999 999999999998653 235
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~--iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
..++||||+++++|..++ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+.+.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 678999999999998887 46999999999999999999999998 9999999999999754478999999999864
Q ss_pred CCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. .......+||+.|||||++.+ .++.++|||||||++|||++|+.||....+..+....+.+
T Consensus 166 ~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 166 R-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227 (270)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred c-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc
Confidence 4 334456789999999999864 5999999999999999999999999655444555555544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-49 Score=368.41 Aligned_cols=212 Identities=23% Similarity=0.439 Sum_probs=188.7
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++++.||+|+||+||+|++..+|+.||||++.... .+.+.+|+.+|+++ +||||++++++|.+ ....++|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 358999999999999999999999999999999986433 35688999999999 99999999999965 4778999
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-CCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~~~~ 275 (344)
||||++|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.......
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999998876 248999999999999999999999999999999999999743 36899999999999887777
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..|.+....+
T Consensus 182 ~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~ 244 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNM 244 (350)
T ss_dssp EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCS
T ss_pred cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCC
Confidence 778899999999999987 78999999999999999999999999 4667778888887655443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=365.39 Aligned_cols=206 Identities=25% Similarity=0.461 Sum_probs=182.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|++++.||+|+||+||+|+++.+++.||+|++++ ...+.+.+|+.+|+++ +||||++++++|.+ ....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--cccc
Confidence 3679999999999999999999999999999999863 2346788999999999 99999999999955 4788
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC-C
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~-~ 273 (344)
++|||||++|+|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... .
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccCC
Confidence 9999999999998887 569999999999999999999999999999999999999998 8999999999987644 3
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||. +.+..+....+..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~ 219 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILM 219 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhc
Confidence 44556789999999999987 789999999999999999999999994 5555665555544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-49 Score=368.06 Aligned_cols=212 Identities=24% Similarity=0.460 Sum_probs=188.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.++|++++.||+|+||+||+|++..+|+.||||+++... .+.+.+|+++|+++ +||||++++++|.+ ....++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 467999999999999999999999999999999986433 35678999999999 99999999999964 4778999
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC-CCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~-~~~~~kl~DFGla~~~~~~~~ 275 (344)
||||++++|...+. .+++.+++.++.||+.||+|||+.||+||||||+|||++. +.+.+||+|||+|+...+...
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999999987652 4899999999999999999999999999999999999983 237899999999999887777
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..|.+....+
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~ 247 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEF 247 (352)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCC
T ss_pred eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCC
Confidence 788899999999999887 78999999999999999999999999 5667777888887654443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-50 Score=364.73 Aligned_cols=208 Identities=27% Similarity=0.480 Sum_probs=165.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence 56799999999999999999999999999999998642 235577999999999 99999999999955 477899
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC--CCCcEEEEecccceecCCCC
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~--~~~~~kl~DFGla~~~~~~~ 274 (344)
||||+++++|.+++ ..+++..+..++.|++.||+|||++||+||||||+|||++. +.+.+||+|||+|+......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999998887 35999999999999999999999999999999999999953 23789999999999877666
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.....+||+.|||||++.+ ..++.++|||||||++|||++|+.||. +.+..+....|.+.
T Consensus 165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~ 224 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKA 224 (307)
T ss_dssp --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTT
T ss_pred eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhcc
Confidence 6667889999999999987 789999999999999999999999994 45556666666553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=356.72 Aligned_cols=208 Identities=26% Similarity=0.478 Sum_probs=185.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++.+.||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+.+|+++ +||||++++++|.+ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 57899999999999999999999999999999998532 246789999999999 99999999999965 4
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCC---CcEEEEecccce
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE 268 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~---~~~kl~DFGla~ 268 (344)
...++|||||++|+|..++ ..+++..++.++.|++.||+|||+.+|+||||||+|||++.+. ..+||+|||+|+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 7789999999999999887 4699999999999999999999999999999999999998762 259999999999
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
............+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..|.+.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf-~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAV 231 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHTT
T ss_pred hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCC-CCCCHHHHHHHHHhc
Confidence 8877777777889999999999987 78999999999999999999999999 466667777776553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-49 Score=356.78 Aligned_cols=208 Identities=19% Similarity=0.366 Sum_probs=181.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.++|++.++||+|+||+||+|++..+++.||||+++. ...+++.+|+++|+++ +||||++++++|.+ ....++|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEE
Confidence 45789999999999999999999999999999999864 3457899999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++|++..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence 9999999998876 358999999999999999999999999999999999999988 7899999999987654433
Q ss_pred c--eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
. ....++..|+|||++.+ ..++.++|||||||++|||++|..||+.+.+..+....+.+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~ 231 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence 2 23457889999999887 78999999999999999999999998777666555554433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-49 Score=360.41 Aligned_cols=203 Identities=22% Similarity=0.473 Sum_probs=180.4
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++++.||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCeee
Confidence 579999999999999999999999999999999853 2346788999999999 99999999999955 47889
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+||||++++++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... .
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--V 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--C
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEecc--c
Confidence 999999999988876 468899999999999999999999999999999999999988 7999999999988753 3
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+||+.|||||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+.+|.+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~ 215 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILN 215 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH
T ss_pred cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC-CcCHHHHHHHHHc
Confidence 345789999999999877 779999999999999999999999994 5566666666655
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-49 Score=358.57 Aligned_cols=203 Identities=28% Similarity=0.470 Sum_probs=176.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
+.|+.+++||+|+||+||+|++..+++.||||+++... .+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEE--CCEEE
Confidence 45999999999999999999999999999999985322 24688999999999 99999999999965 46789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+|||||.++++..+. ..+++.+++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---
Confidence 999999999987654 569999999999999999999999999999999999999988 8999999999987543
Q ss_pred ceecccCCCccCcccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.....||+.|||||++.+ ...|+.++|||||||++|||++|..||. +.+..+.+.++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~~~~~~~i~~ 228 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ 228 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHh
Confidence 345689999999999864 2458999999999999999999999995 4445555655544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=348.27 Aligned_cols=208 Identities=16% Similarity=0.351 Sum_probs=171.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
+.++|++.++||+|+||+||+|++. +++.||||+++. ...+++.+|+++++++ +||||++++|+|.+ ....++|
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceecc--CCceEEE
Confidence 4578999999999999999999865 567899999864 3457899999999999 99999999999954 4678899
Q ss_pred EEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
|||+++|+|..++ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++........
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence 9999999998876 347899999999999999999999999999999999999988 78999999999877544322
Q ss_pred --eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
....||..|+|||++.+ ..++.++|||||||++|||+|+..||+...+..+.+..+.+-
T Consensus 158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 218 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218 (263)
T ss_dssp -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT
T ss_pred eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc
Confidence 33578999999999987 789999999999999999999877877777777777777653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=356.35 Aligned_cols=209 Identities=32% Similarity=0.587 Sum_probs=182.9
Q ss_pred EEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--------hHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
.+++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++++++ +||||+++++++.+ ....++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence 4689999999999999999999999999985321 24588999999999 99999999999954 5778999
Q ss_pred EEeecCCchhhHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-cc
Q 019241 201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY 276 (344)
Q Consensus 201 ~e~~~~~~l~~~l~---~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~~ 276 (344)
|||+.++++..+.. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence 99999998887763 48999999999999999999999999999999999999988 799999999998765433 33
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
...+||+.|+|||++.+...++.++|||||||++|||++|..|| .+.++.+++.+|.+.+|+++.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTE 222 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCT
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCCh
Confidence 45689999999999987677899999999999999999998777 678889999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=349.80 Aligned_cols=207 Identities=17% Similarity=0.356 Sum_probs=180.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.++||+|+||+||+|++. +++.||||+++. ...+.|.+|+++++++ +||||++++|++.+ ...++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEE
Confidence 3578999999999999999999864 678899999964 3457799999999999 99999999998854 456899
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
|||+++|+|..++. .+++..+..++.|+++||.|||+++|+||||||+|||++.+ +.+||+|||+|+...+...
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence 99999999988763 48999999999999999999999999999999999999988 7899999999998765432
Q ss_pred --ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.....+|..|||||++.+ ..++.++|||||||++|||+||..||+...+..+.+..+.+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 233568889999999886 679999999999999999999888887877777777776553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=361.28 Aligned_cols=205 Identities=22% Similarity=0.420 Sum_probs=182.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
.++|+++++||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+|+.+ +||||+++++++.+ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--cccc
Confidence 3689999999999999999999999999999999853 2345688999999999 99999999999955 4678
Q ss_pred EEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
++||||+.++++...+ ..+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSS--
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeeccc--
Confidence 8999999999998877 569999999999999999999999999999999999999988 7999999999998753
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
......||+.|||||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+.+|.+.
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~ 253 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSG 253 (350)
T ss_dssp CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC
T ss_pred ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCC-CCcCHHHHHHHHhcC
Confidence 3345789999999999987 78999999999999999999999999 455666667766553
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=352.03 Aligned_cols=203 Identities=17% Similarity=0.369 Sum_probs=167.2
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCcc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 197 (344)
..++|++.++||+|+||+||+|+.. ..||||+++. ...+.|.+|+++++++ +||||+++++++.+ ...
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEE
Confidence 4678899999999999999999642 3599999853 2346789999999999 99999999999843 457
Q ss_pred EEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC
Q 019241 198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 198 ~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~ 273 (344)
++||||+++|+|..++ ..+++..+..++.|+++||+|||+++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence 8999999999999877 348999999999999999999999999999999999999998 78999999999876533
Q ss_pred C---cceecccCCCccCcccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 019241 274 K---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334 (344)
Q Consensus 274 ~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~ 334 (344)
. ......||+.|||||++... ..++.++|||||||++|||+||+.||. +.++.+++..+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~~ 222 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMV 222 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHHH
Confidence 2 23445789999999998642 358999999999999999999999995 445554444433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.3e-48 Score=344.65 Aligned_cols=209 Identities=25% Similarity=0.442 Sum_probs=183.8
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc------------hHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
.++|++.+.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999985321 23578899999999559999999999954
Q ss_pred cCCCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
..+.++||||+++++|.+++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence 57889999999999999887 569999999999999999999999999999999999999988 799999999999
Q ss_pred ecCCCCcceecccCCCccCcccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
...+........||..|+|||.+.+ ...++.++||||+||++|||++|+.||. +.+..+....+.+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhC
Confidence 8877666677889999999999863 2457889999999999999999999994 55556666666653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=354.32 Aligned_cols=210 Identities=22% Similarity=0.436 Sum_probs=186.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccch--HHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI 200 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 200 (344)
..++|++.+.||+|+||+||+|++..+++.||+|+++.... ..+.+|+++|+.+ +||||++++++|.+ ....|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEE
Confidence 35789999999999999999999999999999999975443 4578999999999 99999999999965 4678999
Q ss_pred EEeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC-CCcEEEEecccceecCCCCc
Q 019241 201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 201 ~e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~-~~~~kl~DFGla~~~~~~~~ 275 (344)
||||++++|..++. .+++.+++.++.||+.||+|||+.||+||||||+|||++.+ ...+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999998873 48999999999999999999999999999999999999854 35799999999998877777
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhh
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
.....+|+.|+|||.+.+ ..++.++||||+||++|+|++|..|| .+.+..+.+..|.+..
T Consensus 160 ~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf-~~~~~~~~~~~i~~~~ 219 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAE 219 (321)
T ss_dssp EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTC
T ss_pred ccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCC
Confidence 777899999999999877 77999999999999999999999999 4566677777776643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=351.27 Aligned_cols=206 Identities=24% Similarity=0.454 Sum_probs=180.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc------cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS 198 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 198 (344)
++|++.+.||+|+||+||+|++..+++.||||++++ ...+.+..|..++.+..+||||+++++++.+ ....+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 679999999999999999999999999999999853 2335677788877653499999999999965 47789
Q ss_pred EEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-C
Q 019241 199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 274 (344)
Q Consensus 199 lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~ 274 (344)
+||||+++|+|..++ ..+++.+++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+|+..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccccc
Confidence 999999999999987 569999999999999999999999999999999999999988 78999999999876543 3
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+.+|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM 217 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHc
Confidence 3445689999999999987 78999999999999999999999999 46666777776654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=351.95 Aligned_cols=208 Identities=23% Similarity=0.419 Sum_probs=175.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe-----EEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~-----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||+||+|++..+++ .||+|.+.. .....+.+|+.+++++.+||||++++++|.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 45789999999999999999999876553 699998853 2345788999999998789999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC--------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP--------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP 247 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~--------------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp 247 (344)
....++|||||++|+|..++. .+++..+..++.|++.||+|||+++|+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 467899999999999998872 278899999999999999999999999999999
Q ss_pred CceEEeCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 019241 248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 323 (344)
Q Consensus 248 ~NiLl~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~ 323 (344)
+|||++.+ +.+||+|||+|+........ ....||+.|||||++.+ ..++.++|||||||++|||+| |..||. +
T Consensus 193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~-~ 269 (325)
T d1rjba_ 193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYP-G 269 (325)
T ss_dssp GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-T
T ss_pred hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCC-C
Confidence 99999988 89999999999876544332 23467999999999987 789999999999999999998 788884 5
Q ss_pred CCCHHHHHHHHH
Q 019241 324 HDNHDQLVKIAK 335 (344)
Q Consensus 324 ~~~~~~l~~i~~ 335 (344)
.+..+.+.++.+
T Consensus 270 ~~~~~~~~~~~~ 281 (325)
T d1rjba_ 270 IPVDANFYKLIQ 281 (325)
T ss_dssp CCCSHHHHHHHH
T ss_pred CCHHHHHHHHHh
Confidence 555555555544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=358.12 Aligned_cols=196 Identities=27% Similarity=0.472 Sum_probs=174.6
Q ss_pred CCCeEEEe-eecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEcc--CCCccEEE
Q 019241 124 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLI 200 (344)
Q Consensus 124 ~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv 200 (344)
.++|++++ .||+|+||+||+|++..+++.||||+++ ....+.+|++++.++.+||||++++++|.+. ....+|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE--CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC--CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 46799886 5999999999999999999999999996 3466889999988776899999999998652 34678999
Q ss_pred EEeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCC
Q 019241 201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG 273 (344)
Q Consensus 201 ~e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~ 273 (344)
||||++|+|.+++. .+++.+++.++.|++.||+|||+.||+||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 99999999998872 48999999999999999999999999999999999999863 357999999999988777
Q ss_pred CcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||..
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 77777899999999999877 7899999999999999999999999943
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-48 Score=351.28 Aligned_cols=207 Identities=19% Similarity=0.359 Sum_probs=164.5
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe---EEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.++||+|+||+||+|++..+++ .||||.+... ..+.|.+|+++|+++ +||||++++|+|.+ ..
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~ 100 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--ST 100 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CC
Confidence 35789999999999999999999876664 5889987532 235689999999999 99999999999954 46
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++|||||++|+|..++ ..+++.++..++.|+++||+|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 179 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence 788999999999998876 348999999999999999999999999999999999999988 789999999998775
Q ss_pred CCCcc------eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEY------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
+.... ....+|+.|||||++.+ ..++.++|||||||++|||+| |..|| .+.+..+.+..+.+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf-~~~~~~~~~~~i~~ 248 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMTNQDVINAIEQ 248 (299)
T ss_dssp ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHT
T ss_pred CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 43322 12356888999999887 789999999999999999998 78887 45555666666654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-47 Score=344.00 Aligned_cols=208 Identities=24% Similarity=0.424 Sum_probs=172.6
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccCC--C
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--K 195 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~ 195 (344)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+|+++++++ +||||+++++++..... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 57899999999999999999999999999999998632 234688999999999 99999999999876543 3
Q ss_pred ccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
..|+||||+++++|..++ ..+++.+++.++.|++.||+|||+.||+||||||+|||++.+ +..+++|||.++....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC-
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhcc
Confidence 478999999999998776 469999999999999999999999999999999999999988 7889999999876543
Q ss_pred CC----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 273 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||+||+.|| .+.+..+.+.++.+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVR 228 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHH
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCC-CCcCHHHHHHHHHh
Confidence 32 3344589999999999877 78999999999999999999999999 45555555555544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=349.57 Aligned_cols=213 Identities=33% Similarity=0.639 Sum_probs=186.3
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|+++++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+++++++ +||||++++++|.+ ....++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccccc--ccceeE
Confidence 6899999999999999999999999999999998532 246788999999999 99999999999965 467899
Q ss_pred EEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCC-C
Q 019241 200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K 274 (344)
Q Consensus 200 v~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~-~ 274 (344)
||||+.++.+.... ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||.|+..... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSB
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCcc
Confidence 99999887655443 458999999999999999999999999999999999999988 78999999999877543 3
Q ss_pred cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
......||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.++.+++.++.+..+.++-
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCch
Confidence 4455689999999999887666789999999999999999999999 567778889998888877653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=346.23 Aligned_cols=206 Identities=17% Similarity=0.368 Sum_probs=174.8
Q ss_pred CCCCeEEEe-eecccCCeeEEEEEEcC--CCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVR-KVGRGKYSEVFEGINVN--TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~-~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|.+.+ +||+|+||+||+|.+.. ++..||||+++.. ..+.|.+|+++|+++ +||||++++|+|.+ .
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~ 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---C
Confidence 456788888 49999999999997654 4557999998643 236789999999999 99999999999954 3
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++|+|..++ ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccc
Confidence 578999999999999875 348999999999999999999999999999999999999988 799999999999876
Q ss_pred CCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
..... ....||+.|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....|.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf-~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQ 227 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHT
T ss_pred ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 54332 23467889999999887 679999999999999999998 89888 45566777766654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-47 Score=356.15 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=169.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc------chHHHHHHH---HHHHHHhCCCCccceeeEEEccCC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREI---KILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~---~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
.++|++.+.||+|+||+||+|++..+|+.||||++... ....+.+|. .+++.+ +||||++++++|.+ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEE--C
Confidence 46899999999999999999999999999999998532 223345554 444444 79999999999965 4
Q ss_pred CccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
...++||||+++++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence 6789999999999999887 458999999999999999999999999999999999999988 799999999998776
Q ss_pred CCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
.. .....+||+.|+|||++.....++.++|||||||++|||++|+.||...
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 43 3455689999999999976577999999999999999999999999643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=347.73 Aligned_cols=215 Identities=31% Similarity=0.595 Sum_probs=186.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCC-CeEEEEEEeccc-----chHHHHHHHHHHHHHh--CCCCccceeeEEEcc---
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ--- 192 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~--- 192 (344)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ....+.+|+.+++.+. +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999765 678999998532 2345778998888773 799999999998643
Q ss_pred CCCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccce
Q 019241 193 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268 (344)
Q Consensus 193 ~~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~ 268 (344)
.....+++|||+.++++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhh
Confidence 235678999999998775443 458999999999999999999999999999999999999988 789999999998
Q ss_pred ecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
............||+.|+|||++.+ ..|+.++||||+||++|||++|+.|| .+.++.+++.+|.+.+|.++
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCc
Confidence 7766666677899999999999987 78999999999999999999999998 57778899999999888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=354.91 Aligned_cols=213 Identities=32% Similarity=0.572 Sum_probs=186.6
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCCCCccceeeEEEcc----CCCccEEEE
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSLIF 201 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~lv~ 201 (344)
+|+.+++||+|+||+||+|++..+++.||||+++... ....+|+++|+++ +|+||++++++|... +..+.++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6889999999999999999999999999999996432 3345899999999 999999999998543 334678999
Q ss_pred EeecCCchhhHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 202 e~~~~~~l~~~l------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
||++++++..+. ..+++.+++.++.|++.||+|||++||+||||||+|||++.+...+||+|||+++.......
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999987554432 35999999999999999999999999999999999999998755899999999998877777
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.....||+.|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++.+|.+.+|+++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPT 243 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCCh
Confidence 777899999999999887678999999999999999999999998 56677889999999888764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=339.00 Aligned_cols=207 Identities=18% Similarity=0.341 Sum_probs=179.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc--cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.++||+|+||+||+|++ .+++.||||+++. ...++|.+|+.+++++ +||||++++|+|.+ ....++||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~--~~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECC--SSSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEee--CCceEEEE
Confidence 46788899999999999999987 5788999999864 3557899999999999 99999999999954 46788999
Q ss_pred EeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc--
Q 019241 202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 275 (344)
Q Consensus 202 e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~-- 275 (344)
||+++|++..++ ..+++..+.+++.|+++||+|||+.||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCCcee
Confidence 999999988875 458899999999999999999999999999999999999988 7899999999987654433
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHhh
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVT 337 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~~~ 337 (344)
.....+|..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+...++.+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~ 218 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGL 218 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTC
T ss_pred ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCC
Confidence 234578899999999987 789999999999999999998 67777 5666777777776643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=342.48 Aligned_cols=209 Identities=17% Similarity=0.331 Sum_probs=171.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC----eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|++.+.||+|+||+||+|.+..++ ..||||.++.. ...+|.+|+++++++ +||||++++|+|.+ .
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~ 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--C
Confidence 4567999999999999999999876654 47999998642 234688999999999 99999999999954 4
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++||||+.++++...+ ..+++.++..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhcc
Confidence 6778999999999987765 468999999999999999999999999999999999999998 79999999999876
Q ss_pred CCCCc----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 271 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
..... .....||..|||||++.+ ..++.++|||||||++|||++|..||+.+.+..+.+..+.+-
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 54322 223467889999999887 789999999999999999999888887777777777666553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=340.95 Aligned_cols=198 Identities=19% Similarity=0.379 Sum_probs=166.4
Q ss_pred eeecccCCeeEEEEEEc--CCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEEe
Q 019241 131 RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203 (344)
Q Consensus 131 ~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 203 (344)
++||+|+||+||+|.+. .+++.||||+++.. ..+++.+|+++++++ +||||++++|+|.+ ...++||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCEEEEEEc
Confidence 47999999999999764 34578999998532 235789999999999 99999999999954 346899999
Q ss_pred ecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc----
Q 019241 204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---- 276 (344)
Q Consensus 204 ~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~---- 276 (344)
+++|+|..++ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+|+........
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhccccccccccc
Confidence 9999998887 459999999999999999999999999999999999999988 79999999999887544332
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....||+.|||||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+
T Consensus 168 ~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf-~~~~~~~~~~~i~~ 225 (277)
T d1xbba_ 168 THGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEK 225 (277)
T ss_dssp ---CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHT
T ss_pred cccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCC-CCCCHHHHHHHHHc
Confidence 23468889999999987 779999999999999999998 78888 45555555555544
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=340.90 Aligned_cols=206 Identities=19% Similarity=0.342 Sum_probs=174.0
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
.++|++.+.||+|+||+||+|++..+ +.||||+++.. ..+.|.+|+.+++++ +|+||++++|+|.+ ...++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence 46899999999999999999987654 67999999643 347799999999999 99999999999843 3468999
Q ss_pred EeecCCchhhHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc-
Q 019241 202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 275 (344)
Q Consensus 202 e~~~~~~l~~~l-----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~- 275 (344)
||+++|++..++ ..+++.++..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCce
Confidence 999999988776 358999999999999999999999999999999999999988 7899999999987654432
Q ss_pred -ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHh
Q 019241 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||+.+....+.+..+.+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~ 230 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230 (285)
T ss_dssp ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 234578999999999987 789999999999999999999988998888877777777654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-46 Score=339.72 Aligned_cols=213 Identities=30% Similarity=0.595 Sum_probs=183.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|+++++||+|+||+||+|++. +++.||||+++.. ..+.+.+|+.+|+++ +||||++++++|.+ ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeeccc--CCceeE
Confidence 68999999999999999999875 7789999998532 246789999999999 99999999999955 467889
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
++||+.++++..+. ..+++..++.++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||.|....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCccc
Confidence 99999998887775 458999999999999999999999999999999999999998 789999999998765433 3
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDFS 343 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~~ 343 (344)
.....+++.|+|||.+.+...++.++||||+||++|||++|+.|| .+.++.+++.++.+.+|.++..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChh
Confidence 345578999999999988677899999999999999999999999 5677788999999998887643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=337.79 Aligned_cols=195 Identities=27% Similarity=0.481 Sum_probs=169.1
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------hHHHHHHHHHHHHHh-CCCCccceeeEEEccC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVRDQH 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~ 193 (344)
.++|++.+.||+|+||+||+|++..+++.||||+++... ..++.+|+.+++++. .||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 578999999999999999999999999999999985321 234678999999993 38999999999965
Q ss_pred CCccEEEEEeecC-CchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 SKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 ~~~~~lv~e~~~~-~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....++||||+.+ +++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 4678899999976 5666554 56999999999999999999999999999999999999997657899999999987
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
... .......||+.|+|||++.+...++.++||||+||++|||++|+.||.
T Consensus 161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 643 344567899999999999874556788999999999999999999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=344.27 Aligned_cols=215 Identities=33% Similarity=0.616 Sum_probs=180.7
Q ss_pred cCCCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCC-
Q 019241 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS- 194 (344)
Q Consensus 121 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~- 194 (344)
|...++|+++++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+++|+++ +||||++++++|...+.
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence 34578999999999999999999999999999999998642 235678999999999 99999999999965432
Q ss_pred ---CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 195 ---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 195 ---~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
...++||||+ +.++..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+|++|||+|+.
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ 170 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceec
Confidence 3579999999 45565554 579999999999999999999999999999999999999998 7899999999987
Q ss_pred cCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.. ...+...+|+.|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+.+..+.+..+.++
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCC
T ss_pred cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCc
Confidence 64 34456789999999999987677899999999999999999999998 56677888888888887764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=339.58 Aligned_cols=207 Identities=18% Similarity=0.341 Sum_probs=169.6
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCe----EEEEEEecc----cchHHHHHHHHHHHHHhCCCCccceeeEEEccCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 194 (344)
..++|+++++||+|+||+||+|++..+++ .||+|.++. ...+++.+|+.+++++ +||||++++|+|.+
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--- 82 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT--- 82 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES---
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---
Confidence 34679999999999999999999887776 588888753 2346799999999999 99999999999965
Q ss_pred CccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...++++||+.+++|...+ ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL 161 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHT
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceec
Confidence 3457899999999887765 458999999999999999999999999999999999999988 79999999999877
Q ss_pred CCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 271 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
...... ....||..|+|||++.+ ..++.++|||||||++|||+|+..|++.+.+..+....+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~ 228 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 543332 23468999999999987 78999999999999999999944444466665555555544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=338.24 Aligned_cols=216 Identities=32% Similarity=0.524 Sum_probs=185.3
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-----cchHHHHHHHHHHHHHhCCCCccceeeEEEccC-----
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----- 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----- 193 (344)
-++|+++++||+|+||+||+|++..+|+.||||++.. .....+.+|+++|+++ +|+|++++++.+....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999842 2346688999999999 9999999999986532
Q ss_pred -CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 -~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
....++||||++++++.... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~~ 166 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARA 166 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceeee
Confidence 34678999999998877665 468999999999999999999999999999999999999998 7899999999987
Q ss_pred cCCCC-----cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCCC
Q 019241 270 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILDF 342 (344)
Q Consensus 270 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~~ 342 (344)
..... .....+||+.|+|||++.+...++.++||||+||++|||++|+.|| .+.++.+.+..+.+.++.++-
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCCh
Confidence 65322 2233579999999999987668999999999999999999999888 577788899999998887763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=337.99 Aligned_cols=208 Identities=21% Similarity=0.365 Sum_probs=166.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||+||+|++.. +++.||||+++.. ..+.+.+|..++.++.+|+||+.+++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 35789999999999999999998754 3468999998642 2356788899999987899999999988543
Q ss_pred CCccEEEEEeecCCchhhHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~-------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~ 254 (344)
....++|||||++|+|..++. .+++.++..++.|+++||+|||+++|+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 356789999999999998862 3788999999999999999999999999999999999998
Q ss_pred CCCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 019241 255 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331 (344)
Q Consensus 255 ~~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~ 331 (344)
+ +.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+.+.
T Consensus 170 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 170 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp G-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred C-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 8 7899999999987654332 234578999999999987 7899999999999999999998665445555444444
Q ss_pred HH
Q 019241 332 KI 333 (344)
Q Consensus 332 ~i 333 (344)
++
T Consensus 248 ~~ 249 (299)
T d1ywna1 248 RR 249 (299)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=332.51 Aligned_cols=213 Identities=32% Similarity=0.607 Sum_probs=189.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL 199 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 199 (344)
++|+++++||+|+||+||+|++..+++.||||+++.. ..+++.+|+.+++.+ +|+||++++++|.+ ....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccc--ccceeE
Confidence 6899999999999999999999999999999998532 246788999999999 99999999999955 467789
Q ss_pred EEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC-c
Q 019241 200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E 275 (344)
Q Consensus 200 v~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~-~ 275 (344)
+++++.++++..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.|+...... .
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCcc
Confidence 99999999887765 468999999999999999999999999999999999999988 789999999998876543 3
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.....++..|+|||++.+...++.++||||+||++|||++|+.||+.+.+..+++.++....++++
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence 344567888999999887566899999999999999999999999999999999999998888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=339.15 Aligned_cols=216 Identities=29% Similarity=0.555 Sum_probs=180.4
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccCC--Cc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--KT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~~ 196 (344)
.+++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+++|+++ +|||++++++++..... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence 4678999999999999999999999999999999996432 35678999999999 99999999999965422 12
Q ss_pred cEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCC
Q 019241 197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~ 274 (344)
.+++++|+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGG
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccCCC
Confidence 34566777889998887 579999999999999999999999999999999999999988 789999999998765432
Q ss_pred c----ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 275 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
. ....+||+.|+|||++.....++.++||||+||++|||++|+.|| .+.+..++...+...++.++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCC
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCC
Confidence 2 344578999999999877677899999999999999999999998 45566777777777666553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=343.21 Aligned_cols=212 Identities=26% Similarity=0.497 Sum_probs=177.6
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEcc----CCC
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSK 195 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~ 195 (344)
++|+++++||+|+||+||+|++..+|+.||||+++.. ..+++.+|+.+++++ +||||++++++|... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 7899999999999999999999999999999998632 234688999999999 999999999999654 236
Q ss_pred ccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCc
Q 019241 196 TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~ 275 (344)
+.|+||||+.++++......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+|++|||+++.......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC---------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhccccccc
Confidence 789999999999998888999999999999999999999999999999999999999998 7889999999988777666
Q ss_pred ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCC
Q 019241 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTIL 340 (344)
Q Consensus 276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~ 340 (344)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.|| .+.++..++.++.+.++.+
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCC
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCC
Confidence 777789999999999987 78999999999999999999999888 5777788888888777654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=338.96 Aligned_cols=208 Identities=20% Similarity=0.383 Sum_probs=178.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
.+++|++++.||+|+||+||+|++. .+++.||||+++... .+++.+|+++++++ +||||++++++|.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-- 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence 4678999999999999999999875 356789999986432 35689999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCC
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~---------------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlk 246 (344)
....+++|||+++++|..++. .+++..+..++.|++.||+|||+++++|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 467889999999999988762 27888999999999999999999999999999
Q ss_pred CCceEEeCCCCcEEEEecccceecCCCC---cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 019241 247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323 (344)
Q Consensus 247 p~NiLl~~~~~~~kl~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~ 323 (344)
|+|||++.+ +.+||+|||+|+...+.. ......+|+.|+|||++.+ ..++.++|||||||++|||++|..|++.+
T Consensus 168 p~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999988 789999999998764432 2234578889999999987 78999999999999999999998766677
Q ss_pred CCCHHHHHHHHH
Q 019241 324 HDNHDQLVKIAK 335 (344)
Q Consensus 324 ~~~~~~l~~i~~ 335 (344)
.++.+.+..+.+
T Consensus 246 ~~~~e~~~~v~~ 257 (301)
T d1lufa_ 246 MAHEEVIYYVRD 257 (301)
T ss_dssp SCHHHHHHHHHT
T ss_pred CCHHHHHHHHHc
Confidence 777777777655
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=332.48 Aligned_cols=206 Identities=22% Similarity=0.435 Sum_probs=164.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK 195 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 195 (344)
..++|++.+.||+|+||+||+|++..++ ..||||.++.. ..+.+.+|+++++++ +||||++++|+|.+ .
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 80 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---C
Confidence 3578999999999999999999886554 46889988632 235688999999999 99999999999943 5
Q ss_pred ccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecC
Q 019241 196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271 (344)
Q Consensus 196 ~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~ 271 (344)
..++||||+++|++..++ ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME 159 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheecc
Confidence 678999999999998765 358999999999999999999999999999999999999988 799999999998765
Q ss_pred CCCc--ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 019241 272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 272 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+...++.+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~ 224 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIEN 224 (273)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHT
T ss_pred CCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHc
Confidence 4332 234567889999999987 789999999999999999998 66666 56666677666655
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=330.21 Aligned_cols=207 Identities=20% Similarity=0.340 Sum_probs=167.1
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCC-C--eEEEEEEeccc------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNT-N--ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-~--~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
+.++|++++.||+|+||+||+|+.... + ..||||++++. ..+.|.+|+++++++ +||||++++|+|.+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-- 82 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-- 82 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--
Confidence 356799999999999999999986533 2 46899998632 235789999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
...++||||++++++...+ ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA 160 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhh
Confidence 3568999999999988765 459999999999999999999999999999999999999998 7999999999998
Q ss_pred cCCCCcc----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHh
Q 019241 270 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV 336 (344)
Q Consensus 270 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~-g~~Pf~~~~~~~~~l~~i~~~ 336 (344)
....... ....++..|+|||++.+ ..++.++|||||||++|||+| |..|| .+.+..+.+.++.+-
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKE 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTS
T ss_pred cccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhC
Confidence 7554332 22356778999999987 789999999999999999998 78887 566767777766543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=330.50 Aligned_cols=209 Identities=22% Similarity=0.388 Sum_probs=178.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEc-----CCCeEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
..++|++.++||+|+||.||+|++. .+++.||||+++.. ....+.+|+.+++++.+||||++++++|.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 4578999999999999999999863 45678999999643 335688999999999779999999999954
Q ss_pred CCccEEEEEeecCCchhhHcC---------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l~---------------------~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....++|||||+++++..++. .+++..+..++.||+.||+|||+++++||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 466889999999999988862 48899999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCcc---eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
+.+ +.+|++|||+++........ ....+|+.|+|||++.+ ..++.++|||||||++|||+|++.||+.+.+..+.
T Consensus 179 ~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 988 79999999999877644332 33578999999999987 78999999999999999999977777777777666
Q ss_pred HHHHHH
Q 019241 330 LVKIAK 335 (344)
Q Consensus 330 l~~i~~ 335 (344)
+.++.+
T Consensus 257 ~~~~i~ 262 (311)
T d1t46a_ 257 FYKMIK 262 (311)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 655544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=337.30 Aligned_cols=209 Identities=19% Similarity=0.319 Sum_probs=177.8
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeE--EEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT 196 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 196 (344)
+.++|++.++||+|+||+||+|++..++.. ||||.++.. ..+.+.+|+++|+++.+||||++++|+|.+ ...
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCe
Confidence 457899999999999999999999888874 677776432 345789999999998679999999999965 467
Q ss_pred cEEEEEeecCCchhhHc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCC
Q 019241 197 PSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257 (344)
Q Consensus 197 ~~lv~e~~~~~~l~~~l-------------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~ 257 (344)
.++||||+++|+|.+++ ..+++..+..++.|++.||.|||+.+|+||||||+|||++.+ +
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-~ 164 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y 164 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-C
Confidence 88999999999999987 348999999999999999999999999999999999999988 7
Q ss_pred cEEEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 258 ~~kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
.+||+|||+|+............+|..|+|||.+.+ ..++.++|||||||++|||++|..||+.+.+..+....+.+
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 899999999987665555556678999999999987 78999999999999999999988777677777777766654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=324.91 Aligned_cols=205 Identities=17% Similarity=0.344 Sum_probs=166.0
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
..++|++.++||+|+||+||+|++ .++.||||+++.. ..+.+.+|+++++++ +||||++++|+|.+. ....++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEec-CCcEEEEE
Confidence 356799999999999999999986 4778999999754 346799999999999 999999999998543 24578999
Q ss_pred EeecCCchhhHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc
Q 019241 202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276 (344)
Q Consensus 202 e~~~~~~l~~~l~-----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~ 276 (344)
||+++|+|.+++. .+++..+..++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||+++...+. .
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~--~ 157 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q 157 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecCCC--C
Confidence 9999999999873 38999999999999999999999999999999999999998 78999999999876432 3
Q ss_pred eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....+|..|+|||++.+ ..++.++|||||||++|||+|+..|++.+.+..+....|.+
T Consensus 158 ~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~ 215 (262)
T d1byga_ 158 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215 (262)
T ss_dssp ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 44577889999999987 78999999999999999999954444456665665555543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=326.70 Aligned_cols=209 Identities=19% Similarity=0.354 Sum_probs=170.3
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCC-------eEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEc
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD 191 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 191 (344)
..++|++.+.||+|+||+||+|++..++ ..||||+++... ..++.+|...+.++.+||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4678999999999999999999876554 479999986432 35678899999999789999999999954
Q ss_pred cCCCccEEEEEeecCCchhhHc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~l-------------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl 252 (344)
....++||||+++|++..++ ..+++.++..++.|++.||+|||+.+|+||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 46789999999999999987 247999999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 019241 253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329 (344)
Q Consensus 253 ~~~~~~~kl~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~ 329 (344)
+.+ +.+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||+++..|++.+.+..+.
T Consensus 169 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 169 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp CTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred cCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 998 7899999999987754332 233578889999999987 78999999999999999999854444456665655
Q ss_pred HHHHHH
Q 019241 330 LVKIAK 335 (344)
Q Consensus 330 l~~i~~ 335 (344)
...+.+
T Consensus 247 ~~~i~~ 252 (299)
T d1fgka_ 247 FKLLKE 252 (299)
T ss_dssp HHHHHT
T ss_pred HHHHHc
Confidence 555544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-44 Score=322.62 Aligned_cols=195 Identities=18% Similarity=0.338 Sum_probs=168.4
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.++|++.++||+|+||+||+|++..+++.||||+++. .....+.+|+++++.+.+|+|++.+++++.+ ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 4789999999999999999999999999999999853 3446788999999999666999999999854 467789999
Q ss_pred eecCCchhhHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC----CCcEEEEecccceecCCCC
Q 019241 203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK 274 (344)
Q Consensus 203 ~~~~~~l~~~l----~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~----~~~~kl~DFGla~~~~~~~ 274 (344)
|+. ++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+|+......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 995 5665555 458999999999999999999999999999999999999742 3579999999998765321
Q ss_pred --------cceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 275 --------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 275 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
......||+.|||||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 2234579999999999987 7899999999999999999999999954
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=332.72 Aligned_cols=214 Identities=29% Similarity=0.585 Sum_probs=181.7
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-----chHHHHHHHHHHHHHhCCCCccceeeEEEccC---C
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---S 194 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~ 194 (344)
..++|+++++||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+++|+++ +|+|++++++++.... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence 467899999999999999999999999999999998643 235678999999999 9999999999986432 2
Q ss_pred CccEEEEEeecCCchhhHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCC
Q 019241 195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272 (344)
Q Consensus 195 ~~~~lv~e~~~~~~l~~~l--~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~ 272 (344)
...+++++|+.+++|..++ +.+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+|++|||++....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTD- 172 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCT-
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccC-
Confidence 3446778888999999887 469999999999999999999999999999999999999998 789999999997643
Q ss_pred CCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHhhCCCC
Q 019241 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVTTILD 341 (344)
Q Consensus 273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~~~~~~~ 341 (344)
.......||+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+....|.+..+.++
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCC
Confidence 34455678899999999887667899999999999999999999998 57777888888887777654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=326.49 Aligned_cols=208 Identities=19% Similarity=0.345 Sum_probs=177.9
Q ss_pred CCCCeEEEeeecccCCeeEEEEEEcC-----CCeEEEEEEecccc----hHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 123 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
+.++|++.++||+|+||+||+|.+.. +++.||||+++... ...+.+|+++++++ +||||++++++|..
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~-- 94 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 94 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--
Confidence 45789999999999999999998752 35789999996432 24588999999999 99999999999954
Q ss_pred CCccEEEEEeecCCchhhHc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEE
Q 019241 194 SKTPSLIFEYVNSTDFKVLY-------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l-------------~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~k 260 (344)
....++||||+++|+|..++ ..+++..+..++.|+++||.|||+++|+||||||+|||++.+ +.+|
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~K 173 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK 173 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEE
Confidence 46778999999999998876 236888999999999999999999999999999999999988 7899
Q ss_pred EEecccceecCCCCc---ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 261 l~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
|+|||+|+....... .....+|+.|+|||.+.+ ..++.++|||||||++|||+||..|++.+.+..+.+..+.+
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999987654332 223368899999999987 78999999999999999999997777688888888777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=325.01 Aligned_cols=193 Identities=21% Similarity=0.280 Sum_probs=162.8
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHH--HHHhCCCCccceeeEEEccCC--CccEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL--QNLCGGPNVVKLLDIVRDQHS--KTPSLI 200 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~~h~niv~l~~~~~~~~~--~~~~lv 200 (344)
++|.+.++||+|+||+||+|++ +|+.||||+++....+.+.+|.+++ .++ +||||++++++|.+.+. ...++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence 4688899999999999999975 6889999999876666666666555 456 89999999999976543 357899
Q ss_pred EEeecCCchhhHcC--CCCHHHHHHHHHHHHHHHHHHHH--------cCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 201 ~e~~~~~~l~~~l~--~l~~~~~~~~~~~i~~~L~~LH~--------~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
|||+++|+|..++. .+++..+..++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccc
Confidence 99999999999984 68999999999999999999996 599999999999999988 79999999999887
Q ss_pred CCCCc-----ceecccCCCccCcccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCC
Q 019241 271 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFF 321 (344)
Q Consensus 271 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~ell~g~~Pf~ 321 (344)
..... .....||+.|+|||++.+.. .++.++|||||||++|||+||..||.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 55432 23457999999999987522 25679999999999999999988763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=323.36 Aligned_cols=203 Identities=22% Similarity=0.383 Sum_probs=165.5
Q ss_pred EEeeecccCCeeEEEEEEcCCC---eEEEEEEeccc----chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 129 VVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.++||+|+||+||+|++..++ ..||||.++.. ..++|.+|+++++++ +||||++++|++.+. ....++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEE
Confidence 3578999999999999986644 36899998632 236689999999999 999999999998643 35678999
Q ss_pred EeecCCchhhHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceecCCCCcc-
Q 019241 202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY- 276 (344)
Q Consensus 202 e~~~~~~l~~~l~----~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~~~~~~~- 276 (344)
|||+++++..++. .+++..+..++.|++.||.|||+.+|+||||||+|||++++ +.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhcccccccc
Confidence 9999999988763 46788889999999999999999999999999999999988 78999999999876543222
Q ss_pred ----eecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 019241 277 ----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335 (344)
Q Consensus 277 ----~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~~~~~~l~~i~~ 335 (344)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||....+..+....+.+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~ 249 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 22467889999999887 78999999999999999999999999877666655555543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-43 Score=320.68 Aligned_cols=196 Identities=18% Similarity=0.319 Sum_probs=163.2
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEEE
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 202 (344)
.++|++.+.||+|+||+||+|++..+++.||||++.. ...+++.+|+++++.+ +|+|++..+..+.. .....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~-~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHS-TTSTTCCCEEEEEE-ETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHc-cCCCcccEEEEEEe-cCCEEEEEEE
Confidence 4689999999999999999999999999999999764 3346788999999999 66655554444432 2467789999
Q ss_pred eecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCC--CCcEEEEecccceecCCCCc--
Q 019241 203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE-- 275 (344)
Q Consensus 203 ~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~--~~~~kl~DFGla~~~~~~~~-- 275 (344)
|++++...... ..+++..+..++.|++.||+|||++||+||||||+|||++.. ...+||+|||+|+.+.....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 99776555443 469999999999999999999999999999999999998643 24699999999998754322
Q ss_pred ------ceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 276 ------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 276 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccc
Confidence 234579999999999887 7799999999999999999999999954
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=324.84 Aligned_cols=196 Identities=23% Similarity=0.455 Sum_probs=168.5
Q ss_pred CCCeEEEeeecccCCeeEEEEEEc---CCCeEEEEEEeccc-------chHHHHHHHHHHHHHhCCCCccceeeEEEccC
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH 193 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 193 (344)
.++|+++++||+|+||+||+|++. .+|+.||||+++.. ..+.+.+|+++++++.+||||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 377999999999999999999874 46899999998532 2456889999999995558999999999654
Q ss_pred CCccEEEEEeecCCchhhHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 194 ~~~~~lv~e~~~~~~l~~~l---~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
...+++|||+.+++|..++ ..+++..++.++.|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 179 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence 6788999999999998877 568899999999999999999999999999999999999998 79999999999876
Q ss_pred CCC--CcceecccCCCccCcccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 019241 271 HPG--KEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 322 (344)
Q Consensus 271 ~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ell~g~~Pf~~ 322 (344)
... .......|++.|+|||.+.+. ..++.++|||||||+||||++|+.||..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 433 233456899999999999763 3578899999999999999999999954
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-39 Score=299.46 Aligned_cols=215 Identities=25% Similarity=0.454 Sum_probs=175.9
Q ss_pred CCCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc--hHHHHHHHHHHHHHh----------CCCCccceeeEEEc
Q 019241 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC----------GGPNVVKLLDIVRD 191 (344)
Q Consensus 124 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~~ 191 (344)
.++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+++++.+. +|+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 357999999999999999999999999999999997543 366788999998872 36889999999877
Q ss_pred cCCCccEEEEEeecCCchhhH------cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeecCCCCceEEeCCCC-----cE
Q 019241 192 QHSKTPSLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR-----KL 259 (344)
Q Consensus 192 ~~~~~~~lv~e~~~~~~l~~~------l~~l~~~~~~~~~~~i~~~L~~LH~-~~iiHrDlkp~NiLl~~~~~-----~~ 259 (344)
......+++++++........ ...+++..++.++.|++.||+|||+ .||+||||||+|||++.+.. .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 666777788887765542222 1468899999999999999999998 89999999999999976521 48
Q ss_pred EEEecccceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHH
Q 019241 260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVKIA 334 (344)
Q Consensus 260 kl~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell~g~~Pf~~~~-----~~~~~l~~i~ 334 (344)
+++|||.+.... ......+||+.|+|||++.+ ..++.++|+||+||+++||++|+.||.... ...+.+.++.
T Consensus 172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 999999998654 33455789999999999987 789999999999999999999999995432 2356778888
Q ss_pred HhhCCCC
Q 019241 335 KVTTILD 341 (344)
Q Consensus 335 ~~~~~~~ 341 (344)
..+|+++
T Consensus 249 ~~lg~~~ 255 (362)
T d1q8ya_ 249 ELLGELP 255 (362)
T ss_dssp HHHCSCC
T ss_pred HHhCCCC
Confidence 8888764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.9e-27 Score=195.95 Aligned_cols=167 Identities=18% Similarity=0.217 Sum_probs=121.3
Q ss_pred eEEEeeecccCCeeEEEEEEcCCCeEEEEEEecccc---------------------hHHHHHHHHHHHHHhCCCCccce
Q 019241 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNVVKL 185 (344)
Q Consensus 127 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~~h~niv~l 185 (344)
+.+.++||+|+||+||+|++ .+|+.||||+++... .....+|...+.++ .|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 35679999999999999987 468899999875211 12345688889998 89999998
Q ss_pred eeEEEccCCCccEEEEEeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeecCCCCceEEeCCCCcEEEEecc
Q 019241 186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265 (344)
Q Consensus 186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~~~iiHrDlkp~NiLl~~~~~~~kl~DFG 265 (344)
+++. . .+++|||+++..+.. ++......++.|++.+++|||++||+||||||+|||++++ .++|+|||
T Consensus 80 ~~~~--~----~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 80 YAWE--G----NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EEEE--T----TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred EEec--C----CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 8764 1 269999999877643 4556677899999999999999999999999999999965 58999999
Q ss_pred cceecCCCCcceecccCCCccCcccccCCCCCCchhhHHHHHHHH
Q 019241 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310 (344)
Q Consensus 266 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwSlGv~l 310 (344)
.|.....+........... .-.+.+ . ..|+.++|+||..--+
T Consensus 148 ~a~~~~~~~~~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWREILERDVR-NIITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHHH
Confidence 9977643322110000000 001111 1 4678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.62 E-value=2.2e-07 Score=79.56 Aligned_cols=138 Identities=18% Similarity=0.223 Sum_probs=91.2
Q ss_pred CCeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc---chHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 125 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
+.|+.++..+-++.+.||+.. .+++.+++|+.... ....+.+|...++.+..+--+.+++.++.+. ...++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEE
Confidence 345555554445557899883 45666788887543 2345789999999886665578888887543 6678999
Q ss_pred EeecCCchhhHcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 019241 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------- 237 (344)
Q Consensus 202 e~~~~~~l~~~l~~l~~~~~~~~~~~i~~~L~~LH~-------------------------------------------- 237 (344)
+++++..+........ ....++.++++.+..||+
T Consensus 90 ~~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred Eecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 9999988765432211 112223333333333331
Q ss_pred ---------------cCcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 238 ---------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 238 ---------------~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
..++|+|+.|.|||++++ +..-|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence 126899999999999976 4556999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=3.3e-06 Score=71.61 Aligned_cols=132 Identities=17% Similarity=0.124 Sum_probs=85.4
Q ss_pred eecccCC-eeEEEEEEcCCCeEEEEEEecccchHHHHHHHHHHHHHhCC-CCccceeeEEEccCCCccEEEEEeecCCch
Q 019241 132 KVGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209 (344)
Q Consensus 132 ~lG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l 209 (344)
.+..|.. +.||+.. ..++..+++|.........+..|...++.+..+ -.+.+++.+..+ ....++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecccc
Confidence 3445554 6789985 456667889998777777788999999988443 236677877754 3567899999988665
Q ss_pred hhHcCCCCHHHHHH-H---------------------------HH--------------------HHHHHHHHHHHc---
Q 019241 210 KVLYPTLTDYDIRY-Y---------------------------IY--------------------ELLKALDYCHSQ--- 238 (344)
Q Consensus 210 ~~~l~~l~~~~~~~-~---------------------------~~--------------------~i~~~L~~LH~~--- 238 (344)
.... ........ + .. .....+..+.+.
T Consensus 94 ~~~~--~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 94 LSSH--LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp TTSC--CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred cccc--ccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 3321 01000000 0 00 011223333322
Q ss_pred ----CcEeecCCCCceEEeCCCCcEEEEeccccee
Q 019241 239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269 (344)
Q Consensus 239 ----~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~ 269 (344)
.++|+|+.|.|||++.+ +.+-|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence 37999999999999976 5567999998865
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=1.1e-05 Score=73.09 Aligned_cols=75 Identities=16% Similarity=0.187 Sum_probs=50.1
Q ss_pred EeeecccCCeeEEEEEEcCCCeEEEEEEecc----------cchHHHHHHHHHHHHHhCC--CCccceeeEEEccCCCcc
Q 019241 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP 197 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~ 197 (344)
.+.||.|....||++.+..+++.+++|.-.+ ....+...|.+.|+.+..+ ..+++++.+. . ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence 4678999999999998777788899996432 1224566799999887544 3466666654 3 234
Q ss_pred EEEEEeecCCc
Q 019241 198 SLIFEYVNSTD 208 (344)
Q Consensus 198 ~lv~e~~~~~~ 208 (344)
++|||++++..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 69999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.45 E-value=0.00032 Score=63.21 Aligned_cols=74 Identities=15% Similarity=0.178 Sum_probs=52.6
Q ss_pred EeeecccCCeeEEEEEEcC-------CCeEEEEEEecc-cchHHHHHHHHHHHHHhCCCCccceeeEEEccCCCccEEEE
Q 019241 130 VRKVGRGKYSEVFEGINVN-------TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF 201 (344)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 201 (344)
++.|+-|-.-.+|++.... ..+.+++++... ...-...+|..+++.+..+.-..+++++|.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEE
Confidence 3678888889999987543 345677887652 2334466899999999666556788888732 4899
Q ss_pred EeecCCch
Q 019241 202 EYVNSTDF 209 (344)
Q Consensus 202 e~~~~~~l 209 (344)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00019 Score=63.01 Aligned_cols=127 Identities=14% Similarity=0.162 Sum_probs=74.6
Q ss_pred CeeEEEEEEcCCCeEEEEEEeccc--chHHHHHHHHHHHHHhCCC-Cccceee-----EEEccCCCccEEEEEeecCCch
Q 019241 138 YSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLD-----IVRDQHSKTPSLIFEYVNSTDF 209 (344)
Q Consensus 138 fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~-----~~~~~~~~~~~lv~e~~~~~~l 209 (344)
--.||+++ ..+|+.+++|+..+. ..+++..|...+..|.++. -++..+. .+ ......+.+++++.|..+
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~--~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL--NHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE--EETTEEEEEEECCCCEEC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeee--eeeeEEEEEEeecCCcCC
Confidence 46899995 467888999999764 4577889999999884331 1121111 11 123456788898876432
Q ss_pred hh-----H------c-------C--------CCC-------------------HHHHHHHHHHHHHHHHHHHH-------
Q 019241 210 KV-----L------Y-------P--------TLT-------------------DYDIRYYIYELLKALDYCHS------- 237 (344)
Q Consensus 210 ~~-----~------l-------~--------~l~-------------------~~~~~~~~~~i~~~L~~LH~------- 237 (344)
.. . + . ..+ ......+...+...++.+..
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 11 0 0 0 011 11111122222223333332
Q ss_pred cCcEeecCCCCceEEeCCCCcEEEEecccceec
Q 019241 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270 (344)
Q Consensus 238 ~~iiHrDlkp~NiLl~~~~~~~kl~DFGla~~~ 270 (344)
.++||+|+.+.|||++++ . .++||+.+...
T Consensus 192 ~~liHgDlh~~NvL~~~~--~-~~IDFdd~~~g 221 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--P-MFVDLDDARNG 221 (325)
T ss_dssp CEECCSSCSGGGEEESSS--E-EECCCTTCCEE
T ss_pred ceeecCCCCcccEEEeCC--c-eEEechhcccC
Confidence 368999999999999754 3 58999998653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.85 E-value=0.0007 Score=58.68 Aligned_cols=50 Identities=12% Similarity=0.187 Sum_probs=32.8
Q ss_pred CeEEEeeecccCCeeEEEEEEcCCCeEEEEEEeccc-chHHHHHHHHHHHHHh
Q 019241 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLC 177 (344)
Q Consensus 126 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~ 177 (344)
...-.+.|..|---+.|+.... +| .+++|++... ..+++..|++++..|.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence 4455567778888899998643 34 5899998653 4566778888888884
|